<SEC-DOCUMENT>0000859737-23-000011.txt : 20230502
<SEC-HEADER>0000859737-23-000011.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502075208
ACCESSION NUMBER:		0000859737-23-000011
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20230401
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		23876654

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx-20230401.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41,d:cd78113a44f14cfdadfd32f75d6ce8c9--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:holx="http://www.hologic.com/20230401" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20230401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY18yLTEtMS0xLTEwNzk1Nw_760b1527-e1ee-4b3e-a253-5a95d3f1a3f9">false</ix:nonNumeric><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY18zLTEtMS0xLTEwNzk1Nw_68ecde69-b2e8-49d4-bd2f-f676825f78e5">2023</ix:nonNumeric><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY180LTEtMS0xLTEwNzk1Nw_53415caf-abb2-4743-a83d-266026e3d348">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY181LTEtMS0xLTEwNzk1Nw_c2d4ec31-d407-4676-9f27-25e351e2d79a">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY182LTEtMS0xLTEwNzk1Nw_5357edeb-da3a-4b2c-9ad9-d67eac6a2d60">9-28</ix:nonNumeric><ix:nonNumeric contextRef="i04aefe98ed524fa9b9e204dc0508b87f_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfMi0yLTEtMS0xMDc5NTc_975367f9-2d01-4884-834f-84b67dec7af4">P3M</ix:nonNumeric><ix:nonNumeric contextRef="i7c473319bb7c41ebbe6a91f325696f90_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfMy0yLTEtMS0xMDc5NTc_75643e74-0247-4fac-b008-ca52b301d1bf">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ibf681aba2c0745179379eda917259f24_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNC0yLTEtMS0xMDc5NTc_ae7c286a-ab0d-4851-b441-f298159a6e18">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="iae8494d630974166892e8a6e322ce2c4_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNS0yLTEtMS0xMDc5NTc_dd883d5e-d5fd-45c2-9a63-3009d99f45f3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i201acc12848f4295aca92e64a29fae3e_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNi0yLTEtMS0xMDc5NTc_bd15b435-ce00-4a09-888c-7994165d79d7">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20230401.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bdb4fc46664af8a84c1c523f7ace9c_I20230425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e15af082687422bbd21dc55ec8a2595_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb909bbe5f2540069cf207a78f1cb2e6_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7810cad7d02247f1b5f6e85c336e9c52_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e7edafb8449411a8c76ac568092157e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e73db97997e4106b0bc73a6ad117fa1_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728193aa1ef04e4885f20273a8721f30_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefb8d073427345198f8e66225de022d3_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d792fb77c74175a153de2fee725a92_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1312159d6804c03a112ae774c849cbc_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59ce45cfb8f644079576717c187966e7_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82f62b3f136743bfaea9f76d6dccb550_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f733818a0ef4bb196bde5377e392367_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b8515303b04633b81845a6340517a2_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673ceda2567b4fa094005314999c6692_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia85329a5af434956b507a245eec1e665_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b259872da0e4891b258402238020b91_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99199df891b54e60b263241f795a8011_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90312f39be0e4ef6b8f3efd53c5c985c_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c725645e1ff419d8af3688fb583ae78_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id04350ab7f4942d6aab89335886fa0e8_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee84ef7457ef44eeb536b6069b3b635c_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if17809e1aa754e809b00400ef2e7e9df_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d882caad56e40fca4cbee08e9438a1e_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08891923a5404211866f245155440f87_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ba07efafd444b4a850d6efce144fbbb_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaf436100d4049459a74792e8e6a0154_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb18f90afb34984ae954b76e9f109e1_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85799d0eb64349758943ccfaa1cd193c_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508b938b9bd04731a116a511304508d0_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e54d72ad324c54a434cbf20c7e1636_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3002622281154961926b0802bdcfa78d_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5f81fbde654721b420a4cceaa0f658_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203832cf31694163bdbf1410232cae9d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc29699290454610abbfbea53d3b09d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d95c79e50f4f2c96697ca8aac2736e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0326c94c4f849e78bc4ed1ba0305489_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6693a30bd6c4709a18368e12c88e1e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24c41465ac6b4629acc426e96781619e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81231f9a527e4841b03062694c05a420_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018c97cc9d50417598b74b0bc1e7d870_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66a35a33618446cb52289632d995392_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd87583fd904b4ea56862fe48bd6b48_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd73e1d3acb402da10be07c5fc515f2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e5484a0f4c43d3a4b5386b8dd0cdfe_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2dcc05bea314588b412a9f27a0d2096_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6643d03654fc4e74abb8215ae7099bc5_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27fb968480674498b86f260f5c557cd2_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86ced2c50224d87b806cfe2700e9451_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20558280389d4b6882132ba9b3803cd3_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59b200cdcd64399ac289fd7af196ea9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d2c2c178954ebd9a39527357d76c74_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84dfba6a6bc4632b38560142cba9e81_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ffef3244c874e85b508fa350a2554e6_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2168b403a0ee4e46af7c9636f54dfd4b_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d09a84e2db4fa7882cd618c44a4279_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c08c95f31c343c48236eb8ce8c31567_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b1e7bfe27e4e76be3bf69f2d53e02c_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f37682f6f5145a58f06d84f7b8e61cb_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9838ba0466484bb137158e7a1567da_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb0b1cfe7eb4bd1a09a13946bcd2bcd_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib398b6fc80d746a2b8ae5fc069cae6a0_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565fca98edfe40c8a7d74fcf1421de87_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65e97210e574278b454ce584c3cad8d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i099e7069f9c44890bb40a7afe3614761_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb7b04583b44661b5c05b7efe129429_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781a7f522edd4c4d951e77997571c15f_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24aec643f412452fb0caae5eef3a39d9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13676ccbf324673bdda7326d7f4f08b_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd32066656d441a86201c5e12956de1_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i619d5722b4ca48d6a5f05a12991734fe_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b1fa5ac56b84e7aabaa1944179b29a0_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbef055aeb94448c964ef00d2ce1fa7f_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf08815cbd2a48b4bf69282fcffa315d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if76e12316bf64558aad72df91e631bbe_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8f65bc9a643471eb4699958d5a56b0e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ec9d62d7b24c9aa3d020e9fd43fde0_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d3508f3a72645e19ce96e3f933f92e3_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2ddbfb01cc43e6ad631c8c163cf4c5_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeecee944b96477993784167af0ec4e9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c381398c324f19a228c262c54de902_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie61d3c1656c444e2af045a6884b5cd0f_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i387d4056e84b4ac180d2aa7e3393329f_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad2b30985d644f0a50a8cdc970d6f5d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12fc4260d3174dda9b586fb230fa8f91_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88ec2152274467d88041d6be4c30ff6_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58119cf2e18e4040ad7d0545f5502d37_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231da92875a34437a5282b675e6426d9_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18684c24e2714ec8a43866e747472e7c_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e11b702840946b7a882d86468c5c654_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i620f31a3d0b94dc7a06fa436a267fa09_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33460790b19b4a16b5c379ca34c18e06_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie287b34c173446e4b3ae5678053afeb1_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i349699c3313a4532a7a576011d54ac58_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8841fc4453d947b1abc6b677fcdf4c75_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1353f3f554864abca59c0d2acd652329_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32f4de0bdaca42439e9615354a987d7c_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb875e603fbc4fe1a1e9ca9acea597bd_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d1acff3bb149edaaf709f12e763dc4_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifceb9765ec71498ebc94cc6a41dfb085_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i071c0ae1705441148ac8e82637f13843_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab114a082dd4e6b82610ed0a84ed5ac_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db81a73fb034bce8b07cb4d54adb4d5_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e2dac027774b4fbe6ae5f2f7c513a0_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5940fd34036f48a8b0d1a0f4d3246913_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78d825bcee284151aa724fb0e57ab91e_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd73e2dccdf845d988743f5b2afd0a7c_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4160efde569446d6a70f5cb043ff5bed_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a2096ceff74f10ab7ea238449b6ebb_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i010f85da839c4f788ae3c9678dcfee88_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7435b5e546944ceabfd36aaed78afb22_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7cf0a8c804c43e78bbd2ecab53fa929_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddfb59c21d064a0095827e9fee15c650_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008fea210a79421792efe38c181b3afe_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38424d055ed4ce5b58b21cb84139032_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c824d2f804b4f8cbe8774772c549f65_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7bb65acf97a4446adca1cf306eb6abc_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic404fc96f0c64f51b5b4f5e6737f2d54_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie823dd7cc3af472b9bd804c6b639b007_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a312bb9f01c4777b32b902e8248d9cb_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i919b1976ae604ccd9ecae3f5a1044a6a_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e166105ee044f2891a1e4feecf8f137_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc35b3bc4774106ba45e0abe86067ab_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188645d6d3b14ab7bb87691db06a8205_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8a579c3edee4243a5457698bafb3ba4_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8a695c629c41f2bdb54152ed3a5cae_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7132a15dec44f3599d3ef99c1e30826_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d77f036b144ab2bf62c85dff6e86fc_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbd3e99c4b6349de8cdb1e8f0a2b6311_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc7b0243cde744aebbd25a510394a248_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie705a94ebd6c4795aff105e679f1be54_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b9944219eb46c087a0481d0206b4cc_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28bab2b9c104428e8c55999a506f0906_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f619cf4bfd430793d0539858960750_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc6d823fbbc94feab179d253e4be9aa3_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefac68ca0bdb40f387bdb4a775659af8_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i962c4b39ad9b43f789b8793465348724_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifff7e3a68df34606bf1106251ac4c25e_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i763fd5b73588457eaf359445f8e85c8a_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c2774c2d1e44689b12b1bf19aad67f_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0bef0470fb04031bd8d1f8ca4de2a26_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736cfdfe36b64ca6be804529485f2142_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd755a8928c347638dc5777e510229a4_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d2b38d322445518df9d6519589e24a_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe30b8b63776445486aad925dd9774cb_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00be1902f11b446090c0c094fcc5c85e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48755cfd484a4e62a2c8362de38c8b4f_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i327da3cafe3c4d0aa665e7ce8be8698a_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24dcaeab411b4af8a6f85a2871d1bbc9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0a871a4c3174df7933da7c6f14e608e_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i058c9fcddfcb4b1fbe11fc320f77993d_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6dda388f7b41c38ba9e6e639ffcccc_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05806bc883904e079e94fe4711a9df85_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694b9650b4154c7a9932f7c343e478ad_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904efd675fc84cb4a2bd864cdd35efb3_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364049c727f64c5fb9da068da0a5f058_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefff25e1fa9f4bf28ac85461fcab5263_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb1b8233acc4dc4b6b32e2401873bfa_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1344c7b5279d47b78b2c5cf3500112f0_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f792878945149fbaac1be5445470b02_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92c691696ff746668ac0cedf53217ef9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e8a0fe062b74f88bdbdc98402f1f734_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80ed6153920c41a589f4f344f8dc62d0_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44fcf0cfb084b098571baf1d7dead87_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04aefe98ed524fa9b9e204dc0508b87f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i7c473319bb7c41ebbe6a91f325696f90_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf681aba2c0745179379eda917259f24_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae8494d630974166892e8a6e322ce2c4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i201acc12848f4295aca92e64a29fae3e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd296de48514683a96ee90d09cf647b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb3334f07144b1eb56036eff778881d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i931efb624c5240ec87bbbb2d5e3977f2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e076bd0f834d7587361fc0c5740091_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd04ba0e0c14cbabfcf0fd0dbb55c00_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b47f9030b34b429bca8c704864b6a6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc0703bcc24f48e681cbcfeb3a9412ed_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i363eb4ee29e54e13ac0aefa0ccbb0a81_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7048c5fe4e141f89ff18d17889ef492_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia339d290baa7479185ee1c02c1479b85_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1e849e105045cc82813ffd84975071_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib76b381e70524c158eaecba0aab88c70_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0364527a074f269837eb697e13e3e9_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52cc5c24426b411f8a9f807c5312d497_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3611e0322f3842f69d4e5f89028d5c5a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad19bdd30714b10a58f86bc3fcc3d06_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide78313ff5a246378c00a3dc183d036a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f863ea4d044887a4fe175344a4ca00_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95a1ff83f2346e5bcbf04f2536fd2f8_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5abefbe66a5f4800a36fd4789769988d_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccdf15e8de9a4fc8a097e876e609f31f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4c567216914b23a257e8ed2e840c5c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ad1713d489f4ef1bef77718bdac89c7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c8339ad8e024acf93252e724b2036bd_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba44341dbd4c49499423c450d88a5f7b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c89a75c14ea452587934b85e1cfe79f_I20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b8baa43f0c444d9967f0f28cc75f205_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47652b3263ee45bebe444c08c403cbb7_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928aae1d79e6431e905c9e98405eefaa_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dfbd32be37f4246a381b2110a8442cf_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e135792ff2e44028a70fbd8451b5761_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4433cc201f8a4406b5cfe583df4d23c5_D20210926-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd53b814f8d744b79592fbfe99c58ed7_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic36e281c399144c0bad6cda43a4171d1_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife2f479793bd48879075f83c4865d01a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a2cca1bc72f4a3b8b4112b767c117da_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a5378b5efe4b46aadd68616949b0e6_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b57347bb632482e8fc7285916ac3e23_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5117d87aa771468c8a93f0fb49b868e5_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae729caa8b26476fa7e95ea535cdece8_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e366dca1317445a953da3bfcef32ef7_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf6687d788e4af28817964ae346e8c1_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id871579f75c04445a8b7aca98eb0f84b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a8fa6d9cf640188c80440fc42539f2_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7d8a9c2381e4790949255fbef7b39ab_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia56ec6c8bc03468eb039dadf25c0a74d_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8578d43dfaf64c8aa2e2a99308499a06_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3e905270394c109f6dc2a65bef2a27_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5618fbac4e2b4be5a3ede449c24b7524_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c7a85f58744f0b81a452662f16cdf2_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d817532d0340fc8fdcd0aa45fe0b08_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362f953e083846c1a0d8a19e3a3d35a4_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b0a0a905884991b094498a4388a459_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d18c480fcf4620b188b43833f9d17f_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26561fc220c41d4965d21fca20289a2_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736ad9f5dec146508d1fd621891e1303_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11c06da9d32e45ea8c28dfd12b49dd4f_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68128aa8157c4c17b7462201023eebd7_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2199bd16f8427796fe11603f851c83_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec05146aaacd45a6ba9801ae96e2a6b4_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4009b1b411c4bd99225528c5754c15a_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i246a361fa54143f2b5d14724951a2680_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88474659b3544a10823c37e769f86d35_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib471a4ccd83240ae9ed952772145134a_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie900720f8e2b4ab09db04fe14ad224e5_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i037d769c2b574a0992ee94f32441bc77_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i382a786b487046818da8713340a3f1bc_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AssetSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9277edbc6f004c26b5932c60235a6b84_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5860214d3274cd895e658c77224dcc3_I20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia270fd5f123248878a148a83df3feb24_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1013586a3c0b4067b24800f58a35dfe2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7733cefdaf04d268e9460397af1c814_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i388bb22d67bc405a988ad5c4cc5a8547_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i687a30dc10784ff3953d24ed83075533_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b069471a6fd4ce1941c6017866f9304_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784d2587627b47089f80bcf128fac206_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ea93c725c840b2ab4f76c58a3c62ed_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f4ede37bd5491c9c3625e94d0c9aa6_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee4564531536478f92ff8960a39160e7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c899443173415699ab4d5da5e77fc7_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542498cff24b4020926268c17c708196_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafea2d522ec04d37847e57b9cb641004_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic766fff5fd0948058ce9d491f9b85de5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b6e3f3bd25843a195f629f91c7fd0af_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i291463358b624afe8c68e32119ade5ec_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f153a4f042425ba023e92476fa0a40_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaad33fabd43401bb9e20fe1c59e848a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i734d4c683d694f60ad32d47670c8e8cb_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a435b609b8d4c0d8f1f4465429c3589_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6a7d62503b44f490049c2405cde9d0_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419d4edca16d4132b372c619b71876ba_I20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8865820575c4b57a1e17f866a521496_D20160304-20160304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-04</xbrli:startDate><xbrli:endDate>2016-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>holx:petition</xbrli:measure></xbrli:unit><xbrli:context id="i81a0b7eab81d4b8d92c778a4c8d79fcd_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i795d7b50270e46b59859da10505b600e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd31e84ed8143f59b13dce68511f55f_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3779670e49d4581b2341db1f4f31165_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3a076f8486b462fb0308507b0cfd5da_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8efcfc733c084819bce8abd34750c81e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e92370bf72c4c3d8b8468b47a8d76a3_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89bee2a95d3497e8c28b3ae3c70aeb6_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d2587dcb18149b982e88c5da8cb0cc7_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if545f6845c9f47cda87d291c6a78c44b_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ed81ad27694ec28082eac891f6d828_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a667398f82417da0b693cf783d30f2_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487840b9375544c692f3e4f0eafc76b6_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4a5ccb5a2d4441a9792f5dd886c64c_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3730699eecd4e8fb9c34c17fc322da1_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5aae5573096400bba7f7fdd96e479e4_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32fbb9fff77847d99951beda09715376_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67e3e8ebefcf44d38d43290015d3cc68_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20176e0cc3a546dab26b5191397f4122_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e3a20cda34489b926a83d90efbd85e_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bbf39abedf04a86aebfbda7cfdb9417_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50daa327fe0142aa9a9468a3e86f64c6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i509052b355f0473bb8198ebe916a409f_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a246129f343418eab464098000292bf_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a08777635e4e009b32b403ac06831d_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2eccbfd571a4ca7aa01513771ff388f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia577a32b749748fbbca9c17d38a8ea86_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3f922b1bdf4d05b948c12d6a48fae3_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb0eac28104f433fa408c7b9929c8afb_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i522660b505a2425fb1ae75796bfa1231_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ec6b91f8dc4e839b0621fa03ea273f_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia326a75496cf4845bd1f54f9ac1dd86d_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf55613aebd4ac69743fad69a456a00_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa97bebc3b004733b9c34994ac8eba59_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5108570aa8d24fd39f37539e9a93e166_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4425324e9249c3b78b220d544a2a6e_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56c17ccb48574e919a33ce08e5de772b_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0da1df1fe1a44d4bcb27d37cff8897a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83b89bbba274da1aecdd2d283d1ce13_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa02d3fe1f124afaa799f62caa9b7a35_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eeb9ddbf5a34bb3a14921940aad31a0_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id601e4f7392c49f69fb44fca0c219a32_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61146379fc1346a09fc79ae328fc4ae7_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987c4cf9a87c4b33a5d8acfe456b5212_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5d286446e24832a9b09dd26e54365c_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6940db18e044ac4baf19aa208d8ab33_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1505009eac544214a4c5d2a5083d4b87_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c33a8795c3a41f5bd50f90ed5b9bf52_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia73b8a87766948a89773af45de8aa1a2_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib59e7423fc3348d2aba0bd00f14d79a2_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69214a927e6a42459ef14fb9247a6f7c_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d97279b97e3493bae5fe07e0a15dabf_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e39021ecd254dd09befad99c3986073_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07828dc44634020a4b14b73f7eb87fa_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f748d0709e6431ba2b044bda85c7b9d_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib179c1e06a7443498a0049053c6f4bce_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9059edfb45a4a2d86a83a32fbb97888_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i998a08b240cb4165815a4c0f245cb61d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2dc025fcef4752948c5b989d73d843_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d03d024a12410989ca0f3bd337f2c3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idad017932b214b8bb1c244596a2c3da4_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98fa1a0f46224950aca1017cb9727897_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26556cf1cbe64603999108ceccd4b8c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i716db929cf324a8bba183dfc7e6ce250_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6fe4337c2984c3d86c299d64abafdc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f066bb0ba54024856a9b5805b1de7c_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36f522d615d45cc9db23bf02926e03d_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb87637671c4962a157d8c69ffb2d58_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc79822f08d45ccada45b5d08c85f45_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4577c73735428b8f48f2233c6a5b4c_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4f5794ab1cc4d90b0150fded4465f9d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de6ecf9ab0b44ac88fad82530f8c45d_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9c6bece29543538e4949188c1b8250_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08795cf6d72a47e39f4e264449f2e14d_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib439241bfa8c49b394aef2e2769df894_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ca154a812442e69660b5624f4c20c1_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1f163e64434b4098d3210b8c8872a1_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic417b6f69d4a4c8f8db217c37f35a4c6_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i975de9ea5e4c4452bb7f5ce1b9e42fac_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f082150b16640738cb5d6c0f5be0de9_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f11753d84724189a8eb0ac0a40c5e1d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b24c3fbef44f539ea8da6b56c6635e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8947efb99844ba8ea929d65eebcd7d_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie52504be379e47e3a03f6ea3ee3b79fb_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87488652d2ac42b786bc94af875d7063_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17798170e5634c5681bad6fa53526f87_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4386093d3b87463587e092da86bad387_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038a9776dfcb49e8b6ae15ed7ba884f7_D20210926-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i176f6f8fef46496b9bd2ba8947704790_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f431b6d0dae4178a459f78b51529416_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c5c4ff0e55242cd99cce7ae6bc9417b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93ac80af1864da895ea77544df73563_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i564316675084451483c816bd42aec061_D20220925-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg1_5f3ec55a-c5f4-4633-a23a-97f46455cbfe">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;__________________________________________________________&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6NDI2YzRhNjZjMjI0NGU0NWE2NWE2ZDQ1YmJiZWRlMTcvdGFibGVyYW5nZTo0MjZjNGE2NmMyMjQ0ZTQ1YTY1YTZkNDViYmJlZGUxN18wLTAtMS0xLTEwNzk1Nw_f7261090-7fd1-4374-92de-4579b28657f5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yNjA_bd02df8e-b2f1-4a29-8e0d-1419733e1b7e">April&#160;1, 2023</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6MzUyN2M2NzNhYzc4NDU5MjliNjZiOTVhNjc5ZWE3NzMvdGFibGVyYW5nZTozNTI3YzY3M2FjNzg0NTkyOWI2NmI5NWE2NzllYTc3M18wLTAtMS0xLTEwNzk1Nw_33e5a826-5ad0-4cfd-a87f-fbfe621fa30b">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg2_7cda7d01-a5ef-4e26-976f-6d712eed4a09">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgx_8c04cef0-ff29-4eef-92bb-8d6c3a16955f">HOLOGIC, INC</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8wLTAtMS0xLTEwNzk1Nw_8c38fc51-d229-4f14-b9c2-d2879d0ea841">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8wLTItMS0xLTEwNzk1Nw_337d7df4-1feb-41e0-9079-ec80cbf27b27">04-2902449</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8yLTAtMS0xLTEwNzk1Nw_63bf32b0-82e4-4ea1-972e-0e63c39ba17b">250 Campus Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8zLTAtMS0xLTEwNzk1Nw_4aff1176-b225-4b3b-8dd8-8abb564fe772">Marlborough,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV80LTAtMS0xLTEwNzk1Nw_6b710717-0edf-4f23-81a8-67620c205c6f">Massachusetts</ix:nonNumeric><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV80LTItMS0xLTEwNzk1Nw_1ba4f2c1-2a45-4307-9e35-081ad5ebadf6">01752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgy_84eb516a-c6fd-48f7-ad47-48599cbaaa8d">(508)</ix:nonNumeric> <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgz_34f2afbd-a61f-449f-96ff-b327750d3b91">263-2900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTAtMS0xLTEwNzk1Nw_5e368464-8ac8-489d-8f01-49a70aac6072">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTEtMS0xLTEwNzk1Nw_719d693a-7b72-4d44-a098-0872d57820f1">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTItMS0xLTEwNzk1Nw_9de673d5-0aaf-4253-8bc0-d423b686d2e6">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjc5_69b5adcb-f606-4dbf-a4d1-26c5973ad1e9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg0_1d4b92ca-2832-4361-8a95-a5927f9cc8e9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8wLTAtMS0xLTEwNzk1Nw_dabe2492-6a33-4429-8ba8-626c3af354ec">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8xLTYtMS0xLTEwNzk1Nw_9c1813c2-4e55-4057-9265-81cf93f60bb8">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8yLTYtMS0xLTEwNzk1Nw_f739d4da-327f-4237-803a-2e71c08ca99a">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgw_2bafceea-2655-4cf2-8b65-e40573fe9b49">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;25, 2023, <ix:nonFraction unitRef="shares" contextRef="ib9bdb4fc46664af8a84c1c523f7ace9c_I20230425" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjAw_b3bef8e0-f4ad-48d4-b835-6228b243eb6a">246,118,192</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_13">Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_16">Consolidated Statements of Income for the Three and Six Months Ended April 1, 2023 and March 26. 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_19">Consolidated Statements of Comprehensive Income for the Three and Six Months Ended April 1, 2023 and March 26, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_19">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_22">Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_22">April 1, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_22">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_22"> and September 24, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25">Consolidated Statements of Stockholders</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25"> Equity for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25"> and Six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25">April</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25"> 1, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25"> and Year Ended September 24, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_28">Consolidated Statements of Cash Flows for the Six Months Ended April 1, 2023 and March 26, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_28">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_97">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_118">43</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_121">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_124">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_127">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_130">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_133">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_136">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_139">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_139">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements (unaudited)</span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy0xLTEtMS0xMDc5NTc_d8d65700-a127-4f23-b68e-17bf70a919ac">837.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="holx:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy0zLTEtMS0xMDc5NTc_ef512525-8d92-47a8-b897-da8d8a66779c">1,268.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy01LTEtMS0xMDc5NTc_2da6931e-e286-4cdf-b66a-75198ae55438">1,723.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy03LTEtMS0xMDc5NTc_64ec7727-7cfa-4b4d-842b-2672798681e2">2,571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC0xLTEtMS0xMDc5NTc_2c7310ec-802a-4b77-b11f-30b9a4756b8e">189.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC0zLTEtMS0xMDc5NTc_dc5deab6-c112-4d2d-a7a1-3d0fd5208609">167.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC01LTEtMS0xMDc5NTc_6fc383a7-c2bc-43d0-bd7b-dfe0622d1ade">376.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC03LTEtMS0xMDc5NTc_9ce03b71-d5f9-4bd7-8566-f725cc34d0a2">335.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS0xLTEtMS0xMDc5NTc_62f378ba-02a7-4a91-abcb-c372ff19ccdf">1,026.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS0zLTEtMS0xMDc5NTc_89c4c246-8a90-458d-8681-049cdf5ee7fa">1,435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS01LTEtMS0xMDc5NTc_bfde4058-d804-4a08-a265-774b09ec1335">2,100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS03LTEtMS0xMDc5NTc_56884f70-36b0-406d-8af2-bee3a0f40cbc">2,906.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy0xLTEtMS0xMDc5NTc_161495f3-8420-4939-aad5-819b8233fd7e">292.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy0zLTEtMS0xMDc5NTc_e55cb2de-5bb0-4722-a8c0-126a36c275a9">322.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy01LTEtMS0xMDc5NTc_648f69a8-259e-4be6-8238-956b2ebd8f60">588.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy03LTEtMS0xMDc5NTc_30b4b256-85cc-4b50-bab5-896fc43c5daa">640.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC0xLTEtMS0xMDc5NTc_486804f6-f335-4765-9e2b-cb9ed66649d5">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC0zLTEtMS0xMDc5NTc_94c97dc3-ff93-48d9-9d1b-2965148b6c4e">72.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC01LTEtMS0xMDc5NTc_fca18146-aa21-490f-bd1a-7e8336f0c2b1">107.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC03LTEtMS0xMDc5NTc_31861bdd-6b48-4755-bcb7-6e28a97ed0d5">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtMS0xLTEtMTA3OTU3_789f42d7-56af-4d51-a653-2efd60fe680e">96.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtMy0xLTEtMTA3OTU3_91471bb7-0a93-4138-8a0d-9c8ccef77568">94.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtNS0xLTEtMTA3OTU3_1766b533-94f5-4ba1-b422-35b6c2e219a0">201.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtNy0xLTEtMTA3OTU3_0d7b2eb7-6b8c-4d77-86bf-5599e51fcb89">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtMS0xLTEtMTA3OTU3_adcbe472-bdfb-42c6-af04-f3eb45185c1d">585.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtMy0xLTEtMTA3OTU3_5d952f00-f6c7-4024-a4ac-be69c2739b52">946.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtNS0xLTEtMTA3OTU3_b45e47a0-e847-483f-bd79-7e45cf90e795">1,203.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtNy0xLTEtMTA3OTU3_783b9262-0722-4857-98c2-fe1a08c03af2">1,932.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtMS0xLTEtMTA3OTU3_69b7bac1-1ef4-4d26-9620-4187540476c7">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtMy0xLTEtMTA3OTU3_3e1d18ef-25b3-4f2d-a370-24e46d13c5e6">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtNS0xLTEtMTA3OTU3_e544ed62-743c-40f5-b623-b3f4c1c3d08a">148.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtNy0xLTEtMTA3OTU3_d7cfc034-25d8-4fa2-8a09-2df7730dcf28">142.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtMS0xLTEtMTA3OTU3_73f16747-2673-498c-ba1d-835726f17bd5">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtMy0xLTEtMTA3OTU3_3ea3c9f6-1edc-4d9e-b273-4c67c543972d">171.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtNS0xLTEtMTA3OTU3_cec75862-672e-4c83-9b07-64afc918a15a">305.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtNy0xLTEtMTA3OTU3_8ebd5067-24c2-4ecb-9bce-c24b8504f25d">318.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtMS0xLTEtMTA3OTU3_4b67d47b-f399-4a9b-9678-17659b2f9fa6">100.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtMy0xLTEtMTA3OTU3_a944fe91-86ff-4860-a2b3-465655910edb">100.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtNS0xLTEtMTA3OTU3_79185d96-a191-45f1-ba15-f1bc8b03854c">209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtNy0xLTEtMTA3OTU3_40fb03e2-63f9-4830-b7b6-95ae86034abc">218.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtMS0xLTEtMTA3OTU3_a97b75a4-7da0-46b8-8115-f84126df27df">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtMy0xLTEtMTA3OTU3_31587ecd-ac1a-4596-b083-d29a6a09095b">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtNS0xLTEtMTA3OTU3_d09e4773-e80f-49cc-ae70-dc216d5dc5b7">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtNy0xLTEtMTA3OTU3_6eb01a4a-986d-4429-b2f1-fd56cd3da340">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktMS0xLTEtMTA3OTU3_40f2da86-0c25-48e5-a090-1b949b4cdbe1">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktMy0xLTEtMTA3OTU3_e5b9d8ce-32bf-442c-8698-a1b73e998eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktNS0xLTEtMTA3OTU3_64cac5ab-c37c-46e4-a4e0-039340b2a34b">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktNy0xLTEtMTA3OTU3_1581be58-dc8c-4c72-b54c-d102325621ed">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItMS0xLTEtMTA3OTU3_1f9774f7-2549-4806-9578-71ce7e509f0e">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItMy0xLTEtMTA3OTU3_31955d6a-ff13-4c14-9aae-17a05eb210d4">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItNS0xLTEtMTA3OTU3_ec226c47-7a7c-4979-a35d-083a52500017">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItNy0xLTEtMTA3OTU3_0334869f-662e-4242-8707-911e1655577c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtMS0xLTEtMTA3OTU3_74ec36bb-94dd-4bfd-9151-376f99e1fa73">313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtMy0xLTEtMTA3OTU3_3491fed7-af81-4a2e-a02d-c20f16fa484d">352.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtNS0xLTEtMTA3OTU3_4a82239e-ff18-4bac-9b54-0afdfec00f3b">669.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtNy0xLTEtMTA3OTU3_317ee6fc-8995-4167-a87a-ed8fa6f36480">697.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtMS0xLTEtMTA3OTU3_ac96a0d0-d0ff-4c5a-ab44-89b365fb449d">272.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtMy0xLTEtMTA3OTU3_b8c5bbde-a35b-4ca8-91d8-f6e566b7b0ef">594.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtNS0xLTEtMTA3OTU3_a04013f2-c2f1-428e-912f-c2b47fcecaac">534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtNy0xLTEtMTA3OTU3_c60a2c5f-b27b-4d5d-b7fc-2a5a47a2df6f">1,235.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtMS0xLTEtMTA3OTU3_4b60cb8f-5998-4c79-8068-bca4bb768bb9">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtMy0xLTEtMTA3OTU3_92e66964-d580-49cb-9f03-789e27e6d062">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtNS0xLTEtMTA3OTU3_1a018b4c-e019-427b-9a69-054a2e2edc7c">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtNy0xLTEtMTA3OTU3_a90f160f-179d-420f-af16-495e4e2257ff">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtMS0xLTEtMTA3OTU3_5ce20a38-3cf9-46f6-901d-156e01795147">27.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtMy0xLTEtMTA3OTU3_3f2a411f-8e17-4758-b045-42d980b07944">22.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtNS0xLTEtMTA3OTU3_016bd848-e5d7-4ed0-bf36-1773fc41b5cd">55.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtNy0xLTEtMTA3OTU3_37ea356a-f5eb-4f5c-af9e-6ef2b6ef1413">48.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctMS0xLTEtMTA3OTU3_b9531184-b2e5-4a0e-b26b-1eb94f7760ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctMy0xLTEtMTA3OTU3_8e2f3854-fc20-42e9-97a5-afddbda9aa57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctNS0xLTEtMTA3OTU3_2f800600-e417-4f87-9d18-16ff91c2691c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctNy0xLTEtMTA3OTU3_33f2bfff-aef5-44b3-a79f-85df1fdc8cbe">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtMS0xLTEtMTA3OTU3_2f5f0fcd-3b83-4371-b10f-1c8858529ba8">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtMy0xLTEtMTA3OTU3_66c192ea-08d3-4f0c-a71b-56b6577367b5">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtNS0xLTEtMTA3OTU3_ddd592e1-fb3d-4c44-89ab-033c53cc297b">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtNy0xLTEtMTA3OTU3_da2ea8a7-74a9-4110-aee0-08e9ba3c8b26">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktMS0xLTEtMTA3OTU3_93201142-41b9-4797-bbf2-830eb8f725b9">279.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktMy0xLTEtMTA3OTU3_d28e73db-f879-4ea5-8573-b1123ebaa95c">574.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktNS0xLTEtMTA3OTU3_5ddbd3e7-1c61-4bb8-8ffe-c2fc19e12719">518.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktNy0xLTEtMTA3OTU3_7bb953dc-bfeb-484a-be42-31347ba03b39">1,196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtMS0xLTEtMTA3OTU3_e549d88e-c95a-4fa7-9a80-bbcd4cc1c639">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtMy0xLTEtMTA3OTU3_516752e7-cfec-47eb-af26-88991008c56d">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtNS0xLTEtMTA3OTU3_1ccb7de9-8d20-4878-a5c7-126358462c51">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtNy0xLTEtMTA3OTU3_cfb0fd5e-bf26-4ee6-989c-0be83d0d0f95">241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtMS0xLTEtMTA3OTU3_720efae8-7517-4e66-90ad-37285f371d98">218.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtMy0xLTEtMTA3OTU3_f1157b2e-43aa-43f1-a0cb-cf75d03d8308">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtNS0xLTEtMTA3OTU3_0ffec2be-dd15-4273-9135-a2bd94773b5c">405.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtNy0xLTEtMTA3OTU3_4e1d1182-b876-4bcc-b687-514f9cb82f16">954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtMS0xLTEtMTA3OTU3_5ba10299-5925-477d-ad30-1dd51b5d6c5e">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtMy0xLTEtMTA3OTU3_2eb982c7-1d6e-4980-8f6d-962d608a2dee">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtNS0xLTEtMTA3OTU3_bce594db-7d1f-438f-ba5e-c0db8bd5a835">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtNy0xLTEtMTA3OTU3_d030d3e3-ba47-4221-a5b1-3eb2e711dd00">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtMS0xLTEtMTA3OTU3_b6a023d2-0ff5-4a55-aade-b8da94ff20ad">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtMy0xLTEtMTA3OTU3_be168c21-2838-411f-8e90-772151ef9ae2">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtNS0xLTEtMTA3OTU3_756d603c-7ce8-4e50-bd16-3d46e17fd12b">1.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtNy0xLTEtMTA3OTU3_bd57ae97-fa1e-4f4c-a50c-145e9cb3ba26">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtMS0xLTEtMTA3OTU3_efb9adcf-902f-42e8-bdfd-e83a3445b6ee">247,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtMy0xLTEtMTA3OTU3_7117924b-c4dd-449c-9d46-f8bca6c73816">251,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtNS0xLTEtMTA3OTU3_37b8f7df-7dd8-421f-b4dc-0d31db6dc7f2">247,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtNy0xLTEtMTA3OTU3_f43f2cb4-c088-46a8-8b9c-db0c461f2c28">252,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctMS0xLTEtMTA3OTU3_da8cd906-fcc4-4b45-b936-574149d4cf2c">249,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctMy0xLTEtMTA3OTU3_25fc4599-d329-406b-9bdc-406def7003ad">253,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctNS0xLTEtMTA3OTU3_b37ebcfb-c746-44dd-b68d-da373eda72fe">249,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctNy0xLTEtMTA3OTU3_76b56e80-69ed-4f97-8126-4a945276b855">254,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi0xLTEtMS0xMDc5NTc_aef3f230-df32-48cc-a88c-072f101fb996">218.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi0zLTEtMS0xMDc5NTc_bfcb4989-eb86-43b4-9291-7607db818cd1">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi01LTEtMS0xMDc5NTc_859cae86-b150-4a07-8db0-8b0fcb104e90">405.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi03LTEtMS0xMDc5NTc_4e1d1182-b876-4bcc-b687-514f9cb82f16">954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy0xLTEtMS0xMDc5NTc_2dc739b2-e6f7-4f70-95a7-cde88747fe9b">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy0zLTEtMS0xMDc5NTc_77a1c201-1a76-42e7-9a89-3285c8d13a4b">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy01LTEtMS0xMDc5NTc_f9f04d5d-23a0-4504-9bdc-5814792b379c">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy03LTEtMS0xMDc5NTc_507e0551-d55d-40c0-8ea7-05f23d30716f">72.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate swaps, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="1" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM185MA_3f543889-4dd1-4b95-848a-57eabfb55b1b">2.0</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="1" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xNDM_a759c0e0-5241-4171-a9cf-a42429b3acad">2.9</ix:nonFraction>) for the three and six months ended April 1, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="1" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xMDk5NTExNjI4NzUx_3d728a98-19cb-46f1-bfa5-bf1261f43a13">6.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="1" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xMDk5NTExNjI4NzYx_4e7daead-298a-4da3-851b-f66411608db1">9.1</ix:nonFraction> for the three and six months ended March 26, 2022.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other comprehensive income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS0xLTEtMS0xMDc5NTc_14eeab24-baa0-46e7-9f46-6629400d4a94">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS0zLTEtMS0xMDc5NTc_7e621169-c162-4e69-86f4-a211e3feac06">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS01LTEtMS0xMDc5NTc_22bf3814-3e19-46d1-998e-32fed2ff7c26">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS03LTEtMS0xMDc5NTc_40ee8ca5-d71a-4bb3-a41c-8d411b801167">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtMS0xLTEtMTA3OTU3_c4278411-9730-4595-8cb2-affc818062e7">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtMy0xLTEtMTA3OTU3_e5d60432-0c2b-44cf-ad71-0f93f45884e8">15.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtNS0xLTEtMTA3OTU3_1c754f40-75d4-4728-a243-816d5c6a81a8">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtNy0xLTEtMTA3OTU3_d8d48ce5-c81d-4509-937f-afb7f344d9a8">45.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItMS0xLTEtMTA3OTU3_9e9db360-38d5-40c5-b309-5228b8c38f89">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItMy0xLTEtMTA3OTU3_0fddb32e-5e40-4a8f-9eb3-b37a3597a936">440.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItNS0xLTEtMTA3OTU3_4a0267e9-37e4-4387-8a92-8ce92962db94">525.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItNy0xLTEtMTA3OTU3_1526ab2b-8bc5-4998-96b0-c166d5ed769d">909.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMy0xLTEtMS0xMDc5NTc_63f9bedd-4eb8-4292-8c08-55447aa3c36d">2,582.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMy0zLTEtMS0xMDc5NTc_6139babb-b93b-4011-8e57-316a1835ffab">2,339.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNi0xLTEtMS0xMDc5NTc_44bd3b08-af54-4ab4-a1dd-298dbf111b04">714.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNi0zLTEtMS0xMDc5NTc_97e6d046-3863-461c-b611-dcf21a9e98f9">617.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNy0xLTEtMS0xMDc5NTc_b7c24e07-a779-40fc-8fe3-66121c18f5a7">687.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNy0zLTEtMS0xMDc5NTc_363fe0f3-f3f8-456a-b317-fb5d3e5fa1a0">623.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOC0xLTEtMS0xMDc5NTc_26231a68-479f-494a-bde2-6e4af1ee8640">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOC0zLTEtMS0xMDc5NTc_1fd8be13-258a-48d2-80bb-d55103480aa2">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOS0xLTEtMS0xMDc5NTc_08e059f0-bc44-4494-a2b4-b43f7db4cd62">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOS0zLTEtMS0xMDc5NTc_84010f01-0bbb-4161-954e-bb4b552b7844">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTItMS0xLTEtMTA3OTU3_3ddce4b3-9829-45eb-9f9a-cfc38d94d202">4,211.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTItMy0xLTEtMTA3OTU3_34512c81-1c11-4785-ba70-3e95dd4f48c0">3,862.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTMtMS0xLTEtMTA3OTU3_895c6a1a-1c3a-4e60-bdcb-a3d422db1c6f">497.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTMtMy0xLTEtMTA3OTU3_7ec01d3d-0fa8-472d-868c-a2dd9e651553">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTQtMS0xLTEtMTA3OTU3_1df97cb1-9c0b-45fa-883d-16b1737fb274">1,202.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTQtMy0xLTEtMTA3OTU3_1bd5b5da-3380-477b-a5b6-ca0c91aaf2f6">1,280.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTUtMS0xLTEtMTA3OTU3_27b7bd29-638c-4bf7-a21f-70ec91286646">3,296.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTUtMy0xLTEtMTA3OTU3_5adfac21-2de7-4056-a7e0-daa4a2f4fceb">3,236.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTYtMS0xLTEtMTA3OTU3_7bad095c-cba3-40f8-a8f3-7fce0c16070f">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTYtMy0xLTEtMTA3OTU3_d775aa79-ce90-450d-8b5d-9722bd2ed175">210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTctMS0xLTEtMTA3OTU3_495e57f4-55a8-4915-bcfd-250bafa502b5">9,448.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTctMy0xLTEtMTA3OTU3_da652f33-250a-4109-82b8-c7668f3df9ad">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjAtMS0xLTEtMTA3OTU3_f6e7d5c8-e6cd-4242-97d0-95ee6cbcef1b">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjAtMy0xLTEtMTA3OTU3_67b11007-e21f-47c4-972e-9182d081e84e">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjEtMS0xLTEtMTA3OTU3_513b8964-ea65-4c7b-ad18-b241f6f641b5">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjEtMy0xLTEtMTA3OTU3_f1d30c37-a36d-4f13-b94c-4c1e3be233de">197.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjItMS0xLTEtMTA3OTU3_00360ea3-9617-4ec1-91c2-6d9ca555ac2a">508.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjItMy0xLTEtMTA3OTU3_0b019e7f-c8df-4c32-b990-e5863fda802f">535.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjMtMS0xLTEtMTA3OTU3_07175207-70b5-4d33-a61d-7a318a4f597e">230.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjMtMy0xLTEtMTA3OTU3_4cb51d17-ddaa-448b-a699-d1cb27ea1b58">186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjQtMS0xLTEtMTA3OTU3_877a0d62-07f4-4b30-989f-1d9446ef32ea">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjQtMy0xLTEtMTA3OTU3_24da4027-482e-4243-ada1-d57e5fe5de1a">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjctMS0xLTEtMTA3OTU3_5039c38f-992d-4870-b2a1-70d68f09d507">955.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjctMy0xLTEtMTA3OTU3_491ae0b9-e794-4e91-9e8b-14969aff56f0">937.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjgtMS0xLTEtMTA3OTU3_8c9df385-4494-45c6-8031-634369eebf88">2,797.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjgtMy0xLTEtMTA3OTU3_ab5eefe7-052b-4a69-8c64-c699e1b5f651">2,808.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjktMS0xLTEtMTA3OTU3_52099d6e-56e9-4a99-87db-fdee49fb457c">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjktMy0xLTEtMTA3OTU3_d0f3f95e-8e00-40b0-a9d2-3b18bdfc94e8">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzAtMS0xLTEtMTA3OTU3_15a2c338-3c21-407f-8fa9-508d6209d2fd">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzAtMy0xLTEtMTA3OTU3_0ae310ba-86c8-4742-b930-7433c25e9a00">90.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzEtMS0xLTEtMTA3OTU3_1a80ad75-55e4-4e1a-92fb-2cb19772f81a">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzEtMy0xLTEtMTA3OTU3_5a32b292-fb02-4998-b914-b0164ccd68f2">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzItMS0xLTEtMTA3OTU3_53f6a64d-5495-4ec8-9d02-89a442e0a0a3">332.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzItMy0xLTEtMTA3OTU3_7311c947-bd05-4665-83d5-413bc4668f67">330.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMjE_04a66cfc-537c-4e9b-a5bf-dc86885d2e56"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMjE_e2e3a3ef-df44-4607-bdc4-3467ae2431ba">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMzY_c547b25e-a1a5-41db-8424-aae7a58ef865"><ix:nonFraction unitRef="shares" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMzY_f8d965dd-f235-44f6-b370-fe10fbf54e3a">1,623</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfNTg_0875f0c6-d27d-4618-b7ec-b9345cef74fe"><ix:nonFraction unitRef="shares" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfNTg_f9e7bd71-6b41-48c9-9ad4-e2647b2e45a4">0</ix:nonFraction></ix:nonFraction> shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMS0xLTEtMTA3OTU3_4e460c8b-afec-4376-8f70-016b7534f643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMy0xLTEtMTA3OTU3_c39ce673-315e-4303-b415-7c2171f031b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMTg_3a511388-7735-424a-8682-e56d15f1437a"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMTg_42ab19bf-c185-4fda-afb1-19f7dfaf52a6">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMzM_0f63498f-ef7b-4ec1-8c37-41f19409635c"><ix:nonFraction unitRef="shares" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMzM_32308ade-b7c1-44db-beb7-cbcdfc80d8d1">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfNTU_b831c0ae-4708-4ccf-b676-69bb6870ac85">299,676</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfNjI_abd8881c-2539-448b-9df6-f02fb0bf2962">298,533</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMS0xLTEtMTA3OTU3_9361cbf0-a239-4574-9df4-fa3abe51dd4a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMy0xLTEtMTA3OTU3_83be3495-b775-4278-b7eb-8fa9cb9d3695">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzYtMS0xLTEtMTA3OTU3_aa819a82-668e-488a-9ed2-0436639f4342">6,091.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzYtMy0xLTEtMTA3OTU3_c2a05e01-dc2a-43cb-a312-40ef91cca78b">6,042.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzctMS0xLTEtMTA3OTU3_556cfbc4-fb1e-4830-88ce-abddf8084202">2,006.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzctMy0xLTEtMTA3OTU3_d54e3cbe-f195-495d-a12b-6f77314e99cd">1,600.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGM1NTUzMWY0NjU0NDMzOThlZDI5NDU4YjY1ZGIzMjRfMzA_73a1617c-c917-4f54-9222-59ec0e7b46d0">53,566</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGM1NTUzMWY0NjU0NDMzOThlZDI5NDU4YjY1ZGIzMjRfMzc_a337e865-69fa-4d37-b7ac-5830edbf9790">51,401</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMS0xLTEtMTA3OTU3_0efe7665-0e26-43f0-8d83-e91bd00c51ff">2,681.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMy0xLTEtMTA3OTU3_c63d3dfc-da7c-485a-87ef-98104d43fefd">2,531.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzktMS0xLTEtMTA3OTU3_997a8918-5e08-40c2-8b2c-c9af4186cd1f">118.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzktMy0xLTEtMTA3OTU3_861ff90a-f19c-4fd6-b557-a34491645948">238.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDAtMS0xLTEtMTA3OTU3_b796aee7-561d-4f0b-a95e-a3652ab0d968">5,300.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDAtMy0xLTEtMTA3OTU3_7aaea4d4-5986-497a-91c9-99f93331716b">4,876.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDEtMS0xLTEtMTA3OTU3_04c5d287-b3de-4049-8389-16582f66c97b">9,448.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDEtMy0xLTEtMTA3OTU3_c7c518e5-f6cf-4b35-9c8f-01e899273b97">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.980%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb909bbe5f2540069cf207a78f1cb2e6_I20210925" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTItMS0xLTEwNzk1Nw_b63c0627-7416-48c4-ada5-e7cc135e7de8">297,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb909bbe5f2540069cf207a78f1cb2e6_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTQtMS0xLTEwNzk1Nw_e4047d39-d3ca-4d6c-b5b3-b87488666af3">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7810cad7d02247f1b5f6e85c336e9c52_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTYtMS0xLTEwNzk1Nw_1048de00-c91f-4345-a98b-8915595b5e9b">5,965.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7edafb8449411a8c76ac568092157e_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTgtMS0xLTEwNzk1Nw_a11758d1-7eda-4087-99df-0c0e04b0b4c5">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e73db97997e4106b0bc73a6ad117fa1_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTEwLTEtMS0xMDc5NTc_30802dec-36d0-4065-a973-8e41d5827a42">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728193aa1ef04e4885f20273a8721f30_I20210925" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTEyLTEtMS0xMDc5NTc_b9815321-2aa2-4623-9a62-19a3297a3746">43,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728193aa1ef04e4885f20273a8721f30_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTE0LTEtMS0xMDc5NTc_42914ee7-ce72-4a35-9714-cc88068f78ef">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTE4LTEtMS0xMDc5NTc_74a24ef4-55f1-485b-acf0-dcfa39c10ec8">4,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTItMS0xLTEwNzk1Nw_056df0c1-1cd7-41d4-98e3-6c41227bd46a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTYtMS0xLTEwNzk1Nw_715f9b39-064f-4dc2-9457-6e24bdb88fb5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTE4LTEtMS0xMDc5NTc_f9022f3f-1dcf-4191-8ebb-d5e98befc066">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTItMS0xLTEwNzk1Nw_3ef64e9c-c1a7-4a5d-93d1-7daabe9314c0">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTYtMS0xLTEwNzk1Nw_6093349d-14f6-489c-a00b-201b080bc1f6">22.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTE4LTEtMS0xMDc5NTc_2d67406f-8f4f-4d30-9945-6118edd59a0e">22.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk2LTYtMS0xLTEwNzk1Nw_fa376208-0c7a-4e0d-9373-34d4b3a27bd2">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk2LTE4LTEtMS0xMDc5NTc_fa1f90c0-5c02-4a3e-87c5-456184238412">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk3LTgtMS0xLTEwNzk1Nw_5ea76886-4b51-4621-bffb-e27dff8b8f9a">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk3LTE4LTEtMS0xMDc5NTc_51291f99-05ee-43be-ba81-a682b43e05a7">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d792fb77c74175a153de2fee725a92_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk4LTEwLTEtMS0xMDc5NTc_9c94901b-6cb6-425a-8bf7-e7467b9db974">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d792fb77c74175a153de2fee725a92_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk4LTE4LTEtMS0xMDc5NTc_8d17dd5d-9138-4150-aea8-762e90b9c92b">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTEyLTEtMS0xMDc5NTc_1516f5b8-7a7d-4856-b3f3-904f9a5733f8">2,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTE0LTEtMS0xMDc5NTc_7e888b34-d5f1-4fdf-820c-9aa7a62f087b">167.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTE4LTEtMS0xMDc5NTc_17096462-b17f-49a0-9ffd-1d0ff33dea68">167.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1312159d6804c03a112ae774c849cbc_I20211225" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTItMS0xLTEwNzk1Nw_5c748f24-9fd5-4970-b3f6-8684c3173253">297,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1312159d6804c03a112ae774c849cbc_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTQtMS0xLTEwNzk1Nw_8b2ad565-a502-470a-82d5-9cb65262cdd7">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59ce45cfb8f644079576717c187966e7_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTYtMS0xLTEwNzk1Nw_110d3638-073f-4c31-b00b-08dd64d6863d">5,964.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f62b3f136743bfaea9f76d6dccb550_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTgtMS0xLTEwNzk1Nw_ccd4aa13-5a9e-459b-898d-161e7717d8ab">797.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f733818a0ef4bb196bde5377e392367_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTEwLTEtMS0xMDc5NTc_be459199-d844-4741-b578-5aac4a5a9522">89.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10b8515303b04633b81845a6340517a2_I20211225" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTEyLTEtMS0xMDc5NTc_a63a2e2c-dbda-497d-a12d-3fcc4bce041f">45,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b8515303b04633b81845a6340517a2_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTE0LTEtMS0xMDc5NTc_9156b63a-a676-4be9-a98a-6cae8b5d31e0">2,156.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673ceda2567b4fa094005314999c6692_I20211225" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTE4LTEtMS0xMDc5NTc_f78dae25-b7f8-42de-9719-34bc0086faab">4,519.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTItMS0xLTEwNzk1Nw_f9ca4c74-4d03-4994-98cc-f20000e8ff1d">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTYtMS0xLTEwNzk1Nw_74355ca0-1ac2-490b-a9da-ab03395442fe">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTE4LTEtMS0xMDc5NTc_9c89ef83-841b-4dd0-92c0-78a06073737a">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTItMS0xLTEwNzk1Nw_8a6e180e-8fe4-4723-9b58-4a6dc1d078e3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTYtMS0xLTEwNzk1Nw_4efb2e8c-f9ad-4456-b3bd-5baed34c70ec">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTE4LTEtMS0xMDc5NTc_dbc65184-65cb-4137-be14-5536ca228694">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTItMS0xLTEwNzk1Nw_3d891da9-259d-4a25-8968-ecb9c3ae6b43">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTYtMS0xLTEwNzk1Nw_e1167721-246d-4342-ae3e-d98c42186350">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTE4LTEtMS0xMDc5NTc_43081a77-af7c-4c23-826c-c445ed4c9294">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA0LTYtMS0xLTEwNzk1Nw_2d327150-b007-440f-9588-efcb3858098b">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA0LTE4LTEtMS0xMDc5NTc_0fb584eb-1670-4059-8f3a-ed504f441102">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA1LTgtMS0xLTEwNzk1Nw_b2a585b7-34de-4bda-9a82-b50bbce0a35c">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA1LTE4LTEtMS0xMDc5NTc_45d822d9-508f-4b9c-98ee-c30398c9493c">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99199df891b54e60b263241f795a8011_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA2LTEwLTEtMS0xMDc5NTc_69a7ace8-9f13-411c-b315-81f639ab2257">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99199df891b54e60b263241f795a8011_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA2LTE4LTEtMS0xMDc5NTc_5c6ca1b5-f064-4fc6-ae9b-11af8ed8ffc9">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTEyLTEtMS0xMDc5NTc_d85dbbe7-2907-48e4-a781-833107d8972d">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTE0LTEtMS0xMDc5NTc_2df96d75-5b9d-4d98-a54c-c64b1054083d">200.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTE4LTEtMS0xMDc5NTc_89827da5-bec0-40af-9baf-a11356d8c688">200.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTItMS0xLTEwNzk1Nw_9d38f83f-34ab-4ba2-bbe2-60b6bef794f3">298,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTQtMS0xLTEwNzk1Nw_4493e1d7-f53a-41e1-88f6-01ef13fcf8e7">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90312f39be0e4ef6b8f3efd53c5c985c_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTYtMS0xLTEwNzk1Nw_e4ce80a6-d9fa-41e2-8218-5404ba0eefe7">5,997.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c725645e1ff419d8af3688fb583ae78_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTgtMS0xLTEwNzk1Nw_6158d200-2653-4803-a201-00b3c59f5374">1,253.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTEwLTEtMS0xMDc5NTc_a5b76f5f-e876-4eb4-a07f-8af4c3092a7a">104.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee84ef7457ef44eeb536b6069b3b635c_I20220326" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTEyLTEtMS0xMDc5NTc_8309dd32-bb7b-4c0c-acba-fdd06fad8739">48,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee84ef7457ef44eeb536b6069b3b635c_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTE0LTEtMS0xMDc5NTc_365bd1c6-a492-48da-8951-1f4c88b3db0d">2,356.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTE4LTEtMS0xMDc5NTc_2e165e3f-c378-48df-8d84-b5d41da80f4e">4,792.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTItMS0xLTEwNzk1Nw_da20d81d-b0c7-4cab-9a95-cf24c911c4cb">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTYtMS0xLTEwNzk1Nw_0ac27258-1834-44f8-9b49-a67d86df5493">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTE4LTEtMS0xMDc5NTc_57cf1409-ae8e-4929-a415-5587f8b644f8">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTItMS0xLTEwNzk1Nw_183c3676-d80c-4a8e-8745-ea837f7546e0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTYtMS0xLTEwNzk1Nw_fc0e0aec-1f82-4b5d-b878-481171032a56">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTE4LTEtMS0xMDc5NTc_480c5294-bc25-41dc-bc71-28e2c9596327">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEyLTYtMS0xLTEwNzk1Nw_cd78a35d-ce7b-4ea4-b1ed-401fbceb5568">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEyLTE4LTEtMS0xMDc5NTc_a5b9dd74-1e6c-444f-a07d-a9912713722d">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEzLTgtMS0xLTEwNzk1Nw_8ba520c7-bb3c-49b6-bf7a-0a8327f86323">228.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEzLTE4LTEtMS0xMDc5NTc_bc267900-bfff-472c-b591-a05e0fc330af">228.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE0LTEwLTEtMS0xMDc5NTc_126db83d-ce42-4ea9-862f-1c41d626f9d8">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE0LTE4LTEtMS0xMDc5NTc_9788634b-975c-46ea-bce5-4190a004f589">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d882caad56e40fca4cbee08e9438a1e_I20220625" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTItMS0xLTEwNzk1Nw_66071ff5-d942-4d78-b84d-72a12cc36da3">298,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d882caad56e40fca4cbee08e9438a1e_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTQtMS0xLTEwNzk1Nw_c6bd5c2a-cc8b-4edb-81a2-0d2ed3f249fd">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08891923a5404211866f245155440f87_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTYtMS0xLTEwNzk1Nw_baafb786-5f71-41da-ac0a-032bf5ee2790">6,017.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba07efafd444b4a850d6efce144fbbb_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTgtMS0xLTEwNzk1Nw_aba431fd-ed40-405c-b9a3-2aa184c87a0e">1,481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaf436100d4049459a74792e8e6a0154_I20220625" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTEwLTEtMS0xMDc5NTc_12549d3b-3751-4641-a2bf-96582dacd874">147.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb18f90afb34984ae954b76e9f109e1_I20220625" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTEyLTEtMS0xMDc5NTc_293af59f-b74d-4dcc-a42e-2465aad93a71">48,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7eb18f90afb34984ae954b76e9f109e1_I20220625" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTE0LTEtMS0xMDc5NTc_b69e0e3f-44dc-4317-9ac0-037eaf783d43">2,356.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85799d0eb64349758943ccfaa1cd193c_I20220625" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTE4LTEtMS0xMDc5NTc_f5c20b77-5cc4-45b0-881c-ff2fc18f58d4">4,997.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTItMS0xLTEwNzk1Nw_c45d46b7-ef15-496c-b9af-173a0d4a8d7d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTYtMS0xLTEwNzk1Nw_52c1ad1e-a098-42e3-a2ad-1ab725a96732">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTE4LTEtMS0xMDc5NTc_7a5e987b-80ad-4919-b60d-f430c8d87eff">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTItMS0xLTEwNzk1Nw_bd521e5c-9c9a-497f-8896-d4df68ad5acc">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTYtMS0xLTEwNzk1Nw_1bbd5b11-23ad-49d0-b253-44bab11d1e04">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTE4LTEtMS0xMDc5NTc_b5eb8b55-c7e0-48a3-add5-c333515a590d">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTItMS0xLTEwNzk1Nw_cdf823ff-bb89-40cf-83f9-ddbd006baef9">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTYtMS0xLTEwNzk1Nw_c869e898-57e5-4b7c-a2a6-fc081c096f02">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTE4LTEtMS0xMDc5NTc_facef3d6-15ff-4517-a664-96d4590caf2e">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIwLTYtMS0xLTEwNzk1Nw_69b366c2-1ab0-4afc-9777-e6b62b060769">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIwLTE4LTEtMS0xMDc5NTc_5d3d1ba6-4e26-4169-8f18-eaa985f48d88">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIxLTgtMS0xLTEwNzk1Nw_3c2bcd31-9767-4eff-b9ed-17e40b63cd58">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIxLTE4LTEtMS0xMDc5NTc_f467278d-37ac-4e25-88a0-4892af5baa5b">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIyLTEwLTEtMS0xMDc5NTc_ef49c7ca-b287-44b5-9dbf-9c3997a2a1aa">90.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIyLTE4LTEtMS0xMDc5NTc_74571aa6-8897-43bc-a8ed-669a85ed86f5">90.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTEyLTEtMS0xMDc5NTc_5d1aca07-53f9-4c5e-a54d-e5c1498fd7ec">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTE0LTEtMS0xMDc5NTc_fe608183-13a2-4994-b76e-937b9cb6f061">175.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTE4LTEtMS0xMDc5NTc_57725774-93aa-485b-b31c-815c02505425">175.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 24, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTItMS0xLTEwNzk1Nw_5777101f-8805-48a5-8502-577e28cfbe88">298,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTQtMS0xLTEwNzk1Nw_6db8e521-5e64-4a34-8d39-b7504414f6df">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e54d72ad324c54a434cbf20c7e1636_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTYtMS0xLTEwNzk1Nw_db1be1c7-867c-43da-a648-72bee3fb7a88">6,042.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3002622281154961926b0802bdcfa78d_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTgtMS0xLTEwNzk1Nw_f4b40a2f-f096-4707-82d4-a64c583a0fe3">1,600.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5f81fbde654721b420a4cceaa0f658_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTEwLTEtMS0xMDc5NTc_25aa5fbf-d46b-4399-8b8b-37a9bed5b1a2">238.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTEyLTEtMS0xMDc5NTc_90a12e93-f2dd-464b-acd6-6d55314579c5">51,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTE0LTEtMS0xMDc5NTc_9a97b62f-7a2d-460a-a24e-d26000ebe65a">2,531.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTE4LTEtMS0xMDc5NTc_ae4fcb74-4c8c-4ca9-96df-6a7d8b1be8b1">4,876.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTItMS0xLTEwNzk1Nw_5032e082-4636-455d-8ad7-e36384546310">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTYtMS0xLTEwNzk1Nw_567dc028-716b-4a5c-ba6e-5b3c4a99ca15">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTE4LTEtMS0xMDc5NTc_f2ede61f-3b9c-4e21-b398-89a07245bd32">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTItMS0xLTEwNzk1Nw_679876a0-447f-44e4-aede-50b2f2f6c4c4">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTYtMS0xLTEwNzk1Nw_2442e545-3c0e-4e14-9d2b-9a991521495e">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTE4LTEtMS0xMDc5NTc_82008755-bbfd-49bb-b0f5-c76491ad2433">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTItMS0xLTEwNzk1Nw_7e82a4cc-022f-45b9-9a62-f74f0501d92e">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTYtMS0xLTEwNzk1Nw_a72fd94e-56d4-4072-90c4-abd535d23f1e">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTE4LTEtMS0xMDc5NTc_e80bb84b-8e9d-4a95-b37b-93829f1fdb0f">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI4LTYtMS0xLTEwNzk1Nw_1a52e841-f187-4d58-b6a4-2a1bae2a5a74">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI4LTE4LTEtMS0xMDc5NTc_de097d94-e5c2-49e6-b36a-77b34874442c">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI5LTgtMS0xLTEwNzk1Nw_f6af537f-f149-4576-a3f9-972047a46685">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI5LTE4LTEtMS0xMDc5NTc_53ec33ca-eb99-4d2a-8581-c6e13015a33b">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMwLTEwLTEtMS0xMDc5NTc_c32724c7-36e5-48ed-8538-8349336cd12c">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMwLTE4LTEtMS0xMDc5NTc_9394a359-30b1-49eb-a1d3-a81708592123">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTEyLTEtMS0xMDc5NTc_8052a1a5-90f2-4358-a7e1-c2d272011e69">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTE0LTEtMS0xMDc5NTc_9a610706-9842-4e20-ba39-63ac6af53f82">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTE4LTEtMS0xMDc5NTc_fe8198c4-ae80-42ae-824f-7d1ed2d445ed">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc29699290454610abbfbea53d3b09d9_I20221231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTItMS0xLTEwNzk1Nw_68e33171-25b0-4cbc-85e6-b68e4b8974fc">299,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc29699290454610abbfbea53d3b09d9_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTQtMS0xLTEwNzk1Nw_40b37e8e-fbbf-4ca4-b658-b51ca0d48c74">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d95c79e50f4f2c96697ca8aac2736e_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTYtMS0xLTEwNzk1Nw_3caae670-813d-43f9-959f-dc8c5148eb65">6,060.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0326c94c4f849e78bc4ed1ba0305489_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTgtMS0xLTEwNzk1Nw_6299825c-2df9-4ebd-96da-7db02ce595bd">1,787.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTEwLTEtMS0xMDc5NTc_ac96b38c-c1ba-47fe-8b64-c3ad33a83a21">127.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6693a30bd6c4709a18368e12c88e1e0_I20221231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTEyLTEtMS0xMDc5NTc_4650db6d-54a5-483b-9ffe-5586a1dbc5f9">52,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6693a30bd6c4709a18368e12c88e1e0_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTE0LTEtMS0xMDc5NTc_a4697a7e-ed76-45ef-b684-00ff2ba14a43">2,631.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTE4LTEtMS0xMDc5NTc_63dee765-ae25-4b3c-96bf-c40b3d378bb1">5,092.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTItMS0xLTEyNDQ2Ng_679c5385-d2a7-4c80-ac8f-c733a9b5469e">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTYtMS0xLTEyMDM0MA_29d9b30f-597b-4a82-8870-569a39bc0718">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTE4LTEtMS0xMjQ0ODU_74c357e4-2713-4c4b-8807-cdbee566d7ac">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTItMS0xLTEyNDQ2OQ_f3edcd4e-e25d-4011-b244-c5e8c848254e">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTYtMS0xLTEyNDQ3Mw_e8c014bf-25ae-49da-9dbe-e7321a2180ab">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTE4LTEtMS0xMjQ0ODc_9280f6f0-813f-4266-9379-8739b92de65a">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM2LTYtMS0xLTEyNDQ3NQ_4d1d52f7-393b-4fb4-be86-a33c39624b96">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM2LTE4LTEtMS0xMjQ0ODk_faa6d869-864d-4aab-89bc-cd1c89634b01">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM3LTgtMS0xLTEyNDQ3Nw_b7327c88-11d0-46e7-a62d-18e258332b77">218.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM3LTE4LTEtMS0xMjQ0OTE_6d877872-a2d7-4119-952e-47ec5f9e438a">218.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c41465ac6b4629acc426e96781619e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM4LTEwLTEtMS0xMjQ0Nzk_9aa232e9-ef67-4903-b0f1-136e08a25213">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c41465ac6b4629acc426e96781619e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM4LTE4LTEtMS0xMjQ0OTM_221969b1-b437-48d1-9fae-26538fc1cd86">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTEyLTEtMS0xMjQ0ODE_9cc708ab-6d79-4452-bedd-ffa1105fef11">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTE0LTEtMS0xMjQ0ODM_1ba180d7-075a-49ae-90f2-a165532d6a37">50.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTE4LTEtMS0xMjQ0OTU_448bcd42-0f18-4cf8-adb2-9f837fbd4011">50.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81231f9a527e4841b03062694c05a420_I20230401" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTItMS0xLTEyNDQ5Nw_1275b969-95c0-45af-a9cd-878a1968af87">299,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81231f9a527e4841b03062694c05a420_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTQtMS0xLTEyNDQ5OQ_19061d4f-0883-44e5-90d9-49326533465c">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018c97cc9d50417598b74b0bc1e7d870_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTYtMS0xLTExODAwNw_5bceb1df-7f52-465e-ac64-1d621d44ba2b">6,091.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66a35a33618446cb52289632d995392_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTgtMS0xLTEyNDUwMw_bbb3402b-2017-4167-85c5-a832ee81f303">2,006.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTEwLTEtMS0xMjQ1MDU_5aac4695-ed0f-4e85-a6ed-76392f67410f">118.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iacd73e1d3acb402da10be07c5fc515f2_I20230401" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTEyLTEtMS0xMjQ1MDc_7041d5f3-d547-464e-8053-138bb59138e4">53,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd73e1d3acb402da10be07c5fc515f2_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTE0LTEtMS0xMjQ1MDk_611d5b99-ce70-46bb-a866-c3c2a2a9104e">2,681.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTE4LTEtMS0xMjQ1MTE_b7344b68-f576-494d-9a5d-4e8ad587240b">5,300.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMy0xLTEtMS0xMDc5NTc_859cae86-b150-4a07-8db0-8b0fcb104e90">405.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMy0zLTEtMS0xMDc5NTc_4e1d1182-b876-4bcc-b687-514f9cb82f16">954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNS0xLTEtMS0xMDc5NTc_57f07aa8-0370-4c51-811b-405b3ec4ee23">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNS0zLTEtMS0xMDc5NTc_535c470a-0539-48aa-b361-e28d438e4c7e">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNi0xLTEtMS0xMDc5NTc_a0339705-53fa-40f9-bfbd-ad14977f3aa9">122.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNi0zLTEtMS0xMDc5NTc_82530a0b-5a5c-4389-9570-64d96558f681">169.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOC0xLTEtMS0xMDc5NTc_ac27ce76-708f-4d1f-b517-960838f569c1">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOC0zLTEtMS0xMDc5NTc_0550e915-4005-4fe7-bf68-e4b75338d85d">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOS0xLTEtMS0xMDc5NTc_d04177cb-ce87-44e0-b896-2d5c8c4802bd">61.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOS0zLTEtMS0xMDc5NTc_f21b1574-6016-46ef-b38f-e5fbc51d3149">41.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMTUtMS0xLTEtMTA3OTU3_c1ea9ebb-1c3c-43ec-9fd7-f811c1b95077">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMTUtMy0xLTEtMTA3OTU3_48f925a1-b7fe-4c29-9f0a-4d031844cc41">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjEtMS0xLTEtMTA3OTU3_b6e155f2-ec01-4927-b690-07d44445c63d">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjEtMy0xLTEtMTA3OTU3_4264b9c0-e366-46f9-867d-b5636f61a527">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjMtMS0xLTEtMTA3OTU3_10966daa-b940-452c-b58f-19b2646e02f8">81.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjMtMy0xLTEtMTA3OTU3_9633e85f-836c-4165-b538-998ad87514a1">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjQtMS0xLTEtMTA3OTU3_12409467-1baa-4c78-99d7-03a4db4d1d10">56.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjQtMy0xLTEtMTA3OTU3_a554f9e4-9f16-4ddb-8a07-bf4be9cd036f">26.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjUtMS0xLTEtMTA3OTU3_b0226ef1-62d9-4450-9ee9-b8a2497274e2">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjUtMy0xLTEtMTA3OTU3_457f0cef-bb45-477b-963e-44b78ab87e5e">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjYtMS0xLTEtMTA3OTU3_64a36c24-4979-4a8b-b69c-c0a612375c60">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjYtMy0xLTEtMTA3OTU3_29e4e8cc-52f6-4077-8ea7-0e71a069f417">355.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjctMS0xLTEtMTA3OTU3_435fbe32-d897-4c67-9910-081b86f53a31">13.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjctMy0xLTEtMTA3OTU3_080f9c7f-0381-4b7a-9094-6a0c32c7a93a">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjgtMS0xLTEtMTA3OTU3_5def3bb0-cb07-4499-b9dd-01315113b367">22.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjgtMy0xLTEtMTA3OTU3_846cbb91-5c8d-46c3-ba02-916e0fbb04fc">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjktMS0xLTEtMTA3OTU3_714eb84e-f348-49df-95c1-0b97b0abf111">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjktMy0xLTEtMTA3OTU3_c50a16ec-c8fd-489f-a557-068ce732c07e">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzAtMS0xLTEtMTA3OTU3_f4a87e33-2839-44de-93e9-a43040480184">459.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzAtMy0xLTEtMTA3OTU3_e3ece946-6602-4125-a4a9-bcbd19efa56f">1,626.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of business, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzItMS0xLTEtMTA3OTU3_d2d5f5d9-a245-4b07-8ada-46b949d84805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzItMy0xLTEtMTA3OTU3_000abe59-6b43-42d6-b63b-742d760879ff">158.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsForProceedsFromProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzUtMS0xLTEtMTA3OTU3_4f4df579-2dfb-4783-8a11-e81fe949c5b2">34.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsForProceedsFromProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzUtMy0xLTEtMTA3OTU3_d69e070e-2363-4668-acde-9e85c8cfc3f6">36.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the Department of Defense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzctMS0xLTEtMTA3OTU3_370ad5c5-2ae1-4ba4-b1e3-79630f75e35b">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzctMy0xLTEtMTA3OTU3_b1412a0d-3989-467d-9138-6367f2ff16ab">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzgtMS0xLTEtMTA3OTU3_ed58de2b-0b7c-4933-9798-10a35c48b5de">26.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzgtMy0xLTEtMTA3OTU3_207a0e46-39d5-47bc-9a2e-4634e8dd1c83">33.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDQtMS0xLTEtMTA3OTU3_707585c3-5438-4db7-a943-76d41da7f91e">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDQtMy0xLTEtMTA3OTU3_556e9df3-ecd4-4a77-b004-cbbacacb9cfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDctMS0xLTEtMTA3OTU3_cd74ed7a-00f2-43e3-860b-370db03bd4ba">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDctMy0xLTEtMTA3OTU3_9dce393e-1e2a-406c-a68f-922811172a1f">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDktMS0xLTEtMTA3OTU3_a9375d81-8c2c-40e4-91a5-6568fb100f03">57.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDktMy0xLTEtMTA3OTU3_2f2b7be1-b6a8-4425-9351-ed913dc382dc">164.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTEtMS0xLTEtMTA3OTU3_0e5a60f3-9f01-4088-ad74-de333107c662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTEtMy0xLTEtMTA3OTU3_b5e97455-096b-4b18-8851-451bcbf6df40">1,491.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTItMS0xLTEtMTA3OTU3_3a204359-68a1-4045-8f2f-cb890e477649">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTItMy0xLTEtMTA3OTU3_e6fdd417-280b-48c3-a47d-ca431824dba9">1,387.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjAtMS0xLTEtMTA3OTU3_32ab1d35-a328-4f2f-8dbe-2aef9d426712">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjAtMy0xLTEtMTA3OTU3_bb6ceec4-1621-404e-ba41-98feb43cf601">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="holx:PaymentOfDeferredAcquisitionConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjItMS0xLTEtMTA3OTU3_7faed485-38d1-4173-a2a7-6d527e20dbb4">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:PaymentOfDeferredAcquisitionConsideration" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjItMy0xLTEtMTA3OTU3_5dfabbed-9a4b-46ca-8ae5-26c49e7fd2c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of acquired long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:Repaymentsofacquiredlongtermdebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjMtMS0xLTEtMTA3OTU3_bd21951d-080c-4f1b-bd65-7164a7134634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:Repaymentsofacquiredlongtermdebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjMtMy0xLTEtMTA3OTU3_05b756a8-1bcf-4338-94db-bca727062e7c">63.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjYtMS0xLTEtMTA3OTU3_f6268e5f-cec9-4d4d-ad92-ddee16bca3ae">150.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjYtMy0xLTEtMTA3OTU3_384af64e-00ea-4085-89fa-33752bf3e729">367.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjgtMS0xLTEtMTA3OTU3_1f7f9546-4337-4d49-9704-1f0c8d2727d1">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjgtMy0xLTEtMTA3OTU3_9b46dd6e-f324-4297-8230-3f88d32c9840">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjktMS0xLTEtMTA3OTU3_6331e79a-2e5c-4778-b36d-38b74dd54191">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjktMy0xLTEtMTA3OTU3_cea7ddd5-151b-4f6e-af38-0fdd2abecf19">22.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzAtMS0xLTEtMTA3OTU3_f5781e13-7c77-4a7e-ac93-27a596eaca93">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzAtMy0xLTEtMTA3OTU3_f75f693e-4cec-4cc0-ba89-1f6a09fd6465">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzEtMS0xLTEtMTA3OTU3_46796c9c-bb30-4a5a-a495-ab2291ebdb97">163.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzEtMy0xLTEtMTA3OTU3_bbec5043-00ab-4143-9916-0b0414def2d9">346.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzItMS0xLTEtMTA3OTU3_edee79b9-7269-4f64-94b3-c734845f1a0c">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzItMy0xLTEtMTA3OTU3_cc89bd3d-33c8-4586-91df-0fafaa441177">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzMtMS0xLTEtMTA3OTU3_bda7c72e-55cb-47ed-990a-76f466ebffcb">242.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzMtMy0xLTEtMTA3OTU3_6ad43608-4558-42d2-a6bd-e217ab5d556c">1,120.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzQtMS0xLTEtMTA3OTU3_6139babb-b93b-4011-8e57-316a1835ffab">2,339.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzQtMy0xLTEtMTA3OTU3_fd55a14e-6688-4e64-9b57-2f07c932022c">1,170.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzUtMS0xLTEtMTA3OTU3_91d10ddb-191a-4443-b1a4-ff3fc5e72793">2,582.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzUtMy0xLTEtMTA3OTU3_e01b9da8-8c08-4f75-ae96-8c89e59df50e">2,290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(All tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (1) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNC9mcmFnOjk2N2E0NGFhNDk5ZjQwMzRiZTI2NjBkYzE4MTEwMmY2L3RleHRyZWdpb246OTY3YTQ0YWE0OTlmNDAzNGJlMjY2MGRjMTgxMTAyZjZfMjU0Mg_9bd65b12-84ab-48f5-914c-96aa5d08d3e3" continuedAt="i3c52719934df4d259fb570e67464892f" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3c52719934df4d259fb570e67464892f" continuedAt="i85f237362428446ab8c83e69c76b38fb"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#8217;s annual report on Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended April&#160;1, 2023 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company&#8217;s historical fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i85f237362428446ab8c83e69c76b38fb">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended April&#160;1, 2023.</ix:continuation> </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNTQ5NzU1ODI0NjI1_ff09f342-eaae-4bfc-9820-40dd700a4f40" continuedAt="i5f67c08150ad40e3b0701275d20e6688" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company&#8217;s products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfOTE0Nw_137cdd81-a714-49dc-8b8a-b9a8df9aa20c" continuedAt="ifbb398d09df444418cafc94585a58778" escape="true">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="ifbb398d09df444418cafc94585a58778" continuedAt="icec1d1bc8d32453296993050aca39e68"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e5484a0f4c43d3a4b5386b8dd0cdfe_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy0yLTEtMS0xMDc5NTc_dc78c599-a504-4615-9432-c038291725e6">69.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2dcc05bea314588b412a9f27a0d2096_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy0zLTEtMS0xMDc5NTc_80856e45-440f-4b68-b805-37ae88f165ed">42.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6643d03654fc4e74abb8215ae7099bc5_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy00LTEtMS0xMDc5NTc_a587b65a-5f8c-4bfd-97c0-413e6310f250">111.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27fb968480674498b86f260f5c557cd2_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy02LTEtMS0xMDc5NTc_65cd0f02-bd3c-46ae-9ce6-359bab1c2300">72.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86ced2c50224d87b806cfe2700e9451_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy03LTEtMS0xMDc5NTc_e70748f2-1f13-42e8-ab2d-2b9988212e53">43.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20558280389d4b6882132ba9b3803cd3_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy04LTEtMS0xMDc5NTc_c255fe20-ed12-46ed-ab49-81d17193d165">115.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59b200cdcd64399ac289fd7af196ea9_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC0yLTEtMS0xMDc5NTc_2bf93e21-2bcc-4132-89d2-da6c1313002b">263.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d2c2c178954ebd9a39527357d76c74_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC0zLTEtMS0xMDc5NTc_d99a5643-8f47-4f17-b52f-709d5e6ac0f0">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84dfba6a6bc4632b38560142cba9e81_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC00LTEtMS0xMDc5NTc_7637ee49-0ea2-4fde-b4d0-19d94ebe80f2">342.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffef3244c874e85b508fa350a2554e6_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC02LTEtMS0xMDc5NTc_240137de-7c8e-4fdc-b3da-07b13a140bd8">563.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2168b403a0ee4e46af7c9636f54dfd4b_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC03LTEtMS0xMDc5NTc_ba9f3515-6ff2-495c-a73d-57378346bf30">298.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d09a84e2db4fa7882cd618c44a4279_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC04LTEtMS0xMDc5NTc_2fb8903a-d430-4bec-8e2c-6ed096abc50b">862.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c08c95f31c343c48236eb8ce8c31567_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS0yLTEtMS0xMDc5NTc_172859a0-02a8-4ba4-9f65-e6f487dd0dd2">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b1e7bfe27e4e76be3bf69f2d53e02c_D20230101-20230401" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS0zLTEtMS0xMDc5NTc_783716b0-fdc7-4e03-96f7-f925db399f80">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f37682f6f5145a58f06d84f7b8e61cb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS00LTEtMS0xMDc5NTc_48077405-f16a-45d0-813b-bc5a6b93d4fe">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9838ba0466484bb137158e7a1567da_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS02LTEtMS0xMDc5NTc_6432c4d3-b1ca-4da4-8ab7-8d4d81ded7c2">9.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb0b1cfe7eb4bd1a09a13946bcd2bcd_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS03LTEtMS0xMDc5NTc_28e506aa-a233-43fd-8311-54e894d7336e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib398b6fc80d746a2b8ae5fc069cae6a0_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS04LTEtMS0xMDc5NTc_be2eb653-1ff4-46c5-ac65-7c0eb093b92b">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565fca98edfe40c8a7d74fcf1421de87_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi0yLTEtMS0xMDc5NTc_80cf8461-bc13-4513-9888-a87e8d91001f">342.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65e97210e574278b454ce584c3cad8d_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi0zLTEtMS0xMDc5NTc_938a98d8-d26b-4274-aacb-522321264c91">122.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi00LTEtMS0xMDc5NTc_8e6a0fbe-a187-4ef9-a41e-8438b34363dd">464.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099e7069f9c44890bb40a7afe3614761_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi02LTEtMS0xMDc5NTc_7637c032-830f-49b1-8d00-f9487574f4c2">645.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb7b04583b44661b5c05b7efe129429_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi03LTEtMS0xMDc5NTc_1ce00b63-047e-4f05-8e81-ba9a6b1a6485">342.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi04LTEtMS0xMDc5NTc_2f211338-a8c3-4a00-814e-cf1d0b936097">987.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781a7f522edd4c4d951e77997571c15f_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS0yLTEtMS0xMDc5NTc_e9c0ad32-7c6f-46b8-9204-2de27d8df6c7">233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24aec643f412452fb0caae5eef3a39d9_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS0zLTEtMS0xMDc5NTc_e481ef48-b7e9-46b3-84f8-1edf4321c562">78.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13676ccbf324673bdda7326d7f4f08b_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS00LTEtMS0xMDc5NTc_ca33add2-1960-418c-99bf-310a4d3b4a78">311.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd32066656d441a86201c5e12956de1_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS02LTEtMS0xMDc5NTc_f62f6df2-b69c-4a1a-ae6c-2433806690c5">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i619d5722b4ca48d6a5f05a12991734fe_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS03LTEtMS0xMDc5NTc_6059248d-b0d5-4ce4-90d2-25ca271988e7">57.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1fa5ac56b84e7aabaa1944179b29a0_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS04LTEtMS0xMDc5NTc_024b95f0-436a-4ca3-95fc-f1f9dea6fa2f">245.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbef055aeb94448c964ef00d2ce1fa7f_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtMi0xLTEtMTA3OTU3_915a4633-45c8-4f36-bd38-08496a0c282b">59.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf08815cbd2a48b4bf69282fcffa315d_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtMy0xLTEtMTA3OTU3_b5c2f7b9-fd18-4cbd-b0c7-6f0bcc4af3f3">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76e12316bf64558aad72df91e631bbe_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNC0xLTEtMTA3OTU3_41477867-8b1e-454e-9a4d-398f44076d14">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f65bc9a643471eb4699958d5a56b0e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNi0xLTEtMTA3OTU3_6ecba23e-b478-4dc1-a73d-6b11c3c47512">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ec9d62d7b24c9aa3d020e9fd43fde0_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNy0xLTEtMTA3OTU3_5855ba68-b6a0-46a5-89a6-f4a5f1e7c2ab">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3508f3a72645e19ce96e3f933f92e3_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtOC0xLTEtMTA3OTU3_4b96faa2-e68d-4f76-bba3-c34df38f3483">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2ddbfb01cc43e6ad631c8c163cf4c5_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItMi0xLTEtMTA3OTU3_ae5da6db-b259-4222-8e27-cfc20234f1f9">293.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeecee944b96477993784167af0ec4e9_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItMy0xLTEtMTA3OTU3_b686d9d3-2643-42d8-bf8b-6ed531075ef5">92.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNC0xLTEtMTA3OTU3_7db0c59b-4791-4645-96e4-af3f8ecaa5d3">385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie61d3c1656c444e2af045a6884b5cd0f_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNi0xLTEtMTA3OTU3_262d5adb-f5db-4333-a545-f387746840f2">239.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387d4056e84b4ac180d2aa7e3393329f_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNy0xLTEtMTA3OTU3_f1a4a573-3645-440b-9941-ba26071c62e4">70.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItOC0xLTEtMTA3OTU3_7499fafd-801d-4edd-bced-3dac10db9eec">310.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad2b30985d644f0a50a8cdc970d6f5d_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtMi0xLTEtMTA3OTU3_388ee4aa-120e-4686-8d84-3b192b7e5109">113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fc4260d3174dda9b586fb230fa8f91_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtMy0xLTEtMTA3OTU3_feeed701-187d-4d07-887e-ac8a24186364">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNC0xLTEtMTA3OTU3_d08a1c74-2ebf-46a7-866e-ff42d83f55e3">144.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88ec2152274467d88041d6be4c30ff6_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNi0xLTEtMTA3OTU3_16b86e17-76a7-4741-8170-17e7b1867b38">94.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58119cf2e18e4040ad7d0545f5502d37_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNy0xLTEtMTA3OTU3_36abb70a-5a22-4fa8-8592-ec8d07c22015">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtOC0xLTEtMTA3OTU3_8a366cc0-d1ef-45aa-ba63-0b69bf71e442">117.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18684c24e2714ec8a43866e747472e7c_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtMi0xLTEtMTA3OTU3_13f8e0f9-b6f6-4ca3-8200-757e8ba6621d">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e11b702840946b7a882d86468c5c654_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtMy0xLTEtMTA3OTU3_71f00ff6-2a5a-477f-9c96-fb96af6096a9">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNC0xLTEtMTA3OTU3_32b795cd-6982-439d-a4a8-a819d0b89793">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620f31a3d0b94dc7a06fa436a267fa09_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNi0xLTEtMTA3OTU3_04145f41-f970-4c4f-b9ab-f9929a90c2a7">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33460790b19b4a16b5c379ca34c18e06_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNy0xLTEtMTA3OTU3_5a7e8749-7850-48d5-adf6-eecfc7d7163b">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtOC0xLTEtMTA3OTU3_31b089ee-f8aa-4746-b164-69ae8d0b7b04">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctMi0xLTEtMTA3OTU3_553ed57d-af46-4ade-9bde-76cdfa268e20">768.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie287b34c173446e4b3ae5678053afeb1_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctMy0xLTEtMTA3OTU3_b8de9e9d-e71b-45ad-99cc-5461b920cb92">257.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNC0xLTEtMTA3OTU3_b0da0e03-bcad-47ef-93a4-a8e31b31209e">1,026.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNi0xLTEtMTA3OTU3_a95a121c-7f82-43fb-a7fa-dc014c10b560">992.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349699c3313a4532a7a576011d54ac58_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNy0xLTEtMTA3OTU3_3c8f13ef-f9d5-4272-a8bc-a7b4d188a43e">443.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctOC0xLTEtMTA3OTU3_e582aab5-612a-41df-94a6-3241b403c09d">1,435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8841fc4453d947b1abc6b677fcdf4c75_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy0yLTEtMS0xMDc5NTc_b83758eb-6148-44de-b9ca-abe704dd9f49">147.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1353f3f554864abca59c0d2acd652329_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy0zLTEtMS0xMDc5NTc_3b6248e1-9fb1-4e94-a958-c23071307fc2">91.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f4de0bdaca42439e9615354a987d7c_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy00LTEtMS0xMDc5NTc_89dd312d-c5c9-44ca-a0fe-cf5116721ff0">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb875e603fbc4fe1a1e9ca9acea597bd_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy02LTEtMS0xMDc5NTc_32d6b135-1069-4b12-a3bc-b7e68b60de20">153.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d1acff3bb149edaaf709f12e763dc4_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy03LTEtMS0xMDc5NTc_731bce6d-186e-4ca7-8442-80ec991c6e18">92.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifceb9765ec71498ebc94cc6a41dfb085_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy04LTEtMS0xMDc5NTc_e2f1ffee-0051-4e22-a4b4-c4973aea6ef7">245.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071c0ae1705441148ac8e82637f13843_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC0yLTEtMS0xMDc5NTc_6bdad3ec-be4b-4dfb-887f-da13207dfdc7">591.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab114a082dd4e6b82610ed0a84ed5ac_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC0zLTEtMS0xMDc5NTc_e0e9c87f-1c1b-420a-ae28-be54e568721e">176.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db81a73fb034bce8b07cb4d54adb4d5_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC00LTEtMS0xMDc5NTc_ed50e700-d55e-4d4d-8111-30b4bb17c047">767.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e2dac027774b4fbe6ae5f2f7c513a0_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC02LTEtMS0xMDc5NTc_0743809c-8ed2-4ec5-88dd-b2aa641d3a04">1,091.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5940fd34036f48a8b0d1a0f4d3246913_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC03LTEtMS0xMDc5NTc_f181d114-8959-4f78-adde-38ab2af9ed3a">584.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d825bcee284151aa724fb0e57ab91e_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC04LTEtMS0xMDc5NTc_799046bd-dd33-40d8-a85c-d051893334a2">1,676.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd73e2dccdf845d988743f5b2afd0a7c_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS0yLTEtMS0xMDc5NTc_6ff857c7-b0e8-4977-ada7-5f310d4a78df">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4160efde569446d6a70f5cb043ff5bed_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS0zLTEtMS0xMDc5NTc_d8b5ed42-b4f3-472d-82ba-47c638c400fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a2096ceff74f10ab7ea238449b6ebb_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS00LTEtMS0xMDc5NTc_a72100bc-4a1b-4513-89d2-3f5ede598274">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010f85da839c4f788ae3c9678dcfee88_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS02LTEtMS0xMDc5NTc_4feb3c29-16ec-4acc-bfa5-2cef13a62dad">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7435b5e546944ceabfd36aaed78afb22_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS03LTEtMS0xMDc5NTc_a4b31926-143c-495b-bd7d-ad316e9a71cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7cf0a8c804c43e78bbd2ecab53fa929_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS04LTEtMS0xMDc5NTc_c0d9d672-2a71-454d-a615-6138c2046142">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfb59c21d064a0095827e9fee15c650_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi0yLTEtMS0xMDc5NTc_ef3541da-65a7-4f91-808d-16f314749339">756.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008fea210a79421792efe38c181b3afe_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi0zLTEtMS0xMDc5NTc_9dc39c53-47f2-49b8-babd-e40a0f9f1bce">267.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi00LTEtMS0xMDc5NTc_0a076bb8-42e8-42dd-b961-31c3e38e0056">1,024.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38424d055ed4ce5b58b21cb84139032_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi02LTEtMS0xMDc5NTc_d8fbc24d-8504-43c2-875d-72d9ac76eba6">1,260.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c824d2f804b4f8cbe8774772c549f65_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi03LTEtMS0xMDc5NTc_b1fc2437-baa3-490c-a4f2-779e722ac66a">677.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi04LTEtMS0xMDc5NTc_18e9ee9e-be5b-4f6e-987b-8d3f04250b6c">1,937.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7bb65acf97a4446adca1cf306eb6abc_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS0yLTEtMS0xMDc5NTc_376f0e44-00cd-459d-a044-2a74b9737b63">445.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic404fc96f0c64f51b5b4f5e6737f2d54_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS0zLTEtMS0xMDc5NTc_3d392241-598a-4355-9472-51c17f090bf4">130.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie823dd7cc3af472b9bd804c6b639b007_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS00LTEtMS0xMDc5NTc_be83644e-bd12-4842-904a-901d12301af1">575.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a312bb9f01c4777b32b902e8248d9cb_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS02LTEtMS0xMDc5NTc_e9b8e6c9-57ab-436c-817b-09ac82101e50">396.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919b1976ae604ccd9ecae3f5a1044a6a_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS03LTEtMS0xMDc5NTc_35cafca1-7921-41b6-9324-dab50b2db196">131.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e166105ee044f2891a1e4feecf8f137_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS04LTEtMS0xMDc5NTc_1882fde0-db92-40ea-9ff2-7660b84c20c7">527.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc35b3bc4774106ba45e0abe86067ab_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtMi0xLTEtMTA3OTU3_4a19ffee-1e84-4745-93bb-c320c7437518">117.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188645d6d3b14ab7bb87691db06a8205_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtMy0xLTEtMTA3OTU3_fb928988-974e-4fd6-bd52-7c8c5c6e1ccf">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a579c3edee4243a5457698bafb3ba4_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNC0xLTEtMTA3OTU3_2fedefce-72c8-4b1f-b6a3-219ae40fc761">143.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8a695c629c41f2bdb54152ed3a5cae_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNi0xLTEtMTA3OTU3_371a8a70-9c45-4fe1-8966-a0907e575d17">114.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7132a15dec44f3599d3ef99c1e30826_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNy0xLTEtMTA3OTU3_66ed8c21-b991-4e15-be06-276508d87a37">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d77f036b144ab2bf62c85dff6e86fc_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtOC0xLTEtMTA3OTU3_d30ab4f3-444b-4f9f-80db-35b81027c878">142.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd3e99c4b6349de8cdb1e8f0a2b6311_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItMi0xLTEtMTA3OTU3_261d138e-d629-4b43-b1c6-6b764015de6a">563.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc7b0243cde744aebbd25a510394a248_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItMy0xLTEtMTA3OTU3_7817577d-e3c4-4f98-8837-f7dd66e3b83a">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNC0xLTEtMTA3OTU3_c7f73d38-9456-467b-84b3-ebe92f9d3d08">719.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie705a94ebd6c4795aff105e679f1be54_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNi0xLTEtMTA3OTU3_cdb327cd-63fd-43ef-b969-f4ad19fc8025">510.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b9944219eb46c087a0481d0206b4cc_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNy0xLTEtMTA3OTU3_9138d6bd-4c8f-4bc6-a327-56f57d0e3179">159.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItOC0xLTEtMTA3OTU3_84b60627-c76f-4d77-ac50-52b4b776da32">669.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28bab2b9c104428e8c55999a506f0906_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtMi0xLTEtMTA3OTU3_9cc6b050-0f98-404e-80b9-96d7e37d705f">236.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f619cf4bfd430793d0539858960750_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtMy0xLTEtMTA3OTU3_5080eed8-6193-4309-a288-946dacafc9fb">62.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNC0xLTEtMTA3OTU3_185f42bb-a69c-4719-96c3-03855f063134">298.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6d823fbbc94feab179d253e4be9aa3_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNi0xLTEtMTA3OTU3_f8ef7ddb-8e4b-4563-9870-11bc0cb1bf61">203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefac68ca0bdb40f387bdb4a775659af8_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNy0xLTEtMTA3OTU3_4e1f41c5-fe30-4f58-bb13-af5f524d4f67">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtOC0xLTEtMTA3OTU3_5ee83c47-4327-471b-abb1-607b0334534b">251.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962c4b39ad9b43f789b8793465348724_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtMi0xLTEtMTA3OTU3_9083e66c-6d0d-4fc7-acfd-cdc468eea3a3">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff7e3a68df34606bf1106251ac4c25e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtMy0xLTEtMTA3OTU3_9f46251b-c9d1-4cc6-b584-0c9d9f217ca3">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNC0xLTEtMTA3OTU3_9362dea4-cff2-452d-965b-a01c438cf60f">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763fd5b73588457eaf359445f8e85c8a_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNi0xLTEtMTA3OTU3_db2e09d7-7bf4-484e-b437-c8ce85df1382">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c2774c2d1e44689b12b1bf19aad67f_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNy0xLTEtMTA3OTU3_7787d22e-6184-4b61-bc79-ebf104f30de5">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtOC0xLTEtMTA3OTU3_1b7b6220-22c2-4055-b55f-49d4ce5c5fd9">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctMi0xLTEtMTA3OTU3_22cea9bf-54d6-4c0b-82c7-05958abecaee">1,592.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0bef0470fb04031bd8d1f8ca4de2a26_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctMy0xLTEtMTA3OTU3_276cc2bb-fa6f-4f35-bac4-1260a915e762">508.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNC0xLTEtMTA3OTU3_a5305ef1-4694-4573-85a7-d776a6e6e2ba">2,100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNi0xLTEtMTA3OTU3_516f407d-3d02-4b9f-8497-b35af0c5c59e">2,004.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736cfdfe36b64ca6be804529485f2142_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNy0xLTEtMTA3OTU3_0e5d1859-9db4-4bf8-83ef-d1e67417abe9">902.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctOC0xLTEtMTA3OTU3_cfc34197-ab08-40bb-9eb4-088227727b15">2,906.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="i5f67c08150ad40e3b0701275d20e6688" continuedAt="ib4c05d63c7214b64ac65fbfafb9d0bb7"><ix:continuation id="icec1d1bc8d32453296993050aca39e68"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi0yLTEtMS0xMDc5NTc_1b034be4-9950-4a48-bcba-342fd5cf374f">768.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi0zLTEtMS0xMDc5NTc_f10d951b-c3eb-4f01-b2d9-aaa31e6a3add">992.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi01LTEtMS0xMDc5NTc_a10b0ae4-4c53-4974-a7bb-82fe3afbe158">1,592.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi02LTEtMS0xMDc5NTc_d5bc3ede-6683-44fc-8228-b399a50a36c4">2,004.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy0yLTEtMS0xMDc5NTc_13a8a0dc-1cdf-4098-9666-c76bc0207576">151.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd755a8928c347638dc5777e510229a4_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy0zLTEtMS0xMDc5NTc_27c9286f-9545-41eb-924b-f99f2f5881f6">291.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy01LTEtMS0xMDc5NTc_8caf4873-337d-41d7-9995-22d101fb1f5d">298.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy02LTEtMS0xMDc5NTc_4c31f85c-9375-4b15-9e37-39a6037f4f16">586.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC0yLTEtMS0xMDc5NTc_034a3a85-6e8d-4121-9f5f-2690f43244d5">65.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC0zLTEtMS0xMDc5NTc_276cf5ac-9f29-4086-a5fd-bf77c33d473a">109.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d2b38d322445518df9d6519589e24a_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC01LTEtMS0xMDc5NTc_56b661e3-34f6-4b87-b125-b7999a9f5afc">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC02LTEtMS0xMDc5NTc_3bb28275-08b4-4f16-a81d-92695ea8c617">229.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe30b8b63776445486aad925dd9774cb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS0yLTEtMS0xMDc5NTc_507ccd39-0e2f-4a35-bd49-e091c202806e">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00be1902f11b446090c0c094fcc5c85e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS0zLTEtMS0xMDc5NTc_7398763f-ab6b-4e01-b083-e8c301bfe728">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48755cfd484a4e62a2c8362de38c8b4f_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS01LTEtMS0xMDc5NTc_77773f66-ab31-4769-b531-aa17622095f2">80.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327da3cafe3c4d0aa665e7ce8be8698a_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS02LTEtMS0xMDc5NTc_9e269b82-70ee-4e95-b80b-73bd0c4ab784">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi0yLTEtMS0xMDc5NTc_1cde585b-4cec-4199-8781-ff84d452c418">1,026.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi0zLTEtMS0xMDc5NTc_07c7c274-8b7c-4fe0-9e3c-3966f50bff30">1,435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi01LTEtMS0xMDc5NTc_f418800a-d77e-4c4d-9cb4-a98f7b41d034">2,100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi02LTEtMS0xMDc5NTc_c623a656-0ee5-44bd-870f-0a9929e94ce7">2,906.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24dcaeab411b4af8a6f85a2871d1bbc9_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi0yLTEtMS0xMDc5NTc_4d101c68-1f66-45fe-a143-54ac439d8158">626.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a871a4c3174df7933da7c6f14e608e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi0zLTEtMS0xMDc5NTc_868cd627-e5d6-41e4-ab02-3d0a29012272">1,111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058c9fcddfcb4b1fbe11fc320f77993d_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi01LTEtMS0xMDc5NTc_dbcd5d48-63d9-48f7-bf09-7fe0261c82fc">1,354.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6dda388f7b41c38ba9e6e639ffcccc_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi02LTEtMS0xMDc5NTc_94ab84cf-9399-4f2f-98a0-9c8c504d2682">2,217.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05806bc883904e079e94fe4711a9df85_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy0yLTEtMS0xMDc5NTc_9083b427-d573-4ec9-bba1-262f2ed901c6">210.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694b9650b4154c7a9932f7c343e478ad_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy0zLTEtMS0xMDc5NTc_3408357e-9151-43d7-b86f-c16cadf6f311">157.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904efd675fc84cb4a2bd864cdd35efb3_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy01LTEtMS0xMDc5NTc_06df51a8-5cb3-4ab6-805f-e90f052407fe">369.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364049c727f64c5fb9da068da0a5f058_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy02LTEtMS0xMDc5NTc_b034504b-1aeb-410d-949a-a9aae93cd915">354.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefff25e1fa9f4bf28ac85461fcab5263_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC0yLTEtMS0xMDc5NTc_07114a11-72b7-491d-92d2-1e2c7088dbf4">183.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb1b8233acc4dc4b6b32e2401873bfa_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC0zLTEtMS0xMDc5NTc_4d16a74a-6c43-4825-9313-66cfd6467986">162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1344c7b5279d47b78b2c5cf3500112f0_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC01LTEtMS0xMDc5NTc_0a3c0016-6ca0-4ff2-a972-b541f88c8fe3">366.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f792878945149fbaac1be5445470b02_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC02LTEtMS0xMDc5NTc_fe1e4bd4-6605-45bc-9fef-c3d64accd593">325.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c691696ff746668ac0cedf53217ef9_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS0yLTEtMS0xMDc5NTc_9803248f-a73b-4c2d-9f54-04615c14bc70">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8a0fe062b74f88bdbdc98402f1f734_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS0zLTEtMS0xMDc5NTc_a770d66c-7cd1-44cb-af87-4f21288bae24">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ed6153920c41a589f4f344f8dc62d0_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS01LTEtMS0xMDc5NTc_ba400d69-b5ea-40fc-a2be-3e6964d8f88a">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44fcf0cfb084b098571baf1d7dead87_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS02LTEtMS0xMDc5NTc_4d74b615-e8b6-4343-960c-b8e27e941b99">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi0yLTEtMS0xMDc5NTc_7528de01-8e2d-4a00-9886-f4f2ba9d889b">1,026.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi0zLTEtMS0xMDc5NTc_29b10a60-cd69-457c-91ee-7565e945b5c3">1,435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi01LTEtMS0xMDc5NTc_682bd24e-11b9-4a54-a07a-c16a79085e65">2,100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi02LTEtMS0xMDc5NTc_cec9398b-0f8f-49da-abfb-a90d6bf842e7">2,906.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company&#8217;s products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company&#8217;s performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from laboratory testing services, which is generated by the Company&#8217;s Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="ib4c05d63c7214b64ac65fbfafb9d0bb7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company&#8217;s contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company&#8217;s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNjkzNQ_cadfa5bc-5154-4212-875d-5e47a0df1f5b">857.4</ix:nonFraction> million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company&#8217;s Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="i04aefe98ed524fa9b9e204dc0508b87f_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzE3Ng_b1c6b20d-8b79-4b2b-9a3f-d935ca3aad98">26</ix:nonFraction>% of this amount as revenue in fiscal 2023, <ix:nonFraction unitRef="number" contextRef="i7c473319bb7c41ebbe6a91f325696f90_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzIyMQ_00fef6fb-761e-422c-a722-c7389e3f9ecb">36</ix:nonFraction>% in fiscal 2024, <ix:nonFraction unitRef="number" contextRef="ibf681aba2c0745179379eda917259f24_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI0MA_479e140c-f856-4fff-befe-c0878e2bbc4c">23</ix:nonFraction>% in fiscal 2025, <ix:nonFraction unitRef="number" contextRef="iae8494d630974166892e8a6e322ce2c4_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI1OQ_6a279906-d103-4e32-b9a7-5032870bb3ab">11</ix:nonFraction>% in fiscal 2026, and <ix:nonFraction unitRef="number" contextRef="i201acc12848f4295aca92e64a29fae3e_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI4Mg_2925d1b8-32d2-4de4-9547-69b002a658c6">4</ix:nonFraction>% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company&#8217;s conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company&#8217;s Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfODU2OA_46c91f1b-c5b0-47f7-9411-f26c1a20e619">34.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfMTA5OTUxMTYzNzQ0Nw_5313331f-8218-4b80-af68-cbebfaa05a3e">101.3</ix:nonFraction>&#160;million in the three and six months ended April&#160;1, 2023, respectively, that was included in the contract liability balance at September&#160;24, 2022. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfODU3NQ_a2a24f0c-e8d9-4ed1-b31c-4f6d42bfe099">30.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfMTA5OTUxMTYzNzQzMg_7a7f5f9f-5b3b-49df-aa37-cafe8cefaa4c">87.3</ix:nonFraction>&#160;million in the three and six months ended March&#160;26, 2022, respectively, that was included in the contract liability balance at September&#160;25, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfMTAwNA_9832bd40-a1e3-428c-8718-b77fd2910073" continuedAt="i144213ffa596444eb34aa5cc10ecccd2" escape="true"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfMTAwNA_db9fc8f8-d5aa-4177-a423-ea1a4a8cd3c2" continuedAt="i55224be10cd8430ebdb026073f0d3d8d" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i144213ffa596444eb34aa5cc10ecccd2" continuedAt="i09268671702c40cd9072f616f6d7b2f6"><ix:continuation id="i55224be10cd8430ebdb026073f0d3d8d" continuedAt="i9a1c73c004c246ce97d9dc2df9f1a967">Lessor Activity - Leases where Hologic is the Lessor</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i09268671702c40cd9072f616f6d7b2f6"><ix:continuation id="i9a1c73c004c246ce97d9dc2df9f1a967">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than <ix:nonFraction unitRef="number" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfOTM1_0576676c-e2d8-4efc-ab55-5cac3f48dcba">3</ix:nonFraction>% of the Company&#8217;s consolidated revenue for all periods presented.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (4) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzQwNg_ae57131d-5a3d-456c-a7d3-3ba5c9144011" continuedAt="i7ad6866cf6a74041bf8e327559bab7b3" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7ad6866cf6a74041bf8e327559bab7b3" continuedAt="ie1ef5fc12f704eadbc4c1bbf141ad1a8"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of interest rate swaps, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value, which is based on Level 3 inputs. The contingent consideration liability as of April&#160;1, 2023 and March&#160;26, 2022 was related to the Acessa acquisition. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="ie1ef5fc12f704eadbc4c1bbf141ad1a8" continuedAt="i51e30ec2acc54c27a20cf5a5efb9056d"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzQyMA_6fd78634-33d9-4d27-852f-004472726295" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at April&#160;1, 2023:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:41.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.741%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd296de48514683a96ee90d09cf647b_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC0xLTEtMS0xMDc5NTc_1f6962d4-6185-4c0b-91af-c68efdd5a1ae">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb3334f07144b1eb56036eff778881d_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC0zLTEtMS0xMDc5NTc_5abec9c2-d928-4802-8d86-4fcb92c35cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931efb624c5240ec87bbbb2d5e3977f2_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC01LTEtMS0xMDc5NTc_1326dc11-465c-43c4-8c57-a626d290efd2">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e076bd0f834d7587361fc0c5740091_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC03LTEtMS0xMDc5NTc_a7d5fb47-ace3-401d-a3ac-ddad78d9c9e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd04ba0e0c14cbabfcf0fd0dbb55c00_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi0xLTEtMS0xMDc5NTc_c232bc7f-a5ee-46a8-9673-0105105e8cee">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b47f9030b34b429bca8c704864b6a6_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi0zLTEtMS0xMjUyNzE_1d145ca7-a5e9-4cd1-9005-6c401f235b2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0703bcc24f48e681cbcfeb3a9412ed_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi01LTEtMS0xMDc5NTc_4e10d954-8ed1-4847-8fc3-df4719e9f279">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363eb4ee29e54e13ac0aefa0ccbb0a81_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi03LTEtMS0xMjUyNzM_16bc3ad8-7fce-4f18-930b-87715c2023b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7048c5fe4e141f89ff18d17889ef492_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy0xLTEtMS0xMDc5NTc_0a1f6855-c805-4cd1-8594-984a4fa1f80c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia339d290baa7479185ee1c02c1479b85_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy0zLTEtMS0xMDc5NTc_94833bfc-dec3-4a33-80d9-4b3047e575e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1e849e105045cc82813ffd84975071_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy01LTEtMS0xMDc5NTc_59a6aeb5-536f-485a-b22e-29bb7409f05a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76b381e70524c158eaecba0aab88c70_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy03LTEtMS0xMDc5NTc_bbbffaa1-dc0f-4841-8fec-ee32b473d2e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC0xLTEtMS0xMDc5NTc_6f888091-54d4-4746-8710-be8a3177092e">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0364527a074f269837eb697e13e3e9_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC0zLTEtMS0xMDc5NTc_edefb9a6-7759-436c-be12-65fbb462ae53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cc5c24426b411f8a9f807c5312d497_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC01LTEtMS0xMDc5NTc_69e6eef6-0877-46c6-9438-fcf68997a88e">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3611e0322f3842f69d4e5f89028d5c5a_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC03LTEtMS0xMDc5NTc_728308e2-77b5-4c20-b3d7-be41cee11fcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad19bdd30714b10a58f86bc3fcc3d06_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtMS0xLTEtMTA3OTU3_4b49b93b-36d7-4005-887d-6d6a572e1d46">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide78313ff5a246378c00a3dc183d036a_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtMy0xLTEtMTA3OTU3_9401099c-f118-40ca-aead-7cc203c77426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f863ea4d044887a4fe175344a4ca00_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtNS0xLTEtMTA3OTU3_a7258fbe-f30e-4c71-9da1-195f9856b4a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95a1ff83f2346e5bcbf04f2536fd2f8_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtNy0xLTEtMTA3OTU3_30c2bb87-65eb-4d9a-a0c9-fc16d637c2a8">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd296de48514683a96ee90d09cf647b_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtMS0xLTEtMTA3OTU3_475b4354-72f4-4c5c-9a3e-62dc030e546d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb3334f07144b1eb56036eff778881d_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtMy0xLTEtMTA3OTU3_65726090-5ac9-4a61-9201-ff26a65c49b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931efb624c5240ec87bbbb2d5e3977f2_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtNS0xLTEtMTA3OTU3_c1493a04-4fbe-4d8d-9a08-4f3e6e4b12d2">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e076bd0f834d7587361fc0c5740091_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtNy0xLTEtMTA3OTU3_1791c4c5-ef2c-4179-9e55-d2ef3abf4306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7048c5fe4e141f89ff18d17889ef492_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItMS0xLTEtMTA3OTU3_3619a727-fec9-4690-85e1-5aaa7ba08d72">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia339d290baa7479185ee1c02c1479b85_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItMy0xLTEtMTA3OTU3_544c84de-c9cb-45d6-abc0-2c9e0221e17d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1e849e105045cc82813ffd84975071_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItNS0xLTEtMTA3OTU3_832457c6-8115-4d60-a322-cec6e5923e66">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76b381e70524c158eaecba0aab88c70_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItNy0xLTEtMTA3OTU3_c59310bb-bc2c-4ee2-b8e9-e39d7faa4e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtMS0xLTEtMTA3OTU3_8c11ed75-890f-4097-8724-fe95700d9236">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0364527a074f269837eb697e13e3e9_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtMy0xLTEtMTA3OTU3_14b54c83-7cf3-4988-9d50-d0723ba1acd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cc5c24426b411f8a9f807c5312d497_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtNS0xLTEtMTA3OTU3_0858dc19-dfee-414f-97e4-7067f4640d12">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3611e0322f3842f69d4e5f89028d5c5a_I20230401" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtNy0xLTEtMTA3OTU3_36ebbb75-7b4b-45a1-8e28-d5d55860d7aa">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended April&#160;1, 2023 and March&#160;26, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi0yLTEtMS0xMDc5NTc_f596af47-4bec-4597-9e6c-1f4a63319b85">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673ceda2567b4fa094005314999c6692_I20211225" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi00LTEtMS0xMDc5NTc_1e87ece9-e130-452a-a93c-1030061a268d">71.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi02LTEtMS0xMDc5NTc_c4cbafb1-31ae-4f43-a136-f854ee83c9b5">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi04LTEtMS0xMDc5NTc_d26dc0a2-c148-486a-8fdd-759efeb9f18f">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy0yLTEtMS0xMDc5NTc_515ae71f-dd2e-42e2-b22f-8dae6ad18028">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy00LTEtMS0xMDc5NTc_cdd7edde-309b-497f-9856-551ada356e20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy02LTEtMS0xMDc5NTc_18305027-d6cb-47a0-9dfb-6edade69a942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy04LTEtMS0xMDc5NTc_045aac6f-0f22-4044-bc05-d6b1d9cbbf33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC0yLTEtMS0xMDc5NTc_a6f4a284-933e-419c-a743-383ff5f3f39a">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC00LTEtMS0xMDc5NTc_16d27818-56bb-4351-81a2-47fdfb09733a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC02LTEtMS0xMDc5NTc_5232f4e5-7567-497f-bf71-7728ba324156">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC04LTEtMS0xMDc5NTc_e5092b15-4304-4662-9d67-b06ded34290c">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS0yLTEtMS0xMDc5NTc_1d11a4f8-0a20-4e96-bfcb-b57226306121">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS00LTEtMS0xMDc5NTc_d5ed0cd2-343f-4735-b050-6a3c8a50226a">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS02LTEtMS0xMDc5NTc_47e18b54-1825-4bd2-9f8b-bf9a60eb268d">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS04LTEtMS0xMDc5NTc_a18e87a6-ad38-43ce-bf7a-051b5743bf6e">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi0yLTEtMS0xMDc5NTc_191137a4-377d-4743-8f3c-2293ce7d2822">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi00LTEtMS0xMDc5NTc_74abe91f-8f47-4f8c-8057-749fe1a439ff">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi02LTEtMS0xMDc5NTc_147e5bdc-a3e0-4da1-89a9-a036ec9947b4">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi04LTEtMS0xMDc5NTc_dbf4f3c3-74f7-43e7-bf51-334f153e5f80">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i5abefbe66a5f4800a36fd4789769988d_D20211226-20220326" decimals="-5" name="us-gaap:LossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTc1NA_cd7af470-6552-4a3f-9047-5154babf6bac">4.3</ix:nonFraction>&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, interest rate swaps, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swaps, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i51e30ec2acc54c27a20cf5a5efb9056d">Amounts outstanding under the Company&#8217;s 2021 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401" decimals="-7" name="holx:PrincipalAmountOfBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTQxMg_0d1d8716-36e2-49de-8843-e74df44085b6">1.5</ix:nonFraction> billion aggregate principal as of April&#160;1, 2023 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzA4NQ_628e7258-4f02-4b0c-86f4-93a0c77de26c">4.625</ix:nonFraction>% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) and <ix:nonFraction unitRef="number" contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzE0MA_32630c55-e5f1-4efa-8e00-a6482dab80e5">3.250</ix:nonFraction>% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) had fair values of $<ix:nonFraction unitRef="usd" contextRef="i1c8339ad8e024acf93252e724b2036bd_I20230401" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTMyOQ_4922880b-4630-451a-9dbd-f0d685e0ef1f">388.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iba44341dbd4c49499423c450d88a5f7b_I20230401" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTM2MA_d808fed3-0c05-43a6-b6da-e3c11c3a533d">848.4</ix:nonFraction>&#160;million, respectively, as of April&#160;1, 2023 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.</ix:continuation></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (5) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwMA_ca9314ef-d26e-4cd9-8313-411ae18b5253" continuedAt="ia78b4ad27e6f4c19ac6b40b0ad02c3c7" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="ia78b4ad27e6f4c19ac6b40b0ad02c3c7" continuedAt="i4e04ab91b1704c81924f81e6df2d4750"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2022 Acquisition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. (&#8220;Bolder&#8221;), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMjA1_dd62bcd2-581b-4006-8eca-dac3c9515f55">160.1</ix:nonFraction>&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder&#8217;s results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwOQ_36ac64a3-35ba-4814-beb9-faa33cd808c4" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder&#8217;s tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMC0yLTEtMS0xMDc5NTc_21ac41e9-84c8-460e-9319-1176c604b365">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMS0yLTEtMS0xMDc5NTc_502b1188-0e02-434e-a994-da6472f5f380">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMi0yLTEtMS0xMDc5NTc_16f9b410-6437-4be0-a184-e03bf62f7d3f">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfNC0yLTEtMS0xMDc5NTc_eaa80f97-16cc-44df-a4e6-9c70f43df9d8">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfNS0yLTEtMS0xMDc5NTc_ec76aa96-8e90-4a3e-8602-39e3d6d97d53">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfOC0yLTEtMS0xMDc5NTc_490c73ec-2cf3-4318-8547-acd1287e26c4">73.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfOS0yLTEtMS0xMDc5NTc_04e8d6d0-5609-4071-84c4-4025ba0e1213">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTAtMi0xLTEtMTA3OTU3_798444b6-2bcd-43d6-a7b7-ed614593dbe0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTMtMi0xLTEtMTA3OTU3_a63e1491-18c8-41f6-a870-122d8c8e6778">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTQtMi0xLTEtMTA3OTU3_f1c0aa68-8ab4-413b-9148-4bd37dfba70d">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTUtMi0xLTEtMTA3OTU3_02d7dd07-da73-475c-8a73-5792b80a2a4b">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder&#8217;s business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129" decimals="2" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTIzMQ_db7dde95-b323-4e44-8160-d268c127f287">16.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder&#8217;s products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is <ix:nonNumeric contextRef="i3b8baa43f0c444d9967f0f28cc75f205_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_0621d8f3-6b4f-4140-beae-db5af14ce9cc"><ix:nonNumeric contextRef="i47652b3263ee45bebe444c08c403cbb7_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_0df04b2b-fb55-474e-85bf-64c99ad43a62"><ix:nonNumeric contextRef="i928aae1d79e6431e905c9e98405eefaa_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_8ae6d13c-30a9-4f4e-a038-5d10fffd5eb3">10</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company&#8217;s surgical portfolio and utilizing GYN Surgical&#8217;s sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i4e04ab91b1704c81924f81e6df2d4750"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. (&#8220;Acessa&#8221;), which was acquired in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $<ix:nonFraction unitRef="usd" contextRef="i6dfbd32be37f4246a381b2110a8442cf_I20200823" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMjc4OQ_b21041cc-e9f2-4f75-bdcf-734104da2ee6">81.8</ix:nonFraction>&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a <ix:nonNumeric contextRef="i0e135792ff2e44028a70fbd8451b5761_D20200823-20200823" name="holx:AnnualIncrementalRevenueGrowthPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwMw_ce7031ca-c851-49da-adc4-57d38b046e26">three-year</ix:nonNumeric> period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change, and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company&#8217;s estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i4433cc201f8a4406b5cfe583df4d23c5_D20210926-20220924" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDExMA_64f75754-2c2d-4e81-83f4-ca08bc6ca399">39.5</ix:nonFraction>&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="ibd53b814f8d744b79592fbfe99c58ed7_D20210926-20211225" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDQ3Ng_5f1f5d56-d6a9-4125-b1bb-c174a1b44494">4.1</ix:nonFraction>&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $<ix:nonFraction unitRef="usd" contextRef="ic36e281c399144c0bad6cda43a4171d1_D20211226-20220326" decimals="-5" name="holx:BusinessCombinationContingentConsiderationPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDY3OA_db6c6f14-d055-4c4c-8c5a-055facdcc6e4">12.2</ix:nonFraction>&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in a payment of $<ix:nonFraction unitRef="usd" contextRef="ife2f479793bd48879075f83c4865d01a_D20230101-20230401" decimals="-5" name="holx:BusinessCombinationContingentConsiderationPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDg0Mg_f729b032-1a6b-4781-991a-d6037020c7b8">7.6</ix:nonFraction>&#160;million, which was made in the second quarter of fiscal 2023. During the second quarter of fiscal 2023, the Company updated its forecasted revenue and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="ife2f479793bd48879075f83c4865d01a_D20230101-20230401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTQ5NzU1ODE5Njkz_779f7809-2214-4108-ab08-6f9438841079">12.4</ix:nonFraction>&#160;million to record the liability to fair value. The reduction in fair value was due to a decrease in forecasted revenues over the remaining measurement period. As of April&#160;1, 2023, the contingent consideration liability was $<ix:nonFraction unitRef="usd" contextRef="i2a2cca1bc72f4a3b8b4112b767c117da_I20230401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDk5Mg_d9f8272b-ed14-4589-ac1d-181ebcfc27a7">3.4</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_52"></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE5ODAy_f9724492-ba7e-42c0-a27a-af4d4d064789" continuedAt="i5e51705618b64ff197446dca48d2c853" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company&#8217;s Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022 but were not informed of their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $<ix:nonFraction unitRef="usd" contextRef="i24a5378b5efe4b46aadd68616949b0e6_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTMwOA_26b05f93-8619-4586-b33f-3cbe23f1f96c">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9b57347bb632482e8fc7285916ac3e23_D20220925-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE1NjYx_619c9c36-6d6e-4bfc-aed9-41b7d7f1221b">1.0</ix:nonFraction>&#160;million during the three and six months ended April 1, 2023, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i5117d87aa771468c8a93f0fb49b868e5_D20210926-20220326" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTM1MQ_199d3a15-d4e0-4c2d-b3ef-69ed85ad1eaa">1.6</ix:nonFraction>&#160;million in fiscal 2022. The Company estimates that total severance charges, including retention, will be approximately $<ix:nonFraction unitRef="usd" contextRef="iae729caa8b26476fa7e95ea535cdece8_I20230401" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTQ3OQ_0a1117b6-7b6a-4ba2-92d5-34e1cf950fbb">5.5</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:continuation id="i5e51705618b64ff197446dca48d2c853" continuedAt="i31f1df0b474e46088dac5d03983ac164"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first and second quarters of fiscal 2023, the Company made various decisions to consolidate and close certain offices in Germany and in connection with such actions to terminate certain individuals across all divisions in multiple departments. For the three and six months ended April 1, 2023, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i0e366dca1317445a953da3bfcef32ef7_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4Mzc1_b4900c8d-7ff2-4252-8574-b8496e116f24">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1cf6687d788e4af28817964ae346e8c1_D20220925-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4Mzg5_440f2efc-225c-4300-ba83-b32ddcba75e6">1.9</ix:nonFraction>&#160;million, respectively, primarily for severance benefits related to these actions. These charges were recorded pursuant to ASC 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Postemployment Benefits</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i31f1df0b474e46088dac5d03983ac164"> (ASC 712) or ASC 420, depending on the employee. The Company estimates that total severance charges will be approximately $<ix:nonFraction unitRef="usd" contextRef="id871579f75c04445a8b7aca98eb0f84b_I20230401" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4NjIw_f0c093dc-9ecd-4769-80bc-61bfbb73afe6">3.9</ix:nonFraction>&#160;million, and the actions will be completed by September 2023.</ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI2MQ_0a6f4614-48f0-4fd1-a46e-c41608b8c2d3" continuedAt="i7a05faef8059416dabd1ece02ad2d19c" escape="true">Borrowings and Credit Arrangements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7a05faef8059416dabd1ece02ad2d19c" continuedAt="i9b298b31732245ab9b9a02b87d12138d"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI1OA_4faceacf-197b-430e-8823-bba1a1ecdd5e" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMi0xLTEtMS0xMDc5NTc_1b348a09-201b-4d3b-abff-b4a2f2452552">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a8fa6d9cf640188c80440fc42539f2_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMi0zLTEtMS0xMDc5NTc_d08a9b3d-1e9f-4a55-ba73-7fa4fcf1af55">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfNi0xLTEtMS0xMDc5NTc_b3c57850-02c1-4608-b910-9a601334a660">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfNi0zLTEtMS0xMDc5NTc_525a5f4d-6e47-449e-8893-c849e204cc5f">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfOC0xLTEtMS0xMDc5NTc_c8a88333-44cd-42eb-94d9-62337dacf2fe">1,463.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a8fa6d9cf640188c80440fc42539f2_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfOC0zLTEtMS0xMDc5NTc_1846f8a4-592a-496a-8368-450bfa4c2393">1,475.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d8a9c2381e4790949255fbef7b39ab_I20230401" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTAtMS0xLTEtMTA3OTU3_784e7f2b-dc7a-4339-a4d6-121ed50620ee">396.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia56ec6c8bc03468eb039dadf25c0a74d_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTAtMy0xLTEtMTA3OTU3_ca174611-ba8d-4463-ba63-f68517cb315d">396.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8578d43dfaf64c8aa2e2a99308499a06_I20230401" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTEtMS0xLTEtMTA3OTU3_b27015a5-d169-4ac3-a5d5-8cb0181f6570">937.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3e905270394c109f6dc2a65bef2a27_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTEtMy0xLTEtMTA3OTU3_8ac1c842-9c25-451b-a7e4-2b138d105fd8">936.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTMtMS0xLTEtMTA3OTU3_6e2bbfa6-d393-4919-825a-8214309452b4">2,797.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTMtMy0xLTEtMTA3OTU3_5438b017-d795-4b2e-aed8-33c4cef35918">2,808.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTQtMS0xLTEtMTA3OTU3_7fb5a0ba-500d-4331-b6f7-e4905e4bdb7a">2,823.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTQtMy0xLTEtMTA3OTU3_6df4334d-f25a-4e32-b5ca-a824046e63e0">2,823.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the &#8220;2018 Credit Agreement&#8221;) by entering into a Refinancing Amendment (the &#8220;2021 Credit Agreement&#8221;). On August 22, 2022, the Company further amended the 2021 Credit Agreement to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provided a $<ix:nonFraction unitRef="usd" contextRef="i5618fbac4e2b4be5a3ede449c24b7524_I20210927" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfOTkz_b1d0c014-a666-4309-b3f8-8b49c4720e8d">1.5</ix:nonFraction>&#160;billion secured term loan facility (the &#8220;2021 Term Loan&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="ic3c7a85f58744f0b81a452662f16cdf2_I20210927" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA1Mg_82a5bf94-6c2d-4a98-8ee5-1a86982a62ff">2.0</ix:nonFraction>&#160;billion revolving credit facility (the &#8220;2021 Revolver&#8221;). As of April&#160;1, 2023, the principal amount outstanding under the 2021 Term Loan was $<ix:nonFraction unitRef="usd" contextRef="ib2d817532d0340fc8fdcd0aa45fe0b08_I20230401" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTE5MQ_0286e8f3-ced2-4575-ac81-e380cb97f6da">1.5</ix:nonFraction>&#160;billion, and the interest rate was <ix:nonFraction unitRef="number" contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjA3NA_c6feaeab-e1aa-4743-91dd-e44c814333bb">5.91</ix:nonFraction>% per annum. No amounts were outstanding under the 2021 Revolver, and the full amount was available to be borrowed by the Company. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="i362f953e083846c1a0d8a19e3a3d35a4_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTc4MA_67cb05ac-46f9-4b9b-926e-2f3e44431ddd">0.7</ix:nonFraction>&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $<ix:nonFraction unitRef="usd" contextRef="i36b0a0a905884991b094498a4388a459_I20230401" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjA2OQ_b502b2bc-fc8a-4e1d-b911-e9d0193f19c1">7.0</ix:nonFraction>&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI2OQ_3f9450e9-d38a-4e3d-aa01-3a31229076aa" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi0xLTEtMS0xMDc5NTc_df9ca517-bb0e-436a-9605-06d680df9d46">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi0zLTEtMS0xMDc5NTc_0937a620-3c7e-482f-a9e3-235ec8911bfe">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi01LTEtMS0xMDc5NTc_ee9e590b-3491-4a81-9745-c26794bdd38b">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi03LTEtMS0xMDc5NTc_7019add7-57bb-4716-a648-e1f160da0ee1">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy0xLTEtMS0xMDc5NTc_214af9cc-83a6-4943-9734-acd7f3f4e8d6">5.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy0zLTEtMS0xMDc5NTc_6c08ccc0-a8db-4de4-a1fa-0c6173f908c2">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy01LTEtMS0xMDc5NTc_1e0a02e2-1b92-4cc3-b0b4-feb5d13aecee">5.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy03LTEtMS0xMDc5NTc_98de32d7-36fa-4fa7-8c87-42365d9f2b49">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC0xLTEtMS0xMDc5NTc_c6feaeab-e1aa-4743-91dd-e44c814333bb">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03d18c480fcf4620b188b43833f9d17f_I20220326" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC0zLTEtMS0xMDc5NTc_8a413712-885a-4ce3-8735-402c1087fce0">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC01LTEtMS0xMDc5NTc_9ccf7def-cf50-4b22-869b-313e627de41a">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03d18c480fcf4620b188b43833f9d17f_I20220326" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC03LTEtMS0xMDc5NTc_2fe0b3dd-86c2-4525-acf4-a7a86f439ba5">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s currently effective interest rate swap agreement, which fixes the floating rate on $<ix:nonFraction unitRef="usd" contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjM5Mg_407d29d3-5fd4-4d85-9299-ebbbe4a6405c">1.0</ix:nonFraction>&#160;billion of aggregate principal under the 2021 Term Loan at <ix:nonFraction unitRef="number" contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjQ0Ng_fb0dc333-5740-4c71-92a2-c09d5ea212b3">1.23</ix:nonFraction>%, resulted in the Company receiving $<ix:nonFraction unitRef="usd" contextRef="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjQ4NA_5d8dca88-2e47-418a-aa74-908641ff6089">8.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjIzOQ_caf696e3-1aa8-4132-9611-54bdb2db6ce6">15.2</ix:nonFraction>&#160;million in the three and six months ended April&#160;1, 2023, respectively, which was recorded as a reduction to interest expense.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="i9b298b31732245ab9b9a02b87d12138d" continuedAt="icb88b1884b3840ea9460d2bb7b4680be"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of April&#160;1, 2023, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had <ix:nonFraction unitRef="number" contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjMxNA_628e7258-4f02-4b0c-86f4-93a0c77de26c">4.625</ix:nonFraction>% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzEwNA_fcb8784e-8d2b-4e58-85d9-aa3ca1e25830">400</ix:nonFraction> million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#8217;s domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had <ix:nonFraction unitRef="number" contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjMxOQ_32630c55-e5f1-4efa-8e00-a6482dab80e5">3.250</ix:nonFraction>% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzQ3OA_42daf6ff-3c50-49b8-816f-bffa97f57a33">950</ix:nonFraction>&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#8217;s domestic subsidiaries and mature on February 15, 2029.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI0OQ_f4b2420b-f3a8-4f8a-9c3e-e88e957f1888" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy0xLTEtMS0xMDc5NTc_628e7258-4f02-4b0c-86f4-93a0c77de26c">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26561fc220c41d4965d21fca20289a2_D20230101-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy0zLTEtMS0xMDc5NTc_0cab1f68-16da-47e4-86fa-9b17a0c0db17">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736ad9f5dec146508d1fd621891e1303_D20211226-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy01LTEtMS0xMDc5NTc_cdb4f438-5269-4413-84fd-27daee9336da">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c06da9d32e45ea8c28dfd12b49dd4f_D20220925-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy03LTEtMS0xMDc5NTc_8848fe32-9028-40ea-a9ed-d21bb0b3091a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68128aa8157c4c17b7462201023eebd7_D20210926-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy05LTEtMS0xMDc5NTc_ad9f06c5-22ef-48a0-bde3-01ac801d85d5">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC0xLTEtMS0xMDc5NTc_32630c55-e5f1-4efa-8e00-a6482dab80e5">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2199bd16f8427796fe11603f851c83_D20230101-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC0zLTEtMS0xMDc5NTc_069daeca-98a7-4b1a-8896-23fe4e13d90e">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec05146aaacd45a6ba9801ae96e2a6b4_D20211226-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC01LTEtMS0xMDc5NTc_7e83cb36-efb6-4bc4-9fee-3edf7758cdd8">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4009b1b411c4bd99225528c5754c15a_D20220925-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC03LTEtMS0xMDc5NTc_8df82f03-c03f-419a-bb68-01f134bf4712">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246a361fa54143f2b5d14724951a2680_D20210926-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC05LTEtMS0xMDc5NTc_a6fb36ec-9384-4389-8504-0a92ec25995b">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88474659b3544a10823c37e769f86d35_D20230101-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS0zLTEtMS0xMDc5NTc_5b9755ec-a92f-4530-9b7f-6166b814d438">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib471a4ccd83240ae9ed952772145134a_D20211226-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS01LTEtMS0xMDc5NTc_581ef99d-f111-4fa7-ab2e-0a6200b3c65d">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie900720f8e2b4ab09db04fe14ad224e5_D20220925-20230401" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS03LTEtMS0xMDc5NTc_cc865ff2-355f-4a54-969d-7bab34a59704">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037d769c2b574a0992ee94f32441bc77_D20210926-20220326" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS05LTEtMS0xMDc5NTc_452fcb58-2587-4158-be80-b1294de8d140">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb88b1884b3840ea9460d2bb7b4680be">During April 2022, the Company repaid the outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="i382a786b487046818da8713340a3f1bc_D20220401-20220430" decimals="-5" name="us-gaap:RepaymentsOfOtherDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzg4NQ_23cd7501-b3bc-4d39-8306-5a21b984bb17">248.5</ix:nonFraction>&#160;million under its accounts receivable securitization program (the &#8220;Securitization Program&#8221;). On June 10, 2022, the Company amended the agreement governing the Securitization Program temporarily suspending its ability to borrow and the need to comply with covenants for up to a year. On March 31, 2023, the Company terminated the Securitization Program.</ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RleHRyZWdpb246ZjQ2YTQzMTE5OGE1NGQxMWEwYWMwYmUxYThhNGIyNDVfMTkwMQ_48e60e32-d61b-4cc9-8961-6d1c56630fef" continuedAt="ia6a9f468ab314e59b539d126a777eec6" escape="true">Trade Receivables and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia6a9f468ab314e59b539d126a777eec6" continuedAt="i9c05115a6d054852bd8ec2986c1190e6"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic and inflation, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RleHRyZWdpb246ZjQ2YTQzMTE5OGE1NGQxMWEwYWMwYmUxYThhNGIyNDVfMTkwMg_afefa246-9b96-43d8-b631-d0b1813e80ec" escape="true">The following is a rollforward of the allowance for credit losses as of April&#160;1, 2023 compared to March&#160;26, 2022:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i9c05115a6d054852bd8ec2986c1190e6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:22.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-offs,<br/>Payments and Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi0yLTEtMS0xMDc5NTc_75824aa6-6435-48a6-9139-7280caab4afe">37.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi00LTEtMS0xMDc5NTc_9a922750-4087-4dd5-8d92-d138aa3c8a6d">1.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi04LTEtMS0xMDc5NTc_ce258002-5679-40fe-bd53-c7208316245f">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi0xMC0xLTEtMTA3OTU3_fd195e30-5518-487c-a79c-c79d96925d61">39.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy0yLTEtMS0xMDc5NTc_5cc43940-260f-4356-a93b-fd9038caaee5">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy00LTEtMS0xMDc5NTc_1aa85082-88a4-4033-ae4e-5985b262f074">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy04LTEtMS0xMDc5NTc_9da65642-f5a5-4202-90a5-f3db0a496d2d">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy0xMC0xLTEtMTA3OTU3_3425de09-618b-4941-be61-f75f5a80412f">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzcyNQ_04a45016-15d3-4553-b7d8-3fc2d10f75c6" continuedAt="iff9312cfdfe042558a0eac78eaf3082f" escape="true">Derivatives</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iff9312cfdfe042558a0eac78eaf3082f" continuedAt="idf6db23524e549f99209e725ef309b71"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps - Cash Flow Hedge</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income (&#8220;AOCI&#8221;) to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023 to hedge a portion of its variable rate debt. On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement) to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to evaluate the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTQyMA_ee3ae9ba-db58-4be3-aa95-0de736224fed">1.0</ix:nonFraction> billion. The restructured interest rate swap fixes the SOFR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTUzMA_ee5f44f8-ac0e-4ca6-acfa-5676ffaf5850">1.0</ix:nonFraction> billion of the notional amount under the 2021 Credit Agreement at <ix:nonFraction unitRef="number" contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTU5MQ_ec8d511f-cb8f-4c41-91e9-1657fba8cddd">1.23</ix:nonFraction>%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTk1Mw_117712a9-c003-485d-9e57-bfcff12af128">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $<ix:nonFraction unitRef="usd" contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMjEwMw_a0913edf-f309-4601-aa95-c4472aa06bdc">26.0</ix:nonFraction> million as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2023, the Company entered into two consecutive interest rate swap contracts with the first contract having an effective date of December 17, 2023 and terminating on December 27, 2024, and the second contract having an effective date of December 27, 2024 and terminating on September 25, 2026. The notional amount of these swaps is $<ix:nonFraction unitRef="usd" contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ1OQ_102ffea0-1c0a-4c67-b993-671a5ac7734d"><ix:nonFraction unitRef="usd" contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ1OQ_e935310b-f43d-445e-93af-f6f82573935f">500</ix:nonFraction></ix:nonFraction> million, and the first interest rate swap fixes the SOFR component of the variable interest rate at <ix:nonFraction unitRef="number" contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ2OQ_72016364-b8be-4fb4-b832-eef048af48bc">3.46</ix:nonFraction>%, and the second interest rate swap fixes the SOFR component of the variable interest rate at <ix:nonFraction unitRef="number" contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ3OQ_3a05e3b4-298b-44bc-8325-342408dad35a">2.98</ix:nonFraction>%. The critical terms of the interest rate swaps are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ4OA_83dcd697-dc47-453e-b69a-91ad93e6860e"><ix:nonFraction unitRef="usd" contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ4OA_fdc4d58f-30d8-4375-a542-54ade1d7cc2c">500</ix:nonFraction></ix:nonFraction>&#160;million of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of these swaps was an asset position of $<ix:nonFraction unitRef="usd" contextRef="ia270fd5f123248878a148a83df3feb24_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzUwMg_07e36867-abd2-4842-b354-739432badafe">1.2</ix:nonFraction>&#160;million and a liability position of $<ix:nonFraction unitRef="usd" contextRef="i1013586a3c0b4067b24800f58a35dfe2_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzUxNg_b82a0309-7e7c-4baf-a672-92bfca91597e">0.4</ix:nonFraction>&#160;million, respectively, as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company&#8217;s cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of April&#160;1, 2023 the notional amount was $<ix:nonFraction unitRef="usd" contextRef="id7733cefdaf04d268e9460397af1c814_I20230401" decimals="-5" name="holx:NotationalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMjk5Mg_0045aec1-cc7d-4970-8dc8-f0569e27515c">200.3</ix:nonFraction>&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, were as follows:</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="idf6db23524e549f99209e725ef309b71" continuedAt="i33d3f8829ec84d9cb095487c62400a3f"><div style="text-align:justify"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczNg_0d288198-58ed-4e45-9ce8-6b35ed48fed7" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy0xLTEtMS0xMDc5NTc_3952387c-2d20-4062-a714-59e9efe5ee82">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy0zLTEtMS0xMDc5NTc_5f1e6983-ecbe-428d-bc44-d5c2518646ab">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy01LTEtMS0xMDc5NTc_1110d13c-9f27-469c-bdec-6fec70a1a6c6">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy03LTEtMS0xMDc5NTc_242a8783-72ef-46ea-a195-3f27e611d5a7">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC0xLTEtMS0xMDc5NTc_6afdccd0-ea43-4f54-9bc7-ae888d17a30c">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC0zLTEtMS0xMDc5NTc_0914c7dc-b2d8-4141-8e62-737e67e809d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC01LTEtMS0xMDc5NTc_faa5d2ad-4fe2-4954-ae42-81ad1f4e35b2">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC03LTEtMS0xMDc5NTc_bd0428ab-85c3-4822-ad9b-da3047ebf9ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS0xLTEtMS0xMDc5NTc_909c1fc1-5b80-49d5-a2c9-0549ffa3b1c9">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS0zLTEtMS0xMDc5NTc_063a8258-1b54-4da1-89f4-3c96430be2d5">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS01LTEtMS0xMDc5NTc_16b9bc13-9f81-46ed-a374-011dd7c4a3ab">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS03LTEtMS0xMDc5NTc_e5abc9ce-f755-4f63-815d-ab8f24451c1d">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy0xLTEtMS0xMDc5NTc_0f0aa0ec-9334-4e1d-8579-f8fadd881c93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy0zLTEtMS0xMDc5NTc_c60748d3-5c47-428d-9136-5ae902b4f744">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy01LTEtMS0xMDc5NTc_4f4d7553-b981-4580-bddf-ccecd02e5620">13.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy03LTEtMS0xMDc5NTc_3f961e2c-6386-492f-a6bc-f8b4c2dca281">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC0xLTEtMS0xMDc5NTc_3f289137-7060-4e06-a4a9-1ca792967171">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC0zLTEtMS0xMDc5NTc_60b9d9f5-15bc-422c-ad01-a6354436a9af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC01LTEtMS0xMDc5NTc_a38c3c91-0f79-4e04-87a2-f990978498d7">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC03LTEtMS0xMDc5NTc_dfdfc7af-7aac-4ee1-9857-05d29e81b93f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS0xLTEtMS0xMDc5NTc_0607fd57-f64f-4a11-b15c-2e7ce8fca165">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS0zLTEtMS0xMDc5NTc_fdd07b8f-9b7e-4c7a-b23e-a1a2f8591da8">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS01LTEtMS0xMDc5NTc_b1c31ead-f182-43de-9498-b902132ed56f">21.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS03LTEtMS0xMDc5NTc_6824b232-f33e-4448-907e-217de5f8e543">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtMS0xLTEtMTA3OTU3_bfc3f980-c49e-4fc4-b6eb-faec4ad81826">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtMy0xLTEtMTA3OTU3_60284582-b2ad-427f-8142-b6b864166dbc">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtNS0xLTEtMTA3OTU3_421a7cff-461c-4cd3-b9d6-1433d804bc35">25.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtNy0xLTEtMTA3OTU3_8a939108-a41a-4917-b368-295d87c17010">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczOA_8d13612e-75ae-4a0c-9edd-131fd35c1a6f" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments as well as their classification on the balance sheet as of April&#160;1, 2023: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388bb22d67bc405a988ad5c4cc5a8547_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNS0zLTEtMS0xMDc5NTc_2f339922-781a-4f8b-8558-8cbcd04c9a28">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i687a30dc10784ff3953d24ed83075533_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNS01LTEtMS0xMDc5NTc_6aae5aef-48fd-405e-b74a-77f5cfb48647">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b069471a6fd4ce1941c6017866f9304_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNi0zLTEtMS0xMTAyMTU_697d08ba-b520-41bb-be3d-7b20ed7a690e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i784d2587627b47089f80bcf128fac206_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNi01LTEtMS0xMDc5NTc_c73dc4f8-6e0c-4a63-9522-72adaa68985c">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ea93c725c840b2ab4f76c58a3c62ed_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNy0zLTEtMS0xMDc5NTc_0da35090-84aa-47d7-b704-cb482d092118">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f4ede37bd5491c9c3625e94d0c9aa6_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNy01LTEtMS0xMDc5NTc_cde46716-8975-4d60-9350-5b87492cb0c3">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4564531536478f92ff8960a39160e7_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTAtMy0xLTEtMTA3OTU3_478cb96a-46d1-4bf5-88ff-4770d490e556">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c899443173415699ab4d5da5e77fc7_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTAtNS0xLTEtMTA3OTU3_517e37a3-d3ff-45db-8152-b64b11ecee7f">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i542498cff24b4020926268c17c708196_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTEtMy0xLTEtMTA3OTU3_05afff63-62ad-42de-bcb3-99c31414e19a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafea2d522ec04d37847e57b9cb641004_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTEtNS0xLTEtMTA3OTU3_b3ffdce6-f131-4331-9bb7-7e31cf8f4854">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic766fff5fd0948058ce9d491f9b85de5_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTItMy0xLTEtMTA3OTU3_364f9181-ade6-42df-95c1-d199d2787f49">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6e3f3bd25843a195f629f91c7fd0af_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTItNS0xLTEtMTA3OTU3_795bfe23-8c45-4b0f-b94f-3a2512f947fb">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291463358b624afe8c68e32119ade5ec_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTctMy0xLTEtMTA3OTU3_9deaf8a3-9234-41cd-b679-aeaa126c3bd7">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f153a4f042425ba023e92476fa0a40_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTctNS0xLTEtMTA3OTU3_5b4d8cb8-d8c3-4922-ba30-b16911c4083a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaad33fabd43401bb9e20fe1c59e848a_I20230401" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMjAtMy0xLTEtMTA3OTU3_71fea3b1-1bdd-4c9d-b1fd-07ca76235565">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i734d4c683d694f60ad32d47670c8e8cb_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMjAtNS0xLTEtMTA3OTU3_c48217af-0d7b-4710-9012-655fcebef294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczMQ_159f6ef1-a69a-4192-a29d-65f066d80412" continuedAt="i5004a666b30e48369bf863c0b331784a" escape="true">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><ix:continuation id="i33d3f8829ec84d9cb095487c62400a3f"><ix:continuation id="i5004a666b30e48369bf863c0b331784a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy0xLTEtMS0xMDc5NTc_f50dda05-1b4c-49f6-9bb2-86fbdf9eec88">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a435b609b8d4c0d8f1f4465429c3589_D20211226-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy0zLTEtMS0xMDc5NTc_8c11b20e-8011-425f-b8b2-83dab6ae4751">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy01LTEtMS0xMDc5NTc_e7a568f4-4aee-49f5-ab42-558fcf44b3e8">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6a7d62503b44f490049c2405cde9d0_D20210926-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy03LTEtMS0xMDc5NTc_56dad036-af13-42d2-86da-7b32c2164470">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS0xLTEtMS0xMDc5NTc_5e873d3d-a432-4264-94a9-fb5435743080">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS0zLTEtMS0xMDc5NTc_b49c9fa3-f00f-4237-bf8a-5dd955068fad">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS01LTEtMS0xMDc5NTc_b713cca5-0818-4995-91f1-f09dc9d41c89">9.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS03LTEtMS0xMDc5NTc_89b7ccef-16e9-4741-b6fa-c5c001a57ce4">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_64"></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODU4MzQz_c11b31a6-7baa-4eef-b137-76a1be9d8d67" continuedAt="i1927ce73bfe1405ca938fc3f34159c8e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) Commitments and Contingencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company&#8217;s summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="i419d4edca16d4132b372c619b71876ba_I20180727" decimals="-5" name="holx:AmountAssessedInDamages" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMTM5_1bf8ec40-6c05-4647-9a5c-066f3bd7b9c9">4.8</ix:nonFraction>&#160;million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties&#8217; post-trial motions, including the Company&#8217;s motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court&#8217;s rulings regarding the post-trial motions. On March 4, 2016, Minerva filed <ix:nonFraction unitRef="petition" contextRef="ie8865820575c4b57a1e17f866a521496_D20160304-20160304" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODU4MjQ2_2555706d-3532-4322-ae3b-f6b9699d3795">two</ix:nonFraction> petitions at the United States Patent and Trademark Office (&#8220;USPTO&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#8220;PTAB&#8221;) declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit (&#8220;Court of Appeals&#8221;). On April 19, 2019, the Court of Appeals affirmed the PTAB&#8217;s final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties&#8217; petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied the Company&#8217;s petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="i81a0b7eab81d4b8d92c778a4c8d79fcd_D20230101-20230401" decimals="-5" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMDk0_1cb876e4-2c14-467d-b4c9-d999d8f7184f">7.4</ix:nonFraction>&#160;million, which included the original award of $<ix:nonFraction unitRef="usd" contextRef="i419d4edca16d4132b372c619b71876ba_I20180727" decimals="-5" name="holx:AmountAssessedInDamages" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMTA4_bc001a3a-aec8-48af-a5e8-ad4893bab87f">4.8</ix:nonFraction>&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses in the first quarter of fiscal 2023.&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1927ce73bfe1405ca938fc3f34159c8e"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva&#8217;s motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#8217;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. On February 15, 2023, the Court of Appeals affirmed the district court&#8217;s judgment in favor of the Company and dismissed the other rulings Minerva appealed as moot. On April 18, 2023, the Company entered into a settlement agreement with Minerva to resolve all remaining patent litigation matters, the impact of which was immaterial.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 450). Legal costs are expensed as incurred.</span></div></ix:continuation><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RleHRyZWdpb246ZDExZDZjNGUxNzIyNGE1NmI3M2Q0YjdjMWQwNGY3OTdfMTA5_3a7d5379-fd8f-4121-a9a7-25b6ca513935" continuedAt="i6f9c54c1f4bc461187aa358682f564d9" escape="true">Net Income Per Share</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6f9c54c1f4bc461187aa358682f564d9"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RleHRyZWdpb246ZDExZDZjNGUxNzIyNGE1NmI3M2Q0YjdjMWQwNGY3OTdfMTA3_4bca92ca-6fae-4ca1-9fe3-e926b5e97740" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi0xLTEtMS0xMDc5NTc_efb9adcf-902f-42e8-bdfd-e83a3445b6ee">247,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi0zLTEtMS0xMDc5NTc_7117924b-c4dd-449c-9d46-f8bca6c73816">251,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi01LTEtMS0xMDc5NTc_37b8f7df-7dd8-421f-b4dc-0d31db6dc7f2">247,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi03LTEtMS0xMDc5NTc_f43f2cb4-c088-46a8-8b9c-db0c461f2c28">252,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy0xLTEtMS0xMDc5NTc_85c087fc-6bf0-4bbb-80b0-8e0b2f662698">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy0zLTEtMS0xMDc5NTc_cb0402c7-f6cd-425a-a040-6af255410c60">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy01LTEtMS0xMDc5NTc_fc3425f8-16a0-4f36-a088-2de4ad0bec41">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy03LTEtMS0xMDc5NTc_65dcf03b-9506-4796-8552-4280a0c13af2">2,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS0xLTEtMS0xMDc5NTc_ce51d86d-767c-4d46-bd83-0679cb585cc8">249,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS0zLTEtMS0xMDc5NTc_8a71329c-7919-4767-a039-1eb8fd2c72d8">253,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS01LTEtMS0xMDc5NTc_aac8e32d-94a8-491b-950c-5eff668d965c">249,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS03LTEtMS0xMDc5NTc_d5ef5e85-148f-4e8c-9af0-66b1947a8136">254,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i795d7b50270e46b59859da10505b600e_D20230101-20230401" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy0xLTEtMS0xMDc5NTc_1efa83c0-3b3f-4bfd-a575-d15d9092f584">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9dd31e84ed8143f59b13dce68511f55f_D20211226-20220326" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy0zLTEtMS0xMDc5NTc_1bed98b2-4cb5-4d89-9985-730b6835a384">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3779670e49d4581b2341db1f4f31165_D20220925-20230401" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy01LTEtMS0xMDc5NTc_a742c7c3-a4b6-41b3-863f-24d7ee924820">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3a076f8486b462fb0308507b0cfd5da_D20210926-20220326" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy03LTEtMS0xMDc5NTc_fb7749f6-a5c5-43df-afad-e01efd6cdaa1">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:4pt;text-indent:24.75pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI2MA_52d08742-b0a3-4f54-ae1e-d6713b10688f" continuedAt="i78c44ed9aaa34b8ca8b1fa1bc34e8bac" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i78c44ed9aaa34b8ca8b1fa1bc34e8bac" continuedAt="if4876409ffc64899963e961e6dcf2af8"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI3NA_2a0ba4ec-ff93-4287-9ef2-cd0d67955bc8" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efcfc733c084819bce8abd34750c81e_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi0xLTEtMS0xMDc5NTc_255c228e-3671-44c9-acf6-ad492d10aabc">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e92370bf72c4c3d8b8468b47a8d76a3_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi0zLTEtMS0xMDc5NTc_5197f991-8cec-409c-a1ae-f44e19629552">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89bee2a95d3497e8c28b3ae3c70aeb6_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi01LTEtMS0xMDc5NTc_99f06c5f-c545-4b5d-83c6-930afc95c0af">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2587dcb18149b982e88c5da8cb0cc7_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi03LTEtMS0xMDc5NTc_419d5d38-9e81-4de9-8450-ae400b548037">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if545f6845c9f47cda87d291c6a78c44b_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy0xLTEtMS0xMDc5NTc_316f7900-9f96-4057-af87-ecb096c2c6ce">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ed81ad27694ec28082eac891f6d828_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy0zLTEtMS0xMDc5NTc_6925eedd-c83b-47e9-b829-f667ce36fdf8">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a667398f82417da0b693cf783d30f2_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy01LTEtMS0xMDc5NTc_98c0f828-6fe0-4c01-8fc0-0f99ea0c7620">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i487840b9375544c692f3e4f0eafc76b6_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy03LTEtMS0xMDc5NTc_9b53496e-4d76-4d4a-8849-27aabb835441">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4a5ccb5a2d4441a9792f5dd886c64c_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC0xLTEtMS0xMDc5NTc_201a52df-27c8-4280-b9d8-00403dfde4d1">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3730699eecd4e8fb9c34c17fc322da1_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC0zLTEtMS0xMDc5NTc_d2acb8e7-a890-4558-9ecf-84e96af97153">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5aae5573096400bba7f7fdd96e479e4_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC01LTEtMS0xMDc5NTc_c8cfb07d-afc2-4e0f-9e42-49f5648a5232">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32fbb9fff77847d99951beda09715376_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC03LTEtMS0xMDc5NTc_4b1e4ef2-8033-4761-91cb-907a94f14b04">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e3e8ebefcf44d38d43290015d3cc68_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS0xLTEtMS0xMDc5NTc_1b3c9936-6468-414d-a7e4-cdbaf9f3638d">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20176e0cc3a546dab26b5191397f4122_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS0zLTEtMS0xMDc5NTc_953ef048-2151-4d71-9527-112f80263c19">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e3a20cda34489b926a83d90efbd85e_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS01LTEtMS0xMDc5NTc_e34cc87b-84bc-401b-8ce1-061da7b145d6">25.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbf39abedf04a86aebfbda7cfdb9417_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS03LTEtMS0xMDc5NTc_84196586-ca4f-4995-9ad0-a9730b23dbac">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy0xLTEtMS0xMDc5NTc_c926c03c-9532-4f30-970c-c1715e2c0b3e">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy0zLTEtMS0xMDc5NTc_0ca23026-eab6-483a-b96e-e6c653583205">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy01LTEtMS0xMDc5NTc_1016846f-98bb-4580-8eca-77aba931f466">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy03LTEtMS0xMDc5NTc_0550e915-4005-4fe7-bf68-e4b75338d85d">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTg4_94624f74-911e-4c84-9057-db0d9e8145cf">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTk1_df6ffd20-a26d-4fff-aec9-e622f009f375">0.6</ix:nonFraction> million shares of the Company&#8217;s common stock during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzE1_5ee169da-62b2-4ebd-b193-b5de9dba81ec">74.59</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIy_fe65eaab-68ec-4c67-873b-f3396b74724b">71.10</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzUx_2910e3ec-1de7-454b-aa5e-0d62f180556e">4.3</ix:nonFraction> million options outstanding at April&#160;1, 2023 with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNDIy_bf1de43a-d56a-457b-90f0-9a45369674d5">51.87</ix:nonFraction>.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="if4876409ffc64899963e961e6dcf2af8"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI2OA_e279a944-70e0-4014-91ce-12dbd6fcc596" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi0xLTEtMS0xMDc5NTc_3e7d6e95-e7fc-4f58-9dfe-410d30f5f2e4">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi0zLTEtMS0xMDc5NTc_996de371-cdf7-4921-bc20-4b24c56aed9a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi01LTEtMS0xMDc5NTc_1587e192-45e9-45c2-86ad-1066ad113610">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi03LTEtMS0xMDc5NTc_1e0f0bb1-f824-435d-80d0-255c384e2b45">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy0xLTEtMS0xMDc5NTc_10b97f8b-afb0-4edb-91a0-0f6d41e2c976">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy0zLTEtMS0xMDc5NTc_d1818b31-c528-4fdb-8743-94d253ddbe69">34.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy01LTEtMS0xMDc5NTc_eddf302c-b3f6-4b36-af02-5eea8a9a408c">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy03LTEtMS0xMDc5NTc_a9e5e1f4-0522-4a32-be70-04f5a8a1f85c">34.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC0xLTEtMS0xMDc5NTc_9dd55c35-4cd8-4839-8a34-af6196137a8f">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC0zLTEtMS0xMDc5NTc_a868032b-af59-4452-bdcb-79dead09309b">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC01LTEtMS0xMDc5NTc_3ee20c8f-7c7a-4f48-a460-3d13235f66cd">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC03LTEtMS0xMDc5NTc_419ecc14-33d8-41f2-a8ad-ec12ef8afc54">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS0xLTEtMS0xMDc5NTc_f6100062-a77b-45bb-805c-343da237e396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS0zLTEtMS0xMDc5NTc_aa1708f5-cd61-4d37-bead-e4aeebeda88b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS01LTEtMS0xMDc5NTc_eac9f1a9-87e3-43ee-a0b1-04bd53b817d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS03LTEtMS0xMDc5NTc_65c43a45-074e-4528-a634-6bc8ba114b32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi0xLTEtMS0xMDc5NTc_2159e24a-4885-4a80-97f1-0d3569956ecc">27.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi0zLTEtMS0xMDc5NTc_f8dbd107-3ade-4d51-aa02-dcf7aa13f2a0">20.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi01LTEtMS0xMDc5NTc_4eac9d20-00a2-4e38-bd3b-c119c6e00121">25.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi03LTEtMS0xMDc5NTc_110a54ce-7310-484d-93ad-fc174577b69e">21.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNjQ0_8c6988cd-1fae-407c-a431-bb8d1be50570">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i4a246129f343418eab464098000292bf_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNjUx_39fedfe5-77bc-4731-ac51-180b87105593">0.6</ix:nonFraction> million restricted stock units (&#8220;RSUs&#8221;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNzg2_0e60caa6-bd01-4609-9e58-18ac1166dff9">74.44</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i4a246129f343418eab464098000292bf_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNzkz_cf6ffee3-4dbf-499d-b037-dd06f6f284a4">71.15</ix:nonFraction> per unit, respectively. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfODUz_da450cf9-b661-405e-abe2-86943d43febf">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i27a08777635e4e009b32b403ac06831d_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfODYw_b0d8e0b7-d55c-420b-beeb-b9f7b485f699">0.1</ix:nonFraction> million performance stock units (&#8220;PSUs&#8221;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTA0NQ_6e3475e4-46d2-4dc6-92fe-7bf1e8600529">74.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i27a08777635e4e009b32b403ac06831d_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTA1Mg_9f09bdda-52df-4776-9d74-4c98501367a9">71.16</ix:nonFraction> per unit, respectively. Each recipient of PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTEzMw_027b3663-e6ac-42f2-ad73-77e2e6cc7aed">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTE0MA_70604470-74db-4470-9bc5-a908a16c7fd5">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period, provided that the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTM2MQ_ec92642e-fd31-473e-bc8a-f18d70a37508">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTM2OA_cbe51960-32dc-453f-8a04-83491d06a7cf">0.1</ix:nonFraction>&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure (&#8220;FCF PSUs&#8221;) to members of its senior management team, which had a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTUyMA_930dd4ac-66c3-4379-a916-8900efd130b6">74.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTUyNw_4e565ece-399f-4491-9d8d-0b98d6a46576">71.16</ix:nonFraction> per unit during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of FCF PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTY4Mg_a8bcde61-4fee-4d09-af6c-af2fd24484f7">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTY4OQ_5b31bff3-4708-4a82-8a4b-86be6e084f2d">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest <ix:nonNumeric contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTgzNQ_61ff3a57-5b23-4a06-ad58-a6d349787869">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the probable number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjI3OA_dc5abd87-c8d8-4fe8-85f4-992e340b2fe2">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjI4NQ_d3a5d544-677d-41a5-a52c-9ff2fe8b125c">0.1</ix:nonFraction> million market-based awards (&#8220;MSUs&#8221;) to members of its senior management team during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjQ1Ng_027b3663-e6ac-42f2-ad73-77e2e6cc7aed">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjQ2Mw_70604470-74db-4470-9bc5-a908a16c7fd5">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjY4Nw_b88a139d-a8d1-4c70-b692-8160567a6183">97.91</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjY5NA_4c5cbf57-5f3d-41d9-a4b2-18980e825f5f">75.43</ix:nonFraction> per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest <ix:nonNumeric contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjgwNQ_45033ab6-97e3-4b27-b5cb-fe1dc10b5c39">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At April&#160;1, 2023, there was <ix:nonFraction unitRef="shares" contextRef="id2eccbfd571a4ca7aa01513771ff388f_I20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjk0Mw_b7ca91e6-a1d6-446f-ae7e-d7cd1b3fca51">1.7</ix:nonFraction> million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;1, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzAzMA_3c588a6a-a258-4ac0-a2d8-a2c4c10abdb9">18.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia577a32b749748fbbca9c17d38a8ea86_I20230401" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzAzNw_f6d1497a-100b-433a-a85e-75d84c6ad762">77.3</ix:nonFraction> million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of <ix:nonNumeric contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIyOQ_9471d9d8-4224-473d-ab4c-0b56edd32b78">2.2</ix:nonNumeric> and <ix:nonNumeric contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIzNg_ab98822a-47b7-479f-8a24-14a8e8e33cb1">1.9</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" name="holx:DetailsOfCertainBalanceSheetAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjEwMw_b8c71043-1520-49c2-9de9-419c8633bb04" continuedAt="i19d727ca196242a48262e9651fd91349" escape="true">Other Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="i19d727ca196242a48262e9651fd91349"><div style="text-align:center"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjEwNA_f282ca52-3e7f-4f48-8d73-c2beb9cb8e4d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMi0xLTEtMS0xMDc5NTc_9e22f5d5-dfd1-470f-b6ab-159abb31e797">293.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMi0zLTEtMS0xMDc5NTc_9692cfa2-d75b-4577-bf1f-61999c85e851">252.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMy0xLTEtMS0xMDc5NTc_3df41497-b194-49f8-9554-45bfbc1609fa">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMy0zLTEtMS0xMDc5NTc_134c3173-9470-4d02-9fee-47412df92455">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNC0xLTEtMS0xMDc5NTc_3b606e9a-d0c9-4730-b1d0-4ec94dbe7ff1">328.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNC0zLTEtMS0xMDc5NTc_27a6daad-70d5-4be4-9f6c-529324a26c23">310.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNS0xLTEtMS0xMDc5NTc_47583fad-2fed-4dc9-bf05-e07762f55da6">687.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNS0zLTEtMS0xMDc5NTc_ec47a599-37c5-4eae-9dbb-573574e7608a">623.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjExMg_ef112e78-b5e5-4795-ba3f-ea4e3c82de52" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMS0xLTEtMS0xMDc5NTc_14ba7f7f-b263-4d26-bdb2-fbd1077ce5c4">407.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMS0zLTEtMS0xMDc5NTc_df9a71ae-9949-4dcd-b098-fca2ab07d851">394.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMi0xLTEtMS0xMDc5NTc_e03bee6a-f6e0-4550-921f-f74b89037ad5">506.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMi0zLTEtMS0xMDc5NTc_78fc1204-a189-424b-811e-f0f16c65d7bd">486.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMy0xLTEtMS0xMDc5NTc_5a7d9044-f557-452c-80c1-4951276c43a3">206.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMy0zLTEtMS0xMDc5NTc_bb48f882-ef91-4489-909e-7e1fce5c8eba">196.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNC0xLTEtMS0xMDc5NTc_58dfd51c-fd2e-4fe1-a02b-d3a8c605af0b">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNC0zLTEtMS0xMDc5NTc_1643aa53-0655-4d9e-a187-7f61fab33d14">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNS0xLTEtMS0xMDc5NTc_5f598883-65b4-44d9-a89c-bf40c49a745a">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNS0zLTEtMS0xMDc5NTc_98827f80-6ec9-4616-8fbe-d316c1626179">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNi0xLTEtMS0xMDc5NTc_6d455cd4-928f-4270-aeb2-0a1ea78bd027">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNi0zLTEtMS0xMDc5NTc_817f7319-7184-42d8-9e5c-c80f3d76f330">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNy0xLTEtMS0xMDc5NTc_c91460c5-2a4f-4585-94e4-3b1aa6aae12a">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNy0zLTEtMS0xMDc5NTc_11b3fc9c-6646-4890-a09a-769e5792586a">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOC0xLTEtMS0xMDc5NTc_bdb2d435-0308-4ce5-935b-6f16c515d16c">1,236.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOC0zLTEtMS0xMDc5NTc_fe104ed0-a137-46d9-85ba-62146177309e">1,187.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOS0xLTEtMS0xMDc5NTc_ca818bfd-15ff-4b2d-af9d-027d9779be64">738.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOS0zLTEtMS0xMDc5NTc_aba88ac5-02f3-4e0d-b8b0-6dc912b0aee4">705.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMTAtMS0xLTEtMTA3OTU3_f8775b7c-881d-4ac7-bc16-aea36fb1446d">497.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMTAtMy0xLTEtMTA3OTU3_0242cf67-ba19-4427-aeac-a495f63ddb79">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company was awarded grants of $<ix:nonFraction unitRef="usd" contextRef="i4a3f922b1bdf4d05b948c12d6a48fae3_D20200628-20200926" decimals="-5" name="holx:GrantsReceivedFromDepartmentOfDefense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMTE4_eaac6552-c377-403e-8003-26ef76c4bde0">7.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ieb0eac28104f433fa408c7b9929c8afb_D20200927-20201226" decimals="-5" name="holx:GrantsReceivedFromDepartmentOfDefense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMTI1_3083d4d7-d101-46cf-b373-d8723c62ca73">119.3</ix:nonFraction>&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force (&#8220;DOD&#8221;) to expand production capacity for the Company&#8217;s two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company has accounted for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procured and paid for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD reimbursed the Company upon it meeting certain requirements. However, the DOD retained title to the assets purchased under the agreement, and title was transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone had been met. As of the end of fiscal 2022, the Company had completed all milestones under the agreement and was waiting for approval by the DOD. During the second quarter of fiscal 2023, the Company received the final DOD approvals and the final payment from the DOD of $<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfNTQ5NzU1ODE4MTgy_d8ab2295-74ff-4d3c-9d6e-7758e5a6b68f">20.5</ix:nonFraction>&#160;million, which was recorded as a reduction of the cost basis of the purchased equipment. As of April&#160;1, 2023, no other amounts were awaiting approval and all defined milestones were completed.</span></div></ix:continuation><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc1MQ_31fb25c8-83ab-4586-af92-5e2e57df2c00" continuedAt="i6c8fb09a292e497d84d8c4ffc105262e" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c8fb09a292e497d84d8c4ffc105262e" continuedAt="if0c3e80f50674d449adbbe6216bd3ced">The Company has <ix:nonFraction unitRef="segment" contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfNzI_f2307da8-f699-4378-b18c-c887601cb6d2">four</ix:nonFraction> reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. </ix:continuation></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="if0c3e80f50674d449adbbe6216bd3ced" continuedAt="i6a8b5b5bf6c84dcc990fe7f2ffbaf743"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="i522660b505a2425fb1ae75796bfa1231_D20230101-20230401" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_7fda888a-640c-4ba8-afba-7fb3639a87a0"><ix:nonFraction unitRef="usd" contextRef="i99ec6b91f8dc4e839b0621fa03ea273f_D20211226-20220326" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_8c26f075-9d88-4b00-a486-6e0b1587c3bf"><ix:nonFraction unitRef="usd" contextRef="ia326a75496cf4845bd1f54f9ac1dd86d_D20210926-20220326" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_96958f98-ab69-493c-a54b-3b423e07f881"><ix:nonFraction unitRef="usd" contextRef="ibdf55613aebd4ac69743fad69a456a00_D20220925-20230401" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_d1b00589-bd07-4c36-a1d7-459927c76d0b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> inter-segment revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. S<ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc0Nw_1067207a-d15f-4c1a-b335-837d3643553c" continuedAt="i5d7060bd2f9e46eb883a307172a96b06" escape="true">egment information is as follows:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i5d7060bd2f9e46eb883a307172a96b06"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy0xLTEtMS0xMDc5NTc_63f910bb-57da-43e4-afa2-f178d957a118">464.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy0zLTEtMS0xMDc5NTc_b25663a8-5a61-4131-99f5-381d87a709dc">987.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy01LTEtMS0xMDc5NTc_6f528c93-02b3-4976-ba9b-db9b2540efff">1,024.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy03LTEtMS0xMDc5NTc_f605b74d-f560-4d01-bc08-8771c6636f34">1,937.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC0xLTEtMS0xMDc5NTc_ccc05489-4648-4041-be28-3cb6a3a36a89">385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC0zLTEtMS0xMDc5NTc_bf58cd38-b986-490b-a117-76a64d22a0b1">310.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC01LTEtMS0xMDc5NTc_82314e96-0d43-4304-be8d-9f1246fefd37">719.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC03LTEtMS0xMDc5NTc_5cb7a266-a350-4e92-be10-205c39496fca">669.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS0xLTEtMS0xMDc5NTc_60dd5ac6-e7c2-414f-a7d0-86a16a07470f">144.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS0zLTEtMS0xMDc5NTc_63358878-009f-42d1-a8b0-2e19c9ab7546">117.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS01LTEtMS0xMDc5NTc_62ebdf55-8033-4324-8779-9d2fd5dd070f">298.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS03LTEtMS0xMDc5NTc_26a27963-6960-4341-bb90-569a13c443db">251.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi0xLTEtMS0xMDc5NTc_7f9258c5-789b-4d95-bc72-587a7ef45447">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi0zLTEtMS0xMDc5NTc_3f64e46c-564d-49d0-bc16-c1330e93eaa2">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi01LTEtMS0xMDc5NTc_97fdbf55-5235-4a42-b74d-d8e9fa94d1e8">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi03LTEtMS0xMDc5NTc_6911a795-b955-4eb3-90c5-f3262a067a8a">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC0xLTEtMS0xMDc5NTc_51e194a5-2d68-4ff2-a302-6a0bd2dfc63a">1,026.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC0zLTEtMS0xMDc5NTc_e0b03fb0-7acc-4b1b-8271-c853ab9a9e08">1,435.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC01LTEtMS0xMDc5NTc_41f43702-4fb9-406e-be4d-6cf7b3e6a008">2,100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC03LTEtMS0xMDc5NTc_cd4eb733-797d-42a1-839e-9b660c3794a4">2,906.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtMS0xLTEtMTA3OTU3_f06de39a-0e43-4e8a-92e2-b5114c46f863">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtMy0xLTEtMTA3OTU3_487a44c8-33e3-40c3-a24f-ed0287d181aa">540.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtNS0xLTEtMTA3OTU3_20d7ea35-3aae-4c5b-94a5-c92f0661cb65">256.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtNy0xLTEtMTA3OTU3_00229947-aa88-4f39-90ca-22e0d97374af">1,072.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtMS0xLTEtMTA3OTU3_2618999c-01a9-4250-87ef-85f6bc5a66bf">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtMy0xLTEtMTA3OTU3_238bfb2c-b604-453f-9343-112756d6376c">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtNS0xLTEtMTA3OTU3_92597295-0bb8-4afa-a10b-453fc86d4bc9">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtNy0xLTEtMTA3OTU3_a2d8a96a-2064-4e27-aabb-fafb428e492a">131.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItMS0xLTEtMTA3OTU3_b5b97069-537f-4247-b4b2-4801fe7771e8">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItMy0xLTEtMTA3OTU3_a6b03347-4690-433a-be0a-a5c8c2940a32">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItNS0xLTEtMTA3OTU3_7bcbb7e0-338e-4719-a0c5-2029bdd6c17a">101.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItNy0xLTEtMTA3OTU3_28d93923-8bcf-406c-a5f5-39af4961ea56">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtMS0xLTEtMTA3OTU3_1497e920-2cb7-463d-a996-b0b5a9c30cc0">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtMy0xLTEtMTA3OTU3_ae8c5176-4bb7-48b2-8c3d-643682d00ec5">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtNS0xLTEtMTA3OTU3_99f36520-3b51-4a22-98ea-ab49bce96c1c">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtNy0xLTEtMTA3OTU3_98352e96-7702-4888-8910-ef84fa187475">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtMS0xLTEtMTA3OTU3_4998f93d-45c1-4094-8ece-f1757e2a342e">272.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtMy0xLTEtMTA3OTU3_d7625213-fa88-458f-992a-a8a4ee383290">594.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtNS0xLTEtMTA3OTU3_08ab9b4c-c6dd-4609-a12d-6b14693e32d4">534.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtNy0xLTEtMTA3OTU3_dbcfe430-6fcb-43a7-bdda-257a6350fd3a">1,235.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctMS0xLTEtMTA3OTU3_dab415f7-cd7b-424a-a44a-97ed0c06f314">56.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctMy0xLTEtMTA3OTU3_8ddc3d02-5c27-4a58-b4b0-0e62b95e46dc">68.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctNS0xLTEtMTA3OTU3_73c92225-4201-408b-8826-c2d0b48518fb">116.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctNy0xLTEtMTA3OTU3_9008c48c-eb3e-4f3d-8d2d-7ad35b0fb0d0">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtMS0xLTEtMTA3OTU3_cc14ac77-0452-41d4-9907-3b8870c95f14">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtMy0xLTEtMTA3OTU3_2580fda5-91f5-4e49-b5be-b68c07cb867d">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtNS0xLTEtMTA3OTU3_5c4a4739-8e85-40ea-91e4-5eb4d2957afc">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtNy0xLTEtMTA3OTU3_59fd6200-38f1-4757-9757-cffb010d4538">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktMS0xLTEtMTA3OTU3_0532eaf2-dc7c-4ded-b64b-5788842e0825">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktMy0xLTEtMTA3OTU3_33ab0cab-9e6e-4c0c-a32e-59687db60674">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktNS0xLTEtMTA3OTU3_1a99bd81-daa3-415e-8e60-0c7d1ee73df3">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktNy0xLTEtMTA3OTU3_d35091f0-31ab-4d19-9caa-48abe976fe24">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtMS0xLTEtMTA3OTU3_aff78968-7a16-4fba-962e-a328e727a1c2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtMy0xLTEtMTA3OTU3_1fe83651-5c64-4522-90e9-70e832f29e45">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtNS0xLTEtMTA3OTU3_2b2f5ad3-66ef-4f30-9309-29e99465aeae">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtNy0xLTEtMTA3OTU3_dabc5a67-3198-4108-a1a0-33592053ea31">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItMS0xLTEtMTA3OTU3_3a042531-8206-40e5-b126-9891ac081a9d">80.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItMy0xLTEtMTA3OTU3_b0a27d5c-7fb1-4287-9dd5-de393d1c8e6a">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItNS0xLTEtMTA3OTU3_e3e83d3b-9149-40c2-a580-5cb769a7f665">166.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItNy0xLTEtMTA3OTU3_fcb48dfb-ba14-4641-b5f2-594767b29eb0">214.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtMS0xLTEtMTA3OTU3_dc9c3875-684d-4db5-9c0b-018887530d12">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtMy0xLTEtMTA3OTU3_d773ca9c-5cda-4459-8c6c-57c6bd8d183e">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtNS0xLTEtMTA3OTU3_3eda2842-9e51-4b1a-99b9-83100ef92b7e">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtNy0xLTEtMTA3OTU3_56b1d5a8-8820-415f-8beb-f005de62faad">57.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtMS0xLTEtMTA3OTU3_33bb5343-f1b7-4e4b-b3c0-fc385229cfe1">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtMy0xLTEtMTA3OTU3_885976d2-cea6-439c-bea3-f1d007ff7c08">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtNS0xLTEtMTA3OTU3_54e2414a-72b5-4d6d-8b9b-1ebb1594c863">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtNy0xLTEtMTA3OTU3_0d6d3011-269a-4b72-908a-eb4947247f98">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtMS0xLTEtMTA3OTU3_3a109b93-844e-41f7-b70c-59a977350de8">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtMy0xLTEtMTA3OTU3_ed47d078-3710-4a5c-8d1f-935546a7e7b6">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtNS0xLTEtMTA3OTU3_86fa6852-4288-4373-b4e5-691c3f480c26">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtNy0xLTEtMTA3OTU3_fe149cea-d51f-4f52-949c-94e5fc545e00">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctMS0xLTEtMTA3OTU3_76900700-23f1-4a07-866f-0c8394ae6fb0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctMy0xLTEtMTA3OTU3_f9eab9e3-4388-483a-9178-482d553f9833">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctNS0xLTEtMTA3OTU3_1b0710f6-72c4-4f7f-86a1-685cbe2f8e80">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctNy0xLTEtMTA3OTU3_1339477c-d17d-40de-b9ef-5700bdfbd136">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa97bebc3b004733b9c34994ac8eba59_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktMS0xLTEtMTA3OTU3_60e32698-2788-454b-9a67-189d7f468dad">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5108570aa8d24fd39f37539e9a93e166_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktMy0xLTEtMTA3OTU3_d725bb62-812e-4d20-93e6-9f49f2f4dfc0">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4425324e9249c3b78b220d544a2a6e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktNS0xLTEtMTA3OTU3_be466c44-c753-4ebe-92d2-fd9b1698ac45">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c17ccb48574e919a33ce08e5de772b_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktNy0xLTEtMTA3OTU3_e9e7f128-05a3-419d-bbd9-5a2545c22856">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtMS0xLTEtMTA3OTU3_74b36341-a594-4f83-81bc-9bd46875ad46">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtMy0xLTEtMTA3OTU3_46a9ef51-b3a1-4eef-b1c6-4f98a2f35210">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtNS0xLTEtMTA3OTU3_ba154599-02ea-495f-91d9-c686eb837585">61.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtNy0xLTEtMTA3OTU3_1849a726-cfb0-452e-a898-d842244f9c08">69.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:66.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0da1df1fe1a44d4bcb27d37cff8897a_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMi0xLTEtMS0xMDc5NTc_1bde998b-94a7-4320-b279-c92d4c6761ab">2,940.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83b89bbba274da1aecdd2d283d1ce13_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMi0zLTEtMS0xMDc5NTc_dd7b9628-e47b-4536-bfee-994fd902ed72">2,881.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa02d3fe1f124afaa799f62caa9b7a35_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMy0xLTEtMS0xMDc5NTc_49503792-496f-4c50-8cdc-85e16a0dc3b6">1,250.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eeb9ddbf5a34bb3a14921940aad31a0_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMy0zLTEtMS0xMDc5NTc_89772e20-fd1f-4131-91a3-86212aa6ab3f">1,245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id601e4f7392c49f69fb44fca0c219a32_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNC0xLTEtMS0xMDc5NTc_804a9a6f-286d-47f3-9766-612b9a32ff35">1,464.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61146379fc1346a09fc79ae328fc4ae7_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNC0zLTEtMS0xMDc5NTc_dd4b51d5-c75c-4c8f-b634-491c2ba4e0f6">1,461.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c4cf9a87c4b33a5d8acfe456b5212_I20230401" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNi0xLTEtMS0xMDc5NTc_ffa6310e-440e-4955-8095-b123f6b3efff">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5d286446e24832a9b09dd26e54365c_I20220924" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNi0zLTEtMS0xMDc5NTc_45f22da5-1e44-424a-b46d-998857203823">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6940db18e044ac4baf19aa208d8ab33_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNy0xLTEtMS0xMDc5NTc_d445d85f-3312-4688-876e-d107d01f6c33">3,770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1505009eac544214a4c5d2a5083d4b87_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNy0zLTEtMS0xMDc5NTc_b54a21b2-c5bd-49d9-bce4-9c5b444ee722">3,454.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfOC0xLTEtMS0xMDc5NTc_a495dc6b-0fe9-4db4-91c9-9472cd86f5f9">9,448.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfOC0zLTEtMS0xMDc5NTc_ab426596-aa8a-4822-8b25-b74167729bd2">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><ix:continuation id="i6a8b5b5bf6c84dcc990fe7f2ffbaf743"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc1Ng_159bf629-dfae-4dfe-a4d8-dddb979c9942" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi0xLTEtMS0xMDc5NTc_566e2631-04a3-48c4-b639-7cb04c34c5fa">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi0zLTEtMS0xMDc5NTc_9b63bbf1-b1c9-4918-b546-50d3eb6c1e92">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi01LTEtMS0xMDc5NTc_29fcf2ae-3d4c-4030-95a6-881ec1b24509">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi03LTEtMS0xMDc5NTc_03e1a567-9f9c-4889-b2cd-29aa98b70885">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy0xLTEtMS0xMDc5NTc_66cdcf46-87fb-405a-a378-f6e8ca129321">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd755a8928c347638dc5777e510229a4_D20211226-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy0zLTEtMS0xMDc5NTc_c400077d-908b-47ef-9044-f3c70297e514">20.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy01LTEtMS0xMDc5NTc_2c049bed-83ea-48a1-b834-4e043baa442a">14.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy03LTEtMS0xMDc5NTc_978a2df4-f3ce-4136-b066-73eabd91a2d5">20.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC0xLTEtMS0xMDc5NTc_c86cc671-8a10-4947-ab7a-cb3ace24210b">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC0zLTEtMS0xMDc5NTc_3561102f-e394-44ae-9647-beaf2dc4273e">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28d2b38d322445518df9d6519589e24a_D20220925-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC01LTEtMS0xMDc5NTc_435d0b88-857b-4395-b4e3-dfe0e705fef8">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC03LTEtMS0xMDc5NTc_737042c3-4c67-4ec4-a2b1-2299376df23e">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c33a8795c3a41f5bd50f90ed5b9bf52_D20230101-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS0xLTEtMS0xMDc5NTc_fe135fae-05f6-4f20-84f8-d595f744c361">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia73b8a87766948a89773af45de8aa1a2_D20211226-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS0zLTEtMS0xMDc5NTc_b047a434-19f2-4111-b179-0a91bd42e9c5">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib59e7423fc3348d2aba0bd00f14d79a2_D20220925-20230401" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS01LTEtMS0xMDc5NTc_6d975fb7-e680-4448-bef6-48ab17734a84">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69214a927e6a42459ef14fb9247a6f7c_D20210926-20220326" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS03LTEtMS0xMDc5NTc_9152e724-a3d0-43c5-bff9-e0b5b601686a">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi0xLTEtMS0xMDc5NTc_ef137f1e-c902-4f90-8343-74de770fa435">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi0zLTEtMS0xMDc5NTc_da0b5525-d790-4eec-bd90-b02cf58e3323">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi01LTEtMS0xMDc5NTc_8e521ebd-4c10-4ad5-bc0e-ef53cf80917d">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi03LTEtMS0xMDc5NTc_f8c5f830-3c7b-4dfd-8f89-8e813d475353">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMjQzMQ_37073580-0eb4-4d90-b2f6-c8ba0ab31ab4" continuedAt="if5d46b0f438c495598dc83b6725403ba" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="if5d46b0f438c495598dc83b6725403ba"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates for the three and six months ended April&#160;1, 2023 were <ix:nonFraction unitRef="number" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfNjAy_69f45ed5-c417-42f5-a650-5b63af82671a">21.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfNjA5_b8bb8c82-e42e-4c3f-818c-0b878200d86b">21.7</ix:nonFraction>%, respectively, compared to <ix:nonFraction unitRef="number" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMTA5OTUxMTYzMDM3OQ_132b26f1-7b39-423e-8699-9457d7d37155">20.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMTA5OTUxMTYzMDM4Ng_0c81f3be-4b44-4672-8e65-a6131ea20470">20.2</ix:nonFraction>%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three and six months ended April&#160;1, 2023 were higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company&#8217;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rates for the three and six months ended March&#160;26, 2022 were lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by the Company&#8217;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company&#8217;s positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjYz_df0871d0-648d-418f-b70d-7004220be270" continuedAt="i074bf4a6305a44339da688aafd5873e4" escape="true">Intangible Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i074bf4a6305a44339da688aafd5873e4"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjQ0_30e07da9-6c97-44fd-9393-a8b6e590aaae" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:30pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d97279b97e3493bae5fe07e0a15dabf_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy0xLTEtMS0xMDc5NTc_622b8e64-c575-4466-9bba-fbcb9e82c850">4,607.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d97279b97e3493bae5fe07e0a15dabf_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy0zLTEtMS0xMDc5NTc_84e85f15-a8a4-4ae0-91ca-1ce1a9e2a3a4">3,574.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e39021ecd254dd09befad99c3986073_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy01LTEtMS0xMDc5NTc_ea1210c7-f88a-47d4-9f88-902162bb499e">4,565.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e39021ecd254dd09befad99c3986073_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy03LTEtMS0xMDc5NTc_3bf576c4-2074-4e8c-9ffc-f55108edde89">3,458.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC0xLTEtMS0xMDc5NTc_f6437d28-e66b-4335-85e1-4e6d937058a6">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC0zLTEtMS0xMDc5NTc_01e994d6-8690-4532-b38d-6f6ec9311303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07828dc44634020a4b14b73f7eb87fa_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC01LTEtMS0xMDc5NTc_583c9f6b-fde4-41c7-b177-a213e7ce692d">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07828dc44634020a4b14b73f7eb87fa_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC03LTEtMS0xMDc5NTc_2569d781-533a-4a73-bbaa-9ec97bd30913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS0xLTEtMS0xMDc5NTc_11f535ff-41bc-45e4-bed1-f71ead4626f7">607.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS0zLTEtMS0xMDc5NTc_67103cc2-1f13-45c7-ba60-13d42b82f082">547.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f748d0709e6431ba2b044bda85c7b9d_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS01LTEtMS0xMDc5NTc_80ba4e62-0124-4928-bbc6-32e2347b3c62">601.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f748d0709e6431ba2b044bda85c7b9d_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS03LTEtMS0xMDc5NTc_a38eba05-0177-4430-a22d-39f4fc12b607">535.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib179c1e06a7443498a0049053c6f4bce_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi0xLTEtMS0xMDc5NTc_f262b923-e97e-4e4e-a90a-8fa96f7a675d">267.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib179c1e06a7443498a0049053c6f4bce_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi0zLTEtMS0xMDc5NTc_b0bd5d2b-c09a-49b9-bfed-76926b4d5786">209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9059edfb45a4a2d86a83a32fbb97888_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi01LTEtMS0xMDc5NTc_c61dac05-053e-439f-919b-355bfe0e15e0">265.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9059edfb45a4a2d86a83a32fbb97888_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi03LTEtMS0xMDc5NTc_823b743e-00e1-4a0d-8783-a485d8fc24b9">203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998a08b240cb4165815a4c0f245cb61d_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtMS0xLTEtMTA3OTU3_2a3dd6cb-7d85-442e-8ba5-d1aa21731dc3">5,519.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998a08b240cb4165815a4c0f245cb61d_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtMy0xLTEtMTA3OTU3_a99649c3-e495-4e8e-aaee-c61ec72c2d72">4,330.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2dc025fcef4752948c5b989d73d843_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtNS0xLTEtMTA3OTU3_5cc702a3-18f0-43b8-990f-8520a6369d12">5,465.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2dc025fcef4752948c5b989d73d843_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtNy0xLTEtMTA3OTU3_0553a625-3ae7-42a0-8531-e1f96d28bded">4,197.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d03d024a12410989ca0f3bd337f2c3_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItMS0xLTEtMTA3OTU3_a3544822-9f36-49f4-a2f7-f09c66d73284">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d03d024a12410989ca0f3bd337f2c3_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItMy0xLTEtMTA3OTU3_3d44042b-bc0d-472b-98a8-17c1d7f694cd">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad017932b214b8bb1c244596a2c3da4_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItNS0xLTEtMTA3OTU3_cbf67fc8-5f75-49e9-ab57-b016642518a9">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad017932b214b8bb1c244596a2c3da4_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItNy0xLTEtMTA3OTU3_186600a3-a4c6-4ee6-b028-652a09a64b81">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtMS0xLTEtMTA3OTU3_b68a11a8-647e-485f-953e-f228506d84ea">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtMy0xLTEtMTA3OTU3_cbad2731-d5d9-477c-bf1b-da199054aa62">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fa1a0f46224950aca1017cb9727897_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtNS0xLTEtMTA3OTU3_f7faa84c-1dd2-466f-9222-0d5a4560f09e">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fa1a0f46224950aca1017cb9727897_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtNy0xLTEtMTA3OTU3_58cf388c-8668-4eb4-8486-65a555398f2e">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtMS0xLTEtMTA3OTU3_e7843193-87f2-406e-b850-66d8ad05a3c2">5,575.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtMy0xLTEtMTA3OTU3_502b5dc0-60c3-4db1-b019-08651680a1cf">4,373.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtNS0xLTEtMTA3OTU3_a0e6c1ad-287c-41da-b045-6b93eafbfce9">5,518.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtNy0xLTEtMTA3OTU3_f728e8a5-7251-4a7c-a4bc-75ea3f6f2976">4,237.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjY0_d94d6ab7-8a71-4d5d-9177-f5f9d254d003" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company&#8217;s acquired intangible assets as of April&#160;1, 2023 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"></td><td style="width:76.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.752%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMC0xLTEtMS0xMDc5NTc_e23da942-9990-4935-9b3a-1d4bd14e7ce4">117.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMS0xLTEtMS0xMDc5NTc_b8636fbb-afe6-4f34-9870-30be9cfc323c">225.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMi0xLTEtMS0xMDc5NTc_67fd34fc-3ba2-453f-b944-af1b6a110d60">210.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMy0xLTEtMS0xMDc5NTc_1fe43a60-ea1a-4254-ade1-05a7129b82fd">177.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfNC0xLTEtMS0xMDc5NTc_d06ebc9b-7276-407b-b852-993166b039e3">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RleHRyZWdpb246MGQ4YjZhYzZhNzUxNGYyN2E2MzlhMzU4YzQ5ZGUzYWZfODU_efd765c1-aeb9-441c-a2b1-65433b16d880" continuedAt="ifb7873b615374e42a1120f2a22c23378" escape="true">Product Warranties</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifb7873b615374e42a1120f2a22c23378"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RleHRyZWdpb246MGQ4YjZhYzZhNzUxNGYyN2E2MzlhMzU4YzQ5ZGUzYWZfNzU_5845e492-9842-4fcf-b944-3467961f6216" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0xLTEtMS0xMDc5NTc_b912e0c3-3a96-4c6a-834b-f6df01e7e74b">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0zLTEtMS0xMDc5NTc_23e3ad70-5e87-440d-b336-8f160d3fc600">3.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi05LTEtMS0xMDc5NTc_ab2a6374-c1ef-45f1-a17f-e782101119d3">3.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0xMS0xLTEtMTA3OTU3_528dfed7-e5e1-4c7e-90e6-6d31edfc98a3">7.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0xLTEtMS0xMDc5NTc_9d34a212-1cf7-4e85-b363-e981743d7f17">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0zLTEtMS0xMDc5NTc_f0be47fb-50a3-46d2-8603-d027c88ae1b2">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy05LTEtMS0xMDc5NTc_bca2e92a-b0f2-47b5-8cdf-8fd1ad6bc1eb">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0xMS0xLTEtMTA3OTU3_b87f0bd0-6e4c-4624-9c9b-0506d5a695d3">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RleHRyZWdpb246MzJlMjU1MWZhMWVmNGYzMTgyNzMwZTZiYWE3ZjljNjZfMTg4_c67c3d5b-fde2-4814-9930-d75f4b5305bd" continuedAt="i306322353ad241c6a84b8afce647e4fc" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i306322353ad241c6a84b8afce647e4fc" continuedAt="i2dacf820e6a24d2f8ce081450d961335"><ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RleHRyZWdpb246MzJlMjU1MWZhMWVmNGYzMTgyNzMwZTZiYWE3ZjljNjZfMTgz_f3b12e76-a8da-46c7-a25e-badb43895964" continuedAt="i8f1c98ce21dc47f19691e569ca6f560d" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26556cf1cbe64603999108ceccd4b8c0_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xLTEtMS0xMDc5NTc_788cd468-94e1-48f0-b136-45b1df0c153c">153.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i716db929cf324a8bba183dfc7e6ce250_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0zLTEtMS0xMDc5NTc_11675858-5483-437a-a465-6be7b2996932">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fe4337c2984c3d86c299d64abafdc2_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi03LTEtMS0xMDc5NTc_2c184964-5bb9-4207-9de7-008e7bf21c82">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi05LTEtMS0xMDc5NTc_6f470f90-d4d5-45b0-8c70-608076f5e278">127.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4f066bb0ba54024856a9b5805b1de7c_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xMS0xLTEtMTA3OTU3_5b1326b9-2bcc-461b-879d-ef72e7b8e7e2">267.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id36f522d615d45cc9db23bf02926e03d_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xMy0xLTEtMTA3OTU3_bb0aabfb-9117-4d8c-ad61-8c3a40891b31">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fb87637671c4962a157d8c69ffb2d58_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xNy0xLTEtMTA3OTU3_63edddd3-3b5d-4435-9ff4-b83c8804d582">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5f81fbde654721b420a4cceaa0f658_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xOC0xLTEtMTA3OTU3_4fbd56bc-c585-4b95-8c28-8baf4c870c32">238.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc79822f08d45ccada45b5d08c85f45_D20230101-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xLTEtMS0xMDc5NTc_96c47386-1ff2-465d-b4ab-9c998f4fb4f0">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4577c73735428b8f48f2233c6a5b4c_D20230101-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0zLTEtMS0xMDc5NTc_6c36a179-782e-44d4-9a8d-d91c6ef54d90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f5794ab1cc4d90b0150fded4465f9d_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy03LTEtMS0xMDc5NTc_ca2c31fb-1f9c-4389-8b57-376e2f99a241">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy05LTEtMS0xMDc5NTc_7a2e0ed5-e5b8-43f0-ae6c-856922377cb8">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de6ecf9ab0b44ac88fad82530f8c45d_D20220925-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xMS0xLTEtMTA3OTU3_f3045ad7-fd4f-49a5-957e-3345882bd12d">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9c6bece29543538e4949188c1b8250_D20220925-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xMy0xLTEtMTA3OTU3_cebc62ea-4373-4316-a682-7536f3507d6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08795cf6d72a47e39f4e264449f2e14d_D20220925-20230401" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xNy0xLTEtMTA3OTU3_b8c7e079-ee83-4b41-b9eb-dcd483372f63">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xOC0xLTEtMTA3OTU3_aa47bffb-ace0-45ed-920a-a0f4f37b05ad">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xLTEtMS0xMDc5NTc_f65918e6-87d8-4600-b79a-958a139dabd3">138.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib439241bfa8c49b394aef2e2769df894_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0zLTEtMS0xMDc5NTc_d69f2ea8-f982-4e08-93d8-53492da50bd1">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ca154a812442e69660b5624f4c20c1_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi03LTEtMS0xMDc5NTc_723dcc8b-276a-4319-a9f5-8acea8220fe7">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi05LTEtMS0xMDc5NTc_532a1623-47cc-419b-81bd-ec581d562ff5">118.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xMS0xLTEtMTA3OTU3_2ba432e3-0dea-4d25-9f0c-4cd53121fc89">138.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib439241bfa8c49b394aef2e2769df894_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xMy0xLTEtMTA3OTU3_de748ef7-4cf3-4927-8760-56dcd70a48ee">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ca154a812442e69660b5624f4c20c1_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xNy0xLTEtMTA3OTU3_60d93b25-8bb9-4453-afcb-54b94ddfe8a8">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xOC0xLTEtMTA3OTU3_ebacc997-63da-42d1-b04c-c9122c63f1d1">118.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i2dacf820e6a24d2f8ce081450d961335"><ix:continuation id="i8f1c98ce21dc47f19691e569ca6f560d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c1f163e64434b4098d3210b8c8872a1_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xLTEtMS0xMDc5NTc_e56e100a-d227-49bd-857f-08d4e1760d4e">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic417b6f69d4a4c8f8db217c37f35a4c6_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi01LTEtMS0xMDc5NTc_c473e3bf-f657-4192-8432-10d0b78ce9f6">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975de9ea5e4c4452bb7f5ce1b9e42fac_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi05LTEtMS0xMDc5NTc_916aff04-d09e-4d7b-a997-7a29ca7d2eb5">6.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f733818a0ef4bb196bde5377e392367_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xMS0xLTEtMTA3OTU3_31183eef-f4c0-4cbe-bfee-d46c1ae85911">89.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f082150b16640738cb5d6c0f5be0de9_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xMy0xLTEtMTA3OTU3_33b1b361-0484-4bc8-97ef-3011fbfa20e0">43.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f11753d84724189a8eb0ac0a40c5e1d_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xNS0xLTEtMTA3OTU3_55c5a08f-964f-4a32-b1eb-336c6b48cb62">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b24c3fbef44f539ea8da6b56c6635e_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xOS0xLTEtMTA3OTU3_5527d03b-baf9-4878-ba54-66e0e8619042">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e73db97997e4106b0bc73a6ad117fa1_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0yMC0xLTEtMTA3OTU3_8b85ceb5-bb1f-4a44-985e-2f53472f9323">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b8947efb99844ba8ea929d65eebcd7d_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xLTEtMS0xMDc5NTc_b8ee6717-1839-45d0-b7cf-3e390c9bdfff">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie52504be379e47e3a03f6ea3ee3b79fb_D20211226-20220326" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy01LTEtMS0xMDc5NTc_0f240278-f4db-4eb8-b8a3-5133d1750c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87488652d2ac42b786bc94af875d7063_D20211226-20220326" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy05LTEtMS0xMDc5NTc_65d556d3-dd4c-42b6-9f70-afff9c17e6f6">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xMS0xLTEtMTA3OTU3_ea6dbdbd-ea89-431f-b46a-6d2933bcd3f6">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17798170e5634c5681bad6fa53526f87_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xMy0xLTEtMTA3OTU3_f1f95b9d-b845-4ebf-8c0f-37f35348439b">72.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4386093d3b87463587e092da86bad387_D20210926-20220326" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xNS0xLTEtMTA3OTU3_d339e1a5-af85-4ddd-9bb6-472c36781af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038a9776dfcb49e8b6ae15ed7ba884f7_D20210926-20220326" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xOS0xLTEtMTA3OTU3_654201c2-b1f1-4c17-81df-a43f08844bc6">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0yMC0xLTEtMTA3OTU3_f6f2f897-a6a1-403e-9602-dd6f91a3cdef">45.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xLTEtMS0xMDc5NTc_a6b5039e-22ab-4c0b-962c-652d7fe107b8">115.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS01LTEtMS0xMDc5NTc_3746941a-66e3-4934-8815-b9d81d6ed15b">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i176f6f8fef46496b9bd2ba8947704790_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS05LTEtMS0xMDc5NTc_5752734e-d9e7-43bf-a309-4aa694e43a93">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xMS0xLTEtMTA3OTU3_f217aa6d-6e55-47af-9750-b625450f65cf">104.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xMy0xLTEtMTA3OTU3_c0e4a3d8-9b3d-4599-a92f-2981349d4a6f">115.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xNS0xLTEtMTA3OTU3_f6914648-7e06-4e69-9564-a931464acfc2">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i176f6f8fef46496b9bd2ba8947704790_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xOS0xLTEtMTA3OTU3_5b3825ef-899d-403f-bc39-dcd5ddbd7d6e">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0yMC0xLTEtMTA3OTU3_74867357-eafa-4303-83c5-59005b8b0420">104.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19) <ix:nonNumeric contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTM5_1ddcd0e0-ae8b-41ec-b280-1cbc57a835b7" continuedAt="i8ea00d9b727c4d4eac41e9cb6830d3b1" escape="true">Share Repurchase</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ea00d9b727c4d4eac41e9cb6830d3b1">On September 22, 2022, the Board of Directors authorized a stock repurchase program, with a five-year term, to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i4f431b6d0dae4178a459f78b51529416_I20230401" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfMTYw_1e1af375-1494-484f-87dc-9f0e51726704">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s outstanding common stock, effective as of the close of trading September 23, 2022. This repurchase program replaced the previous $<ix:nonFraction unitRef="usd" contextRef="i2c5c4ff0e55242cd99cce7ae6bc9417b_I20230401" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfMzEz_5ddec1e2-2257-42dd-a2c4-95411f0976d5">1.0</ix:nonFraction>&#160;billion authorization. During the three and six months ended April&#160;1, 2023, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="id93ac80af1864da895ea77544df73563_D20230101-20230401" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDA0_fd4acd50-8a24-412b-8b0d-8883b5034737">0.6</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i564316675084451483c816bd42aec061_D20220925-20230401" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTQ5NzU1ODE0OTE4_b6721d91-69ae-4831-9bfc-1f5e1e760178">2.2</ix:nonFraction>&#160;million shares of its common stock for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDYx_a63e53df-7b7d-4169-8aa5-7d47cc7bbc60">50.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTQ5NzU1ODE1MjY1_5846a343-e1f0-4a73-8a25-b4ee278575ef">150.0</ix:nonFraction>&#160;million, respectively. As of April&#160;1, 2023, $<ix:nonFraction unitRef="usd" contextRef="i4f431b6d0dae4178a459f78b51529416_I20230401" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDkw_5b335709-8b04-4356-88b0-b1e4a2721748">850.0</ix:nonFraction>&#160;million remained available under this authorization.</ix:continuation></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of global challenges, including macroeconomic uncertainties, the war in Ukraine, other economic disruptions and U.S. and global recession concerns, on our customers and suppliers and on our business, financial condition, results of operations and cash flows and our ability to draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the worldwide political and social uncertainty and divisions, including the impact on trade regulation and tariffs, that may adversely impact the cost and sale of our products in certain countries, or increase the costs we may incur to purchase materials, parts and equipment from our suppliers;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of supply chain constraints, including the availability of critical raw materials and components, including semiconductor chips, as well as cost inflation in materials, packaging and transportation;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the development of new competitive technologies and products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and any future public health crises; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to execute and integrate acquisitions and the impact and anticipated benefits of completed acquisitions and acquisitions we may complete in the future;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments; </span></div><div style="padding-left:18pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:7.75pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the European Union Medical Device and In Vitro Diagnostic Regulation requirements, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">business strategies; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">estimated asset and liability values; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact of future tax legislation;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact and costs and expenses of any litigation we may be subject to now or in the future; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our compliance with covenants contained in our debt agreements; and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our liquidity, capital resources and the adequacy thereof.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;intends,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;likely,&#8221; &#8220;future,&#8221; &#8220;strategy,&#8221; &#8220;potential,&#8221; &#8220;seeks,&#8221; &#8220;goal&#8221; and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women&#8217;s health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or CTGC; certain high-risk strains of human papillomavirus, or HPV; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Trichomonas vaginalis,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the parasite that causes trichomoniasis; Mycoplasma genitalium; and Herpes Simplex viruses 1 and 2. We also offer viral load tests for the quantitation of Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, or HIV, and human cytomegalo virus, or CMV, for use on our Panther instrument system. In addition, we offer bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis, a common and complex ailment affecting millions of women a year. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, various strains of influenza and parainfluenza, and respiratory syncytial virus that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In response to the COVID-19 pandemic, we developed and launched the Aptima SARS-CoV-2 assay and the Aptima SARS-CoV-2/Flu assay (each of which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). In May 2022, we CE-marked two new molecular assays, Panther Fusion EBV Quant assay for quantitation of Epstein-Barr virus, and the Panther Fusion BKV Quant assay for quantitation of the BK virus. These two new assays are the first quantitative real-time PCR assays on the Panther Fusion system. These assays, along with the Aptima CMV Quant assay, expand our Panther Fusion menu of transplant monitoring assays. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. We also generate service revenues from our CLIA-certified laboratory for testing related to breast cancer and all metastatic cancers.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. These solutions include 3D digital mammography systems, image analytics software utilizing artificial intelligence, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, our Fluent Fluid Management system, or Fluent, our Acessa ProVu </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laparoscopic radiofrequency ablation system, or Acessa ProVu system, as well as our CoolSeal vessel sealing portfolio and our JustRight surgical stapler. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and most recently, the NovaSure V5 device for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures. The Acessa ProVu system is a fully integrated system that uses laparoscopic ultrasound, guidance mapping and radio frequency ablation to treat nearly all types of fibroids. The CoolSeal portfolio includes the Trinity, Reveal, and Mini advanced bipolar vessel sealing devices. The JustRight surgical stapler features a smaller instrument profile and is used for laparoscopic general and pediatric surgery.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment&#8217;s products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan InSight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient&#8217;s extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our Company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Considerations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current worldwide supply chain shortages and constraints continue to impact, although to a lesser extent compared to fiscal 2022, our ability to obtain certain critical raw materials and components used primarily in our Breast Health capital equipment products. The supply chain shortages and disruptions primarily affecting our Breast Health manufacturing lines are related to electronic components, primarily semiconductor chips. We are dependent on a small number of semiconductor manufacturers and their allocation of chips to us. Based on our recent experience and current understanding of their allocation of chips to us, we have been able to and expect that we will continue to be able to increase production on a sequential quarterly basis throughout fiscal 2023. If such allocation does not meet our expectations or we are not able to obtain alternative sources of chips, we believe we will not be able to manufacture sufficient quantities of our capital equipment products, primarily 3D Dimension systems, Trident specimen radiography systems and Affirm Prone biopsy systems to meet customer demand and our results of operations would be adversely affected. In addition, the prices of raw materials and components, as well as freight, have been rising due to certain supply chain shortages as well as inflation and could increase the costs further. Our procurement team has and will continue to expend significant time and resources to try to secure sufficient quantities to meet demand.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademark Notice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, Acessa, Acessa ProVu, Affirm, Amplidiag, Aptima, ATEC, Biotheranostics, Brevera, CoolSeal, Diagenode, Eviva, Faxitron, Fluent, Fluoroscan, Focal, Genius 3D, Genius 3D Mammography, Horizon , InSight, JustRight, Mobidiag, MyoSure, Novodiag, NovaSure, Panther, Panther Fusion, Rapid fFN, Selenia, Selenia Dimensions, Somatex, SuperSonic Imagine, ThinPrep, Tigris, Trident, and Tumark. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective owners. Hologic&#8217;s use or display of other parties&#8217; trademarks, trade dress or products in this Quarterly Report does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, we completed the acquisition of Bolder Surgical Holdings, Inc., or Bolder, for a purchase price of $160.1 million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Based on our valuation, we allocated $96.7 million of the purchase price to the value of intangible assets and $68.8 million to goodwill. Bolder&#8217;s results of operations are reported in our GYN Surgical segment. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts in tables are presented in millions.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">964.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(528.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">968.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,894.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(925.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(48.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">417.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">296.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">837.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,268.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,723.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(847.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a decrease in product revenues in both the current three and six month periods of 34.0% and 33.0%, respectively, compared to the corresponding periods in the prior year. This was primarily due to the decrease in revenues in the Diagnostics business as COVID-19 assay sales declined significantly. These decreases were partially offset by an increase in Breast Health revenue as supply chain constraints begin to ease, an increase in GYN Surgical revenues, as well as an extra week of activity in the current six month period compared to the corresponding period in the prior year due to our fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues decreased $528.2 million and $925.4 million, or 54.7% and 48.9%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a decrease in Molecular Diagnostics of $526.3 million and $920.7 million, respectively, a decrease in Cytology and Perinatal of $3.1 million and $6.9 million, respectively, partially offset by an increase in Blood Screening of $1.3 million and $2.3 million respectively. Molecular Diagnostics product revenue was $316.6 million and $717.0 million, respectively, in the current three and six month periods compared to $842.9 million and $1,637.7 million, respectively, in the corresponding periods in the prior year. The decrease was primarily attributable to a decrease of $512.9 million and $908.8 million, respectively, in sales from our two SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay) due to lower volumes, which we primarily attribute to lower demand from an improvement in the COVID-19 pandemic compared to the prior year, the increasing use of rapid tests and a decrease in average selling prices in international markets. We expect sales of our SARS-CoV-2 assays to continue to be significantly lower in fiscal 2023 compared to fiscal 2022. We also had a decrease in sales of collection devices as a result of lower assay sales, and lower Panther instruments sales as demand for those instruments has decreased, which we primarily attribute to our significantly expanded install base and the decline in the COVID-19 pandemic in the current year. These decreases were partially offset by an increase in sales of $24.0 million and $44.8 million in the current three and six month periods, respectively, from our Aptima assays, (exclusive of our Aptima SARS-CoV-2 assays), primarily driven by an increase in our CV Candida, Bacterial Vaginosis, and CTGC assay volumes. This increase was primarily due to expanded adoption by our laboratory customers. In addition, we had an increase in sales of our Fusion respiratory assays and Quant Viral assays, primarily HIV sold in Africa. The decrease in Cytology &amp; Perinatal was primarily due to a decrease in sales in China, which we primarily attribute to COVID-19 related shutdowns. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues increased $61.8 million and $24.2 million, or 35.7% and 6.2%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in volumes of our digital mammography systems, primarily 3D Dimensions systems and related workstation and workflow products including software, an increase in average selling prices for 3D Dimensions systems, and an increase in Trident systems unit sales. The increase in volume was primarily driven by the ease in supply chain constraints related to electronic components, primarily semiconductor chips, which impacted our ability to manufacture sufficient quantities to meet customer demand in the prior year. The increase in capital equipment sales in the current six month period was partially offset by lower sales of the Affirm Prone biopsy systems. In addition, we had an increase in sales of our interventional breast solutions products in the current three and six month periods compared to the corresponding periods in the prior year primarily driven by Brevera systems and related needles. We also experienced a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased $26.2 million and $45.5 million, or 22.4% and 18.1%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year primarily due to increases in the sales volume of our MyoSure systems, NovaSure systems, and Fluent Fluid Management disposables as procedure rates continue to recover from the impact of the COVID-19 pandemic and to a lesser extent an increase in sales volume of our CoolSeal vessel sealers. These increases were partially offset by a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues increased $9.4 million and $7.9 million, or 69.6% and 23.9%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in sales volume of our Horizon DXA systems, InSight FD Fluoroscan systems, and system upgrades. The sales volume increases were largely associated with the easing of supply chain constraints. These increases were partially offset by a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total product revenues were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current three and six month periods compared to the corresponding periods in the prior year, the percentage of product revenue derived from the U.S. increased while Europe and Asia-Pacific decreased, which we primarily attribute to a larger increase in the U.S. for Breast Health capital equipment and related workflow and workstation products including software, Aptima and Fusion assay sales (exclusive of our Aptima SARS-CoV-2 assays), as well as a lesser decline in SARS-CoV-2 assay volume compared to Europe and Asia-Pacific. Product revenue decreased in China, which we primarily attribute to continued surges of COVID-19 and related shutdowns, which primarily impacted the sale of our Diagnostics products (excluding SARS-CoV-2 assays) and digital mammography systems. In addition, the strengthening of the U.S. dollar against a number of currencies contributed to the increase in the percentage of revenue derived from the U.S. compared to revenue derived from the other geographic regions. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">335.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation, and repair of our products. The majority of these revenues are generated within our Breast Health segment. The increase in service and other revenue in the current three and six month periods compared to the corresponding periods in the prior year was primarily due to the continued conversion of a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, an increase in service contract pricing and higher spare parts. In the current six month period, revenues were also higher from the extra week of service contract activity, resulting in $7.9 million of incremental revenue. In our Diagnostics business, service revenue increased as a result of higher lab testing volumes from our Biotheranostics business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">588.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">640.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(39.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">344.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">394.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">696.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">787.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(91.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 34.9% and 34.1%, respectively, in the current three and six month periods compared to 25.4% and 24.9%, respectively, in the corresponding periods in the prior year. Cost of product revenues as a percentage of revenue increased in the current three and six month periods primarily due to a decrease in sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 8.5% and 11.5%, respectively, of total product revenue in the current three and six month periods compared to 46.0% and 43.0%, respectively, in the corresponding periods in the prior year. Higher product costs from supply chain constraints and inflation also contributed to the increase in the cost of product revenue. This increase was partially offset by higher sales of our digital mammography systems and related software products and a decrease in inventory reserves in the current three month period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics&#8217; product costs as a percentage of revenue increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to lower sales of our SARS-CoV-2 assays, unfavorable manufacturing variances at certain of our manufacturing facilities, an increase in scrap and higher field service costs from our expanded instrument installed base, partially offset by an increase in core Aptima, Fusion, and Quant Viral assay volume, a decrease in inventory reserves and lower freight internationally.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to higher sales volumes of our higher margin products, primarily 3D Dimensions, which also experienced an increase in average selling prices, and improved manufacturing utilization partially offset by a slight decline in average selling prices of our biopsy disposables, higher prices of raw materials and components from supply chain constraints and inflation, an increase in inventory reserves and an increase in freight.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue decreased in the current three month period compared to the corresponding period in the prior year primarily due to an increase in volume of higher margin products, primarily MyoSure and NovaSure, as procedure rates continue to recover from the impact of the COVID-19 pandemic. Product costs as a percentage of revenue increased in the current six month period compared to the corresponding period in the prior year primarily due to product mix of higher volumes of lower margin products, mostly attributable to sales of our Fluent Fluid Management systems and CoolSeal vessel sealers, partially offset by higher average selling prices of our NovaSure V5 device.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue decreased in the current three month period compared to the corresponding period in the prior year primarily due to an increase in volume of Horizon DXA systems and upgrades as well as an increase in average selling prices of Horizon DXA and Insight FD Fluoroscan systems. Product costs as a percentage of revenue increased in the current six month period compared to the corresponding period in the prior year due to higher component costs from supply chain constraints and inflation partially offset by an increase in volume of Horizon DXA systems and upgrades as well as an increase in average selling prices of Horizon DXA and Insight FD Fluoroscan systems.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to lower amortization of intangible assets acquired in the Cytyc acquisition which became fully amortized in the beginning of the first quarter of fiscal 2023 and to a lesser extent, lower amortization of intangible assets acquired in the Focal and Faxitron acquisitions due to impairments in the prior year, partially offset by an increase from developed technology intangible assets acquired in the Bolder acquisition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin increased to 49.0% and 46.7%, respectively, in the current three and six month periods compared to 43.8% and 44.5%, respectively, in the corresponding periods in the prior year. The increase in the current three and six month periods was primarily due to an increase in lab testing revenue from Biotheranostics, which has higher margins than our legacy service business, and an increase in the average selling prices and attachment rates of our Breast Health service contracts and time and material billings.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and Divestiture charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">352.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">669.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Percentage not meaningful</span></div><div style="padding-left:27pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses increased 6.5% and 4.6% in the current three and six month periods, respectively, compared to the corresponding periods in the prior year primarily due to a lower credits of $5.3 million and $3.8 million in the current three and six month periods, respectively, compared to the corresponding periods in the prior year, recorded for funds received from the Biomedical Advanced Research and Development Authority (BARDA) grant to obtain FDA approval of our SARS-CoV-2 assays. In addition, the current six month period included an extra week of compensation and benefits. Partially offsetting these increases was a reduction in certain project spend. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses decreased 16.9% and 4.0% in the current three and six month periods, respectively, compared to the corresponding periods in the prior year. The decrease was primarily due to lower spending on advertising and marketing initiatives as the prior year periods included spend on our Super Bowl commercial and a larger sponsorship amount for the Women&#8217;s Tennis Association and grants supporting women&#8217;s health initiatives. These decreases were partially offset by higher compensation and benefits primarily from an increase in commissions expense as sales were higher for our Breast Health and Surgical businesses and to a lesser extent an increase in headcount, and an increase in travel and meetings. In the current six month period, the decrease in expenses was also partially offset by an extra week of compensation and benefits and an increase in severance expense. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 0.3% and decreased 4.2% in the current three and six month periods, respectively, compared to the corresponding periods in the prior year. The increase in the current three month period was primarily due to an increase in compensation and benefits from higher expense from our deferred compensation plan due to stock market gains and an increase in stock compensation partially offset by a decrease in non-income tax charges and a decrease in charitable donations of $2.0 million. The decrease in the current six month period was primarily due to a decrease in charitable donations of $12.0 million, a $7.4 million settlement awarded in the Minerva litigation received in the first quarter of fiscal 2023, lower tax project and legal expenses, and a decrease in bad debt expense. These decreases were partially offset by an increase in compensation and benefits from higher expense from our deferred compensation plan due to stock market gains and an increase in stock compensation, an $8.9 million charge to settle a business dispute in connection with terminating the Mobidiag joint venture agreement in China, an increase in reserves for sales and use tax matters, higher travel, an increase in information systems infrastructure costs and higher compensation and benefits from the extra week in the current six month period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets primarily results from customer relationships and trade names related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 5 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense decreased in the current year periods primarily due to assets from our Cytyc acquisition becoming fully amortized at the beginning of the first quarter of fiscal 2023. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa Health, Inc., or Acessa, we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. As of the acquisition date, we recorded a contingent consideration liability for the estimated fair value of the amount we expected to pay to the former shareholders of the acquired business. This liability is not contingent on future employment, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable company revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liability can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. In the second quarter of fiscal 2023, we recorded a gain of $12.4 million based on a decrease in forecasted revenues over the remaining earn-out period. In the first quarter of fiscal 2022, we recorded a gain of $4.1 million based on actual amounts owed for the first earn-out period being lower than the amount accrued as of September 25, 2021. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Percentage not meaningful</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased significantly in the current year periods compared to the corresponding periods in the prior year due to the significant increase in interest rates over the past twelve months as the U.S. Federal Reserve began periodically raising its Federal Funds Rate starting in March 2022. To a lesser extent, the increase in interest income was due to higher average cash balances in the current year periods compared to the corresponding periods in the prior year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in the variable interest rate, SOFR, under our 2021 Credit Agreement partially offset by amounts received under our interest rate swap, which hedges the benchmark interest rate, versus payments made under the interest rate swap in the prior year period. In addition, the prior year interest expense included debt refinancing costs for our 2021 Credit Agreement, and interest expense related to debt acquired in the Mobidiag acquisition that was paid off in the prior year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2022, we entered into a Refinancing Amendment to our 2021 Credit Agreement with Bank of America, N.A. The proceeds were used to pay off the term loan outstanding under our 2018 Credit Agreement. In connection with this transaction we recorded a debt extinguishment charge of $0.7 million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:14.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:5pt;padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the current three month period, this account primarily consisted of a gain of $2.8 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains, partially offset by net foreign currency exchange losses of $0.3 million. For the second quarter of fiscal 2022, this account primarily consisted of net foreign currency exchange gains of $3.3 million, primarily from settling hedging transactions, and a $2.4 million gain on life insurance proceeds as a result of the death of a former employee, partially offset by a loss of $3.5 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market losses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current six month period, this account primarily consisted of net foreign currency exchange losses of $18.4 million, primarily from the mark-to-market of foreign currency contracts used to hedge operating results, partially offset by a gain of $5.3 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains. For the corresponding six month period in the prior year, this account primarily consisted of net foreign currency exchange gains of $12.6 million, primarily from settling transactions, and a $2.4 million gain on life insurance proceeds, partially offset by a charge of $4.3 million to write off an equity method investment acquired in the Mobidiag acquisition and a loss of $2.2 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market losses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:15.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.879%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rates for the three and six months ended April&#160;1, 2023 were 21.8% and 21.7%, respectively, compared to 20.7% and 20.2% for the corresponding periods in the prior year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rates for the three and six months ended April&#160;1, 2023 were higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div><span><br/></span></div><div style="text-indent:24.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our effective tax rates for the three and six months ended March 26, 2022 were lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes. </span></div><div style="text-indent:24pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022. We measure segment performance based on total revenues and operating income. Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(522.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,937.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(913.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(435.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(816.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76.1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the decrease in product revenues discussed above, partially offset by higher lab testing revenue from our Biotheranostics business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current three and six month periods compared to the corresponding periods in the prior year due to a decrease in gross profit from lower COVID-19 assay sales partially offset by a decrease in operating expenses. Gross margin was 55.0% and 56.6% in the current three and six month periods, respectively, compared to 71.8% and 72.3% in the corresponding periods in the prior year, respectively. The decrease in gross profit in the current three and six month periods was primarily due to lower sales volumes of our SARS-CoV-2 assays which have a higher margin, unfavorable manufacturing variances at certain of our manufacturing facilities, an increase in scrap, and higher field service costs from our expanded instrument installed base, partially offset by increases in core Aptima, Fusion and Quant Viral assay volumes, a decrease in inventory reserves, higher lab testing revenue and a decrease in intangible asset amortization expense and lower freight internationally.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a decrease in marketing initiatives and allocated advertising and charitable contributions, a decrease in intangible asset amortization expense, and a decrease in commissions. Partially offsetting these decreases was a decrease in the BARDA credit, an increase in research and development project spend, an increase in travel and meeting expenses and an increase in compensation and benefits from the extra week in the current six month period. Also partially offsetting these decreases in the current six month period compared to the corresponding period in the prior year is a settlement charge of $8.9 million related to the termination of the Mobidiag joint venture in China.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.033%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">719.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues increased in the current three and six month periods compared to the corresponding periods in the prior year due to an increase in product and service revenue discussed above.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in product sales, a decrease in operating expenses and an increase in service gross profit. Gross margin was 57.3% and 55.8% in the current three and six month periods, respectively, compared to 53.4% and 54.6% in the corresponding periods in the prior year, respectively. The increase in gross margin is primarily due to higher volumes of our capital equipment and related software sales, and interventional breast solutions devices, an increase in service margin from the continued conversion of digital mammography systems to service contracts and to a lesser extent the extra week in the current six month period, partially offset by higher costs for raw materials and components from supply chain constraints and inflation, an increase in inventory reserves and an increase in freight.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a decrease in marketing initiatives and allocated advertising and charitable contributions and lower research and development project spend, partially offset by an increase in commission expense from higher sales, an increase in travel and meetings and higher restructuring costs. In addition, there was an increase in compensation and benefits from the extra week in the current six month period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in gross profit and to a lesser extent a decrease in operating expenses. Gross margin was 67.9% and 68.3% in the current three and six month periods, respectively, compared to 56.4% and 59.5% in the corresponding periods in the prior year, respectively. The increase in gross margin was primarily due to a decrease in intangible asset amortization expense and an increase in higher margin product sales in the current three month period, partially offset by an increase in lower margin product sales in the current six month period discussed above.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a gain of $12.4 million recorded in the current three month period to decrease the contingent consideration liability to fair value related to the Acessa acquisition compared to a gain of $4.1 million recorded in the prior year six month period, a decrease in intangible asset amortization expense, and lower marketing initiative spend. These decreases were partially offset by an increase in compensation and benefits primarily due to an increase in commissions and higher salaries and an increase in travel and meeting expenses. In addition, in the current six month period we received $7.4 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million in infringement damages from the Minerva litigation, which was recorded as a credit to general and administrative expenses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Percentage not meaningful</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues discussed above and to a lesser extent the increase in service contract revenue from the extra week in the current six month period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in gross profit and a decrease in operating expenses. Gross margin was 35.6% and 33.0% in the current three and six month periods, respectively, compared to 30.4% and 33.5% in the corresponding periods in the prior year, respectively. The increase in gross margin in the current three month period was primarily due to an increase in product and service revenues partially offset by increased costs from supply chain constraints and inflation. The decrease in gross margin in the current six month period was primarily due to increased costs from supply chain constraints and inflation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a decrease in research and development project spend and marketing initiatives partially offset by an increase in commissions from higher sales.</span></div><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;1, 2023, we had $3,256.4 million of working capital and our cash and cash equivalents totaled $2,582.2 million. Our cash and cash equivalents increased by $242.7 million during the first six months of fiscal 2023 primarily due to cash generated from operating activities, partially offset by cash used in investing and financing activities primarily related to repurchases of our common stock and capital expenditures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2023, our operating activities provided cash of $459.7 million, primarily due to net income of $405.9 million, non-cash charges for depreciation and amortization aggregating $166.7 million, and stock-based compensation expense of $43.7 million. These adjustments to net income were partially offset by a decrease in deferred taxes of $61.6 million primarily due to the capitalization of research expenditures under the tax rules and to a lesser extent the amortization of intangible assets. Cash provided by operations included a net cash outflow of $112.2 million from changes in our operating assets and liabilities. The net cash outflow was primarily driven by an increase of $81.8 million in accounts receivable due to the timing of billings for service contracts as well as higher sales of capital equipment in the second quarter of fiscal 2023 in our Breast Health division compared to the fourth quarter of fiscal 2022, an increase in inventory of $56.1 million principally due to the strategic buildup of emergency sourced components for our Breast Health business to hedge against the continuing worldwide supply constraints, a $22.4 million decrease in accrued expenses primarily due to net payments of the annual bonus and commissions partially offset by the timing of income tax and value-added tax payments, and a $13.2 million decrease in accounts payable due to the timing of payments. These cash outflows were partially offset by an increase of $42.5 million in deferred revenue primarily due to billings for annual service contracts, a decrease in prepaid expenses and other assets of $10.5 million primarily due to the Department of Defense reimbursement received in the second quarter partially offset by normal amortization related to the Women&#8217;s Tennis Association sponsorship and service and software subscriptions, and a decrease in prepaid income taxes of $8.3 million primarily due to timing of tax payments relative to the provision for income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2023, our investing activities used cash of $57.4 million primarily due to capital expenditures of $61.2 million, which primarily consisted of the placement of equipment under customer usage agreements and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase of manufacturing equipment and to a lesser extent building improvements, and $10.0 million for the purchase of an equity investment. These uses of cash were partially offset by a final reimbursement of $20.5 million received from the Department of Defense under a grant to increase production capacity of our two SARS-CoV-2 assays.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2023, our financing activities used cash of $163.0 million primarily due to $150.0 million for repurchases of our common stock and $23.2 million for the payment of employee taxes withheld for the net share settlement of vested restricted stock units. Partially offsetting these uses of cash were $28.4 million from our equity plans, primarily from the exercise of stock options. </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $2.82 billion at April&#160;1, 2023, which was comprised of amounts outstanding under our 2021 Credit Agreement of $1.49 billion (principal of $1.5 billion), 2029 Senior Notes of $937.7 million (principal of $950.0 million), and 2028 Senior Notes of $396.4 million (principal of $400.0 million).</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, we refinanced our existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto (the &#8220;2018 Credit Agreement&#8221;) by entering into a Refinancing Amendment (the &#8220;2021 Credit Agreement&#8221;). Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first priority security interest in, substantially all of our and our Subsidiary Guarantors&#8217; U.S. assets. The credit facilities (the &#8220;2021 Credit Facilities&#8221;) under the 2021 Credit Agreement consist of:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan (&#8220;2021 Term Loan&#8221;) with a stated maturity date of September 25, 2026; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility (the &#8220;2021 Revolver&#8221;) under which the Borrowers may borrow up to $2.0 billion, subject to certain sublimits, with a stated maturity date of September 25, 2026.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the principal amount outstanding under the 2021 Term Loan was $1.5 billion, no amounts were outstanding under the 2021 Revolver, and the full amount of the 2021 Revolver was available to be borrowed by the Company.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 22, 2022, we further amended the 2021 Credit Agreement to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rate applicable to the loans under the 2021 Credit Agreement denominated in U.S. dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;) plus an applicable spread. As of April&#160;1, 2023, the interest rate under the 2021 Term Loan was 5.91% per annum.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to pay a quarterly commitment fee calculated on a daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the 2021 Revolver. As of April&#160;1, 2023, this commitment fee was 0.15% per annum. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $3.75 million per three-month period commencing with the three-month period ended on December 29, 2022 to $18.75 million per three-month period commencing with the three-month period ending on December 26, 2025. The remaining scheduled balance of $1.335 billion (or such lesser aggregate principal amount then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at their respective maturities. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances (excluding permitted debt) and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination if certain financial covenants are met. Subject to certain limitations, we may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including the requirement that we maintain certain financial ratios. As of April&#160;1, 2023, we were in compliance with these covenants. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2028 Senior Notes is $400.0 million. The 2028 Senior Notes are general senior unsecured obligations and are guaranteed on a senior unsecured basis by certain of our domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year. We have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February 15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, our only contingent consideration liability is related to our Acessa acquisition. We have an obligation to the former Acessa shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the contingent consideration was deemed to be part of the purchase price, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies&#8217; revenue growth rates, implied volatility and applying a risk adjusted discount rate. The first earn-out period was completed in December 2021, and we paid $12.2 million to the former shareholders in the second quarter of fiscal 2022. The second earn-out period was completed in December 2022, resulting in a payment amount of $7.6 million in the second quarter of fiscal 2023. During the second quarter of fiscal 2023, we updated our forecasted revenue and recorded a gain of $12.4&#160;million to record the liability to fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues. As of April&#160;1, 2023, the contingent consideration liability was recorded at its fair value of $3.4 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2022, the Board of Directors authorized a stock repurchase program, with a five-year term, to repurchase up to $1.0 billion of our outstanding common stock, effective as of the close of trading September 23, 2022. This repurchase program replaced the previous $1.0 billion authorization. During the three and six months ended April&#160;1, 2023, we repurchased 0.6&#160;million and 2.2 million shares of our common stock for total consideration of $50.0&#160;million and $150.0 million, respectively. As of April&#160;1, 2023, $850.0&#160;million remained available under this authorization. The timing of the share repurchases will be based upon our continuing analysis of market, financial, and other factors. Repurchases under the authorized share repurchase plan may be made using a variety of methods, which may include, but are not limited to, open market purchases, privately negotiated transactions, accelerated share repurchase agreements, or purchases pursuant to a Rule 10b5-1 plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the Exchange Act. The authorized share repurchase plan may be suspended, delayed or discontinued at any time.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions that we believe will complement our current or future business. Subject to the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports, and the general disclaimers set forth in our &#8220;Cautionary Statement&#8221; regarding forward-looking statements at the outset of this Item 2, we believe that our cash and cash equivalents, cash flows from operations, and the cash available under our 2021 Revolver will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2021 Credit Agreement, 2028 Senior Notes, and 2029 Senior Notes. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in Part I, Item&#160;1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022.</span></div><div><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; regarding forward-looking statements set forth at the outset of this Item 2 and the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q as well as those described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency derivative contracts, interest rate swap agreements, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 and 2029 Senior Notes, the fair value of these financial instruments approximate their carrying amount. The fair value of our 2028 and 2029 Senior Notes was approximately $388.9&#160;million and $848.4&#160;million, respectively, as of April&#160;1, 2023. Amounts outstanding under our 2021 Credit Agreement of $1.5 billion aggregate principal as of April&#160;1, 2023 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 and 2029 Senior Notes, and 2021 Credit Agreement. The 2028 and 2029 Senior Notes have fixed interest rates. Effective September 25, 2022 (the first day of fiscal 2023), borrowings under our 2021 Credit Agreement bear interest at the SOFR Rate plus SOFR Adjustment of 0.10% plus the applicable margin of 1.00% per annum.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $1.5 billion of aggregate principal outstanding under our 2021 Credit Agreement. Since this debt obligation is a variable rate instrument, our interest expense associated with the instrument is subject to change. A hypothetical 10% adverse movement (increase in the SOFR rate) would increase annual interest expense by approximately $2.4 million, which is net of the impact of our interest rate swap hedge. We previously entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding under our credit facilities. The critical terms of the interest rate swap were designed to mirror the terms of our SOFR-based borrowings under our 2021 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the Term SOFR-based interest payments on $1.0 billion of principal. This interest rate swap contract expires on December 17, 2023. On March 23, 2023, we entered into two new consecutive interest rate swap contracts with the first contract having an effective date of December 17, 2023 and the second contract terminating September 25, 2026. The notional amount of these swaps is $500 million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase in market interest rates would increase annual interest income by approximately $12.7 million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the U.S. as well as manufacturing facilities primarily in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Chinese Yuan. The majority of our foreign subsidiaries&#8217; functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely affected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Canadian dollar and Chinese Yuan. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Income due to (i) the impact of unrealized gains and losses reported in other income, net on the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against those currencies and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. We believe a hypothetical 10% increase or decrease in foreign currencies that we transact in would not have a material adverse impact on our financial condition or results of operations. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2023, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended September&#160;24, 2022.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended September&#160;24, 2022 or any of our subsequently filed reports.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer&#8217;s Purchases of Equity Securities</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs ($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs  <br/>(in millions) <br/>($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 &#8211; January 28, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 29, 2023 &#8211; February 25, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2023 &#8211; April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On September 22, 2022, the Board of Directors authorized a stock repurchase program, with a five-year term, to repurchase up to $1.0 billion of the Company&#8217;s outstanding common stock, effective as of the close of trading on September 23, 2022. This stock repurchase authorization replaced the previous $1.0 billion authorization.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Exhibits </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Hologic, Inc. Amended and Restated Deferred Compensation Program (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc. Amended and Restated 2008 Equity Incentive Plan (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/10/2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc. Amended and Restated 2012 Employee Stock Purchase Plan (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/10/2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2023ex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2023ex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2023ex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2023ex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)  Indicates management contract or compensatory plan, contract or arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*             Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="icd78113a44f14cfdadfd32f75d6ce8c9_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icd78113a44f14cfdadfd32f75d6ce8c9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan<br/>Chairman, President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Karleen M. Oberton&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>holx_q2-2023ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0137caed440b4ccc9bf2e77430439cb8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;2, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>holx_q2-2023ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3619af3adcbd4b028b6716f6c19383c5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;2, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>holx_q2-2023ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifdd38dc516f04161b44a3e6a9dccc470_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended April&#160;1, 2023 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; May&#160;2, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>holx_q2-2023ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i921bc47205c04caea35e87e449f54d05_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended April&#160;1, 2023 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; May&#160;2, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>holx-20230401.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20230401" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20230401">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20230401_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20230401_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20230401_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20230401_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.hologic.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.hologic.com/role/Revenue">
        <link:definition>0000010 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>0000011 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>0000012 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>0000013 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLosses" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses">
        <link:definition>0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.hologic.com/role/Restructuring">
        <link:definition>0000015 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>0000016 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>0000017 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>0000018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.hologic.com/role/NetIncomeLossPerShare">
        <link:definition>0000019 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>0000020 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>0000021 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>0000022 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>0000023 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill">
        <link:definition>0000024 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>0000025 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000026 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchase" roleURI="http://www.hologic.com/role/ShareRepurchase">
        <link:definition>0000027 - Disclosure - Share Repurchase</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractwithCustomerPolicies" roleURI="http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies">
        <link:definition>0000028 - Disclosure - Revenue from Contract with Customer (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>0000029 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>0000030 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>0000031 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesTables" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables">
        <link:definition>0000032 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>0000033 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.hologic.com/role/DerivativesTables">
        <link:definition>0000034 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables">
        <link:definition>0000035 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>0000036 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>0000037 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>0000038 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>0000039 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>0000040 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>0000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>0000042 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>0000043 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>0000044 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>0000045 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails">
        <link:definition>0000046 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1">
        <link:definition>0000046 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>0000047 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>0000048 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollForwardDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails">
        <link:definition>0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>0000050 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>0000051 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>0000052 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesDetails" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails">
        <link:definition>0000053 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringDetails" roleURI="http://www.hologic.com/role/RestructuringDetails">
        <link:definition>0000054 - Disclosure - Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>0000055 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>0000056 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>0000058 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>0000059 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
        <link:definition>0000060 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueofDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
        <link:definition>0000061 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
        <link:definition>0000062 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetail" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail">
        <link:definition>0000063 - Disclosure - Commitments and Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>0000064 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
        <link:definition>0000065 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>0000066 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail">
        <link:definition>0000067 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail">
        <link:definition>0000068 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail">
        <link:definition>0000069 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>0000070 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>0000071 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>0000072 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>0000073 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
        <link:definition>0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>0000075 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>0000076 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>0000077 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchaseSharerepurchaseDetails" roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails">
        <link:definition>0000078 - Disclosure - Share Repurchase Share repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_MarketBasedAwardsMember" abstract="true" name="MarketBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SecuredTermLoanMember" abstract="true" name="SecuredTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2028And2029SeniorNotesMember" abstract="true" name="A2028And2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_Netincome" abstract="false" name="Netincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentsUnderFinanceLeaseObligations" abstract="false" name="PaymentsUnderFinanceLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ServiceRevenue" abstract="false" name="ServiceRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationContingentConsiderationPayments" abstract="false" name="BusinessCombinationContingentConsiderationPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InterestRateSwap2023Member" abstract="true" name="InterestRateSwap2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SharerepurchaseplanLineItems" abstract="true" name="SharerepurchaseplanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_PaymentOfDeferredAcquisitionConsideration" abstract="false" name="PaymentOfDeferredAcquisitionConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MinervaMember" abstract="true" name="MinervaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_BasisofPresentationAbstract" abstract="true" name="BasisofPresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_Costofservice" abstract="false" name="Costofservice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmountAssessedInDamages" abstract="false" name="AmountAssessedInDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AmortizationCostofGoodsSold" abstract="false" name="AmortizationCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" abstract="false" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" abstract="false" name="ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DanburyClosureMember" abstract="true" name="DanburyClosureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_A2021RevolverMember" abstract="true" name="A2021RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PrepaidIncomeTaxesCurrent" abstract="false" name="PrepaidIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Repaymentsofacquiredlongtermdebt" abstract="false" name="Repaymentsofacquiredlongtermdebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2021CreditAgreementMember" abstract="true" name="A2021CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveIncomeAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_NotationalAmount" abstract="false" name="NotationalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AnnualIncrementalRevenueGrowthPeriod" abstract="false" name="AnnualIncrementalRevenueGrowthPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_December112020Member" abstract="true" name="December112020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_September222022Member" abstract="true" name="September222022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_GrantsReceivedFromDepartmentOfDefense" abstract="false" name="GrantsReceivedFromDepartmentOfDefense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2021TermLoanMember" abstract="true" name="A2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BolderSurgicalMember" abstract="true" name="BolderSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InterestRateSwap2024Member" abstract="true" name="InterestRateSwap2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SharerepurchaseplanTable" abstract="true" name="SharerepurchaseplanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RSUPSUMSUMember" abstract="true" name="RSUPSUMSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_AssetSecuritizationMember" abstract="true" name="AssetSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_GermanyPlanMember" abstract="true" name="GermanyPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" abstract="false" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>holx-20230401_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c909bc8e-c943-42c7-8e06-93dc4207b331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c909bc8e-c943-42c7-8e06-93dc4207b331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_fdd61828-4caf-4ce2-9773-89201185c62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_fdd61828-4caf-4ce2-9773-89201185c62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9889e7c2-707e-4eeb-a20b-e3094172f5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9889e7c2-707e-4eeb-a20b-e3094172f5d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d05045a1-2d10-49b5-ac05-2af1b68db257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d05045a1-2d10-49b5-ac05-2af1b68db257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_15ed16f4-5e3a-485d-a5c6-5c7d382c419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_15ed16f4-5e3a-485d-a5c6-5c7d382c419e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_46095348-edde-4843-9621-fc00db89c4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a274662-2e55-4b75-ade8-f0941f3854f4" xlink:to="loc_us-gaap_RestructuringCharges_46095348-edde-4843-9621-fc00db89c4eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9ca33358-0055-4a09-9f1e-87ec07051b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:to="loc_us-gaap_OperatingIncomeLoss_9ca33358-0055-4a09-9f1e-87ec07051b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_17111e64-8c89-44a5-92b0-4646f5fce026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_17111e64-8c89-44a5-92b0-4646f5fce026" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b067df54-20d7-4fe2-b72a-220fa5ab6ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:to="loc_us-gaap_InterestExpense_b067df54-20d7-4fe2-b72a-220fa5ab6ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_640c074b-3379-4431-83e9-89011fe557da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_640c074b-3379-4431-83e9-89011fe557da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9da57e91-7226-4136-8e37-a796fe9a1d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98bf4641-c327-431a-bc13-b82a4ba413a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9da57e91-7226-4136-8e37-a796fe9a1d3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2da7d8f9-f521-4912-91b7-a214b45a9fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_485a1808-0d89-49eb-9fc4-1967e2c1dce9" xlink:href="holx-20230401.xsd#holx_ProductRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2da7d8f9-f521-4912-91b7-a214b45a9fcb" xlink:to="loc_holx_ProductRevenue_485a1808-0d89-49eb-9fc4-1967e2c1dce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_c0149deb-76c9-4c7a-afeb-0dce4c1177b8" xlink:href="holx-20230401.xsd#holx_ServiceRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2da7d8f9-f521-4912-91b7-a214b45a9fcb" xlink:to="loc_holx_ServiceRevenue_c0149deb-76c9-4c7a-afeb-0dce4c1177b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a3c25938-b77b-4f5f-9e5d-131e85c4f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e85951e0-3676-4569-928a-1d7d2751ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a3c25938-b77b-4f5f-9e5d-131e85c4f71a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e85951e0-3676-4569-928a-1d7d2751ce5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32b7e819-94c9-4652-869c-9367e6fce21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a3c25938-b77b-4f5f-9e5d-131e85c4f71a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32b7e819-94c9-4652-869c-9367e6fce21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6b292f8c-7b89-4b96-adb2-9be3f22e1ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9aabb207-b6b4-4c81-b6de-0e91daebe3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6b292f8c-7b89-4b96-adb2-9be3f22e1ddc" xlink:to="loc_us-gaap_Revenues_9aabb207-b6b4-4c81-b6de-0e91daebe3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_12766d77-2a04-43dc-8404-9b86ee3d0e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6b292f8c-7b89-4b96-adb2-9be3f22e1ddc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_12766d77-2a04-43dc-8404-9b86ee3d0e83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_54001c5f-59a4-4e2d-a6e7-b64f261dd423" xlink:href="holx-20230401.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6b292f8c-7b89-4b96-adb2-9be3f22e1ddc" xlink:to="loc_holx_AmortizationCostofGoodsSold_54001c5f-59a4-4e2d-a6e7-b64f261dd423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_f4a45f08-cdd7-4e33-87f5-1691d80f5f13" xlink:href="holx-20230401.xsd#holx_Costofservice"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6b292f8c-7b89-4b96-adb2-9be3f22e1ddc" xlink:to="loc_holx_Costofservice_f4a45f08-cdd7-4e33-87f5-1691d80f5f13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_587861fe-1e22-431b-a7da-3c2d75726b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cbc2e222-7ca9-4ae3-9804-7e134a4da8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_587861fe-1e22-431b-a7da-3c2d75726b42" xlink:to="loc_us-gaap_GrossProfit_cbc2e222-7ca9-4ae3-9804-7e134a4da8d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_88dcf762-7054-4e8d-a2f6-1456b1721cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_587861fe-1e22-431b-a7da-3c2d75726b42" xlink:to="loc_us-gaap_OperatingExpenses_88dcf762-7054-4e8d-a2f6-1456b1721cee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1fb1c483-909d-4a57-9157-6b3be933f3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_19eeda1f-165b-4d89-9958-26c72f6de341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1fb1c483-909d-4a57-9157-6b3be933f3b1" xlink:to="loc_us-gaap_NetIncomeLoss_19eeda1f-165b-4d89-9958-26c72f6de341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_037f1431-197d-41de-81fc-8397d954ab91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1fb1c483-909d-4a57-9157-6b3be933f3b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_037f1431-197d-41de-81fc-8397d954ab91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77b12c93-7f22-40bd-861a-42b381eb5e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_b2ec6330-3dbd-443b-bafa-12a4208fc1a8" xlink:href="holx-20230401.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77b12c93-7f22-40bd-861a-42b381eb5e92" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_b2ec6330-3dbd-443b-bafa-12a4208fc1a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26c44842-a93e-4b35-9895-9bf2fb022320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77b12c93-7f22-40bd-861a-42b381eb5e92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26c44842-a93e-4b35-9895-9bf2fb022320" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_17c68bd3-3fa6-4029-9bfe-940b8bf70d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_LiabilitiesCurrent_17c68bd3-3fa6-4029-9bfe-940b8bf70d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_59d22c84-13a8-4905-9c99-cfad59d06b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_59d22c84-13a8-4905-9c99-cfad59d06b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f9f8b56-8c95-4c1c-87b3-43338296c497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f9f8b56-8c95-4c1c-87b3-43338296c497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f109b524-ceb8-4373-9261-cb12c8dd7a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f109b524-ceb8-4373-9261-cb12c8dd7a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_89f2df1e-b1f3-44e7-b8b9-dead907baae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_89f2df1e-b1f3-44e7-b8b9-dead907baae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b8ef27b3-e9a2-4dd9-8403-7aaf84138296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b8ef27b3-e9a2-4dd9-8403-7aaf84138296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a447ef1-a6df-4d44-8198-555230b8383b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a630ec51-df04-4b9e-87ac-a5172a6baaca" xlink:to="loc_us-gaap_StockholdersEquity_0a447ef1-a6df-4d44-8198-555230b8383b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_073f408b-3aa7-418f-9c85-82695e34ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_PreferredStockValue_073f408b-3aa7-418f-9c85-82695e34ee32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7fcc9021-b37c-4f22-8037-36cd9548fc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_CommonStockValue_7fcc9021-b37c-4f22-8037-36cd9548fc4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_de9ebc3a-e6dc-435b-9355-d493d02500a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_de9ebc3a-e6dc-435b-9355-d493d02500a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e1c09ed-31d2-4fc5-998b-a35f72a82c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e1c09ed-31d2-4fc5-998b-a35f72a82c39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ee2fd9f5-9f8e-4de9-a31a-bd8f0643c669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_TreasuryStockValue_ee2fd9f5-9f8e-4de9-a31a-bd8f0643c669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_83d9442e-ab26-47d1-8e21-face93d199bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_688be8c5-6cff-4095-adfd-fb6dee2237eb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_83d9442e-ab26-47d1-8e21-face93d199bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_97f08f84-15f1-447b-b980-57c7bd357e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:to="loc_us-gaap_LongTermDebtCurrent_97f08f84-15f1-447b-b980-57c7bd357e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_33e29e4d-b07c-481f-bd09-378f494481d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:to="loc_us-gaap_AccountsPayableCurrent_33e29e4d-b07c-481f-bd09-378f494481d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_87fe7f03-88d3-472b-9b0f-6502430c7a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_87fe7f03-88d3-472b-9b0f-6502430c7a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_7c75feee-2099-44d4-907e-0497050c517a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:to="loc_us-gaap_DeferredRevenueCurrent_7c75feee-2099-44d4-907e-0497050c517a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0a29d63d-7d54-4cf4-827e-1815df953aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4902aacf-4eda-4560-9217-441fc8bc684f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0a29d63d-7d54-4cf4-827e-1815df953aab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_897ad2b6-b23f-4d13-986e-58a1c94dc422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_897ad2b6-b23f-4d13-986e-58a1c94dc422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a985054d-6fe8-4774-b748-29816182f55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a985054d-6fe8-4774-b748-29816182f55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6cd6f540-1392-496b-8515-ab0db4857d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:to="loc_us-gaap_InventoryNet_6cd6f540-1392-496b-8515-ab0db4857d3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_16b4edab-8039-402d-ab91-7b2fb1281ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_16b4edab-8039-402d-ab91-7b2fb1281ebf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_92c71c44-51e6-4f25-a551-7bfb40b288e4" xlink:href="holx-20230401.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa4d6b77-b8f6-452c-b389-135df5ee60fc" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_92c71c44-51e6-4f25-a551-7bfb40b288e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_99e3e56f-2c19-4c9c-85d8-19f450e6aed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:to="loc_us-gaap_AssetsCurrent_99e3e56f-2c19-4c9c-85d8-19f450e6aed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9179ed7-de4e-4899-8756-e4dfe5f7c104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9179ed7-de4e-4899-8756-e4dfe5f7c104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_abc5db6c-21fd-459d-9b38-e6573835a6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_abc5db6c-21fd-459d-9b38-e6573835a6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_add48c1c-edb0-4a47-a1f8-3ad537647feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:to="loc_us-gaap_Goodwill_add48c1c-edb0-4a47-a1f8-3ad537647feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_808c8ef2-a21d-4310-b2ca-06d74f0e222a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_838f9ecf-3c06-4e91-aaa5-60c0471fefb6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_808c8ef2-a21d-4310-b2ca-06d74f0e222a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_e9d36fee-14c7-4435-a9f9-474c6f8d4049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_e9d36fee-14c7-4435-a9f9-474c6f8d4049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2ce6fbb2-834a-4fb5-a60b-f4fd4a3bde22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2ce6fbb2-834a-4fb5-a60b-f4fd4a3bde22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_aeb365cb-9a72-4ba4-87a1-7d1ecedfadb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_aeb365cb-9a72-4ba4-87a1-7d1ecedfadb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt_ed816624-4375-4d79-94d4-a1e6cb1aca14" xlink:href="holx-20230401.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_holx_Repaymentsofacquiredlongtermdebt_ed816624-4375-4d79-94d4-a1e6cb1aca14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6cb470d5-6862-4452-9ddb-0ef8cb60a772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6cb470d5-6862-4452-9ddb-0ef8cb60a772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_237ffa7b-97db-448b-bea5-00d7ea3b9bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_237ffa7b-97db-448b-bea5-00d7ea3b9bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_78dd4165-048c-4067-a828-0bb56786df5c" xlink:href="holx-20230401.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_78dd4165-048c-4067-a828-0bb56786df5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_83378b5b-ce7b-43b3-a9e5-cf576c5ca50c" xlink:href="holx-20230401.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_83378b5b-ce7b-43b3-a9e5-cf576c5ca50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfDeferredAcquisitionConsideration_387745f0-88fb-4c79-abb8-bb25759e7e4a" xlink:href="holx-20230401.xsd#holx_PaymentOfDeferredAcquisitionConsideration"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba02134a-e3d5-4c81-93f7-9e6716e215d6" xlink:to="loc_holx_PaymentOfDeferredAcquisitionConsideration_387745f0-88fb-4c79-abb8-bb25759e7e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_05b82abd-2440-4213-93a6-bd6676fca890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_05b82abd-2440-4213-93a6-bd6676fca890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_de8e823a-cd8e-4ad0-9b07-ab28e61198fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_de8e823a-cd8e-4ad0-9b07-ab28e61198fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_bb9de8f3-6f35-4e17-b923-4117af879b9f" xlink:href="holx-20230401.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_bb9de8f3-6f35-4e17-b923-4117af879b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_a887ae24-0e94-4b09-bab8-9ca2a27f4f6e" xlink:href="holx-20230401.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_a887ae24-0e94-4b09-bab8-9ca2a27f4f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_581ad6b2-5967-4b41-91ff-d20f2d2686ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_581ad6b2-5967-4b41-91ff-d20f2d2686ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c5b9fd18-657d-4bbd-ad56-d7cfb2d75298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be606161-0ab6-4809-8f1a-a97f95d723d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c5b9fd18-657d-4bbd-ad56-d7cfb2d75298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c7dc8fee-9441-43b5-a5d9-f4dc9bcc3c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_48e9145c-38b3-40fc-aca0-004e69209e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c7dc8fee-9441-43b5-a5d9-f4dc9bcc3c08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_48e9145c-38b3-40fc-aca0-004e69209e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_97102875-2aad-4a86-aa3d-5daab2ef7eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c7dc8fee-9441-43b5-a5d9-f4dc9bcc3c08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_97102875-2aad-4a86-aa3d-5daab2ef7eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58799fc6-49e8-4ac5-b337-88ad246dbdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c7dc8fee-9441-43b5-a5d9-f4dc9bcc3c08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58799fc6-49e8-4ac5-b337-88ad246dbdf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3cff18b3-7817-47dc-b995-15e58598b460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c7dc8fee-9441-43b5-a5d9-f4dc9bcc3c08" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3cff18b3-7817-47dc-b995-15e58598b460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5faf2ba5-a320-4468-815b-4ef21ccdfc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_NetIncomeLoss_5faf2ba5-a320-4468-815b-4ef21ccdfc27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_33b78277-056c-485c-8ae3-d821975c455c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_Depreciation_33b78277-056c-485c-8ae3-d821975c455c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_6ac92e2a-5b9c-4605-aeef-89aaa1b96fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_AdjustmentForAmortization_6ac92e2a-5b9c-4605-aeef-89aaa1b96fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0cd3a027-969e-4f6b-b647-f8ee99c2a025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_ShareBasedCompensation_0cd3a027-969e-4f6b-b647-f8ee99c2a025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5817432f-0dc4-4351-aed8-8eda31bce899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5817432f-0dc4-4351-aed8-8eda31bce899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_bd459697-abf8-4672-aade-c54c8a25431e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_bd459697-abf8-4672-aade-c54c8a25431e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b7d4ded7-1ace-4867-9987-b17d876cdc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b7d4ded7-1ace-4867-9987-b17d876cdc0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_11f0e2a6-968e-4412-a392-88799027ec4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_11f0e2a6-968e-4412-a392-88799027ec4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_20250bb3-3ed4-47ef-96f1-2685654e79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_20250bb3-3ed4-47ef-96f1-2685654e79a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca62517f-5291-4e15-9b7b-955dd70fa4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca62517f-5291-4e15-9b7b-955dd70fa4f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a0099c83-1777-433a-8667-15a7df0742cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a0099c83-1777-433a-8667-15a7df0742cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8e915c9b-4e78-4f51-8aa4-ace6be596612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8e915c9b-4e78-4f51-8aa4-ace6be596612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_df7ef83d-a0f9-4ecf-941f-cd67911c5713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_df7ef83d-a0f9-4ecf-941f-cd67911c5713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3b226938-8056-4156-8878-b8402c0d3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a464b8c-2e34-4e0e-9f45-17f023079325" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3b226938-8056-4156-8878-b8402c0d3bea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee95da16-ea04-47eb-b3bb-6473b355260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee95da16-ea04-47eb-b3bb-6473b355260a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6d535d07-1d38-4d7c-9db7-f338bb4b8dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6d535d07-1d38-4d7c-9db7-f338bb4b8dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_af87d1de-4c04-4e14-aa8e-47e480962a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_af87d1de-4c04-4e14-aa8e-47e480962a06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f9340372-c34c-4efc-8ca6-75cf0b177c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f9340372-c34c-4efc-8ca6-75cf0b177c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_01557548-8639-4757-ad2b-b45daf3284f2" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_01557548-8639-4757-ad2b-b45daf3284f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b9c98101-e295-4780-9b67-a69096e56be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b9c98101-e295-4780-9b67-a69096e56be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f357ef9f-ed11-4a86-9495-1c28ae3c14b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_Goodwill_f357ef9f-ed11-4a86-9495-1c28ae3c14b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_97528cc7-a5fa-4843-86db-7a212f9866ea" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_97528cc7-a5fa-4843-86db-7a212f9866ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_bd61eb79-3c5d-4152-96a2-5825f9778e91" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_bd61eb79-3c5d-4152-96a2-5825f9778e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a3dd4f9a-c059-4c6d-a7ae-0682b09082ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_78a26a1c-008b-49da-bbf8-8a02b2e09f75" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a3dd4f9a-c059-4c6d-a7ae-0682b09082ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab8df827-b911-493d-99b7-a6fe823f63a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_33a58f23-2b95-4323-a55e-524332db2c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ab8df827-b911-493d-99b7-a6fe823f63a5" xlink:to="loc_us-gaap_LongTermDebtCurrent_33a58f23-2b95-4323-a55e-524332db2c87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f0518b52-9645-42b8-bb19-e8ecb724ed22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ab8df827-b911-493d-99b7-a6fe823f63a5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f0518b52-9645-42b8-bb19-e8ecb724ed22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_fc881cd7-d1f5-42c8-99e0-02474e9d0f0e" xlink:href="holx-20230401.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ab8df827-b911-493d-99b7-a6fe823f63a5" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_fc881cd7-d1f5-42c8-99e0-02474e9d0f0e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80b12972-9ccb-490a-916d-73942efa3a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6322e3e-f3cf-4ecd-86d0-ae47de97a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80b12972-9ccb-490a-916d-73942efa3a33" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6322e3e-f3cf-4ecd-86d0-ae47de97a225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1c496d7b-0b53-4d2a-9592-a89888326d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80b12972-9ccb-490a-916d-73942efa3a33" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1c496d7b-0b53-4d2a-9592-a89888326d2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_49066871-afae-489d-afa8-88eeb637f29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_54942f5f-fb94-4077-9ee4-fe4a12f967b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_49066871-afae-489d-afa8-88eeb637f29e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_54942f5f-fb94-4077-9ee4-fe4a12f967b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_20dae9ff-6279-44ea-aed9-edf871c22c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_49066871-afae-489d-afa8-88eeb637f29e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_20dae9ff-6279-44ea-aed9-edf871c22c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_769a75d8-6631-4b41-8e8e-9d3cdaca0626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_49066871-afae-489d-afa8-88eeb637f29e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_769a75d8-6631-4b41-8e8e-9d3cdaca0626" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_85af8820-5e69-4c0f-82c6-bed5d15718e8" xlink:href="holx-20230401.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_85af8820-5e69-4c0f-82c6-bed5d15718e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_553c0678-e254-4660-8af0-24d7357fa04f" xlink:href="holx-20230401.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_553c0678-e254-4660-8af0-24d7357fa04f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_9774c60b-29dd-4264-8af7-89f83b3620d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_9774c60b-29dd-4264-8af7-89f83b3620d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_a3e11908-ca9c-4463-9633-9c47b0001c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_a3e11908-ca9c-4463-9633-9c47b0001c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e7b3acf1-9b3c-4301-aad2-e6fb1a637825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_us-gaap_Land_e7b3acf1-9b3c-4301-aad2-e6fb1a637825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_cc287ce6-32ba-4225-a8ef-788dbf4d69a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_cc287ce6-32ba-4225-a8ef-788dbf4d69a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ef5c8984-b72b-4aa6-ac17-0034ce11774f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_87e374c3-4e2d-4602-b82e-da5b57ca697f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ef5c8984-b72b-4aa6-ac17-0034ce11774f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_df98a70c-1c91-4376-bc5e-49148dfe6f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6422bc72-dd99-4d9d-94ff-794c84870bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_df98a70c-1c91-4376-bc5e-49148dfe6f03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6422bc72-dd99-4d9d-94ff-794c84870bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_37040117-5a9c-45a0-9ca9-ef110f97260d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_df98a70c-1c91-4376-bc5e-49148dfe6f03" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_37040117-5a9c-45a0-9ca9-ef110f97260d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>holx-20230401_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i434c9025aa15471c8b3193388499037f_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d996dec1-1e4d-40ae-a6c3-678cc859b855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_SharesIssued_d996dec1-1e4d-40ae-a6c3-678cc859b855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5d8c14f7-b0cc-4bb5-84f1-574fcba9a651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockholdersEquity_5d8c14f7-b0cc-4bb5-84f1-574fcba9a651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45f69996-758a-4d85-b443-a7ebc713a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45f69996-758a-4d85-b443-a7ebc713a5ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2b80b968-6abc-4c84-8911-674e30656ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2b80b968-6abc-4c84-8911-674e30656ee3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c21fb152-17bb-4c6a-8ce7-2eab4dc8e8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c21fb152-17bb-4c6a-8ce7-2eab4dc8e8e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_59b58233-2068-45b1-8da7-8213d602c08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_59b58233-2068-45b1-8da7-8213d602c08f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f673f0a6-effa-47fe-a2b9-74e44fc06578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f673f0a6-effa-47fe-a2b9-74e44fc06578" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_66db4dc4-3526-4922-a2cf-3a610fe2a3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_66db4dc4-3526-4922-a2cf-3a610fe2a3e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_58272575-7e5b-4d47-a8f7-7c259569f4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_58272575-7e5b-4d47-a8f7-7c259569f4e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc0fbc37-2fff-4816-84ea-df4e61af7206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_NetIncomeLoss_bc0fbc37-2fff-4816-84ea-df4e61af7206" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dad9e94e-cc8d-4b8b-ac52-baedd1114f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dad9e94e-cc8d-4b8b-ac52-baedd1114f48" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_17331bf8-2298-4830-8d36-d759704d6b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_17331bf8-2298-4830-8d36-d759704d6b0e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_36155f3d-0737-4b2f-8514-d3420a9ad90e" xlink:href="holx-20230401.xsd#holx_Netincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_holx_Netincome_36155f3d-0737-4b2f-8514-d3420a9ad90e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_b6a086b9-f95d-4f82-a2e0-38c7a80049d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_b6a086b9-f95d-4f82-a2e0-38c7a80049d5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4f632554-58b2-473a-8136-49df4d46f822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3fb5e79-1845-4d7c-9c01-41c144b03b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2fdf3a12-0694-4e51-a7c6-a24bb8dcc91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2fdf3a12-0694-4e51-a7c6-a24bb8dcc91b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:to="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_098f6e90-a4fb-4b1a-9f21-780d6c8016de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:to="loc_us-gaap_EquityComponentDomain_098f6e90-a4fb-4b1a-9f21-780d6c8016de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:to="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7241614-2d4c-4e01-a4f7-050f92e097a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_CommonStockMember_d7241614-2d4c-4e01-a4f7-050f92e097a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01b6f39c-8cd3-413a-bc6b-e202c0aebb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01b6f39c-8cd3-413a-bc6b-e202c0aebb6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb21bc37-7cab-4b67-8b5b-b8ba63b805dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_RetainedEarningsMember_eb21bc37-7cab-4b67-8b5b-b8ba63b805dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7120d8cb-1589-4b0c-8ff6-77ae93c15d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7120d8cb-1589-4b0c-8ff6-77ae93c15d7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0e8e7a62-f6af-4d16-a93b-4f22e1e88128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_TreasuryStockMember_0e8e7a62-f6af-4d16-a93b-4f22e1e88128" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9922733e-dd8c-4849-b9b0-27c4f5194e8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9922733e-dd8c-4849-b9b0-27c4f5194e8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f426e99f-2f15-4c1d-8a2f-402a0b6e8d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f426e99f-2f15-4c1d-8a2f-402a0b6e8d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c8f4a526-7400-47a9-a614-8dd0610cdf1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c8f4a526-7400-47a9-a614-8dd0610cdf1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_150a1882-9f99-4697-8812-c16f1d20642a" xlink:href="holx-20230401.xsd#holx_September222022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:to="loc_holx_September222022Member_150a1882-9f99-4697-8812-c16f1d20642a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="i80b47cca38974bb89b554bb8d3a1cddb_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ac275423-0b23-4abb-aa66-4f16d81c1bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:to="loc_us-gaap_Revenues_ac275423-0b23-4abb-aa66-4f16d81c1bc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_638fc54c-e51a-4bba-a5a1-9078b1e595a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:to="loc_us-gaap_SegmentDomain_638fc54c-e51a-4bba-a5a1-9078b1e595a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:to="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_3cb56dc7-526f-422b-9e3e-9b9f61ec4130" xlink:href="holx-20230401.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_DiagnosticsMember_3cb56dc7-526f-422b-9e3e-9b9f61ec4130" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_7e334019-8012-4c41-8a22-e5dec03f14db" xlink:href="holx-20230401.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_BreastHealthMember_7e334019-8012-4c41-8a22-e5dec03f14db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_04f2c5d6-5d2f-4e3e-b206-29bc6f9fe5e2" xlink:href="holx-20230401.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_GynSurgicalMember_04f2c5d6-5d2f-4e3e-b206-29bc6f9fe5e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_30cb04dc-a771-4e45-82b2-ca3c208b77e3" xlink:href="holx-20230401.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_SkeletalHealthMember_30cb04dc-a771-4e45-82b2-ca3c208b77e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_768513d8-5c1a-4fd2-bd67-416ff059913d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:to="loc_srt_ProductsAndServicesDomain_768513d8-5c1a-4fd2-bd67-416ff059913d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:to="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_04191d4a-6978-42fb-aff8-ff97301871e1" xlink:href="holx-20230401.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_CytologyPerinatalMember_04191d4a-6978-42fb-aff8-ff97301871e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_3395a887-d45e-444f-81f9-b94cb5dca76e" xlink:href="holx-20230401.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_MolecularDiagnosticsMember_3395a887-d45e-444f-81f9-b94cb5dca76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_b5751446-a2dd-4158-8a82-87c790c41750" xlink:href="holx-20230401.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_BloodScreeningMember_b5751446-a2dd-4158-8a82-87c790c41750" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_c2cae714-e357-40e3-8e87-17e17f8a12f2" xlink:href="holx-20230401.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_BreastImagingMember_c2cae714-e357-40e3-8e87-17e17f8a12f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_b8521076-7326-4aee-abb4-83c185dc9809" xlink:href="holx-20230401.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_InterventionalBreastSolutionsMember_b8521076-7326-4aee-abb4-83c185dc9809" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_21726ebb-5999-49f8-880b-e9c1631009d1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:to="loc_srt_SegmentGeographicalDomain_21726ebb-5999-49f8-880b-e9c1631009d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:to="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4e600496-5d19-4c16-be00-75c51061383e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:to="loc_country_US_4e600496-5d19-4c16-be00-75c51061383e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_9fb7608f-5cf9-4b97-b191-8fd8aceee77b" xlink:href="holx-20230401.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:to="loc_holx_InternationalMember_9fb7608f-5cf9-4b97-b191-8fd8aceee77b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="i25f1c2fb48094a46be0004ce62ec57d8_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ebc4b346-c82e-4db4-a1a8-bb1a24a0f14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:to="loc_us-gaap_Revenues_ebc4b346-c82e-4db4-a1a8-bb1a24a0f14e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:to="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6630d78-0c2d-48b2-ab86-5c0d3bc04642_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:to="loc_srt_SegmentGeographicalDomain_b6630d78-0c2d-48b2-ab86-5c0d3bc04642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:to="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_768eb9ce-16ad-4b44-82ae-676036bb9b7b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_country_US_768eb9ce-16ad-4b44-82ae-676036bb9b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6c190312-eecc-4fbb-8dc2-a51b8f9d900b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_srt_EuropeMember_6c190312-eecc-4fbb-8dc2-a51b8f9d900b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_3916f36f-2d2d-4f94-82e6-d6da6d6f53ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_srt_AsiaPacificMember_3916f36f-2d2d-4f94-82e6-d6da6d6f53ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_a0fed5d4-df9b-4b19-b4bf-0f1e6c9c452c" xlink:href="holx-20230401.xsd#holx_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_holx_RestofWorldMember_a0fed5d4-df9b-4b19-b4bf-0f1e6c9c452c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="i338975e27dc54e0d92a95ca7f9ace9c2_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e5163fa-276d-4b87-9784-f4255d195ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:to="loc_us-gaap_Revenues_2e5163fa-276d-4b87-9784-f4255d195ff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:to="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3acfe1d2-4110-4922-ac3b-d9a58ed67256_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:to="loc_srt_ProductsAndServicesDomain_3acfe1d2-4110-4922-ac3b-d9a58ed67256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:to="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_581b4824-7c14-4ae3-8f26-69a74ca06d36" xlink:href="holx-20230401.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_ConsumablesMember_581b4824-7c14-4ae3-8f26-69a74ca06d36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4fc8e075-23b3-4228-ac5e-54e2300a4d8a" xlink:href="holx-20230401.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4fc8e075-23b3-4228-ac5e-54e2300a4d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ab83acd2-890a-40f5-82ea-48820e94483a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_us-gaap_ServiceMember_ab83acd2-890a-40f5-82ea-48820e94483a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_bdb0190b-6526-462a-912a-8dcdfe8852a4" xlink:href="holx-20230401.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_OtherTypeofRevenueMember_bdb0190b-6526-462a-912a-8dcdfe8852a4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i4b60f81d748047f288972cc58d0c3425_RevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7382cccf-c102-4666-8557-116bf6f84835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7382cccf-c102-4666-8557-116bf6f84835" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="ib6285e7e6620465683c3d30c179f61aa_RevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="ib984685f299f43078a829ff76c2662b1_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3ef7bc1b-5337-4010-87bd-43640c8b34bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3ef7bc1b-5337-4010-87bd-43640c8b34bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_54a5e1ae-c858-4898-84a4-73ab6ddfc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_54a5e1ae-c858-4898-84a4-73ab6ddfc0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ceb4f825-63e3-439b-903e-0c4ba4823627_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ceb4f825-63e3-439b-903e-0c4ba4823627_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9099202c-7efe-481d-821b-ae18f73e736b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9099202c-7efe-481d-821b-ae18f73e736b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fa473a81-4d01-44b5-a6e3-bdfe29010954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fa473a81-4d01-44b5-a6e3-bdfe29010954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8274878f-7035-4a13-8033-e28e4fdc6618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8274878f-7035-4a13-8033-e28e4fdc6618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d182aa94-0a5b-4f7e-bbea-628f5226677d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d182aa94-0a5b-4f7e-bbea-628f5226677d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3934ca14-dd43-48ab-a723-b91726b8b333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_InterestRateSwapMember_3934ca14-dd43-48ab-a723-b91726b8b333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_3906030b-e0bf-4b0b-80f9-635276257bfd" xlink:href="holx-20230401.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_holx_ContingentConsiderationMember_3906030b-e0bf-4b0b-80f9-635276257bfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f63ed70c-abc5-4295-b234-fe0ab0e89832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f63ed70c-abc5-4295-b234-fe0ab0e89832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_50c9b3c4-e21c-4033-8ce7-056ed0028e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_50c9b3c4-e21c-4033-8ce7-056ed0028e0e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i31a7e5f9feab43c3a50fc2e3beb89c11_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_cd8f04b7-18c3-42ef-8a94-e910a765cb00" xlink:href="holx-20230401.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_holx_PrincipalAmountOfBorrowings_cd8f04b7-18c3-42ef-8a94-e910a765cb00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad47e38-0aaf-4b9f-8f54-b3efebef9cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad47e38-0aaf-4b9f-8f54-b3efebef9cde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f6a10b76-6299-40da-8c04-3c0a4b82565f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f6a10b76-6299-40da-8c04-3c0a4b82565f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_b1ebe7d9-f9d7-4205-99d5-f52bceeb3238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_b1ebe7d9-f9d7-4205-99d5-f52bceeb3238" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7fb58e5f-76ce-4c50-b700-dd122d25237a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7fb58e5f-76ce-4c50-b700-dd122d25237a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_19f028a8-f024-4cfe-8d2a-0bb657bef54b" xlink:href="holx-20230401.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_CreditAgreementMember_19f028a8-f024-4cfe-8d2a-0bb657bef54b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_8a12b37a-dec8-45e7-a3c7-dd048f415cdc" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_A2028SeniorNotesMember_8a12b37a-dec8-45e7-a3c7-dd048f415cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_317cf862-af1e-41df-a328-1b6e68797dfb" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_A2029SeniorNotesMember_317cf862-af1e-41df-a328-1b6e68797dfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7c960055-4927-4b7b-9a5e-f204b1220d28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7c960055-4927-4b7b-9a5e-f204b1220d28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_e7c8a9bb-0bd5-4cd2-bee0-cb56b6da4f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_e7c8a9bb-0bd5-4cd2-bee0-cb56b6da4f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9c09f384-0af3-4c10-ac7a-a4ab14a695ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:to="loc_us-gaap_SeniorNotesMember_9c09f384-0af3-4c10-ac7a-a4ab14a695ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d9a63d1-d55b-47e5-bbd4-0fd621957e31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d9a63d1-d55b-47e5-bbd4-0fd621957e31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_9c1d332f-e8de-4cf8-b492-bf12eb15c35f" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:to="loc_holx_A2028SeniorNotesMember_9c1d332f-e8de-4cf8-b492-bf12eb15c35f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_702f8a0a-05c3-480e-8378-73b915f2024d" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:to="loc_holx_A2029SeniorNotesMember_702f8a0a-05c3-480e-8378-73b915f2024d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="iabf5ec980e654ac38db85184ee495c1a_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2ec5de65-ca2f-4238-9f7c-a88ca91b7274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2ec5de65-ca2f-4238-9f7c-a88ca91b7274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_be41b59a-bf1f-4716-9184-5c6d9001e334" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_be41b59a-bf1f-4716-9184-5c6d9001e334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d2106da1-8bd9-4bb8-9434-a7aa0d79d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d2106da1-8bd9-4bb8-9434-a7aa0d79d24b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_19267a4c-6d23-453f-a055-da6871d90bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_19267a4c-6d23-453f-a055-da6871d90bf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_dde15ab9-ba82-443f-bbdd-3ae65b4b667b" xlink:href="holx-20230401.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_dde15ab9-ba82-443f-bbdd-3ae65b4b667b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_95deafdf-78b8-4020-951b-c10a69e1fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_95deafdf-78b8-4020-951b-c10a69e1fde8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments_8f36c2dc-8e02-4ec1-b44c-00e447ee5052" xlink:href="holx-20230401.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_BusinessCombinationContingentConsiderationPayments_8f36c2dc-8e02-4ec1-b44c-00e447ee5052" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3c228d19-b9bf-483b-8dae-3dce9b34bf44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3c228d19-b9bf-483b-8dae-3dce9b34bf44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_547ddd1c-b9f9-496c-a28f-5f1af798705d" xlink:href="holx-20230401.xsd#holx_BolderSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:to="loc_holx_BolderSurgicalMember_547ddd1c-b9f9-496c-a28f-5f1af798705d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_6363b80a-11be-48c4-a1ac-015cc8a33f08" xlink:href="holx-20230401.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:to="loc_holx_AcessaHealthMember_6363b80a-11be-48c4-a1ac-015cc8a33f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd6463b0-e34c-439e-bf1c-01eef645c9ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd6463b0-e34c-439e-bf1c-01eef645c9ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_af6568ec-3434-46ff-978a-dad054df9c3d" xlink:href="holx-20230401.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_holx_DevelopedTechnologyMember_af6568ec-3434-46ff-978a-dad054df9c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5d4c9806-3979-4ed9-8d73-7644a910fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5d4c9806-3979-4ed9-8d73-7644a910fd90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e3bca05b-b8c1-41f9-a5bf-937902d1e165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_us-gaap_TradeNamesMember_e3bca05b-b8c1-41f9-a5bf-937902d1e165" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i3f5757559bf6439c86be52d731aca032_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_695c1b78-c0e7-4b78-9fb5-b01fef5e7096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_695c1b78-c0e7-4b78-9fb5-b01fef5e7096" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_12f314f4-7ac6-44a4-8f93-dea382095132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_12f314f4-7ac6-44a4-8f93-dea382095132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4557aed1-4de4-49e8-aedc-5b638eaee570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4557aed1-4de4-49e8-aedc-5b638eaee570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_800d1047-09cc-4571-aab7-0695c8b5c934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_800d1047-09cc-4571-aab7-0695c8b5c934" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d68f245a-06ab-43c5-87e1-05f45258bda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d68f245a-06ab-43c5-87e1-05f45258bda4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_7960f7e5-5198-4c22-be93-59982f000787" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_7960f7e5-5198-4c22-be93-59982f000787" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e791b43-bc30-4da6-99a2-5740da6e034f" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e791b43-bc30-4da6-99a2-5740da6e034f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a3b8aadb-8f62-42a5-8621-3a041b1c43ee" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a3b8aadb-8f62-42a5-8621-3a041b1c43ee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_22b951e6-9724-40a3-ba82-8c4868de9b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_22b951e6-9724-40a3-ba82-8c4868de9b66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bd6ea462-e437-45e7-a046-6dce16563c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_Goodwill_bd6ea462-e437-45e7-a046-6dce16563c8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_037c19d4-5f8f-4c30-bdce-77b09df6ce06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_037c19d4-5f8f-4c30-bdce-77b09df6ce06" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aca1a703-766d-42fa-83b2-6bed1372abd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aca1a703-766d-42fa-83b2-6bed1372abd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_90021baa-3646-4582-b16f-1548dadd782f" xlink:href="holx-20230401.xsd#holx_BolderSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:to="loc_holx_BolderSurgicalMember_90021baa-3646-4582-b16f-1548dadd782f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RestructuringDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringDetails" xlink:type="extended" id="i0754ce50135d47fabff11ad41e73d52c_RestructuringDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_0663afc5-7835-4567-a4a4-dc508e91ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_0663afc5-7835-4567-a4a4-dc508e91ef7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f2db892d-0afe-4a7f-b5df-f733ecc64dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:to="loc_us-gaap_RestructuringCharges_f2db892d-0afe-4a7f-b5df-f733ecc64dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:to="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0bf313ff-10f1-4a60-8ffb-f0b32f53f766_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:to="loc_us-gaap_RestructuringPlanDomain_0bf313ff-10f1-4a60-8ffb-f0b32f53f766_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:to="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember_31d9d5b6-e857-416c-b218-b72c8406fdb1" xlink:href="holx-20230401.xsd#holx_DanburyClosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:to="loc_holx_DanburyClosureMember_31d9d5b6-e857-416c-b218-b72c8406fdb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GermanyPlanMember_7d36a450-06f6-4d2c-a3e6-5f4b7f8c3791" xlink:href="holx-20230401.xsd#holx_GermanyPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:to="loc_holx_GermanyPlanMember_7d36a450-06f6-4d2c-a3e6-5f4b7f8c3791" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="i8724e757317d4ee99e43e2ac7bb8e9c1_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b0b7e9af-e808-444a-a86c-b4a689d78182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebtCurrent_b0b7e9af-e808-444a-a86c-b4a689d78182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_93fd9a3a-42b3-41db-a643-00c415a02121" xlink:href="holx-20230401.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_93fd9a3a-42b3-41db-a643-00c415a02121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d8bff875-53bd-4adf-865c-dbe965d2464c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d8bff875-53bd-4adf-865c-dbe965d2464c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_83cefaae-c1d6-4dc8-ad6e-90e1d43b3e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebt_83cefaae-c1d6-4dc8-ad6e-90e1d43b3e5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_952578c5-9f6b-49ad-b010-aa499140fbdb" xlink:href="holx-20230401.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_TermLoanMember_952578c5-9f6b-49ad-b010-aa499140fbdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_943eb93a-e682-4068-86fc-4d3c08b47f0a" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_A2028SeniorNotesMember_943eb93a-e682-4068-86fc-4d3c08b47f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_640c6df2-85e9-47ff-93ef-e73c2ae4dbb3" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_A2029SeniorNotesMember_640c6df2-85e9-47ff-93ef-e73c2ae4dbb3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="icd881602b6ff4496a88ec0a2bed4bd2e_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_188f1d9c-a4ff-4c12-a118-1b7a1435d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_188f1d9c-a4ff-4c12-a118-1b7a1435d399" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c6152133-0e26-4573-b2ec-7f69f8ddcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c6152133-0e26-4573-b2ec-7f69f8ddcb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5c0a7b7d-6683-43ea-99db-b45666fd8425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5c0a7b7d-6683-43ea-99db-b45666fd8425" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1abf7abe-9e2a-43ea-a5af-8a9548fee412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1abf7abe-9e2a-43ea-a5af-8a9548fee412" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7c3a4aae-1011-4f2e-afee-fa34ac77329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7c3a4aae-1011-4f2e-afee-fa34ac77329c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_fdcaea68-8ed0-47c6-bca2-bb90241699d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_fdcaea68-8ed0-47c6-bca2-bb90241699d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_86ae2c20-a941-4c3a-ad1c-be02ee044a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_86ae2c20-a941-4c3a-ad1c-be02ee044a1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_5d4d4c00-8ca4-4959-a43a-7af7f5b8eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_SeniorNotes_5d4d4c00-8ca4-4959-a43a-7af7f5b8eb46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_b3649e99-6233-4f91-a849-82eb0b54376d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_b3649e99-6233-4f91-a849-82eb0b54376d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_4e117bbb-ed4d-4c01-bad6-1a6244536685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_4e117bbb-ed4d-4c01-bad6-1a6244536685" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_64358cfc-5596-4f6e-84b5-106e01722046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_64358cfc-5596-4f6e-84b5-106e01722046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_f665ddbb-9706-446a-8461-9f281e697514" xlink:href="holx-20230401.xsd#holx_SecuredTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_SecuredTermLoanMember_f665ddbb-9706-446a-8461-9f281e697514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_9eed4dfd-f617-4277-98de-c1b692a9d160" xlink:href="holx-20230401.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_RevolverMember_9eed4dfd-f617-4277-98de-c1b692a9d160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_be7933b3-26b0-4e82-a2b2-0cd2bf029fc3" xlink:href="holx-20230401.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_TermLoanMember_be7933b3-26b0-4e82-a2b2-0cd2bf029fc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3ae663dc-293d-4862-a1f1-d94c356f601e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_us-gaap_SeniorNotesMember_3ae663dc-293d-4862-a1f1-d94c356f601e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember_9712d112-fb5b-456c-8f0b-23599025b8a2" xlink:href="holx-20230401.xsd#holx_AssetSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_AssetSecuritizationMember_9712d112-fb5b-456c-8f0b-23599025b8a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_008d9065-f07c-432a-9c8e-be6835bc3778_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_008d9065-f07c-432a-9c8e-be6835bc3778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_982efde7-b315-4653-b414-b8a75562400e" xlink:href="holx-20230401.xsd#holx_A2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021TermLoanMember_982efde7-b315-4653-b414-b8a75562400e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_3f1d41b9-8a67-49ee-8d16-a6b6575c878f" xlink:href="holx-20230401.xsd#holx_A2021RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021RevolverMember_3f1d41b9-8a67-49ee-8d16-a6b6575c878f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_9679c42f-dc6c-48a0-9a2e-d8e2995414ec" xlink:href="holx-20230401.xsd#holx_A2021CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021CreditAgreementMember_9679c42f-dc6c-48a0-9a2e-d8e2995414ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3f6f7ea5-119e-4e8c-a1fa-96e67e2991f5" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2028SeniorNotesMember_3f6f7ea5-119e-4e8c-a1fa-96e67e2991f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_cbdcc6f3-4e93-4f1e-85e6-cdfbe981afdd" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2029SeniorNotesMember_cbdcc6f3-4e93-4f1e-85e6-cdfbe981afdd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3ec3622d-05b3-4882-bdc3-280881d9a28a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3ec3622d-05b3-4882-bdc3-280881d9a28a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4b42923b-ede4-45e9-9bed-a7b8da270813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:to="loc_us-gaap_InterestRateSwapMember_4b42923b-ede4-45e9-9bed-a7b8da270813" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="i58578f1befe448888cd75f2d89ef58b2_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_9a6e73fd-2b6c-40df-a2b0-d4e1a450590c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_InterestExpenseBorrowings_9a6e73fd-2b6c-40df-a2b0-d4e1a450590c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_fa1e31c6-fc82-4f57-ab66-6d3479e62219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_fa1e31c6-fc82-4f57-ab66-6d3479e62219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_613d3384-e7c8-44e6-82b2-f8e048a0b214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_613d3384-e7c8-44e6-82b2-f8e048a0b214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f780e1a-09af-4327-8754-b0296332a88f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f780e1a-09af-4327-8754-b0296332a88f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_e3113ced-b6c5-4b46-b897-15a97d4a448c" xlink:href="holx-20230401.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:to="loc_holx_CreditAgreementMember_e3113ced-b6c5-4b46-b897-15a97d4a448c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i252afdc11b1d4f7d95dacd2dc1a22286_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_450a6dfa-27cb-482c-8025-9ba90b5ce5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_450a6dfa-27cb-482c-8025-9ba90b5ce5bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_e0d13a95-7619-4286-a1c6-1237a57e7d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:to="loc_us-gaap_InterestExpenseBorrowings_e0d13a95-7619-4286-a1c6-1237a57e7d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eb713d58-172f-4814-9313-45133388e7dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eb713d58-172f-4814-9313-45133388e7dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_db401452-b16d-49a2-a4b9-2fe51c987a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:to="loc_us-gaap_SeniorNotesMember_db401452-b16d-49a2-a4b9-2fe51c987a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8412816-6042-43c8-93e2-0470fbd2dad8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8412816-6042-43c8-93e2-0470fbd2dad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ac35cda9-5efe-4796-8da1-98cfc9f96fd3" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2028SeniorNotesMember_ac35cda9-5efe-4796-8da1-98cfc9f96fd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b318ba7b-1d84-4b7b-9c8f-e47fc3e68382" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2029SeniorNotesMember_b318ba7b-1d84-4b7b-9c8f-e47fc3e68382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember_3123b445-c8f9-4ae6-b0bb-d58f98448752" xlink:href="holx-20230401.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2028And2029SeniorNotesMember_3123b445-c8f9-4ae6-b0bb-d58f98448752" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" id="i242daa9ad1664c0a9127ab699f70edf3_DerivativesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_40c05c63-f4cf-4097-ab73-dcbe949e4e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_DerivativeNotionalAmount_40c05c63-f4cf-4097-ab73-dcbe949e4e0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_048cd820-2444-45e8-aeb9-a5d13236607d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_048cd820-2444-45e8-aeb9-a5d13236607d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_3cab03ec-2a87-4ab9-9966-914b172a6d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_3cab03ec-2a87-4ab9-9966-914b172a6d7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_70a1b4aa-d7e2-4296-a8e8-08fb00f037f7" xlink:href="holx-20230401.xsd#holx_NotationalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_holx_NotationalAmount_70a1b4aa-d7e2-4296-a8e8-08fb00f037f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_488a3cd2-32c1-412f-91f7-e2018006b065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_488a3cd2-32c1-412f-91f7-e2018006b065" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fc61f57c-0054-40a1-a38e-dc237071b21a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fc61f57c-0054-40a1-a38e-dc237071b21a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_42f29553-d635-4727-8c51-b5dcd6cc7f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_InterestRateSwapMember_42f29553-d635-4727-8c51-b5dcd6cc7f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_84d178a0-50fc-43a8-8f04-1c27ee583005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_84d178a0-50fc-43a8-8f04-1c27ee583005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_3700129e-6b53-4f37-8c59-6680a9fcf6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_ForwardContractsMember_3700129e-6b53-4f37-8c59-6680a9fcf6e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2023Member_6f8102c8-3a58-4115-911b-cb36f10d3ef1" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_holx_InterestRateSwap2023Member_6f8102c8-3a58-4115-911b-cb36f10d3ef1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2024Member_59c1232c-05ef-4fe5-9b20-6a52e73992b4" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_holx_InterestRateSwap2024Member_59c1232c-05ef-4fe5-9b20-6a52e73992b4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended" id="i772b2b55bbcd470abe4a39fc29b34e03_DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea273a3-b8ee-40a8-abcc-db01a8352b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea273a3-b8ee-40a8-abcc-db01a8352b6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_3a39c7c5-1741-479e-aa4d-43877f7395be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_3a39c7c5-1741-479e-aa4d-43877f7395be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a424150f-9e44-490d-94d8-99e17b76e5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a424150f-9e44-490d-94d8-99e17b76e5d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8324a55a-f4b3-421f-85cb-8f9cd9c583cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8324a55a-f4b3-421f-85cb-8f9cd9c583cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1922858e-e980-4306-9ae7-45721376374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1922858e-e980-4306-9ae7-45721376374c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_7d705783-0801-44e5-83ae-3fb9d2d742de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_7d705783-0801-44e5-83ae-3fb9d2d742de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:to="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d81829bd-b96d-421b-ac0b-9769fba89daa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:to="loc_us-gaap_HedgingDesignationDomain_d81829bd-b96d-421b-ac0b-9769fba89daa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:to="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ec89f626-94bd-4c9e-907e-d62d86c61de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:to="loc_us-gaap_NondesignatedMember_ec89f626-94bd-4c9e-907e-d62d86c61de0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i772f59c32aa947ff9ce57a1b82f62dc5_DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bfe91f37-c3de-4141-84f6-32e5497e4884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bfe91f37-c3de-4141-84f6-32e5497e4884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5e205232-08bb-408d-b151-5b5be9048569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5e205232-08bb-408d-b151-5b5be9048569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d5b2c691-583d-4640-89f0-9b82d6735134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:to="loc_us-gaap_HedgingDesignationDomain_d5b2c691-583d-4640-89f0-9b82d6735134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:to="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6b2072d-8eb1-45d1-8f47-866afbcf71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6b2072d-8eb1-45d1-8f47-866afbcf71ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_262dbc38-9bdb-496d-a668-a659038a47b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:to="loc_us-gaap_NondesignatedMember_262dbc38-9bdb-496d-a668-a659038a47b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_83a1839f-5e20-45fe-a32f-e647c9d1e1bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_83a1839f-5e20-45fe-a32f-e647c9d1e1bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d4140c55-3416-4099-851d-8ad8d872d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_InterestRateCapMember_d4140c55-3416-4099-851d-8ad8d872d8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_44efdf5e-10fe-474f-94fe-fb685932def8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_InterestRateSwapMember_44efdf5e-10fe-474f-94fe-fb685932def8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d5427860-a999-46de-8358-3b0188af0af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d5427860-a999-46de-8358-3b0188af0af9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_3af28bc0-88a3-4183-b730-d690a8227233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_3af28bc0-88a3-4183-b730-d690a8227233" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_169f19b9-4bed-4acf-9233-509b197a8be8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_169f19b9-4bed-4acf-9233-509b197a8be8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_5ecb9a3b-d8c5-478f-8855-fceb1e2d19e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_5ecb9a3b-d8c5-478f-8855-fceb1e2d19e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61043563-df59-43a6-9363-93c49cc429c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61043563-df59-43a6-9363-93c49cc429c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea4593a2-1c62-4e95-a4ba-6d0dece873d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea4593a2-1c62-4e95-a4ba-6d0dece873d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c78b608f-55d9-4540-8b65-bfa522ee4988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c78b608f-55d9-4540-8b65-bfa522ee4988" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended" id="i13179e912bb34adbbf28fcffa3edb50d_DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5fbf23a6-f77c-4fe7-bd44-7ae1eba2ab03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5fbf23a6-f77c-4fe7-bd44-7ae1eba2ab03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5887d61-2f59-4f7d-acb8-56e7ffdee736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5887d61-2f59-4f7d-acb8-56e7ffdee736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_06a86d58-5720-4848-8e43-aadb2b4b7693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:to="loc_us-gaap_InterestRateSwapMember_06a86d58-5720-4848-8e43-aadb2b4b7693" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#CommitmentsandContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended" id="i022038a3ffac4beabf47e40410d568d3_CommitmentsandContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_bfa30918-3b2f-472e-8133-7414248270fb" xlink:href="holx-20230401.xsd#holx_AmountAssessedInDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_holx_AmountAssessedInDamages_bfa30918-3b2f-472e-8133-7414248270fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5ab11419-c3eb-4ba4-b8f9-d50ee373f0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5ab11419-c3eb-4ba4-b8f9-d50ee373f0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_151be0f1-a877-48fc-930d-5d2c4da30a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_151be0f1-a877-48fc-930d-5d2c4da30a81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:to="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e36d4892-9786-4b60-b09d-f1dd875c3fed_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:to="loc_dei_EntityDomain_e36d4892-9786-4b60-b09d-f1dd875c3fed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:to="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_dd06b649-eba9-41ee-b19a-3c0c81ad20ba" xlink:href="holx-20230401.xsd#holx_MinervaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:to="loc_holx_MinervaMember_dd06b649-eba9-41ee-b19a-3c0c81ad20ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i8e1e80e71f624f8db936036623d7618e_NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:href="holx-20230401.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29286d87-6a07-4a03-adff-6402f1bb2b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29286d87-6a07-4a03-adff-6402f1bb2b77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_413127f2-d99b-4b94-a172-092c57f031ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_413127f2-d99b-4b94-a172-092c57f031ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cb870ee9-fa7b-4e4b-a1e7-d370d0db48b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cb870ee9-fa7b-4e4b-a1e7-d370d0db48b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9a6346e3-7aab-4377-95fd-fb9a8a87bdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9a6346e3-7aab-4377-95fd-fb9a8a87bdd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:href="holx-20230401.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2ee356b2-70ee-4ade-88d1-a9ac2c66a065_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2ee356b2-70ee-4ade-88d1-a9ac2c66a065_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9f21682d-3d14-41f3-8499-8d56428aa070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:to="loc_us-gaap_StockCompensationPlanMember_9f21682d-3d14-41f3-8499-8d56428aa070" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended" id="i808b07f316c04952855fc01da354b884_StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1fcb4c2e-f268-4813-8133-c57f74a486cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:to="loc_us-gaap_ShareBasedCompensation_1fcb4c2e-f268-4813-8133-c57f74a486cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_51b250ca-2dd9-4d30-9903-c913e68ea58b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_51b250ca-2dd9-4d30-9903-c913e68ea58b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f3ba538c-b39b-41e7-8fd3-49f5301449d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_CostOfSalesMember_f3ba538c-b39b-41e7-8fd3-49f5301449d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_df51dd23-3a07-4424-91c7-54e39d4bc266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_df51dd23-3a07-4424-91c7-54e39d4bc266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5d558bc5-f1ba-42f2-b0cf-7dfa0a9041af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5d558bc5-f1ba-42f2-b0cf-7dfa0a9041af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_30603d82-3722-4988-aac8-0e2341007ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_30603d82-3722-4988-aac8-0e2341007ccb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="iaf0cfee375624be29303ac2cedfb146f_StockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_41f2cef6-13f1-4217-87d3-cdedc72ee7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_41f2cef6-13f1-4217-87d3-cdedc72ee7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_048a16de-0bb6-4bbb-8762-9ea141c92719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_048a16de-0bb6-4bbb-8762-9ea141c92719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8ac19d4-8a32-4cea-9765-f2d04ddbcdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8ac19d4-8a32-4cea-9765-f2d04ddbcdc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd0bf922-a903-4e5e-b8e7-a35e5e972a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd0bf922-a903-4e5e-b8e7-a35e5e972a0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fb2ae8b-ce2f-42f6-84d5-ab15d3ba6196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fb2ae8b-ce2f-42f6-84d5-ab15d3ba6196" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e89a05ae-ed41-42ab-b375-2eeb50da2a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e89a05ae-ed41-42ab-b375-2eeb50da2a16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7690c47-0617-44ab-87e6-78f050060264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7690c47-0617-44ab-87e6-78f050060264" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_7192b38c-1d2d-463f-8079-8385747b5ba9" xlink:href="holx-20230401.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_7192b38c-1d2d-463f-8079-8385747b5ba9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_0f75ae4f-b764-4e06-abe6-cce0b288a7f4" xlink:href="holx-20230401.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_0f75ae4f-b764-4e06-abe6-cce0b288a7f4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_b48ee980-f340-4455-94a8-07dfdb09191b" xlink:href="holx-20230401.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_b48ee980-f340-4455-94a8-07dfdb09191b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec1472d7-3101-4adb-9b6f-f904decca7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec1472d7-3101-4adb-9b6f-f904decca7ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6c63b472-9a2b-414b-ad86-297afceae872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6c63b472-9a2b-414b-ad86-297afceae872" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:to="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11404575-0065-4cdb-9a64-c03d020cf663_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11404575-0065-4cdb-9a64-c03d020cf663_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff00221a-1506-40eb-994b-a8e2145dc932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff00221a-1506-40eb-994b-a8e2145dc932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ef9a2362-44f7-45ca-bd99-49e0d48ec4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ef9a2362-44f7-45ca-bd99-49e0d48ec4b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_22257bf9-e453-437c-a2cf-fe520bde7679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_PerformanceSharesMember_22257bf9-e453-437c-a2cf-fe520bde7679" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_6cb013b1-5524-40d6-8634-2bc434457e9b" xlink:href="holx-20230401.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_PSUFreeCashFlowMember_6cb013b1-5524-40d6-8634-2bc434457e9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_99d99432-3964-4352-89d3-e366f45a2b0f" xlink:href="holx-20230401.xsd#holx_MarketBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_MarketBasedAwardsMember_99d99432-3964-4352-89d3-e366f45a2b0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_25ae1b8e-4386-441e-859f-9ebf4f66a18b" xlink:href="holx-20230401.xsd#holx_RSUPSUMSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_RSUPSUMSUMember_25ae1b8e-4386-441e-859f-9ebf4f66a18b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="ia1c80820d84f41b39b9e16dba8acb83e_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:href="holx-20230401.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f78db673-3e18-4818-8fcc-172f6ff6577f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:to="loc_us-gaap_NumberOfReportableSegments_f78db673-3e18-4818-8fcc-172f6ff6577f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0f3fb56a-fd86-4bd6-8184-0dab5f8aaf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:to="loc_us-gaap_Revenues_0f3fb56a-fd86-4bd6-8184-0dab5f8aaf04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:to="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_713d2d42-df11-4776-9e2b-78e1484d0e72_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:to="loc_srt_ConsolidationItemsDomain_713d2d42-df11-4776-9e2b-78e1484d0e72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:to="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6dc23671-f2d3-4009-ad3d-437feea7a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6dc23671-f2d3-4009-ad3d-437feea7a89e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="ib66833e2a8ef409e95c27652f5ffc206_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_01a11447-6757-47c8-b953-acc80694fef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_Revenues_01a11447-6757-47c8-b953-acc80694fef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3935bc32-a758-4b68-b392-0fd1495495b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_OperatingIncomeLoss_3935bc32-a758-4b68-b392-0fd1495495b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_00627bb7-02d1-47b4-a17c-27f66d3a8040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_00627bb7-02d1-47b4-a17c-27f66d3a8040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce0dd024-0331-47fe-812e-6e929e6307f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce0dd024-0331-47fe-812e-6e929e6307f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2f7abfb3-5ccb-4486-84aa-274dd1ed3051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_Assets_2f7abfb3-5ccb-4486-84aa-274dd1ed3051" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83436345-89b3-4f48-b539-a7e3104d6fe2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:to="loc_us-gaap_SegmentDomain_83436345-89b3-4f48-b539-a7e3104d6fe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:to="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_6fb77947-abdb-4846-86dc-f9f6d0d7fd97" xlink:href="holx-20230401.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_DiagnosticsMember_6fb77947-abdb-4846-86dc-f9f6d0d7fd97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_d340eb33-0958-48fd-992d-69235efeca27" xlink:href="holx-20230401.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_BreastHealthMember_d340eb33-0958-48fd-992d-69235efeca27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_5c330e66-1fc9-4890-b70d-184970c35071" xlink:href="holx-20230401.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_GynSurgicalMember_5c330e66-1fc9-4890-b70d-184970c35071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_6587919b-0ab7-4398-b603-cea09b2c7c7b" xlink:href="holx-20230401.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_SkeletalHealthMember_6587919b-0ab7-4398-b603-cea09b2c7c7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_7db583bc-eba2-4c60-bb26-e69a087cede8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_us-gaap_CorporateMember_7db583bc-eba2-4c60-bb26-e69a087cede8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="ie4bcc788c2e9490fa18bca9bc547907a_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_65cd229b-217f-45dc-abcb-72064dd315d2" xlink:href="holx-20230401.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:to="loc_holx_PercentageOfRevenues_65cd229b-217f-45dc-abcb-72064dd315d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:to="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad0f64c8-5dca-45a1-80e6-61d1735a66bb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:to="loc_srt_SegmentGeographicalDomain_ad0f64c8-5dca-45a1-80e6-61d1735a66bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:to="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7d3709b1-6486-42c6-9340-f60585e0ab38" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_country_US_7d3709b1-6486-42c6-9340-f60585e0ab38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_fd3b74f0-b2d7-41d9-aead-d6843f192fca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_srt_EuropeMember_fd3b74f0-b2d7-41d9-aead-d6843f192fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e8929435-c157-4cc6-9c04-1a66b93a55ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_srt_AsiaPacificMember_e8929435-c157-4cc6-9c04-1a66b93a55ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_9e75a5ad-df75-4ff3-a8d3-b0dac69590cc" xlink:href="holx-20230401.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_holx_AllOtherCountriesMember_9e75a5ad-df75-4ff3-a8d3-b0dac69590cc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended" id="id8a4051f30b44438bb31c73e2cc0175c_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d60dec9-f09a-4063-aab3-973e804e7c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d60dec9-f09a-4063-aab3-973e804e7c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_707a5590-f0fb-487e-b346-f96507745fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_707a5590-f0fb-487e-b346-f96507745fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4cd2045-5f44-42cb-8de9-40d63dfd946b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4cd2045-5f44-42cb-8de9-40d63dfd946b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_302787f4-28cc-4a1d-9356-94f3cb0d3d55" xlink:href="holx-20230401.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_DevelopedTechnologyMember_302787f4-28cc-4a1d-9356-94f3cb0d3d55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_fea300a9-db2b-415c-b784-2e3f2b9aec83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_fea300a9-db2b-415c-b784-2e3f2b9aec83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_b5d4f09d-433e-4ec1-ac03-f22329466c4a" xlink:href="holx-20230401.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_CustomerRelationshipsContractsMember_b5d4f09d-433e-4ec1-ac03-f22329466c4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5e2356da-a312-4744-a7ac-c2d34957d65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_us-gaap_TradeNamesMember_5e2356da-a312-4744-a7ac-c2d34957d65e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_9e3d4911-0f67-4f36-8d6d-59c7c904532a" xlink:href="holx-20230401.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_AcquiredintangibleassetsMember_9e3d4911-0f67-4f36-8d6d-59c7c904532a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_19f16ea1-31a3-48ae-b39f-4ac9e126d820" xlink:href="holx-20230401.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_InternalusesoftwareMember_19f16ea1-31a3-48ae-b39f-4ac9e126d820" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_40982b91-94a1-4563-9c66-7d15800bafe6" xlink:href="holx-20230401.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_CapitalizedsoftwareMember_40982b91-94a1-4563-9c66-7d15800bafe6" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended" id="i140ffb7c3bb149c7998afc5bdc4c6c6b_AccumulatedOtherComprehensiveIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c0cbb38-8be4-44c3-bc2e-dc514ed2112d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_StockholdersEquity_1c0cbb38-8be4-44c3-bc2e-dc514ed2112d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9ec0b2f1-3e4a-458f-9f69-07075026ad53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9ec0b2f1-3e4a-458f-9f69-07075026ad53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3fd299d-5b57-491a-a84e-513b0553c14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fbe603f9-62f6-4235-b527-88e4d7ffffe7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fbe603f9-62f6-4235-b527-88e4d7ffffe7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_59749013-aa16-4cba-828e-473db1b1be0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:to="loc_us-gaap_InterestRateSwapMember_59749013-aa16-4cba-828e-473db1b1be0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:to="loc_us-gaap_EquityComponentDomain_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:to="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86cad88e-bb4a-464f-8e1d-74dc4fda9100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86cad88e-bb4a-464f-8e1d-74dc4fda9100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_5f29daf0-e312-464a-8b9e-196d8b047442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_5f29daf0-e312-464a-8b9e-196d8b047442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_639ff912-867f-44a5-81c6-900bda654c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_639ff912-867f-44a5-81c6-900bda654c4d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended" id="ia2bc74031248422e8bfc8229b1232d5e_ShareRepurchaseSharerepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f1647b31-3907-4cd9-8959-6c40fcb1c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f1647b31-3907-4cd9-8959-6c40fcb1c0a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_80208a22-34a8-4efb-ab1f-4ac53a1cb335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_80208a22-34a8-4efb-ab1f-4ac53a1cb335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2af8bac-0b72-41f7-9f44-c03e93ad344d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2af8bac-0b72-41f7-9f44-c03e93ad344d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c9786027-1fb1-45b2-9872-ed9ca3f2c827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c9786027-1fb1-45b2-9872-ed9ca3f2c827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c6148481-f42d-46f3-829d-deaf7a455046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c6148481-f42d-46f3-829d-deaf7a455046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_5380294c-e537-4fdf-9c79-f1276afa734f" xlink:href="holx-20230401.xsd#holx_September222022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:to="loc_holx_September222022Member_5380294c-e537-4fdf-9c79-f1276afa734f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_8cf16fe5-3c4b-43a1-9580-0a51ab7baf4b" xlink:href="holx-20230401.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:to="loc_holx_December112020Member_8cf16fe5-3c4b-43a1-9580-0a51ab7baf4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>holx-20230401_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_3007407a-568b-43fe-84db-01fdd3b4de6f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6800a009-2385-4779-9ee8-bc570701d056_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_30e8d4e3-2a20-475e-bdfd-7209749d9258_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_740082c3-ad91-4931-9a35-6ca244ed3f49_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_f30e28e6-a5b4-43c0-991d-8a28b2348c9d_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20230401.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_aadf8212-e6eb-491d-8e2e-43d038e7d14d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e2f22a98-3e73-4fcc-a05f-bd7bd37aa625_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e25ef076-560f-4266-b2ba-2a80659c2648_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_da4ad45d-a8a7-4e73-bc81-8a45c7f74bc6_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2c4379a3-c642-4cd0-88a8-14eb3592411f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_df10e73d-66e0-4479-bfb5-db90b35ef1b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_7ac7e4e0-0158-4a42-9bef-de36c72d2ed6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_a34521bc-fc3f-4e62-b34d-999d41c91127_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20230401.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_753dee48-e7d8-4ada-a311-4ec3ecb89367_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Financing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_85dfd6b8-e945-4b3a-9e5b-84b49c4a24b3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BolderSurgicalMember_9ae0ffbf-fc38-491c-a090-5ec432bdf033_terseLabel_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_label_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical [Member]</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_documentation_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember" xlink:href="holx-20230401.xsd#holx_BolderSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BolderSurgicalMember" xlink:to="lab_holx_BolderSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0ed7af43-36c1-497d-9fb4-24ca68dbfa94_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_79b27314-c855-4784-91ed-97505206c00a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6f0da7c9-eab4-47c7-b26f-c6597b7505fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2fd0a426-7ffc-45ca-8fc9-1dd90813a11b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9b024957-0a58-4098-aadc-f9f8ee11bb04_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_58f41d90-7c4e-42f5-842f-0555025573a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_55f44a9b-7d35-48cf-bd0c-f9e62ade3deb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_adb3c1c2-5522-46a1-ac2f-3045825b8a0c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_16598137-c16b-4854-a303-0ebf98ba8967_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_267b0de4-b941-4e38-94ba-e41162da5fb9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_db8d4d59-ceb8-44a7-82f0-20717ba78354_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20230401.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a6d84c24-2338-40dc-ac88-6f508359f986_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_54005830-8855-43c3-8944-edab3e2b92bb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e2576a80-32b8-4b62-a29c-6c0f4620afe6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_a00b4cd6-0014-4faa-9e05-7c4210ea4672_terseLabel_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual incremental revenue growth period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_label_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_documentation_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:href="holx-20230401.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:to="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a77887ba-12dc-4f3e-9720-387f51b0fa03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25758bda-433d-41e0-827b-4d6a05b78102_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_bc437406-7b83-43cf-988a-cd25ca06eb7b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_0323c589-6ead-482d-8e24-a9f27f1eec19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_791c1bbe-1ce2-4fd2-b177-b2d3a30ba286_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_a69a3927-3e52-4e41-b196-14b0f68fa625_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_d1b8bbcf-370f-43eb-8fe1-f93cf8d31dd6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_08a556fd-cdfa-4890-b176-841b7d78b6ee_terseLabel_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from government grants for capacity expansion</link:label>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_label_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from government grants for capacity expansion</link:label>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_documentation_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from government grants for capacity expansion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:href="holx-20230401.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:to="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_074b576a-fc77-47d0-a414-5385c18fed54_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5efc1670-baf4-4baf-bc82-a893b1caa4f7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_693ab75a-1a4c-491b-9538-878a971425da_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20230401.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d3f58658-e915-44f0-ba52-46fc616da3ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3369a1ac-299a-4e36-a94b-e6a374c504cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0f414419-e4e7-4a59-8d76-d477102c4b87_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b4e6eaf1-3cdd-4715-a897-aa7f7ac516bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DanburyClosureMember_37528288-f0a8-4d6c-bba9-0a1f39ddfb92_terseLabel_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure</link:label>
    <link:label id="lab_holx_DanburyClosureMember_label_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure [Member]</link:label>
    <link:label id="lab_holx_DanburyClosureMember_documentation_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember" xlink:href="holx-20230401.xsd#holx_DanburyClosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DanburyClosureMember" xlink:to="lab_holx_DanburyClosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_b099f63d-8a73-4d2d-9433-b50de80f5cff_terseLabel_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_label_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_documentation_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:href="holx-20230401.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:to="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SecuredTermLoanMember_3a5139dd-2364-4cbf-881d-814e97ddd581_terseLabel_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_label_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_documentation_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember" xlink:href="holx-20230401.xsd#holx_SecuredTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SecuredTermLoanMember" xlink:to="lab_holx_SecuredTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3e0fb79c-392d-47ec-8c1b-cdc7fa3e79da_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_bad9fa20-b811-4a3d-b5e4-3b343f0640a4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_10df8e7a-312a-47e8-96ef-3913fac71f14_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_18afc884-93bf-4613-9075-966fff2b2d92_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_e7974e93-c0c9-44da-8bb9-6cdf19bae7ca_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_075c72a7-0980-4127-bbac-610934bd871d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_bdb40a78-5935-4f68-9982-3d5bd7346899_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_1c641823-6235-4acf-abfc-25211b08fe72_verboseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20230401.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_28bd66da-0b00-419b-a286-788a9a67dcad_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20230401.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_7e93be5d-cdc7-416b-8126-9c421e71386e_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20230401.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_4d7792da-7cff-4a4d-b9bd-f7c511bc362c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_678d8e94-33fa-45fa-901d-833f505ae48c_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, fair value (percentage)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4d8a7660-2667-4df9-93cd-eba0e34dced3_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_97259a5f-eaf1-4272-8e6c-fad3cee24c29_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20230401.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_98e44743-1816-4472-80f1-332bd748013e_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_e29e7b69-7919-4bc9-9b88-a005fe73e541_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_463ca5a4-a4e6-4367-bbd4-9630c31d8389_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_81d7af96-403e-4146-b640-5db5585f28ae_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_55c9a14d-0f55-4e28-b353-d6425efd653d_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021CreditAgreementMember_1a70887f-06b0-4cd6-bf6e-c6094380c887_terseLabel_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_label_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember" xlink:href="holx-20230401.xsd#holx_A2021CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021CreditAgreementMember" xlink:to="lab_holx_A2021CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Costofservice_b21bc401-c4ea-4f3d-ba0e-a2535f7815dd_terseLabel_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_Costofservice_label_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_holx_Costofservice_documentation_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice" xlink:href="holx-20230401.xsd#holx_Costofservice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Costofservice" xlink:to="lab_holx_Costofservice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66559194-931b-49ca-9927-40520c28ce66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_da6c5b16-731d-4881-898b-21b8b6c8bc1a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c1a0637-4cf8-4880-ae3c-c017c607a6ff_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8c6c4a9d-9d9c-44c4-a7c9-98cd334fcf2a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_0080f174-828a-4136-9337-48644979b43f_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_d5319336-bdc4-4a53-8437-8df706aeaf37_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ef6d2f92-80cc-4f4f-915a-a74081bcfc93_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ccdb3fc0-f60a-483c-9bef-69b682b505ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_5c9e11e8-bed9-4f14-b823-2f18b1e14cad_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_898a93bd-e85a-4ea6-bc50-e8594a9f473d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_dd6e742b-7229-4de8-b073-b89217947608_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20230401.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_524dd4e1-f869-4b61-88b7-104b641462ca_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce1451ac-0682-4c29-ada2-b22b5e56d052_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_63422a17-9e50-4dde-aac5-aee34c64a679_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_db625b6e-2f2e-43d6-b93d-61a2ca742610_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_c3a4f2fb-0c7f-4fc9-93df-860c755bcbfa_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedAwardsMember_f27a830d-c604-4c58-8d42-aef3495bd577_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember" xlink:href="holx-20230401.xsd#holx_MarketBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember" xlink:to="lab_holx_MarketBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_82b4c209-1942-44e5-968a-dfda4a71d1b8_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8b99a7b0-2766-47ea-b201-2b12a336c008_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_3dfdfe23-2f83-4159-b36a-cbad0dba53d6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_23650db1-616d-47a5-9d96-1ed2ff49ee2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_d20f5a5b-86d3-4eb9-b8bc-ac75459e474f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_bd7ce6e2-df46-4034-8ae3-f092a21cdff0_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20230401.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_a5202628-5d02-4dd1-8873-b79a0b808b8f_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20230401.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_02e46eca-ba16-48cf-95d5-98baaa47f14b_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20230401.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_abf1405d-4b26-4aeb-a565-59f74aa5e0e5_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20230401.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_c6b950f4-5c02-437d-8e57-15b9614c86f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e7153195-8f41-466f-a0b0-98131b9d18b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_daf04b95-07f5-42a7-8195-2750cd2d2de7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_196e207a-4e90-4775-8405-bb1e3d0870a3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_cb5be3e8-3e6d-424a-884b-775031f92934_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateSwap2023Member_80e5eb56-a502-4e07-8bab-1a7dbd0fc11a_terseLabel_en-US" xlink:label="lab_holx_InterestRateSwap2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2023</link:label>
    <link:label id="lab_holx_InterestRateSwap2023Member_label_en-US" xlink:label="lab_holx_InterestRateSwap2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2023 [Member]</link:label>
    <link:label id="lab_holx_InterestRateSwap2023Member_documentation_en-US" xlink:label="lab_holx_InterestRateSwap2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2023Member" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateSwap2023Member" xlink:to="lab_holx_InterestRateSwap2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_275c04b3-ea49-4071-acfa-e0e1b3ca325d_terseLabel_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_label_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_documentation_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold" xlink:href="holx-20230401.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationCostofGoodsSold" xlink:to="lab_holx_AmortizationCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_024f9109-c6ac-4493-9d3b-04750495c98a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_18bc4aee-5c9a-405a-9e8f-3bbfaba84391_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cc8fce68-d2b5-412e-924a-d9095b9c26a9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_a8137ba2-a817-486c-a6ef-8f9aadad9597_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_f9ec9b7d-f79a-40a6-b5e2-fe3a220a90ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs, Payments and Foreign Exchange</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_28a1d1dd-7f61-4d0e-8367-f01020010ffe_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20230401.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_fd5e6a7b-a5c4-4bee-a71b-fdd445dd99d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ea2ed1de-17ca-474e-8993-f5726fcab6fa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_373c46e7-99b4-4023-bca8-a7637dea42eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_c48d2d5e-a6c4-4ed6-99aa-206557a1ca1c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_00dcd036-ac73-42ab-b376-e5e2fea3a2c7_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_9fcc37ad-d8a4-4033-981f-ad72588a5f92_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_95486cf0-1b28-4bbc-8a0e-15a3e8dbc1be_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_d59e7108-883a-4335-9939-ef7f7cc8b288_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_label_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanLineItems" xlink:to="lab_holx_SharerepurchaseplanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_022f74dd-2d9b-4646-9c2c-128b43a60e23_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_23e20e52-1f4b-4ca8-84c2-9befde54dc67_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_788a05c8-00b4-4205-a48b-d984e1fb7841_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_273f6dcb-2bec-4069-a48d-44f4a970a102_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_e2aea1bf-b93a-4eb6-ac7a-96b16b371405_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_643639f0-cc6e-4ba8-8d1b-417c370d2bf9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f2d390f-d4fb-4716-be51-d6e6ee139d7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_955e4c82-407d-4f80-b8a5-249f9c52e6ee_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fe41599-e366-46c0-bd2f-885c2e0582cf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0b0d45d-320d-4b46-a067-d444c35cdd77_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8f837f75-a5e6-4879-9d11-dc634317be8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_532b29ea-0cd3-422b-9340-99c6d2b8f179_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20230401.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetSecuritizationMember_a63c36e5-c35e-4244-b9fe-bcb7cfed1439_terseLabel_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization</link:label>
    <link:label id="lab_holx_AssetSecuritizationMember_label_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization [Member]</link:label>
    <link:label id="lab_holx_AssetSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember" xlink:href="holx-20230401.xsd#holx_AssetSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetSecuritizationMember" xlink:to="lab_holx_AssetSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a49e5c01-91d1-4293-86d2-6362fa5d49b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e68c6cf5-fc41-4353-a06e-a83d7f0c09d6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_2c78b03f-964b-426d-8daa-b9d6117230a1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_e9573fda-ed36-4d09-9b19-5b2e53ea7757_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_ae13a706-f837-4263-b4dc-244b1752a328_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:href="holx-20230401.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_11352d5c-c755-41fd-a002-240bc9614c9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_276f3094-f51b-42ae-9dc5-44114c406aeb_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d25599ce-a701-4989-a9a2-1d6abc5e5d60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_8012cd29-88d2-4a50-bede-e08333745369_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_1e792932-2826-47dd-a115-4ea960ee0d1e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_1902ed4f-3b11-4b0a-b4e7-9a848af6b29d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2caa84b9-be39-4ec1-9bd3-a54172be6013_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_0b318bc9-fd55-4a97-b285-85f6a37643e5_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0aed14e3-902f-449b-99bb-3873da4bedb5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1e3499e4-6263-449d-bda0-9fb8131d7f46_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_92bf592e-d198-4ff5-8947-82b4c4cbc571_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_cf570803-9b13-43cb-bbc5-a40bf81d3947_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2adbbe17-3fd9-4a22-942f-76555cb68700_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_September222022Member_2bcda20c-5fa1-45b0-8a0d-b0acd13f9536_terseLabel_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022</link:label>
    <link:label id="lab_holx_September222022Member_label_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022 [Member]</link:label>
    <link:label id="lab_holx_September222022Member_documentation_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member" xlink:href="holx-20230401.xsd#holx_September222022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_September222022Member" xlink:to="lab_holx_September222022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_aa70b711-e3ce-460e-b6b6-2d866def0cad_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquired intangible assets</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20230401.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_858c4780-0ccf-4db5-9607-7a655b3de342_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_91d6fcec-4fa1-4174-8b28-d1a42f25293e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0b1ae53e-a39d-40ce-96a5-1491eea9de85_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_b0a52c3d-d14d-46be-89b0-dcbf6e77ab7b_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20230401.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_19f09802-0710-48ef-8158-9f829ada165d_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20230401.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d7b68b36-9bd2-45fb-9d7c-e06abcab1cf7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_7d64e390-71b1-4a09-ba82-901916db805f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_89c3e10e-0847-45ab-8013-284abf3d368a_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_913db1ba-d51b-479b-8d8e-96ea7efd7bc0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a28fe530-13b7-4ac0-b9c4-d7fbd84dd838_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c7b38eb1-69d5-4ea1-b385-6290e1c557a1_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4a884372-ec2d-4089-8c33-f96599fcc849_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_089b1e9e-31bf-4675-af89-29c43b11ea65_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_44d59267-0da0-4af0-92d2-44b90b8755e3_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_a6e18a38-11bc-4cec-a37e-9f62a729e433_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_8fb6c29f-3daa-4a91-b3da-00b4e9da1b99_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20230401.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_aa8cab9e-91b3-4891-88a5-aaecb1d27a76_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Liabilities at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_9560b1a5-4d85-4a37-bb79-dac125b1938b_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20230401.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d68423b6-e00d-4530-91e0-f616db769693_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_86f4b66b-08ed-433f-9770-644bf527e093_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0383b03e-dd79-4fb9-bff9-af3e1dec6b3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_55f3cbc3-8338-43e4-b507-ecf4bb286f06_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1628e54f-f4e8-44a6-bc94-6125a55d9893_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_9c504be3-a3e0-40f2-b87f-602237aad459_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_0bd48e09-fca3-4e27-a74f-8dcbf507617e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_580a9a50-1fdf-47df-bfcf-2bcecda9b52a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_925f6de1-0048-4f70-bb81-52add5ab0720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_216fab6c-34a3-4011-85c3-3213d7c0fe7b_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:href="holx-20230401.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_26838a4d-3340-4581-80ca-c1f23175b058_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1e0688b7-2f69-40c6-aa10-250761489dd2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2f9924cf-a042-4cb7-83c2-4bb6c6bd7a8f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_d3e9c6ce-3a79-4cb8-9714-d38c8e292ce0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31c9bc23-3098-4f23-8aa9-e2ca2af8fd67_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a7a4fc11-eca5-40af-a33a-3d528edf94bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b64c3635-9666-4c7a-8bf4-3af116d0c2a8_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_5b08b856-2976-4bdb-a4be-1f752e36ecd4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_be35339b-bc1b-4358-816c-9f8fe1e39600_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c1688fed-7e9f-48f6-a24f-68fa741723df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_915ba9d8-4865-48a1-88a3-7893423e58ce_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3f5cccd0-44bb-4ad7-a7d4-db20accfac82_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_5edd6feb-5db9-4dfb-bc76-9d5597fbf091_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e42cb067-ee82-43af-8192-acf670285259_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_501b52b7-b399-4951-8fa5-840c6d05fe3e_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payment</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_label_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Payments</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_documentation_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments" xlink:href="holx-20230401.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationContingentConsiderationPayments" xlink:to="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e6190d22-78de-4401-8bcf-f19d917b4a6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_89501934-6962-41b3-a9a2-5fc07c6f452f_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20230401.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5bba2b5-0d70-4c4b-b9da-83c751f34042_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_35d67ff1-4e78-4929-b3e6-c987d94788f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3bb2775c-f0fb-4610-8dc4-3859f9741694_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_2a764d7e-bd6c-4ba7-8d69-8711961e6f25_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_f6385b68-39be-42e1-b0b9-d79cbbf41977_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_7e00b147-b717-481d-9ac6-4ad0ecded165_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_e19911f0-51c7-4c25-bd8e-ae7e9d14a051_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20230401.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_3536faf7-1f80-4d9f-b1f9-0a74b9fd3143_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_625a264e-3ec2-4458-a80b-ba52eaa5a16f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e5af2f31-bc88-4138-85fc-4e565ef97c70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountAssessedInDamages_f8e99015-d479-4874-a720-2e793fc2cbbe_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages" xlink:href="holx-20230401.xsd#holx_AmountAssessedInDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages" xlink:to="lab_holx_AmountAssessedInDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_cf8f1e99-8c49-466a-84ad-3df094096efd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration - fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_0e371595-47c0-4bec-92eb-e54b68e63e54_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_b03e75de-ceb1-4c14-a6db-66952db42e07_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_e6df500c-92de-42b3-97ea-d13e2f14d570_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20230401.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_823427f4-d288-4d07-b6a4-06456d98cbfb_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_5c378c39-fd7d-4d27-93da-35f6839dec38_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20230401.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_bbc90f95-590d-4f5c-945b-5acbd5767317_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112020Member_6594c974-1e20-41e4-afbd-3a3ed501be37_terseLabel_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:label id="lab_holx_December112020Member_label_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020 [Member]</link:label>
    <link:label id="lab_holx_December112020Member_documentation_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member" xlink:href="holx-20230401.xsd#holx_December112020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112020Member" xlink:to="lab_holx_December112020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_379e8d20-bebf-441d-a6a6-cab0828c88de_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total (percentage)</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20230401.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_feb5d681-3e8a-4f91-b717-1b1bac5cf411_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20230401.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d30013ae-db1c-4ba0-aaf9-9440e62483db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7282825a-355f-40fc-9fed-8dae1ba855d5_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021RevolverMember_c7cc95c2-3263-4ef2-aa34-b72012adb616_terseLabel_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:label id="lab_holx_A2021RevolverMember_label_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver [Member]</link:label>
    <link:label id="lab_holx_A2021RevolverMember_documentation_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember" xlink:href="holx-20230401.xsd#holx_A2021RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021RevolverMember" xlink:to="lab_holx_A2021RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAbstract" xlink:to="lab_us-gaap_RestructuringCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_b1e87ec5-a12d-49fa-a0e4-12f76438f16d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_3345474e-ca39-44b9-b03e-9dc9f375a402_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_15e8d0c8-c401-40af-9236-85ab6c0d681d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_98ab66a0-e975-44f1-9fda-ee928f23b6c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_013f4411-f2b1-457e-bbbc-b211a6b80727_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_1a415565-140f-4b84-a2b3-c2ac9544a97f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_35a75e27-a106-4847-9b39-d575697d509b_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20230401.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_66697db7-ccea-47c1-88fc-a0cb9e6369ad_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_dd69820c-312d-473a-8c2d-872dc696f1e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ac004e29-8e36-40a0-a178-4efbf9a802e8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2869776c-4c07-48d1-8417-3859fe4754c0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_15d57ebb-e089-4e57-9645-4e5d1a93e1f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_508f3fd6-ece3-4b67-b7ce-b234a28d355b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fb66159c-cc73-4437-ab49-9b61520eeef5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasisofPresentationAbstract_51119f56-7078-4029-9c3d-71b75f808a04_terseLabel_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_label_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_documentation_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract" xlink:href="holx-20230401.xsd#holx_BasisofPresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasisofPresentationAbstract" xlink:to="lab_holx_BasisofPresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2114862-13e5-4c17-bba3-70eb001803b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_22b8d58d-ee38-4abb-a26a-6cd91954ad4b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c716de7c-e8e9-4ae8-8ad7-a651082921fd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bf72b9af-126c-40b9-b930-e337a1bf8a8e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021TermLoanMember_027c0aec-9a5b-4723-aeea-c3b544d545d7_terseLabel_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_label_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan [Member]</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_documentation_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember" xlink:href="holx-20230401.xsd#holx_A2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021TermLoanMember" xlink:to="lab_holx_A2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_50e3d36f-7481-4839-8ef0-247a42653bfe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a45bc78-ba9a-47c0-8f93-6cc4064a3af2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_978721a4-aae0-4320-bf6c-563cdc63a7b3_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_abc2fb97-1079-453d-bece-1d42c489c96b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_cbdfccd8-9e5a-43ac-965d-84c5e09b83ad_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f11124de-172a-44c5-a467-7073928fed1f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_46cb9ebe-a6fc-44ba-a7e7-96847b0bc81e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d68c8680-32b4-4d21-849c-43a535d3a7da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_2619ee05-bf94-4808-8919-d773be614649_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1ede48d8-7246-4d2f-8f74-c6eb134ee5a5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentOfDeferredAcquisitionConsideration_328c3ae0-6099-46ab-9458-3148ca1ee582_terseLabel_en-US" xlink:label="lab_holx_PaymentOfDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_holx_PaymentOfDeferredAcquisitionConsideration_label_en-US" xlink:label="lab_holx_PaymentOfDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_holx_PaymentOfDeferredAcquisitionConsideration_documentation_en-US" xlink:label="lab_holx_PaymentOfDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfDeferredAcquisitionConsideration" xlink:href="holx-20230401.xsd#holx_PaymentOfDeferredAcquisitionConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentOfDeferredAcquisitionConsideration" xlink:to="lab_holx_PaymentOfDeferredAcquisitionConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_d629c107-8466-4e44-b039-ce4236578e05_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cd157df8-131c-47ad-93d1-902462204841_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b0998fea-fafb-4135-bede-43d747b5d535_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_f30818dd-27ac-445f-9f39-5520406d7b8a_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20230401.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_6fca0d70-20e7-4c75-8db9-39e514c00bad_negatedTerseLabel_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_label_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_documentation_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt" xlink:href="holx-20230401.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Repaymentsofacquiredlongtermdebt" xlink:to="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_065e7ac9-3068-4dd9-9fa6-c242a79a064d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3bf4d05c-e325-44d3-866c-1c73e4c60f0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_2e7c90ee-6a8d-45b7-9de3-cba070b5cfbd_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20230401.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_49feb2db-25d9-4826-9e34-182bf30cbeee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_de7040c7-6282-40bb-96a4-cd3f4e2acd82_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7594b400-c9cd-4429-a56b-de041f698ac7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ff642180-9a2a-4aca-9721-8d52067f300a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f9266624-6324-4c13-845a-2cc78ab4b729_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_6f061482-553a-43d8-bfd8-2af8bb9a4518_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap at fair value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_63413596-c40d-4440-bee7-f721e6551f87_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8738d698-041d-4f67-b85b-27099643c2b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2f210004-48e4-4361-a7d1-0c2ea1201b56_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_0f0b8186-d53c-4332-a5d8-6330d0dabbef_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_949205e9-fa73-45b0-912a-7289c7a4f22d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_0487dfe4-b622-4ee0-8613-add9c77ec4ba_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20230401.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_2ddd5399-1ebe-4cc0-b4d1-be12ca9786b7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5387c12e-fe08-4c86-be3d-433fd0a29a12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_d0e379ec-8d30-4c6e-9201-f259838850aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2d098649-ace6-4dad-92b1-e34b34983a69_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4738cdd2-1a83-4638-9096-5f8a1a2c862e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_026ea60b-5637-4b16-97ae-a9021f27a7e6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_95976f42-129f-42b3-b8ef-3a5c5b11cdd3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7f4a9f09-3d77-4cab-9cfd-20f4c532396e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7fa30b5b-9bbf-4316-9d67-205af9cb34e9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f48b06b9-f5d4-4940-b4c9-b48b44317ac9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_8641cfa2-7445-4a71-a1cc-31f97e8cf33f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_296d790c-d252-4331-bdaa-b3426a6c3693_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_f8876c8a-780d-4977-a353-c3cb83a589a1_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_08a33399-0b81-4752-b0c5-50ad35801261_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1fba68c1-aad7-487c-a8ae-fda517ec124f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_672cf11f-1638-4360-922d-748fad45c709_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_3bb37044-a52e-4126-9b1c-69d029f66a2a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_e36176a3-1988-49bd-ab71-05dedbcc241f_terseLabel_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and 2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and 2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember" xlink:href="holx-20230401.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028And2029SeniorNotesMember" xlink:to="lab_holx_A2028And2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f5358ded-83e7-4d36-b06d-9d9b7bd3fdc9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_72309706-da42-4963-bf3b-3eaa94aaf11a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4776cd0e-da9a-4245-baf7-105852bea45e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_345b4578-3e1e-4cfc-a584-ea4a2a2661f0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_f6138204-9275-4cfa-bf76-c9cad7624089_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4b5cfee6-43ff-4ff3-bee3-68792518ba84_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_f6662af9-0a1e-431c-9870-97fca5f92625_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20230401.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5ac95f44-1ae5-45fd-914c-40aae0342280_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_25300d18-1489-4ceb-909d-0b1019914a91_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4c596efb-25cc-4e84-9166-7e4f38028fa6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4e07a892-e6a1-4c35-a7d5-0090c28e2a08_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_93c9fa66-51f4-4135-a707-c09da4adc5b5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_0101da92-e77d-4024-9656-7a64bd385f98_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f6d9e18-64d8-4a4d-80ba-27ba2239bb71_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdcd6166-774b-41e5-aa44-b89a6b738922_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5345a3d-4bc1-4a67-beea-3530ad3cffd3_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_17730495-0111-487e-994a-d3ff0fbefa5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_489947af-72fb-4dc2-85c8-887a6ae2b7c6_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ada06e90-9d8c-4d41-bad5-233af8cf83c6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_891a3b13-c715-46fe-9b66-48cdca69a1f3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d472a76f-d5ca-4830-a89c-54cebdee9b19_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_48d4b5de-11f1-4fc2-9a87-0a9703305552_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_label_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_documentation_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:href="holx-20230401.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:to="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_8ad29c1c-71b9-4993-af4c-43730a51dc55_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 299,676 and 298,533 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ServiceRevenue_2ba1b5dc-7746-452e-9774-985f8ec05e20_terseLabel_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_ServiceRevenue_label_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_holx_ServiceRevenue_documentation_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue" xlink:href="holx-20230401.xsd#holx_ServiceRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ServiceRevenue" xlink:to="lab_holx_ServiceRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_481e040e-f580-43af-9783-946c6aa43744_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_31b4c9cf-05b7-4e9c-b79f-ed462ecaf3fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_7a83aa12-88e7-4246-8f51-c7dbe1c5f7ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_c58b8c7b-8f4c-4a2f-80aa-8e89d7142140_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_f8b75e47-955f-476d-8194-38db72b7384a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52b174e8-8329-44c2-86e4-057d063c8a8d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_a0cbc5ca-6d78-45e6-b42f-7e99e49c3026_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6f9a55c0-7386-473b-beae-d9a98012c2a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_40a349ca-8725-444d-880c-29cc66e994da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_d5f82374-9310-4eed-b261-341cc0719e6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5c395b65-c9d5-41c4-b8ca-2a313cfe95da_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2075b8cc-d4c8-4012-9c9c-3663a19a44f0_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65e166e1-a122-4eed-9129-f063debe15f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5a14ae3-27e5-4beb-b760-1dea48f85eb9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_2eab2af5-4a24-4ae5-b45d-6d19728ec064_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20230401.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2afe26f7-6e5b-4b0e-bc7b-903524b52a3c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_548a838b-849d-42e8-aed1-ff229e6c8c14_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_262e4608-de61-4020-8ea1-bc0e6cc585c2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ef3a5419-68d4-41b8-be16-48f47ec02a75_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ea0e4e99-58dd-48ff-9bca-e114385588c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_fc81f140-0e08-4d4d-98be-c69dfbf59e75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotationalAmount_da3fdb27-d6f1-4464-9993-1326d8da53ba_terseLabel_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_label_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_documentation_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount" xlink:href="holx-20230401.xsd#holx_NotationalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotationalAmount" xlink:to="lab_holx_NotationalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_dcbb9317-7216-4db6-9533-d992e427b3fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_c906fe86-16c0-4969-b4dd-62e5de8adaa1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f2047584-d6e7-4136-b2c5-fb3135266646_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_45e1f74c-f08c-4eff-b262-2327f06737e9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1e330b6f-a293-4389-aae2-48b5a1baa5d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8431d4bd-49ad-490a-b782-8d1fda1c5720_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_4f6e7db9-a863-4871-97f0-cecd85b6a190_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Petitions filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58a01841-3aa5-4ca7-b5f2-8ce77e4bf534_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a329f831-4ea0-4c62-bf2e-42edfe144885_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_865a3e38-f237-44a5-9a91-a7f4c84425c0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_2540cd17-4adb-44e5-ac89-6600a3895937_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20230401.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_70f828b1-559f-41f2-876e-f479e2b32b79_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8422de41-4c5b-4dc0-b2de-5944a630886f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6d967982-ee30-4ac8-98b7-fe9b98ad6a8d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8729b956-6ac0-42ad-b0c5-3f54193fc3ff_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c8637df1-43fb-4010-9432-0e4a45e3d6a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a284cafd-8562-478d-930f-6f43e1a36b02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_3014eb95-5336-4398-a279-11e3e9e09289_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1e24948a-e92a-49f5-877c-9b511c10add4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_76284292-4186-45a9-9250-879ecf1d66d8_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20230401.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromProductiveAssets_63b56c91-b690-4994-9d3f-f85eac5dd6a3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:to="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6b14ee07-f5a0-49d9-85e9-77f2c7ea4f44_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9aa7af00-e503-4127-9b85-bcce67b6addd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d87d2d11-620f-4155-b0e0-9bdd59139fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_48c90d2b-1ad7-45ae-a832-41c7cc39cae2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8b95f803-4296-4485-a6cc-4db7d6935e13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateSwap2024Member_e850667d-3224-4b1f-af28-2d196d511687_terseLabel_en-US" xlink:label="lab_holx_InterestRateSwap2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2024</link:label>
    <link:label id="lab_holx_InterestRateSwap2024Member_label_en-US" xlink:label="lab_holx_InterestRateSwap2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2024 [Member]</link:label>
    <link:label id="lab_holx_InterestRateSwap2024Member_documentation_en-US" xlink:label="lab_holx_InterestRateSwap2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2024Member" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateSwap2024Member" xlink:to="lab_holx_InterestRateSwap2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d8ef608a-f9f0-43d6-b727-1db59a7737f9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d44f0c13-04e9-46c4-a08f-77b947644835_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0dc0787b-daa8-4a28-9fd7-918c90b3c4fc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1be99964-ab53-4d16-af78-d35500dca0f6_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_4cb5038c-7af1-4221-ac09-d71f8ec417ee_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_3c9dcf56-dc27-4d93-9f2c-3fc0fa3474ea_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d1935014-4a16-458c-8951-ca1adba494f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7fffb1ed-21e0-46ff-b526-ae72b2497a11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c1aedda6-6e79-4d38-846e-85c92458ab45_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_10e373c6-ed24-4714-a0bb-a99c0d6312d5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_76ede0f1-04a5-4a61-9419-320bea927e64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 53,566 and 51,401 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_88272096-b9c6-4b3b-9629-b1703f5d0b82_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bad17563-06e3-4b02-a568-9cbd1798225b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ee37d716-9485-4bb1-9da9-743ad621d8a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_9c35d8a1-ee43-4d5a-9cd8-a321acc843d5_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_49ea6f32-3c51-4e44-870a-27e3c13f775e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d53ffd63-b56c-4855-bc0b-4b0f03428377_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f0170969-da57-4f0e-ae92-d76766a9947c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_02aca70d-b707-4cbd-8ec9-48e2249a90fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c8e6476b-bb14-441f-9d8a-b145ccbcc54e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9742c1d8-1790-4c36-8dbb-10121c407e64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_deda8782-af79-4099-ae21-9b056f6c9583_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f1cf5a53-1f41-4cc2-a7c9-126dace59727_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f68f7dab-b3bf-4e54-8dfc-494a4bfd216d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_735344c3-167e-41ac-a9b5-3994e4229069_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ba9ebd9a-3b65-462c-b90a-4935fd9bf44e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_da17297f-2d2d-4f3d-bc63-2a5e606cdca4_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_fdacedd7-3614-4e12-9a23-4c35be893504_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_d7e4ff21-09c8-43d3-95ee-03020eaa036a_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments designated as a cash flow hedge</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9f975e01-aaea-4bb2-a28f-40b1dae637e9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1abf100a-1637-4a8b-be4c-73f35a19df51_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7316dce7-7995-4a55-93c4-a5bde2c026ca_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_04883ab9-e3f5-4921-bcc8-02235fd1d2dc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_11d217dd-769a-468c-8dcd-6487d1b53e9c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_77d4cc28-26f6-4416-aba7-5d513b3f5e6b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_88e9641d-0b76-491e-bb92-0a81ed8c62eb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0168cae8-ec69-4613-9563-51fcb50bb0a5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinervaMember_a219dd9d-e0d2-4c9f-b7cb-93f1d593b63d_terseLabel_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva</link:label>
    <link:label id="lab_holx_MinervaMember_label_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:label id="lab_holx_MinervaMember_documentation_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember" xlink:href="holx-20230401.xsd#holx_MinervaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinervaMember" xlink:to="lab_holx_MinervaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_394a3e9c-b8d7-4e8d-bd08-4550db47bf2f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9f696b5f-4f15-46b3-b5da-50938f9659b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_53cdb0df-9ef0-424b-843c-c9db1b3cbcdc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4db067f1-f170-4f27-b6a9-df5c2bd5fa0d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_83b8acf9-4ecd-4406-bee1-8a229dc9af65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_700a2750-f725-4e3e-9622-1389b5a03efa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_615db8ba-2c47-44fe-a9fa-cc90d3361624_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, off-Balance-Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_4389c350-a590-4e94-9307-89a46a0ae783_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_80981e19-75f0-46ba-bacf-8f8d9bd6d052_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_5b2aca22-b6a9-409f-b180-81f0b087c26c_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40ea6bea-40ab-4b88-b0ec-18b1bcb1df7f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_5704e443-9725-4d7b-afc9-004d2375633f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of realized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestofWorldMember_5ee9aa23-2c44-4818-b2c4-8858330b461b_terseLabel_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_RestofWorldMember_label_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_holx_RestofWorldMember_documentation_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember" xlink:href="holx-20230401.xsd#holx_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestofWorldMember" xlink:to="lab_holx_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc8e9935-dee2-499b-bd83-43c9d282e5f5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_57408e45-66b2-46ad-8325-de30d908c431_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise prices (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_b27a3c46-adf1-4623-ab78-6bbc59e97509_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20230401.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_470ce380-b775-4f9c-af57-603da70c9ead_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8f4254d2-efce-4818-8b7d-41972076e12f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_bf4e1687-cb0d-40c9-a13a-cf5b886a7784_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_259639f5-ee4c-4432-87a0-9d814888eefa_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_3391df4b-1171-483f-a6a0-68bec044cdf8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a6d4adde-a5d2-45e7-b04f-1327bce79bb9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_69790a6f-c8be-4b94-9f23-1b99d6e0c4fb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_969f4f02-a266-4510-945f-e33a8775bd9e_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20230401.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0171277b-9270-474e-a2c6-bc7d24537a48_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ad07cb3f-a514-4204-89f8-be2ebe9e95d3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0fc2c71c-6939-425c-af23-b48982f85b99_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_f0568713-e3d6-431c-8cfa-12243a14b03b_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_76faefeb-918c-4932-81d9-24b6e8dd4dc5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e495faac-ad89-4e97-b353-99b749368cc2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_035d5e19-ff40-4a47-8e22-a110845dd314_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price of options outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_18b14619-76cc-4867-9f82-90ff51bcbad2_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_e6edbccb-b3b2-45be-9c1f-2d61f12d98bc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_70f4c514-ba22-4b27-b711-fd5bfef1aa8d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5a86c3cd-4b02-4bbf-ae3a-bc91b51f7323_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProductRevenue_743fa5bc-bb25-432f-aa01-ff4843785b52_terseLabel_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_holx_ProductRevenue_label_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_holx_ProductRevenue_documentation_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue" xlink:href="holx-20230401.xsd#holx_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductRevenue" xlink:to="lab_holx_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8c3a0859-9593-43eb-bdef-22f831c29b06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c7bc592b-33eb-40c2-9c2c-fcbb1991362d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RSUPSUMSUMember_d49d80a1-6cf9-4b1f-97e1-0c27c9beacf8_terseLabel_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_label_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_documentation_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember" xlink:href="holx-20230401.xsd#holx_RSUPSUMSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RSUPSUMSUMember" xlink:to="lab_holx_RSUPSUMSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_113d55e5-db11-4096-84a3-f56bba295c04_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationship</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_7c2ebfb3-6e8a-4074-8289-c7bab306d19f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_7c618cdd-57e8-4882-9595-08ff3d1b26c4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_d4235f60-e6eb-4592-8bcb-716611ae3e85_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_78ba967b-105b-4ecb-8a70-81e327becc14_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20230401.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_edfbfc1c-3fad-49d8-a573-801134df7d0a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_1f067018-32ab-470e-9095-04f8f9c38eed_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:href="holx-20230401.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5605e07a-ab19-49dc-91e4-28bc0ace68d0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_b0370a15-62e8-4bac-b06d-5e7068a68b05_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_5756c5fa-feb6-4657-afc7-3697f773ce07_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_34b7f39a-5d25-4838-abb0-6008e0c406ad_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_fa1b6b33-1e41-4b8a-8b81-26913434ae02_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_c73635e4-9124-4f75-9e72-034993f213a7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a7ac60e9-423c-49fc-aaa0-b042c67a5928_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_fef90bb8-9f62-4537-9c1a-84b3fbb351f0_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments" xlink:to="lab_us-gaap_LossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_940d333f-a13b-48b6-8cee-9a22e9d82618_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_21d3e53a-98c5-4795-bd56-50532fa6e78a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cf694db3-5410-4f9a-a048-3e556beadbd7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_183f9e45-f34e-4ae3-9dc5-647f987a98fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_46a7a685-75a4-40a3-a881-272fb99c951c_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4b0135c8-e35b-415d-a82f-1147a22bae30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of business, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_7f7bd746-ad69-4b9c-a20d-04073758f654_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GermanyPlanMember_29bf1ffb-ce57-4727-a049-d8fbd71ec748_terseLabel_en-US" xlink:label="lab_holx_GermanyPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_holx_GermanyPlanMember_label_en-US" xlink:label="lab_holx_GermanyPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany Plan [Member]</link:label>
    <link:label id="lab_holx_GermanyPlanMember_documentation_en-US" xlink:label="lab_holx_GermanyPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GermanyPlanMember" xlink:href="holx-20230401.xsd#holx_GermanyPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GermanyPlanMember" xlink:to="lab_holx_GermanyPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_42eec7d0-4d60-41a2-af4f-281dd8048b31_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsMember" xlink:to="lab_us-gaap_EquityMethodInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9f50b511-c61b-4fb6-a32f-0662cc8e885b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_3de9e1d1-0002-4309-a0c8-c6b57c857719_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20230401.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab3ccc22-be33-4125-96cf-e8a09f44fbd8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ec0eb52-ed47-4069-8d67-d616b70eb54f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fa6fc3fc-fe1e-4831-9004-810d618955c9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Netincome_7b535808-e046-46da-90a4-e5dee0ee5883_terseLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_label_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_documentation_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome" xlink:href="holx-20230401.xsd#holx_Netincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Netincome" xlink:to="lab_holx_Netincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a821b130-869f-45a8-9de3-be2ff5263d62_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ddf4fab9-5084-42af-a173-0de4ee43efc2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_dc195326-1c90-4df5-a8a8-9d8811c34195_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7efa3fc4-7cba-430c-a2d7-58dea09f3323_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanTable_7179e337-5c85-4502-8ffb-65d4497c94de_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_label_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanTable" xlink:to="lab_holx_SharerepurchaseplanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_f9085a76-f59a-4ac5-826e-a83d3e0bb58d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_ea519935-38b2-447d-a012-d9c73835618f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_89bd00ac-e120-4b48-95d1-8ae3b9948e76_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_ef012f8c-beee-4d83-bf5b-1f9e577bfeb8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0bdba57d-98b8-43f9-83be-4a2bcfb591de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_ccf503ed-d583-4131-84a7-dba699a9272b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_bfa443ba-6fe4-431c-b332-21ecba9ab425_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_e637d809-d0af-4b28-a28c-bf281a09734d_terseLabel_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_label_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_documentation_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:href="holx-20230401.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:to="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_9895e9e4-c79e-4271-9f19-4a02621f6bbf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_44f92cfa-6151-430f-b369-427fcf057e08_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_34495c59-3e1d-462b-8967-b310fc9602ce_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_be41a484-e156-42d4-b596-9bdbcecc978d_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_38dcba83-7484-44d5-afe4-d94e6bf52f8b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f2a9daf5-eac4-4d1c-b86a-f7e9d796690e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_19ad5f90-cd72-4dcb-b289-1b2b3b101702_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_93673425-7326-41f2-ad09-a24f76d15432_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_30d344ff-dddb-484f-aaf7-89842104660b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_30ae6eac-e7fd-48cf-8f76-368f3f2a8e86_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_d8017181-42f0-4372-9b43-1ef0c01c77a4_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0899f61b-42ae-4cc1-b9fb-4b503ffbe932_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_255c7183-a055-474e-89ed-8d02ef8fbed1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_c1773bcc-f40a-4348-9179-6ba7a504d112_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a90e73fe-8552-4c4f-a779-2df4009a6f33_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_bd81013b-17c8-4e39-a1dc-0e98af7a9499_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e4108c6c-1d90-4194-8cda-21e2a3cd89d5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c9285c62-e53b-4843-910c-fb8f2c1c3a0a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_4a9bdc9d-3c35-4482-a7db-59ad936b6df1_terseLabel_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_label_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent" xlink:href="holx-20230401.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrepaidIncomeTaxesCurrent" xlink:to="lab_holx_PrepaidIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_db444d01-6ece-498c-be26-221b3fe02fd1_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_cd49b9ba-cd00-4fac-ae01-e28e67012561_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_633ab8ad-7f2f-402e-9175-73fdc7a1fba8_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20230401.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_58d12561-f00c-4127-beac-5ae3af0754f9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_729c0e6a-5ef9-4f31-9679-ab633e672ab4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_0daa249f-0b9a-4c91-afd0-8f9b986b4612_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software embedded in products</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20230401.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5ac12854-b472-41be-86c4-a8ba37dd1655_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_5793e379-70d6-466e-a53f-914e7f79289b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_36fb9d41-a19a-474d-b021-46c29dfd7c98_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16c13ae6-0831-422e-aca4-dd2dee6c7cf5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3342adc-83fc-4ef4-a103-15e3ab8f4ab4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_34c46dd3-d3f9-4c44-8974-3c02c635bef1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_574016cf-cc69-4bc9-a913-722d1720b91b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_67089c20-b343-490e-8396-20820d10deb1_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_2fea7e78-e7d5-4105-8261-b23162823742_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6f26d153-f9ea-4240-89a0-e5cbbc4fa852_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_acf996dd-08bf-4886-806b-132267b120b1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_705dcefc-b03b-45f9-9828-5dc548b63c07_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9ad18f5b-7274-4647-aaf1-6e3d7d73df20_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_4e6cba39-2f01-4f63-9a3c-63aabc0d97ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_b579291d-116a-4ae4-95cd-562705c5e792_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e30b2186-0aa9-49e0-8019-24df57b08574_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_fd655c72-ca59-413e-b3ef-0ac356d05e9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_db0bdf3f-8a20-4bee-ab97-1dc0574bc016_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_85f5669f-ea75-4353-af8f-7f98c995aa5f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d6e2bcf8-adcd-49c3-8321-82931231034c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9e04ee7c-7b64-4e13-bdaf-848b4915b104_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_ed96b289-6e9b-48a1-85b9-c5e74372dc76_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7b5a2a1e-f27b-4a6e-862b-f1d9d3358ee0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_49301939-e077-4baf-852d-9111a3208919_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_f0399129-46f4-4c99-9dd9-9e591371dc8a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_8c3e767f-ff66-4a82-afb1-e8a129852bd7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>holx-20230401_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:01ed101e-7d34-41b1-9378-4f8d2ec44858,g:2b0b58b9-8e44-4caa-9067-22dcbb34ae41-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20230401.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ea15cef9-c0f7-4ae9-9d12-cd576d8a78ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_Security12bTitle_ea15cef9-c0f7-4ae9-9d12-cd576d8a78ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_bd070afd-6a9c-4dad-86cb-970df9fe45cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentTransitionReport_bd070afd-6a9c-4dad-86cb-970df9fe45cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_01155c84-2cc8-4b92-ba1c-db29ec90b105" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentQuarterlyReport_01155c84-2cc8-4b92-ba1c-db29ec90b105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a6a28a4c-6607-408b-91ca-863f4eec8439" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a6a28a4c-6607-408b-91ca-863f4eec8439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_48a46fb1-438c-4a74-965f-05168bb7ad13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityAddressPostalZipCode_48a46fb1-438c-4a74-965f-05168bb7ad13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_40fbf448-57c5-4429-a678-efd8f594a422" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityFileNumber_40fbf448-57c5-4429-a678-efd8f594a422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_04186ca9-d5df-4563-900b-5786fb1503bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentType_04186ca9-d5df-4563-900b-5786fb1503bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_98c3e42c-a131-4652-b472-c8c6f69fe29b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_AmendmentFlag_98c3e42c-a131-4652-b472-c8c6f69fe29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c452775-7365-40af-8233-36f47b5f5e94" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentPeriodEndDate_8c452775-7365-40af-8233-36f47b5f5e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_551cc21e-b570-4aa9-8446-7f7ae64e21d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentFiscalYearFocus_551cc21e-b570-4aa9-8446-7f7ae64e21d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_08f06c34-b020-4a1f-95b9-f2fd4e7cf229" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_DocumentFiscalPeriodFocus_08f06c34-b020-4a1f-95b9-f2fd4e7cf229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_803ac1f2-954e-4b45-ada5-30d2db72bf77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityRegistrantName_803ac1f2-954e-4b45-ada5-30d2db72bf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_eb7040df-2ef0-45d4-bb72-bfef586023a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityCentralIndexKey_eb7040df-2ef0-45d4-bb72-bfef586023a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4470cbd5-4cd0-48ae-8fbf-d868cd14929f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_CurrentFiscalYearEndDate_4470cbd5-4cd0-48ae-8fbf-d868cd14929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b19df567-f2a1-4c6e-9aa4-480fcc115862" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityFilerCategory_b19df567-f2a1-4c6e-9aa4-480fcc115862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d734d00f-461a-4d78-b4fe-262934bb73b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityEmergingGrowthCompany_d734d00f-461a-4d78-b4fe-262934bb73b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d26bc8c3-c73f-4659-8207-8c459284923b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntitySmallBusiness_d26bc8c3-c73f-4659-8207-8c459284923b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_813f4b24-d48b-4d8d-883a-b1558ca717cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_813f4b24-d48b-4d8d-883a-b1558ca717cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0bc5750b-b6a4-4e46-a369-194ee2704687" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityShellCompany_0bc5750b-b6a4-4e46-a369-194ee2704687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6a072382-9f59-4eb8-ad50-ebff2139a8b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityCurrentReportingStatus_6a072382-9f59-4eb8-ad50-ebff2139a8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6b9227a8-a2a6-45e4-bdad-816ff392e162" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityInteractiveDataCurrent_6b9227a8-a2a6-45e4-bdad-816ff392e162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_598b94f4-6ab3-45ba-b030-7b7945b98518" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_CityAreaCode_598b94f4-6ab3-45ba-b030-7b7945b98518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_987632ff-47c8-4d5a-ac2d-d321ca32a7e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_LocalPhoneNumber_987632ff-47c8-4d5a-ac2d-d321ca32a7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e7553f8c-195b-42f5-b956-f7c3cb45b2bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityTaxIdentificationNumber_e7553f8c-195b-42f5-b956-f7c3cb45b2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_07d6dff4-41af-4575-9535-76b949831a39" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityAddressAddressLine1_07d6dff4-41af-4575-9535-76b949831a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_09d79cba-44ec-44af-9a81-aad632bb0f5d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityAddressCityOrTown_09d79cba-44ec-44af-9a81-aad632bb0f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_00f69c19-bfb9-4c55-a4fb-55fb35bfda95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_EntityAddressStateOrProvince_00f69c19-bfb9-4c55-a4fb-55fb35bfda95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc8940cb-a55d-4787-8e79-8a149af35917" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_TradingSymbol_fc8940cb-a55d-4787-8e79-8a149af35917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_450fa733-9acd-4644-bfde-4f7cec652cef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d664233-0817-41f9-8057-0134a5ac53dd" xlink:to="loc_dei_SecurityExchangeName_450fa733-9acd-4644-bfde-4f7cec652cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f6d5954e-a6ff-4fdf-8257-eb4bf253c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:to="loc_us-gaap_RevenuesAbstract_f6d5954e-a6ff-4fdf-8257-eb4bf253c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_df27f148-50ff-439f-8d62-c44ce12abb0b" xlink:href="holx-20230401.xsd#holx_ProductRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f6d5954e-a6ff-4fdf-8257-eb4bf253c03d" xlink:to="loc_holx_ProductRevenue_df27f148-50ff-439f-8d62-c44ce12abb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_98b452ca-28f1-45cd-84df-8d74e98eb514" xlink:href="holx-20230401.xsd#holx_ServiceRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f6d5954e-a6ff-4fdf-8257-eb4bf253c03d" xlink:to="loc_holx_ServiceRevenue_98b452ca-28f1-45cd-84df-8d74e98eb514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_92a6778e-59ed-4fb1-927b-bf9be8a26424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f6d5954e-a6ff-4fdf-8257-eb4bf253c03d" xlink:to="loc_us-gaap_Revenues_92a6778e-59ed-4fb1-927b-bf9be8a26424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:to="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cbe4aaa9-2130-487a-8e34-cdbe7717f956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cbe4aaa9-2130-487a-8e34-cdbe7717f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_d1e49b99-a17b-4647-948a-7c59a1992fb4" xlink:href="holx-20230401.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:to="loc_holx_AmortizationCostofGoodsSold_d1e49b99-a17b-4647-948a-7c59a1992fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_f96849ad-ca3b-41b2-9811-bea1f9546f15" xlink:href="holx-20230401.xsd#holx_Costofservice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:to="loc_holx_Costofservice_f96849ad-ca3b-41b2-9811-bea1f9546f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f82da5e5-3c6d-416a-a5cf-5384190cddef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_fa919cd1-6177-4c98-a24f-6af5d721846d" xlink:to="loc_us-gaap_GrossProfit_f82da5e5-3c6d-416a-a5cf-5384190cddef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_48638387-bc75-4044-895c-2e4d3c676bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_48638387-bc75-4044-895c-2e4d3c676bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_a2b2a03a-54f0-4489-b654-6bec73634ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_SellingAndMarketingExpense_a2b2a03a-54f0-4489-b654-6bec73634ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2e42a30e-dc57-44dd-af5d-254072bfc183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2e42a30e-dc57-44dd-af5d-254072bfc183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_945155f6-b5d4-4298-a0ce-42ca8cb72be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_945155f6-b5d4-4298-a0ce-42ca8cb72be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_9303f880-2831-44a6-aa36-f075e05b1f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_9303f880-2831-44a6-aa36-f075e05b1f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_554b25c2-5963-4cd2-a391-35a8e57661ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_RestructuringCharges_554b25c2-5963-4cd2-a391-35a8e57661ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ee5c98d0-8783-4fbf-a39e-c51852ae2588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_OperatingExpenses_ee5c98d0-8783-4fbf-a39e-c51852ae2588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4218b229-686c-42ba-9294-d380a06093c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_OperatingIncomeLoss_4218b229-686c-42ba-9294-d380a06093c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_624174af-bb30-48c5-bd14-af467099b55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_InvestmentIncomeInterest_624174af-bb30-48c5-bd14-af467099b55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0541e1c8-26b3-4c87-be2f-f05c1f4f0a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_InterestExpense_0541e1c8-26b3-4c87-be2f-f05c1f4f0a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c3e518b-b36e-4a0b-97b6-57ff8d3c2925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c3e518b-b36e-4a0b-97b6-57ff8d3c2925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_32312bdc-a7a1-47d9-a595-f30b6e1bdfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_32312bdc-a7a1-47d9-a595-f30b6e1bdfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_56fbfe8a-2a2e-4a12-b517-5bb85600a310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_56fbfe8a-2a2e-4a12-b517-5bb85600a310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a9572990-cfc0-4d25-a8a7-0115d4b992b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a9572990-cfc0-4d25-a8a7-0115d4b992b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b36e937-baf0-4f80-a4a2-539554709bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ac1e8fb7-ec7a-498b-a2f1-b8a76f5bd781" xlink:to="loc_us-gaap_NetIncomeLoss_9b36e937-baf0-4f80-a4a2-539554709bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cc0affa3-ce96-4715-91fb-207f0dea22cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:to="loc_us-gaap_EarningsPerShareAbstract_cc0affa3-ce96-4715-91fb-207f0dea22cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1c986939-66ba-4ce2-a3a3-354ce0e1edd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cc0affa3-ce96-4715-91fb-207f0dea22cd" xlink:to="loc_us-gaap_EarningsPerShareBasic_1c986939-66ba-4ce2-a3a3-354ce0e1edd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_20ebcd37-ca59-4c91-8d41-c481e2b2c1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cc0affa3-ce96-4715-91fb-207f0dea22cd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_20ebcd37-ca59-4c91-8d41-c481e2b2c1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4c7f4944-a604-41f0-bd70-d0117b1b5302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515a35bf-9242-440d-ba2a-05add6c93f71" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4c7f4944-a604-41f0-bd70-d0117b1b5302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4219c6c6-9768-4394-ae13-2f2d9321cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4c7f4944-a604-41f0-bd70-d0117b1b5302" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4219c6c6-9768-4394-ae13-2f2d9321cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d4eb762-34ff-4b1d-abeb-b3fb3a76a164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4c7f4944-a604-41f0-bd70-d0117b1b5302" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d4eb762-34ff-4b1d-abeb-b3fb3a76a164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9629f1c-49fc-45fb-a7aa-b80d8cd7bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:to="loc_us-gaap_NetIncomeLoss_f9629f1c-49fc-45fb-a7aa-b80d8cd7bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_36c5723b-6b30-4457-84dd-823d1d530bf0" xlink:href="holx-20230401.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_36c5723b-6b30-4457-84dd-823d1d530bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_20b1e321-aedd-4524-a6f8-6e4a4cd7038c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_20b1e321-aedd-4524-a6f8-6e4a4cd7038c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_55181738-6f9f-4338-be92-892008be7e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_55181738-6f9f-4338-be92-892008be7e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28eca38d-9daf-4de5-95a2-2e7e9ebf43bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ef979f2-02ee-4f9a-8918-fd163cc19573" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_28eca38d-9daf-4de5-95a2-2e7e9ebf43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_10dfa59f-ceaf-4aef-bfbb-8eb4b682e2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_aadaace7-85ea-493b-a5d2-0527a5f00766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_10dfa59f-ceaf-4aef-bfbb-8eb4b682e2ed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_aadaace7-85ea-493b-a5d2-0527a5f00766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2149fc99-2ae5-48e3-b8dc-3e39ed078418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2149fc99-2ae5-48e3-b8dc-3e39ed078418" xlink:to="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61c3663c-ab5b-48f3-a7cd-a7664cdea917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61c3663c-ab5b-48f3-a7cd-a7664cdea917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dcd4ae5b-9c93-4768-86fd-4448010ef5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dcd4ae5b-9c93-4768-86fd-4448010ef5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_609e8f89-1e39-4e20-994a-5c656deb1a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_us-gaap_InventoryNet_609e8f89-1e39-4e20-994a-5c656deb1a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_46b1cfa1-d625-4ce8-a57b-1a1bdb67a04e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_46b1cfa1-d625-4ce8-a57b-1a1bdb67a04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_b3d71166-f9e9-44cc-be4d-c79401d8c12e" xlink:href="holx-20230401.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_b3d71166-f9e9-44cc-be4d-c79401d8c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8095dfa4-0913-4d8f-a5c3-2275cc97e7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fecdacd3-ddb1-4700-a399-0e0c6519733c" xlink:to="loc_us-gaap_AssetsCurrent_8095dfa4-0913-4d8f-a5c3-2275cc97e7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0a0fc0a7-4c0a-4ade-8f77-b06bba092197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0a0fc0a7-4c0a-4ade-8f77-b06bba092197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_033d97da-1e2b-4832-9073-66a78290e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_033d97da-1e2b-4832-9073-66a78290e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67a16313-39ff-4b91-a4a1-e0cce60890b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_Goodwill_67a16313-39ff-4b91-a4a1-e0cce60890b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ac2bd402-a9e7-4096-8316-508bc653de43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ac2bd402-a9e7-4096-8316-508bc653de43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7ec8c7df-a154-4ecf-afe5-eda4765e0271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fbc047ab-7b3b-4224-80fb-862da8f1b65d" xlink:to="loc_us-gaap_Assets_7ec8c7df-a154-4ecf-afe5-eda4765e0271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2149fc99-2ae5-48e3-b8dc-3e39ed078418" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a67a1b35-ef19-41ad-885f-f97fbe94c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_LongTermDebtCurrent_a67a1b35-ef19-41ad-885f-f97fbe94c056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2a695975-4575-44cd-83a7-2df3fd997582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_AccountsPayableCurrent_2a695975-4575-44cd-83a7-2df3fd997582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_be2429f1-baeb-4554-a5cb-6f865f6ff115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_be2429f1-baeb-4554-a5cb-6f865f6ff115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_74e0f712-1464-48d6-8ad6-bdb66145ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_DeferredRevenueCurrent_74e0f712-1464-48d6-8ad6-bdb66145ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f0b4ef88-9c89-4e6a-b74a-f56ee80406e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f0b4ef88-9c89-4e6a-b74a-f56ee80406e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e3f83000-97b6-44f4-a014-cbb7cd3d24ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_07930bf0-7bd7-4ee3-a41e-78b0fc442e76" xlink:to="loc_us-gaap_LiabilitiesCurrent_e3f83000-97b6-44f4-a014-cbb7cd3d24ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7d14b976-fb87-44dd-86fe-c9f13eddcafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7d14b976-fb87-44dd-86fe-c9f13eddcafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd15c8c4-fe5f-4f8d-a0ae-0b88adcfd8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd15c8c4-fe5f-4f8d-a0ae-0b88adcfd8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8826e265-a853-4a2b-8538-7a729901c6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8826e265-a853-4a2b-8538-7a729901c6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_a325351f-dae8-4c0e-ada6-256d850c0748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_a325351f-dae8-4c0e-ada6-256d850c0748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1f146c1a-1643-4c93-88b9-a72e76d5c740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1f146c1a-1643-4c93-88b9-a72e76d5c740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4acec811-5d3a-4d1b-b64f-4d55065b3706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_PreferredStockValue_4acec811-5d3a-4d1b-b64f-4d55065b3706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c31e3f8a-aeda-45f4-9b1a-596063304821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_CommonStockValue_c31e3f8a-aeda-45f4-9b1a-596063304821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4ab3a8df-607f-4b62-9bc2-d682e8d6e148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4ab3a8df-607f-4b62-9bc2-d682e8d6e148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a7d5981c-3245-4d21-8126-5bb5e81292ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a7d5981c-3245-4d21-8126-5bb5e81292ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ac15985c-a983-42c1-b3b5-e98b32d7d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_TreasuryStockValue_ac15985c-a983-42c1-b3b5-e98b32d7d79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3d4ed64-324c-4b51-baf8-2731224f05ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3d4ed64-324c-4b51-baf8-2731224f05ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cf124fb-661f-42ad-91a7-4a74f537f33c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9c8bb93-5e74-4966-afa4-d216e34b72f7" xlink:to="loc_us-gaap_StockholdersEquity_6cf124fb-661f-42ad-91a7-4a74f537f33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cfc2fff-b2c2-486c-80c9-ab7712043c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8cce9289-8a08-44fe-b0cf-83651fa266fd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cfc2fff-b2c2-486c-80c9-ab7712043c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bc835410-b7b0-47b7-b024-61411faf9bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bc835410-b7b0-47b7-b024-61411faf9bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2aa1a199-13b5-4d8e-8480-fa2f0e4b1b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2aa1a199-13b5-4d8e-8480-fa2f0e4b1b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2b233b7f-ccc0-47ac-85b3-70a3336e2e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2b233b7f-ccc0-47ac-85b3-70a3336e2e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a60e3eee-ae8d-433b-b9b8-fc001c20f18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a60e3eee-ae8d-433b-b9b8-fc001c20f18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ece05084-598c-49ed-bf3d-03a45c032bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ece05084-598c-49ed-bf3d-03a45c032bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ad36277c-0fff-429c-8a83-9867279df11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_CommonStockSharesIssued_ad36277c-0fff-429c-8a83-9867279df11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d4a149eb-ad11-4976-aa3a-6df992a9ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a3da190-1193-45d2-9f11-d9f2e5bf6db0" xlink:to="loc_us-gaap_TreasuryStockShares_d4a149eb-ad11-4976-aa3a-6df992a9ce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_244aeeaa-6337-4db1-bcb9-a7cc7db7ee0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_244aeeaa-6337-4db1-bcb9-a7cc7db7ee0e" xlink:to="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_098f6e90-a4fb-4b1a-9f21-780d6c8016de" xlink:to="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7241614-2d4c-4e01-a4f7-050f92e097a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_CommonStockMember_d7241614-2d4c-4e01-a4f7-050f92e097a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01b6f39c-8cd3-413a-bc6b-e202c0aebb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01b6f39c-8cd3-413a-bc6b-e202c0aebb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb21bc37-7cab-4b67-8b5b-b8ba63b805dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_RetainedEarningsMember_eb21bc37-7cab-4b67-8b5b-b8ba63b805dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7120d8cb-1589-4b0c-8ff6-77ae93c15d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7120d8cb-1589-4b0c-8ff6-77ae93c15d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_0e8e7a62-f6af-4d16-a93b-4f22e1e88128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fe25eed-217f-4986-ac51-7be74932fef7" xlink:to="loc_us-gaap_TreasuryStockMember_0e8e7a62-f6af-4d16-a93b-4f22e1e88128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f426e99f-2f15-4c1d-8a2f-402a0b6e8d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9922733e-dd8c-4849-b9b0-27c4f5194e8a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f426e99f-2f15-4c1d-8a2f-402a0b6e8d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c8f4a526-7400-47a9-a614-8dd0610cdf1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_150a1882-9f99-4697-8812-c16f1d20642a" xlink:href="holx-20230401.xsd#holx_September222022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_18e753c1-0232-4be8-9a7e-e62028461737" xlink:to="loc_holx_September222022Member_150a1882-9f99-4697-8812-c16f1d20642a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_467c472b-cb2b-407e-ade1-9a77ef8405e5" xlink:to="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48d3ed50-a186-4880-b1a6-53921515a0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d996dec1-1e4d-40ae-a6c3-678cc859b855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_SharesIssued_d996dec1-1e4d-40ae-a6c3-678cc859b855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5d8c14f7-b0cc-4bb5-84f1-574fcba9a651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockholdersEquity_5d8c14f7-b0cc-4bb5-84f1-574fcba9a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45f69996-758a-4d85-b443-a7ebc713a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45f69996-758a-4d85-b443-a7ebc713a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2b80b968-6abc-4c84-8911-674e30656ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2b80b968-6abc-4c84-8911-674e30656ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c21fb152-17bb-4c6a-8ce7-2eab4dc8e8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c21fb152-17bb-4c6a-8ce7-2eab4dc8e8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_59b58233-2068-45b1-8da7-8213d602c08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_59b58233-2068-45b1-8da7-8213d602c08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f673f0a6-effa-47fe-a2b9-74e44fc06578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f673f0a6-effa-47fe-a2b9-74e44fc06578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_66db4dc4-3526-4922-a2cf-3a610fe2a3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_66db4dc4-3526-4922-a2cf-3a610fe2a3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_58272575-7e5b-4d47-a8f7-7c259569f4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_58272575-7e5b-4d47-a8f7-7c259569f4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc0fbc37-2fff-4816-84ea-df4e61af7206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_NetIncomeLoss_bc0fbc37-2fff-4816-84ea-df4e61af7206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dad9e94e-cc8d-4b8b-ac52-baedd1114f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dad9e94e-cc8d-4b8b-ac52-baedd1114f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_17331bf8-2298-4830-8d36-d759704d6b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_17331bf8-2298-4830-8d36-d759704d6b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_36155f3d-0737-4b2f-8514-d3420a9ad90e" xlink:href="holx-20230401.xsd#holx_Netincome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_holx_Netincome_36155f3d-0737-4b2f-8514-d3420a9ad90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_b6a086b9-f95d-4f82-a2e0-38c7a80049d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_b6a086b9-f95d-4f82-a2e0-38c7a80049d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4f632554-58b2-473a-8136-49df4d46f822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_SharesIssued_4f632554-58b2-473a-8136-49df4d46f822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3fb5e79-1845-4d7c-9c01-41c144b03b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockholdersEquity_f3fb5e79-1845-4d7c-9c01-41c144b03b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2fdf3a12-0694-4e51-a7c6-a24bb8dcc91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999c0264-f1ad-494e-a359-b2e6b76dea82" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2fdf3a12-0694-4e51-a7c6-a24bb8dcc91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20230401.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_319045a0-9982-474a-863e-35599ab7ad61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:to="loc_us-gaap_NetIncomeLoss_319045a0-9982-474a-863e-35599ab7ad61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5b3f0a04-1552-48e0-a7d6-224b0bd1860d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_Depreciation_5b3f0a04-1552-48e0-a7d6-224b0bd1860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_73bb547c-36fb-4b3d-8d00-17ad8e389809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_AdjustmentForAmortization_73bb547c-36fb-4b3d-8d00-17ad8e389809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5a5d9d80-31dd-4c93-bfaf-f644a2b01bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_ShareBasedCompensation_5a5d9d80-31dd-4c93-bfaf-f644a2b01bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_25ebafc1-169e-4d1d-bc3e-b1d6ecab86b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_25ebafc1-169e-4d1d-bc3e-b1d6ecab86b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b89552-a5ab-411e-b29d-ebf31d814ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b4b89552-a5ab-411e-b29d-ebf31d814ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cb55fe41-d9b8-455a-8993-0bd902fa6727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c02dce0e-a3b7-4392-bfac-54add0650268" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cb55fe41-d9b8-455a-8993-0bd902fa6727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_20d8e6ad-e015-4af7-b2bb-8ff19624958f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_20d8e6ad-e015-4af7-b2bb-8ff19624958f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3988e889-13b8-4482-ae1c-e5cd199fa77f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3988e889-13b8-4482-ae1c-e5cd199fa77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_20b45072-ce9e-46e1-bee0-cae744447b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_20b45072-ce9e-46e1-bee0-cae744447b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_78eeeed0-eecc-40de-912d-dd88b1b1f6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_78eeeed0-eecc-40de-912d-dd88b1b1f6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cd5c1cb2-7d6d-4c09-a34e-5a36f41e56e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cd5c1cb2-7d6d-4c09-a34e-5a36f41e56e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_23e520e6-27c6-4c32-9f40-b88cd66ff90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_23e520e6-27c6-4c32-9f40-b88cd66ff90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a6df7f5f-0da6-4e8b-8c48-55c9e65fe2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b308e7ae-73a4-4eec-80ee-f1ed7a21b2b4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a6df7f5f-0da6-4e8b-8c48-55c9e65fe2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fbe159d8-6822-4748-b2cb-58afbb923fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8da3202-b29e-4eba-89b4-8856b1bf1412" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fbe159d8-6822-4748-b2cb-58afbb923fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fb68663-ede9-4ff9-9cdf-a98546c87308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fb68663-ede9-4ff9-9cdf-a98546c87308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_890f691f-d8e4-4b1b-8d9d-68ac46ba055d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_890f691f-d8e4-4b1b-8d9d-68ac46ba055d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_23a0f6a9-1a37-4e92-8a08-8d817fca900a" xlink:href="holx-20230401.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_23a0f6a9-1a37-4e92-8a08-8d817fca900a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_93fe5cb9-648d-464c-be56-320f0b7401ab" xlink:href="holx-20230401.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_93fe5cb9-648d-464c-be56-320f0b7401ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f9b67d47-80a1-4ac8-a488-803b6eeba661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f9b67d47-80a1-4ac8-a488-803b6eeba661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a9ec9357-820c-4222-80cf-9d4cb21f8946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a9ec9357-820c-4222-80cf-9d4cb21f8946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d922a240-59a3-47fb-84d4-9b56878400a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5c399e76-ef69-405a-b882-c7d7359331d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d922a240-59a3-47fb-84d4-9b56878400a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_9bd3a612-7b2a-44f8-8cb0-0e4612a0e28a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_9bd3a612-7b2a-44f8-8cb0-0e4612a0e28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_bffaf660-01c5-4373-994d-3fc5c5106e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_bffaf660-01c5-4373-994d-3fc5c5106e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_6994d344-83f6-41e3-be76-3705bb676b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_6994d344-83f6-41e3-be76-3705bb676b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentOfDeferredAcquisitionConsideration_0dbdaca0-cf9f-43cd-8572-ab69516262a0" xlink:href="holx-20230401.xsd#holx_PaymentOfDeferredAcquisitionConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_holx_PaymentOfDeferredAcquisitionConsideration_0dbdaca0-cf9f-43cd-8572-ab69516262a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt_69e17f48-b10e-4154-905f-2faa8205a817" xlink:href="holx-20230401.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_holx_Repaymentsofacquiredlongtermdebt_69e17f48-b10e-4154-905f-2faa8205a817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_409c4bac-5568-4e8f-9f7a-d011b295d46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_409c4bac-5568-4e8f-9f7a-d011b295d46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6fdecf23-15e3-460a-90f2-59383f499a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6fdecf23-15e3-460a-90f2-59383f499a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_7bedd324-9def-436e-b789-627115645d85" xlink:href="holx-20230401.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_7bedd324-9def-436e-b789-627115645d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_0393e9e5-1376-419d-ae82-1d3fd8f6bbca" xlink:href="holx-20230401.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_0393e9e5-1376-419d-ae82-1d3fd8f6bbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac751023-9c4e-47f9-bc30-ec0b398e4e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5254156b-abd4-42ea-a48b-5df4ec46ffe3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac751023-9c4e-47f9-bc30-ec0b398e4e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f80213e5-a4dd-442b-92d7-dc4a79cb514c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f80213e5-a4dd-442b-92d7-dc4a79cb514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b0e1038c-da74-43ee-96dd-9a8d24cb06d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b0e1038c-da74-43ee-96dd-9a8d24cb06d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be3a1c5c-940d-4867-adf4-13d69d0be1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be3a1c5c-940d-4867-adf4-13d69d0be1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53cc399a-a0d7-4aec-b30a-1aef6641f4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_09c35a43-fc47-4f08-8777-7d0486083375" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53cc399a-a0d7-4aec-b30a-1aef6641f4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20230401.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_1e251c56-5806-4b1a-a1dd-5a2b3b502407" xlink:href="holx-20230401.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8f866773-7c83-4356-8dba-928625e5f089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_1e251c56-5806-4b1a-a1dd-5a2b3b502407" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8f866773-7c83-4356-8dba-928625e5f089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20230401.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20230401.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ff60d61b-419a-48de-bfad-69f9ec17a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5c8b207d-d12b-469f-920e-ff0958ca07ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ff60d61b-419a-48de-bfad-69f9ec17a9f6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5c8b207d-d12b-469f-920e-ff0958ca07ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_96c49e9b-77df-4b9c-9725-c379a8124b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ff60d61b-419a-48de-bfad-69f9ec17a9f6" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_96c49e9b-77df-4b9c-9725-c379a8124b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_855ef472-237b-4213-ba8b-c76da813cd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_72e90708-f951-43f7-bf71-db1bae34accb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_855ef472-237b-4213-ba8b-c76da813cd7e" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_72e90708-f951-43f7-bf71-db1bae34accb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0e9699f2-ee14-47b8-8bde-e16a2a2bbc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e17c5bd1-cefc-4f0e-ab6b-e21fae9cbb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0e9699f2-ee14-47b8-8bde-e16a2a2bbc8d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e17c5bd1-cefc-4f0e-ab6b-e21fae9cbb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20230401.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_9a80d6b7-6ba1-4705-a128-c85729cea4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_709a2b48-4c7f-449e-9cf9-386c7f98d425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_9a80d6b7-6ba1-4705-a128-c85729cea4cd" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_709a2b48-4c7f-449e-9cf9-386c7f98d425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Restructuring" xlink:type="simple" xlink:href="holx-20230401.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract_cb38657f-5d7a-4041-a665-76213d9a4262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b51ed948-1539-4614-a311-c75d34fe3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_cb38657f-5d7a-4041-a665-76213d9a4262" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b51ed948-1539-4614-a311-c75d34fe3b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4ded928a-0b54-4306-963d-3836244c0775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c880adbb-3f27-489c-ab51-b287bdf12232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4ded928a-0b54-4306-963d-3836244c0775" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c880adbb-3f27-489c-ab51-b287bdf12232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20230401.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b2f5684-c014-47ea-8443-47ea584f8138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_b20786c0-4cf2-4ef7-845d-503806adfc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b2f5684-c014-47ea-8443-47ea584f8138" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_b20786c0-4cf2-4ef7-845d-503806adfc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20230401.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c64aa1c6-38d8-401f-8fa5-faa1f675daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fd202f97-d591-43a6-98e4-c505117a5f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c64aa1c6-38d8-401f-8fa5-faa1f675daf7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fd202f97-d591-43a6-98e4-c505117a5f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20230401.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4c4f9679-d790-4797-b274-3ece028e73ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0211b97d-eb0e-4bc5-b4b9-59733c9448cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4c4f9679-d790-4797-b274-3ece028e73ff" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0211b97d-eb0e-4bc5-b4b9-59733c9448cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77cbecf4-3e57-47c2-869f-a636c22da2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0a0f7c4e-c8dc-4afb-943e-bd56c9dabddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77cbecf4-3e57-47c2-869f-a636c22da2cc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0a0f7c4e-c8dc-4afb-943e-bd56c9dabddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_fa2c2f85-5e37-48c9-a54a-1b58f9d4d67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_04ff2c04-2356-447f-adaf-31b14a563016" xlink:href="holx-20230401.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_fa2c2f85-5e37-48c9-a54a-1b58f9d4d67d" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_04ff2c04-2356-447f-adaf-31b14a563016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_51d5d57d-b8c4-49b2-afd3-31d29c6e95a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8be16065-25e7-414d-a8e9-e7768ec487fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_51d5d57d-b8c4-49b2-afd3-31d29c6e95a3" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8be16065-25e7-414d-a8e9-e7768ec487fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20230401.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97c453a2-3bd5-41aa-9275-2aa291ef2d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ce0ab91a-4d25-4eab-90dd-a59ce7cbc6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97c453a2-3bd5-41aa-9275-2aa291ef2d9c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ce0ab91a-4d25-4eab-90dd-a59ce7cbc6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20230401.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_831088fc-5cb5-4e3a-9d66-eff96969e423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_405f5cf7-aba1-4503-ba0d-7b8a2c35fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_831088fc-5cb5-4e3a-9d66-eff96969e423" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_405f5cf7-aba1-4503-ba0d-7b8a2c35fa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20230401.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_7c7c50ef-e4c1-414c-9c81-1ccc0730adae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_4dfe9486-b749-4942-9289-a5e58b6bceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_7c7c50ef-e4c1-414c-9c81-1ccc0730adae" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_4dfe9486-b749-4942-9289-a5e58b6bceb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20230401.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_f3a2b0ba-5ff3-4919-b287-6432700c7213" xlink:href="holx-20230401.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_d35219c9-d7c5-40d1-90b6-e1c9182f0783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_f3a2b0ba-5ff3-4919-b287-6432700c7213" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_d35219c9-d7c5-40d1-90b6-e1c9182f0783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchase" xlink:type="simple" xlink:href="holx-20230401.xsd#ShareRepurchase"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchase" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_99c82d49-6e75-410b-97ae-cc03309a63b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e5d7fbb2-81c6-402a-aa52-800e54062cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99c82d49-6e75-410b-97ae-cc03309a63b0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e5d7fbb2-81c6-402a-aa52-800e54062cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b57dd254-e4cf-4924-a987-c3db95d78ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_de5c3f22-8872-4ee6-bb00-34a83ec93902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b57dd254-e4cf-4924-a987-c3db95d78ec6" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_de5c3f22-8872-4ee6-bb00-34a83ec93902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13bb4688-ac57-4da3-a8bd-9330f3b9db42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_56861a94-4649-4baa-9e88-53c670c80684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13bb4688-ac57-4da3-a8bd-9330f3b9db42" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_56861a94-4649-4baa-9e88-53c670c80684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8b4503f4-0c32-46ad-a207-2ff8a4bfb2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c38d4aee-3b91-4a32-aa1a-d797d4766fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8b4503f4-0c32-46ad-a207-2ff8a4bfb2dd" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c38d4aee-3b91-4a32-aa1a-d797d4766fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a9dae99c-ee3c-445c-9408-c54c81eac974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_31f49805-27ba-4d64-b12b-72e632758306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a9dae99c-ee3c-445c-9408-c54c81eac974" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_31f49805-27ba-4d64-b12b-72e632758306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20230401.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_dc6afb38-a5ed-477f-ad5d-50a2b8e003dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_35baad00-d50f-428b-b670-3828e53b925a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_dc6afb38-a5ed-477f-ad5d-50a2b8e003dd" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_35baad00-d50f-428b-b670-3828e53b925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_566d9049-d0ab-4036-a45f-ba056446c7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_1bdf8171-24c1-4880-87b6-9d889df0a09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_566d9049-d0ab-4036-a45f-ba056446c7aa" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_1bdf8171-24c1-4880-87b6-9d889df0a09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_fdcb6f4a-f2d2-4bea-9c0c-a4d82ab19f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_566d9049-d0ab-4036-a45f-ba056446c7aa" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_fdcb6f4a-f2d2-4bea-9c0c-a4d82ab19f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_31ee7211-b346-4831-8100-7b1c5ae19e2f" xlink:href="holx-20230401.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_566d9049-d0ab-4036-a45f-ba056446c7aa" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_31ee7211-b346-4831-8100-7b1c5ae19e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_295a8129-3a44-4045-8fef-612ed45a82de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_944cb008-61cc-49e0-9452-365818c13356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_295a8129-3a44-4045-8fef-612ed45a82de" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_944cb008-61cc-49e0-9452-365818c13356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_85bc6400-c3d3-4350-b2f5-fa3bc9f44bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_295a8129-3a44-4045-8fef-612ed45a82de" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_85bc6400-c3d3-4350-b2f5-fa3bc9f44bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fd6696b0-5ad7-47e3-bf31-4d8854764d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_295a8129-3a44-4045-8fef-612ed45a82de" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fd6696b0-5ad7-47e3-bf31-4d8854764d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20230401.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_23f2218d-c9d2-4ac5-8c53-3339dcc6823a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cf96b1ea-c972-4028-9984-ba09924aebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_23f2218d-c9d2-4ac5-8c53-3339dcc6823a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cf96b1ea-c972-4028-9984-ba09924aebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_627fb635-5ef1-430b-99b7-a69df9702073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_89017265-6e00-4027-bf92-af4371a797a3" xlink:href="holx-20230401.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_627fb635-5ef1-430b-99b7-a69df9702073" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_89017265-6e00-4027-bf92-af4371a797a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bbb674bc-faf4-4664-a867-643828ebc1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_627fb635-5ef1-430b-99b7-a69df9702073" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bbb674bc-faf4-4664-a867-643828ebc1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6dd38b17-528e-4a65-89e4-171fa5ab1cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f8df2958-753b-4b9e-8211-422affc728e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6dd38b17-528e-4a65-89e4-171fa5ab1cbb" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f8df2958-753b-4b9e-8211-422affc728e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5a912e5d-b8c3-4304-97b2-24160aa99762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6dd38b17-528e-4a65-89e4-171fa5ab1cbb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5a912e5d-b8c3-4304-97b2-24160aa99762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b48e9d82-55a7-4324-83ca-56b1889ac575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8efe68df-bce0-4a03-a86c-447c6861a2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b48e9d82-55a7-4324-83ca-56b1889ac575" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8efe68df-bce0-4a03-a86c-447c6861a2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_15292f47-6c2d-474c-85da-3c87feb1e126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b48e9d82-55a7-4324-83ca-56b1889ac575" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_15292f47-6c2d-474c-85da-3c87feb1e126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20230401.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d6b6d6a2-55c3-4f35-81be-605d51f7a84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_02be4e3c-e09f-4e7c-bc73-a0a623670881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d6b6d6a2-55c3-4f35-81be-605d51f7a84f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_02be4e3c-e09f-4e7c-bc73-a0a623670881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9d8ea60a-9e78-48c4-af0e-03869832774f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d6b6d6a2-55c3-4f35-81be-605d51f7a84f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9d8ea60a-9e78-48c4-af0e-03869832774f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20230401.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_9d21c1d1-cb03-4e7e-922c-751bf9701072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_63ca49fd-e4c1-4941-988b-8c5447004011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_9d21c1d1-cb03-4e7e-922c-751bf9701072" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_63ca49fd-e4c1-4941-988b-8c5447004011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20230401.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_632e39e9-4894-4f70-8b48-d712479d541a" xlink:href="holx-20230401.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dc7d2982-fcdb-46a6-97a2-80a9e65b26f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_632e39e9-4894-4f70-8b48-d712479d541a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dc7d2982-fcdb-46a6-97a2-80a9e65b26f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3205fde7-de43-4b83-8862-3ef0e839217e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3205fde7-de43-4b83-8862-3ef0e839217e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_638fc54c-e51a-4bba-a5a1-9078b1e595a7" xlink:to="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_3cb56dc7-526f-422b-9e3e-9b9f61ec4130" xlink:href="holx-20230401.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_DiagnosticsMember_3cb56dc7-526f-422b-9e3e-9b9f61ec4130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_7e334019-8012-4c41-8a22-e5dec03f14db" xlink:href="holx-20230401.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_BreastHealthMember_7e334019-8012-4c41-8a22-e5dec03f14db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_04f2c5d6-5d2f-4e3e-b206-29bc6f9fe5e2" xlink:href="holx-20230401.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_GynSurgicalMember_04f2c5d6-5d2f-4e3e-b206-29bc6f9fe5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_30cb04dc-a771-4e45-82b2-ca3c208b77e3" xlink:href="holx-20230401.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4c09706f-1996-4ef3-8690-084e6e59e386" xlink:to="loc_holx_SkeletalHealthMember_30cb04dc-a771-4e45-82b2-ca3c208b77e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_768513d8-5c1a-4fd2-bd67-416ff059913d" xlink:to="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_04191d4a-6978-42fb-aff8-ff97301871e1" xlink:href="holx-20230401.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_CytologyPerinatalMember_04191d4a-6978-42fb-aff8-ff97301871e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_3395a887-d45e-444f-81f9-b94cb5dca76e" xlink:href="holx-20230401.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_MolecularDiagnosticsMember_3395a887-d45e-444f-81f9-b94cb5dca76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_b5751446-a2dd-4158-8a82-87c790c41750" xlink:href="holx-20230401.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_BloodScreeningMember_b5751446-a2dd-4158-8a82-87c790c41750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_c2cae714-e357-40e3-8e87-17e17f8a12f2" xlink:href="holx-20230401.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_BreastImagingMember_c2cae714-e357-40e3-8e87-17e17f8a12f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_b8521076-7326-4aee-abb4-83c185dc9809" xlink:href="holx-20230401.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3c044ff-19b1-4c82-8d59-e24b8f3fd346" xlink:to="loc_holx_InterventionalBreastSolutionsMember_b8521076-7326-4aee-abb4-83c185dc9809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_21726ebb-5999-49f8-880b-e9c1631009d1" xlink:to="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4e600496-5d19-4c16-be00-75c51061383e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:to="loc_country_US_4e600496-5d19-4c16-be00-75c51061383e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_9fb7608f-5cf9-4b97-b191-8fd8aceee77b" xlink:href="holx-20230401.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d262094c-dedc-4992-a564-fd1a7600cc30" xlink:to="loc_holx_InternationalMember_9fb7608f-5cf9-4b97-b191-8fd8aceee77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_83633e75-e6c5-45b2-90d0-382a64aa5c85" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ac275423-0b23-4abb-aa66-4f16d81c1bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4de575ae-52a4-4ea1-810d-6470fe252f47" xlink:to="loc_us-gaap_Revenues_ac275423-0b23-4abb-aa66-4f16d81c1bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06cd61a9-ab57-4018-a34a-a3c3517e27eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06cd61a9-ab57-4018-a34a-a3c3517e27eb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:to="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b6630d78-0c2d-48b2-ab86-5c0d3bc04642" xlink:to="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_768eb9ce-16ad-4b44-82ae-676036bb9b7b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_country_US_768eb9ce-16ad-4b44-82ae-676036bb9b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6c190312-eecc-4fbb-8dc2-a51b8f9d900b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_srt_EuropeMember_6c190312-eecc-4fbb-8dc2-a51b8f9d900b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_3916f36f-2d2d-4f94-82e6-d6da6d6f53ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_srt_AsiaPacificMember_3916f36f-2d2d-4f94-82e6-d6da6d6f53ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_a0fed5d4-df9b-4b19-b4bf-0f1e6c9c452c" xlink:href="holx-20230401.xsd#holx_RestofWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_591adf1b-c49a-41f6-8f4e-a4a5a1fd708b" xlink:to="loc_holx_RestofWorldMember_a0fed5d4-df9b-4b19-b4bf-0f1e6c9c452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_97fe3a19-1b88-439e-8589-3690b4caa2ac" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ebc4b346-c82e-4db4-a1a8-bb1a24a0f14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8548c86f-b341-459f-92b3-c7d188fd5808" xlink:to="loc_us-gaap_Revenues_ebc4b346-c82e-4db4-a1a8-bb1a24a0f14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cac0f36f-ba1b-4363-a42c-b84397fb1468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cac0f36f-ba1b-4363-a42c-b84397fb1468" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:to="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3acfe1d2-4110-4922-ac3b-d9a58ed67256" xlink:to="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_581b4824-7c14-4ae3-8f26-69a74ca06d36" xlink:href="holx-20230401.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_ConsumablesMember_581b4824-7c14-4ae3-8f26-69a74ca06d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4fc8e075-23b3-4228-ac5e-54e2300a4d8a" xlink:href="holx-20230401.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4fc8e075-23b3-4228-ac5e-54e2300a4d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ab83acd2-890a-40f5-82ea-48820e94483a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_us-gaap_ServiceMember_ab83acd2-890a-40f5-82ea-48820e94483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_bdb0190b-6526-462a-912a-8dcdfe8852a4" xlink:href="holx-20230401.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_00b0b84b-0416-4ea4-9d5a-5c6684abe8c4" xlink:to="loc_holx_OtherTypeofRevenueMember_bdb0190b-6526-462a-912a-8dcdfe8852a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_46f106d4-a7a0-43fb-8ef4-5783ae9a2b0a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e5163fa-276d-4b87-9784-f4255d195ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3e17989b-c81d-4d93-8691-3a70f3589a62" xlink:to="loc_us-gaap_Revenues_2e5163fa-276d-4b87-9784-f4255d195ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9ed5bea3-e9f8-4726-be31-bb88a44b0f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cac0f36f-ba1b-4363-a42c-b84397fb1468" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9ed5bea3-e9f8-4726-be31-bb88a44b0f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f162cb9-f687-40ba-a119-641aeeded79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_8d31146a-5dd5-4c02-b424-6d00038a7f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f162cb9-f687-40ba-a119-641aeeded79a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_8d31146a-5dd5-4c02-b424-6d00038a7f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0c50470b-0439-45bc-b7d7-474e534427f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f162cb9-f687-40ba-a119-641aeeded79a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0c50470b-0439-45bc-b7d7-474e534427f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07b847fd-1110-4a15-bc69-7595031be8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07b847fd-1110-4a15-bc69-7595031be8f2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7382cccf-c102-4666-8557-116bf6f84835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7382cccf-c102-4666-8557-116bf6f84835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5a3f9321-2e18-467a-a033-97836c43c726" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1dcbf88b-516c-406d-865b-7d6eb60f0872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bd7e5695-c24a-4664-95ac-85125cebcd36" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8e301651-cdd7-4c0d-b208-83ebf7f79b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20230401.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e78d44a8-55a3-4131-b492-7c1ae158c46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_5fff3032-f32e-471c-8058-4a6310e55007" xlink:href="holx-20230401.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e78d44a8-55a3-4131-b492-7c1ae158c46f" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_5fff3032-f32e-471c-8058-4a6310e55007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_edaa3bfc-805c-4ce8-a2d6-f77c8225ae16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_edaa3bfc-805c-4ce8-a2d6-f77c8225ae16" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ceb4f825-63e3-439b-903e-0c4ba4823627" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9099202c-7efe-481d-821b-ae18f73e736b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9099202c-7efe-481d-821b-ae18f73e736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fa473a81-4d01-44b5-a6e3-bdfe29010954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fa473a81-4d01-44b5-a6e3-bdfe29010954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8274878f-7035-4a13-8033-e28e4fdc6618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c73f226-41ad-4312-9ca0-4c631b3a4a2e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8274878f-7035-4a13-8033-e28e4fdc6618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d182aa94-0a5b-4f7e-bbea-628f5226677d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3934ca14-dd43-48ab-a723-b91726b8b333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_InterestRateSwapMember_3934ca14-dd43-48ab-a723-b91726b8b333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_3906030b-e0bf-4b0b-80f9-635276257bfd" xlink:href="holx-20230401.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_holx_ContingentConsiderationMember_3906030b-e0bf-4b0b-80f9-635276257bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f63ed70c-abc5-4295-b234-fe0ab0e89832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f63ed70c-abc5-4295-b234-fe0ab0e89832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_50c9b3c4-e21c-4033-8ce7-056ed0028e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_14b5363d-e7a6-4880-a1ea-f25c2d656d0e" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_50c9b3c4-e21c-4033-8ce7-056ed0028e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e026e567-5423-4c9e-b14b-8958235f122e" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3ef7bc1b-5337-4010-87bd-43640c8b34bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_06ce75ef-d503-49f9-a45d-f9a78e42449f" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3ef7bc1b-5337-4010-87bd-43640c8b34bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b875a68a-b8ce-4248-91e7-0bad5ac39315" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_54a5e1ae-c858-4898-84a4-73ab6ddfc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88cd0d54-213c-4c1f-bf6e-db654a01c400" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_54a5e1ae-c858-4898-84a4-73ab6ddfc0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2f22c47d-5bdc-4085-a838-7a4bb9e69eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2f22c47d-5bdc-4085-a838-7a4bb9e69eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_c99d88ea-231d-430b-8d10-ee4c96b54689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_c99d88ea-231d-430b-8d10-ee4c96b54689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6c4d5b45-de2d-41c8-bdeb-3027397a76e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6c4d5b45-de2d-41c8-bdeb-3027397a76e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_abc6c6f3-acdf-4836-aff2-7d3af8d61c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_abc6c6f3-acdf-4836-aff2-7d3af8d61c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_71ba0c8e-c541-4f07-a647-ac206a6cd8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed625dab-1a40-409d-962c-c2c813ad15f0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_71ba0c8e-c541-4f07-a647-ac206a6cd8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_09b0219e-34cb-44d4-9258-0f63e873c49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_09b0219e-34cb-44d4-9258-0f63e873c49c" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fb58e5f-76ce-4c50-b700-dd122d25237a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_19f028a8-f024-4cfe-8d2a-0bb657bef54b" xlink:href="holx-20230401.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_CreditAgreementMember_19f028a8-f024-4cfe-8d2a-0bb657bef54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_8a12b37a-dec8-45e7-a3c7-dd048f415cdc" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_A2028SeniorNotesMember_8a12b37a-dec8-45e7-a3c7-dd048f415cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_317cf862-af1e-41df-a328-1b6e68797dfb" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49d8ffa0-f30b-4cdf-a706-ff95a0fe5651" xlink:to="loc_holx_A2029SeniorNotesMember_317cf862-af1e-41df-a328-1b6e68797dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c960055-4927-4b7b-9a5e-f204b1220d28" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_e7c8a9bb-0bd5-4cd2-bee0-cb56b6da4f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1ee1fd27-420b-4a6e-9a26-4977351225ec" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_e7c8a9bb-0bd5-4cd2-bee0-cb56b6da4f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f1ac0ab-0045-4d70-ab67-41c4fc184bcb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9c09f384-0af3-4c10-ac7a-a4ab14a695ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bc3f5059-85c1-422e-a75e-5a8feb3e7d05" xlink:to="loc_us-gaap_SeniorNotesMember_9c09f384-0af3-4c10-ac7a-a4ab14a695ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7d9a63d1-d55b-47e5-bbd4-0fd621957e31" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_9c1d332f-e8de-4cf8-b492-bf12eb15c35f" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:to="loc_holx_A2028SeniorNotesMember_9c1d332f-e8de-4cf8-b492-bf12eb15c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_702f8a0a-05c3-480e-8378-73b915f2024d" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab03a1f9-6313-4baf-aabf-b4336ca18c15" xlink:to="loc_holx_A2029SeniorNotesMember_702f8a0a-05c3-480e-8378-73b915f2024d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_b4f1ead2-a8b5-405d-b9c3-60b6c4914148" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_cd8f04b7-18c3-42ef-8a94-e910a765cb00" xlink:href="holx-20230401.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_holx_PrincipalAmountOfBorrowings_cd8f04b7-18c3-42ef-8a94-e910a765cb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad47e38-0aaf-4b9f-8f54-b3efebef9cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad47e38-0aaf-4b9f-8f54-b3efebef9cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f6a10b76-6299-40da-8c04-3c0a4b82565f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f6a10b76-6299-40da-8c04-3c0a4b82565f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_b1ebe7d9-f9d7-4205-99d5-f52bceeb3238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_c2e013b4-ae96-4f7e-bef4-9810705ebc97" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_b1ebe7d9-f9d7-4205-99d5-f52bceeb3238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d3ecdf30-6b14-4c1b-ab44-e8afea9e08dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d3ecdf30-6b14-4c1b-ab44-e8afea9e08dd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3c228d19-b9bf-483b-8dae-3dce9b34bf44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_547ddd1c-b9f9-496c-a28f-5f1af798705d" xlink:href="holx-20230401.xsd#holx_BolderSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:to="loc_holx_BolderSurgicalMember_547ddd1c-b9f9-496c-a28f-5f1af798705d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_6363b80a-11be-48c4-a1ac-015cc8a33f08" xlink:href="holx-20230401.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e80052eb-7708-4526-b73b-07ec8dee4552" xlink:to="loc_holx_AcessaHealthMember_6363b80a-11be-48c4-a1ac-015cc8a33f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd6463b0-e34c-439e-bf1c-01eef645c9ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_af6568ec-3434-46ff-978a-dad054df9c3d" xlink:href="holx-20230401.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_holx_DevelopedTechnologyMember_af6568ec-3434-46ff-978a-dad054df9c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5d4c9806-3979-4ed9-8d73-7644a910fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5d4c9806-3979-4ed9-8d73-7644a910fd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e3bca05b-b8c1-41f9-a5bf-937902d1e165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d2d54c-2993-44ce-9cdb-32c87fe864d8" xlink:to="loc_us-gaap_TradeNamesMember_e3bca05b-b8c1-41f9-a5bf-937902d1e165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d04b64ff-6c57-4c6a-9f5e-373f9fb50616" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2ec5de65-ca2f-4238-9f7c-a88ca91b7274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2ec5de65-ca2f-4238-9f7c-a88ca91b7274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_be41b59a-bf1f-4716-9184-5c6d9001e334" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_be41b59a-bf1f-4716-9184-5c6d9001e334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d2106da1-8bd9-4bb8-9434-a7aa0d79d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d2106da1-8bd9-4bb8-9434-a7aa0d79d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_19267a4c-6d23-453f-a055-da6871d90bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_19267a4c-6d23-453f-a055-da6871d90bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_dde15ab9-ba82-443f-bbdd-3ae65b4b667b" xlink:href="holx-20230401.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_dde15ab9-ba82-443f-bbdd-3ae65b4b667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_95deafdf-78b8-4020-951b-c10a69e1fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_95deafdf-78b8-4020-951b-c10a69e1fde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments_8f36c2dc-8e02-4ec1-b44c-00e447ee5052" xlink:href="holx-20230401.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_009866ee-bf36-461c-8389-f83cddab7dc3" xlink:to="loc_holx_BusinessCombinationContingentConsiderationPayments_8f36c2dc-8e02-4ec1-b44c-00e447ee5052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_34e9f4be-da77-42d0-a7a0-68438745efdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_34e9f4be-da77-42d0-a7a0-68438745efdb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aca1a703-766d-42fa-83b2-6bed1372abd3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_90021baa-3646-4582-b16f-1548dadd782f" xlink:href="holx-20230401.xsd#holx_BolderSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91f2f56d-8f30-43c0-bf74-6a699a77a1cb" xlink:to="loc_holx_BolderSurgicalMember_90021baa-3646-4582-b16f-1548dadd782f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36f02105-06ad-4f7c-a448-4c3c2eb6b50b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_695c1b78-c0e7-4b78-9fb5-b01fef5e7096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_695c1b78-c0e7-4b78-9fb5-b01fef5e7096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_12f314f4-7ac6-44a4-8f93-dea382095132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_12f314f4-7ac6-44a4-8f93-dea382095132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4557aed1-4de4-49e8-aedc-5b638eaee570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4557aed1-4de4-49e8-aedc-5b638eaee570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_800d1047-09cc-4571-aab7-0695c8b5c934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_800d1047-09cc-4571-aab7-0695c8b5c934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d68f245a-06ab-43c5-87e1-05f45258bda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d68f245a-06ab-43c5-87e1-05f45258bda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_7960f7e5-5198-4c22-be93-59982f000787" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_7960f7e5-5198-4c22-be93-59982f000787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e791b43-bc30-4da6-99a2-5740da6e034f" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e791b43-bc30-4da6-99a2-5740da6e034f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a3b8aadb-8f62-42a5-8621-3a041b1c43ee" xlink:href="holx-20230401.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a3b8aadb-8f62-42a5-8621-3a041b1c43ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_22b951e6-9724-40a3-ba82-8c4868de9b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_22b951e6-9724-40a3-ba82-8c4868de9b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bd6ea462-e437-45e7-a046-6dce16563c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_Goodwill_bd6ea462-e437-45e7-a046-6dce16563c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_037c19d4-5f8f-4c30-bdce-77b09df6ce06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_69f4aba0-3815-43b5-95c3-219601d5d9cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_037c19d4-5f8f-4c30-bdce-77b09df6ce06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e3c562af-f191-4c30-a018-61b9b889612c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e3c562af-f191-4c30-a018-61b9b889612c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7d3f08e5-8680-45a8-9b51-03ce220112d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7d3f08e5-8680-45a8-9b51-03ce220112d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_4bd480c5-26ca-4508-9c25-a7e2ad244263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_4bd480c5-26ca-4508-9c25-a7e2ad244263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1db34fca-8685-496c-b289-c1393a2cbd01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1db34fca-8685-496c-b289-c1393a2cbd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_84a14bcf-ace6-47a5-a1cb-fc5f888a2c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a4252d7a-d6fc-4f3a-a34f-d73978c2b981" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_84a14bcf-ace6-47a5-a1cb-fc5f888a2c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#RestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract_497dd9ce-6dee-4672-9fb3-f9ee66ceaa49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9418234b-7e47-477a-8bc6-d79ca0cb2098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_497dd9ce-6dee-4672-9fb3-f9ee66ceaa49" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9418234b-7e47-477a-8bc6-d79ca0cb2098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_497dd9ce-6dee-4672-9fb3-f9ee66ceaa49" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:to="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0bf313ff-10f1-4a60-8ffb-f0b32f53f766" xlink:to="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember_31d9d5b6-e857-416c-b218-b72c8406fdb1" xlink:href="holx-20230401.xsd#holx_DanburyClosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:to="loc_holx_DanburyClosureMember_31d9d5b6-e857-416c-b218-b72c8406fdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GermanyPlanMember_7d36a450-06f6-4d2c-a3e6-5f4b7f8c3791" xlink:href="holx-20230401.xsd#holx_GermanyPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a4c3d9cd-b703-465c-8adf-a5f4d2c78e08" xlink:to="loc_holx_GermanyPlanMember_7d36a450-06f6-4d2c-a3e6-5f4b7f8c3791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4616d8d7-ccec-414c-9dcb-af4a1b9ee9b4" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_0663afc5-7835-4567-a4a4-dc508e91ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_0663afc5-7835-4567-a4a4-dc508e91ef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f2db892d-0afe-4a7f-b5df-f733ecc64dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_77f909b6-2934-4cce-8ab4-227acee41403" xlink:to="loc_us-gaap_RestructuringCharges_f2db892d-0afe-4a7f-b5df-f733ecc64dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a38f6ee2-30c4-462d-8ee1-8e7c444bcf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a38f6ee2-30c4-462d-8ee1-8e7c444bcf0c" xlink:to="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff3f5d3f-f5a0-4374-88ee-c74481ed2b7f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_952578c5-9f6b-49ad-b010-aa499140fbdb" xlink:href="holx-20230401.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_TermLoanMember_952578c5-9f6b-49ad-b010-aa499140fbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_943eb93a-e682-4068-86fc-4d3c08b47f0a" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_A2028SeniorNotesMember_943eb93a-e682-4068-86fc-4d3c08b47f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_640c6df2-85e9-47ff-93ef-e73c2ae4dbb3" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56bad03f-0ba0-41e2-8f8a-a2ebb6c198f6" xlink:to="loc_holx_A2029SeniorNotesMember_640c6df2-85e9-47ff-93ef-e73c2ae4dbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b918df73-c9e7-4004-9499-e4983146eb46" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b0b7e9af-e808-444a-a86c-b4a689d78182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebtCurrent_b0b7e9af-e808-444a-a86c-b4a689d78182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_93fd9a3a-42b3-41db-a643-00c415a02121" xlink:href="holx-20230401.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_93fd9a3a-42b3-41db-a643-00c415a02121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d8bff875-53bd-4adf-865c-dbe965d2464c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d8bff875-53bd-4adf-865c-dbe965d2464c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_83cefaae-c1d6-4dc8-ad6e-90e1d43b3e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4ce6b28d-5c44-4424-99b4-3b748e52a38a" xlink:to="loc_us-gaap_LongTermDebt_83cefaae-c1d6-4dc8-ad6e-90e1d43b3e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c57e4ba-62e6-4084-a1c5-11b13fe46c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c57e4ba-62e6-4084-a1c5-11b13fe46c16" xlink:to="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64358cfc-5596-4f6e-84b5-106e01722046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_f665ddbb-9706-446a-8461-9f281e697514" xlink:href="holx-20230401.xsd#holx_SecuredTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_SecuredTermLoanMember_f665ddbb-9706-446a-8461-9f281e697514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_9eed4dfd-f617-4277-98de-c1b692a9d160" xlink:href="holx-20230401.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_RevolverMember_9eed4dfd-f617-4277-98de-c1b692a9d160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_be7933b3-26b0-4e82-a2b2-0cd2bf029fc3" xlink:href="holx-20230401.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_TermLoanMember_be7933b3-26b0-4e82-a2b2-0cd2bf029fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3ae663dc-293d-4862-a1f1-d94c356f601e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_us-gaap_SeniorNotesMember_3ae663dc-293d-4862-a1f1-d94c356f601e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember_9712d112-fb5b-456c-8f0b-23599025b8a2" xlink:href="holx-20230401.xsd#holx_AssetSecuritizationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_51d6b3ee-83c4-4ddf-9f60-66446d2680ba" xlink:to="loc_holx_AssetSecuritizationMember_9712d112-fb5b-456c-8f0b-23599025b8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_008d9065-f07c-432a-9c8e-be6835bc3778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_982efde7-b315-4653-b414-b8a75562400e" xlink:href="holx-20230401.xsd#holx_A2021TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021TermLoanMember_982efde7-b315-4653-b414-b8a75562400e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_3f1d41b9-8a67-49ee-8d16-a6b6575c878f" xlink:href="holx-20230401.xsd#holx_A2021RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021RevolverMember_3f1d41b9-8a67-49ee-8d16-a6b6575c878f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_9679c42f-dc6c-48a0-9a2e-d8e2995414ec" xlink:href="holx-20230401.xsd#holx_A2021CreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2021CreditAgreementMember_9679c42f-dc6c-48a0-9a2e-d8e2995414ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3f6f7ea5-119e-4e8c-a1fa-96e67e2991f5" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2028SeniorNotesMember_3f6f7ea5-119e-4e8c-a1fa-96e67e2991f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_cbdcc6f3-4e93-4f1e-85e6-cdfbe981afdd" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_209c3715-eaa5-4e99-aa98-e72817ff0367" xlink:to="loc_holx_A2029SeniorNotesMember_cbdcc6f3-4e93-4f1e-85e6-cdfbe981afdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ec3622d-05b3-4882-bdc3-280881d9a28a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4b42923b-ede4-45e9-9bed-a7b8da270813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6e5d6ca8-724d-4685-80fe-2a83beb3316e" xlink:to="loc_us-gaap_InterestRateSwapMember_4b42923b-ede4-45e9-9bed-a7b8da270813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3f8ee148-07cb-45d3-9a14-0bc8e67318b0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_188f1d9c-a4ff-4c12-a118-1b7a1435d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_188f1d9c-a4ff-4c12-a118-1b7a1435d399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c6152133-0e26-4573-b2ec-7f69f8ddcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c6152133-0e26-4573-b2ec-7f69f8ddcb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5c0a7b7d-6683-43ea-99db-b45666fd8425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5c0a7b7d-6683-43ea-99db-b45666fd8425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1abf7abe-9e2a-43ea-a5af-8a9548fee412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1abf7abe-9e2a-43ea-a5af-8a9548fee412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7c3a4aae-1011-4f2e-afee-fa34ac77329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7c3a4aae-1011-4f2e-afee-fa34ac77329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_fdcaea68-8ed0-47c6-bca2-bb90241699d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_fdcaea68-8ed0-47c6-bca2-bb90241699d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_86ae2c20-a941-4c3a-ad1c-be02ee044a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_86ae2c20-a941-4c3a-ad1c-be02ee044a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_5d4d4c00-8ca4-4959-a43a-7af7f5b8eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_SeniorNotes_5d4d4c00-8ca4-4959-a43a-7af7f5b8eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_b3649e99-6233-4f91-a849-82eb0b54376d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_b3649e99-6233-4f91-a849-82eb0b54376d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_4e117bbb-ed4d-4c01-bad6-1a6244536685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_97f2f3f7-e582-4cb9-a8b4-c09706965d1f" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_4e117bbb-ed4d-4c01-bad6-1a6244536685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_09ef0888-809e-4893-ba97-222e2032354a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09ef0888-809e-4893-ba97-222e2032354a" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f780e1a-09af-4327-8754-b0296332a88f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_e3113ced-b6c5-4b46-b897-15a97d4a448c" xlink:href="holx-20230401.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c172af3-f9f7-464c-a9c8-2118b753748a" xlink:to="loc_holx_CreditAgreementMember_e3113ced-b6c5-4b46-b897-15a97d4a448c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_26e42006-6561-4caf-998b-c7a03dd66c2b" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_9a6e73fd-2b6c-40df-a2b0-d4e1a450590c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_InterestExpenseBorrowings_9a6e73fd-2b6c-40df-a2b0-d4e1a450590c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_fa1e31c6-fc82-4f57-ab66-6d3479e62219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_fa1e31c6-fc82-4f57-ab66-6d3479e62219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_613d3384-e7c8-44e6-82b2-f8e048a0b214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ccc78407-e69f-47d5-afbb-86e5397c9b72" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_613d3384-e7c8-44e6-82b2-f8e048a0b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_27cb0b4e-8e67-4f91-b582-3f33fd8878a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_27cb0b4e-8e67-4f91-b582-3f33fd8878a1" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb713d58-172f-4814-9313-45133388e7dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_db401452-b16d-49a2-a4b9-2fe51c987a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43653b47-bf1f-4175-bcfe-3f4123df941b" xlink:to="loc_us-gaap_SeniorNotesMember_db401452-b16d-49a2-a4b9-2fe51c987a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8412816-6042-43c8-93e2-0470fbd2dad8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ac35cda9-5efe-4796-8da1-98cfc9f96fd3" xlink:href="holx-20230401.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2028SeniorNotesMember_ac35cda9-5efe-4796-8da1-98cfc9f96fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b318ba7b-1d84-4b7b-9c8f-e47fc3e68382" xlink:href="holx-20230401.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2029SeniorNotesMember_b318ba7b-1d84-4b7b-9c8f-e47fc3e68382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember_3123b445-c8f9-4ae6-b0bb-d58f98448752" xlink:href="holx-20230401.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd5e4e02-68ee-46de-8b50-8590e9500e7a" xlink:to="loc_holx_A2028And2029SeniorNotesMember_3123b445-c8f9-4ae6-b0bb-d58f98448752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7d833d44-3ca6-4add-a1fc-6b3f77656064" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_450a6dfa-27cb-482c-8025-9ba90b5ce5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_450a6dfa-27cb-482c-8025-9ba90b5ce5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_e0d13a95-7619-4286-a1c6-1237a57e7d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5941b350-409e-4eea-9b8b-b4bf50553263" xlink:to="loc_us-gaap_InterestExpenseBorrowings_e0d13a95-7619-4286-a1c6-1237a57e7d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b3f1a90a-892c-4601-b6d2-065ddc4abf86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b3f1a90a-892c-4601-b6d2-065ddc4abf86" xlink:to="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fc61f57c-0054-40a1-a38e-dc237071b21a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_42f29553-d635-4727-8c51-b5dcd6cc7f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_InterestRateSwapMember_42f29553-d635-4727-8c51-b5dcd6cc7f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_84d178a0-50fc-43a8-8f04-1c27ee583005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_84d178a0-50fc-43a8-8f04-1c27ee583005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_3700129e-6b53-4f37-8c59-6680a9fcf6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_us-gaap_ForwardContractsMember_3700129e-6b53-4f37-8c59-6680a9fcf6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2023Member_6f8102c8-3a58-4115-911b-cb36f10d3ef1" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_holx_InterestRateSwap2023Member_6f8102c8-3a58-4115-911b-cb36f10d3ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateSwap2024Member_59c1232c-05ef-4fe5-9b20-6a52e73992b4" xlink:href="holx-20230401.xsd#holx_InterestRateSwap2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a58103a-951b-45e3-9476-c1a84be5d539" xlink:to="loc_holx_InterestRateSwap2024Member_59c1232c-05ef-4fe5-9b20-6a52e73992b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bfb3ee60-c42a-4ffc-9ba0-2ea342c840d2" xlink:to="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_40c05c63-f4cf-4097-ab73-dcbe949e4e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_DerivativeNotionalAmount_40c05c63-f4cf-4097-ab73-dcbe949e4e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_048cd820-2444-45e8-aeb9-a5d13236607d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_048cd820-2444-45e8-aeb9-a5d13236607d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_3cab03ec-2a87-4ab9-9966-914b172a6d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_3cab03ec-2a87-4ab9-9966-914b172a6d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_70a1b4aa-d7e2-4296-a8e8-08fb00f037f7" xlink:href="holx-20230401.xsd#holx_NotationalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_holx_NotationalAmount_70a1b4aa-d7e2-4296-a8e8-08fb00f037f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_488a3cd2-32c1-412f-91f7-e2018006b065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_80b8d7f3-38dd-4fea-8117-e87869b7c452" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_488a3cd2-32c1-412f-91f7-e2018006b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb13804b-5958-424d-933c-e4d8a1a229d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb13804b-5958-424d-933c-e4d8a1a229d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8324a55a-f4b3-421f-85cb-8f9cd9c583cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1922858e-e980-4306-9ae7-45721376374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1922858e-e980-4306-9ae7-45721376374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_7d705783-0801-44e5-83ae-3fb9d2d742de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5653bfca-c79b-4977-8d73-b7953f0e81e0" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_7d705783-0801-44e5-83ae-3fb9d2d742de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:to="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d81829bd-b96d-421b-ac0b-9769fba89daa" xlink:to="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ec89f626-94bd-4c9e-907e-d62d86c61de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4f28e390-4f87-4499-a649-bbb8bdd1cd7e" xlink:to="loc_us-gaap_NondesignatedMember_ec89f626-94bd-4c9e-907e-d62d86c61de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7738dbf8-7753-4cce-bd91-eab32e078dc0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea273a3-b8ee-40a8-abcc-db01a8352b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea273a3-b8ee-40a8-abcc-db01a8352b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_3a39c7c5-1741-479e-aa4d-43877f7395be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_3a39c7c5-1741-479e-aa4d-43877f7395be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a424150f-9e44-490d-94d8-99e17b76e5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4750f74a-6212-4ec3-bd5c-ad2514856b59" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a424150f-9e44-490d-94d8-99e17b76e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a7ee026c-fcd5-4816-bb5b-55d7400927f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a7ee026c-fcd5-4816-bb5b-55d7400927f1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5b2c691-583d-4640-89f0-9b82d6735134" xlink:to="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6b2072d-8eb1-45d1-8f47-866afbcf71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6b2072d-8eb1-45d1-8f47-866afbcf71ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_262dbc38-9bdb-496d-a668-a659038a47b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b8249eef-98fa-47e5-a28f-a5731448e4dc" xlink:to="loc_us-gaap_NondesignatedMember_262dbc38-9bdb-496d-a668-a659038a47b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a1839f-5e20-45fe-a32f-e647c9d1e1bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d4140c55-3416-4099-851d-8ad8d872d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_InterestRateCapMember_d4140c55-3416-4099-851d-8ad8d872d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_44efdf5e-10fe-474f-94fe-fb685932def8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_InterestRateSwapMember_44efdf5e-10fe-474f-94fe-fb685932def8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d5427860-a999-46de-8358-3b0188af0af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d5427860-a999-46de-8358-3b0188af0af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_3af28bc0-88a3-4183-b730-d690a8227233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d67ab1b-d5b9-48d0-9d8c-3cb078fdbcaf" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_3af28bc0-88a3-4183-b730-d690a8227233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_169f19b9-4bed-4acf-9233-509b197a8be8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_5ecb9a3b-d8c5-478f-8855-fceb1e2d19e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_5ecb9a3b-d8c5-478f-8855-fceb1e2d19e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61043563-df59-43a6-9363-93c49cc429c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_61043563-df59-43a6-9363-93c49cc429c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea4593a2-1c62-4e95-a4ba-6d0dece873d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea4593a2-1c62-4e95-a4ba-6d0dece873d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c78b608f-55d9-4540-8b65-bfa522ee4988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cf0af34-a125-4ffb-a225-b0243e28092b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c78b608f-55d9-4540-8b65-bfa522ee4988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b72d2f1d-8e40-4d28-9763-7e4da342b55b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bfe91f37-c3de-4141-84f6-32e5497e4884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_bfe91f37-c3de-4141-84f6-32e5497e4884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5e205232-08bb-408d-b151-5b5be9048569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_79501c17-fd53-478a-98aa-f2e763aa90f5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5e205232-08bb-408d-b151-5b5be9048569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4875abea-c4bd-41aa-b392-646818c4f02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4875abea-c4bd-41aa-b392-646818c4f02d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b5887d61-2f59-4f7d-acb8-56e7ffdee736" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_06a86d58-5720-4848-8e43-aadb2b4b7693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_31193325-d69d-42dc-9978-1c38cef838bd" xlink:to="loc_us-gaap_InterestRateSwapMember_06a86d58-5720-4848-8e43-aadb2b4b7693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5f5925a9-ad6b-4799-8a31-6c36e3d9bfa6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5fbf23a6-f77c-4fe7-bd44-7ae1eba2ab03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7325e91b-f815-44df-ac5b-f440869e5099" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5fbf23a6-f77c-4fe7-bd44-7ae1eba2ab03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#CommitmentsandContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_255e162a-63e8-4ba9-bd1f-1d1f73c87dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_255e162a-63e8-4ba9-bd1f-1d1f73c87dcd" xlink:to="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:to="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e36d4892-9786-4b60-b09d-f1dd875c3fed" xlink:to="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_dd06b649-eba9-41ee-b19a-3c0c81ad20ba" xlink:href="holx-20230401.xsd#holx_MinervaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d2a3be72-f51d-430a-b432-0f69dd1842c7" xlink:to="loc_holx_MinervaMember_dd06b649-eba9-41ee-b19a-3c0c81ad20ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ad2bfad6-795a-4e4c-96f3-29efee4d6503" xlink:to="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_bfa30918-3b2f-472e-8133-7414248270fb" xlink:href="holx-20230401.xsd#holx_AmountAssessedInDamages"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_holx_AmountAssessedInDamages_bfa30918-3b2f-472e-8133-7414248270fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5ab11419-c3eb-4ba4-b8f9-d50ee373f0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5ab11419-c3eb-4ba4-b8f9-d50ee373f0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_151be0f1-a877-48fc-930d-5d2c4da30a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4a91b72-7b25-4aff-a877-e78f4f7f0f0d" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_151be0f1-a877-48fc-930d-5d2c4da30a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d2b6be31-f5f8-4516-97a0-240fa26571b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:href="holx-20230401.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d2b6be31-f5f8-4516-97a0-240fa26571b6" xlink:to="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ee356b2-70ee-4ade-88d1-a9ac2c66a065" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9f21682d-3d14-41f3-8499-8d56428aa070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_921f0ffc-976d-410a-87c0-8cd847122cfd" xlink:to="loc_us-gaap_StockCompensationPlanMember_9f21682d-3d14-41f3-8499-8d56428aa070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:href="holx-20230401.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_3ca084cc-4a91-4b16-ab42-eca1f5fb2410" xlink:to="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29286d87-6a07-4a03-adff-6402f1bb2b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29286d87-6a07-4a03-adff-6402f1bb2b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_413127f2-d99b-4b94-a172-092c57f031ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_413127f2-d99b-4b94-a172-092c57f031ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cb870ee9-fa7b-4e4b-a1e7-d370d0db48b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cb870ee9-fa7b-4e4b-a1e7-d370d0db48b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_584b9df5-009f-4a0c-957f-fbd46853786c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9a6346e3-7aab-4377-95fd-fb9a8a87bdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4813a676-5d64-4bfc-9bec-0be127d81801" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9a6346e3-7aab-4377-95fd-fb9a8a87bdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fdef0000-cf9a-454e-b5ae-bb39e649a547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fdef0000-cf9a-454e-b5ae-bb39e649a547" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_51b250ca-2dd9-4d30-9903-c913e68ea58b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f3ba538c-b39b-41e7-8fd3-49f5301449d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_CostOfSalesMember_f3ba538c-b39b-41e7-8fd3-49f5301449d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_df51dd23-3a07-4424-91c7-54e39d4bc266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_df51dd23-3a07-4424-91c7-54e39d4bc266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5d558bc5-f1ba-42f2-b0cf-7dfa0a9041af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5d558bc5-f1ba-42f2-b0cf-7dfa0a9041af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_30603d82-3722-4988-aac8-0e2341007ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_87fc1169-22d8-4f94-84fb-dcf7b441afd6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_30603d82-3722-4988-aac8-0e2341007ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_63af8e67-d184-42b2-aca9-a63e59cda526" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1fcb4c2e-f268-4813-8133-c57f74a486cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4401200d-e16a-4e1c-8827-e903d2d1cfe5" xlink:to="loc_us-gaap_ShareBasedCompensation_1fcb4c2e-f268-4813-8133-c57f74a486cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9f00326-35db-4e7d-bb96-19f2bbbe2498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9f00326-35db-4e7d-bb96-19f2bbbe2498" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:to="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_11404575-0065-4cdb-9a64-c03d020cf663" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff00221a-1506-40eb-994b-a8e2145dc932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff00221a-1506-40eb-994b-a8e2145dc932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ef9a2362-44f7-45ca-bd99-49e0d48ec4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ef9a2362-44f7-45ca-bd99-49e0d48ec4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_22257bf9-e453-437c-a2cf-fe520bde7679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_us-gaap_PerformanceSharesMember_22257bf9-e453-437c-a2cf-fe520bde7679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_6cb013b1-5524-40d6-8634-2bc434457e9b" xlink:href="holx-20230401.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_PSUFreeCashFlowMember_6cb013b1-5524-40d6-8634-2bc434457e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_99d99432-3964-4352-89d3-e366f45a2b0f" xlink:href="holx-20230401.xsd#holx_MarketBasedAwardsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_MarketBasedAwardsMember_99d99432-3964-4352-89d3-e366f45a2b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_25ae1b8e-4386-441e-859f-9ebf4f66a18b" xlink:href="holx-20230401.xsd#holx_RSUPSUMSUMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8acd7052-7c2d-43e2-9c68-be21fd020d11" xlink:to="loc_holx_RSUPSUMSUMember_25ae1b8e-4386-441e-859f-9ebf4f66a18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec4fda0-64a9-4e47-a6de-9bff2b0089d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_41f2cef6-13f1-4217-87d3-cdedc72ee7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_41f2cef6-13f1-4217-87d3-cdedc72ee7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_048a16de-0bb6-4bbb-8762-9ea141c92719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_048a16de-0bb6-4bbb-8762-9ea141c92719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8ac19d4-8a32-4cea-9765-f2d04ddbcdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8ac19d4-8a32-4cea-9765-f2d04ddbcdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd0bf922-a903-4e5e-b8e7-a35e5e972a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd0bf922-a903-4e5e-b8e7-a35e5e972a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fb2ae8b-ce2f-42f6-84d5-ab15d3ba6196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fb2ae8b-ce2f-42f6-84d5-ab15d3ba6196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e89a05ae-ed41-42ab-b375-2eeb50da2a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e89a05ae-ed41-42ab-b375-2eeb50da2a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7690c47-0617-44ab-87e6-78f050060264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7690c47-0617-44ab-87e6-78f050060264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_7192b38c-1d2d-463f-8079-8385747b5ba9" xlink:href="holx-20230401.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_7192b38c-1d2d-463f-8079-8385747b5ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_0f75ae4f-b764-4e06-abe6-cce0b288a7f4" xlink:href="holx-20230401.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_0f75ae4f-b764-4e06-abe6-cce0b288a7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_b48ee980-f340-4455-94a8-07dfdb09191b" xlink:href="holx-20230401.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_b48ee980-f340-4455-94a8-07dfdb09191b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec1472d7-3101-4adb-9b6f-f904decca7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec1472d7-3101-4adb-9b6f-f904decca7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6c63b472-9a2b-414b-ad86-297afceae872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_536df976-208c-4842-9518-59203ac3c51e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6c63b472-9a2b-414b-ad86-297afceae872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220564b7-fdcf-43c0-b39d-4dfcf3fba6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220564b7-fdcf-43c0-b39d-4dfcf3fba6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_4cc284ee-7c98-4791-9d2f-e8a53ce6f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_4cc284ee-7c98-4791-9d2f-e8a53ce6f2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_df337d90-1163-4c50-bed0-1c45c427cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_df337d90-1163-4c50-bed0-1c45c427cea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_a42df75f-248f-4194-a7d8-fbaaa59471c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_a42df75f-248f-4194-a7d8-fbaaa59471c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1881b53d-dbc3-46ef-8020-2e38acd40ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14d98f7c-b228-462e-84db-b33db44cf0b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1881b53d-dbc3-46ef-8020-2e38acd40ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_702c0d4c-3221-4bbb-9c03-b94c34e095ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8d02c819-5cac-44bd-8283-fcea99f7a95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_702c0d4c-3221-4bbb-9c03-b94c34e095ed" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8d02c819-5cac-44bd-8283-fcea99f7a95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8222cc8a-4458-48b0-b0d4-d8395d73dcca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_702c0d4c-3221-4bbb-9c03-b94c34e095ed" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8222cc8a-4458-48b0-b0d4-d8395d73dcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6cfce67b-7e6a-4ce3-98ac-5155f8ece3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_702c0d4c-3221-4bbb-9c03-b94c34e095ed" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6cfce67b-7e6a-4ce3-98ac-5155f8ece3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ae7aea8a-3777-426c-8ff9-83c4312a5538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_702c0d4c-3221-4bbb-9c03-b94c34e095ed" xlink:to="loc_us-gaap_InventoryNet_ae7aea8a-3777-426c-8ff9-83c4312a5538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_991b87aa-b723-4776-bff1-0fd47b5cc9b7" xlink:href="holx-20230401.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_991b87aa-b723-4776-bff1-0fd47b5cc9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_62c8216b-3625-42c8-9bb8-c5bf84c9899d" xlink:href="holx-20230401.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_62c8216b-3625-42c8-9bb8-c5bf84c9899d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_4b7f5cea-3cba-4151-bf78-c9e3c14cf5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_4b7f5cea-3cba-4151-bf78-c9e3c14cf5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_26874ffc-0566-41b0-8b1d-1b755dd3e12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_26874ffc-0566-41b0-8b1d-1b755dd3e12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_a5a05058-0352-47ee-badc-e01abf39416f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_Land_a5a05058-0352-47ee-badc-e01abf39416f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_321388dd-9e4b-4669-a8bd-a1d869e9612f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_321388dd-9e4b-4669-a8bd-a1d869e9612f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_fb6b1fcb-bbdc-4af2-972c-8d8fb2293a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_fb6b1fcb-bbdc-4af2-972c-8d8fb2293a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_618438a4-f81e-47e8-ab45-1984d84f7b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_618438a4-f81e-47e8-ab45-1984d84f7b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6116e8e5-29db-40c1-93df-9db536a673a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6116e8e5-29db-40c1-93df-9db536a673a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea4c9607-3d72-44a0-9a58-270803e7f108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ea4c9607-3d72-44a0-9a58-270803e7f108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense_242e7a50-af8d-4e86-b17e-cd7a50c972b9" xlink:href="holx-20230401.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_holx_GrantsReceivedFromDepartmentOfDefense_242e7a50-af8d-4e86-b17e-cd7a50c972b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_213fb62f-6d5e-408b-8a52-e8058c541b5b" xlink:href="holx-20230401.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_faf38764-41d8-4281-8a1f-7c789a7eaee5" xlink:to="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_213fb62f-6d5e-408b-8a52-e8058c541b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dea3cb1d-4d2e-4dec-ab31-4dec441131e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dea3cb1d-4d2e-4dec-ab31-4dec441131e4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:to="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_713d2d42-df11-4776-9e2b-78e1484d0e72" xlink:to="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6dc23671-f2d3-4009-ad3d-437feea7a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_256d28ff-47ed-4a81-ba2a-2698374bc3c4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6dc23671-f2d3-4009-ad3d-437feea7a89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:href="holx-20230401.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e72c6ec-b9bd-4ab0-aa67-46544143949c" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f78db673-3e18-4818-8fcc-172f6ff6577f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:to="loc_us-gaap_NumberOfReportableSegments_f78db673-3e18-4818-8fcc-172f6ff6577f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0f3fb56a-fd86-4bd6-8184-0dab5f8aaf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_e79ad2e2-e18b-4273-8441-76f611f7a253" xlink:to="loc_us-gaap_Revenues_0f3fb56a-fd86-4bd6-8184-0dab5f8aaf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b9f09941-51fd-4740-bc97-3d2c3e2618f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b9f09941-51fd-4740-bc97-3d2c3e2618f2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83436345-89b3-4f48-b539-a7e3104d6fe2" xlink:to="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_6fb77947-abdb-4846-86dc-f9f6d0d7fd97" xlink:href="holx-20230401.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_DiagnosticsMember_6fb77947-abdb-4846-86dc-f9f6d0d7fd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_d340eb33-0958-48fd-992d-69235efeca27" xlink:href="holx-20230401.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_BreastHealthMember_d340eb33-0958-48fd-992d-69235efeca27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_5c330e66-1fc9-4890-b70d-184970c35071" xlink:href="holx-20230401.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_GynSurgicalMember_5c330e66-1fc9-4890-b70d-184970c35071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_6587919b-0ab7-4398-b603-cea09b2c7c7b" xlink:href="holx-20230401.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_holx_SkeletalHealthMember_6587919b-0ab7-4398-b603-cea09b2c7c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_7db583bc-eba2-4c60-bb26-e69a087cede8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0ba23a3-fa96-43e6-b800-726d44c1b95b" xlink:to="loc_us-gaap_CorporateMember_7db583bc-eba2-4c60-bb26-e69a087cede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bbc731ed-c8e5-46b9-9fc2-757e2267c563" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_01a11447-6757-47c8-b953-acc80694fef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_Revenues_01a11447-6757-47c8-b953-acc80694fef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3935bc32-a758-4b68-b392-0fd1495495b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_OperatingIncomeLoss_3935bc32-a758-4b68-b392-0fd1495495b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_00627bb7-02d1-47b4-a17c-27f66d3a8040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_00627bb7-02d1-47b4-a17c-27f66d3a8040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce0dd024-0331-47fe-812e-6e929e6307f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ce0dd024-0331-47fe-812e-6e929e6307f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2f7abfb3-5ccb-4486-84aa-274dd1ed3051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_73ca2e95-1e50-4b96-a983-526e2fa36604" xlink:to="loc_us-gaap_Assets_2f7abfb3-5ccb-4486-84aa-274dd1ed3051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dad0e37a-d0bd-494a-b3c4-ae132540ddab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dad0e37a-d0bd-494a-b3c4-ae132540ddab" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:to="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ad0f64c8-5dca-45a1-80e6-61d1735a66bb" xlink:to="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7d3709b1-6486-42c6-9340-f60585e0ab38" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_country_US_7d3709b1-6486-42c6-9340-f60585e0ab38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_fd3b74f0-b2d7-41d9-aead-d6843f192fca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_srt_EuropeMember_fd3b74f0-b2d7-41d9-aead-d6843f192fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e8929435-c157-4cc6-9c04-1a66b93a55ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_srt_AsiaPacificMember_e8929435-c157-4cc6-9c04-1a66b93a55ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_9e75a5ad-df75-4ff3-a8d3-b0dac69590cc" xlink:href="holx-20230401.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_679e36dc-3f70-4f9d-a204-683607c614a6" xlink:to="loc_holx_AllOtherCountriesMember_9e75a5ad-df75-4ff3-a8d3-b0dac69590cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:href="holx-20230401.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_0e04e188-ff6e-47bd-a528-5bc625ff4370" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_65cd229b-217f-45dc-abcb-72064dd315d2" xlink:href="holx-20230401.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_9d383d61-dde9-43ee-91ff-85271d2c0cc0" xlink:to="loc_holx_PercentageOfRevenues_65cd229b-217f-45dc-abcb-72064dd315d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e7064fea-ace7-4c6d-8462-d6084442acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dd0f385-6e6f-4f3c-b1d1-cc274194d214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e7064fea-ace7-4c6d-8462-d6084442acdc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dd0f385-6e6f-4f3c-b1d1-cc274194d214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce82461b-a4e3-47ad-8087-a6615c8b0643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce82461b-a4e3-47ad-8087-a6615c8b0643" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d4cd2045-5f44-42cb-8de9-40d63dfd946b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_302787f4-28cc-4a1d-9356-94f3cb0d3d55" xlink:href="holx-20230401.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_DevelopedTechnologyMember_302787f4-28cc-4a1d-9356-94f3cb0d3d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_fea300a9-db2b-415c-b784-2e3f2b9aec83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_fea300a9-db2b-415c-b784-2e3f2b9aec83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_b5d4f09d-433e-4ec1-ac03-f22329466c4a" xlink:href="holx-20230401.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_CustomerRelationshipsContractsMember_b5d4f09d-433e-4ec1-ac03-f22329466c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5e2356da-a312-4744-a7ac-c2d34957d65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_us-gaap_TradeNamesMember_5e2356da-a312-4744-a7ac-c2d34957d65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_9e3d4911-0f67-4f36-8d6d-59c7c904532a" xlink:href="holx-20230401.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_AcquiredintangibleassetsMember_9e3d4911-0f67-4f36-8d6d-59c7c904532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_19f16ea1-31a3-48ae-b39f-4ac9e126d820" xlink:href="holx-20230401.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_InternalusesoftwareMember_19f16ea1-31a3-48ae-b39f-4ac9e126d820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_40982b91-94a1-4563-9c66-7d15800bafe6" xlink:href="holx-20230401.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1183d19c-0b18-41cc-9cd4-a9e904011fda" xlink:to="loc_holx_CapitalizedsoftwareMember_40982b91-94a1-4563-9c66-7d15800bafe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3dee9df4-3c1c-43b1-b1d4-0c20294e5aa1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d60dec9-f09a-4063-aab3-973e804e7c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4d60dec9-f09a-4063-aab3-973e804e7c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_707a5590-f0fb-487e-b346-f96507745fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_be324d32-78d5-4c47-90a3-47177600ea59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_707a5590-f0fb-487e-b346-f96507745fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_edc1f67c-7033-4131-a7a5-d90706f2ad93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_edc1f67c-7033-4131-a7a5-d90706f2ad93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ed35714f-c82c-4215-8b3c-38bed9fd05b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ed35714f-c82c-4215-8b3c-38bed9fd05b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_74a92800-6847-4bf8-9b75-be0ac22ff18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_74a92800-6847-4bf8-9b75-be0ac22ff18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dc340feb-9eaf-4b59-a62e-92f75a4df955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dc340feb-9eaf-4b59-a62e-92f75a4df955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a3c28fd-0cc5-4400-bd1e-f22658cfea3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6744568-02c7-459d-9f7f-fb397bb2a4f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a3c28fd-0cc5-4400-bd1e-f22658cfea3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_a69d3879-5025-4f54-965d-982e77fa5bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_a69d3879-5025-4f54-965d-982e77fa5bf5" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_1f31d49c-11e8-4ea5-a54b-df0bd47b25ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:to="loc_us-gaap_ProductWarrantyAccrual_1f31d49c-11e8-4ea5-a54b-df0bd47b25ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_2a3d4e7b-2f77-43b5-bc18-4bb37a0f6f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_2a3d4e7b-2f77-43b5-bc18-4bb37a0f6f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_24823118-f80a-484f-b59d-5265826a96fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_24823118-f80a-484f-b59d-5265826a96fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_dedc7603-e123-4783-91fe-9ee9b79b55f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_559d8701-e03a-4339-bdd6-459855320d44" xlink:to="loc_us-gaap_ProductWarrantyAccrual_dedc7603-e123-4783-91fe-9ee9b79b55f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20230401.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_80593805-e086-4741-a8e6-7d8f177ed028" xlink:href="holx-20230401.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_80593805-e086-4741-a8e6-7d8f177ed028" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fbe603f9-62f6-4235-b527-88e4d7ffffe7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_59749013-aa16-4cba-828e-473db1b1be0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb300cf4-1949-4841-b89c-960c60570377" xlink:to="loc_us-gaap_InterestRateSwapMember_59749013-aa16-4cba-828e-473db1b1be0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_61ffa8a9-55d3-4bd1-bc9a-7b87cc80e82a" xlink:to="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aa916949-f7d9-41da-a94e-86300736432b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86cad88e-bb4a-464f-8e1d-74dc4fda9100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86cad88e-bb4a-464f-8e1d-74dc4fda9100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_5f29daf0-e312-464a-8b9e-196d8b047442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_5f29daf0-e312-464a-8b9e-196d8b047442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_639ff912-867f-44a5-81c6-900bda654c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7baa70f3-01ad-4016-b881-4ff37390982a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_639ff912-867f-44a5-81c6-900bda654c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_557e5926-d80c-424c-a15e-70afd8038375" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c0cbb38-8be4-44c3-bc2e-dc514ed2112d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_StockholdersEquity_1c0cbb38-8be4-44c3-bc2e-dc514ed2112d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9ec0b2f1-3e4a-458f-9f69-07075026ad53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9ec0b2f1-3e4a-458f-9f69-07075026ad53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3fd299d-5b57-491a-a84e-513b0553c14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_40215080-47f2-4cb0-b38d-b91a3bd88d7d" xlink:to="loc_us-gaap_StockholdersEquity_c3fd299d-5b57-491a-a84e-513b0553c14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20230401.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d2b12bb6-f8f1-41d0-aef8-3d325c7d33c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d2b12bb6-f8f1-41d0-aef8-3d325c7d33c6" xlink:to="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c6148481-f42d-46f3-829d-deaf7a455046" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_5380294c-e537-4fdf-9c79-f1276afa734f" xlink:href="holx-20230401.xsd#holx_September222022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:to="loc_holx_September222022Member_5380294c-e537-4fdf-9c79-f1276afa734f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_8cf16fe5-3c4b-43a1-9580-0a51ab7baf4b" xlink:href="holx-20230401.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70a3ff44-216c-4aa3-a378-973dd35c2cd5" xlink:to="loc_holx_December112020Member_8cf16fe5-3c4b-43a1-9580-0a51ab7baf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:href="holx-20230401.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_7acf1739-0c9d-447c-a8a2-4a0941d1ae98" xlink:to="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f1647b31-3907-4cd9-8959-6c40fcb1c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f1647b31-3907-4cd9-8959-6c40fcb1c0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_80208a22-34a8-4efb-ab1f-4ac53a1cb335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_80208a22-34a8-4efb-ab1f-4ac53a1cb335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2af8bac-0b72-41f7-9f44-c03e93ad344d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2af8bac-0b72-41f7-9f44-c03e93ad344d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c9786027-1fb1-45b2-9872-ed9ca3f2c827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_345425b9-fdd5-4b68-a59e-68af94bcf591" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c9786027-1fb1-45b2-9872-ed9ca3f2c827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122535984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,118,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122216336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ProductRevenue', window );">Product</a></td>
<td class="nump">$ 837.4<span></span>
</td>
<td class="nump">$ 1,268.2<span></span>
</td>
<td class="nump">$ 1,723.8<span></span>
</td>
<td class="nump">$ 2,571.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ServiceRevenue', window );">Service and other</a></td>
<td class="nump">189.1<span></span>
</td>
<td class="nump">167.5<span></span>
</td>
<td class="nump">376.9<span></span>
</td>
<td class="nump">335.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,026.5<span></span>
</td>
<td class="nump">1,435.7<span></span>
</td>
<td class="nump">2,100.7<span></span>
</td>
<td class="nump">2,906.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Product</a></td>
<td class="nump">292.1<span></span>
</td>
<td class="nump">322.6<span></span>
</td>
<td class="nump">588.3<span></span>
</td>
<td class="nump">640.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AmortizationCostofGoodsSold', window );">Amortization, Cost of Goods Sold</a></td>
<td class="nump">52.1<span></span>
</td>
<td class="nump">72.3<span></span>
</td>
<td class="nump">107.7<span></span>
</td>
<td class="nump">147.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Costofservice', window );">Service and other</a></td>
<td class="nump">96.5<span></span>
</td>
<td class="nump">94.2<span></span>
</td>
<td class="nump">201.0<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">585.8<span></span>
</td>
<td class="nump">946.6<span></span>
</td>
<td class="nump">1,203.7<span></span>
</td>
<td class="nump">1,932.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
<td class="nump">148.8<span></span>
</td>
<td class="nump">142.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">142.4<span></span>
</td>
<td class="nump">171.4<span></span>
</td>
<td class="nump">305.9<span></span>
</td>
<td class="nump">318.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">100.8<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
<td class="nump">209.3<span></span>
</td>
<td class="nump">218.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration - fair value adjustments</a></td>
<td class="num">(12.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">313.7<span></span>
</td>
<td class="nump">352.5<span></span>
</td>
<td class="nump">669.2<span></span>
</td>
<td class="nump">697.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">272.1<span></span>
</td>
<td class="nump">594.1<span></span>
</td>
<td class="nump">534.5<span></span>
</td>
<td class="nump">1,235.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">31.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">52.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(27.2)<span></span>
</td>
<td class="num">(22.6)<span></span>
</td>
<td class="num">(55.3)<span></span>
</td>
<td class="num">(48.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(12.9)<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">279.3<span></span>
</td>
<td class="nump">574.4<span></span>
</td>
<td class="nump">518.4<span></span>
</td>
<td class="nump">1,196.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">60.8<span></span>
</td>
<td class="nump">118.7<span></span>
</td>
<td class="nump">112.5<span></span>
</td>
<td class="nump">241.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 218.5<span></span>
</td>
<td class="nump">$ 455.7<span></span>
</td>
<td class="nump">$ 405.9<span></span>
</td>
<td class="nump">$ 954.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 1.81<span></span>
</td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="nump">$ 3.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 1.63<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">247,730<span></span>
</td>
<td class="nump">251,574<span></span>
</td>
<td class="nump">247,524<span></span>
</td>
<td class="nump">252,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">249,793<span></span>
</td>
<td class="nump">253,658<span></span>
</td>
<td class="nump">249,537<span></span>
</td>
<td class="nump">254,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization, Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Costofservice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of service</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Costofservice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118934080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 218.5<span></span>
</td>
<td class="nump">$ 455.7<span></span>
</td>
<td class="nump">$ 405.9<span></span>
</td>
<td class="nump">$ 954.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="num">(34.5)<span></span>
</td>
<td class="nump">129.1<span></span>
</td>
<td class="num">(72.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain (loss) recognized in other comprehensive income (loss), net</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">19.4<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
<td class="num">(45.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 227.4<span></span>
</td>
<td class="nump">$ 440.6<span></span>
</td>
<td class="nump">$ 525.7<span></span>
</td>
<td class="nump">$ 909.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118780816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Tax</a></td>
<td class="num">$ (2,000,000.0)<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="num">$ (2,900,000)<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200120212608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,582.2<span></span>
</td>
<td class="nump">$ 2,339.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves</a></td>
<td class="nump">714.0<span></span>
</td>
<td class="nump">617.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">687.6<span></span>
</td>
<td class="nump">623.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="nump">187.0<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PrepaidIncomeTaxesCurrent', window );">Prepaid Income Taxes-Current</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,211.4<span></span>
</td>
<td class="nump">3,862.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">497.9<span></span>
</td>
<td class="nump">481.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,202.2<span></span>
</td>
<td class="nump">1,280.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,296.9<span></span>
</td>
<td class="nump">3,236.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">240.3<span></span>
</td>
<td class="nump">210.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,448.7<span></span>
</td>
<td class="nump">9,071.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="nump">197.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">508.0<span></span>
</td>
<td class="nump">535.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">230.5<span></span>
</td>
<td class="nump">186.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligations</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">955.0<span></span>
</td>
<td class="nump">937.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,797.7<span></span>
</td>
<td class="nump">2,808.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations, net of current portion</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">33.4<span></span>
</td>
<td class="nump">90.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">332.0<span></span>
</td>
<td class="nump">330.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 299,676 and 298,533 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">6,091.5<span></span>
</td>
<td class="nump">6,042.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,006.2<span></span>
</td>
<td class="nump">1,600.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 53,566 and 51,401 shares, respectively</a></td>
<td class="num">(2,681.5)<span></span>
</td>
<td class="num">(2,531.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(118.4)<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">5,300.8<span></span>
</td>
<td class="nump">4,876.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 9,448.7<span></span>
</td>
<td class="nump">$ 9,071.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrepaidIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income Taxes-Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrepaidIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119755776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000,000<span></span>
</td>
<td class="nump">1,623,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000,000<span></span>
</td>
<td class="nump">750,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">299,676,000,000<span></span>
</td>
<td class="nump">298,533,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">53,566,000,000<span></span>
</td>
<td class="nump">51,401,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114646512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 4,218.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 5,965.8<span></span>
</td>
<td class="nump">$ 298.3<span></span>
</td>
<td class="num">$ (59.1)<span></span>
</td>
<td class="num">$ (1,989.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(22.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">499.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">499.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (167.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,988<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,964.0<span></span>
</td>
<td class="nump">797.5<span></span>
</td>
<td class="num">(89.0)<span></span>
</td>
<td class="num">$ (2,156.4)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,965.8<span></span>
</td>
<td class="nump">298.3<span></span>
</td>
<td class="num">(59.1)<span></span>
</td>
<td class="num">$ (1,989.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">954.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,851<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,997.0<span></span>
</td>
<td class="nump">1,253.2<span></span>
</td>
<td class="num">(104.1)<span></span>
</td>
<td class="num">$ (2,356.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,519.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,988<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,964.0<span></span>
</td>
<td class="nump">797.5<span></span>
</td>
<td class="num">(89.0)<span></span>
</td>
<td class="num">$ (2,156.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">455.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">455.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,851<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,997.0<span></span>
</td>
<td class="nump">1,253.2<span></span>
</td>
<td class="num">(104.1)<span></span>
</td>
<td class="num">$ (2,356.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,792.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">228.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">228.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 25, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,851<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 25, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,017.4<span></span>
</td>
<td class="nump">1,481.6<span></span>
</td>
<td class="num">(147.7)<span></span>
</td>
<td class="num">$ (2,356.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,997.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">118.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">118.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (175.1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 24, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,401<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 24, 2022</a></td>
<td class="nump">4,876.2<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,042.6<span></span>
</td>
<td class="nump">1,600.3<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
<td class="nump">$ 2,531.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,876.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(23.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,940<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,060.6<span></span>
</td>
<td class="nump">1,787.7<span></span>
</td>
<td class="num">(127.3)<span></span>
</td>
<td class="num">$ (2,631.5)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 24, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,401<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 24, 2022</a></td>
<td class="nump">4,876.2<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,042.6<span></span>
</td>
<td class="nump">1,600.3<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
<td class="nump">$ 2,531.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">405.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Apr. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,566<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 01, 2023</a></td>
<td class="nump">5,300.8<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,091.5<span></span>
</td>
<td class="nump">2,006.2<span></span>
</td>
<td class="num">(118.4)<span></span>
</td>
<td class="num">$ (2,681.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">5,092.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,940<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,060.6<span></span>
</td>
<td class="nump">1,787.7<span></span>
</td>
<td class="num">(127.3)<span></span>
</td>
<td class="num">$ (2,631.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">218.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">218.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (50.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Apr. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,566<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 01, 2023</a></td>
<td class="nump">5,300.8<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 6,091.5<span></span>
</td>
<td class="nump">$ 2,006.2<span></span>
</td>
<td class="num">$ (118.4)<span></span>
</td>
<td class="num">$ (2,681.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 5,300.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122320384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 405.9<span></span>
</td>
<td class="nump">$ 954.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">44.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">122.4<span></span>
</td>
<td class="nump">169.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">36.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(61.6)<span></span>
</td>
<td class="num">(41.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="num">(12.4)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(81.8)<span></span>
</td>
<td class="nump">101.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(56.1)<span></span>
</td>
<td class="num">(26.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">8.3<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">355.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(13.2)<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(22.4)<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">459.7<span></span>
</td>
<td class="nump">1,626.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of business, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(158.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(34.5)<span></span>
</td>
<td class="num">(36.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion', window );">Proceeds received from government grants for capacity expansion</a></td>
<td class="nump">20.5<span></span>
</td>
<td class="nump">58.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(26.7)<span></span>
</td>
<td class="num">(33.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for (Proceeds from) Other Investing Activities</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(57.4)<span></span>
</td>
<td class="num">(164.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,491.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(1,387.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of deferred acquisition consideration</a></td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentOfDeferredAcquisitionConsideration', window );">Payment of deferred acquisition consideration</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Repaymentsofacquiredlongtermdebt', window );">Repayments of acquired long term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(63.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(150.0)<span></span>
</td>
<td class="num">(367.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">28.4<span></span>
</td>
<td class="nump">17.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(23.2)<span></span>
</td>
<td class="num">(22.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentsUnderFinanceLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(163.0)<span></span>
</td>
<td class="num">(346.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">242.7<span></span>
</td>
<td class="nump">1,120.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,339.5<span></span>
</td>
<td class="nump">1,170.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 2,582.2<span></span>
</td>
<td class="nump">$ 2,290.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentOfDeferredAcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred acquisition consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentOfDeferredAcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsUnderFinanceLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments under finance lease obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsUnderFinanceLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from government grants for capacity expansion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Repaymentsofacquiredlongtermdebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments of acquired long term debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Repaymentsofacquiredlongtermdebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121126640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BasisofPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#8217;s annual report on Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended April&#160;1, 2023 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company&#8217;s historical fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div>The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended April&#160;1, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasisofPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasisofPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122534240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company&#8217;s consolidated revenue for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company&#8217;s consolidated revenue for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121136400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of interest rate swaps, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value, which is based on Level 3 inputs. The contingent consideration liability as of April&#160;1, 2023 and March&#160;26, 2022 was related to the Acessa acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at April&#160;1, 2023:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:41.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended April&#160;1, 2023 and March&#160;26, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $4.3&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, interest rate swaps, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swaps, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.</span></div>Amounts outstanding under the Company&#8217;s 2021 Credit Agreement of $1.5 billion aggregate principal as of April&#160;1, 2023 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) and 3.250% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) had fair values of $388.9&#160;million and $848.4&#160;million, respectively, as of April&#160;1, 2023 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121086640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2022 Acquisition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. (&#8220;Bolder&#8221;), for a purchase price of $160.1&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder&#8217;s results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder&#8217;s tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder&#8217;s business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 16.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder&#8217;s products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company&#8217;s surgical portfolio and utilizing GYN Surgical&#8217;s sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. (&#8220;Acessa&#8221;), which was acquired in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $81.8&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change, and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company&#8217;s estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $39.5&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $4.1&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $12.2&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in a payment of $7.6&#160;million, which was made in the second quarter of fiscal 2023. During the second quarter of fiscal 2023, the Company updated its forecasted revenue and recorded a gain of $12.4&#160;million to record the liability to fair value. The reduction in fair value was due to a decrease in forecasted revenues over the remaining measurement period. As of April&#160;1, 2023, the contingent consideration liability was $3.4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121223616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Trade Receivables and Allowance for Credit Losses</a></td>
<td class="text">Trade Receivables and Allowance for Credit Losses<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic and inflation, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses as of April&#160;1, 2023 compared to March&#160;26, 2022:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:22.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-offs,<br/>Payments and Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121086640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAbstract', window );"><strong>Restructuring Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company&#8217;s Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022 but were not informed of their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $0.3&#160;million and $1.0&#160;million during the three and six months ended April 1, 2023, respectively, and $1.6&#160;million in fiscal 2022. The Company estimates that total severance charges, including retention, will be approximately $5.5&#160;million.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first and second quarters of fiscal 2023, the Company made various decisions to consolidate and close certain offices in Germany and in connection with such actions to terminate certain individuals across all divisions in multiple departments. For the three and six months ended April 1, 2023, the Company recorded $1.5&#160;million and $1.9&#160;million, respectively, primarily for severance benefits related to these actions. These charges were recorded pursuant to ASC 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Postemployment Benefits</span> (ASC 712) or ASC 420, depending on the employee. The Company estimates that total severance charges will be approximately $3.9&#160;million, and the actions will be completed by September 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121223616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Arrangements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the &#8220;2018 Credit Agreement&#8221;) by entering into a Refinancing Amendment (the &#8220;2021 Credit Agreement&#8221;). On August 22, 2022, the Company further amended the 2021 Credit Agreement to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provided a $1.5&#160;billion secured term loan facility (the &#8220;2021 Term Loan&#8221;) and a $2.0&#160;billion revolving credit facility (the &#8220;2021 Revolver&#8221;). As of April&#160;1, 2023, the principal amount outstanding under the 2021 Term Loan was $1.5&#160;billion, and the interest rate was 5.91% per annum. No amounts were outstanding under the 2021 Revolver, and the full amount was available to be borrowed by the Company. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.7&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $7.0&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s currently effective interest rate swap agreement, which fixes the floating rate on $1.0&#160;billion of aggregate principal under the 2021 Term Loan at 1.23%, resulted in the Company receiving $8.6&#160;million and $15.2&#160;million in the three and six months ended April&#160;1, 2023, respectively, which was recorded as a reduction to interest expense.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of April&#160;1, 2023, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had 4.625% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#8217;s domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had 3.250% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#8217;s domestic subsidiaries and mature on February 15, 2029.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div>During April 2022, the Company repaid the outstanding balance of $248.5&#160;million under its accounts receivable securitization program (the &#8220;Securitization Program&#8221;). On June 10, 2022, the Company amended the agreement governing the Securitization Program temporarily suspending its ability to borrow and the need to comply with covenants for up to a year. On March 31, 2023, the Company terminated the Securitization Program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121936896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps - Cash Flow Hedge</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income (&#8220;AOCI&#8221;) to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023 to hedge a portion of its variable rate debt. On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement) to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to evaluate the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $1.0 billion. The restructured interest rate swap fixes the SOFR component of the variable interest rate on $1.0 billion of the notional amount under the 2021 Credit Agreement at 1.23%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $26.0 million as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2023, the Company entered into two consecutive interest rate swap contracts with the first contract having an effective date of December 17, 2023 and terminating on December 27, 2024, and the second contract having an effective date of December 27, 2024 and terminating on September 25, 2026. The notional amount of these swaps is $500 million, and the first interest rate swap fixes the SOFR component of the variable interest rate at 3.46%, and the second interest rate swap fixes the SOFR component of the variable interest rate at 2.98%. The critical terms of the interest rate swaps are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $500&#160;million of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of these swaps was an asset position of $1.2&#160;million and a liability position of $0.4&#160;million, respectively, as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company&#8217;s cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of April&#160;1, 2023 the notional amount was $200.3&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments as well as their classification on the balance sheet as of April&#160;1, 2023: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118900320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) Commitments and Contingencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company&#8217;s summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8&#160;million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties&#8217; post-trial motions, including the Company&#8217;s motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court&#8217;s rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the United States Patent and Trademark Office (&#8220;USPTO&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#8220;PTAB&#8221;) declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit (&#8220;Court of Appeals&#8221;). On April 19, 2019, the Court of Appeals affirmed the PTAB&#8217;s final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties&#8217; petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied the Company&#8217;s petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $7.4&#160;million, which included the original award of $4.8&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses in the first quarter of fiscal 2023.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva&#8217;s motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#8217;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. On February 15, 2023, the Court of Appeals affirmed the district court&#8217;s judgment in favor of the Company and dismissed the other rulings Minerva appealed as moot. On April 18, 2023, the Company entered into a settlement agreement with Minerva to resolve all remaining patent litigation matters, the impact of which was immaterial.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 450). Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121079440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income Per Share<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121229712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase 0.5 million and 0.6 million shares of the Company&#8217;s common stock during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average exercise prices of $74.59 and $71.10, respectively. There were 4.3 million options outstanding at April&#160;1, 2023 with a weighted-average exercise price of $51.87.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.6 million and 0.6 million restricted stock units (&#8220;RSUs&#8221;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average grant date fair values of $74.44 and $71.15 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (&#8220;PSUs&#8221;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $74.35 and $71.16 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period, provided that the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure (&#8220;FCF PSUs&#8221;) to members of its senior management team, which had a grant date fair value of $74.35 and $71.16 per unit during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the probable number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (&#8220;MSUs&#8221;) to members of its senior management team during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $97.91 and $75.43 per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At April&#160;1, 2023, there was 1.7 million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;1, 2023, there was $18.8 million and $77.3 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.2 and 1.9 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121091360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text">Other Balance Sheet Information<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(738.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force (&#8220;DOD&#8221;) to expand production capacity for the Company&#8217;s two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company has accounted for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procured and paid for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD reimbursed the Company upon it meeting certain requirements. However, the DOD retained title to the assets purchased under the agreement, and title was transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone had been met. As of the end of fiscal 2022, the Company had completed all milestones under the agreement and was waiting for approval by the DOD. During the second quarter of fiscal 2023, the Company received the final DOD approvals and the final payment from the DOD of $20.5&#160;million, which was recorded as a reduction of the cost basis of the purchased equipment. As of April&#160;1, 2023, no other amounts were awaiting approval and all defined milestones were completed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121066032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic InformationThe Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. Segment information is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:66.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,448.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121936896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates for the three and six months ended April&#160;1, 2023 were 21.8% and 21.7%, respectively, compared to 20.7% and 20.2%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three and six months ended April&#160;1, 2023 were higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company&#8217;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rates for the three and six months ended March&#160;26, 2022 were lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by the Company&#8217;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company&#8217;s positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121058960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:30pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,519.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,330.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,465.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,575.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company&#8217;s acquired intangible assets as of April&#160;1, 2023 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"/><td style="width:76.048%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.752%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118836368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121043184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:22.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(153.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(238.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(118.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(118.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:22.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(89.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(72.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(115.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(115.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121943888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Repurchase</a></td>
<td class="text">Share RepurchaseOn September 22, 2022, the Board of Directors authorized a stock repurchase program, with a five-year term, to repurchase up to $1.0&#160;billion of the Company&#8217;s outstanding common stock, effective as of the close of trading September 23, 2022. This repurchase program replaced the previous $1.0&#160;billion authorization. During the three and six months ended April&#160;1, 2023, the Company repurchased 0.6&#160;million and 2.2&#160;million shares of its common stock for total consideration of $50.0&#160;million and $150.0&#160;million, respectively. As of April&#160;1, 2023, $850.0&#160;million remained available under this authorization.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121058960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contract with Customer (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company&#8217;s products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:3.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:3.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company&#8217;s products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company&#8217;s performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from laboratory testing services, which is generated by the Company&#8217;s Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company&#8217;s contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company&#8217;s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $857.4 million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company&#8217;s Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 26% of this amount as revenue in fiscal 2023, 36% in fiscal 2024, 23% in fiscal 2025, 11% in fiscal 2026, and 4% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company&#8217;s conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company&#8217;s Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $34.5&#160;million and $101.3&#160;million in the three and six months ended April&#160;1, 2023, respectively, that was included in the contract liability balance at September&#160;24, 2022. The Company recognized $30.9&#160;million and $87.3&#160;million in the three and six months ended March&#160;26, 2022, respectively, that was included in the contract liability balance at September&#160;25, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118900320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:3.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:3.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121061552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at April&#160;1, 2023:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:41.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended April&#160;1, 2023 and March&#160;26, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121039760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder&#8217;s tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121128304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">The following is a rollforward of the allowance for credit losses as of April&#160;1, 2023 compared to March&#160;26, 2022:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200211038800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Schedule Of Interest Expense Under Convertible Notes</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121147952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments as well as their classification on the balance sheet as of April&#160;1, 2023: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121208512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121913200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121907632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(738.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118818928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">egment information is as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:66.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,448.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 26,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121929312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:30pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,519.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,330.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,465.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,575.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company&#8217;s acquired intangible assets as of April&#160;1, 2023 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"/><td style="width:76.048%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.752%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119211792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121249472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:22.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(153.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(238.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(118.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(118.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:22.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 26, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 26, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(89.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(72.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(115.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(115.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113043888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,026.5<span></span>
</td>
<td class="nump">$ 1,435.7<span></span>
</td>
<td class="nump">$ 2,100.7<span></span>
</td>
<td class="nump">$ 2,906.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">768.7<span></span>
</td>
<td class="nump">992.4<span></span>
</td>
<td class="nump">1,592.3<span></span>
</td>
<td class="nump">2,004.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">257.8<span></span>
</td>
<td class="nump">443.3<span></span>
</td>
<td class="nump">508.4<span></span>
</td>
<td class="nump">902.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">464.7<span></span>
</td>
<td class="nump">987.1<span></span>
</td>
<td class="nump">1,024.0<span></span>
</td>
<td class="nump">1,937.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">342.6<span></span>
</td>
<td class="nump">645.1<span></span>
</td>
<td class="nump">756.3<span></span>
</td>
<td class="nump">1,260.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">122.1<span></span>
</td>
<td class="nump">342.0<span></span>
</td>
<td class="nump">267.7<span></span>
</td>
<td class="nump">677.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">111.9<span></span>
</td>
<td class="nump">115.4<span></span>
</td>
<td class="nump">238.6<span></span>
</td>
<td class="nump">245.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">72.1<span></span>
</td>
<td class="nump">147.1<span></span>
</td>
<td class="nump">153.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">42.9<span></span>
</td>
<td class="nump">43.3<span></span>
</td>
<td class="nump">91.5<span></span>
</td>
<td class="nump">92.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">342.2<span></span>
</td>
<td class="nump">862.5<span></span>
</td>
<td class="nump">767.5<span></span>
</td>
<td class="nump">1,676.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">263.0<span></span>
</td>
<td class="nump">563.8<span></span>
</td>
<td class="nump">591.3<span></span>
</td>
<td class="nump">1,091.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">79.2<span></span>
</td>
<td class="nump">298.7<span></span>
</td>
<td class="nump">176.2<span></span>
</td>
<td class="nump">584.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">15.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">15.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">385.4<span></span>
</td>
<td class="nump">310.4<span></span>
</td>
<td class="nump">719.5<span></span>
</td>
<td class="nump">669.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">293.3<span></span>
</td>
<td class="nump">239.5<span></span>
</td>
<td class="nump">563.3<span></span>
</td>
<td class="nump">510.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">92.1<span></span>
</td>
<td class="nump">70.9<span></span>
</td>
<td class="nump">156.2<span></span>
</td>
<td class="nump">159.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">311.5<span></span>
</td>
<td class="nump">245.0<span></span>
</td>
<td class="nump">575.9<span></span>
</td>
<td class="nump">527.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">233.5<span></span>
</td>
<td class="nump">187.4<span></span>
</td>
<td class="nump">445.8<span></span>
</td>
<td class="nump">396.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">78.0<span></span>
</td>
<td class="nump">57.6<span></span>
</td>
<td class="nump">130.1<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">143.6<span></span>
</td>
<td class="nump">142.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">59.8<span></span>
</td>
<td class="nump">52.1<span></span>
</td>
<td class="nump">117.5<span></span>
</td>
<td class="nump">114.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">144.8<span></span>
</td>
<td class="nump">117.3<span></span>
</td>
<td class="nump">298.9<span></span>
</td>
<td class="nump">251.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">113.6<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
<td class="nump">236.7<span></span>
</td>
<td class="nump">203.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
<td class="nump">62.2<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">58.3<span></span>
</td>
<td class="nump">47.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 22.3<span></span>
</td>
<td class="nump">$ 17.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200117836240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,026.5<span></span>
</td>
<td class="nump">$ 1,435.7<span></span>
</td>
<td class="nump">$ 2,100.7<span></span>
</td>
<td class="nump">$ 2,906.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">768.7<span></span>
</td>
<td class="nump">992.4<span></span>
</td>
<td class="nump">1,592.3<span></span>
</td>
<td class="nump">2,004.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">151.5<span></span>
</td>
<td class="nump">291.2<span></span>
</td>
<td class="nump">298.8<span></span>
</td>
<td class="nump">586.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">65.2<span></span>
</td>
<td class="nump">109.7<span></span>
</td>
<td class="nump">129.1<span></span>
</td>
<td class="nump">229.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_RestofWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 41.1<span></span>
</td>
<td class="nump">$ 42.4<span></span>
</td>
<td class="nump">$ 80.5<span></span>
</td>
<td class="nump">$ 86.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113027904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,026.5<span></span>
</td>
<td class="nump">$ 1,435.7<span></span>
</td>
<td class="nump">$ 2,100.7<span></span>
</td>
<td class="nump">$ 2,906.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">101.3<span></span>
</td>
<td class="nump">87.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Disposables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">626.5<span></span>
</td>
<td class="nump">1,111.1<span></span>
</td>
<td class="nump">1,354.3<span></span>
</td>
<td class="nump">2,217.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">210.9<span></span>
</td>
<td class="nump">157.1<span></span>
</td>
<td class="nump">369.5<span></span>
</td>
<td class="nump">354.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">183.0<span></span>
</td>
<td class="nump">162.6<span></span>
</td>
<td class="nump">366.2<span></span>
</td>
<td class="nump">325.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 10.7<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119666432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 857.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 857.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 34.5<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
<td class="nump">$ 101.3<span></span>
</td>
<td class="nump">$ 87.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119133856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121131184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total (percentage)</a></td>
<td class="nump">0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113603696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">30.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119043824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="nump">$ 71.0<span></span>
</td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="nump">$ 75.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="num">(12.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 58.8<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 58.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122267296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on Sale of Investments</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200112662352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 29, 2021</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12.4)<span></span>
</td>
<td class="num">$ (4.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 160.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AnnualIncrementalRevenueGrowthPeriod', window );">Annual incremental revenue growth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationContingentConsiderationPayments', window );">Contingent consideration payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AnnualIncrementalRevenueGrowthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual Incremental Revenue Growth Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AnnualIncrementalRevenueGrowthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationContingentConsiderationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationContingentConsiderationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200117850288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
<th class="th"><div>Nov. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,296.9<span></span>
</td>
<td class="nump">$ 3,236.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114624864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 37.7<span></span>
</td>
<td class="nump">$ 40.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit Loss</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs, Payments and Foreign Exchange</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 39.4<span></span>
</td>
<td class="nump">$ 42.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113560128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember', window );">Danbury closure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAbstract', window );"><strong>Restructuring Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_GermanyPlanMember', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAbstract', window );"><strong>Restructuring Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_GermanyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_GermanyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119774912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 26.2<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,797.7<span></span>
</td>
<td class="nump">2,808.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">2,823.9<span></span>
</td>
<td class="nump">2,823.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,463.6<span></span>
</td>
<td class="nump">1,475.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">396.4<span></span>
</td>
<td class="nump">396.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 937.7<span></span>
</td>
<td class="nump">$ 936.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200111965152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from Derivative Instrument, Financing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver | 2021 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan | 2021 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember', window );">Asset Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Repayments of Other Debt</a></td>
<td class="nump">$ 248.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113556240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - Credit Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 22.5<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 42.9<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">5.74%<span></span>
</td>
<td class="nump">1.13%<span></span>
</td>
<td class="nump">5.39%<span></span>
</td>
<td class="nump">1.11%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">5.91%<span></span>
</td>
<td class="nump">1.46%<span></span>
</td>
<td class="nump">5.91%<span></span>
</td>
<td class="nump">1.46%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200117766912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 27.1<span></span>
</td>
<td class="nump">$ 26.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028And2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028And2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122046064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_NotationalAmount', window );">Notational Amount</a></td>
<td class="nump">200.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2023Member', window );">Interest Rate Swap, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2024Member', window );">Interest Rate Swap, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Cash Flow Hedge Derivative Instrument Liabilities at Fair Value</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotationalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notational Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotationalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all liability derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=holx_InterestRateSwap2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114332112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Total</a></td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="num">$ (25.8)<span></span>
</td>
<td class="nump">$ 29.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(21.6)<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (7.8)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119106160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap contracts</a></td>
<td class="nump">$ 26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate caps - derivative | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap contracts</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">$ 31.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Foreign currency option contracts</a></td>
<td class="nump">27.2<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate swap | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Foreign currency option contracts</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Foreign currency option contracts</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest rate swap | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap contracts</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap contracts</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap contracts</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Foreign currency option contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Foreign currency option contracts</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113589072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (6.4)<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="num">$ (9.3)<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (6.4)<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="num">$ (9.3)<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118763808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Detail) - Minerva<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>petition</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Petitions filed | petition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MinervaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MinervaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114332272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">247,730<span></span>
</td>
<td class="nump">251,574<span></span>
</td>
<td class="nump">247,524<span></span>
</td>
<td class="nump">252,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,327<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">249,793<span></span>
</td>
<td class="nump">253,658<span></span>
</td>
<td class="nump">249,537<span></span>
</td>
<td class="nump">254,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122044320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 23.2<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
<td class="nump">$ 43.7<span></span>
</td>
<td class="nump">$ 36.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 14.4<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="nump">$ 25.3<span></span>
</td>
<td class="nump">$ 20.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200112674624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices (in dollars per share)</a></td>
<td class="nump">$ 74.59<span></span>
</td>
<td class="nump">$ 71.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock options outstanding (in shares)</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding (in dollars per share)</a></td>
<td class="nump">$ 51.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.44<span></span>
</td>
<td class="nump">$ 71.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 77.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.35<span></span>
</td>
<td class="nump">$ 71.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.35<span></span>
</td>
<td class="nump">$ 71.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 97.91<span></span>
</td>
<td class="nump">$ 75.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember', window );">RSU, PSU, MSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121584944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 27.42<span></span>
</td>
<td class="nump">$ 20.80<span></span>
</td>
<td class="nump">$ 25.92<span></span>
</td>
<td class="nump">$ 21.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122317552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 293.3<span></span>
</td>
<td class="nump">$ 252.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">65.8<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">328.5<span></span>
</td>
<td class="nump">310.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 687.6<span></span>
</td>
<td class="nump">$ 623.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200112648016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information - Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 407.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 394.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">506.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">206.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">47.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,236.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,236.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,187.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(738.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(738.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(705.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">497.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 481.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_GrantsReceivedFromDepartmentOfDefense', window );">Grants received from Department of defense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion', window );">Proceeds received from government grants for capacity expansion</a></td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrantsReceivedFromDepartmentOfDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received from Department of defense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrantsReceivedFromDepartmentOfDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from government grants for capacity expansion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122593824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Mar. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 26, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,026,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,435,700,000<span></span>
</td>
<td class="nump">$ 2,100,700,000<span></span>
</td>
<td class="nump">$ 2,906,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114224240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,026.5<span></span>
</td>
<td class="nump">$ 1,435.7<span></span>
</td>
<td class="nump">$ 2,100.7<span></span>
</td>
<td class="nump">$ 2,906.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">272.1<span></span>
</td>
<td class="nump">594.1<span></span>
</td>
<td class="nump">534.5<span></span>
</td>
<td class="nump">1,235.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">80.8<span></span>
</td>
<td class="nump">106.1<span></span>
</td>
<td class="nump">166.7<span></span>
</td>
<td class="nump">214.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="nump">32.3<span></span>
</td>
<td class="nump">61.2<span></span>
</td>
<td class="nump">69.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">9,448.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,448.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,071.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">464.7<span></span>
</td>
<td class="nump">987.1<span></span>
</td>
<td class="nump">1,024.0<span></span>
</td>
<td class="nump">1,937.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">540.6<span></span>
</td>
<td class="nump">256.4<span></span>
</td>
<td class="nump">1,072.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">56.1<span></span>
</td>
<td class="nump">68.2<span></span>
</td>
<td class="nump">116.0<span></span>
</td>
<td class="nump">137.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">57.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,940.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,940.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,881.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">385.4<span></span>
</td>
<td class="nump">310.4<span></span>
</td>
<td class="nump">719.5<span></span>
</td>
<td class="nump">669.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">109.9<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
<td class="nump">170.4<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,250.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,245.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">144.8<span></span>
</td>
<td class="nump">117.3<span></span>
</td>
<td class="nump">298.9<span></span>
</td>
<td class="nump">251.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">52.3<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">101.0<span></span>
</td>
<td class="nump">32.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,464.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,464.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,461.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">58.3<span></span>
</td>
<td class="nump">47.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 3,770.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,770.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,454.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200122675952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">74.90%<span></span>
</td>
<td class="nump">69.10%<span></span>
</td>
<td class="nump">75.80%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">14.80%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">14.20%<span></span>
</td>
<td class="nump">20.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">7.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200119218880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="nump">21.80%<span></span>
</td>
<td class="nump">20.70%<span></span>
</td>
<td class="nump">21.70%<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200114511248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,575.8<span></span>
</td>
<td class="nump">$ 5,518.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,373.6<span></span>
</td>
<td class="nump">4,237.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,607.5<span></span>
</td>
<td class="nump">4,565.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,574.1<span></span>
</td>
<td class="nump">3,458.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">36.8<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">607.9<span></span>
</td>
<td class="nump">601.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">547.1<span></span>
</td>
<td class="nump">535.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">267.6<span></span>
</td>
<td class="nump">265.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">209.3<span></span>
</td>
<td class="nump">203.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Total acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,519.8<span></span>
</td>
<td class="nump">5,465.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,330.5<span></span>
</td>
<td class="nump">4,197.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">28.5<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">19.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software embedded in products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="nump">$ 20.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121566496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2023</a></td>
<td class="nump">$ 117.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">225.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">210.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2026</a></td>
<td class="nump">177.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2027</a></td>
<td class="nump">$ 90.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200118932064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at End&#160;of&#160;Period</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200113542832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,876.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="num">$ (15.1)<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
<td class="num">$ (45.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">5,300.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(127.3)<span></span>
</td>
<td class="num">(89.0)<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
<td class="num">(59.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(118.4)<span></span>
</td>
<td class="num">(104.1)<span></span>
</td>
<td class="num">(118.4)<span></span>
</td>
<td class="num">(104.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(153.4)<span></span>
</td>
<td class="num">(80.9)<span></span>
</td>
<td class="num">(267.2)<span></span>
</td>
<td class="num">(43.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="num">(34.5)<span></span>
</td>
<td class="nump">129.1<span></span>
</td>
<td class="num">(72.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(138.1)<span></span>
</td>
<td class="num">(115.4)<span></span>
</td>
<td class="num">(138.1)<span></span>
</td>
<td class="num">(115.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">19.4<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140200121489120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase Share repurchase (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member', window );">September 22, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares | shares</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 850.0<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharerepurchaseplanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for share repurchase plan [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharerepurchaseplanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>holx-20230401_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:holx="http://www.hologic.com/20230401"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="holx-20230401.xsd" xlink:type="simple"/>
    <context id="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib9bdb4fc46664af8a84c1c523f7ace9c_I20230425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2023-04-25</instant>
        </period>
    </context>
    <context id="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5e15af082687422bbd21dc55ec8a2595_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="idb909bbe5f2540069cf207a78f1cb2e6_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i7810cad7d02247f1b5f6e85c336e9c52_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i4e7edafb8449411a8c76ac568092157e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6e73db97997e4106b0bc73a6ad117fa1_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i728193aa1ef04e4885f20273a8721f30_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia5e31f17a8d64c899b2a4d460af241d4_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="iefb8d073427345198f8e66225de022d3_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i51d792fb77c74175a153de2fee725a92_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ic1312159d6804c03a112ae774c849cbc_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i59ce45cfb8f644079576717c187966e7_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i82f62b3f136743bfaea9f76d6dccb550_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i8f733818a0ef4bb196bde5377e392367_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i10b8515303b04633b81845a6340517a2_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i673ceda2567b4fa094005314999c6692_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="ia85329a5af434956b507a245eec1e665_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i2b259872da0e4891b258402238020b91_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i99199df891b54e60b263241f795a8011_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i90312f39be0e4ef6b8f3efd53c5c985c_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i0c725645e1ff419d8af3688fb583ae78_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="id04350ab7f4942d6aab89335886fa0e8_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="iee84ef7457ef44eeb536b6069b3b635c_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="if17809e1aa754e809b00400ef2e7e9df_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i3d882caad56e40fca4cbee08e9438a1e_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i08891923a5404211866f245155440f87_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i8ba07efafd444b4a850d6efce144fbbb_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="icaf436100d4049459a74792e8e6a0154_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i7eb18f90afb34984ae954b76e9f109e1_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i85799d0eb64349758943ccfaa1cd193c_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i508b938b9bd04731a116a511304508d0_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i98e54d72ad324c54a434cbf20c7e1636_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i3002622281154961926b0802bdcfa78d_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i5e5f81fbde654721b420a4cceaa0f658_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i203832cf31694163bdbf1410232cae9d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc29699290454610abbfbea53d3b09d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11d95c79e50f4f2c96697ca8aac2736e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0326c94c4f849e78bc4ed1ba0305489_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id6693a30bd6c4709a18368e12c88e1e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i24c41465ac6b4629acc426e96781619e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i81231f9a527e4841b03062694c05a420_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i018c97cc9d50417598b74b0bc1e7d870_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if66a35a33618446cb52289632d995392_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idbd87583fd904b4ea56862fe48bd6b48_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iacd73e1d3acb402da10be07c5fc515f2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i80e5484a0f4c43d3a4b5386b8dd0cdfe_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id2dcc05bea314588b412a9f27a0d2096_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6643d03654fc4e74abb8215ae7099bc5_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i27fb968480674498b86f260f5c557cd2_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic86ced2c50224d87b806cfe2700e9451_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i20558280389d4b6882132ba9b3803cd3_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic59b200cdcd64399ac289fd7af196ea9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i51d2c2c178954ebd9a39527357d76c74_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia84dfba6a6bc4632b38560142cba9e81_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4ffef3244c874e85b508fa350a2554e6_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i2168b403a0ee4e46af7c9636f54dfd4b_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic2d09a84e2db4fa7882cd618c44a4279_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i2c08c95f31c343c48236eb8ce8c31567_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia4b1e7bfe27e4e76be3bf69f2d53e02c_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3f37682f6f5145a58f06d84f7b8e61cb_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iaa9838ba0466484bb137158e7a1567da_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="icfb0b1cfe7eb4bd1a09a13946bcd2bcd_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ib398b6fc80d746a2b8ae5fc069cae6a0_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i565fca98edfe40c8a7d74fcf1421de87_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia65e97210e574278b454ce584c3cad8d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i099e7069f9c44890bb40a7afe3614761_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i5eb7b04583b44661b5c05b7efe129429_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i781a7f522edd4c4d951e77997571c15f_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i24aec643f412452fb0caae5eef3a39d9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia13676ccbf324673bdda7326d7f4f08b_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1fd32066656d441a86201c5e12956de1_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i619d5722b4ca48d6a5f05a12991734fe_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i9b1fa5ac56b84e7aabaa1944179b29a0_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="icbef055aeb94448c964ef00d2ce1fa7f_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icf08815cbd2a48b4bf69282fcffa315d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if76e12316bf64558aad72df91e631bbe_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia8f65bc9a643471eb4699958d5a56b0e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i65ec9d62d7b24c9aa3d020e9fd43fde0_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i1d3508f3a72645e19ce96e3f933f92e3_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4b2ddbfb01cc43e6ad631c8c163cf4c5_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ifeecee944b96477993784167af0ec4e9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia1c381398c324f19a228c262c54de902_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie61d3c1656c444e2af045a6884b5cd0f_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i387d4056e84b4ac180d2aa7e3393329f_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4ad2b30985d644f0a50a8cdc970d6f5d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i12fc4260d3174dda9b586fb230fa8f91_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if88ec2152274467d88041d6be4c30ff6_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i58119cf2e18e4040ad7d0545f5502d37_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i231da92875a34437a5282b675e6426d9_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i18684c24e2714ec8a43866e747472e7c_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4e11b702840946b7a882d86468c5c654_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i620f31a3d0b94dc7a06fa436a267fa09_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i33460790b19b4a16b5c379ca34c18e06_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie287b34c173446e4b3ae5678053afeb1_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i349699c3313a4532a7a576011d54ac58_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i8841fc4453d947b1abc6b677fcdf4c75_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1353f3f554864abca59c0d2acd652329_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i32f4de0bdaca42439e9615354a987d7c_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idb875e603fbc4fe1a1e9ca9acea597bd_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="id4d1acff3bb149edaaf709f12e763dc4_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ifceb9765ec71498ebc94cc6a41dfb085_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i071c0ae1705441148ac8e82637f13843_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0ab114a082dd4e6b82610ed0a84ed5ac_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4db81a73fb034bce8b07cb4d54adb4d5_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i33e2dac027774b4fbe6ae5f2f7c513a0_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i5940fd34036f48a8b0d1a0f4d3246913_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i78d825bcee284151aa724fb0e57ab91e_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="idd73e2dccdf845d988743f5b2afd0a7c_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4160efde569446d6a70f5cb043ff5bed_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia8a2096ceff74f10ab7ea238449b6ebb_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i010f85da839c4f788ae3c9678dcfee88_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i7435b5e546944ceabfd36aaed78afb22_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="if7cf0a8c804c43e78bbd2ecab53fa929_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iddfb59c21d064a0095827e9fee15c650_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i008fea210a79421792efe38c181b3afe_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id38424d055ed4ce5b58b21cb84139032_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i9c824d2f804b4f8cbe8774772c549f65_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="if7bb65acf97a4446adca1cf306eb6abc_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic404fc96f0c64f51b5b4f5e6737f2d54_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie823dd7cc3af472b9bd804c6b639b007_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6a312bb9f01c4777b32b902e8248d9cb_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i919b1976ae604ccd9ecae3f5a1044a6a_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i1e166105ee044f2891a1e4feecf8f137_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i8bc35b3bc4774106ba45e0abe86067ab_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i188645d6d3b14ab7bb87691db06a8205_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if8a579c3edee4243a5457698bafb3ba4_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6e8a695c629c41f2bdb54152ed3a5cae_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ib7132a15dec44f3599d3ef99c1e30826_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i71d77f036b144ab2bf62c85dff6e86fc_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="idbd3e99c4b6349de8cdb1e8f0a2b6311_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idc7b0243cde744aebbd25a510394a248_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie705a94ebd6c4795aff105e679f1be54_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="id0b9944219eb46c087a0481d0206b4cc_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i28bab2b9c104428e8c55999a506f0906_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i53f619cf4bfd430793d0539858960750_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idc6d823fbbc94feab179d253e4be9aa3_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iefac68ca0bdb40f387bdb4a775659af8_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i962c4b39ad9b43f789b8793465348724_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ifff7e3a68df34606bf1106251ac4c25e_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic726db062cfb4ce3bba024370023e079_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i763fd5b73588457eaf359445f8e85c8a_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i18c2774c2d1e44689b12b1bf19aad67f_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib0bef0470fb04031bd8d1f8ca4de2a26_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i736cfdfe36b64ca6be804529485f2142_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ifd755a8928c347638dc5777e510229a4_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i28d2b38d322445518df9d6519589e24a_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ibe30b8b63776445486aad925dd9774cb_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i00be1902f11b446090c0c094fcc5c85e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i48755cfd484a4e62a2c8362de38c8b4f_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i327da3cafe3c4d0aa665e7ce8be8698a_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i24dcaeab411b4af8a6f85a2871d1bbc9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic0a871a4c3174df7933da7c6f14e608e_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i058c9fcddfcb4b1fbe11fc320f77993d_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6f6dda388f7b41c38ba9e6e639ffcccc_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i05806bc883904e079e94fe4711a9df85_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i694b9650b4154c7a9932f7c343e478ad_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i904efd675fc84cb4a2bd864cdd35efb3_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i364049c727f64c5fb9da068da0a5f058_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iefff25e1fa9f4bf28ac85461fcab5263_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ifeb1b8233acc4dc4b6b32e2401873bfa_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i1344c7b5279d47b78b2c5cf3500112f0_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6f792878945149fbaac1be5445470b02_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i92c691696ff746668ac0cedf53217ef9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3e8a0fe062b74f88bdbdc98402f1f734_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i80ed6153920c41a589f4f344f8dc62d0_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic44fcf0cfb084b098571baf1d7dead87_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i04aefe98ed524fa9b9e204dc0508b87f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7c473319bb7c41ebbe6a91f325696f90_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibf681aba2c0745179379eda917259f24_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iae8494d630974166892e8a6e322ce2c4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i201acc12848f4295aca92e64a29fae3e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6bd296de48514683a96ee90d09cf647b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifeb3334f07144b1eb56036eff778881d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i931efb624c5240ec87bbbb2d5e3977f2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if3e076bd0f834d7587361fc0c5740091_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6fd04ba0e0c14cbabfcf0fd0dbb55c00_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i82b47f9030b34b429bca8c704864b6a6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idc0703bcc24f48e681cbcfeb3a9412ed_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i363eb4ee29e54e13ac0aefa0ccbb0a81_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id7048c5fe4e141f89ff18d17889ef492_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia339d290baa7479185ee1c02c1479b85_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ide1e849e105045cc82813ffd84975071_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib76b381e70524c158eaecba0aab88c70_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5a0364527a074f269837eb697e13e3e9_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i52cc5c24426b411f8a9f807c5312d497_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i3611e0322f3842f69d4e5f89028d5c5a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i9ad19bdd30714b10a58f86bc3fcc3d06_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ide78313ff5a246378c00a3dc183d036a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i22f863ea4d044887a4fe175344a4ca00_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib95a1ff83f2346e5bcbf04f2536fd2f8_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5abefbe66a5f4800a36fd4789769988d_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iccdf15e8de9a4fc8a097e876e609f31f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4b4c567216914b23a257e8ed2e840c5c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5ad1713d489f4ef1bef77718bdac89c7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1c8339ad8e024acf93252e724b2036bd_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iba44341dbd4c49499423c450d88a5f7b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i9c89a75c14ea452587934b85e1cfe79f_I20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-29</instant>
        </period>
    </context>
    <context id="i3b8baa43f0c444d9967f0f28cc75f205_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i47652b3263ee45bebe444c08c403cbb7_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i928aae1d79e6431e905c9e98405eefaa_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i6dfbd32be37f4246a381b2110a8442cf_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i0e135792ff2e44028a70fbd8451b5761_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i4433cc201f8a4406b5cfe583df4d23c5_D20210926-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="ibd53b814f8d744b79592fbfe99c58ed7_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ic36e281c399144c0bad6cda43a4171d1_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ife2f479793bd48879075f83c4865d01a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2a2cca1bc72f4a3b8b4112b767c117da_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i24a5378b5efe4b46aadd68616949b0e6_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9b57347bb632482e8fc7285916ac3e23_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5117d87aa771468c8a93f0fb49b868e5_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iae729caa8b26476fa7e95ea535cdece8_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0e366dca1317445a953da3bfcef32ef7_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1cf6687d788e4af28817964ae346e8c1_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id871579f75c04445a8b7aca98eb0f84b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:GermanyPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if4a8fa6d9cf640188c80440fc42539f2_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ic7d8a9c2381e4790949255fbef7b39ab_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia56ec6c8bc03468eb039dadf25c0a74d_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i8578d43dfaf64c8aa2e2a99308499a06_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifb3e905270394c109f6dc2a65bef2a27_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i5618fbac4e2b4be5a3ede449c24b7524_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="ic3c7a85f58744f0b81a452662f16cdf2_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="ib2d817532d0340fc8fdcd0aa45fe0b08_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i362f953e083846c1a0d8a19e3a3d35a4_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i36b0a0a905884991b094498a4388a459_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i03d18c480fcf4620b188b43833f9d17f_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if26561fc220c41d4965d21fca20289a2_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i736ad9f5dec146508d1fd621891e1303_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i11c06da9d32e45ea8c28dfd12b49dd4f_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i68128aa8157c4c17b7462201023eebd7_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ice2199bd16f8427796fe11603f851c83_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iec05146aaacd45a6ba9801ae96e2a6b4_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic4009b1b411c4bd99225528c5754c15a_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i246a361fa54143f2b5d14724951a2680_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i88474659b3544a10823c37e769f86d35_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib471a4ccd83240ae9ed952772145134a_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ie900720f8e2b4ab09db04fe14ad224e5_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i037d769c2b574a0992ee94f32441bc77_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i382a786b487046818da8713340a3f1bc_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AssetSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i9277edbc6f004c26b5932c60235a6b84_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-23</instant>
        </period>
    </context>
    <context id="ie5860214d3274cd895e658c77224dcc3_I20230323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-23</instant>
        </period>
    </context>
    <context id="ia270fd5f123248878a148a83df3feb24_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1013586a3c0b4067b24800f58a35dfe2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">holx:InterestRateSwap2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id7733cefdaf04d268e9460397af1c814_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i388bb22d67bc405a988ad5c4cc5a8547_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i687a30dc10784ff3953d24ed83075533_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i8b069471a6fd4ce1941c6017866f9304_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i784d2587627b47089f80bcf128fac206_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i14ea93c725c840b2ab4f76c58a3c62ed_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i41f4ede37bd5491c9c3625e94d0c9aa6_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="iee4564531536478f92ff8960a39160e7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i20c899443173415699ab4d5da5e77fc7_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i542498cff24b4020926268c17c708196_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iafea2d522ec04d37847e57b9cb641004_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ic766fff5fd0948058ce9d491f9b85de5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0b6e3f3bd25843a195f629f91c7fd0af_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i291463358b624afe8c68e32119ade5ec_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i21f153a4f042425ba023e92476fa0a40_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ieaad33fabd43401bb9e20fe1c59e848a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i734d4c683d694f60ad32d47670c8e8cb_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i2a435b609b8d4c0d8f1f4465429c3589_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ifb6a7d62503b44f490049c2405cde9d0_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i419d4edca16d4132b372c619b71876ba_I20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="ie8865820575c4b57a1e17f866a521496_D20160304-20160304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-04</startDate>
            <endDate>2016-03-04</endDate>
        </period>
    </context>
    <context id="i81a0b7eab81d4b8d92c778a4c8d79fcd_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i795d7b50270e46b59859da10505b600e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9dd31e84ed8143f59b13dce68511f55f_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic3779670e49d4581b2341db1f4f31165_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic3a076f8486b462fb0308507b0cfd5da_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i8efcfc733c084819bce8abd34750c81e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3e92370bf72c4c3d8b8468b47a8d76a3_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="if89bee2a95d3497e8c28b3ae3c70aeb6_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5d2587dcb18149b982e88c5da8cb0cc7_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="if545f6845c9f47cda87d291c6a78c44b_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if7ed81ad27694ec28082eac891f6d828_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i75a667398f82417da0b693cf783d30f2_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i487840b9375544c692f3e4f0eafc76b6_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i8a4a5ccb5a2d4441a9792f5dd886c64c_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic3730699eecd4e8fb9c34c17fc322da1_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ia5aae5573096400bba7f7fdd96e479e4_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i32fbb9fff77847d99951beda09715376_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i67e3e8ebefcf44d38d43290015d3cc68_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i20176e0cc3a546dab26b5191397f4122_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i58e3a20cda34489b926a83d90efbd85e_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2bbf39abedf04a86aebfbda7cfdb9417_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i50daa327fe0142aa9a9468a3e86f64c6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i509052b355f0473bb8198ebe916a409f_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4a246129f343418eab464098000292bf_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i27a08777635e4e009b32b403ac06831d_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="id2eccbfd571a4ca7aa01513771ff388f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia577a32b749748fbbca9c17d38a8ea86_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4a3f922b1bdf4d05b948c12d6a48fae3_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ieb0eac28104f433fa408c7b9929c8afb_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i522660b505a2425fb1ae75796bfa1231_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i99ec6b91f8dc4e839b0621fa03ea273f_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ia326a75496cf4845bd1f54f9ac1dd86d_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ibdf55613aebd4ac69743fad69a456a00_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iaa97bebc3b004733b9c34994ac8eba59_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5108570aa8d24fd39f37539e9a93e166_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i5c4425324e9249c3b78b220d544a2a6e_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i56c17ccb48574e919a33ce08e5de772b_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ic0da1df1fe1a44d4bcb27d37cff8897a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id83b89bbba274da1aecdd2d283d1ce13_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="iaa02d3fe1f124afaa799f62caa9b7a35_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2eeb9ddbf5a34bb3a14921940aad31a0_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="id601e4f7392c49f69fb44fca0c219a32_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i61146379fc1346a09fc79ae328fc4ae7_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i987c4cf9a87c4b33a5d8acfe456b5212_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2e5d286446e24832a9b09dd26e54365c_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="if6940db18e044ac4baf19aa208d8ab33_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1505009eac544214a4c5d2a5083d4b87_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i0c33a8795c3a41f5bd50f90ed5b9bf52_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia73b8a87766948a89773af45de8aa1a2_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ib59e7423fc3348d2aba0bd00f14d79a2_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i69214a927e6a42459ef14fb9247a6f7c_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4d97279b97e3493bae5fe07e0a15dabf_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i3e39021ecd254dd09befad99c3986073_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id07828dc44634020a4b14b73f7eb87fa_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5f748d0709e6431ba2b044bda85c7b9d_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ib179c1e06a7443498a0049053c6f4bce_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id9059edfb45a4a2d86a83a32fbb97888_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i998a08b240cb4165815a4c0f245cb61d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0b2dc025fcef4752948c5b989d73d843_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i53d03d024a12410989ca0f3bd337f2c3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idad017932b214b8bb1c244596a2c3da4_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i98fa1a0f46224950aca1017cb9727897_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i26556cf1cbe64603999108ceccd4b8c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i716db929cf324a8bba183dfc7e6ce250_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6fe4337c2984c3d86c299d64abafdc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4f066bb0ba54024856a9b5805b1de7c_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="id36f522d615d45cc9db23bf02926e03d_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i6fb87637671c4962a157d8c69ffb2d58_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="iefc79822f08d45ccada45b5d08c85f45_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9f4577c73735428b8f48f2233c6a5b4c_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if4f5794ab1cc4d90b0150fded4465f9d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7de6ecf9ab0b44ac88fad82530f8c45d_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3b9c6bece29543538e4949188c1b8250_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i08795cf6d72a47e39f4e264449f2e14d_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib439241bfa8c49b394aef2e2769df894_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i05ca154a812442e69660b5624f4c20c1_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4c1f163e64434b4098d3210b8c8872a1_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="ic417b6f69d4a4c8f8db217c37f35a4c6_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i975de9ea5e4c4452bb7f5ce1b9e42fac_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i5f082150b16640738cb5d6c0f5be0de9_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1f11753d84724189a8eb0ac0a40c5e1d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i99b24c3fbef44f539ea8da6b56c6635e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6b8947efb99844ba8ea929d65eebcd7d_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ie52504be379e47e3a03f6ea3ee3b79fb_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i87488652d2ac42b786bc94af875d7063_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i17798170e5634c5681bad6fa53526f87_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i4386093d3b87463587e092da86bad387_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i038a9776dfcb49e8b6ae15ed7ba884f7_D20210926-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i176f6f8fef46496b9bd2ba8947704790_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i4f431b6d0dae4178a459f78b51529416_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2c5c4ff0e55242cd99cce7ae6bc9417b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id93ac80af1864da895ea77544df73563_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i564316675084451483c816bd42aec061_D20220925-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="petition">
        <measure>holx:petition</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY18yLTEtMS0xLTEwNzk1Nw_760b1527-e1ee-4b3e-a253-5a95d3f1a3f9">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY18zLTEtMS0xLTEwNzk1Nw_68ecde69-b2e8-49d4-bd2f-f676825f78e5">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY180LTEtMS0xLTEwNzk1Nw_53415caf-abb2-4743-a83d-266026e3d348">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY181LTEtMS0xLTEwNzk1Nw_c2d4ec31-d407-4676-9f27-25e351e2d79a">0000859737</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80L2ZyYWc6ODljYWRjNGUzNzJjNDM3Mzg1ZDYzYjUzYTZlMzIxYjcvdGFibGU6ZjA3NDkwYTE0MDcyNGUyOGI4OWRmOGJiODRhMWIyZmMvdGFibGVyYW5nZTpmMDc0OTBhMTQwNzI0ZTI4Yjg5ZGY4YmI4NGExYjJmY182LTEtMS0xLTEwNzk1Nw_5357edeb-da3a-4b2c-9ad9-d67eac6a2d60">--09-28</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i04aefe98ed524fa9b9e204dc0508b87f_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfMi0yLTEtMS0xMDc5NTc_975367f9-2d01-4884-834f-84b67dec7af4">P3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i7c473319bb7c41ebbe6a91f325696f90_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfMy0yLTEtMS0xMDc5NTc_75643e74-0247-4fac-b008-ca52b301d1bf">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ibf681aba2c0745179379eda917259f24_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNC0yLTEtMS0xMDc5NTc_ae7c286a-ab0d-4851-b441-f298159a6e18">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="iae8494d630974166892e8a6e322ce2c4_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNS0yLTEtMS0xMDc5NTc_dd883d5e-d5fd-45c2-9a63-3009d99f45f3">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i201acc12848f4295aca92e64a29fae3e_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80MC9mcmFnOjk4MWFmNmJmNDdlMzQ1N2FhMjVhMjA0ZmU1ZjJkODkyL3RhYmxlOmQxNjgyNTNlY2NiYzQ0YTI4ZWM1MGFlMjczMGU4YzEzL3RhYmxlcmFuZ2U6ZDE2ODI1M2VjY2JjNDRhMjhlYzUwYWUyNzMwZThjMTNfNi0yLTEtMS0xMDc5NTc_bd15b435-ce00-4a09-888c-7994165d79d7">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg1_5f3ec55a-c5f4-4633-a23a-97f46455cbfe">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6NDI2YzRhNjZjMjI0NGU0NWE2NWE2ZDQ1YmJiZWRlMTcvdGFibGVyYW5nZTo0MjZjNGE2NmMyMjQ0ZTQ1YTY1YTZkNDViYmJlZGUxN18wLTAtMS0xLTEwNzk1Nw_f7261090-7fd1-4374-92de-4579b28657f5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yNjA_bd02df8e-b2f1-4a29-8e0d-1419733e1b7e">2023-04-01</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6MzUyN2M2NzNhYzc4NDU5MjliNjZiOTVhNjc5ZWE3NzMvdGFibGVyYW5nZTozNTI3YzY3M2FjNzg0NTkyOWI2NmI5NWE2NzllYTc3M18wLTAtMS0xLTEwNzk1Nw_33e5a826-5ad0-4cfd-a87f-fbfe621fa30b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg2_7cda7d01-a5ef-4e26-976f-6d712eed4a09">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgx_8c04cef0-ff29-4eef-92bb-8d6c3a16955f">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8wLTAtMS0xLTEwNzk1Nw_8c38fc51-d229-4f14-b9c2-d2879d0ea841">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8wLTItMS0xLTEwNzk1Nw_337d7df4-1feb-41e0-9079-ec80cbf27b27">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8yLTAtMS0xLTEwNzk1Nw_63bf32b0-82e4-4ea1-972e-0e63c39ba17b">250 Campus Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV8zLTAtMS0xLTEwNzk1Nw_4aff1176-b225-4b3b-8dd8-8abb564fe772">Marlborough,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV80LTAtMS0xLTEwNzk1Nw_6b710717-0edf-4f23-81a8-67620c205c6f">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6Y2QwMTI2NjM3YjJhNGUwYmJlZGZjMzVmOTllZWIwODkvdGFibGVyYW5nZTpjZDAxMjY2MzdiMmE0ZTBiYmVkZmMzNWY5OWVlYjA4OV80LTItMS0xLTEwNzk1Nw_1ba4f2c1-2a45-4307-9e35-081ad5ebadf6">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgy_84eb516a-c6fd-48f7-ad47-48599cbaaa8d">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgz_34f2afbd-a61f-449f-96ff-b327750d3b91">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTAtMS0xLTEwNzk1Nw_5e368464-8ac8-489d-8f01-49a70aac6072">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTEtMS0xLTEwNzk1Nw_719d693a-7b72-4d44-a098-0872d57820f1">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZGVjNmZjYzRjNDkyNDZlYWI1MmJlNzAyM2Y3NzYwN2MvdGFibGVyYW5nZTpkZWM2ZmNjNGM0OTI0NmVhYjUyYmU3MDIzZjc3NjA3Y18xLTItMS0xLTEwNzk1Nw_9de673d5-0aaf-4253-8bc0-d423b686d2e6">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjc5_69b5adcb-f606-4dbf-a4d1-26c5973ad1e9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjg0_1d4b92ca-2832-4361-8a95-a5927f9cc8e9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8wLTAtMS0xLTEwNzk1Nw_dabe2492-6a33-4429-8ba8-626c3af354ec">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8xLTYtMS0xLTEwNzk1Nw_9c1813c2-4e55-4057-9265-81cf93f60bb8">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGFibGU6ZTJlOGJiNmZkNTFkNGI0ZDk4MmE1ODM5MTc3MGI1NDYvdGFibGVyYW5nZTplMmU4YmI2ZmQ1MWQ0YjRkOTgyYTU4MzkxNzcwYjU0Nl8yLTYtMS0xLTEwNzk1Nw_f739d4da-327f-4237-803a-2e71c08ca99a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjgw_2bafceea-2655-4cf2-8b65-e40573fe9b49">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib9bdb4fc46664af8a84c1c523f7ace9c_I20230425"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xL2ZyYWc6ZDNhMjJmMTVkMmI4NGE4Y2I2OTAyNWE2ODkyYTQ0YjUvdGV4dHJlZ2lvbjpkM2EyMmYxNWQyYjg0YThjYjY5MDI1YTY4OTJhNDRiNV8yMjAw_b3bef8e0-f4ad-48d4-b835-6228b243eb6a"
      unitRef="shares">246118192</dei:EntityCommonStockSharesOutstanding>
    <holx:ProductRevenue
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy0xLTEtMS0xMDc5NTc_d8d65700-a127-4f23-b68e-17bf70a919ac"
      unitRef="usd">837400000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy0zLTEtMS0xMDc5NTc_ef512525-8d92-47a8-b897-da8d8a66779c"
      unitRef="usd">1268200000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy01LTEtMS0xMDc5NTc_2da6931e-e286-4cdf-b66a-75198ae55438"
      unitRef="usd">1723800000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMy03LTEtMS0xMDc5NTc_64ec7727-7cfa-4b4d-842b-2672798681e2"
      unitRef="usd">2571600000</holx:ProductRevenue>
    <holx:ServiceRevenue
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC0xLTEtMS0xMDc5NTc_2c7310ec-802a-4b77-b11f-30b9a4756b8e"
      unitRef="usd">189100000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC0zLTEtMS0xMDc5NTc_dc5deab6-c112-4d2d-a7a1-3d0fd5208609"
      unitRef="usd">167500000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC01LTEtMS0xMDc5NTc_6fc383a7-c2bc-43d0-bd7b-dfe0622d1ade"
      unitRef="usd">376900000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNC03LTEtMS0xMDc5NTc_9ce03b71-d5f9-4bd7-8566-f725cc34d0a2"
      unitRef="usd">335300000</holx:ServiceRevenue>
    <us-gaap:Revenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS0xLTEtMS0xMDc5NTc_62f378ba-02a7-4a91-abcb-c372ff19ccdf"
      unitRef="usd">1026500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS0zLTEtMS0xMDc5NTc_89c4c246-8a90-458d-8681-049cdf5ee7fa"
      unitRef="usd">1435700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS01LTEtMS0xMDc5NTc_bfde4058-d804-4a08-a265-774b09ec1335"
      unitRef="usd">2100700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNS03LTEtMS0xMDc5NTc_56884f70-36b0-406d-8af2-bee3a0f40cbc"
      unitRef="usd">2906900000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy0xLTEtMS0xMDc5NTc_161495f3-8420-4939-aad5-819b8233fd7e"
      unitRef="usd">292100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy0zLTEtMS0xMDc5NTc_e55cb2de-5bb0-4722-a8c0-126a36c275a9"
      unitRef="usd">322600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy01LTEtMS0xMDc5NTc_648f69a8-259e-4be6-8238-956b2ebd8f60"
      unitRef="usd">588300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfNy03LTEtMS0xMDc5NTc_30b4b256-85cc-4b50-bab5-896fc43c5daa"
      unitRef="usd">640700000</us-gaap:CostOfGoodsAndServicesSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC0xLTEtMS0xMDc5NTc_486804f6-f335-4765-9e2b-cb9ed66649d5"
      unitRef="usd">52100000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC0zLTEtMS0xMDc5NTc_94c97dc3-ff93-48d9-9d1b-2965148b6c4e"
      unitRef="usd">72300000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC01LTEtMS0xMDc5NTc_fca18146-aa21-490f-bd1a-7e8336f0c2b1"
      unitRef="usd">107700000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfOC03LTEtMS0xMDc5NTc_31861bdd-6b48-4755-bcb7-6e28a97ed0d5"
      unitRef="usd">147200000</holx:AmortizationCostofGoodsSold>
    <holx:Costofservice
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtMS0xLTEtMTA3OTU3_789f42d7-56af-4d51-a653-2efd60fe680e"
      unitRef="usd">96500000</holx:Costofservice>
    <holx:Costofservice
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtMy0xLTEtMTA3OTU3_91471bb7-0a93-4138-8a0d-9c8ccef77568"
      unitRef="usd">94200000</holx:Costofservice>
    <holx:Costofservice
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtNS0xLTEtMTA3OTU3_1766b533-94f5-4ba1-b422-35b6c2e219a0"
      unitRef="usd">201000000.0</holx:Costofservice>
    <holx:Costofservice
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTAtNy0xLTEtMTA3OTU3_0d7b2eb7-6b8c-4d77-86bf-5599e51fcb89"
      unitRef="usd">186100000</holx:Costofservice>
    <us-gaap:GrossProfit
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtMS0xLTEtMTA3OTU3_adcbe472-bdfb-42c6-af04-f3eb45185c1d"
      unitRef="usd">585800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtMy0xLTEtMTA3OTU3_5d952f00-f6c7-4024-a4ac-be69c2739b52"
      unitRef="usd">946600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtNS0xLTEtMTA3OTU3_b45e47a0-e847-483f-bd79-7e45cf90e795"
      unitRef="usd">1203700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTEtNy0xLTEtMTA3OTU3_783b9262-0722-4857-98c2-fe1a08c03af2"
      unitRef="usd">1932900000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtMS0xLTEtMTA3OTU3_69b7bac1-1ef4-4d26-9620-4187540476c7"
      unitRef="usd">74000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtMy0xLTEtMTA3OTU3_3e1d18ef-25b3-4f2d-a370-24e46d13c5e6"
      unitRef="usd">69500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtNS0xLTEtMTA3OTU3_e544ed62-743c-40f5-b623-b3f4c1c3d08a"
      unitRef="usd">148800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTMtNy0xLTEtMTA3OTU3_d7cfc034-25d8-4fa2-8a09-2df7730dcf28"
      unitRef="usd">142300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtMS0xLTEtMTA3OTU3_73f16747-2673-498c-ba1d-835726f17bd5"
      unitRef="usd">142400000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtMy0xLTEtMTA3OTU3_3ea3c9f6-1edc-4d9e-b273-4c67c543972d"
      unitRef="usd">171400000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtNS0xLTEtMTA3OTU3_cec75862-672e-4c83-9b07-64afc918a15a"
      unitRef="usd">305900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTQtNy0xLTEtMTA3OTU3_8ebd5067-24c2-4ecb-9bce-c24b8504f25d"
      unitRef="usd">318700000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtMS0xLTEtMTA3OTU3_4b67d47b-f399-4a9b-9678-17659b2f9fa6"
      unitRef="usd">100800000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtMy0xLTEtMTA3OTU3_a944fe91-86ff-4860-a2b3-465655910edb"
      unitRef="usd">100500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtNS0xLTEtMTA3OTU3_79185d96-a191-45f1-ba15-f1bc8b03854c"
      unitRef="usd">209300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTUtNy0xLTEtMTA3OTU3_40fb03e2-63f9-4830-b7b6-95ae86034abc"
      unitRef="usd">218500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtMS0xLTEtMTA3OTU3_a97b75a4-7da0-46b8-8115-f84126df27df"
      unitRef="usd">7100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtMy0xLTEtMTA3OTU3_31587ecd-ac1a-4596-b083-d29a6a09095b"
      unitRef="usd">11300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtNS0xLTEtMTA3OTU3_d09e4773-e80f-49cc-ae70-dc216d5dc5b7"
      unitRef="usd">14700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTYtNy0xLTEtMTA3OTU3_6eb01a4a-986d-4429-b2f1-fd56cd3da340"
      unitRef="usd">22100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktMS0xLTEtMTA3OTU3_40f2da86-0c25-48e5-a090-1b949b4cdbe1"
      unitRef="usd">12400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktMy0xLTEtMTA3OTU3_e5b9d8ce-32bf-442c-8698-a1b73e998eb6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktNS0xLTEtMTA3OTU3_64cac5ab-c37c-46e4-a4e0-039340b2a34b"
      unitRef="usd">12400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMTktNy0xLTEtMTA3OTU3_1581be58-dc8c-4c72-b54c-d102325621ed"
      unitRef="usd">4100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItMS0xLTEtMTA3OTU3_1f9774f7-2549-4806-9578-71ce7e509f0e"
      unitRef="usd">1800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItMy0xLTEtMTA3OTU3_31955d6a-ff13-4c14-9aae-17a05eb210d4"
      unitRef="usd">-200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItNS0xLTEtMTA3OTU3_ec226c47-7a7c-4979-a35d-083a52500017"
      unitRef="usd">2900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjItNy0xLTEtMTA3OTU3_0334869f-662e-4242-8707-911e1655577c"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtMS0xLTEtMTA3OTU3_74ec36bb-94dd-4bfd-9151-376f99e1fa73"
      unitRef="usd">313700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtMy0xLTEtMTA3OTU3_3491fed7-af81-4a2e-a02d-c20f16fa484d"
      unitRef="usd">352500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtNS0xLTEtMTA3OTU3_4a82239e-ff18-4bac-9b54-0afdfec00f3b"
      unitRef="usd">669200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjMtNy0xLTEtMTA3OTU3_317ee6fc-8995-4167-a87a-ed8fa6f36480"
      unitRef="usd">697500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtMS0xLTEtMTA3OTU3_ac96a0d0-d0ff-4c5a-ab44-89b365fb449d"
      unitRef="usd">272100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtMy0xLTEtMTA3OTU3_b8c5bbde-a35b-4ca8-91d8-f6e566b7b0ef"
      unitRef="usd">594100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtNS0xLTEtMTA3OTU3_a04013f2-c2f1-428e-912f-c2b47fcecaac"
      unitRef="usd">534500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjQtNy0xLTEtMTA3OTU3_c60a2c5f-b27b-4d5d-b7fc-2a5a47a2df6f"
      unitRef="usd">1235400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtMS0xLTEtMTA3OTU3_4b60cb8f-5998-4c79-8068-bca4bb768bb9"
      unitRef="usd">31500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtMy0xLTEtMTA3OTU3_92e66964-d580-49cb-9f03-789e27e6d062"
      unitRef="usd">800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtNS0xLTEtMTA3OTU3_1a018b4c-e019-427b-9a69-054a2e2edc7c"
      unitRef="usd">52100000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjUtNy0xLTEtMTA3OTU3_a90f160f-179d-420f-af16-495e4e2257ff"
      unitRef="usd">1200000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtMS0xLTEtMTA3OTU3_5ce20a38-3cf9-46f6-901d-156e01795147"
      unitRef="usd">27200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtMy0xLTEtMTA3OTU3_3f2a411f-8e17-4758-b045-42d980b07944"
      unitRef="usd">22600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtNS0xLTEtMTA3OTU3_016bd848-e5d7-4ed0-bf36-1773fc41b5cd"
      unitRef="usd">55300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjYtNy0xLTEtMTA3OTU3_37ea356a-f5eb-4f5c-af9e-6ef2b6ef1413"
      unitRef="usd">48300000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctMS0xLTEtMTA3OTU3_b9531184-b2e5-4a0e-b26b-1eb94f7760ee"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctMy0xLTEtMTA3OTU3_8e2f3854-fc20-42e9-97a5-afddbda9aa57"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctNS0xLTEtMTA3OTU3_2f800600-e417-4f87-9d18-16ff91c2691c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjctNy0xLTEtMTA3OTU3_33f2bfff-aef5-44b3-a79f-85df1fdc8cbe"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtMS0xLTEtMTA3OTU3_2f5f0fcd-3b83-4371-b10f-1c8858529ba8"
      unitRef="usd">2900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtMy0xLTEtMTA3OTU3_66c192ea-08d3-4f0c-a71b-56b6577367b5"
      unitRef="usd">2100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtNS0xLTEtMTA3OTU3_ddd592e1-fb3d-4c44-89ab-033c53cc297b"
      unitRef="usd">-12900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjgtNy0xLTEtMTA3OTU3_da2ea8a7-74a9-4110-aee0-08e9ba3c8b26"
      unitRef="usd">8700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktMS0xLTEtMTA3OTU3_93201142-41b9-4797-bbf2-830eb8f725b9"
      unitRef="usd">279300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktMy0xLTEtMTA3OTU3_d28e73db-f879-4ea5-8573-b1123ebaa95c"
      unitRef="usd">574400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktNS0xLTEtMTA3OTU3_5ddbd3e7-1c61-4bb8-8ffe-c2fc19e12719"
      unitRef="usd">518400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMjktNy0xLTEtMTA3OTU3_7bb953dc-bfeb-484a-be42-31347ba03b39"
      unitRef="usd">1196300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtMS0xLTEtMTA3OTU3_e549d88e-c95a-4fa7-9a80-bbcd4cc1c639"
      unitRef="usd">60800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtMy0xLTEtMTA3OTU3_516752e7-cfec-47eb-af26-88991008c56d"
      unitRef="usd">118700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtNS0xLTEtMTA3OTU3_1ccb7de9-8d20-4878-a5c7-126358462c51"
      unitRef="usd">112500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzAtNy0xLTEtMTA3OTU3_cfb0fd5e-bf26-4ee6-989c-0be83d0d0f95"
      unitRef="usd">241400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtMS0xLTEtMTA3OTU3_720efae8-7517-4e66-90ad-37285f371d98"
      unitRef="usd">218500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtMy0xLTEtMTA3OTU3_f1157b2e-43aa-43f1-a0cb-cf75d03d8308"
      unitRef="usd">455700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtNS0xLTEtMTA3OTU3_0ffec2be-dd15-4273-9135-a2bd94773b5c"
      unitRef="usd">405900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzEtNy0xLTEtMTA3OTU3_4e1d1182-b876-4bcc-b687-514f9cb82f16"
      unitRef="usd">954900000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtMS0xLTEtMTA3OTU3_5ba10299-5925-477d-ad30-1dd51b5d6c5e"
      unitRef="usdPerShare">0.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtMy0xLTEtMTA3OTU3_2eb982c7-1d6e-4980-8f6d-962d608a2dee"
      unitRef="usdPerShare">1.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtNS0xLTEtMTA3OTU3_bce594db-7d1f-438f-ba5e-c0db8bd5a835"
      unitRef="usdPerShare">1.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzMtNy0xLTEtMTA3OTU3_d030d3e3-ba47-4221-a5b1-3eb2e711dd00"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtMS0xLTEtMTA3OTU3_b6a023d2-0ff5-4a55-aade-b8da94ff20ad"
      unitRef="usdPerShare">0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtMy0xLTEtMTA3OTU3_be168c21-2838-411f-8e90-772151ef9ae2"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtNS0xLTEtMTA3OTU3_756d603c-7ce8-4e50-bd16-3d46e17fd12b"
      unitRef="usdPerShare">1.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzQtNy0xLTEtMTA3OTU3_bd57ae97-fa1e-4f4c-a50c-145e9cb3ba26"
      unitRef="usdPerShare">3.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtMS0xLTEtMTA3OTU3_efb9adcf-902f-42e8-bdfd-e83a3445b6ee"
      unitRef="shares">247730000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtMy0xLTEtMTA3OTU3_7117924b-c4dd-449c-9d46-f8bca6c73816"
      unitRef="shares">251574000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtNS0xLTEtMTA3OTU3_37b8f7df-7dd8-421f-b4dc-0d31db6dc7f2"
      unitRef="shares">247524000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzYtNy0xLTEtMTA3OTU3_f43f2cb4-c088-46a8-8b9c-db0c461f2c28"
      unitRef="shares">252537000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctMS0xLTEtMTA3OTU3_da8cd906-fcc4-4b45-b936-574149d4cf2c"
      unitRef="shares">249793000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctMy0xLTEtMTA3OTU3_25fc4599-d329-406b-9bdc-406def7003ad"
      unitRef="shares">253658000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctNS0xLTEtMTA3OTU3_b37ebcfb-c746-44dd-b68d-da373eda72fe"
      unitRef="shares">249537000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xNi9mcmFnOmVlMDljMTk1YWRjZTQyNjg4MWU4YzRlYzFhYzg0OGExL3RhYmxlOjBkOTA1MDRlZjcyMDQwOWZhNjAwOThhMjZjNmVmYzViL3RhYmxlcmFuZ2U6MGQ5MDUwNGVmNzIwNDA5ZmE2MDA5OGEyNmM2ZWZjNWJfMzctNy0xLTEtMTA3OTU3_76b56e80-69ed-4f97-8126-4a945276b855"
      unitRef="shares">254864000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi0xLTEtMS0xMDc5NTc_aef3f230-df32-48cc-a88c-072f101fb996"
      unitRef="usd">218500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi0zLTEtMS0xMDc5NTc_bfcb4989-eb86-43b4-9291-7607db818cd1"
      unitRef="usd">455700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi01LTEtMS0xMDc5NTc_859cae86-b150-4a07-8db0-8b0fcb104e90"
      unitRef="usd">405900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMi03LTEtMS0xMDc5NTc_4e1d1182-b876-4bcc-b687-514f9cb82f16"
      unitRef="usd">954900000</us-gaap:NetIncomeLoss>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy0xLTEtMS0xMDc5NTc_2dc739b2-e6f7-4f70-95a7-cde88747fe9b"
      unitRef="usd">15300000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy0zLTEtMS0xMDc5NTc_77a1c201-1a76-42e7-9a89-3285c8d13a4b"
      unitRef="usd">-34500000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy01LTEtMS0xMDc5NTc_f9f04d5d-23a0-4504-9bdc-5814792b379c"
      unitRef="usd">129100000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMy03LTEtMS0xMDc5NTc_507e0551-d55d-40c0-8ea7-05f23d30716f"
      unitRef="usd">-72300000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM185MA_3f543889-4dd1-4b95-848a-57eabfb55b1b"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xNDM_a759c0e0-5241-4171-a9cf-a42429b3acad"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xMDk5NTExNjI4NzUx_3d728a98-19cb-46f1-bfa5-bf1261f43a13"
      unitRef="usd">6.5</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOC0wLTEtMS0xMDc5NTcvdGV4dHJlZ2lvbjphZGNjY2VlZDRmOGQ0MzI4OGM5NDhjNmZjMTE5OTdkM18xMDk5NTExNjI4NzYx_4e7daead-298a-4da3-851b-f66411608db1"
      unitRef="usd">9.1</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS0xLTEtMS0xMDc5NTc_14eeab24-baa0-46e7-9f46-6629400d4a94"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS0zLTEtMS0xMDc5NTc_7e621169-c162-4e69-86f4-a211e3feac06"
      unitRef="usd">19400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS01LTEtMS0xMDc5NTc_22bf3814-3e19-46d1-998e-32fed2ff7c26"
      unitRef="usd">-9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfOS03LTEtMS0xMDc5NTc_40ee8ca5-d71a-4bb3-a41c-8d411b801167"
      unitRef="usd">27300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtMS0xLTEtMTA3OTU3_c4278411-9730-4595-8cb2-affc818062e7"
      unitRef="usd">8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtMy0xLTEtMTA3OTU3_e5d60432-0c2b-44cf-ad71-0f93f45884e8"
      unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtNS0xLTEtMTA3OTU3_1c754f40-75d4-4728-a243-816d5c6a81a8"
      unitRef="usd">119800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTEtNy0xLTEtMTA3OTU3_d8d48ce5-c81d-4509-937f-afb7f344d9a8"
      unitRef="usd">-45000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItMS0xLTEtMTA3OTU3_9e9db360-38d5-40c5-b309-5228b8c38f89"
      unitRef="usd">227400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItMy0xLTEtMTA3OTU3_0fddb32e-5e40-4a8f-9eb3-b37a3597a936"
      unitRef="usd">440600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItNS0xLTEtMTA3OTU3_4a0267e9-37e4-4387-8a92-8ce92962db94"
      unitRef="usd">525700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8xOS9mcmFnOjQxNjM3NzhhZTY0ZjQwNzE5NDliN2M4MDY1YjYzYzExL3RhYmxlOjcyODBmZGIyNzI2YjRjMTk5OGMwNWU4MDFkM2I4MWJlL3RhYmxlcmFuZ2U6NzI4MGZkYjI3MjZiNGMxOTk4YzA1ZTgwMWQzYjgxYmVfMTItNy0xLTEtMTA3OTU3_1526ab2b-8bc5-4998-96b0-c166d5ed769d"
      unitRef="usd">909900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMy0xLTEtMS0xMDc5NTc_63f9bedd-4eb8-4292-8c08-55447aa3c36d"
      unitRef="usd">2582200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMy0zLTEtMS0xMDc5NTc_6139babb-b93b-4011-8e57-316a1835ffab"
      unitRef="usd">2339500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNi0xLTEtMS0xMDc5NTc_44bd3b08-af54-4ab4-a1dd-298dbf111b04"
      unitRef="usd">714000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNi0zLTEtMS0xMDc5NTc_97e6d046-3863-461c-b611-dcf21a9e98f9"
      unitRef="usd">617600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNy0xLTEtMS0xMDc5NTc_b7c24e07-a779-40fc-8fe3-66121c18f5a7"
      unitRef="usd">687600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNy0zLTEtMS0xMDc5NTc_363fe0f3-f3f8-456a-b317-fb5d3e5fa1a0"
      unitRef="usd">623700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOC0xLTEtMS0xMDc5NTc_26231a68-479f-494a-bde2-6e4af1ee8640"
      unitRef="usd">187000000.0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOC0zLTEtMS0xMDc5NTc_1fd8be13-258a-48d2-80bb-d55103480aa2"
      unitRef="usd">232200000</us-gaap:PrepaidExpenseCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOS0xLTEtMS0xMDc5NTc_08e059f0-bc44-4494-a2b4-b43f7db4cd62"
      unitRef="usd">40600000</holx:PrepaidIncomeTaxesCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfOS0zLTEtMS0xMDc5NTc_84010f01-0bbb-4161-954e-bb4b552b7844"
      unitRef="usd">49000000.0</holx:PrepaidIncomeTaxesCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTItMS0xLTEtMTA3OTU3_3ddce4b3-9829-45eb-9f9a-cfc38d94d202"
      unitRef="usd">4211400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTItMy0xLTEtMTA3OTU3_34512c81-1c11-4785-ba70-3e95dd4f48c0"
      unitRef="usd">3862000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTMtMS0xLTEtMTA3OTU3_895c6a1a-1c3a-4e60-bdcb-a3d422db1c6f"
      unitRef="usd">497900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTMtMy0xLTEtMTA3OTU3_7ec01d3d-0fa8-472d-868c-a2dd9e651553"
      unitRef="usd">481600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTQtMS0xLTEtMTA3OTU3_1df97cb1-9c0b-45fa-883d-16b1737fb274"
      unitRef="usd">1202200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTQtMy0xLTEtMTA3OTU3_1bd5b5da-3380-477b-a5b6-ca0c91aaf2f6"
      unitRef="usd">1280600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTUtMS0xLTEtMTA3OTU3_27b7bd29-638c-4bf7-a21f-70ec91286646"
      unitRef="usd">3296900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTUtMy0xLTEtMTA3OTU3_5adfac21-2de7-4056-a7e0-daa4a2f4fceb"
      unitRef="usd">3236500000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTYtMS0xLTEtMTA3OTU3_7bad095c-cba3-40f8-a8f3-7fce0c16070f"
      unitRef="usd">240300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTYtMy0xLTEtMTA3OTU3_d775aa79-ce90-450d-8b5d-9722bd2ed175"
      unitRef="usd">210500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTctMS0xLTEtMTA3OTU3_495e57f4-55a8-4915-bcfd-250bafa502b5"
      unitRef="usd">9448700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMTctMy0xLTEtMTA3OTU3_da652f33-250a-4109-82b8-c7668f3df9ad"
      unitRef="usd">9071200000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjAtMS0xLTEtMTA3OTU3_f6e7d5c8-e6cd-4242-97d0-95ee6cbcef1b"
      unitRef="usd">26200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjAtMy0xLTEtMTA3OTU3_67b11007-e21f-47c4-972e-9182d081e84e"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjEtMS0xLTEtMTA3OTU3_513b8964-ea65-4c7b-ad18-b241f6f641b5"
      unitRef="usd">187400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjEtMy0xLTEtMTA3OTU3_f1d30c37-a36d-4f13-b94c-4c1e3be233de"
      unitRef="usd">197700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjItMS0xLTEtMTA3OTU3_00360ea3-9617-4ec1-91c2-6d9ca555ac2a"
      unitRef="usd">508000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjItMy0xLTEtMTA3OTU3_0b019e7f-c8df-4c32-b990-e5863fda802f"
      unitRef="usd">535300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjMtMS0xLTEtMTA3OTU3_07175207-70b5-4d33-a61d-7a318a4f597e"
      unitRef="usd">230500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjMtMy0xLTEtMTA3OTU3_4cb51d17-ddaa-448b-a699-d1cb27ea1b58"
      unitRef="usd">186500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjQtMS0xLTEtMTA3OTU3_877a0d62-07f4-4b30-989f-1d9446ef32ea"
      unitRef="usd">2900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjQtMy0xLTEtMTA3OTU3_24da4027-482e-4243-ada1-d57e5fe5de1a"
      unitRef="usd">3200000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjctMS0xLTEtMTA3OTU3_5039c38f-992d-4870-b2a1-70d68f09d507"
      unitRef="usd">955000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjctMy0xLTEtMTA3OTU3_491ae0b9-e794-4e91-9e8b-14969aff56f0"
      unitRef="usd">937700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjgtMS0xLTEtMTA3OTU3_8c9df385-4494-45c6-8031-634369eebf88"
      unitRef="usd">2797700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjgtMy0xLTEtMTA3OTU3_ab5eefe7-052b-4a69-8c64-c699e1b5f651"
      unitRef="usd">2808400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjktMS0xLTEtMTA3OTU3_52099d6e-56e9-4a99-87db-fdee49fb457c"
      unitRef="usd">17000000.0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMjktMy0xLTEtMTA3OTU3_d0f3f95e-8e00-40b0-a9d2-3b18bdfc94e8"
      unitRef="usd">18000000.0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzAtMS0xLTEtMTA3OTU3_15a2c338-3c21-407f-8fa9-508d6209d2fd"
      unitRef="usd">33400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzAtMy0xLTEtMTA3OTU3_0ae310ba-86c8-4742-b930-7433c25e9a00"
      unitRef="usd">90800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzEtMS0xLTEtMTA3OTU3_1a80ad75-55e4-4e1a-92fb-2cb19772f81a"
      unitRef="usd">12800000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzEtMy0xLTEtMTA3OTU3_5a32b292-fb02-4998-b914-b0164ccd68f2"
      unitRef="usd">9400000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzItMS0xLTEtMTA3OTU3_53f6a64d-5495-4ec8-9d02-89a442e0a0a3"
      unitRef="usd">332000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzItMy0xLTEtMTA3OTU3_7311c947-bd05-4665-83d5-413bc4668f67"
      unitRef="usd">330700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMjE_04a66cfc-537c-4e9b-a5bf-dc86885d2e56"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMjE_e2e3a3ef-df44-4607-bdc4-3467ae2431ba"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMzY_c547b25e-a1a5-41db-8424-aae7a58ef865"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfMzY_f8d965dd-f235-44f6-b370-fe10fbf54e3a"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfNTg_0875f0c6-d27d-4618-b7ec-b9345cef74fe"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246MzhmMzM3NzI1ZTkxNDI5Njk5MGMwNzQ4N2FlNmZmYTBfNTg_f9e7bd71-6b41-48c9-9ad4-e2647b2e45a4"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMS0xLTEtMTA3OTU3_4e460c8b-afec-4376-8f70-016b7534f643"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzQtMy0xLTEtMTA3OTU3_c39ce673-315e-4303-b415-7c2171f031b6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMTg_3a511388-7735-424a-8682-e56d15f1437a"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMTg_42ab19bf-c185-4fda-afb1-19f7dfaf52a6"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMzM_0f63498f-ef7b-4ec1-8c37-41f19409635c"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfMzM_32308ade-b7c1-44db-beb7-cbcdfc80d8d1"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfNTU_b831c0ae-4708-4ccf-b676-69bb6870ac85"
      unitRef="shares">299676000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGNkOThkNDQwMzA2NDMxNTljYzY5NTI0ZGFiYTJlZWNfNjI_abd8881c-2539-448b-9df6-f02fb0bf2962"
      unitRef="shares">298533000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMS0xLTEtMTA3OTU3_9361cbf0-a239-4574-9df4-fa3abe51dd4a"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzUtMy0xLTEtMTA3OTU3_83be3495-b775-4278-b7eb-8fa9cb9d3695"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzYtMS0xLTEtMTA3OTU3_aa819a82-668e-488a-9ed2-0436639f4342"
      unitRef="usd">6091500000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzYtMy0xLTEtMTA3OTU3_c2a05e01-dc2a-43cb-a312-40ef91cca78b"
      unitRef="usd">6042600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzctMS0xLTEtMTA3OTU3_556cfbc4-fb1e-4830-88ce-abddf8084202"
      unitRef="usd">2006200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzctMy0xLTEtMTA3OTU3_d54e3cbe-f195-495d-a12b-6f77314e99cd"
      unitRef="usd">1600300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGM1NTUzMWY0NjU0NDMzOThlZDI5NDU4YjY1ZGIzMjRfMzA_73a1617c-c917-4f54-9222-59ec0e7b46d0"
      unitRef="shares">53566000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMC0xLTEtMTA3OTU3L3RleHRyZWdpb246NGM1NTUzMWY0NjU0NDMzOThlZDI5NDU4YjY1ZGIzMjRfMzc_a337e865-69fa-4d37-b7ac-5830edbf9790"
      unitRef="shares">51401000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMS0xLTEtMTA3OTU3_0efe7665-0e26-43f0-8d83-e91bd00c51ff"
      unitRef="usd">2681500000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzgtMy0xLTEtMTA3OTU3_c63d3dfc-da7c-485a-87ef-98104d43fefd"
      unitRef="usd">2531500000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzktMS0xLTEtMTA3OTU3_997a8918-5e08-40c2-8b2c-c9af4186cd1f"
      unitRef="usd">-118400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfMzktMy0xLTEtMTA3OTU3_861ff90a-f19c-4fd6-b557-a34491645948"
      unitRef="usd">-238200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDAtMS0xLTEtMTA3OTU3_b796aee7-561d-4f0b-a95e-a3652ab0d968"
      unitRef="usd">5300800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDAtMy0xLTEtMTA3OTU3_7aaea4d4-5986-497a-91c9-99f93331716b"
      unitRef="usd">4876200000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDEtMS0xLTEtMTA3OTU3_04c5d287-b3de-4049-8389-16582f66c97b"
      unitRef="usd">9448700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yMi9mcmFnOmNjODdkY2Y5NzZiMTRkMzVhZmIwNjZjODdjMjMxZTExL3RhYmxlOjkxN2ViZGJlNzQ3NDRmNjI4YzA3NTlmNTM3YjRlZmZhL3RhYmxlcmFuZ2U6OTE3ZWJkYmU3NDc0NGY2MjhjMDc1OWY1MzdiNGVmZmFfNDEtMy0xLTEtMTA3OTU3_c7c518e5-f6cf-4b35-9c8f-01e899273b97"
      unitRef="usd">9071200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="idb909bbe5f2540069cf207a78f1cb2e6_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTItMS0xLTEwNzk1Nw_b63c0627-7416-48c4-ada5-e7cc135e7de8"
      unitRef="shares">297306000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idb909bbe5f2540069cf207a78f1cb2e6_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTQtMS0xLTEwNzk1Nw_e4047d39-d3ca-4d6c-b5b3-b87488666af3"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7810cad7d02247f1b5f6e85c336e9c52_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTYtMS0xLTEwNzk1Nw_1048de00-c91f-4345-a98b-8915595b5e9b"
      unitRef="usd">5965800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e7edafb8449411a8c76ac568092157e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTgtMS0xLTEwNzk1Nw_a11758d1-7eda-4087-99df-0c0e04b0b4c5"
      unitRef="usd">298300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e73db97997e4106b0bc73a6ad117fa1_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTEwLTEtMS0xMDc5NTc_30802dec-36d0-4065-a973-8e41d5827a42"
      unitRef="usd">-59100000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i728193aa1ef04e4885f20273a8721f30_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTEyLTEtMS0xMDc5NTc_b9815321-2aa2-4623-9a62-19a3297a3746"
      unitRef="shares">43653000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i728193aa1ef04e4885f20273a8721f30_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTE0LTEtMS0xMDc5NTc_42914ee7-ce72-4a35-9714-cc88068f78ef"
      unitRef="usd">-1989400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkyLTE4LTEtMS0xMDc5NTc_74a24ef4-55f1-485b-acf0-dcfa39c10ec8"
      unitRef="usd">4218600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTItMS0xLTEwNzk1Nw_056df0c1-1cd7-41d4-98e3-6c41227bd46a"
      unitRef="shares">45000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTYtMS0xLTEwNzk1Nw_715f9b39-064f-4dc2-9457-6e24bdb88fb5"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTkzLTE4LTEtMS0xMDc5NTc_f9022f3f-1dcf-4191-8ebb-d5e98befc066"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i870ff7fbb8e54a1492666dd51289d8e5_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTItMS0xLTEwNzk1Nw_3ef64e9c-c1a7-4a5d-93d1-7daabe9314c0"
      unitRef="shares">534000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTYtMS0xLTEwNzk1Nw_6093349d-14f6-489c-a00b-201b080bc1f6"
      unitRef="usd">22400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk0LTE4LTEtMS0xMDc5NTc_2d67406f-8f4f-4d30-9945-6118edd59a0e"
      unitRef="usd">22400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk2LTYtMS0xLTEwNzk1Nw_fa376208-0c7a-4e0d-9373-34d4b3a27bd2"
      unitRef="usd">18700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iefb8d073427345198f8e66225de022d3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk2LTE4LTEtMS0xMDc5NTc_fa1f90c0-5c02-4a3e-87c5-456184238412"
      unitRef="usd">18700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk3LTgtMS0xLTEwNzk1Nw_5ea76886-4b51-4621-bffb-e27dff8b8f9a"
      unitRef="usd">499200000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i735fb7e43bf849d49e5721c25dae8179_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk3LTE4LTEtMS0xMDc5NTc_51291f99-05ee-43be-ba81-a682b43e05a7"
      unitRef="usd">499200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i51d792fb77c74175a153de2fee725a92_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk4LTEwLTEtMS0xMDc5NTc_9c94901b-6cb6-425a-8bf7-e7467b9db974"
      unitRef="usd">-29900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i51d792fb77c74175a153de2fee725a92_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk4LTE4LTEtMS0xMDc5NTc_8d17dd5d-9138-4150-aea8-762e90b9c92b"
      unitRef="usd">-29900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTEyLTEtMS0xMDc5NTc_1516f5b8-7a7d-4856-b3f3-904f9a5733f8"
      unitRef="shares">2335000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTE0LTEtMS0xMDc5NTc_7e888b34-d5f1-4fdf-820c-9aa7a62f087b"
      unitRef="usd">167000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i3dcffbcfa2cd4c799c8dc52ed706b8e7_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMTk5LTE4LTEtMS0xMDc5NTc_17096462-b17f-49a0-9ffd-1d0ff33dea68"
      unitRef="usd">167000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="ic1312159d6804c03a112ae774c849cbc_I20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTItMS0xLTEwNzk1Nw_5c748f24-9fd5-4970-b3f6-8684c3173253"
      unitRef="shares">297885000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic1312159d6804c03a112ae774c849cbc_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTQtMS0xLTEwNzk1Nw_8b2ad565-a502-470a-82d5-9cb65262cdd7"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59ce45cfb8f644079576717c187966e7_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTYtMS0xLTEwNzk1Nw_110d3638-073f-4c31-b00b-08dd64d6863d"
      unitRef="usd">5964000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82f62b3f136743bfaea9f76d6dccb550_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTgtMS0xLTEwNzk1Nw_ccd4aa13-5a9e-459b-898d-161e7717d8ab"
      unitRef="usd">797500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f733818a0ef4bb196bde5377e392367_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTEwLTEtMS0xMDc5NTc_be459199-d844-4741-b578-5aac4a5a9522"
      unitRef="usd">-89000000.0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i10b8515303b04633b81845a6340517a2_I20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTEyLTEtMS0xMDc5NTc_a63a2e2c-dbda-497d-a12d-3fcc4bce041f"
      unitRef="shares">45988000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i10b8515303b04633b81845a6340517a2_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTE0LTEtMS0xMDc5NTc_9156b63a-a676-4be9-a98a-6cae8b5d31e0"
      unitRef="usd">-2156400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i673ceda2567b4fa094005314999c6692_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAwLTE4LTEtMS0xMDc5NTc_f78dae25-b7f8-42de-9719-34bc0086faab"
      unitRef="usd">4519100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTItMS0xLTEwNzk1Nw_f9ca4c74-4d03-4994-98cc-f20000e8ff1d"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTYtMS0xLTEwNzk1Nw_74355ca0-1ac2-490b-a9da-ab03395442fe"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAxLTE4LTEtMS0xMDc5NTc_9c89ef83-841b-4dd0-92c0-78a06073737a"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTItMS0xLTEwNzk1Nw_8a6e180e-8fe4-4723-9b58-4a6dc1d078e3"
      unitRef="shares">14000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTYtMS0xLTEwNzk1Nw_4efb2e8c-f9ad-4456-b3bd-5baed34c70ec"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAyLTE4LTEtMS0xMDc5NTc_dbc65184-65cb-4137-be14-5536ca228694"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia85329a5af434956b507a245eec1e665_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTItMS0xLTEwNzk1Nw_3d891da9-259d-4a25-8968-ecb9c3ae6b43"
      unitRef="shares">164000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTYtMS0xLTEwNzk1Nw_e1167721-246d-4342-ae3e-d98c42186350"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjAzLTE4LTEtMS0xMDc5NTc_43081a77-af7c-4c23-826c-c445ed4c9294"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA0LTYtMS0xLTEwNzk1Nw_2d327150-b007-440f-9588-efcb3858098b"
      unitRef="usd">17800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2b259872da0e4891b258402238020b91_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA0LTE4LTEtMS0xMDc5NTc_0fb584eb-1670-4059-8f3a-ed504f441102"
      unitRef="usd">17800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA1LTgtMS0xLTEwNzk1Nw_b2a585b7-34de-4bda-9a82-b50bbce0a35c"
      unitRef="usd">455700000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA1LTE4LTEtMS0xMDc5NTc_45d822d9-508f-4b9c-98ee-c30398c9493c"
      unitRef="usd">455700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i99199df891b54e60b263241f795a8011_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA2LTEwLTEtMS0xMDc5NTc_69a7ace8-9f13-411c-b315-81f639ab2257"
      unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i99199df891b54e60b263241f795a8011_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA2LTE4LTEtMS0xMDc5NTc_5c6ca1b5-f064-4fc6-ae9b-11af8ed8ffc9"
      unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTEyLTEtMS0xMDc5NTc_d85dbbe7-2907-48e4-a781-833107d8972d"
      unitRef="shares">2863000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTE0LTEtMS0xMDc5NTc_2df96d75-5b9d-4d98-a54c-c64b1054083d"
      unitRef="usd">200000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i45fc9cee25754e1d9851748b883a234e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA3LTE4LTEtMS0xMDc5NTc_89827da5-bec0-40af-9baf-a11356d8c688"
      unitRef="usd">200000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTItMS0xLTEwNzk1Nw_9d38f83f-34ab-4ba2-bbe2-60b6bef794f3"
      unitRef="shares">298203000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i33b6ad4703a247bcbee5c6f85d31ab6d_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTQtMS0xLTEwNzk1Nw_4493e1d7-f53a-41e1-88f6-01ef13fcf8e7"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90312f39be0e4ef6b8f3efd53c5c985c_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTYtMS0xLTEwNzk1Nw_e4ce80a6-d9fa-41e2-8218-5404ba0eefe7"
      unitRef="usd">5997000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c725645e1ff419d8af3688fb583ae78_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTgtMS0xLTEwNzk1Nw_6158d200-2653-4803-a201-00b3c59f5374"
      unitRef="usd">1253200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTEwLTEtMS0xMDc5NTc_a5b76f5f-e876-4eb4-a07f-8af4c3092a7a"
      unitRef="usd">-104100000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iee84ef7457ef44eeb536b6069b3b635c_I20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTEyLTEtMS0xMDc5NTc_8309dd32-bb7b-4c0c-acba-fdd06fad8739"
      unitRef="shares">48851000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iee84ef7457ef44eeb536b6069b3b635c_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTE0LTEtMS0xMDc5NTc_365bd1c6-a492-48da-8951-1f4c88b3db0d"
      unitRef="usd">-2356400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA4LTE4LTEtMS0xMDc5NTc_2e165e3f-c378-48df-8d84-b5d41da80f4e"
      unitRef="usd">4792700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTItMS0xLTEwNzk1Nw_da20d81d-b0c7-4cab-9a95-cf24c911c4cb"
      unitRef="shares">128000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTYtMS0xLTEwNzk1Nw_0ac27258-1834-44f8-9b49-a67d86df5493"
      unitRef="usd">5200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjA5LTE4LTEtMS0xMDc5NTc_57cf1409-ae8e-4929-a415-5587f8b644f8"
      unitRef="usd">5200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i2f4f6bd3a3124a2094e4867ea0d485b5_D20220327-20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTItMS0xLTEwNzk1Nw_183c3676-d80c-4a8e-8745-ea837f7546e0"
      unitRef="shares">4000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTYtMS0xLTEwNzk1Nw_fc0e0aec-1f82-4b5d-b878-481171032a56"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEwLTE4LTEtMS0xMDc5NTc_480c5294-bc25-41dc-bc71-28e2c9596327"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEyLTYtMS0xLTEwNzk1Nw_cd78a35d-ce7b-4ea4-b1ed-401fbceb5568"
      unitRef="usd">15300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i815ca82b5a6d48dcbcc1fdaaf26fcc7b_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEyLTE4LTEtMS0xMDc5NTc_a5b9dd74-1e6c-444f-a07d-a9912713722d"
      unitRef="usd">15300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEzLTgtMS0xLTEwNzk1Nw_8ba520c7-bb3c-49b6-bf7a-0a8327f86323"
      unitRef="usd">228400000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i31e6c0a5bca4400ea934405c1d68d4f9_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjEzLTE4LTEtMS0xMDc5NTc_bc267900-bfff-472c-b591-a05e0fc330af"
      unitRef="usd">228400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE0LTEwLTEtMS0xMDc5NTc_126db83d-ce42-4ea9-862f-1c41d626f9d8"
      unitRef="usd">-43600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i05a4f72649354589a6d9c3ecd873744f_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE0LTE4LTEtMS0xMDc5NTc_9788634b-975c-46ea-bce5-4190a004f589"
      unitRef="usd">-43600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i3d882caad56e40fca4cbee08e9438a1e_I20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTItMS0xLTEwNzk1Nw_66071ff5-d942-4d78-b84d-72a12cc36da3"
      unitRef="shares">298335000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3d882caad56e40fca4cbee08e9438a1e_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTQtMS0xLTEwNzk1Nw_c6bd5c2a-cc8b-4edb-81a2-0d2ed3f249fd"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i08891923a5404211866f245155440f87_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTYtMS0xLTEwNzk1Nw_baafb786-5f71-41da-ac0a-032bf5ee2790"
      unitRef="usd">6017400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ba07efafd444b4a850d6efce144fbbb_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTgtMS0xLTEwNzk1Nw_aba431fd-ed40-405c-b9a3-2aa184c87a0e"
      unitRef="usd">1481600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icaf436100d4049459a74792e8e6a0154_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTEwLTEtMS0xMDc5NTc_12549d3b-3751-4641-a2bf-96582dacd874"
      unitRef="usd">-147700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i7eb18f90afb34984ae954b76e9f109e1_I20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTEyLTEtMS0xMDc5NTc_293af59f-b74d-4dcc-a42e-2465aad93a71"
      unitRef="shares">48851000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7eb18f90afb34984ae954b76e9f109e1_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTE0LTEtMS0xMDc5NTc_b69e0e3f-44dc-4317-9ac0-037eaf783d43"
      unitRef="usd">-2356400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85799d0eb64349758943ccfaa1cd193c_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE2LTE4LTEtMS0xMDc5NTc_f5c20b77-5cc4-45b0-881c-ff2fc18f58d4"
      unitRef="usd">4997900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTItMS0xLTEwNzk1Nw_c45d46b7-ef15-496c-b9af-173a0d4a8d7d"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTYtMS0xLTEwNzk1Nw_52c1ad1e-a098-42e3-a2ad-1ab725a96732"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE3LTE4LTEtMS0xMDc5NTc_7a5e987b-80ad-4919-b60d-f430c8d87eff"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTItMS0xLTEwNzk1Nw_bd521e5c-9c9a-497f-8896-d4df68ad5acc"
      unitRef="shares">9000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTYtMS0xLTEwNzk1Nw_1bbd5b11-23ad-49d0-b253-44bab11d1e04"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE4LTE4LTEtMS0xMDc5NTc_b5eb8b55-c7e0-48a3-add5-c333515a590d"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i389781dc4fa8453fa0eb377ebccd0963_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTItMS0xLTEwNzk1Nw_cdf823ff-bb89-40cf-83f9-ddbd006baef9"
      unitRef="shares">166000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTYtMS0xLTEwNzk1Nw_c869e898-57e5-4b7c-a2a6-fc081c096f02"
      unitRef="usd">9700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjE5LTE4LTEtMS0xMDc5NTc_facef3d6-15ff-4517-a664-96d4590caf2e"
      unitRef="usd">9700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIwLTYtMS0xLTEwNzk1Nw_69b366c2-1ab0-4afc-9777-e6b62b060769"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia5a7b590758244b7b3e51a8f4890d650_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIwLTE4LTEtMS0xMDc5NTc_5d3d1ba6-4e26-4169-8f18-eaa985f48d88"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIxLTgtMS0xLTEwNzk1Nw_3c2bcd31-9767-4eff-b9ed-17e40b63cd58"
      unitRef="usd">118700000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i508b938b9bd04731a116a511304508d0_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIxLTE4LTEtMS0xMDc5NTc_f467278d-37ac-4e25-88a0-4892af5baa5b"
      unitRef="usd">118700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIyLTEwLTEtMS0xMDc5NTc_ef49c7ca-b287-44b5-9dbf-9c3997a2a1aa"
      unitRef="usd">-90500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5af43185cfb44b7dbcb1c499a762bca1_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIyLTE4LTEtMS0xMDc5NTc_74571aa6-8897-43bc-a8ed-669a85ed86f5"
      unitRef="usd">-90500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTEyLTEtMS0xMDc5NTc_5d1aca07-53f9-4c5e-a54d-e5c1498fd7ec"
      unitRef="shares">2550000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTE0LTEtMS0xMDc5NTc_fe608183-13a2-4994-b76e-937b9cb6f061"
      unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ie1e46ba50642452a8ee00d6e5eef5592_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjIzLTE4LTEtMS0xMDc5NTc_57725774-93aa-485b-b31c-815c02505425"
      unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTItMS0xLTEwNzk1Nw_5777101f-8805-48a5-8502-577e28cfbe88"
      unitRef="shares">298533000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i381caf5ca14a4254b02c8bc1b6c733ca_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTQtMS0xLTEwNzk1Nw_6db8e521-5e64-4a34-8d39-b7504414f6df"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i98e54d72ad324c54a434cbf20c7e1636_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTYtMS0xLTEwNzk1Nw_db1be1c7-867c-43da-a648-72bee3fb7a88"
      unitRef="usd">6042600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3002622281154961926b0802bdcfa78d_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTgtMS0xLTEwNzk1Nw_f4b40a2f-f096-4707-82d4-a64c583a0fe3"
      unitRef="usd">1600300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e5f81fbde654721b420a4cceaa0f658_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTEwLTEtMS0xMDc5NTc_25aa5fbf-d46b-4399-8b8b-37a9bed5b1a2"
      unitRef="usd">-238200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTEyLTEtMS0xMDc5NTc_90a12e93-f2dd-464b-acd6-6d55314579c5"
      unitRef="shares">51401000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibd9bc9905a184f95aa0b96a755d4c2d8_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTE0LTEtMS0xMDc5NTc_9a97b62f-7a2d-460a-a24e-d26000ebe65a"
      unitRef="usd">2531500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI0LTE4LTEtMS0xMDc5NTc_ae4fcb74-4c8c-4ca9-96df-6a7d8b1be8b1"
      unitRef="usd">4876200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTItMS0xLTEwNzk1Nw_5032e082-4636-455d-8ad7-e36384546310"
      unitRef="shares">267000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTYtMS0xLTEwNzk1Nw_567dc028-716b-4a5c-ba6e-5b3c4a99ca15"
      unitRef="usd">10300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI1LTE4LTEtMS0xMDc5NTc_f2ede61f-3b9c-4e21-b398-89a07245bd32"
      unitRef="usd">10300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTItMS0xLTEwNzk1Nw_679876a0-447f-44e4-aede-50b2f2f6c4c4"
      unitRef="shares">514000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTYtMS0xLTEwNzk1Nw_2442e545-3c0e-4e14-9d2b-9a991521495e"
      unitRef="usd">23000000.0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI2LTE4LTEtMS0xMDc5NTc_82008755-bbfd-49bb-b0f5-c76491ad2433"
      unitRef="usd">23000000.0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i203832cf31694163bdbf1410232cae9d_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTItMS0xLTEwNzk1Nw_7e82a4cc-022f-45b9-9a62-f74f0501d92e"
      unitRef="shares">171000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTYtMS0xLTEwNzk1Nw_a72fd94e-56d4-4072-90c4-abd535d23f1e"
      unitRef="usd">10200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI3LTE4LTEtMS0xMDc5NTc_e80bb84b-8e9d-4a95-b37b-93829f1fdb0f"
      unitRef="usd">10200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI4LTYtMS0xLTEwNzk1Nw_1a52e841-f187-4d58-b6a4-2a1bae2a5a74"
      unitRef="usd">20500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i165d7281231643ba8174e32d50a95ae3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI4LTE4LTEtMS0xMDc5NTc_de097d94-e5c2-49e6-b36a-77b34874442c"
      unitRef="usd">20500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI5LTgtMS0xLTEwNzk1Nw_f6af537f-f149-4576-a3f9-972047a46685"
      unitRef="usd">187400000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjI5LTE4LTEtMS0xMDc5NTc_53ec33ca-eb99-4d2a-8581-c6e13015a33b"
      unitRef="usd">187400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMwLTEwLTEtMS0xMDc5NTc_c32724c7-36e5-48ed-8538-8349336cd12c"
      unitRef="usd">110900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icd91aa901d04431eb9e79d5db30ab2fd_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMwLTE4LTEtMS0xMDc5NTc_9394a359-30b1-49eb-a1d3-a81708592123"
      unitRef="usd">110900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTEyLTEtMS0xMDc5NTc_8052a1a5-90f2-4358-a7e1-c2d272011e69"
      unitRef="shares">1539000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTE0LTEtMS0xMDc5NTc_9a610706-9842-4e20-ba39-63ac6af53f82"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ifa685b055edd487ca15329cbe25c7635_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMxLTE4LTEtMS0xMDc5NTc_fe8198c4-ae80-42ae-824f-7d1ed2d445ed"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="idc29699290454610abbfbea53d3b09d9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTItMS0xLTEwNzk1Nw_68e33171-25b0-4cbc-85e6-b68e4b8974fc"
      unitRef="shares">299485000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idc29699290454610abbfbea53d3b09d9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTQtMS0xLTEwNzk1Nw_40b37e8e-fbbf-4ca4-b658-b51ca0d48c74"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11d95c79e50f4f2c96697ca8aac2736e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTYtMS0xLTEwNzk1Nw_3caae670-813d-43f9-959f-dc8c5148eb65"
      unitRef="usd">6060600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0326c94c4f849e78bc4ed1ba0305489_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTgtMS0xLTEwNzk1Nw_6299825c-2df9-4ebd-96da-7db02ce595bd"
      unitRef="usd">1787700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTEwLTEtMS0xMDc5NTc_ac96b38c-c1ba-47fe-8b64-c3ad33a83a21"
      unitRef="usd">-127300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="id6693a30bd6c4709a18368e12c88e1e0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTEyLTEtMS0xMDc5NTc_4650db6d-54a5-483b-9ffe-5586a1dbc5f9"
      unitRef="shares">52940000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="id6693a30bd6c4709a18368e12c88e1e0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTE0LTEtMS0xMDc5NTc_a4697a7e-ed76-45ef-b684-00ff2ba14a43"
      unitRef="usd">-2631500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMyLTE4LTEtMS0xMDc5NTc_63dee765-ae25-4b3c-96bf-c40b3d378bb1"
      unitRef="usd">5092500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTItMS0xLTEyNDQ2Ng_679c5385-d2a7-4c80-ac8f-c733a9b5469e"
      unitRef="shares">173000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTYtMS0xLTEyMDM0MA_29d9b30f-597b-4a82-8870-569a39bc0718"
      unitRef="usd">7900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjMzLTE4LTEtMS0xMjQ0ODU_74c357e4-2713-4c4b-8807-cdbee566d7ac"
      unitRef="usd">7900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i483b774ebe7f4cfd9db26b40f1cf7b61_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTItMS0xLTEyNDQ2OQ_f3edcd4e-e25d-4011-b244-c5e8c848254e"
      unitRef="shares">18000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTYtMS0xLTEyNDQ3Mw_e8c014bf-25ae-49da-9dbe-e7321a2180ab"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM0LTE4LTEtMS0xMjQ0ODc_9280f6f0-813f-4266-9379-8739b92de65a"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM2LTYtMS0xLTEyNDQ3NQ_4d1d52f7-393b-4fb4-be86-a33c39624b96"
      unitRef="usd">23200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icf3e1a190c9d40b69a523c35c2f384db_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM2LTE4LTEtMS0xMjQ0ODk_faa6d869-864d-4aab-89bc-cd1c89634b01"
      unitRef="usd">23200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM3LTgtMS0xLTEyNDQ3Nw_b7327c88-11d0-46e7-a62d-18e258332b77"
      unitRef="usd">218500000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM3LTE4LTEtMS0xMjQ0OTE_6d877872-a2d7-4119-952e-47ec5f9e438a"
      unitRef="usd">218500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i24c41465ac6b4629acc426e96781619e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM4LTEwLTEtMS0xMjQ0Nzk_9aa232e9-ef67-4903-b0f1-136e08a25213"
      unitRef="usd">8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i24c41465ac6b4629acc426e96781619e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM4LTE4LTEtMS0xMjQ0OTM_221969b1-b437-48d1-9fae-26538fc1cd86"
      unitRef="usd">8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTEyLTEtMS0xMjQ0ODE_9cc708ab-6d79-4452-bedd-ffa1105fef11"
      unitRef="shares">626000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTE0LTEtMS0xMjQ0ODM_1ba180d7-075a-49ae-90f2-a165532d6a37"
      unitRef="usd">50000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i8e36ec635417418ab05bc04c9f41df8e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjM5LTE4LTEtMS0xMjQ0OTU_448bcd42-0f18-4cf8-adb2-9f837fbd4011"
      unitRef="usd">50000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i81231f9a527e4841b03062694c05a420_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTItMS0xLTEyNDQ5Nw_1275b969-95c0-45af-a9cd-878a1968af87"
      unitRef="shares">299676000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i81231f9a527e4841b03062694c05a420_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTQtMS0xLTEyNDQ5OQ_19061d4f-0883-44e5-90d9-49326533465c"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i018c97cc9d50417598b74b0bc1e7d870_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTYtMS0xLTExODAwNw_5bceb1df-7f52-465e-ac64-1d621d44ba2b"
      unitRef="usd">6091500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if66a35a33618446cb52289632d995392_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTgtMS0xLTEyNDUwMw_bbb3402b-2017-4167-85c5-a832ee81f303"
      unitRef="usd">2006200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTEwLTEtMS0xMjQ1MDU_5aac4695-ed0f-4e85-a6ed-76392f67410f"
      unitRef="usd">-118400000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iacd73e1d3acb402da10be07c5fc515f2_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTEyLTEtMS0xMjQ1MDc_7041d5f3-d547-464e-8053-138bb59138e4"
      unitRef="shares">53566000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iacd73e1d3acb402da10be07c5fc515f2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTE0LTEtMS0xMjQ1MDk_611d5b99-ce70-46bb-a866-c3c2a2a9104e"
      unitRef="usd">-2681500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yNS9mcmFnOjBlNmU1Y2ZiN2NjODQwOTI5Y2U3OGYzYmI2MWNjODlkL3RhYmxlOjEwMWFjMzY1YTgyZTQ4NGE4YmUxY2Y3MmYwNjc3OGFhL3RhYmxlcmFuZ2U6MTAxYWMzNjVhODJlNDg0YThiZTFjZjcyZjA2Nzc4YWFfMjQwLTE4LTEtMS0xMjQ1MTE_b7344b68-f576-494d-9a5d-4e8ad587240b"
      unitRef="usd">5300800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMy0xLTEtMS0xMDc5NTc_859cae86-b150-4a07-8db0-8b0fcb104e90"
      unitRef="usd">405900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMy0zLTEtMS0xMDc5NTc_4e1d1182-b876-4bcc-b687-514f9cb82f16"
      unitRef="usd">954900000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNS0xLTEtMS0xMDc5NTc_57f07aa8-0370-4c51-811b-405b3ec4ee23"
      unitRef="usd">44300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNS0zLTEtMS0xMDc5NTc_535c470a-0539-48aa-b361-e28d438e4c7e"
      unitRef="usd">44900000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNi0xLTEtMS0xMDc5NTc_a0339705-53fa-40f9-bfbd-ad14977f3aa9"
      unitRef="usd">122400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNi0zLTEtMS0xMDc5NTc_82530a0b-5a5c-4389-9570-64d96558f681"
      unitRef="usd">169200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOC0xLTEtMS0xMDc5NTc_ac27ce76-708f-4d1f-b517-960838f569c1"
      unitRef="usd">43700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOC0zLTEtMS0xMDc5NTc_0550e915-4005-4fe7-bf68-e4b75338d85d"
      unitRef="usd">36500000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOS0xLTEtMS0xMDc5NTc_d04177cb-ce87-44e0-b896-2d5c8c4802bd"
      unitRef="usd">-61600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfOS0zLTEtMS0xMDc5NTc_f21b1574-6016-46ef-b38f-e5fbc51d3149"
      unitRef="usd">-41500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMTUtMS0xLTEtMTA3OTU3_c1ea9ebb-1c3c-43ec-9fd7-f811c1b95077"
      unitRef="usd">-12400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMTUtMy0xLTEtMTA3OTU3_48f925a1-b7fe-4c29-9f0a-4d031844cc41"
      unitRef="usd">-4100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjEtMS0xLTEtMTA3OTU3_b6e155f2-ec01-4927-b690-07d44445c63d"
      unitRef="usd">-29600000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjEtMy0xLTEtMTA3OTU3_4264b9c0-e366-46f9-867d-b5636f61a527"
      unitRef="usd">-23500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjMtMS0xLTEtMTA3OTU3_10966daa-b940-452c-b58f-19b2646e02f8"
      unitRef="usd">81800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjMtMy0xLTEtMTA3OTU3_9633e85f-836c-4165-b538-998ad87514a1"
      unitRef="usd">-101600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjQtMS0xLTEtMTA3OTU3_12409467-1baa-4c78-99d7-03a4db4d1d10"
      unitRef="usd">56100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjQtMy0xLTEtMTA3OTU3_a554f9e4-9f16-4ddb-8a07-bf4be9cd036f"
      unitRef="usd">26400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjUtMS0xLTEtMTA3OTU3_b0226ef1-62d9-4450-9ee9-b8a2497274e2"
      unitRef="usd">-8300000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjUtMy0xLTEtMTA3OTU3_457f0cef-bb45-477b-963e-44b78ab87e5e"
      unitRef="usd">6400000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjYtMS0xLTEtMTA3OTU3_64a36c24-4979-4a8b-b69c-c0a612375c60"
      unitRef="usd">-10500000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjYtMy0xLTEtMTA3OTU3_29e4e8cc-52f6-4077-8ea7-0e71a069f417"
      unitRef="usd">-355300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjctMS0xLTEtMTA3OTU3_435fbe32-d897-4c67-9910-081b86f53a31"
      unitRef="usd">-13200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjctMy0xLTEtMTA3OTU3_080f9c7f-0381-4b7a-9094-6a0c32c7a93a"
      unitRef="usd">9100000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjgtMS0xLTEtMTA3OTU3_5def3bb0-cb07-4499-b9dd-01315113b367"
      unitRef="usd">-22400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjgtMy0xLTEtMTA3OTU3_846cbb91-5c8d-46c3-ba02-916e0fbb04fc"
      unitRef="usd">2900000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjktMS0xLTEtMTA3OTU3_714eb84e-f348-49df-95c1-0b97b0abf111"
      unitRef="usd">42500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMjktMy0xLTEtMTA3OTU3_c50a16ec-c8fd-489f-a557-068ce732c07e"
      unitRef="usd">6900000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzAtMS0xLTEtMTA3OTU3_f4a87e33-2839-44de-93e9-a43040480184"
      unitRef="usd">459700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzAtMy0xLTEtMTA3OTU3_e3ece946-6602-4125-a4a9-bcbd19efa56f"
      unitRef="usd">1626400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzItMS0xLTEtMTA3OTU3_d2d5f5d9-a245-4b07-8ada-46b949d84805"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzItMy0xLTEtMTA3OTU3_000abe59-6b43-42d6-b63b-742d760879ff"
      unitRef="usd">158400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzUtMS0xLTEtMTA3OTU3_4f4df579-2dfb-4783-8a11-e81fe949c5b2"
      unitRef="usd">34500000</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzUtMy0xLTEtMTA3OTU3_d69e070e-2363-4668-acde-9e85c8cfc3f6"
      unitRef="usd">36100000</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzctMS0xLTEtMTA3OTU3_370ad5c5-2ae1-4ba4-b1e3-79630f75e35b"
      unitRef="usd">20500000</holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion>
    <holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzctMy0xLTEtMTA3OTU3_b1412a0d-3989-467d-9138-6367f2ff16ab"
      unitRef="usd">58700000</holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzgtMS0xLTEtMTA3OTU3_ed58de2b-0b7c-4933-9798-10a35c48b5de"
      unitRef="usd">26700000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfMzgtMy0xLTEtMTA3OTU3_207a0e46-39d5-47bc-9a2e-4634e8dd1c83"
      unitRef="usd">33800000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDQtMS0xLTEtMTA3OTU3_707585c3-5438-4db7-a943-76d41da7f91e"
      unitRef="usd">10000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDQtMy0xLTEtMTA3OTU3_556e9df3-ecd4-4a77-b004-cbbacacb9cfb"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDctMS0xLTEtMTA3OTU3_cd74ed7a-00f2-43e3-860b-370db03bd4ba"
      unitRef="usd">6700000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDctMy0xLTEtMTA3OTU3_9dce393e-1e2a-406c-a68f-922811172a1f"
      unitRef="usd">-5200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDktMS0xLTEtMTA3OTU3_a9375d81-8c2c-40e4-91a5-6568fb100f03"
      unitRef="usd">-57400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNDktMy0xLTEtMTA3OTU3_2f2b7be1-b6a8-4425-9351-ed913dc382dc"
      unitRef="usd">-164400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTEtMS0xLTEtMTA3OTU3_0e5a60f3-9f01-4088-ad74-de333107c662"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTEtMy0xLTEtMTA3OTU3_b5e97455-096b-4b18-8851-451bcbf6df40"
      unitRef="usd">1491200000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTItMS0xLTEtMTA3OTU3_3a204359-68a1-4045-8f2f-cb890e477649"
      unitRef="usd">7500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNTItMy0xLTEtMTA3OTU3_e6fdd417-280b-48c3-a47d-ca431824dba9"
      unitRef="usd">1387500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjAtMS0xLTEtMTA3OTU3_32ab1d35-a328-4f2f-8dbe-2aef9d426712"
      unitRef="usd">7600000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjAtMy0xLTEtMTA3OTU3_bb6ceec4-1621-404e-ba41-98feb43cf601"
      unitRef="usd">12200000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <holx:PaymentOfDeferredAcquisitionConsideration
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjItMS0xLTEtMTA3OTU3_7faed485-38d1-4173-a2a7-6d527e20dbb4"
      unitRef="usd">-800000</holx:PaymentOfDeferredAcquisitionConsideration>
    <holx:PaymentOfDeferredAcquisitionConsideration
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjItMy0xLTEtMTA3OTU3_5dfabbed-9a4b-46ca-8ae5-26c49e7fd2c0"
      unitRef="usd">0</holx:PaymentOfDeferredAcquisitionConsideration>
    <holx:Repaymentsofacquiredlongtermdebt
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjMtMS0xLTEtMTA3OTU3_bd21951d-080c-4f1b-bd65-7164a7134634"
      unitRef="usd">0</holx:Repaymentsofacquiredlongtermdebt>
    <holx:Repaymentsofacquiredlongtermdebt
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjMtMy0xLTEtMTA3OTU3_05b756a8-1bcf-4338-94db-bca727062e7c"
      unitRef="usd">63600000</holx:Repaymentsofacquiredlongtermdebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjYtMS0xLTEtMTA3OTU3_f6268e5f-cec9-4d4d-ad92-ddee16bca3ae"
      unitRef="usd">150000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjYtMy0xLTEtMTA3OTU3_384af64e-00ea-4085-89fa-33752bf3e729"
      unitRef="usd">367000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjgtMS0xLTEtMTA3OTU3_1f7f9546-4337-4d49-9704-1f0c8d2727d1"
      unitRef="usd">28400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjgtMy0xLTEtMTA3OTU3_9b46dd6e-f324-4297-8230-3f88d32c9840"
      unitRef="usd">17300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjktMS0xLTEtMTA3OTU3_6331e79a-2e5c-4778-b36d-38b74dd54191"
      unitRef="usd">23200000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNjktMy0xLTEtMTA3OTU3_cea7ddd5-151b-4f6e-af38-0fdd2abecf19"
      unitRef="usd">22500000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzAtMS0xLTEtMTA3OTU3_f5781e13-7c77-4a7e-ac93-27a596eaca93"
      unitRef="usd">2300000</holx:PaymentsUnderFinanceLeaseObligations>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzAtMy0xLTEtMTA3OTU3_f75f693e-4cec-4cc0-ba89-1f6a09fd6465"
      unitRef="usd">1700000</holx:PaymentsUnderFinanceLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzEtMS0xLTEtMTA3OTU3_46796c9c-bb30-4a5a-a495-ab2291ebdb97"
      unitRef="usd">-163000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzEtMy0xLTEtMTA3OTU3_bbec5043-00ab-4143-9916-0b0414def2d9"
      unitRef="usd">-346000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzItMS0xLTEtMTA3OTU3_edee79b9-7269-4f64-94b3-c734845f1a0c"
      unitRef="usd">3400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzItMy0xLTEtMTA3OTU3_cc89bd3d-33c8-4586-91df-0fafaa441177"
      unitRef="usd">4500000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzMtMS0xLTEtMTA3OTU3_bda7c72e-55cb-47ed-990a-76f466ebffcb"
      unitRef="usd">242700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzMtMy0xLTEtMTA3OTU3_6ad43608-4558-42d2-a6bd-e217ab5d556c"
      unitRef="usd">1120500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzQtMS0xLTEtMTA3OTU3_6139babb-b93b-4011-8e57-316a1835ffab"
      unitRef="usd">2339500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzQtMy0xLTEtMTA3OTU3_fd55a14e-6688-4e64-9b57-2f07c932022c"
      unitRef="usd">1170300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzUtMS0xLTEtMTA3OTU3_91d10ddb-191a-4443-b1a4-ff3fc5e72793"
      unitRef="usd">2582200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8yOC9mcmFnOjI5OWJiNTYzOWRlOTRlMDlhNzE2NjdlMmMxNmRiY2UyL3RhYmxlOjlhZjU4ZjRmNmJkOTQwYzc4MzkwMWUzMjY1MGU2NzI0L3RhYmxlcmFuZ2U6OWFmNThmNGY2YmQ5NDBjNzgzOTAxZTMyNjUwZTY3MjRfNzUtMy0xLTEtMTA3OTU3_e01b9da8-8c08-4f75-ae96-8c89e59df50e"
      unitRef="usd">2290800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNC9mcmFnOjk2N2E0NGFhNDk5ZjQwMzRiZTI2NjBkYzE4MTEwMmY2L3RleHRyZWdpb246OTY3YTQ0YWE0OTlmNDAzNGJlMjY2MGRjMTgxMTAyZjZfMjU0Mg_9bd65b12-84ab-48f5-914c-96aa5d08d3e3">Basis of Presentation&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated financial statements of Hologic, Inc. (&#x201c;Hologic&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#x2019;s annual report on Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended April&#160;1, 2023 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company&#x2019;s historical fiscal calendar.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended April&#160;1, 2023.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNTQ5NzU1ODI0NjI1_ff09f342-eaae-4bfc-9820-40dd700a4f40">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(2) Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for revenue pursuant to ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company&#x2019;s products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company&#x2019;s products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company&#x2019;s performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue from laboratory testing services, which is generated by the Company&#x2019;s Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company&#x2019;s contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $857.4 million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company&#x2019;s Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 26% of this amount as revenue in fiscal 2023, 36% in fiscal 2024, 23% in fiscal 2025, 11% in fiscal 2026, and 4% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company&#x2019;s conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company&#x2019;s Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $34.5&#160;million and $101.3&#160;million in the three and six months ended April&#160;1, 2023, respectively, that was included in the contract liability balance at September&#160;24, 2022. The Company recognized $30.9&#160;million and $87.3&#160;million in the three and six months ended March&#160;26, 2022, respectively, that was included in the contract liability balance at September&#160;25, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfOTE0Nw_137cdd81-a714-49dc-8b8a-b9a8df9aa20c">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i80e5484a0f4c43d3a4b5386b8dd0cdfe_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy0yLTEtMS0xMDc5NTc_dc78c599-a504-4615-9432-c038291725e6"
      unitRef="usd">69000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2dcc05bea314588b412a9f27a0d2096_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy0zLTEtMS0xMDc5NTc_80856e45-440f-4b68-b805-37ae88f165ed"
      unitRef="usd">42900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6643d03654fc4e74abb8215ae7099bc5_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy00LTEtMS0xMDc5NTc_a587b65a-5f8c-4bfd-97c0-413e6310f250"
      unitRef="usd">111900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27fb968480674498b86f260f5c557cd2_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy02LTEtMS0xMDc5NTc_65cd0f02-bd3c-46ae-9ce6-359bab1c2300"
      unitRef="usd">72100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic86ced2c50224d87b806cfe2700e9451_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy03LTEtMS0xMDc5NTc_e70748f2-1f13-42e8-ab2d-2b9988212e53"
      unitRef="usd">43300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i20558280389d4b6882132ba9b3803cd3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMy04LTEtMS0xMDc5NTc_c255fe20-ed12-46ed-ab49-81d17193d165"
      unitRef="usd">115400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic59b200cdcd64399ac289fd7af196ea9_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC0yLTEtMS0xMDc5NTc_2bf93e21-2bcc-4132-89d2-da6c1313002b"
      unitRef="usd">263000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51d2c2c178954ebd9a39527357d76c74_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC0zLTEtMS0xMDc5NTc_d99a5643-8f47-4f17-b52f-709d5e6ac0f0"
      unitRef="usd">79200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia84dfba6a6bc4632b38560142cba9e81_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC00LTEtMS0xMDc5NTc_7637ee49-0ea2-4fde-b4d0-19d94ebe80f2"
      unitRef="usd">342200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ffef3244c874e85b508fa350a2554e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC02LTEtMS0xMDc5NTc_240137de-7c8e-4fdc-b3da-07b13a140bd8"
      unitRef="usd">563800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2168b403a0ee4e46af7c9636f54dfd4b_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC03LTEtMS0xMDc5NTc_ba9f3515-6ff2-495c-a73d-57378346bf30"
      unitRef="usd">298700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2d09a84e2db4fa7882cd618c44a4279_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNC04LTEtMS0xMDc5NTc_2fb8903a-d430-4bec-8e2c-6ed096abc50b"
      unitRef="usd">862500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c08c95f31c343c48236eb8ce8c31567_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS0yLTEtMS0xMDc5NTc_172859a0-02a8-4ba4-9f65-e6f487dd0dd2"
      unitRef="usd">10600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4b1e7bfe27e4e76be3bf69f2d53e02c_D20230101-20230401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS0zLTEtMS0xMDc5NTc_783716b0-fdc7-4e03-96f7-f925db399f80"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f37682f6f5145a58f06d84f7b8e61cb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS00LTEtMS0xMDc5NTc_48077405-f16a-45d0-813b-bc5a6b93d4fe"
      unitRef="usd">10600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa9838ba0466484bb137158e7a1567da_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS02LTEtMS0xMDc5NTc_6432c4d3-b1ca-4da4-8ab7-8d4d81ded7c2"
      unitRef="usd">9200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icfb0b1cfe7eb4bd1a09a13946bcd2bcd_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS03LTEtMS0xMDc5NTc_28e506aa-a233-43fd-8311-54e894d7336e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib398b6fc80d746a2b8ae5fc069cae6a0_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNS04LTEtMS0xMDc5NTc_be2eb653-1ff4-46c5-ac65-7c0eb093b92b"
      unitRef="usd">9200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i565fca98edfe40c8a7d74fcf1421de87_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi0yLTEtMS0xMDc5NTc_80cf8461-bc13-4513-9888-a87e8d91001f"
      unitRef="usd">342600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia65e97210e574278b454ce584c3cad8d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi0zLTEtMS0xMDc5NTc_938a98d8-d26b-4274-aacb-522321264c91"
      unitRef="usd">122100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi00LTEtMS0xMDc5NTc_8e6a0fbe-a187-4ef9-a41e-8438b34363dd"
      unitRef="usd">464700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i099e7069f9c44890bb40a7afe3614761_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi02LTEtMS0xMDc5NTc_7637c032-830f-49b1-8d00-f9487574f4c2"
      unitRef="usd">645100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5eb7b04583b44661b5c05b7efe129429_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi03LTEtMS0xMDc5NTc_1ce00b63-047e-4f05-8e81-ba9a6b1a6485"
      unitRef="usd">342000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfNi04LTEtMS0xMDc5NTc_2f211338-a8c3-4a00-814e-cf1d0b936097"
      unitRef="usd">987100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i781a7f522edd4c4d951e77997571c15f_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS0yLTEtMS0xMDc5NTc_e9c0ad32-7c6f-46b8-9204-2de27d8df6c7"
      unitRef="usd">233500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24aec643f412452fb0caae5eef3a39d9_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS0zLTEtMS0xMDc5NTc_e481ef48-b7e9-46b3-84f8-1edf4321c562"
      unitRef="usd">78000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia13676ccbf324673bdda7326d7f4f08b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS00LTEtMS0xMDc5NTc_ca33add2-1960-418c-99bf-310a4d3b4a78"
      unitRef="usd">311500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1fd32066656d441a86201c5e12956de1_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS02LTEtMS0xMDc5NTc_f62f6df2-b69c-4a1a-ae6c-2433806690c5"
      unitRef="usd">187400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i619d5722b4ca48d6a5f05a12991734fe_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS03LTEtMS0xMDc5NTc_6059248d-b0d5-4ce4-90d2-25ca271988e7"
      unitRef="usd">57600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b1fa5ac56b84e7aabaa1944179b29a0_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfOS04LTEtMS0xMDc5NTc_024b95f0-436a-4ca3-95fc-f1f9dea6fa2f"
      unitRef="usd">245000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icbef055aeb94448c964ef00d2ce1fa7f_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtMi0xLTEtMTA3OTU3_915a4633-45c8-4f36-bd38-08496a0c282b"
      unitRef="usd">59800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf08815cbd2a48b4bf69282fcffa315d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtMy0xLTEtMTA3OTU3_b5c2f7b9-fd18-4cbd-b0c7-6f0bcc4af3f3"
      unitRef="usd">14100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if76e12316bf64558aad72df91e631bbe_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNC0xLTEtMTA3OTU3_41477867-8b1e-454e-9a4d-398f44076d14"
      unitRef="usd">73900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8f65bc9a643471eb4699958d5a56b0e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNi0xLTEtMTA3OTU3_6ecba23e-b478-4dc1-a73d-6b11c3c47512"
      unitRef="usd">52100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65ec9d62d7b24c9aa3d020e9fd43fde0_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtNy0xLTEtMTA3OTU3_5855ba68-b6a0-46a5-89a6-f4a5f1e7c2ab"
      unitRef="usd">13300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d3508f3a72645e19ce96e3f933f92e3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTAtOC0xLTEtMTA3OTU3_4b96faa2-e68d-4f76-bba3-c34df38f3483"
      unitRef="usd">65400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b2ddbfb01cc43e6ad631c8c163cf4c5_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItMi0xLTEtMTA3OTU3_ae5da6db-b259-4222-8e27-cfc20234f1f9"
      unitRef="usd">293300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifeecee944b96477993784167af0ec4e9_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItMy0xLTEtMTA3OTU3_b686d9d3-2643-42d8-bf8b-6ed531075ef5"
      unitRef="usd">92100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNC0xLTEtMTA3OTU3_7db0c59b-4791-4645-96e4-af3f8ecaa5d3"
      unitRef="usd">385400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie61d3c1656c444e2af045a6884b5cd0f_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNi0xLTEtMTA3OTU3_262d5adb-f5db-4333-a545-f387746840f2"
      unitRef="usd">239500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i387d4056e84b4ac180d2aa7e3393329f_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItNy0xLTEtMTA3OTU3_f1a4a573-3645-440b-9941-ba26071c62e4"
      unitRef="usd">70900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTItOC0xLTEtMTA3OTU3_7499fafd-801d-4edd-bced-3dac10db9eec"
      unitRef="usd">310400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ad2b30985d644f0a50a8cdc970d6f5d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtMi0xLTEtMTA3OTU3_388ee4aa-120e-4686-8d84-3b192b7e5109"
      unitRef="usd">113600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12fc4260d3174dda9b586fb230fa8f91_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtMy0xLTEtMTA3OTU3_feeed701-187d-4d07-887e-ac8a24186364"
      unitRef="usd">31200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNC0xLTEtMTA3OTU3_d08a1c74-2ebf-46a7-866e-ff42d83f55e3"
      unitRef="usd">144800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if88ec2152274467d88041d6be4c30ff6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNi0xLTEtMTA3OTU3_16b86e17-76a7-4741-8170-17e7b1867b38"
      unitRef="usd">94000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58119cf2e18e4040ad7d0545f5502d37_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtNy0xLTEtMTA3OTU3_36abb70a-5a22-4fa8-8592-ec8d07c22015"
      unitRef="usd">23300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTQtOC0xLTEtMTA3OTU3_8a366cc0-d1ef-45aa-ba63-0b69bf71e442"
      unitRef="usd">117300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18684c24e2714ec8a43866e747472e7c_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtMi0xLTEtMTA3OTU3_13f8e0f9-b6f6-4ca3-8200-757e8ba6621d"
      unitRef="usd">19200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e11b702840946b7a882d86468c5c654_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtMy0xLTEtMTA3OTU3_71f00ff6-2a5a-477f-9c96-fb96af6096a9"
      unitRef="usd">12400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNC0xLTEtMTA3OTU3_32b795cd-6982-439d-a4a8-a819d0b89793"
      unitRef="usd">31600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i620f31a3d0b94dc7a06fa436a267fa09_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNi0xLTEtMTA3OTU3_04145f41-f970-4c4f-b9ab-f9929a90c2a7"
      unitRef="usd">13800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33460790b19b4a16b5c379ca34c18e06_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtNy0xLTEtMTA3OTU3_5a7e8749-7850-48d5-adf6-eecfc7d7163b"
      unitRef="usd">7100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTYtOC0xLTEtMTA3OTU3_31b089ee-f8aa-4746-b164-69ae8d0b7b04"
      unitRef="usd">20900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctMi0xLTEtMTA3OTU3_553ed57d-af46-4ade-9bde-76cdfa268e20"
      unitRef="usd">768700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie287b34c173446e4b3ae5678053afeb1_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctMy0xLTEtMTA3OTU3_b8de9e9d-e71b-45ad-99cc-5461b920cb92"
      unitRef="usd">257800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNC0xLTEtMTA3OTU3_b0da0e03-bcad-47ef-93a4-a8e31b31209e"
      unitRef="usd">1026500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNi0xLTEtMTA3OTU3_a95a121c-7f82-43fb-a7fa-dc014c10b560"
      unitRef="usd">992400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i349699c3313a4532a7a576011d54ac58_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctNy0xLTEtMTA3OTU3_3c8f13ef-f9d5-4272-a8bc-a7b4d188a43e"
      unitRef="usd">443300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjAyNmI5MzYyYzE0ZDQzNmE4YjI3MmUxNTE2ZDJiNDM1L3RhYmxlcmFuZ2U6MDI2YjkzNjJjMTRkNDM2YThiMjcyZTE1MTZkMmI0MzVfMTctOC0xLTEtMTA3OTU3_e582aab5-612a-41df-94a6-3241b403c09d"
      unitRef="usd">1435700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8841fc4453d947b1abc6b677fcdf4c75_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy0yLTEtMS0xMDc5NTc_b83758eb-6148-44de-b9ca-abe704dd9f49"
      unitRef="usd">147100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1353f3f554864abca59c0d2acd652329_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy0zLTEtMS0xMDc5NTc_3b6248e1-9fb1-4e94-a958-c23071307fc2"
      unitRef="usd">91500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32f4de0bdaca42439e9615354a987d7c_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy00LTEtMS0xMDc5NTc_89dd312d-c5c9-44ca-a0fe-cf5116721ff0"
      unitRef="usd">238600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb875e603fbc4fe1a1e9ca9acea597bd_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy02LTEtMS0xMDc5NTc_32d6b135-1069-4b12-a3bc-b7e68b60de20"
      unitRef="usd">153000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4d1acff3bb149edaaf709f12e763dc4_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy03LTEtMS0xMDc5NTc_731bce6d-186e-4ca7-8442-80ec991c6e18"
      unitRef="usd">92900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifceb9765ec71498ebc94cc6a41dfb085_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMy04LTEtMS0xMDc5NTc_e2f1ffee-0051-4e22-a4b4-c4973aea6ef7"
      unitRef="usd">245900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i071c0ae1705441148ac8e82637f13843_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC0yLTEtMS0xMDc5NTc_6bdad3ec-be4b-4dfb-887f-da13207dfdc7"
      unitRef="usd">591300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ab114a082dd4e6b82610ed0a84ed5ac_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC0zLTEtMS0xMDc5NTc_e0e9c87f-1c1b-420a-ae28-be54e568721e"
      unitRef="usd">176200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4db81a73fb034bce8b07cb4d54adb4d5_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC00LTEtMS0xMDc5NTc_ed50e700-d55e-4d4d-8111-30b4bb17c047"
      unitRef="usd">767500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33e2dac027774b4fbe6ae5f2f7c513a0_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC02LTEtMS0xMDc5NTc_0743809c-8ed2-4ec5-88dd-b2aa641d3a04"
      unitRef="usd">1091800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5940fd34036f48a8b0d1a0f4d3246913_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC03LTEtMS0xMDc5NTc_f181d114-8959-4f78-adde-38ab2af9ed3a"
      unitRef="usd">584200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78d825bcee284151aa724fb0e57ab91e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNC04LTEtMS0xMDc5NTc_799046bd-dd33-40d8-a85c-d051893334a2"
      unitRef="usd">1676000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd73e2dccdf845d988743f5b2afd0a7c_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS0yLTEtMS0xMDc5NTc_6ff857c7-b0e8-4977-ada7-5f310d4a78df"
      unitRef="usd">17900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4160efde569446d6a70f5cb043ff5bed_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS0zLTEtMS0xMDc5NTc_d8b5ed42-b4f3-472d-82ba-47c638c400fe"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8a2096ceff74f10ab7ea238449b6ebb_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS00LTEtMS0xMDc5NTc_a72100bc-4a1b-4513-89d2-3f5ede598274"
      unitRef="usd">17900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i010f85da839c4f788ae3c9678dcfee88_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS02LTEtMS0xMDc5NTc_4feb3c29-16ec-4acc-bfa5-2cef13a62dad"
      unitRef="usd">15600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7435b5e546944ceabfd36aaed78afb22_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS03LTEtMS0xMDc5NTc_a4b31926-143c-495b-bd7d-ad316e9a71cd"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7cf0a8c804c43e78bbd2ecab53fa929_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNS04LTEtMS0xMDc5NTc_c0d9d672-2a71-454d-a615-6138c2046142"
      unitRef="usd">15600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddfb59c21d064a0095827e9fee15c650_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi0yLTEtMS0xMDc5NTc_ef3541da-65a7-4f91-808d-16f314749339"
      unitRef="usd">756300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i008fea210a79421792efe38c181b3afe_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi0zLTEtMS0xMDc5NTc_9dc39c53-47f2-49b8-babd-e40a0f9f1bce"
      unitRef="usd">267700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi00LTEtMS0xMDc5NTc_0a076bb8-42e8-42dd-b961-31c3e38e0056"
      unitRef="usd">1024000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id38424d055ed4ce5b58b21cb84139032_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi02LTEtMS0xMDc5NTc_d8fbc24d-8504-43c2-875d-72d9ac76eba6"
      unitRef="usd">1260400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c824d2f804b4f8cbe8774772c549f65_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi03LTEtMS0xMDc5NTc_b1fc2437-baa3-490c-a4f2-779e722ac66a"
      unitRef="usd">677100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfNi04LTEtMS0xMDc5NTc_18e9ee9e-be5b-4f6e-987b-8d3f04250b6c"
      unitRef="usd">1937500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7bb65acf97a4446adca1cf306eb6abc_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS0yLTEtMS0xMDc5NTc_376f0e44-00cd-459d-a044-2a74b9737b63"
      unitRef="usd">445800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic404fc96f0c64f51b5b4f5e6737f2d54_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS0zLTEtMS0xMDc5NTc_3d392241-598a-4355-9472-51c17f090bf4"
      unitRef="usd">130100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie823dd7cc3af472b9bd804c6b639b007_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS00LTEtMS0xMDc5NTc_be83644e-bd12-4842-904a-901d12301af1"
      unitRef="usd">575900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a312bb9f01c4777b32b902e8248d9cb_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS02LTEtMS0xMDc5NTc_e9b8e6c9-57ab-436c-817b-09ac82101e50"
      unitRef="usd">396300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i919b1976ae604ccd9ecae3f5a1044a6a_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS03LTEtMS0xMDc5NTc_35cafca1-7921-41b6-9324-dab50b2db196"
      unitRef="usd">131000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e166105ee044f2891a1e4feecf8f137_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfOS04LTEtMS0xMDc5NTc_1882fde0-db92-40ea-9ff2-7660b84c20c7"
      unitRef="usd">527300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bc35b3bc4774106ba45e0abe86067ab_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtMi0xLTEtMTA3OTU3_4a19ffee-1e84-4745-93bb-c320c7437518"
      unitRef="usd">117500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i188645d6d3b14ab7bb87691db06a8205_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtMy0xLTEtMTA3OTU3_fb928988-974e-4fd6-bd52-7c8c5c6e1ccf"
      unitRef="usd">26100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8a579c3edee4243a5457698bafb3ba4_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNC0xLTEtMTA3OTU3_2fedefce-72c8-4b1f-b6a3-219ae40fc761"
      unitRef="usd">143600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e8a695c629c41f2bdb54152ed3a5cae_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNi0xLTEtMTA3OTU3_371a8a70-9c45-4fe1-8966-a0907e575d17"
      unitRef="usd">114300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib7132a15dec44f3599d3ef99c1e30826_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtNy0xLTEtMTA3OTU3_66ed8c21-b991-4e15-be06-276508d87a37"
      unitRef="usd">28300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71d77f036b144ab2bf62c85dff6e86fc_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTAtOC0xLTEtMTA3OTU3_d30ab4f3-444b-4f9f-80db-35b81027c878"
      unitRef="usd">142600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idbd3e99c4b6349de8cdb1e8f0a2b6311_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItMi0xLTEtMTA3OTU3_261d138e-d629-4b43-b1c6-6b764015de6a"
      unitRef="usd">563300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc7b0243cde744aebbd25a510394a248_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItMy0xLTEtMTA3OTU3_7817577d-e3c4-4f98-8837-f7dd66e3b83a"
      unitRef="usd">156200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNC0xLTEtMTA3OTU3_c7f73d38-9456-467b-84b3-ebe92f9d3d08"
      unitRef="usd">719500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie705a94ebd6c4795aff105e679f1be54_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNi0xLTEtMTA3OTU3_cdb327cd-63fd-43ef-b969-f4ad19fc8025"
      unitRef="usd">510600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0b9944219eb46c087a0481d0206b4cc_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItNy0xLTEtMTA3OTU3_9138d6bd-4c8f-4bc6-a327-56f57d0e3179"
      unitRef="usd">159300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTItOC0xLTEtMTA3OTU3_84b60627-c76f-4d77-ac50-52b4b776da32"
      unitRef="usd">669900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28bab2b9c104428e8c55999a506f0906_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtMi0xLTEtMTA3OTU3_9cc6b050-0f98-404e-80b9-96d7e37d705f"
      unitRef="usd">236700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53f619cf4bfd430793d0539858960750_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtMy0xLTEtMTA3OTU3_5080eed8-6193-4309-a288-946dacafc9fb"
      unitRef="usd">62200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNC0xLTEtMTA3OTU3_185f42bb-a69c-4719-96c3-03855f063134"
      unitRef="usd">298900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc6d823fbbc94feab179d253e4be9aa3_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNi0xLTEtMTA3OTU3_f8ef7ddb-8e4b-4563-9870-11bc0cb1bf61"
      unitRef="usd">203300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iefac68ca0bdb40f387bdb4a775659af8_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtNy0xLTEtMTA3OTU3_4e1f41c5-fe30-4f58-bb13-af5f524d4f67"
      unitRef="usd">48300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTQtOC0xLTEtMTA3OTU3_5ee83c47-4327-471b-abb1-607b0334534b"
      unitRef="usd">251600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i962c4b39ad9b43f789b8793465348724_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtMi0xLTEtMTA3OTU3_9083e66c-6d0d-4fc7-acfd-cdc468eea3a3"
      unitRef="usd">36000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifff7e3a68df34606bf1106251ac4c25e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtMy0xLTEtMTA3OTU3_9f46251b-c9d1-4cc6-b584-0c9d9f217ca3"
      unitRef="usd">22300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNC0xLTEtMTA3OTU3_9362dea4-cff2-452d-965b-a01c438cf60f"
      unitRef="usd">58300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i763fd5b73588457eaf359445f8e85c8a_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNi0xLTEtMTA3OTU3_db2e09d7-7bf4-484e-b437-c8ce85df1382"
      unitRef="usd">30500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18c2774c2d1e44689b12b1bf19aad67f_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtNy0xLTEtMTA3OTU3_7787d22e-6184-4b61-bc79-ebf104f30de5"
      unitRef="usd">17400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTYtOC0xLTEtMTA3OTU3_1b7b6220-22c2-4055-b55f-49d4ce5c5fd9"
      unitRef="usd">47900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctMi0xLTEtMTA3OTU3_22cea9bf-54d6-4c0b-82c7-05958abecaee"
      unitRef="usd">1592300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0bef0470fb04031bd8d1f8ca4de2a26_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctMy0xLTEtMTA3OTU3_276cc2bb-fa6f-4f35-bac4-1260a915e762"
      unitRef="usd">508400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNC0xLTEtMTA3OTU3_a5305ef1-4694-4573-85a7-d776a6e6e2ba"
      unitRef="usd">2100700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNi0xLTEtMTA3OTU3_516f407d-3d02-4b9f-8497-b35af0c5c59e"
      unitRef="usd">2004800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i736cfdfe36b64ca6be804529485f2142_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctNy0xLTEtMTA3OTU3_0e5d1859-9db4-4bf8-83ef-d1e67417abe9"
      unitRef="usd">902100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjhkZGExMjUyNTBhZjQ4N2E5NTc1MGIyOGM3NDE2MDlhL3RhYmxlcmFuZ2U6OGRkYTEyNTI1MGFmNDg3YTk1NzUwYjI4Yzc0MTYwOWFfMTctOC0xLTEtMTA3OTU3_cfc34197-ab08-40bb-9eb4-088227727b15"
      unitRef="usd">2906900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi0yLTEtMS0xMDc5NTc_1b034be4-9950-4a48-bcba-342fd5cf374f"
      unitRef="usd">768700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi0zLTEtMS0xMDc5NTc_f10d951b-c3eb-4f01-b2d9-aaa31e6a3add"
      unitRef="usd">992400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi01LTEtMS0xMDc5NTc_a10b0ae4-4c53-4974-a7bb-82fe3afbe158"
      unitRef="usd">1592300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMi02LTEtMS0xMDc5NTc_d5bc3ede-6683-44fc-8228-b399a50a36c4"
      unitRef="usd">2004800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy0yLTEtMS0xMDc5NTc_13a8a0dc-1cdf-4098-9666-c76bc0207576"
      unitRef="usd">151500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd755a8928c347638dc5777e510229a4_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy0zLTEtMS0xMDc5NTc_27c9286f-9545-41eb-924b-f99f2f5881f6"
      unitRef="usd">291200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy01LTEtMS0xMDc5NTc_8caf4873-337d-41d7-9995-22d101fb1f5d"
      unitRef="usd">298800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfMy02LTEtMS0xMDc5NTc_4c31f85c-9375-4b15-9e37-39a6037f4f16"
      unitRef="usd">586300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC0yLTEtMS0xMDc5NTc_034a3a85-6e8d-4121-9f5f-2690f43244d5"
      unitRef="usd">65200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC0zLTEtMS0xMDc5NTc_276cf5ac-9f29-4086-a5fd-bf77c33d473a"
      unitRef="usd">109700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28d2b38d322445518df9d6519589e24a_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC01LTEtMS0xMDc5NTc_56b661e3-34f6-4b87-b125-b7999a9f5afc"
      unitRef="usd">129100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNC02LTEtMS0xMDc5NTc_3bb28275-08b4-4f16-a81d-92695ea8c617"
      unitRef="usd">229400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe30b8b63776445486aad925dd9774cb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS0yLTEtMS0xMDc5NTc_507ccd39-0e2f-4a35-bd49-e091c202806e"
      unitRef="usd">41100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00be1902f11b446090c0c094fcc5c85e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS0zLTEtMS0xMDc5NTc_7398763f-ab6b-4e01-b083-e8c301bfe728"
      unitRef="usd">42400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48755cfd484a4e62a2c8362de38c8b4f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS01LTEtMS0xMDc5NTc_77773f66-ab31-4769-b531-aa17622095f2"
      unitRef="usd">80500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i327da3cafe3c4d0aa665e7ce8be8698a_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNS02LTEtMS0xMDc5NTc_9e269b82-70ee-4e95-b80b-73bd0c4ab784"
      unitRef="usd">86400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi0yLTEtMS0xMDc5NTc_1cde585b-4cec-4199-8781-ff84d452c418"
      unitRef="usd">1026500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi0zLTEtMS0xMDc5NTc_07c7c274-8b7c-4fe0-9e3c-3966f50bff30"
      unitRef="usd">1435700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi01LTEtMS0xMDc5NTc_f418800a-d77e-4c4d-9cb4-a98f7b41d034"
      unitRef="usd">2100700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOjg3NTU1NzE5NmFlNzRiZGU5NTBlZWJiOTNhNWRmNDIwL3RhYmxlcmFuZ2U6ODc1NTU3MTk2YWU3NGJkZTk1MGVlYmI5M2E1ZGY0MjBfNi02LTEtMS0xMDc5NTc_c623a656-0ee5-44bd-870f-0a9929e94ce7"
      unitRef="usd">2906900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24dcaeab411b4af8a6f85a2871d1bbc9_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi0yLTEtMS0xMDc5NTc_4d101c68-1f66-45fe-a143-54ac439d8158"
      unitRef="usd">626500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0a871a4c3174df7933da7c6f14e608e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi0zLTEtMS0xMDc5NTc_868cd627-e5d6-41e4-ab02-3d0a29012272"
      unitRef="usd">1111100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i058c9fcddfcb4b1fbe11fc320f77993d_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi01LTEtMS0xMDc5NTc_dbcd5d48-63d9-48f7-bf09-7fe0261c82fc"
      unitRef="usd">1354300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f6dda388f7b41c38ba9e6e639ffcccc_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMi02LTEtMS0xMDc5NTc_94ab84cf-9399-4f2f-98a0-9c8c504d2682"
      unitRef="usd">2217500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05806bc883904e079e94fe4711a9df85_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy0yLTEtMS0xMDc5NTc_9083b427-d573-4ec9-bba1-262f2ed901c6"
      unitRef="usd">210900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i694b9650b4154c7a9932f7c343e478ad_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy0zLTEtMS0xMDc5NTc_3408357e-9151-43d7-b86f-c16cadf6f311"
      unitRef="usd">157100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i904efd675fc84cb4a2bd864cdd35efb3_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy01LTEtMS0xMDc5NTc_06df51a8-5cb3-4ab6-805f-e90f052407fe"
      unitRef="usd">369500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i364049c727f64c5fb9da068da0a5f058_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfMy02LTEtMS0xMDc5NTc_b034504b-1aeb-410d-949a-a9aae93cd915"
      unitRef="usd">354100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iefff25e1fa9f4bf28ac85461fcab5263_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC0yLTEtMS0xMDc5NTc_07114a11-72b7-491d-92d2-1e2c7088dbf4"
      unitRef="usd">183000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifeb1b8233acc4dc4b6b32e2401873bfa_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC0zLTEtMS0xMDc5NTc_4d16a74a-6c43-4825-9313-66cfd6467986"
      unitRef="usd">162600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1344c7b5279d47b78b2c5cf3500112f0_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC01LTEtMS0xMDc5NTc_0a3c0016-6ca0-4ff2-a972-b541f88c8fe3"
      unitRef="usd">366200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f792878945149fbaac1be5445470b02_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNC02LTEtMS0xMDc5NTc_fe1e4bd4-6605-45bc-9fef-c3d64accd593"
      unitRef="usd">325400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i92c691696ff746668ac0cedf53217ef9_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS0yLTEtMS0xMDc5NTc_9803248f-a73b-4c2d-9f54-04615c14bc70"
      unitRef="usd">6100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e8a0fe062b74f88bdbdc98402f1f734_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS0zLTEtMS0xMDc5NTc_a770d66c-7cd1-44cb-af87-4f21288bae24"
      unitRef="usd">4900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ed6153920c41a589f4f344f8dc62d0_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS01LTEtMS0xMDc5NTc_ba400d69-b5ea-40fc-a2be-3e6964d8f88a"
      unitRef="usd">10700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic44fcf0cfb084b098571baf1d7dead87_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNS02LTEtMS0xMDc5NTc_4d74b615-e8b6-4343-960c-b8e27e941b99"
      unitRef="usd">9900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi0yLTEtMS0xMDc5NTc_7528de01-8e2d-4a00-9886-f4f2ba9d889b"
      unitRef="usd">1026500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi0zLTEtMS0xMDc5NTc_29b10a60-cd69-457c-91ee-7565e945b5c3"
      unitRef="usd">1435700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi01LTEtMS0xMDc5NTc_682bd24e-11b9-4a54-a07a-c16a79085e65"
      unitRef="usd">2100700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RhYmxlOmE2MDczYzQ1ZTUxZDQ4YjY4ZDFmNDY4ODljNjliODZkL3RhYmxlcmFuZ2U6YTYwNzNjNDVlNTFkNDhiNjhkMWY0Njg4OWM2OWI4NmRfNi02LTEtMS0xMDc5NTc_cec9398b-0f8f-49da-abfb-a90d6bf842e7"
      unitRef="usd">2906900000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNjkzNQ_cadfa5bc-5154-4212-875d-5e47a0df1f5b"
      unitRef="usd">857400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i04aefe98ed524fa9b9e204dc0508b87f_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzE3Ng_b1c6b20d-8b79-4b2b-9a3f-d935ca3aad98"
      unitRef="number">0.26</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i7c473319bb7c41ebbe6a91f325696f90_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzIyMQ_00fef6fb-761e-422c-a722-c7389e3f9ecb"
      unitRef="number">0.36</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ibf681aba2c0745179379eda917259f24_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI0MA_479e140c-f856-4fff-befe-c0878e2bbc4c"
      unitRef="number">0.23</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="iae8494d630974166892e8a6e322ce2c4_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI1OQ_6a279906-d103-4e32-b9a7-5032870bb3ab"
      unitRef="number">0.11</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i201acc12848f4295aca92e64a29fae3e_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfNzI4Mg_2925d1b8-32d2-4de4-9547-69b002a658c6"
      unitRef="number">0.04</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfODU2OA_46c91f1b-c5b0-47f7-9411-f26c1a20e619"
      unitRef="usd">34500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfMTA5OTUxMTYzNzQ0Nw_5313331f-8218-4b80-af68-cbebfaa05a3e"
      unitRef="usd">101300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfODU3NQ_a2a24f0c-e8d9-4ed1-b31c-4f6d42bfe099"
      unitRef="usd">30900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV8zNy9mcmFnOjUyYTFhZDZjYjJiMzQ4MmU4NTRlNjRmNTc0NjhkMDcwL3RleHRyZWdpb246NTJhMWFkNmNiMmIzNDgyZTg1NGU2NGY1NzQ2OGQwNzBfMTA5OTUxMTYzNzQzMg_7a7f5f9f-5b3b-49df-aa37-cafe8cefaa4c"
      unitRef="usd">87300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfMTAwNA_9832bd40-a1e3-428c-8718-b77fd2910073">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company&#x2019;s consolidated revenue for all periods presented.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfMTAwNA_db9fc8f8-d5aa-4177-a423-ea1a4a8cd3c2">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company&#x2019;s consolidated revenue for all periods presented.</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80My9mcmFnOmMzMjM5NWEzNmYzNTQ1NDE5YWNlM2EyMmZkMDcxM2ZlL3RleHRyZWdpb246YzMyMzk1YTM2ZjM1NDU0MTlhY2UzYTIyZmQwNzEzZmVfOTM1_0576676c-e2d8-4efc-ab55-5cac3f48dcba"
      unitRef="number">0.03</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzQwNg_ae57131d-5a3d-456c-a7d3-3ba5c9144011">Fair Value Measurements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in derivative instruments comprised of interest rate swaps, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value, which is based on Level 3 inputs. The contingent consideration liability as of April&#160;1, 2023 and March&#160;26, 2022 was related to the Acessa acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at April&#160;1, 2023:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended April&#160;1, 2023 and March&#160;26, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $4.3&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure of Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, interest rate swaps, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#x2019;s interest rate swaps, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.&lt;/span&gt;&lt;/div&gt;Amounts outstanding under the Company&#x2019;s 2021 Credit Agreement of $1.5 billion aggregate principal as of April&#160;1, 2023 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#x2019;s 4.625% Senior Notes due 2028 (the &#x201c;2028 Senior Notes&#x201d;) and 3.250% Senior Notes due 2029 (the &#x201c;2029 Senior Notes&#x201d;) had fair values of $388.9&#160;million and $848.4&#160;million, respectively, as of April&#160;1, 2023 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#x2019;s debt.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzQyMA_6fd78634-33d9-4d27-852f-004472726295">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at April&#160;1, 2023:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended April&#160;1, 2023 and March&#160;26, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6bd296de48514683a96ee90d09cf647b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC0xLTEtMS0xMDc5NTc_1f6962d4-6185-4c0b-91af-c68efdd5a1ae"
      unitRef="usd">27200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ifeb3334f07144b1eb56036eff778881d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC0zLTEtMS0xMDc5NTc_5abec9c2-d928-4802-8d86-4fcb92c35cbf"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i931efb624c5240ec87bbbb2d5e3977f2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC01LTEtMS0xMDc5NTc_1326dc11-465c-43c4-8c57-a626d290efd2"
      unitRef="usd">27200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if3e076bd0f834d7587361fc0c5740091_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNC03LTEtMS0xMDc5NTc_a7d5fb47-ace3-401d-a3ac-ddad78d9c9e9"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6fd04ba0e0c14cbabfcf0fd0dbb55c00_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi0xLTEtMS0xMDc5NTc_c232bc7f-a5ee-46a8-9673-0105105e8cee"
      unitRef="usd">2500000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i82b47f9030b34b429bca8c704864b6a6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi0zLTEtMS0xMjUyNzE_1d145ca7-a5e9-4cd1-9005-6c401f235b2e"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idc0703bcc24f48e681cbcfeb3a9412ed_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi01LTEtMS0xMDc5NTc_4e10d954-8ed1-4847-8fc3-df4719e9f279"
      unitRef="usd">2500000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i363eb4ee29e54e13ac0aefa0ccbb0a81_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNi03LTEtMS0xMjUyNzM_16bc3ad8-7fce-4f18-930b-87715c2023b1"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id7048c5fe4e141f89ff18d17889ef492_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy0xLTEtMS0xMDc5NTc_0a1f6855-c805-4cd1-8594-984a4fa1f80c"
      unitRef="usd">300000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia339d290baa7479185ee1c02c1479b85_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy0zLTEtMS0xMDc5NTc_94833bfc-dec3-4a33-80d9-4b3047e575e6"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ide1e849e105045cc82813ffd84975071_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy01LTEtMS0xMDc5NTc_59a6aeb5-536f-485a-b22e-29bb7409f05a"
      unitRef="usd">300000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib76b381e70524c158eaecba0aab88c70_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfNy03LTEtMS0xMDc5NTc_bbbffaa1-dc0f-4841-8fec-ee32b473d2e0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC0xLTEtMS0xMDc5NTc_6f888091-54d4-4746-8710-be8a3177092e"
      unitRef="usd">30000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5a0364527a074f269837eb697e13e3e9_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC0zLTEtMS0xMDc5NTc_edefb9a6-7759-436c-be12-65fbb462ae53"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i52cc5c24426b411f8a9f807c5312d497_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC01LTEtMS0xMDc5NTc_69e6eef6-0877-46c6-9438-fcf68997a88e"
      unitRef="usd">30000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3611e0322f3842f69d4e5f89028d5c5a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfOC03LTEtMS0xMDc5NTc_728308e2-77b5-4c20-b3d7-be41cee11fcb"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i9ad19bdd30714b10a58f86bc3fcc3d06_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtMS0xLTEtMTA3OTU3_4b49b93b-36d7-4005-887d-6d6a572e1d46"
      unitRef="usd">3400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ide78313ff5a246378c00a3dc183d036a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtMy0xLTEtMTA3OTU3_9401099c-f118-40ca-aead-7cc203c77426"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i22f863ea4d044887a4fe175344a4ca00_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtNS0xLTEtMTA3OTU3_a7258fbe-f30e-4c71-9da1-195f9856b4a0"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ib95a1ff83f2346e5bcbf04f2536fd2f8_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTAtNy0xLTEtMTA3OTU3_30c2bb87-65eb-4d9a-a0c9-fc16d637c2a8"
      unitRef="usd">3400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i6bd296de48514683a96ee90d09cf647b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtMS0xLTEtMTA3OTU3_475b4354-72f4-4c5c-9a3e-62dc030e546d"
      unitRef="usd">400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ifeb3334f07144b1eb56036eff778881d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtMy0xLTEtMTA3OTU3_65726090-5ac9-4a61-9201-ff26a65c49b3"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i931efb624c5240ec87bbbb2d5e3977f2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtNS0xLTEtMTA3OTU3_c1493a04-4fbe-4d8d-9a08-4f3e6e4b12d2"
      unitRef="usd">400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="if3e076bd0f834d7587361fc0c5740091_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTEtNy0xLTEtMTA3OTU3_1791c4c5-ef2c-4179-9e55-d2ef3abf4306"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id7048c5fe4e141f89ff18d17889ef492_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItMS0xLTEtMTA3OTU3_3619a727-fec9-4690-85e1-5aaa7ba08d72"
      unitRef="usd">500000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ia339d290baa7479185ee1c02c1479b85_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItMy0xLTEtMTA3OTU3_544c84de-c9cb-45d6-abc0-2c9e0221e17d"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ide1e849e105045cc82813ffd84975071_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItNS0xLTEtMTA3OTU3_832457c6-8115-4d60-a322-cec6e5923e66"
      unitRef="usd">500000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ib76b381e70524c158eaecba0aab88c70_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTItNy0xLTEtMTA3OTU3_c59310bb-bc2c-4ee2-b8e9-e39d7faa4e9d"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtMS0xLTEtMTA3OTU3_8c11ed75-890f-4097-8724-fe95700d9236"
      unitRef="usd">4300000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i5a0364527a074f269837eb697e13e3e9_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtMy0xLTEtMTA3OTU3_14b54c83-7cf3-4988-9d50-d0723ba1acd6"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i52cc5c24426b411f8a9f807c5312d497_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtNS0xLTEtMTA3OTU3_0858dc19-dfee-414f-97e4-7067f4640d12"
      unitRef="usd">900000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i3611e0322f3842f69d4e5f89028d5c5a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOjgyOTQ4ZmNjYjcyZDQ0MmFhZDFlNzA3ZWM2YjU2ZTNkL3RhYmxlcmFuZ2U6ODI5NDhmY2NiNzJkNDQyYWFkMWU3MDdlYzZiNTZlM2RfMTMtNy0xLTEtMTA3OTU3_36ebbb75-7b4b-45a1-8e28-d5d55860d7aa"
      unitRef="usd">3400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi0yLTEtMS0xMDc5NTc_f596af47-4bec-4597-9e6c-1f4a63319b85"
      unitRef="usd">23400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i673ceda2567b4fa094005314999c6692_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi00LTEtMS0xMDc5NTc_1e87ece9-e130-452a-a93c-1030061a268d"
      unitRef="usd">71000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi02LTEtMS0xMDc5NTc_c4cbafb1-31ae-4f43-a136-f854ee83c9b5"
      unitRef="usd">23400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMi04LTEtMS0xMDc5NTc_d26dc0a2-c148-486a-8fdd-759efeb9f18f"
      unitRef="usd">75100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy0yLTEtMS0xMDc5NTc_515ae71f-dd2e-42e2-b22f-8dae6ad18028"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy00LTEtMS0xMDc5NTc_cdd7edde-309b-497f-9856-551ada356e20"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy02LTEtMS0xMDc5NTc_18305027-d6cb-47a0-9dfb-6edade69a942"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfMy04LTEtMS0xMDc5NTc_045aac6f-0f22-4044-bc05-d6b1d9cbbf33"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC0yLTEtMS0xMDc5NTc_a6f4a284-933e-419c-a743-383ff5f3f39a"
      unitRef="usd">-12400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC00LTEtMS0xMDc5NTc_16d27818-56bb-4351-81a2-47fdfb09733a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC02LTEtMS0xMDc5NTc_5232f4e5-7567-497f-bf71-7728ba324156"
      unitRef="usd">-12400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNC04LTEtMS0xMDc5NTc_e5092b15-4304-4662-9d67-b06ded34290c"
      unitRef="usd">-4100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS0yLTEtMS0xMDc5NTc_1d11a4f8-0a20-4e96-bfcb-b57226306121"
      unitRef="usd">-7600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS00LTEtMS0xMDc5NTc_d5ed0cd2-343f-4735-b050-6a3c8a50226a"
      unitRef="usd">-12200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS02LTEtMS0xMDc5NTc_47e18b54-1825-4bd2-9f8b-bf9a60eb268d"
      unitRef="usd">-7600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNS04LTEtMS0xMDc5NTc_a18e87a6-ad38-43ce-bf7a-051b5743bf6e"
      unitRef="usd">-12200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi0yLTEtMS0xMDc5NTc_191137a4-377d-4743-8f3c-2293ce7d2822"
      unitRef="usd">3400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi00LTEtMS0xMDc5NTc_74abe91f-8f47-4f8c-8057-749fe1a439ff"
      unitRef="usd">58800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi02LTEtMS0xMDc5NTc_147e5bdc-a3e0-4da1-89a9-a036ec9947b4"
      unitRef="usd">3400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RhYmxlOmEwYzNhZDZkNGE4MTQzZWM4NjNlZTA5NGIyMzIwMjU3L3RhYmxlcmFuZ2U6YTBjM2FkNmQ0YTgxNDNlYzg2M2VlMDk0YjIzMjAyNTdfNi04LTEtMS0xMDc5NTc_dbf4f3c3-74f7-43e7-bf51-334f153e5f80"
      unitRef="usd">58800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="i5abefbe66a5f4800a36fd4789769988d_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTc1NA_cd7af470-6552-4a3f-9047-5154babf6bac"
      unitRef="usd">4300000</us-gaap:LossOnSaleOfInvestments>
    <holx:PrincipalAmountOfBorrowings
      contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTQxMg_0d1d8716-36e2-49de-8843-e74df44085b6"
      unitRef="usd">1500000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzA4NQ_628e7258-4f02-4b0c-86f4-93a0c77de26c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMzE0MA_32630c55-e5f1-4efa-8e00-a6482dab80e5"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1c8339ad8e024acf93252e724b2036bd_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTMyOQ_4922880b-4630-451a-9dbd-f0d685e0ef1f"
      unitRef="usd">388900000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iba44341dbd4c49499423c450d88a5f7b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80Ni9mcmFnOjQwYWFmN2RlNmZhMTQ5MDE5NTY2OGY4N2EyYTNjMDBhL3RleHRyZWdpb246NDBhYWY3ZGU2ZmExNDkwMTk1NjY4Zjg3YTJhM2MwMGFfMTA5OTUxMTYzMTM2MA_d808fed3-0c05-43a6-b6da-e3c11c3a533d"
      unitRef="usd">848400000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwMA_ca9314ef-d26e-4cd9-8313-411ae18b5253">Business Combinations&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Bolder Surgical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. (&#x201c;Bolder&#x201d;), for a purchase price of $160.1&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder&#x2019;s results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Bolder&#x2019;s tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationship&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder&#x2019;s business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 16.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder&#x2019;s products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company&#x2019;s surgical portfolio and utilizing GYN Surgical&#x2019;s sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. (&#x201c;Acessa&#x201d;), which was acquired in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $81.8&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change, and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair value measurement is directly impacted by the Company&#x2019;s estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $39.5&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $4.1&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $12.2&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in a payment of $7.6&#160;million, which was made in the second quarter of fiscal 2023. During the second quarter of fiscal 2023, the Company updated its forecasted revenue and recorded a gain of $12.4&#160;million to record the liability to fair value. The reduction in fair value was due to a decrease in forecasted revenues over the remaining measurement period. As of April&#160;1, 2023, the contingent consideration liability was $3.4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMjA1_dd62bcd2-581b-4006-8eca-dac3c9515f55"
      unitRef="usd">160100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwOQ_36ac64a3-35ba-4814-beb9-faa33cd808c4">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Bolder&#x2019;s tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationship&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMC0yLTEtMS0xMDc5NTc_21ac41e9-84c8-460e-9319-1176c604b365"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMS0yLTEtMS0xMDc5NTc_502b1188-0e02-434e-a994-da6472f5f380"
      unitRef="usd">1300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMi0yLTEtMS0xMDc5NTc_16f9b410-6437-4be0-a184-e03bf62f7d3f"
      unitRef="usd">3300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfNC0yLTEtMS0xMDc5NTc_eaa80f97-16cc-44df-a4e6-9c70f43df9d8"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfNS0yLTEtMS0xMDc5NTc_ec76aa96-8e90-4a3e-8602-39e3d6d97d53"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfOC0yLTEtMS0xMDc5NTc_490c73ec-2cf3-4318-8547-acd1287e26c4"
      unitRef="usd">73600000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfOS0yLTEtMS0xMDc5NTc_04e8d6d0-5609-4071-84c4-4025ba0e1213"
      unitRef="usd">21700000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTAtMi0xLTEtMTA3OTU3_798444b6-2bcd-43d6-a7b7-ed614593dbe0"
      unitRef="usd">1400000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTMtMi0xLTEtMTA3OTU3_a63e1491-18c8-41f6-a870-122d8c8e6778"
      unitRef="usd">11700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTQtMi0xLTEtMTA3OTU3_f1c0aa68-8ab4-413b-9148-4bd37dfba70d"
      unitRef="usd">68800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9c89a75c14ea452587934b85e1cfe79f_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RhYmxlOmFlZmI0NmEzMzIxZTQwNmM4NDJiYTFmODkxMTdlNDFjL3RhYmxlcmFuZ2U6YWVmYjQ2YTMzMjFlNDA2Yzg0MmJhMWY4OTExN2U0MWNfMTUtMi0xLTEtMTA3OTU3_02d7dd07-da73-475c-8a73-5792b80a2a4b"
      unitRef="usd">160100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTIzMQ_db7dde95-b323-4e44-8160-d268c127f287"
      unitRef="number">0.160</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3b8baa43f0c444d9967f0f28cc75f205_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_0621d8f3-6b4f-4140-beae-db5af14ce9cc">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i47652b3263ee45bebe444c08c403cbb7_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_0df04b2b-fb55-474e-85bf-64c99ad43a62">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i928aae1d79e6431e905c9e98405eefaa_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMTg3NQ_8ae6d13c-30a9-4f4e-a038-5d10fffd5eb3">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6dfbd32be37f4246a381b2110a8442cf_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfMjc4OQ_b21041cc-e9f2-4f75-bdcf-734104da2ee6"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:AnnualIncrementalRevenueGrowthPeriod
      contextRef="i0e135792ff2e44028a70fbd8451b5761_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTAwMw_ce7031ca-c851-49da-adc4-57d38b046e26">P3Y</holx:AnnualIncrementalRevenueGrowthPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4433cc201f8a4406b5cfe583df4d23c5_D20210926-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDExMA_64f75754-2c2d-4e81-83f4-ca08bc6ca399"
      unitRef="usd">39500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibd53b814f8d744b79592fbfe99c58ed7_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDQ3Ng_5f1f5d56-d6a9-4125-b1bb-c174a1b44494"
      unitRef="usd">4100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <holx:BusinessCombinationContingentConsiderationPayments
      contextRef="ic36e281c399144c0bad6cda43a4171d1_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDY3OA_db6c6f14-d055-4c4c-8c5a-055facdcc6e4"
      unitRef="usd">12200000</holx:BusinessCombinationContingentConsiderationPayments>
    <holx:BusinessCombinationContingentConsiderationPayments
      contextRef="ife2f479793bd48879075f83c4865d01a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDg0Mg_f729b032-1a6b-4781-991a-d6037020c7b8"
      unitRef="usd">7600000</holx:BusinessCombinationContingentConsiderationPayments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ife2f479793bd48879075f83c4865d01a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNTQ5NzU1ODE5Njkz_779f7809-2214-4108-ab08-6f9438841079"
      unitRef="usd">12400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2a2cca1bc72f4a3b8b4112b767c117da_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV80OS9mcmFnOjJhODJkZjVlYTg5ZTQzNzk5Mjg4MDkyMjdlMTkzMmI3L3RleHRyZWdpb246MmE4MmRmNWVhODllNDM3OTkyODgwOTIyN2UxOTMyYjdfNDk5Mg_d9f8272b-ed14-4589-ac1d-181ebcfc27a7"
      unitRef="usd">3400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE5ODAy_f9724492-ba7e-42c0-a27a-af4d4d064789">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(6) Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company&#x2019;s Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022 but were not informed of their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $0.3&#160;million and $1.0&#160;million during the three and six months ended April 1, 2023, respectively, and $1.6&#160;million in fiscal 2022. The Company estimates that total severance charges, including retention, will be approximately $5.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first and second quarters of fiscal 2023, the Company made various decisions to consolidate and close certain offices in Germany and in connection with such actions to terminate certain individuals across all divisions in multiple departments. For the three and six months ended April 1, 2023, the Company recorded $1.5&#160;million and $1.9&#160;million, respectively, primarily for severance benefits related to these actions. These charges were recorded pursuant to ASC 712, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Postemployment Benefits&lt;/span&gt; (ASC 712) or ASC 420, depending on the employee. The Company estimates that total severance charges will be approximately $3.9&#160;million, and the actions will be completed by September 2023.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i24a5378b5efe4b46aadd68616949b0e6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTMwOA_26b05f93-8619-4586-b33f-3cbe23f1f96c"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9b57347bb632482e8fc7285916ac3e23_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE1NjYx_619c9c36-6d6e-4bfc-aed9-41b7d7f1221b"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5117d87aa771468c8a93f0fb49b868e5_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTM1MQ_199d3a15-d4e0-4c2d-b3ef-69ed85ad1eaa"
      unitRef="usd">1600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="iae729caa8b26476fa7e95ea535cdece8_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfMTQ3OQ_0a1117b6-7b6a-4ba2-92d5-34e1cf950fbb"
      unitRef="usd">5500000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i0e366dca1317445a953da3bfcef32ef7_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4Mzc1_b4900c8d-7ff2-4252-8574-b8496e116f24"
      unitRef="usd">1500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1cf6687d788e4af28817964ae346e8c1_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4Mzg5_440f2efc-225c-4300-ba83-b32ddcba75e6"
      unitRef="usd">1900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="id871579f75c04445a8b7aca98eb0f84b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81Mi9mcmFnOjUzYjQyYmNhZGNmZTRkYjFhZTc2ZTJiZWIzMWJiNmJmL3RleHRyZWdpb246NTNiNDJiY2FkY2ZlNGRiMWFlNzZlMmJlYjMxYmI2YmZfNTQ5NzU1ODE4NjIw_f0c093dc-9ecd-4769-80bc-61bfbb73afe6"
      unitRef="usd">3900000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI2MQ_0a6f4614-48f0-4fd1-a46e-c41608b8c2d3">Borrowings and Credit Arrangements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,808.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the &#x201c;2018 Credit Agreement&#x201d;) by entering into a Refinancing Amendment (the &#x201c;2021 Credit Agreement&#x201d;). On August 22, 2022, the Company further amended the 2021 Credit Agreement to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. dollars were converted to a variant of the secured overnight financing rate (&#x201c;SOFR&#x201d;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement provided a $1.5&#160;billion secured term loan facility (the &#x201c;2021 Term Loan&#x201d;) and a $2.0&#160;billion revolving credit facility (the &#x201c;2021 Revolver&#x201d;). As of April&#160;1, 2023, the principal amount outstanding under the 2021 Term Loan was $1.5&#160;billion, and the interest rate was 5.91% per annum. No amounts were outstanding under the 2021 Revolver, and the full amount was available to be borrowed by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.7&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $7.0&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s currently effective interest rate swap agreement, which fixes the floating rate on $1.0&#160;billion of aggregate principal under the 2021 Term Loan at 1.23%, resulted in the Company receiving $8.6&#160;million and $15.2&#160;million in the three and six months ended April&#160;1, 2023, respectively, which was recorded as a reduction to interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of April&#160;1, 2023, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company had 4.625% Senior Notes due 2028 (the &#x201c;2028 Senior Notes&#x201d;) outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#x2019;s domestic subsidiaries and mature on February&#160;1, 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company had 3.250% Senior Notes due 2029 (the &#x201c;2029 Senior Notes&#x201d;) outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company&#x2019;s domestic subsidiaries and mature on February 15, 2029.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Securitization Program&lt;/span&gt;&lt;/div&gt;During April 2022, the Company repaid the outstanding balance of $248.5&#160;million under its accounts receivable securitization program (the &#x201c;Securitization Program&#x201d;). On June 10, 2022, the Company amended the agreement governing the Securitization Program temporarily suspending its ability to borrow and the need to comply with covenants for up to a year. On March 31, 2023, the Company terminated the Securitization Program.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI1OA_4faceacf-197b-430e-8823-bba1a1ecdd5e">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,808.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMi0xLTEtMS0xMDc5NTc_1b348a09-201b-4d3b-abff-b4a2f2452552"
      unitRef="usd">26200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if4a8fa6d9cf640188c80440fc42539f2_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMi0zLTEtMS0xMDc5NTc_d08a9b3d-1e9f-4a55-ba73-7fa4fcf1af55"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfNi0xLTEtMS0xMDc5NTc_b3c57850-02c1-4608-b910-9a601334a660"
      unitRef="usd">26200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfNi0zLTEtMS0xMDc5NTc_525a5f4d-6e47-449e-8893-c849e204cc5f"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i7bb71b2b6bb344d7a93b2ea3e26874ce_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfOC0xLTEtMS0xMDc5NTc_c8a88333-44cd-42eb-94d9-62337dacf2fe"
      unitRef="usd">1463600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="if4a8fa6d9cf640188c80440fc42539f2_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfOC0zLTEtMS0xMDc5NTc_1846f8a4-592a-496a-8368-450bfa4c2393"
      unitRef="usd">1475700000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ic7d8a9c2381e4790949255fbef7b39ab_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTAtMS0xLTEtMTA3OTU3_784e7f2b-dc7a-4339-a4d6-121ed50620ee"
      unitRef="usd">396400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ia56ec6c8bc03468eb039dadf25c0a74d_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTAtMy0xLTEtMTA3OTU3_ca174611-ba8d-4463-ba63-f68517cb315d"
      unitRef="usd">396100000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i8578d43dfaf64c8aa2e2a99308499a06_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTEtMS0xLTEtMTA3OTU3_b27015a5-d169-4ac3-a5d5-8cb0181f6570"
      unitRef="usd">937700000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ifb3e905270394c109f6dc2a65bef2a27_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTEtMy0xLTEtMTA3OTU3_8ac1c842-9c25-451b-a7e4-2b138d105fd8"
      unitRef="usd">936600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTMtMS0xLTEtMTA3OTU3_6e2bbfa6-d393-4919-825a-8214309452b4"
      unitRef="usd">2797700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTMtMy0xLTEtMTA3OTU3_5438b017-d795-4b2e-aed8-33c4cef35918"
      unitRef="usd">2808400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTQtMS0xLTEtMTA3OTU3_7fb5a0ba-500d-4331-b6f7-e4905e4bdb7a"
      unitRef="usd">2823900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjc0MTA3NjhhOTc4ODQ4NmQ4MmE2NGJjYjA0ZTVhMjkxL3RhYmxlcmFuZ2U6NzQxMDc2OGE5Nzg4NDg2ZDgyYTY0YmNiMDRlNWEyOTFfMTQtMy0xLTEtMTA3OTU3_6df4334d-f25a-4e32-b5ca-a824046e63e0"
      unitRef="usd">2823400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5618fbac4e2b4be5a3ede449c24b7524_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfOTkz_b1d0c014-a666-4309-b3f8-8b49c4720e8d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic3c7a85f58744f0b81a452662f16cdf2_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA1Mg_82a5bf94-6c2d-4a98-8ee5-1a86982a62ff"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib2d817532d0340fc8fdcd0aa45fe0b08_I20230401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTE5MQ_0286e8f3-ced2-4575-ac81-e380cb97f6da"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjA3NA_c6feaeab-e1aa-4743-91dd-e44c814333bb"
      unitRef="number">0.0591</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i362f953e083846c1a0d8a19e3a3d35a4_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTc4MA_67cb05ac-46f9-4b9b-926e-2f3e44431ddd"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i36b0a0a905884991b094498a4388a459_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjA2OQ_b502b2bc-fc8a-4e1d-b911-e9d0193f19c1"
      unitRef="usd">7000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI2OQ_3f9450e9-d38a-4e3d-aa01-3a31229076aa">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi0xLTEtMS0xMDc5NTc_df9ca517-bb0e-436a-9605-06d680df9d46"
      unitRef="usd">22500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi0zLTEtMS0xMDc5NTc_0937a620-3c7e-482f-a9e3-235ec8911bfe"
      unitRef="usd">5700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi01LTEtMS0xMDc5NTc_ee9e590b-3491-4a81-9745-c26794bdd38b"
      unitRef="usd">42900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMi03LTEtMS0xMDc5NTc_7019add7-57bb-4716-a648-e1f160da0ee1"
      unitRef="usd">11000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy0xLTEtMS0xMDc5NTc_214af9cc-83a6-4943-9734-acd7f3f4e8d6"
      unitRef="number">0.0574</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="ib45828786b614fd6a927d52e20f78b81_D20211226-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy0zLTEtMS0xMDc5NTc_6c08ccc0-a8db-4de4-a1fa-0c6173f908c2"
      unitRef="number">0.0113</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i7dc2f8d93ad64288a09c315fd485107d_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy01LTEtMS0xMDc5NTc_1e0a02e2-1b92-4cc3-b0b4-feb5d13aecee"
      unitRef="number">0.0539</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="iddf5c0200f4a4e29a418c90055af8270_D20210926-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfMy03LTEtMS0xMDc5NTc_98de32d7-36fa-4fa7-8c87-42365d9f2b49"
      unitRef="number">0.0111</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC0xLTEtMS0xMDc5NTc_c6feaeab-e1aa-4743-91dd-e44c814333bb"
      unitRef="number">0.0591</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i03d18c480fcf4620b188b43833f9d17f_I20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC0zLTEtMS0xMDc5NTc_8a413712-885a-4ce3-8735-402c1087fce0"
      unitRef="number">0.0146</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="iccdf15e8de9a4fc8a097e876e609f31f_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC01LTEtMS0xMDc5NTc_9ccf7def-cf50-4b22-869b-313e627de41a"
      unitRef="number">0.0591</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i03d18c480fcf4620b188b43833f9d17f_I20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjM0OGFlZDY0YjNlNzQzZjdhZGY1MjZhNGM3ZTg2ZmY5L3RhYmxlcmFuZ2U6MzQ4YWVkNjRiM2U3NDNmN2FkZjUyNmE0YzdlODZmZjlfNC03LTEtMS0xMDc5NTc_2fe0b3dd-86c2-4525-acf4-a7a86f439ba5"
      unitRef="number">0.0146</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjM5Mg_407d29d3-5fd4-4d85-9299-ebbbe4a6405c"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjQ0Ng_fb0dc333-5740-4c71-92a2-c09d5ea212b3"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMjQ4NA_5d8dca88-2e47-418a-aa74-908641ff6089"
      unitRef="usd">8600000</us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjIzOQ_caf696e3-1aa8-4132-9611-54bdb2db6ce6"
      unitRef="usd">15200000</us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjMxNA_628e7258-4f02-4b0c-86f4-93a0c77de26c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzEwNA_fcb8784e-8d2b-4e58-85d9-aa3ca1e25830"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMTA5OTUxMTYzMjMxOQ_32630c55-e5f1-4efa-8e00-a6482dab80e5"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzQ3OA_42daf6ff-3c50-49b8-816f-bffa97f57a33"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfNDI0OQ_f4b2420b-f3a8-4f8a-9c3e-e88e957f1888">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b4c567216914b23a257e8ed2e840c5c_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy0xLTEtMS0xMDc5NTc_628e7258-4f02-4b0c-86f4-93a0c77de26c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="if26561fc220c41d4965d21fca20289a2_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy0zLTEtMS0xMDc5NTc_0cab1f68-16da-47e4-86fa-9b17a0c0db17"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i736ad9f5dec146508d1fd621891e1303_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy01LTEtMS0xMDc5NTc_cdb4f438-5269-4413-84fd-27daee9336da"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i11c06da9d32e45ea8c28dfd12b49dd4f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy03LTEtMS0xMDc5NTc_8848fe32-9028-40ea-a9ed-d21bb0b3091a"
      unitRef="usd">10000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i68128aa8157c4c17b7462201023eebd7_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfMy05LTEtMS0xMDc5NTc_ad9f06c5-22ef-48a0-bde3-01ac801d85d5"
      unitRef="usd">9600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ad1713d489f4ef1bef77718bdac89c7_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC0xLTEtMS0xMDc5NTc_32630c55-e5f1-4efa-8e00-a6482dab80e5"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ice2199bd16f8427796fe11603f851c83_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC0zLTEtMS0xMDc5NTc_069daeca-98a7-4b1a-8896-23fe4e13d90e"
      unitRef="usd">8200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iec05146aaacd45a6ba9801ae96e2a6b4_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC01LTEtMS0xMDc5NTc_7e83cb36-efb6-4bc4-9fee-3edf7758cdd8"
      unitRef="usd">8200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic4009b1b411c4bd99225528c5754c15a_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC03LTEtMS0xMDc5NTc_8df82f03-c03f-419a-bb68-01f134bf4712"
      unitRef="usd">17100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i246a361fa54143f2b5d14724951a2680_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNC05LTEtMS0xMDc5NTc_a6fb36ec-9384-4389-8504-0a92ec25995b"
      unitRef="usd">16400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i88474659b3544a10823c37e769f86d35_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS0zLTEtMS0xMDc5NTc_5b9755ec-a92f-4530-9b7f-6166b814d438"
      unitRef="usd">13000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ib471a4ccd83240ae9ed952772145134a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS01LTEtMS0xMDc5NTc_581ef99d-f111-4fa7-ab2e-0a6200b3c65d"
      unitRef="usd">13000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ie900720f8e2b4ab09db04fe14ad224e5_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS03LTEtMS0xMDc5NTc_cc865ff2-355f-4a54-969d-7bab34a59704"
      unitRef="usd">27100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i037d769c2b574a0992ee94f32441bc77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RhYmxlOjgxYjNiYjQxOGNmZTQ0NDdhZjg1ZTg2YWJhMjk1ZjVlL3RhYmxlcmFuZ2U6ODFiM2JiNDE4Y2ZlNDQ0N2FmODVlODZhYmEyOTVmNWVfNS05LTEtMS0xMDc5NTc_452fcb58-2587-4158-be80-b1294de8d140"
      unitRef="usd">26000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="i382a786b487046818da8713340a3f1bc_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81NS9mcmFnOjU4YWNhNTQ0YzFiMDQ5NmY5MjA5MjI1MGU0Y2MxYjRkL3RleHRyZWdpb246NThhY2E1NDRjMWIwNDk2ZjkyMDkyMjUwZTRjYzFiNGRfMzg4NQ_23cd7501-b3bc-4d39-8306-5a21b984bb17"
      unitRef="usd">248500000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RleHRyZWdpb246ZjQ2YTQzMTE5OGE1NGQxMWEwYWMwYmUxYThhNGIyNDVfMTkwMQ_48e60e32-d61b-4cc9-8961-6d1c56630fef">Trade Receivables and Allowance for Credit Losses&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic and inflation, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses as of April&#160;1, 2023 compared to March&#160;26, 2022:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-offs,&lt;br/&gt;Payments and Foreign Exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RleHRyZWdpb246ZjQ2YTQzMTE5OGE1NGQxMWEwYWMwYmUxYThhNGIyNDVfMTkwMg_afefa246-9b96-43d8-b631-d0b1813e80ec">The following is a rollforward of the allowance for credit losses as of April&#160;1, 2023 compared to March&#160;26, 2022:</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi0yLTEtMS0xMDc5NTc_75824aa6-6435-48a6-9139-7280caab4afe"
      unitRef="usd">37700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi00LTEtMS0xMDc5NTc_9a922750-4087-4dd5-8d92-d138aa3c8a6d"
      unitRef="usd">1900000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi04LTEtMS0xMDc5NTc_ce258002-5679-40fe-bd53-c7208316245f"
      unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMi0xMC0xLTEtMTA3OTU3_fd195e30-5518-487c-a79c-c79d96925d61"
      unitRef="usd">39400000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy0yLTEtMS0xMDc5NTc_5cc43940-260f-4356-a93b-fd9038caaee5"
      unitRef="usd">40500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy00LTEtMS0xMDc5NTc_1aa85082-88a4-4033-ae4e-5985b262f074"
      unitRef="usd">3700000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy04LTEtMS0xMDc5NTc_9da65642-f5a5-4202-90a5-f3db0a496d2d"
      unitRef="usd">2100000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV81OC9mcmFnOmY0NmE0MzExOThhNTRkMTFhMGFjMGJlMWE4YTRiMjQ1L3RhYmxlOmMxODI5NTY2MWE0OTQzNmRiZWU3YjQ5YzgxY2Q2OGQ4L3RhYmxlcmFuZ2U6YzE4Mjk1NjYxYTQ5NDM2ZGJlZTdiNDljODFjZDY4ZDhfMy0xMC0xLTEtMTA3OTU3_3425de09-618b-4941-be61-f75f5a80412f"
      unitRef="usd">42100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzcyNQ_04a45016-15d3-4553-b7d8-3fc2d10f75c6">Derivatives&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swaps - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income (&#x201c;AOCI&#x201d;) to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023 to hedge a portion of its variable rate debt. On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement) to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to evaluate the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $1.0 billion. The restructured interest rate swap fixes the SOFR component of the variable interest rate on $1.0 billion of the notional amount under the 2021 Credit Agreement at 1.23%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#x2019;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $26.0 million as of April&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 23, 2023, the Company entered into two consecutive interest rate swap contracts with the first contract having an effective date of December 17, 2023 and terminating on December 27, 2024, and the second contract having an effective date of December 27, 2024 and terminating on September 25, 2026. The notional amount of these swaps is $500 million, and the first interest rate swap fixes the SOFR component of the variable interest rate at 3.46%, and the second interest rate swap fixes the SOFR component of the variable interest rate at 2.98%. The critical terms of the interest rate swaps are designed to mirror the terms of the Company&#x2019;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $500&#160;million of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of these swaps was an asset position of $1.2&#160;million and a liability position of $0.4&#160;million, respectively, as of April&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company&#x2019;s cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of April&#160;1, 2023 the notional amount was $200.3&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments as well as their classification on the balance sheet as of April&#160;1, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTQyMA_ee3ae9ba-db58-4be3-aa95-0de736224fed"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTUzMA_ee5f44f8-ac0e-4ca6-acfa-5676ffaf5850"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTU5MQ_ec8d511f-cb8f-4c41-91e9-1657fba8cddd"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9277edbc6f004c26b5932c60235a6b84_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTk1Mw_117712a9-c003-485d-9e57-bfcff12af128"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMjEwMw_a0913edf-f309-4601-aa95-c4472aa06bdc"
      unitRef="usd">26000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ1OQ_102ffea0-1c0a-4c67-b993-671a5ac7734d"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ1OQ_e935310b-f43d-445e-93af-f6f82573935f"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ2OQ_72016364-b8be-4fb4-b832-eef048af48bc"
      unitRef="number">0.0346</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ3OQ_3a05e3b4-298b-44bc-8325-342408dad35a"
      unitRef="number">0.0298</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibf913fa1366b4a2ba94bf4f554c3c906_I20230323"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ4OA_83dcd697-dc47-453e-b69a-91ad93e6860e"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie5860214d3274cd895e658c77224dcc3_I20230323"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzQ4OA_fdc4d58f-30d8-4375-a542-54ade1d7cc2c"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ia270fd5f123248878a148a83df3feb24_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzUwMg_07e36867-abd2-4842-b354-739432badafe"
      unitRef="usd">1200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue
      contextRef="i1013586a3c0b4067b24800f58a35dfe2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMTA5OTUxMTYzMzUxNg_b82a0309-7e7c-4baf-a672-92bfca91597e"
      unitRef="usd">400000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <holx:NotationalAmount
      contextRef="id7733cefdaf04d268e9460397af1c814_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMjk5Mg_0045aec1-cc7d-4970-8dc8-f0569e27515c"
      unitRef="usd">200300000</holx:NotationalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczNg_0d288198-58ed-4e45-9ce8-6b35ed48fed7">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy0xLTEtMS0xMDc5NTc_3952387c-2d20-4062-a714-59e9efe5ee82"
      unitRef="usd">-300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy0zLTEtMS0xMDc5NTc_5f1e6983-ecbe-428d-bc44-d5c2518646ab"
      unitRef="usd">10400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy01LTEtMS0xMDc5NTc_1110d13c-9f27-469c-bdec-6fec70a1a6c6"
      unitRef="usd">-2700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMy03LTEtMS0xMDc5NTc_242a8783-72ef-46ea-a195-3f27e611d5a7"
      unitRef="usd">22800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC0xLTEtMS0xMDc5NTc_6afdccd0-ea43-4f54-9bc7-ae888d17a30c"
      unitRef="usd">-1300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC0zLTEtMS0xMDc5NTc_0914c7dc-b2d8-4141-8e62-737e67e809d0"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC01LTEtMS0xMDc5NTc_faa5d2ad-4fe2-4954-ae42-81ad1f4e35b2"
      unitRef="usd">-1500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNC03LTEtMS0xMDc5NTc_bd0428ab-85c3-4822-ad9b-da3047ebf9ac"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS0xLTEtMS0xMDc5NTc_909c1fc1-5b80-49d5-a2c9-0549ffa3b1c9"
      unitRef="usd">-1600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS0zLTEtMS0xMDc5NTc_063a8258-1b54-4da1-89f4-3c96430be2d5"
      unitRef="usd">10400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS01LTEtMS0xMDc5NTc_16b9bc13-9f81-46ed-a374-011dd7c4a3ab"
      unitRef="usd">-4200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNS03LTEtMS0xMDc5NTc_e5abc9ce-f755-4f63-815d-ab8f24451c1d"
      unitRef="usd">22800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ia9f2930efdbb476b9c9844598c2f14b0_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy0xLTEtMS0xMDc5NTc_0f0aa0ec-9334-4e1d-8579-f8fadd881c93"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="iab6dd5f28ac94162b51d32c71dd8c8d7_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy0zLTEtMS0xMDc5NTc_c60748d3-5c47-428d-9136-5ae902b4f744"
      unitRef="usd">-100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i4e8fb4f919214654b7b006deae35b966_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy01LTEtMS0xMDc5NTc_4f4d7553-b981-4580-bddf-ccecd02e5620"
      unitRef="usd">-13800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ifdbba8a538de42ec8b5ed9cf7fbd6813_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfNy03LTEtMS0xMDc5NTc_3f961e2c-6386-492f-a6bc-f8b4c2dca281"
      unitRef="usd">6700000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i09b4f31922f74680952a4f8d219d9be0_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC0xLTEtMS0xMDc5NTc_3f289137-7060-4e06-a4a9-1ca792967171"
      unitRef="usd">500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i2dd4dccf67154261b146e5f5684a07d4_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC0zLTEtMS0xMDc5NTc_60b9d9f5-15bc-422c-ad01-a6354436a9af"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9bc5fb18886d43db8ef6c59b4d46c6a2_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC01LTEtMS0xMDc5NTc_a38c3c91-0f79-4e04-87a2-f990978498d7"
      unitRef="usd">-7800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib11d084c0bbc4904ba2bd9856d953048_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOC03LTEtMS0xMDc5NTc_dfdfc7af-7aac-4ee1-9857-05d29e81b93f"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i36b3c4e0ad174a798b786a290ac0650d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS0xLTEtMS0xMDc5NTc_0607fd57-f64f-4a11-b15c-2e7ce8fca165"
      unitRef="usd">500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i92945dbfbcdc44db9ba4eb6ff7ff3ccf_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS0zLTEtMS0xMDc5NTc_fdd07b8f-9b7e-4c7a-b23e-a1a2f8591da8"
      unitRef="usd">-100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic125ad7c33b94f15b7d0b8ffdffbd755_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS01LTEtMS0xMDc5NTc_b1c31ead-f182-43de-9498-b902132ed56f"
      unitRef="usd">-21600000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="icf6e201949ff42deaaa5f72b5cf1b9f7_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfOS03LTEtMS0xMDc5NTc_6824b232-f33e-4448-907e-217de5f8e543"
      unitRef="usd">6700000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtMS0xLTEtMTA3OTU3_bfc3f980-c49e-4fc4-b6eb-faec4ad81826"
      unitRef="usd">-1100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtMy0xLTEtMTA3OTU3_60284582-b2ad-427f-8142-b6b864166dbc"
      unitRef="usd">10300000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtNS0xLTEtMTA3OTU3_421a7cff-461c-4cd3-b9d6-1433d804bc35"
      unitRef="usd">-25800000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmJiNDkzMmRjYmU3ODRmOTRhNjU3YzdiMzU1ZDc5YWMwL3RhYmxlcmFuZ2U6YmI0OTMyZGNiZTc4NGY5NGE2NTdjN2IzNTVkNzlhYzBfMTEtNy0xLTEtMTA3OTU3_8a939108-a41a-4917-b368-295d87c17010"
      unitRef="usd">29500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczOA_8d13612e-75ae-4a0c-9edd-131fd35c1a6f">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments as well as their classification on the balance sheet as of April&#160;1, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i388bb22d67bc405a988ad5c4cc5a8547_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNS0zLTEtMS0xMDc5NTc_2f339922-781a-4f8b-8558-8cbcd04c9a28"
      unitRef="usd">27100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i687a30dc10784ff3953d24ed83075533_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNS01LTEtMS0xMDc5NTc_6aae5aef-48fd-405e-b74a-77f5cfb48647"
      unitRef="usd">31900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8b069471a6fd4ce1941c6017866f9304_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNi0zLTEtMS0xMTAyMTU_697d08ba-b520-41bb-be3d-7b20ed7a690e"
      unitRef="usd">100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i784d2587627b47089f80bcf128fac206_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNi01LTEtMS0xMDc5NTc_c73dc4f8-6e0c-4a63-9522-72adaa68985c"
      unitRef="usd">7000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i14ea93c725c840b2ab4f76c58a3c62ed_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNy0zLTEtMS0xMDc5NTc_0da35090-84aa-47d7-b704-cb482d092118"
      unitRef="usd">27200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i41f4ede37bd5491c9c3625e94d0c9aa6_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfNy01LTEtMS0xMDc5NTc_cde46716-8975-4d60-9350-5b87492cb0c3"
      unitRef="usd">38900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="iee4564531536478f92ff8960a39160e7_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTAtMy0xLTEtMTA3OTU3_478cb96a-46d1-4bf5-88ff-4770d490e556"
      unitRef="usd">2500000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i20c899443173415699ab4d5da5e77fc7_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTAtNS0xLTEtMTA3OTU3_517e37a3-d3ff-45db-8152-b64b11ecee7f"
      unitRef="usd">15800000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i542498cff24b4020926268c17c708196_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTEtMy0xLTEtMTA3OTU3_05afff63-62ad-42de-bcb3-99c31414e19a"
      unitRef="usd">300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iafea2d522ec04d37847e57b9cb641004_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTEtNS0xLTEtMTA3OTU3_b3ffdce6-f131-4331-9bb7-7e31cf8f4854"
      unitRef="usd">10600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic766fff5fd0948058ce9d491f9b85de5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTItMy0xLTEtMTA3OTU3_364f9181-ade6-42df-95c1-d199d2787f49"
      unitRef="usd">2800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0b6e3f3bd25843a195f629f91c7fd0af_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTItNS0xLTEtMTA3OTU3_795bfe23-8c45-4b0f-b94f-3a2512f947fb"
      unitRef="usd">26400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i291463358b624afe8c68e32119ade5ec_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTctMy0xLTEtMTA3OTU3_9deaf8a3-9234-41cd-b679-aeaa126c3bd7"
      unitRef="usd">400000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i21f153a4f042425ba023e92476fa0a40_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMTctNS0xLTEtMTA3OTU3_5b4d8cb8-d8c3-4922-ba30-b16911c4083a"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ieaad33fabd43401bb9e20fe1c59e848a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMjAtMy0xLTEtMTA3OTU3_71fea3b1-1bdd-4c9d-b1fd-07ca76235565"
      unitRef="usd">500000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i734d4c683d694f60ad32d47670c8e8cb_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOmIyZGJjYjUwY2RkZDRhOGViYjFlM2I1ZGU1Y2Y1NDU0L3RhYmxlcmFuZ2U6YjJkYmNiNTBjZGRkNGE4ZWJiMWUzYjVkZTVjZjU0NTRfMjAtNS0xLTEtMTA3OTU3_c48217af-0d7b-4710-9012-655fcebef294"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RleHRyZWdpb246NTQ5ZGQ0Zjk3ODNiNGU2OWI0ZjI2OThhMjRkMjRmZTZfMzczMQ_159f6ef1-a69a-4192-a29d-65f066d80412">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy0xLTEtMS0xMDc5NTc_f50dda05-1b4c-49f6-9bb2-86fbdf9eec88"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2a435b609b8d4c0d8f1f4465429c3589_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy0zLTEtMS0xMDc5NTc_8c11b20e-8011-425f-b8b2-83dab6ae4751"
      unitRef="usd">19400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i049e69b9f7b24a2297c9b6525d614e91_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy01LTEtMS0xMDc5NTc_e7a568f4-4aee-49f5-ab42-558fcf44b3e8"
      unitRef="usd">-9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifb6a7d62503b44f490049c2405cde9d0_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfMy03LTEtMS0xMDc5NTc_56dad036-af13-42d2-86da-7b32c2164470"
      unitRef="usd">27300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS0xLTEtMS0xMDc5NTc_5e873d3d-a432-4264-94a9-fb5435743080"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS0zLTEtMS0xMDc5NTc_b49c9fa3-f00f-4237-bf8a-5dd955068fad"
      unitRef="usd">19400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS01LTEtMS0xMDc5NTc_b713cca5-0818-4995-91f1-f09dc9d41c89"
      unitRef="usd">-9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82MS9mcmFnOjU0OWRkNGY5NzgzYjRlNjliNGYyNjk4YTI0ZDI0ZmU2L3RhYmxlOjJmOTk5NTkxZjU3NDRhMGZhZGZmZDQ5NDVlZmY3OTQ5L3RhYmxlcmFuZ2U6MmY5OTk1OTFmNTc0NGEwZmFkZmZkNDk0NWVmZjc5NDlfNS03LTEtMS0xMDc5NTc_89b7ccef-16e9-4741-b6fa-c5c001a57ce4"
      unitRef="usd">27300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODU4MzQz_c11b31a6-7baa-4eef-b137-76a1be9d8d67">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(10) Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company&#x2019;s summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8&#160;million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties&#x2019; post-trial motions, including the Company&#x2019;s motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court&#x2019;s rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the United States Patent and Trademark Office (&#x201c;USPTO&#x201d;) for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#x201c;PTAB&#x201d;) declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit (&#x201c;Court of Appeals&#x201d;). On April 19, 2019, the Court of Appeals affirmed the PTAB&#x2019;s final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties&#x2019; petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#x2019;s petition to address the issue of assignor estoppel and denied the Company&#x2019;s petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#x2019;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;en banc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $7.4&#160;million, which included the original award of $4.8&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses in the first quarter of fiscal 2023.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva&#x2019;s motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#x2019;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. On February 15, 2023, the Court of Appeals affirmed the district court&#x2019;s judgment in favor of the Company and dismissed the other rulings Minerva appealed as moot. On April 18, 2023, the Company entered into a settlement agreement with Minerva to resolve all remaining patent litigation matters, the impact of which was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 450). Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <holx:AmountAssessedInDamages
      contextRef="i419d4edca16d4132b372c619b71876ba_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMTM5_1bf8ec40-6c05-4647-9a5c-066f3bd7b9c9"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ie8865820575c4b57a1e17f866a521496_D20160304-20160304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODU4MjQ2_2555706d-3532-4322-ae3b-f6b9699d3795"
      unitRef="petition">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i81a0b7eab81d4b8d92c778a4c8d79fcd_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMDk0_1cb876e4-2c14-467d-b4c9-d999d8f7184f"
      unitRef="usd">7400000</us-gaap:ProceedsFromLegalSettlements>
    <holx:AmountAssessedInDamages
      contextRef="i419d4edca16d4132b372c619b71876ba_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82NC9mcmFnOmRiOWE3OTVmMGY1NjQwZTU5NzNmMjBkYjhlNTIwODRmL3RleHRyZWdpb246ZGI5YTc5NWYwZjU2NDBlNTk3M2YyMGRiOGU1MjA4NGZfNTQ5NzU1ODUyMTA4_bc001a3a-aec8-48af-a5e8-ad4893bab87f"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RleHRyZWdpb246ZDExZDZjNGUxNzIyNGE1NmI3M2Q0YjdjMWQwNGY3OTdfMTA5_3a7d5379-fd8f-4121-a9a7-25b6ca513935">Net Income Per Share&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RleHRyZWdpb246ZDExZDZjNGUxNzIyNGE1NmI3M2Q0YjdjMWQwNGY3OTdfMTA3_4bca92ca-6fae-4ca1-9fe3-e926b5e97740">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi0xLTEtMS0xMDc5NTc_efb9adcf-902f-42e8-bdfd-e83a3445b6ee"
      unitRef="shares">247730000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi0zLTEtMS0xMDc5NTc_7117924b-c4dd-449c-9d46-f8bca6c73816"
      unitRef="shares">251574000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi01LTEtMS0xMDc5NTc_37b8f7df-7dd8-421f-b4dc-0d31db6dc7f2"
      unitRef="shares">247524000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMi03LTEtMS0xMDc5NTc_f43f2cb4-c088-46a8-8b9c-db0c461f2c28"
      unitRef="shares">252537000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy0xLTEtMS0xMDc5NTc_85c087fc-6bf0-4bbb-80b0-8e0b2f662698"
      unitRef="shares">2063000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy0zLTEtMS0xMDc5NTc_cb0402c7-f6cd-425a-a040-6af255410c60"
      unitRef="shares">2084000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy01LTEtMS0xMDc5NTc_fc3425f8-16a0-4f36-a088-2de4ad0bec41"
      unitRef="shares">2013000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfMy03LTEtMS0xMDc5NTc_65dcf03b-9506-4796-8552-4280a0c13af2"
      unitRef="shares">2327000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS0xLTEtMS0xMDc5NTc_ce51d86d-767c-4d46-bd83-0679cb585cc8"
      unitRef="shares">249793000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS0zLTEtMS0xMDc5NTc_8a71329c-7919-4767-a039-1eb8fd2c72d8"
      unitRef="shares">253658000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS01LTEtMS0xMDc5NTc_aac8e32d-94a8-491b-950c-5eff668d965c"
      unitRef="shares">249537000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNS03LTEtMS0xMDc5NTc_d5ef5e85-148f-4e8c-9af0-66b1947a8136"
      unitRef="shares">254864000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i795d7b50270e46b59859da10505b600e_D20230101-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy0xLTEtMS0xMDc5NTc_1efa83c0-3b3f-4bfd-a575-d15d9092f584"
      unitRef="shares">792000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9dd31e84ed8143f59b13dce68511f55f_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy0zLTEtMS0xMDc5NTc_1bed98b2-4cb5-4d89-9985-730b6835a384"
      unitRef="shares">1129000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic3779670e49d4581b2341db1f4f31165_D20220925-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy01LTEtMS0xMDc5NTc_a742c7c3-a4b6-41b3-863f-24d7ee924820"
      unitRef="shares">1211000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic3a076f8486b462fb0308507b0cfd5da_D20210926-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV82Ny9mcmFnOmQxMWQ2YzRlMTcyMjRhNTZiNzNkNGI3YzFkMDRmNzk3L3RhYmxlOmI2MGJhYzg4YTU5NTQxZTBiMTFkNDZjNDczZDI2NmQxL3RhYmxlcmFuZ2U6YjYwYmFjODhhNTk1NDFlMGIxMWQ0NmM0NzNkMjY2ZDFfNy03LTEtMS0xMDc5NTc_fb7749f6-a5c5-43df-afad-e01efd6cdaa1"
      unitRef="shares">999000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI2MA_52d08742-b0a3-4f54-ae1e-d6713b10688f">Stock-Based Compensation&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted options to purchase 0.5 million and 0.6 million shares of the Company&#x2019;s common stock during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average exercise prices of $74.59 and $71.10, respectively. There were 4.3 million options outstanding at April&#160;1, 2023 with a weighted-average exercise price of $51.87.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.6 million and 0.6 million restricted stock units (&#x201c;RSUs&#x201d;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, with weighted-average grant date fair values of $74.44 and $71.15 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (&#x201c;PSUs&#x201d;) during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $74.35 and $71.16 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of a three-year performance period, provided that the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure (&#x201c;FCF PSUs&#x201d;) to members of its senior management team, which had a grant date fair value of $74.35 and $71.16 per unit during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the probable number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (&#x201c;MSUs&#x201d;) to members of its senior management team during the six months ended April&#160;1, 2023 and March&#160;26, 2022, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $97.91 and $75.43 per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At April&#160;1, 2023, there was 1.7 million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;1, 2023, there was $18.8 million and $77.3 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.2 and 1.9 years, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI3NA_2a0ba4ec-ff93-4287-9ef2-cd0d67955bc8">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i8efcfc733c084819bce8abd34750c81e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi0xLTEtMS0xMDc5NTc_255c228e-3671-44c9-acf6-ad492d10aabc"
      unitRef="usd">2700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3e92370bf72c4c3d8b8468b47a8d76a3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi0zLTEtMS0xMDc5NTc_5197f991-8cec-409c-a1ae-f44e19629552"
      unitRef="usd">2600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if89bee2a95d3497e8c28b3ae3c70aeb6_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi01LTEtMS0xMDc5NTc_99f06c5f-c545-4b5d-83c6-930afc95c0af"
      unitRef="usd">5600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5d2587dcb18149b982e88c5da8cb0cc7_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMi03LTEtMS0xMDc5NTc_419d5d38-9e81-4de9-8450-ae400b548037"
      unitRef="usd">4900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if545f6845c9f47cda87d291c6a78c44b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy0xLTEtMS0xMDc5NTc_316f7900-9f96-4057-af87-ecb096c2c6ce"
      unitRef="usd">3100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if7ed81ad27694ec28082eac891f6d828_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy0zLTEtMS0xMDc5NTc_6925eedd-c83b-47e9-b829-f667ce36fdf8"
      unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i75a667398f82417da0b693cf783d30f2_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy01LTEtMS0xMDc5NTc_98c0f828-6fe0-4c01-8fc0-0f99ea0c7620"
      unitRef="usd">6500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i487840b9375544c692f3e4f0eafc76b6_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfMy03LTEtMS0xMDc5NTc_9b53496e-4d76-4d4a-8849-27aabb835441"
      unitRef="usd">5500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8a4a5ccb5a2d4441a9792f5dd886c64c_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC0xLTEtMS0xMDc5NTc_201a52df-27c8-4280-b9d8-00403dfde4d1"
      unitRef="usd">3000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic3730699eecd4e8fb9c34c17fc322da1_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC0zLTEtMS0xMDc5NTc_d2acb8e7-a890-4558-9ecf-84e96af97153"
      unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia5aae5573096400bba7f7fdd96e479e4_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC01LTEtMS0xMDc5NTc_c8cfb07d-afc2-4e0f-9e42-49f5648a5232"
      unitRef="usd">6300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i32fbb9fff77847d99951beda09715376_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNC03LTEtMS0xMDc5NTc_4b1e4ef2-8033-4761-91cb-907a94f14b04"
      unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i67e3e8ebefcf44d38d43290015d3cc68_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS0xLTEtMS0xMDc5NTc_1b3c9936-6468-414d-a7e4-cdbaf9f3638d"
      unitRef="usd">14400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i20176e0cc3a546dab26b5191397f4122_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS0zLTEtMS0xMDc5NTc_953ef048-2151-4d71-9527-112f80263c19"
      unitRef="usd">9600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i58e3a20cda34489b926a83d90efbd85e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS01LTEtMS0xMDc5NTc_e34cc87b-84bc-401b-8ce1-061da7b145d6"
      unitRef="usd">25300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2bbf39abedf04a86aebfbda7cfdb9417_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNS03LTEtMS0xMDc5NTc_84196586-ca4f-4995-9ad0-a9730b23dbac"
      unitRef="usd">20700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy0xLTEtMS0xMDc5NTc_c926c03c-9532-4f30-970c-c1715e2c0b3e"
      unitRef="usd">23200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy0zLTEtMS0xMDc5NTc_0ca23026-eab6-483a-b96e-e6c653583205"
      unitRef="usd">17800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy01LTEtMS0xMDc5NTc_1016846f-98bb-4580-8eca-77aba931f466"
      unitRef="usd">43700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOmRiZDc3NDgzYWFiYTQ3NWViYzYxYWFkNGJjMWVjYjk5L3RhYmxlcmFuZ2U6ZGJkNzc0ODNhYWJhNDc1ZWJjNjFhYWQ0YmMxZWNiOTlfNy03LTEtMS0xMDc5NTc_0550e915-4005-4fe7-bf68-e4b75338d85d"
      unitRef="usd">36500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTg4_94624f74-911e-4c84-9057-db0d9e8145cf"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTk1_df6ffd20-a26d-4fff-aec9-e622f009f375"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzE1_5ee169da-62b2-4ebd-b193-b5de9dba81ec"
      unitRef="usdPerShare">74.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2772fde037ec41e0b7d7fa17d00b0876_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIy_fe65eaab-68ec-4c67-873b-f3396b74724b"
      unitRef="usdPerShare">71.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzUx_2910e3ec-1de7-454b-aa5e-0d62f180556e"
      unitRef="shares">4300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNDIy_bf1de43a-d56a-457b-90f0-9a45369674d5"
      unitRef="usdPerShare">51.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzI2OA_e279a944-70e0-4014-91ce-12dbd6fcc596">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi0xLTEtMS0xMDc5NTc_3e7d6e95-e7fc-4f58-9dfe-410d30f5f2e4"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi0zLTEtMS0xMDc5NTc_996de371-cdf7-4921-bc20-4b24c56aed9a"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi01LTEtMS0xMDc5NTc_1587e192-45e9-45c2-86ad-1066ad113610"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMi03LTEtMS0xMDc5NTc_1e0f0bb1-f824-435d-80d0-255c384e2b45"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy0xLTEtMS0xMDc5NTc_10b97f8b-afb0-4edb-91a0-0f6d41e2c976"
      unitRef="number">0.339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy0zLTEtMS0xMDc5NTc_d1818b31-c528-4fdb-8743-94d253ddbe69"
      unitRef="number">0.342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy01LTEtMS0xMDc5NTc_eddf302c-b3f6-4b36-af02-5eea8a9a408c"
      unitRef="number">0.339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfMy03LTEtMS0xMDc5NTc_a9e5e1f4-0522-4a32-be70-04f5a8a1f85c"
      unitRef="number">0.342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC0xLTEtMS0xMDc5NTc_9dd55c35-4cd8-4839-8a34-af6196137a8f">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC0zLTEtMS0xMDc5NTc_a868032b-af59-4452-bdcb-79dead09309b">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC01LTEtMS0xMDc5NTc_3ee20c8f-7c7a-4f48-a460-3d13235f66cd">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNC03LTEtMS0xMDc5NTc_419ecc14-33d8-41f2-a8ad-ec12ef8afc54">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS0xLTEtMS0xMDc5NTc_f6100062-a77b-45bb-805c-343da237e396"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS0zLTEtMS0xMDc5NTc_aa1708f5-cd61-4d37-bead-e4aeebeda88b"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS01LTEtMS0xMDc5NTc_eac9f1a9-87e3-43ee-a0b1-04bd53b817d5"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNS03LTEtMS0xMDc5NTc_65c43a45-074e-4528-a634-6bc8ba114b32"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi0xLTEtMS0xMDc5NTc_2159e24a-4885-4a80-97f1-0d3569956ecc"
      unitRef="usdPerShare">27.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi0zLTEtMS0xMDc5NTc_f8dbd107-3ade-4d51-aa02-dcf7aa13f2a0"
      unitRef="usdPerShare">20.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi01LTEtMS0xMDc5NTc_4eac9d20-00a2-4e38-bd3b-c119c6e00121"
      unitRef="usdPerShare">25.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RhYmxlOjgwOGIwNGY4YWI2ZjQxMmU5ZTY1MmUyODIzOTA3MzllL3RhYmxlcmFuZ2U6ODA4YjA0ZjhhYjZmNDEyZTllNjUyZTI4MjM5MDczOWVfNi03LTEtMS0xMDc5NTc_110a54ce-7310-484d-93ad-fc174577b69e"
      unitRef="usdPerShare">21.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNjQ0_8c6988cd-1fae-407c-a431-bb8d1be50570"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4a246129f343418eab464098000292bf_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNjUx_39fedfe5-77bc-4731-ac51-180b87105593"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNzg2_0e60caa6-bd01-4609-9e58-18ac1166dff9"
      unitRef="usdPerShare">74.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4a246129f343418eab464098000292bf_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfNzkz_cf6ffee3-4dbf-499d-b037-dd06f6f284a4"
      unitRef="usdPerShare">71.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfODUz_da450cf9-b661-405e-abe2-86943d43febf"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i27a08777635e4e009b32b403ac06831d_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfODYw_b0d8e0b7-d55c-420b-beeb-b9f7b485f699"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iad65a90458c94e14ac94ab494bee34ff_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTA0NQ_6e3475e4-46d2-4dc6-92fe-7bf1e8600529"
      unitRef="usdPerShare">74.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i27a08777635e4e009b32b403ac06831d_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTA1Mg_9f09bdda-52df-4776-9d74-4c98501367a9"
      unitRef="usdPerShare">71.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTEzMw_027b3663-e6ac-42f2-ad73-77e2e6cc7aed"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTE0MA_70604470-74db-4470-9bc5-a908a16c7fd5"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTM2MQ_ec92642e-fd31-473e-bc8a-f18d70a37508"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTM2OA_cbe51960-32dc-453f-8a04-83491d06a7cf"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTUyMA_930dd4ac-66c3-4379-a916-8900efd130b6"
      unitRef="usdPerShare">74.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idab64e56e124448fb701b0b0d5e322f6_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTUyNw_4e565ece-399f-4491-9d8d-0b98d6a46576"
      unitRef="usdPerShare">71.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTY4Mg_a8bcde61-4fee-4d09-af6c-af2fd24484f7"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTY4OQ_5b31bff3-4708-4a82-8a4b-86be6e084f2d"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i72ebb5e0a4f548b39ba2a3112515af95_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMTgzNQ_61ff3a57-5b23-4a06-ad58-a6d349787869">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjI3OA_dc5abd87-c8d8-4fe8-85f4-992e340b2fe2"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjI4NQ_d3a5d544-677d-41a5-a52c-9ff2fe8b125c"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjQ1Ng_027b3663-e6ac-42f2-ad73-77e2e6cc7aed"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjQ2Mw_70604470-74db-4470-9bc5-a908a16c7fd5"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjY4Nw_b88a139d-a8d1-4c70-b692-8160567a6183"
      unitRef="usdPerShare">97.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4c7c164ff6aa4e24aeb5c49efa0648d8_D20210926-20220326"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjY5NA_4c5cbf57-5f3d-41d9-a4b2-18980e825f5f"
      unitRef="usdPerShare">75.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i989b88385f034c7bba3210e41e103b4b_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjgwNQ_45033ab6-97e3-4b27-b5cb-fe1dc10b5c39">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id2eccbfd571a4ca7aa01513771ff388f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMjk0Mw_b7ca91e6-a1d6-446f-ae7e-d7cd1b3fca51"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i50daa327fe0142aa9a9468a3e86f64c6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzAzMA_3c588a6a-a258-4ac0-a2d8-a2c4c10abdb9"
      unitRef="usd">18800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ia577a32b749748fbbca9c17d38a8ea86_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzAzNw_f6d1497a-100b-433a-a85e-75d84c6ad762"
      unitRef="usd">77300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIyOQ_9471d9d8-4224-473d-ab4c-0b56edd32b78">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i509052b355f0473bb8198ebe916a409f_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83MC9mcmFnOjJkYjVmN2Y5MmU4MTRlNjE4ZmY3YTYwNjEzMGVmYWE1L3RleHRyZWdpb246MmRiNWY3ZjkyZTgxNGU2MThmZjdhNjA2MTMwZWZhYTVfMzIzNg_ab98822a-47b7-479f-8a24-14a8e8e33cb1">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <holx:DetailsOfCertainBalanceSheetAccountsTextBlock
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjEwMw_b8c71043-1520-49c2-9de9-419c8633bb04">Other Balance Sheet Information&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(738.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force (&#x201c;DOD&#x201d;) to expand production capacity for the Company&#x2019;s two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company has accounted for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procured and paid for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD reimbursed the Company upon it meeting certain requirements. However, the DOD retained title to the assets purchased under the agreement, and title was transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone had been met. As of the end of fiscal 2022, the Company had completed all milestones under the agreement and was waiting for approval by the DOD. During the second quarter of fiscal 2023, the Company received the final DOD approvals and the final payment from the DOD of $20.5&#160;million, which was recorded as a reduction of the cost basis of the purchased equipment. As of April&#160;1, 2023, no other amounts were awaiting approval and all defined milestones were completed.&lt;/span&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjEwNA_f282ca52-3e7f-4f48-8d73-c2beb9cb8e4d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMi0xLTEtMS0xMDc5NTc_9e22f5d5-dfd1-470f-b6ab-159abb31e797"
      unitRef="usd">293300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMi0zLTEtMS0xMDc5NTc_9692cfa2-d75b-4577-bf1f-61999c85e851"
      unitRef="usd">252900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMy0xLTEtMS0xMDc5NTc_3df41497-b194-49f8-9554-45bfbc1609fa"
      unitRef="usd">65800000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfMy0zLTEtMS0xMDc5NTc_134c3173-9470-4d02-9fee-47412df92455"
      unitRef="usd">60100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNC0xLTEtMS0xMDc5NTc_3b606e9a-d0c9-4730-b1d0-4ec94dbe7ff1"
      unitRef="usd">328500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNC0zLTEtMS0xMDc5NTc_27a6daad-70d5-4be4-9f6c-529324a26c23"
      unitRef="usd">310700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNS0xLTEtMS0xMDc5NTc_47583fad-2fed-4dc9-bf05-e07762f55da6"
      unitRef="usd">687600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOmI1YzY4Mzk0YjRjMzRlZTY5MDNlYTk2YjlhOTRhZTZkL3RhYmxlcmFuZ2U6YjVjNjgzOTRiNGMzNGVlNjkwM2VhOTZiOWE5NGFlNmRfNS0zLTEtMS0xMDc5NTc_ec47a599-37c5-4eae-9dbb-573574e7608a"
      unitRef="usd">623700000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMjExMg_ef112e78-b5e5-4795-ba3f-ea4e3c82de52">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(738.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMS0xLTEtMS0xMDc5NTc_14ba7f7f-b263-4d26-bdb2-fbd1077ce5c4"
      unitRef="usd">407600000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMS0zLTEtMS0xMDc5NTc_df9a71ae-9949-4dcd-b098-fca2ab07d851"
      unitRef="usd">394800000</holx:ManufacturingEquipmentAndSoftware>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMi0xLTEtMS0xMDc5NTc_e03bee6a-f6e0-4550-921f-f74b89037ad5"
      unitRef="usd">506800000</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMi0zLTEtMS0xMDc5NTc_78fc1204-a189-424b-811e-f0f16c65d7bd"
      unitRef="usd">486500000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMy0xLTEtMS0xMDc5NTc_5a7d9044-f557-452c-80c1-4951276c43a3"
      unitRef="usd">206200000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMy0zLTEtMS0xMDc5NTc_bb48f882-ef91-4489-909e-7e1fce5c8eba"
      unitRef="usd">196000000.0</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNC0xLTEtMS0xMDc5NTc_58dfd51c-fd2e-4fe1-a02b-d3a8c605af0b"
      unitRef="usd">47100000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNC0zLTEtMS0xMDc5NTc_1643aa53-0655-4d9e-a187-7f61fab33d14"
      unitRef="usd">44800000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNS0xLTEtMS0xMDc5NTc_5f598883-65b4-44d9-a89c-bf40c49a745a"
      unitRef="usd">41100000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNS0zLTEtMS0xMDc5NTc_98827f80-6ec9-4616-8fbe-d316c1626179"
      unitRef="usd">40900000</us-gaap:Land>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNi0xLTEtMS0xMDc5NTc_6d455cd4-928f-4270-aeb2-0a1ea78bd027"
      unitRef="usd">19200000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNi0zLTEtMS0xMDc5NTc_817f7319-7184-42d8-9e5c-c80f3d76f330"
      unitRef="usd">16700000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNy0xLTEtMS0xMDc5NTc_c91460c5-2a4f-4585-94e4-3b1aa6aae12a"
      unitRef="usd">8400000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfNy0zLTEtMS0xMDc5NTc_11b3fc9c-6646-4890-a09a-769e5792586a"
      unitRef="usd">7500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOC0xLTEtMS0xMDc5NTc_bdb2d435-0308-4ce5-935b-6f16c515d16c"
      unitRef="usd">1236400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOC0zLTEtMS0xMDc5NTc_fe104ed0-a137-46d9-85ba-62146177309e"
      unitRef="usd">1187200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOS0xLTEtMS0xMDc5NTc_ca818bfd-15ff-4b2d-af9d-027d9779be64"
      unitRef="usd">738500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfOS0zLTEtMS0xMDc5NTc_aba88ac5-02f3-4e0d-b8b0-6dc912b0aee4"
      unitRef="usd">705600000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMTAtMS0xLTEtMTA3OTU3_f8775b7c-881d-4ac7-bc16-aea36fb1446d"
      unitRef="usd">497900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RhYmxlOjcwMzZhMDA0OWU0ODRiZTA4NTI4NWJmYzg3OTk3YTYyL3RhYmxlcmFuZ2U6NzAzNmEwMDQ5ZTQ4NGJlMDg1Mjg1YmZjODc5OTdhNjJfMTAtMy0xLTEtMTA3OTU3_0242cf67-ba19-4427-aeac-a495f63ddb79"
      unitRef="usd">481600000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="i4a3f922b1bdf4d05b948c12d6a48fae3_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMTE4_eaac6552-c377-403e-8003-26ef76c4bde0"
      unitRef="usd">7600000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="ieb0eac28104f433fa408c7b9929c8afb_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfMTI1_3083d4d7-d101-46cf-b373-d8723c62ca73"
      unitRef="usd">119300000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83My9mcmFnOmEzNjA3OTI3ZGI2MzRlY2E5Nzg0OGY2M2UwZGQ2MjYwL3RleHRyZWdpb246YTM2MDc5MjdkYjYzNGVjYTk3ODQ4ZjYzZTBkZDYyNjBfNTQ5NzU1ODE4MTgy_d8ab2295-74ff-4d3c-9d6e-7758e5a6b68f"
      unitRef="usd">20500000</holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc1MQ_31fb25c8-83ab-4586-af92-5e2e57df2c00">Business Segments and Geographic InformationThe Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. Segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,448.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended April&#160;1, 2023 and March&#160;26, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of World&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfNzI_f2307da8-f699-4378-b18c-c887601cb6d2"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="i522660b505a2425fb1ae75796bfa1231_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_7fda888a-640c-4ba8-afba-7fb3639a87a0"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99ec6b91f8dc4e839b0621fa03ea273f_D20211226-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_8c26f075-9d88-4b00-a486-6e0b1587c3bf"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia326a75496cf4845bd1f54f9ac1dd86d_D20210926-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_96958f98-ab69-493c-a54b-3b423e07f881"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdf55613aebd4ac69743fad69a456a00_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfODgy_d1b00589-bd07-4c36-a1d7-459927c76d0b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc0Nw_1067207a-d15f-4c1a-b335-837d3643553c">egment information is as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,448.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy0xLTEtMS0xMDc5NTc_63f910bb-57da-43e4-afa2-f178d957a118"
      unitRef="usd">464700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy0zLTEtMS0xMDc5NTc_b25663a8-5a61-4131-99f5-381d87a709dc"
      unitRef="usd">987100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy01LTEtMS0xMDc5NTc_6f528c93-02b3-4976-ba9b-db9b2540efff"
      unitRef="usd">1024000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMy03LTEtMS0xMDc5NTc_f605b74d-f560-4d01-bc08-8771c6636f34"
      unitRef="usd">1937500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC0xLTEtMS0xMDc5NTc_ccc05489-4648-4041-be28-3cb6a3a36a89"
      unitRef="usd">385400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC0zLTEtMS0xMDc5NTc_bf58cd38-b986-490b-a117-76a64d22a0b1"
      unitRef="usd">310400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC01LTEtMS0xMDc5NTc_82314e96-0d43-4304-be8d-9f1246fefd37"
      unitRef="usd">719500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNC03LTEtMS0xMDc5NTc_5cb7a266-a350-4e92-be10-205c39496fca"
      unitRef="usd">669900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS0xLTEtMS0xMDc5NTc_60dd5ac6-e7c2-414f-a7d0-86a16a07470f"
      unitRef="usd">144800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS0zLTEtMS0xMDc5NTc_63358878-009f-42d1-a8b0-2e19c9ab7546"
      unitRef="usd">117300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS01LTEtMS0xMDc5NTc_62ebdf55-8033-4324-8779-9d2fd5dd070f"
      unitRef="usd">298900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNS03LTEtMS0xMDc5NTc_26a27963-6960-4341-bb90-569a13c443db"
      unitRef="usd">251600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi0xLTEtMS0xMDc5NTc_7f9258c5-789b-4d95-bc72-587a7ef45447"
      unitRef="usd">31600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi0zLTEtMS0xMDc5NTc_3f64e46c-564d-49d0-bc16-c1330e93eaa2"
      unitRef="usd">20900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi01LTEtMS0xMDc5NTc_97fdbf55-5235-4a42-b74d-d8e9fa94d1e8"
      unitRef="usd">58300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfNi03LTEtMS0xMDc5NTc_6911a795-b955-4eb3-90c5-f3262a067a8a"
      unitRef="usd">47900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC0xLTEtMS0xMDc5NTc_51e194a5-2d68-4ff2-a302-6a0bd2dfc63a"
      unitRef="usd">1026500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC0zLTEtMS0xMDc5NTc_e0b03fb0-7acc-4b1b-8271-c853ab9a9e08"
      unitRef="usd">1435700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC01LTEtMS0xMDc5NTc_41f43702-4fb9-406e-be4d-6cf7b3e6a008"
      unitRef="usd">2100700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfOC03LTEtMS0xMDc5NTc_cd4eb733-797d-42a1-839e-9b660c3794a4"
      unitRef="usd">2906900000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtMS0xLTEtMTA3OTU3_f06de39a-0e43-4e8a-92e2-b5114c46f863"
      unitRef="usd">105300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtMy0xLTEtMTA3OTU3_487a44c8-33e3-40c3-a24f-ed0287d181aa"
      unitRef="usd">540600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtNS0xLTEtMTA3OTU3_20d7ea35-3aae-4c5b-94a5-c92f0661cb65"
      unitRef="usd">256400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTAtNy0xLTEtMTA3OTU3_00229947-aa88-4f39-90ca-22e0d97374af"
      unitRef="usd">1072400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtMS0xLTEtMTA3OTU3_2618999c-01a9-4250-87ef-85f6bc5a66bf"
      unitRef="usd">109900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtMy0xLTEtMTA3OTU3_238bfb2c-b604-453f-9343-112756d6376c"
      unitRef="usd">49300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtNS0xLTEtMTA3OTU3_92597295-0bb8-4afa-a10b-453fc86d4bc9"
      unitRef="usd">170400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTEtNy0xLTEtMTA3OTU3_a2d8a96a-2064-4e27-aabb-fafb428e492a"
      unitRef="usd">131000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItMS0xLTEtMTA3OTU3_b5b97069-537f-4247-b4b2-4801fe7771e8"
      unitRef="usd">52300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItMy0xLTEtMTA3OTU3_a6b03347-4690-433a-be0a-a5c8c2940a32"
      unitRef="usd">5700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItNS0xLTEtMTA3OTU3_7bcbb7e0-338e-4719-a0c5-2029bdd6c17a"
      unitRef="usd">101000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTItNy0xLTEtMTA3OTU3_28d93923-8bcf-406c-a5f5-39af4961ea56"
      unitRef="usd">32300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtMS0xLTEtMTA3OTU3_1497e920-2cb7-463d-a996-b0b5a9c30cc0"
      unitRef="usd">4600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtMy0xLTEtMTA3OTU3_ae8c5176-4bb7-48b2-8c3d-643682d00ec5"
      unitRef="usd">-1500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtNS0xLTEtMTA3OTU3_99f36520-3b51-4a22-98ea-ab49bce96c1c"
      unitRef="usd">6700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTMtNy0xLTEtMTA3OTU3_98352e96-7702-4888-8910-ef84fa187475"
      unitRef="usd">-300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtMS0xLTEtMTA3OTU3_4998f93d-45c1-4094-8ece-f1757e2a342e"
      unitRef="usd">272100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtMy0xLTEtMTA3OTU3_d7625213-fa88-458f-992a-a8a4ee383290"
      unitRef="usd">594100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtNS0xLTEtMTA3OTU3_08ab9b4c-c6dd-4609-a12d-6b14693e32d4"
      unitRef="usd">534500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTUtNy0xLTEtMTA3OTU3_dbcfe430-6fcb-43a7-bdda-257a6350fd3a"
      unitRef="usd">1235400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctMS0xLTEtMTA3OTU3_dab415f7-cd7b-424a-a44a-97ed0c06f314"
      unitRef="usd">56100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctMy0xLTEtMTA3OTU3_8ddc3d02-5c27-4a58-b4b0-0e62b95e46dc"
      unitRef="usd">68200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctNS0xLTEtMTA3OTU3_73c92225-4201-408b-8826-c2d0b48518fb"
      unitRef="usd">116000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTctNy0xLTEtMTA3OTU3_9008c48c-eb3e-4f3d-8d2d-7ad35b0fb0d0"
      unitRef="usd">137600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtMS0xLTEtMTA3OTU3_cc14ac77-0452-41d4-9907-3b8870c95f14"
      unitRef="usd">12900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtMy0xLTEtMTA3OTU3_2580fda5-91f5-4e49-b5be-b68c07cb867d"
      unitRef="usd">13100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtNS0xLTEtMTA3OTU3_5c4a4739-8e85-40ea-91e4-5eb4d2957afc"
      unitRef="usd">26500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTgtNy0xLTEtMTA3OTU3_59fd6200-38f1-4757-9757-cffb010d4538"
      unitRef="usd">28600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktMS0xLTEtMTA3OTU3_0532eaf2-dc7c-4ded-b64b-5788842e0825"
      unitRef="usd">11600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktMy0xLTEtMTA3OTU3_33ab0cab-9e6e-4c0c-a32e-59687db60674"
      unitRef="usd">24600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktNS0xLTEtMTA3OTU3_1a99bd81-daa3-415e-8e60-0c7d1ee73df3"
      unitRef="usd">23900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMTktNy0xLTEtMTA3OTU3_d35091f0-31ab-4d19-9caa-48abe976fe24"
      unitRef="usd">47500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtMS0xLTEtMTA3OTU3_aff78968-7a16-4fba-962e-a328e727a1c2"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtMy0xLTEtMTA3OTU3_1fe83651-5c64-4522-90e9-70e832f29e45"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtNS0xLTEtMTA3OTU3_2b2f5ad3-66ef-4f30-9309-29e99465aeae"
      unitRef="usd">300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjAtNy0xLTEtMTA3OTU3_dabc5a67-3198-4108-a1a0-33592053ea31"
      unitRef="usd">400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItMS0xLTEtMTA3OTU3_3a042531-8206-40e5-b126-9891ac081a9d"
      unitRef="usd">80800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItMy0xLTEtMTA3OTU3_b0a27d5c-7fb1-4287-9dd5-de393d1c8e6a"
      unitRef="usd">106100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItNS0xLTEtMTA3OTU3_e3e83d3b-9149-40c2-a580-5cb769a7f665"
      unitRef="usd">166700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjItNy0xLTEtMTA3OTU3_fcb48dfb-ba14-4641-b5f2-594767b29eb0"
      unitRef="usd">214100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i40334debf24c4a4c9f7384c2649d9f0b_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtMS0xLTEtMTA3OTU3_dc9c3875-684d-4db5-9c0b-018887530d12"
      unitRef="usd">20200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2b726f24d66a49299bbad10feca8ee5e_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtMy0xLTEtMTA3OTU3_d773ca9c-5cda-4459-8c6c-57c6bd8d183e"
      unitRef="usd">26500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie8f9607a004042a1868a4d397c8284d8_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtNS0xLTEtMTA3OTU3_3eda2842-9e51-4b1a-99b9-83100ef92b7e"
      unitRef="usd">36100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3b61275bb03a4ba590446d16c6755382_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjQtNy0xLTEtMTA3OTU3_56b1d5a8-8820-415f-8beb-f005de62faad"
      unitRef="usd">57500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia1c381398c324f19a228c262c54de902_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtMS0xLTEtMTA3OTU3_33bb5343-f1b7-4e4b-b3c0-fc385229cfe1"
      unitRef="usd">6900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i41bac8744e354ad2b4640e1490e89b7a_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtMy0xLTEtMTA3OTU3_885976d2-cea6-439c-bea3-f1d007ff7c08"
      unitRef="usd">2800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5a2e7dcf07ff4b3f97324bf80a4f8624_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtNS0xLTEtMTA3OTU3_54e2414a-72b5-4d6d-8b9b-1ebb1594c863"
      unitRef="usd">14100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib4b09a8f41284b04a4918538ef97b46e_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjUtNy0xLTEtMTA3OTU3_0d6d3011-269a-4b72-908a-eb4947247f98"
      unitRef="usd">7000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8d8a8b64c8f74db58b991ee7e84fa224_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtMS0xLTEtMTA3OTU3_3a109b93-844e-41f7-b70c-59a977350de8"
      unitRef="usd">2800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i231da92875a34437a5282b675e6426d9_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtMy0xLTEtMTA3OTU3_ed47d078-3710-4a5c-8d1f-935546a7e7b6"
      unitRef="usd">2000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i71fec6ca2a5f43229e3deceb2a3e8f6f_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtNS0xLTEtMTA3OTU3_86fa6852-4288-4373-b4e5-691c3f480c26"
      unitRef="usd">6700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i282c21a81b1949418c0ed38a8783bf77_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjYtNy0xLTEtMTA3OTU3_fe149cea-d51f-4f52-949c-94e5fc545e00"
      unitRef="usd">4100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8b6f5d6c951e43e6bf7c155bb4109109_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctMS0xLTEtMTA3OTU3_76900700-23f1-4a07-866f-0c8394ae6fb0"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i248760a0fb6f4bd59b0af86c7c56a5d3_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctMy0xLTEtMTA3OTU3_f9eab9e3-4388-483a-9178-482d553f9833"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic726db062cfb4ce3bba024370023e079_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctNS0xLTEtMTA3OTU3_1b0710f6-72c4-4f7f-86a1-685cbe2f8e80"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ieb68b4a88be644d3b6e6136d1333d525_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjctNy0xLTEtMTA3OTU3_1339477c-d17d-40de-b9ef-5700bdfbd136"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iaa97bebc3b004733b9c34994ac8eba59_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktMS0xLTEtMTA3OTU3_60e32698-2788-454b-9a67-189d7f468dad"
      unitRef="usd">2100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5108570aa8d24fd39f37539e9a93e166_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktMy0xLTEtMTA3OTU3_d725bb62-812e-4d20-93e6-9f49f2f4dfc0"
      unitRef="usd">900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5c4425324e9249c3b78b220d544a2a6e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktNS0xLTEtMTA3OTU3_be466c44-c753-4ebe-92d2-fd9b1698ac45"
      unitRef="usd">4100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i56c17ccb48574e919a33ce08e5de772b_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMjktNy0xLTEtMTA3OTU3_e9e7f128-05a3-419d-bbd9-5a2545c22856"
      unitRef="usd">1100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtMS0xLTEtMTA3OTU3_74b36341-a594-4f83-81bc-9bd46875ad46"
      unitRef="usd">32100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtMy0xLTEtMTA3OTU3_46a9ef51-b3a1-4eef-b1c6-4f98a2f35210"
      unitRef="usd">32300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtNS0xLTEtMTA3OTU3_ba154599-02ea-495f-91d9-c686eb837585"
      unitRef="usd">61200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjlhZThjNDUzOTY4NjQ1ZWM5ODY1Y2JjNDBjOTVmNDYxL3RhYmxlcmFuZ2U6OWFlOGM0NTM5Njg2NDVlYzk4NjVjYmM0MGM5NWY0NjFfMzAtNy0xLTEtMTA3OTU3_1849a726-cfb0-452e-a898-d842244f9c08"
      unitRef="usd">69900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="ic0da1df1fe1a44d4bcb27d37cff8897a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMi0xLTEtMS0xMDc5NTc_1bde998b-94a7-4320-b279-c92d4c6761ab"
      unitRef="usd">2940400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id83b89bbba274da1aecdd2d283d1ce13_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMi0zLTEtMS0xMDc5NTc_dd7b9628-e47b-4536-bfee-994fd902ed72"
      unitRef="usd">2881700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaa02d3fe1f124afaa799f62caa9b7a35_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMy0xLTEtMS0xMDc5NTc_49503792-496f-4c50-8cdc-85e16a0dc3b6"
      unitRef="usd">1250900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2eeb9ddbf5a34bb3a14921940aad31a0_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfMy0zLTEtMS0xMDc5NTc_89772e20-fd1f-4131-91a3-86212aa6ab3f"
      unitRef="usd">1245800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id601e4f7392c49f69fb44fca0c219a32_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNC0xLTEtMS0xMDc5NTc_804a9a6f-286d-47f3-9766-612b9a32ff35"
      unitRef="usd">1464200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i61146379fc1346a09fc79ae328fc4ae7_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNC0zLTEtMS0xMDc5NTc_dd4b51d5-c75c-4c8f-b634-491c2ba4e0f6"
      unitRef="usd">1461500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i987c4cf9a87c4b33a5d8acfe456b5212_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNi0xLTEtMS0xMDc5NTc_ffa6310e-440e-4955-8095-b123f6b3efff"
      unitRef="usd">22700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2e5d286446e24832a9b09dd26e54365c_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNi0zLTEtMS0xMDc5NTc_45f22da5-1e44-424a-b46d-998857203823"
      unitRef="usd">27500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if6940db18e044ac4baf19aa208d8ab33_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNy0xLTEtMS0xMDc5NTc_d445d85f-3312-4688-876e-d107d01f6c33"
      unitRef="usd">3770500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1505009eac544214a4c5d2a5083d4b87_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfNy0zLTEtMS0xMDc5NTc_b54a21b2-c5bd-49d9-bce4-9c5b444ee722"
      unitRef="usd">3454700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfOC0xLTEtMS0xMDc5NTc_a495dc6b-0fe9-4db4-91c9-9472cd86f5f9"
      unitRef="usd">9448700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZmE2ZWQyYWJkNDRiZDY5NDk4Njg3NTBlNWQ1ZGIyL3RhYmxlcmFuZ2U6OGZmYTZlZDJhYmQ0NGJkNjk0OTg2ODc1MGU1ZDVkYjJfOC0zLTEtMS0xMDc5NTc_ab426596-aa8a-4822-8b25-b74167729bd2"
      unitRef="usd">9071200000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RleHRyZWdpb246YTI0NmRhYjIxNDI2NDg0ZmI0YmQxMWE5Mzg4YjA5ZDBfMTc1Ng_159bf629-dfae-4dfe-a4d8-dddb979c9942">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 26,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="i50e359ff29cc4b629cf17df60483bcfd_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi0xLTEtMS0xMDc5NTc_566e2631-04a3-48c4-b639-7cb04c34c5fa"
      unitRef="number">0.749</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i32eb2c02e42448deb71836ed52883f2e_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi0zLTEtMS0xMDc5NTc_9b63bbf1-b1c9-4918-b546-50d3eb6c1e92"
      unitRef="number">0.691</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i1f85b6f4893e4e34b33aeae6316f40aa_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi01LTEtMS0xMDc5NTc_29fcf2ae-3d4c-4030-95a6-881ec1b24509"
      unitRef="number">0.758</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i0a9ca1f759dc4b318db1314c9e8b9998_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMi03LTEtMS0xMDc5NTc_03e1a567-9f9c-4889-b2cd-29aa98b70885"
      unitRef="number">0.690</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy0xLTEtMS0xMDc5NTc_66cdcf46-87fb-405a-a378-f6e8ca129321"
      unitRef="number">0.148</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ifd755a8928c347638dc5777e510229a4_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy0zLTEtMS0xMDc5NTc_c400077d-908b-47ef-9044-f3c70297e514"
      unitRef="number">0.203</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="if2045c7b21be41ca89bdb543d1a86f79_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy01LTEtMS0xMDc5NTc_2c049bed-83ea-48a1-b834-4e043baa442a"
      unitRef="number">0.142</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="iff5048cc90b24e60b7ccad54972e49a1_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfMy03LTEtMS0xMDc5NTc_978a2df4-f3ce-4136-b066-73eabd91a2d5"
      unitRef="number">0.201</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i86ad567837a74d5793ae5c9080dc5b2f_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC0xLTEtMS0xMDc5NTc_c86cc671-8a10-4947-ab7a-cb3ace24210b"
      unitRef="number">0.064</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i064844e1ecbf4cca9dfbddf63d0704cf_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC0zLTEtMS0xMDc5NTc_3561102f-e394-44ae-9647-beaf2dc4273e"
      unitRef="number">0.076</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i28d2b38d322445518df9d6519589e24a_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC01LTEtMS0xMDc5NTc_435d0b88-857b-4395-b4e3-dfe0e705fef8"
      unitRef="number">0.061</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9571a33eb8fc4af6961ca3908464e474_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNC03LTEtMS0xMDc5NTc_737042c3-4c67-4ec4-a2b1-2299376df23e"
      unitRef="number">0.079</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i0c33a8795c3a41f5bd50f90ed5b9bf52_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS0xLTEtMS0xMDc5NTc_fe135fae-05f6-4f20-84f8-d595f744c361"
      unitRef="number">0.039</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ia73b8a87766948a89773af45de8aa1a2_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS0zLTEtMS0xMDc5NTc_b047a434-19f2-4111-b179-0a91bd42e9c5"
      unitRef="number">0.030</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ib59e7423fc3348d2aba0bd00f14d79a2_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS01LTEtMS0xMDc5NTc_6d975fb7-e680-4448-bef6-48ab17734a84"
      unitRef="number">0.039</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i69214a927e6a42459ef14fb9247a6f7c_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNS03LTEtMS0xMDc5NTc_9152e724-a3d0-43c5-bff9-e0b5b601686a"
      unitRef="number">0.030</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi0xLTEtMS0xMDc5NTc_ef137f1e-c902-4f90-8343-74de770fa435"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi0zLTEtMS0xMDc5NTc_da0b5525-d790-4eec-bd90-b02cf58e3323"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi01LTEtMS0xMDc5NTc_8e521ebd-4c10-4ad5-bc0e-ef53cf80917d"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83Ni9mcmFnOmEyNDZkYWIyMTQyNjQ4NGZiNGJkMTFhOTM4OGIwOWQwL3RhYmxlOjhmZDE0ZWI2MDBjNDQ3ZjFhZjU4MzI2OWIyOTdkYWIzL3RhYmxlcmFuZ2U6OGZkMTRlYjYwMGM0NDdmMWFmNTgzMjY5YjI5N2RhYjNfNi03LTEtMS0xMDc5NTc_f8c5f830-3c7b-4dfd-8f89-8e813d475353"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMjQzMQ_37073580-0eb4-4d90-b2f6-c8ba0ab31ab4">Income Taxes&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates for the three and six months ended April&#160;1, 2023 were 21.8% and 21.7%, respectively, compared to 20.7% and 20.2%, respectively, for the corresponding periods in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the three and six months ended April&#160;1, 2023 were higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company&#x2019;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The effective tax rates for the three and six months ended March&#160;26, 2022 were lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by the Company&#x2019;s international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Income Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company&#x2019;s positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three and six months ended April&#160;1, 2023 and March&#160;26, 2022. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfNjAy_69f45ed5-c417-42f5-a650-5b63af82671a"
      unitRef="number">0.218</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfNjA5_b8bb8c82-e42e-4c3f-818c-0b878200d86b"
      unitRef="number">0.217</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMTA5OTUxMTYzMDM3OQ_132b26f1-7b39-423e-8699-9457d7d37155"
      unitRef="number">0.207</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV83OS9mcmFnOmJkNzQ0OTRmZTQ4OTQ3NjFiMGQwZjdmYWY5NDVhMTQwL3RleHRyZWdpb246YmQ3NDQ5NGZlNDg5NDc2MWIwZDBmN2ZhZjk0NWExNDBfMTA5OTUxMTYzMDM4Ng_0c81f3be-4b44-4672-8e65-a6131ea20470"
      unitRef="number">0.202</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjYz_df0871d0-648d-418f-b70d-7004220be270">Intangible Assets&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:30pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,458.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,519.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,330.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,465.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,575.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company&#x2019;s acquired intangible assets as of April&#160;1, 2023 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjQ0_30e07da9-6c97-44fd-9393-a8b6e590aaae">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:30pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,458.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,519.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,330.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,465.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,575.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4d97279b97e3493bae5fe07e0a15dabf_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy0xLTEtMS0xMDc5NTc_622b8e64-c575-4466-9bba-fbcb9e82c850"
      unitRef="usd">4607500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d97279b97e3493bae5fe07e0a15dabf_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy0zLTEtMS0xMDc5NTc_84e85f15-a8a4-4ae0-91ca-1ce1a9e2a3a4"
      unitRef="usd">3574100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3e39021ecd254dd09befad99c3986073_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy01LTEtMS0xMDc5NTc_ea1210c7-f88a-47d4-9f88-902162bb499e"
      unitRef="usd">4565600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3e39021ecd254dd09befad99c3986073_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMy03LTEtMS0xMDc5NTc_3bf576c4-2074-4e8c-9ffc-f55108edde89"
      unitRef="usd">3458200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC0xLTEtMS0xMDc5NTc_f6437d28-e66b-4335-85e1-4e6d937058a6"
      unitRef="usd">36800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6369fb44f2a64f1e9cdac4fb57ef3a41_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC0zLTEtMS0xMDc5NTc_01e994d6-8690-4532-b38d-6f6ec9311303"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id07828dc44634020a4b14b73f7eb87fa_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC01LTEtMS0xMDc5NTc_583c9f6b-fde4-41c7-b177-a213e7ce692d"
      unitRef="usd">33000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id07828dc44634020a4b14b73f7eb87fa_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNC03LTEtMS0xMDc5NTc_2569d781-533a-4a73-bbaa-9ec97bd30913"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS0xLTEtMS0xMDc5NTc_11f535ff-41bc-45e4-bed1-f71ead4626f7"
      unitRef="usd">607900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0199f0af1c2d4d21bfa7d3b2d1474b23_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS0zLTEtMS0xMDc5NTc_67103cc2-1f13-45c7-ba60-13d42b82f082"
      unitRef="usd">547100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5f748d0709e6431ba2b044bda85c7b9d_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS01LTEtMS0xMDc5NTc_80ba4e62-0124-4928-bbc6-32e2347b3c62"
      unitRef="usd">601900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f748d0709e6431ba2b044bda85c7b9d_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNS03LTEtMS0xMDc5NTc_a38eba05-0177-4430-a22d-39f4fc12b607"
      unitRef="usd">535600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib179c1e06a7443498a0049053c6f4bce_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi0xLTEtMS0xMDc5NTc_f262b923-e97e-4e4e-a90a-8fa96f7a675d"
      unitRef="usd">267600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib179c1e06a7443498a0049053c6f4bce_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi0zLTEtMS0xMDc5NTc_b0bd5d2b-c09a-49b9-bfed-76926b4d5786"
      unitRef="usd">209300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id9059edfb45a4a2d86a83a32fbb97888_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi01LTEtMS0xMDc5NTc_c61dac05-053e-439f-919b-355bfe0e15e0"
      unitRef="usd">265200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id9059edfb45a4a2d86a83a32fbb97888_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfNi03LTEtMS0xMDc5NTc_823b743e-00e1-4a0d-8783-a485d8fc24b9"
      unitRef="usd">203300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i998a08b240cb4165815a4c0f245cb61d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtMS0xLTEtMTA3OTU3_2a3dd6cb-7d85-442e-8ba5-d1aa21731dc3"
      unitRef="usd">5519800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i998a08b240cb4165815a4c0f245cb61d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtMy0xLTEtMTA3OTU3_a99649c3-e495-4e8e-aaee-c61ec72c2d72"
      unitRef="usd">4330500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0b2dc025fcef4752948c5b989d73d843_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtNS0xLTEtMTA3OTU3_5cc702a3-18f0-43b8-990f-8520a6369d12"
      unitRef="usd">5465700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0b2dc025fcef4752948c5b989d73d843_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTAtNy0xLTEtMTA3OTU3_0553a625-3ae7-42a0-8531-e1f96d28bded"
      unitRef="usd">4197100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i53d03d024a12410989ca0f3bd337f2c3_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItMS0xLTEtMTA3OTU3_a3544822-9f36-49f4-a2f7-f09c66d73284"
      unitRef="usd">28500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i53d03d024a12410989ca0f3bd337f2c3_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItMy0xLTEtMTA3OTU3_3d44042b-bc0d-472b-98a8-17c1d7f694cd"
      unitRef="usd">21400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idad017932b214b8bb1c244596a2c3da4_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItNS0xLTEtMTA3OTU3_cbf67fc8-5f75-49e9-ab57-b016642518a9"
      unitRef="usd">26000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idad017932b214b8bb1c244596a2c3da4_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTItNy0xLTEtMTA3OTU3_186600a3-a4c6-4ee6-b028-652a09a64b81"
      unitRef="usd">19900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtMS0xLTEtMTA3OTU3_b68a11a8-647e-485f-953e-f228506d84ea"
      unitRef="usd">27500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ife2bf6208e3e40a29e5b90be0e78bab0_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtMy0xLTEtMTA3OTU3_cbad2731-d5d9-477c-bf1b-da199054aa62"
      unitRef="usd">21700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i98fa1a0f46224950aca1017cb9727897_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtNS0xLTEtMTA3OTU3_f7faa84c-1dd2-466f-9222-0d5a4560f09e"
      unitRef="usd">26500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i98fa1a0f46224950aca1017cb9727897_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTMtNy0xLTEtMTA3OTU3_58cf388c-8668-4eb4-8486-65a555398f2e"
      unitRef="usd">20600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtMS0xLTEtMTA3OTU3_e7843193-87f2-406e-b850-66d8ad05a3c2"
      unitRef="usd">5575800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtMy0xLTEtMTA3OTU3_502b5dc0-60c3-4db1-b019-08651680a1cf"
      unitRef="usd">4373600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtNS0xLTEtMTA3OTU3_a0e6c1ad-287c-41da-b045-6b93eafbfce9"
      unitRef="usd">5518200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjZmMTZjMWQ2ZTljNjRjN2RhYjQ2M2EwMTA4MWJiMGVjL3RhYmxlcmFuZ2U6NmYxNmMxZDZlOWM2NGM3ZGFiNDYzYTAxMDgxYmIwZWNfMTQtNy0xLTEtMTA3OTU3_f728e8a5-7251-4a7c-a4bc-75ea3f6f2976"
      unitRef="usd">4237600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RleHRyZWdpb246MWFjNzYwZWI2Zjg4NGVmNzkxNDdkMDEwMmYyY2IzYmFfMjY0_d94d6ab7-8a71-4d5d-9177-f5f9d254d003">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company&#x2019;s acquired intangible assets as of April&#160;1, 2023 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMC0xLTEtMS0xMDc5NTc_e23da942-9990-4935-9b3a-1d4bd14e7ce4"
      unitRef="usd">117400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMS0xLTEtMS0xMDc5NTc_b8636fbb-afe6-4f34-9870-30be9cfc323c"
      unitRef="usd">225200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMi0xLTEtMS0xMDc5NTc_67fd34fc-3ba2-453f-b944-af1b6a110d60"
      unitRef="usd">210300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfMy0xLTEtMS0xMDc5NTc_1fe43a60-ea1a-4254-ade1-05a7129b82fd"
      unitRef="usd">177900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84Mi9mcmFnOjFhYzc2MGViNmY4ODRlZjc5MTQ3ZDAxMDJmMmNiM2JhL3RhYmxlOjFhZjkzY2UzNzYyYTQwZmViYmZmNTVmYjI0OWNmOTY0L3RhYmxlcmFuZ2U6MWFmOTNjZTM3NjJhNDBmZWJiZmY1NWZiMjQ5Y2Y5NjRfNC0xLTEtMS0xMDc5NTc_d06ebc9b-7276-407b-b852-993166b039e3"
      unitRef="usd">90900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RleHRyZWdpb246MGQ4YjZhYzZhNzUxNGYyN2E2MzlhMzU4YzQ5ZGUzYWZfODU_efd765c1-aeb9-441c-a2b1-65433b16d880">Product Warranties&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RleHRyZWdpb246MGQ4YjZhYzZhNzUxNGYyN2E2MzlhMzU4YzQ5ZGUzYWZfNzU_5845e492-9842-4fcf-b944-3467961f6216">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i5e15af082687422bbd21dc55ec8a2595_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0xLTEtMS0xMDc5NTc_b912e0c3-3a96-4c6a-834b-f6df01e7e74b"
      unitRef="usd">8000000.0</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0zLTEtMS0xMDc5NTc_23e3ad70-5e87-440d-b336-8f160d3fc600"
      unitRef="usd">3300000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi05LTEtMS0xMDc5NTc_ab2a6374-c1ef-45f1-a17f-e782101119d3"
      unitRef="usd">3800000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i8aa6a9b0f7204e52bbb68b547acb3605_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMi0xMS0xLTEtMTA3OTU3_528dfed7-e5e1-4c7e-90e6-6d31edfc98a3"
      unitRef="usd">7500000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia5e31f17a8d64c899b2a4d460af241d4_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0xLTEtMS0xMDc5NTc_9d34a212-1cf7-4e85-b363-e981743d7f17"
      unitRef="usd">8800000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0zLTEtMS0xMDc5NTc_f0be47fb-50a3-46d2-8603-d027c88ae1b2"
      unitRef="usd">3700000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy05LTEtMS0xMDc5NTc_bca2e92a-b0f2-47b5-8cdf-8fd1ad6bc1eb"
      unitRef="usd">4100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="if17809e1aa754e809b00400ef2e7e9df_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84NS9mcmFnOjBkOGI2YWM2YTc1MTRmMjdhNjM5YTM1OGM0OWRlM2FmL3RhYmxlOmY0MmMwMzMyZjU0MTQ2OTY5MWZmZDU3ZjUxOTQ0YTdjL3RhYmxlcmFuZ2U6ZjQyYzAzMzJmNTQxNDY5NjkxZmZkNTdmNTE5NDRhN2NfMy0xMS0xLTEtMTA3OTU3_b87f0bd0-6e4c-4624-9c9b-0506d5a695d3"
      unitRef="usd">8400000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RleHRyZWdpb246MzJlMjU1MWZhMWVmNGYzMTgyNzMwZTZiYWE3ZjljNjZfMTg4_c67c3d5b-fde2-4814-9930-d75f4b5305bd">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(153.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(267.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(118.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(118.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(89.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(34.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(72.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(45.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(115.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(104.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(115.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(104.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RleHRyZWdpb246MzJlMjU1MWZhMWVmNGYzMTgyNzMwZTZiYWE3ZjljNjZfMTgz_f3b12e76-a8da-46c7-a25e-badb43895964">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(153.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(267.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(118.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(118.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(89.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(34.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(72.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(45.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(115.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(104.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(115.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(104.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i26556cf1cbe64603999108ceccd4b8c0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xLTEtMS0xMDc5NTc_788cd468-94e1-48f0-b136-45b1df0c153c"
      unitRef="usd">-153400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i716db929cf324a8bba183dfc7e6ce250_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0zLTEtMS0xMDc5NTc_11675858-5483-437a-a465-6be7b2996932"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie6fe4337c2984c3d86c299d64abafdc2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi03LTEtMS0xMDc5NTc_2c184964-5bb9-4207-9de7-008e7bf21c82"
      unitRef="usd">26400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73bd1004f3ac4024b0b08de9b1f7f332_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi05LTEtMS0xMDc5NTc_6f470f90-d4d5-45b0-8c70-608076f5e278"
      unitRef="usd">-127300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4f066bb0ba54024856a9b5805b1de7c_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xMS0xLTEtMTA3OTU3_5b1326b9-2bcc-461b-879d-ef72e7b8e7e2"
      unitRef="usd">-267200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id36f522d615d45cc9db23bf02926e03d_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xMy0xLTEtMTA3OTU3_bb0aabfb-9117-4d8c-ad61-8c3a40891b31"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fb87637671c4962a157d8c69ffb2d58_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xNy0xLTEtMTA3OTU3_63edddd3-3b5d-4435-9ff4-b83c8804d582"
      unitRef="usd">29300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e5f81fbde654721b420a4cceaa0f658_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMi0xOC0xLTEtMTA3OTU3_4fbd56bc-c585-4b95-8c28-8baf4c870c32"
      unitRef="usd">-238200000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="iefc79822f08d45ccada45b5d08c85f45_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xLTEtMS0xMDc5NTc_96c47386-1ff2-465d-b4ab-9c998f4fb4f0"
      unitRef="usd">15300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i9f4577c73735428b8f48f2233c6a5b4c_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0zLTEtMS0xMDc5NTc_6c36a179-782e-44d4-9a8d-d91c6ef54d90"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="if4f5794ab1cc4d90b0150fded4465f9d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy03LTEtMS0xMDc5NTc_ca2c31fb-1f9c-4389-8b57-376e2f99a241"
      unitRef="usd">-6400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy05LTEtMS0xMDc5NTc_7a2e0ed5-e5b8-43f0-ae6c-856922377cb8"
      unitRef="usd">8900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i7de6ecf9ab0b44ac88fad82530f8c45d_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xMS0xLTEtMTA3OTU3_f3045ad7-fd4f-49a5-957e-3345882bd12d"
      unitRef="usd">129100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i3b9c6bece29543538e4949188c1b8250_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xMy0xLTEtMTA3OTU3_cebc62ea-4373-4316-a682-7536f3507d6e"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i08795cf6d72a47e39f4e264449f2e14d_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xNy0xLTEtMTA3OTU3_b8c7e079-ee83-4b41-b9eb-dcd483372f63"
      unitRef="usd">-9300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfMy0xOC0xLTEtMTA3OTU3_aa47bffb-ace0-45ed-920a-a0f4f37b05ad"
      unitRef="usd">119800000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xLTEtMS0xMDc5NTc_f65918e6-87d8-4600-b79a-958a139dabd3"
      unitRef="usd">-138100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib439241bfa8c49b394aef2e2769df894_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0zLTEtMS0xMDc5NTc_d69f2ea8-f982-4e08-93d8-53492da50bd1"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05ca154a812442e69660b5624f4c20c1_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi03LTEtMS0xMDc5NTc_723dcc8b-276a-4319-a9f5-8acea8220fe7"
      unitRef="usd">20000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi05LTEtMS0xMDc5NTc_532a1623-47cc-419b-81bd-ec581d562ff5"
      unitRef="usd">-118400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1dd15998c4424b0fbf1f3d8d4d08a202_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xMS0xLTEtMTA3OTU3_2ba432e3-0dea-4d25-9f0c-4cd53121fc89"
      unitRef="usd">-138100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib439241bfa8c49b394aef2e2769df894_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xMy0xLTEtMTA3OTU3_de748ef7-4cf3-4927-8760-56dcd70a48ee"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05ca154a812442e69660b5624f4c20c1_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xNy0xLTEtMTA3OTU3_60d93b25-8bb9-4453-afcb-54b94ddfe8a8"
      unitRef="usd">20000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbd87583fd904b4ea56862fe48bd6b48_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOjI5ODAyY2NlODQzODQ1YTJiOTM1MDBmNTVmMmYxYjA3L3RhYmxlcmFuZ2U6Mjk4MDJjY2U4NDM4NDVhMmI5MzUwMGY1NWYyZjFiMDdfNi0xOC0xLTEtMTA3OTU3_ebacc997-63da-42d1-b04c-c9122c63f1d1"
      unitRef="usd">-118400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c1f163e64434b4098d3210b8c8872a1_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xLTEtMS0xMDc5NTc_e56e100a-d227-49bd-857f-08d4e1760d4e"
      unitRef="usd">-80900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic417b6f69d4a4c8f8db217c37f35a4c6_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi01LTEtMS0xMDc5NTc_c473e3bf-f657-4192-8432-10d0b78ce9f6"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i975de9ea5e4c4452bb7f5ce1b9e42fac_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi05LTEtMS0xMDc5NTc_916aff04-d09e-4d7b-a997-7a29ca7d2eb5"
      unitRef="usd">-6800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f733818a0ef4bb196bde5377e392367_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xMS0xLTEtMTA3OTU3_31183eef-f4c0-4cbe-bfee-d46c1ae85911"
      unitRef="usd">-89000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f082150b16640738cb5d6c0f5be0de9_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xMy0xLTEtMTA3OTU3_33b1b361-0484-4bc8-97ef-3011fbfa20e0"
      unitRef="usd">-43100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f11753d84724189a8eb0ac0a40c5e1d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xNS0xLTEtMTA3OTU3_55c5a08f-964f-4a32-b1eb-336c6b48cb62"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99b24c3fbef44f539ea8da6b56c6635e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0xOS0xLTEtMTA3OTU3_5527d03b-baf9-4878-ba54-66e0e8619042"
      unitRef="usd">-14700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e73db97997e4106b0bc73a6ad117fa1_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMi0yMC0xLTEtMTA3OTU3_8b85ceb5-bb1f-4a44-985e-2f53472f9323"
      unitRef="usd">-59100000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i6b8947efb99844ba8ea929d65eebcd7d_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xLTEtMS0xMDc5NTc_b8ee6717-1839-45d0-b7cf-3e390c9bdfff"
      unitRef="usd">-34500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ie52504be379e47e3a03f6ea3ee3b79fb_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy01LTEtMS0xMDc5NTc_0f240278-f4db-4eb8-b8a3-5133d1750c85"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i87488652d2ac42b786bc94af875d7063_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy05LTEtMS0xMDc5NTc_65d556d3-dd4c-42b6-9f70-afff9c17e6f6"
      unitRef="usd">19400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i3fac0f420d4e48f79624de7a58005e45_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xMS0xLTEtMTA3OTU3_ea6dbdbd-ea89-431f-b46a-6d2933bcd3f6"
      unitRef="usd">-15100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i17798170e5634c5681bad6fa53526f87_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xMy0xLTEtMTA3OTU3_f1f95b9d-b845-4ebf-8c0f-37f35348439b"
      unitRef="usd">-72300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i4386093d3b87463587e092da86bad387_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xNS0xLTEtMTA3OTU3_d339e1a5-af85-4ddd-9bb6-472c36781af9"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i038a9776dfcb49e8b6ae15ed7ba884f7_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0xOS0xLTEtMTA3OTU3_654201c2-b1f1-4c17-81df-a43f08844bc6"
      unitRef="usd">27300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i2f5df899f4bd49b99f04b808aa4c2984_D20210926-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfMy0yMC0xLTEtMTA3OTU3_f6f2f897-a6a1-403e-9602-dd6f91a3cdef"
      unitRef="usd">-45000000.0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xLTEtMS0xMDc5NTc_a6b5039e-22ab-4c0b-962c-652d7fe107b8"
      unitRef="usd">-115400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS01LTEtMS0xMDc5NTc_3746941a-66e3-4934-8815-b9d81d6ed15b"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i176f6f8fef46496b9bd2ba8947704790_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS05LTEtMS0xMDc5NTc_5752734e-d9e7-43bf-a309-4aa694e43a93"
      unitRef="usd">12600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xMS0xLTEtMTA3OTU3_f217aa6d-6e55-47af-9750-b625450f65cf"
      unitRef="usd">-104100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46dd0ab240a741fa829d4ce8599cb6ba_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xMy0xLTEtMTA3OTU3_c0e4a3d8-9b3d-4599-a92f-2981349d4a6f"
      unitRef="usd">-115400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4c2bfa2d6e24f35b751caeb5ac8f278_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xNS0xLTEtMTA3OTU3_f6914648-7e06-4e69-9564-a931464acfc2"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i176f6f8fef46496b9bd2ba8947704790_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0xOS0xLTEtMTA3OTU3_5b3825ef-899d-403f-bc39-dcd5ddbd7d6e"
      unitRef="usd">12600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id04350ab7f4942d6aab89335886fa0e8_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV84OC9mcmFnOjMyZTI1NTFmYTFlZjRmMzE4MjczMGU2YmFhN2Y5YzY2L3RhYmxlOmNmNmQyNzU1N2ZhZjRkMWVhNjVmNjMyMjcwMmZiZjc0L3RhYmxlcmFuZ2U6Y2Y2ZDI3NTU3ZmFmNGQxZWE2NWY2MzIyNzAyZmJmNzRfNS0yMC0xLTEtMTA3OTU3_74867357-eafa-4303-83c5-59005b8b0420"
      unitRef="usd">-104100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTM5_1ddcd0e0-ae8b-41ec-b280-1cbc57a835b7">Share RepurchaseOn September 22, 2022, the Board of Directors authorized a stock repurchase program, with a five-year term, to repurchase up to $1.0&#160;billion of the Company&#x2019;s outstanding common stock, effective as of the close of trading September 23, 2022. This repurchase program replaced the previous $1.0&#160;billion authorization. During the three and six months ended April&#160;1, 2023, the Company repurchased 0.6&#160;million and 2.2&#160;million shares of its common stock for total consideration of $50.0&#160;million and $150.0&#160;million, respectively. As of April&#160;1, 2023, $850.0&#160;million remained available under this authorization.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i4f431b6d0dae4178a459f78b51529416_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfMTYw_1e1af375-1494-484f-87dc-9f0e51726704"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2c5c4ff0e55242cd99cce7ae6bc9417b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfMzEz_5ddec1e2-2257-42dd-a2c4-95411f0976d5"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id93ac80af1864da895ea77544df73563_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDA0_fd4acd50-8a24-412b-8b0d-8883b5034737"
      unitRef="shares">600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i564316675084451483c816bd42aec061_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTQ5NzU1ODE0OTE4_b6721d91-69ae-4831-9bfc-1f5e1e760178"
      unitRef="shares">2200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDYx_a63e53df-7b7d-4169-8aa5-7d47cc7bbc60"
      unitRef="usd">50000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic065f866815c4aabaab37b2623211e1e_D20220925-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNTQ5NzU1ODE1MjY1_5846a343-e1f0-4a73-8a25-b4ee278575ef"
      unitRef="usd">150000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4f431b6d0dae4178a459f78b51529416_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkNzgxMTNhNDRmMTRjZmRhZGZkMzJmNzVkNmNlOGM5L3NlYzpjZDc4MTEzYTQ0ZjE0Y2ZkYWRmZDMyZjc1ZDZjZThjOV85MS9mcmFnOmY2MjZkYjNjZjRjMDQ0OWRhZGZhZTMxY2Q2YzY3YTNmL3RleHRyZWdpb246ZjYyNmRiM2NmNGMwNDQ5ZGFkZmFlMzFjZDZjNjdhM2ZfNDkw_5b335709-8b04-4356-88b0-b1e4a2721748"
      unitRef="usd">850000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MQAR(.RAQ!_O@CGP?M-,C,I&IYB'Y.TAJ$7%!AY[TF(T2#3N0\K2D/-V'\CJ
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M*YC:CCQ/@!#(^!M)*W$35H=67H?N97:N(J$60;P@'T%!+\'.10F/[>BX8/U
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M? (#H-ILEFY.M$SR_<:9U%I&^>%2<%\H\P#<GTNIMR?F!>66]?!_4$L#!!0
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M,\XH;FO$%8V"7GB';'M"E5K9?JB%E.10BVV.CN?6?#@(_?$<MD)@L1> $8W
M*'-<T+48+G;95 &EK*/+K"7TEP.O]:"N=H1_U:M".5%#6R]7*J)7]99<U=OZ
M6MZ&_=$I86H5>GKFECRM-_LFVS(]K17B8)9*:*>X($_"L3)K,8-J& .I@J"H
M%P%AAL+8E%BAG?RD=OWYI!?P9@@:SF5:?^%F0**,/;0!@#0"TP+2&[.&,-?Q
M@4+#8#2:FE!HIT>I79!^X)7.O:)AG69ZT9U+97+QQ%'JB.C40@O4'1P&.AS"
MF!.#J12#:>K^!/5.GE*[/NW/IF8>33=_'/.:9WJ1K])JES\7>KJ1DBM\J0_5
M9 CF501$*9A8,90'JR\B7]GD5-.I5VK59&93Q QTG=UD(RJ99TTIUA&Y(=LT
MK\DI+8XZ#MGO1ZF:[1(T&"%HVPU%4B($M<(9Q^*[/*TQF#<9C$Y!4KN$U(5/
MU5I#'FM3"3;[M-[AZQ<*]1V%:0!!-PX4&H@XA>D?62(W)-N)26I7DW#619E"
M0>=2H U6&$P+39#R$!;HJ8"-Z2*P.)Q*>=:I2&97D>TVW[86)1&'=J2CM!E4
M=BR$PAF!^;$WAB48S/7&T5DC,,KT>M>;X-WI26;7DQ\KQ;504+JTF0"@A*&X
M<RG0S@@*E/\$ <$UQQI!T:EU NND)+-*HXYI.Z91J@SF)0O'@W"%PN!Z$(/Y
M/IC%,)@73<D6UFDU9M=J"7\V9$T>'W.Y-R6:%'KU@!*'6LT9D_XF)/DV9,V@
M1KN97/VR3J(QNT3[Q2S\VC%,WK0]_/8=J3@J31G43*"RKE 0R%\(,K/2N$HC
ML&@>Q(._B1AT@HW9!5M;PI[Y5M3\-18J_8I7;X9HIQ!(K!4"\T,/:%4,II78
M>')&8)3JA?C46.\4&[,KML=:G/+FM9TF_VWN4# %4*LB*#H0UBUU# ;FMS4"
M8QZ=+."=2F-VE?8O;JW=(=RL'BCDEBJ$>3[<3<5@R(H$@<6^-[49P#H-QB+K
M9D!'E>@96HO2LM0=WKR/0W<%F%72_=E=@:MZ2Z[J;7TM;\..Z?0BL^O%AU3F
M&_(FK\A19DW?-)WR%NV4LZMHJ!- [D&45M&@^&*H !0=B-(J-<)'H]LI1M>N
M&).\.)K7Q=]'NW4VHCW6R@@*+!X2%!2,506"TJPG=++;Z4676G/PM^;,@::=
MGK1(WG%2'<MGS5RODML7X^*HI%XE9UIVX"],K8+T3[\QO::WY*K>UM?R-NRJ
M3O"Z=L';9>6Y9_!QR>!FMA>&[EC]83B?^N,-O03WY[-Q4J+^F.].*$&W]Z[^
M&ZJWEY8VWE"J,B\.X['^P7"^&_@@*5%_?3XM;\R?%P5C';#H'68I>;UK3A%)
M/><=*W4^N7"Y>SFI]+XYGS.Z_T!O5Q2YG]#;]?D<4N?^?"SJ4UKO\DJ2@F_U
MH[0XUXVMSR>-SA=*')JC-,]"*5$V7_<\S7AM /KWK1#J]<(\X'+>:_E_4$L#
M!!0    ( ($^HE;@*ZCBC0,  .X+   8    >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&ULK59=;]LV%/TKA%8,+=#H^\/.; &)Y6T%EBUHT.UAV ,CT996B71)
MVF[WZW=)*9HL,5JQQ0^61)US+N_A%7E79\8_BI(0B3XW-15KJY3R<.TX(B])
M@X7-#H3"FQWC#9;PR/>..'"""TUJ:L=WW=AI<$6M=*7'[GFZ8D=95Y3<<R2.
M38/YEUM2L_/:\JRG@??5OI1JP$E7![PG#T1^.-QS>')ZE:)J"!45HXB3W=JZ
M\:ZW"X77@%\K<A:#>Z0R>63LHWIX5ZPM5TV(U"272@'#Y40VI*Z5$$SC4Z=I
M]2$5<7C_I/Z]SAUR><2";%C]6U7(<FTM+%20'3[6\CT[_TBZ?"*EE[-:Z']T
M;K&):Z'\*"1K.C+,H*EH>\6?.Q\&!- Q$_R.X(\)X3.$H",$7QLA[ CAUT:(
M.H).W6ESU\9E6.)TQ=D9<84&-76CW==L\*NBJDX>)(>W%?!DNF%4L+HJL"0%
M>I!P@2*0 K$=VK &2J]4-7$BZ"<F!+I"'QXR]/K5&_0*513=574-JRU6CH2I
M*$$G[\+>MF']9\(&Z(Y160JTI04I#/QLGA_/\!VPH/?!?_+AUI\5O#EP&[G>
M6^2[?F"8SV:>?H>![L>:[IO2^7_1M_\Y^H4905\4@=8+GM'KZV!:!N]HSAJ"
M?K]Y%)+#5_Z':>U;]="LKG:^:W' .5E;("P(/Q$K_?8;+W:_,QG_DF+92XIM
M7TCL8HG"?HG".?7T9SA"*KT6I@5HN;'FJI/BE/K>PHY6SFGH[!051I&=7*(R
M \J-[.4E:CM%+:-P@+I(,NJ3C&:3W)28[HE06PV<B+#G4]@2.2<T_X*@^JBH
M<7O:%'_"3JD*UF1&&R,93,V+[&#DQ11T%81CQS*#E+^TO9$7!JW$'T2\\"+N
MO8AGO?@!SGSTNH9=^ V<SSG;T^HOV+)AD,F2<)1??*9M:73XMX@2HS/Q=**Q
M'8Z<F8*\Y1B4&926=N .?V.7IA0_><ZDI#<IF37IEW^SPN1",IG(8ES>FRGF
M"HIHE%(V17G@U6*4>(N*AEIA9,Y[T>>]F/]0#!F;4EU,]P4P?;SB4U08NG8\
M2G:*BOS)[K&=HI;N<K(O.(,&IB%\KSM' 0MYI+(]MOK1OCF]T3W9:/S6N]YX
MAO$,FMFV]_Q'ONV$X>S<5U2@FNP@E&LGL#"\[2[;!\D.NGUZ9!*:,7U;0D-.
MN + ^QUC\NE!!>A;_/1O4$L#!!0    ( ($^HE9JDW@/G0(  -,'   8
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&ULK95M;],P$,>_BA40VB36/*YC)8W4
M)\0D)E4K@Q>(%VYR;:S%<;#==GQ[SDX:NBVK)EA?-'ZX_^]\EXLOW@EYIW(
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M##^40)H ?+X00C]WS%G<?GK%?P%02P,$%     @ @3ZB5A'OY.>-$@  &>8
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M[CV#ZFOW=65M:A+IVD- :45/TP:9[#H="P(94T!I$D73!:'<248Z5K>_M9W
M:M-*P=[T@7%[HSR_#L9/.=1)A-(XE":@-(FBZ6VO[$1&^XE_;Y;5=M\-;*ME
M-R_VI>JU<)C::C^V6D6!M,7F4%H!I7$H3?0T??3*QZ_$$A54%X5R"AEM%;ZO
M'AZW=\OR\/'C[C E='AOF/@D2H.==8&D%5 :A]($E":9Q68-P]AN=#%E+#+:
M69P8)^+3Q@FDTUA :1Q*$U":1-'TME<N)R.=+Z)+L&H!ZF-":064QJ$T :7)
MGC;TX6<L28]T \JE9+1->60BJ:CNZ"D&&NLL"M.G#/(TR\9>)30JA]($E"8M
M=R2*\RP[TM[*B6035N1F,9I-FFYJJ"/9TZCYI+Z(9CKEB6$*F'9DFJ?7(\D(
M"VR6&:]HF3F?%+ X.3:?Q)3QQVCG[]R)6AKK?---&\\Z50N-RJ$T :5)RQTA
MIFL#9=,%M$UWWH0M#75. _(G'[' --ZL<[:6<K9)6TLQVZQM7^SD:=M V6 !
MN^#$;0 UR*"T DKC4)J TB2*IDMJD.;W+49:8!II>1R-/_O/Z1C.;8_-R<,F
MY6&S\E[#2 N4D1;01MJ14?O7<MOVX\F^'P^LJH Z:3U-'[6SP#<Z<ZA'!J4)
M*$U:[DC4?DI@1X8/Y9$%M$=FOA5/-S74'.MIY)!M^D!QGH]G1OI2VOQ)$(=C
MYT98RLV8'YE#=F1Y,PZ/OQD'RH *XDL.V="<-RBM@-(XE":@-(FBZ9)2OE9
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M0&D21=/;7IFE,9TP>61"XF^/FY<U5U:7FL8Z]PAF.F209\-M]7I90 U/*$U
M:=)R1X@)B7AP@ GM9)H3$M--C3V_Y(0#3$PK-/%9:NQ#;2G'HHR-NU=A*3=C
M43JV5F5L.<:$FI*(E?L77_(@DQAJ"4)I!93&H30!I4D439>4\@YCVCN\P)1$
M;,E>S//4V%6'KJFS@J#IBU":@-(DBJ8K2)F.\9G'H$Q-2=!<Y_['-! #8T2
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M'Z&$;]DQU5_ETW]X;=#4Z(ME6I3_HZ=:-ABA^%AHF=6+ 4$F\NJ5/=<;T5D
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M.I0R"%D4>'TD)HL-SDQ0]6F"/+7=IY5<*SV0V\ O+,A=B2YC% _I)"]<JZX
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MR;$ S@N+FZ!=L(/^!]+R'U!+ P04    " "!/J)6O]T)1]0#  "L#   &0
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M[^RH,/ASG87HJ?9_/:6Q@SA_&H+/PW5H5([+A!H^H-]BLGK]:G8Y?7N$X/E
M\/P8^I',?X_?'8;@/*RYJ77<PRGT@G<5>H1WSKA2YZ #Q JAL[Y%'^F8@@H!
M8SB!QFLZB-KLH="JM"Y$G0?0EA+6TKEC$T58AH$+B*[O1_0!6JJZAYQ:@'/;
M*D.67MD2Q8]BJ@AQW^A<&8+7-C=M@: LT#3Q*FI;=K"T5  MR72Q.8++C"X5
M']@ M$C,0N."R@P2&YHZI>"SER-A0H'FB>Q/X+>*JO0\*Q83VNQO&@BL)J*G
M R6Q*!5NJX-$W54ZK\06M\JT*I)V2EJ!G3U3YY1V]'E->/9J\MRU5N0UK2?B
MS.JVYR/& ;8T^R#;#\D4,;7ZFB77=/)'%%%"'H0!Q1L9X6-$@AA;3."3M,&H
MEJ)(9-)Y[>OWKV*,LG4"@=A!X[PDB$)R -K1AY:@<FS1MBCD,V1AF@LA@D9Y
MIL> 7UIR!>OL:>>;N[IQEM=^Q$DY&6K[$P0EM7S@KU/JH3Y:)T#33P<E12LC
MU09J+Y=W)72;@5"&<8=H1W5B2D\$#WQ ,FEO0@B1S$Z5H2V@WPTC9?0Z9SIW
MWRCV* /!<F\036EX"V<_, D.>DL!E-V_?G4UG[UY&Z1+G=&%--,!A-N&^'/[
M:U<$&" G1Z;+Q3!=+O[C=/D>OY?I\C)=7J;+_VBZI*,;)'5-*?=D1J9^ZRZ3
MP^IP%5]W-]"OYMT]_H/R)74&,=^0ZW3RA@:.[^[&W4MTC=Q',Q>I1>6QHK\3
MZ-F ]C?.Q<,+!QC^H*S^ 5!+ P04    " "!/J)6],VBLN(&  !X$P  &0
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M95XXV5E)["-WED+E)0:\KW0M4<:&P"XHL1#KG:O#:A,IRPA 0/54-E#(:EV
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MOR#'&_!]:6WH7CA _Q_+_%]02P,$%     @ @3ZB5CNGULG<"   [Q<  !D
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MF*B;>9O&YS(PN#QXY $FU(DHJV9*VH 8O#J8\@L2!*V'G$_#_M=HG:>6*>M
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M2PMP?X*L35_H@.8W4K?_!U!+ P04    " "!/J)62,&.V1 #   '!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6R55=N.VS80_96!"A0MH*PD2O(M
MM@$[2=$ 3;+(MLU#D0>N-+:(I4B%I->;O\^0LK5>U#:0%XI#SIPYAT..YGMM
M'FR#Z."IE<HNHL:Y;I8DMFJPY?9&=ZAH9Z--RQV99IO8SB"O0U K$Y:FHZ3E
M0D7+>5B[-<NYWCDI%-X:L+NVY>;[&J7>+Z(L.BY\%MO&^85D.>_X%N_0_=/=
M&K*2 :46+2HKM *#FT6TRF;KPOL'AW\%[NW)'+R2>ZT?O/&^7D2I)X02*^<1
M.'T>\0U*Z8&(QK<#9C2D](&G\R/Z'T$[:;GG%M]H^474KEE$DPAJW/"==)_U
M_D\\Z"D]7J6E#2/L>]\\C:#:6:?;0S Q:(7JO_SI< XG 9-+ >P0P +O/E%@
M^98[OIP;O0?CO0G-3X+4$$WDA/)%N7.&=@7%N>5'JOM[5>D6X;>_M+6_PRT:
MN&NXP7GB*(%W2ZH#V+H'8Q? 1O!!*]=8>*=JK%_&)T1L8,>.[-;L*N"J,S>0
M9C&PE.57\/)!;1[P\@MX[[A10FWMLTCX;W5OG:'+\?6<WAZN. _G'\S,=KS"
M140OPJ)YQ&CYZR_9*'U]A6PQD"VNH?]L::Z"G:=ZDN'Y0%;TUBJM*B$%#P]'
M;_R]%Q5P54,MY,YA#3;X\E;OE+,@+' +&RWIC=L9_-T8Q!=W >[$T\L%*JV0
M0*7]P$W5 !O%YY;6(?$^O"T*XH]HJ%4 46Z)62!A@7J-=42.*@NL&,?C/ 56
M9G$Y+H)=,OJ6+"[S,7RY!.5T]0#X;2<>N42O:6-T2ZJH6Y$W/J&IA$5_&+VK
M[OSAV' H@KRXJL(N$7)&5.&,@N-."4)C<3K*_3@I_)CY><[&\/9PGC\E<1J/
MIP10YO&HG 3;2V-E$4]&Q2#QU1&**R=>A<)1 SPB&I3<YW-Z!I].T/^O[H*B
M\911K3(VI9%E&4RG4SAWZY.3YM2BV886;$D?W9R^3PVK0Y=?]<WMV;W_1="]
MV IB)7%#H>G-N(S ]&VW-YSN0JN[UXX:9Y@V]*="XQUH?Z.U.QH^P?#O6_X
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MB'DF]Y3&6ZXZE:(Z*$%S8/_EW%:U6->W/VZF1]$).;BRA.ZAG,=R%^[W8!;
MHWF0S@?5 :\XA4G"0$ABNYR#LLA3(I&DM&DGMZL%FV&!RN>5L;)-&MN6E4F
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MF8LSW;E&*O'.,-NU+3=W5Z+1^_-),KE?N)'UUM'"[.)LQVNQ%N[GW3N#K]F
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MZ;JCP&&+'"G^C&I)@F%!B>Z_8@R]NY/<+Z9489_15QJ^B&#D!VI@P$"Y!D3
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MWCR"][C'>_R8])^&X^G<XAVG?&Y=(4U.R*I0B<7UI7AU/!N+/<*Q()E70IE
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M./+3.#_0OVYRZ8",3BZY!O767^6&<MU)V]UW1^GQM;#H+LD7\^ZI06N$JF]
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MIQ\N$J!^%O<+;]LX_S;6\S2-GPW_OI"" ^_7UOIA$1(<?XC+'U!+ P04
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M6T"&I;H&!<.N;$J&F>P1CGI_T5*UR>V>$[]_39Y26&^R#L2BJVHQ-;$ (9#
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M+$Z \:4Q?FB@@]W_W^P?4$L#!!0    ( ($^HE9()< %#P0  #4*   9
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;)56;6_;-A#^*P=U*&H@D&3Y)9EK
M&TC2!2O0 %F2=A^&?:"EL\65(E62BI-_OR,E*[3K>-@7FR]WSST/>7?B?*OT
M=U,B6GBNA#2+J+2VGB6)R4NLF(E5C9)VUDI7S-)4;Q)3:V2%=ZI$DJ7I-*D8
ME]%R[M?N]'*N&BNXQ#L-IJDJIE^N4*CM(AI&NX5[OBFM6TB6\YIM\ 'MU_I.
MTRSI40I>H31<2="X7D27P]G5V-E[@V\<MR88@U.R4NJ[FWPN%E'J"*' W#H$
M1G]/>(U".""B\:/#C/J0SC$<[]!OO';2LF(&KY7XDQ>V7$07$12X9HVP]VK[
M.W9Z)@XO5\+X7]BVMM,L@KPQ5E6=,S&HN&S_V7-W#H'#1?J&0]8Y9)YW&\BS
M_,0L6\ZUVH)VUH3F!EZJ]R9R7+I+>;":=CGYV>4-XQJ^,=$@W"(SC48Z<6O@
MPR-;"32#>6(IBK--\@[QJD7,WD"<PJV2MC3PFRRPV/=/B%U/,=M1O,I. E[6
M.H9T> 99FHU.X(UZR2./-_IOR9^XR85RJ@W\=;DR5E.6_'U,<PLY/@[I*F=F
M:I;C(J+2,*B?,%J^?S><IA]/$![WA,>GT$/"E\8@W0Z3!7SA;,4%MYRX=U=7
M .7Y/>:-UEQNX(H9;HZ).1GNN)@@L @"5[O ;D-CKG3A)A;6CO.3Y^QJS^UU
MK%:.%>2*ZMI81WD-MD18*T$-PAF0-UTY%]!=^0R" Z#->ZR5MLZ2,A[AJVFU
M"B9SVC<.<,\?_FB4"W2G>4Z4N80'OI%\S7,F[=ZX%3F#S](B*;>@70"S9;6!
M7R [CS/Z>__N(AMF'W]>H"ZQ9;H@)9IZ@00G&&7^XK3ZQ#*0Q9/>/!S?'+JH
MVO>L5\\T'O76X?A162:(Q"B-TSUR!PM!MLS@FF#IT*C0VWLHD(2Z>.06C_=@
M D#:^?E@B,PX(#;^/Z>1!B<0CG>:QJ0S9)#&OW8\CN:^2\'[( 6#K/$I>% 8
M<%TR.@.?$#X!@XQ=!_D:K%=AAVQ\WID@?1JI5JY<7.<DU+IQ??0+/J& T> ,
MMB7/2S!*H'C9S__\K?L(2NT,BL;S<5QMJ1&]8,.?H7+]%FK47!4&T+7=@PIP
MEK=,4_ALZI<RV-)%NFIIZXZ2XM%C^M[=MFXJC>>]7GX >@!X<K,O3PLKW' I
MG1)2WI)VM=0FWOG09^UN-HF';R=KV&Y8_J/AAOOU7<*\]7_S>J&L^(<^L=T7
M;YC%XT%OU4T_C./A .[82V=T'D\'?B\;[$\"A70#>]I:,9.+^&)_<NS3D 2?
M\@KUQC]87+MLI&V_ZOUJ_R:Z;)\"K^;M@XJN@$[:@, UN:;Q^20"W3Y2VHE5
MM7\8K)2E9X8?EO2N0^T,:'^MJ&]V$Q>@?RDN_P502P,$%     @ @3ZB5@3$
M)\Q  P  R08  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULE55M;]LV
M$/XK!W4H$J#0JV.[J6W =K<VP+H92;I]*/J!DDX648I42<I.]NMWI&S%&UP#
M_6+SR+OGGN?(.\WV2G\S-:*%IT9(,P]J:]O;*#)%C0TSH6I1TDFE=,,LF7H;
MF58C*WU0(Z(TCL=1P[@,%C._M]&+F>JLX!(W&DS7-$P_KU"H_3Q(@N/&/=_6
MUFU$BUG+MOB ]G.[T61% TK)&Y2&*PD:JWFP3&Y7(^?O'?[BN#<G:W!*<J6^
M.>.NG >Q(X0""^L0&/WM<(U".""B\?V &0PI7>#I^HC^F]=.6G)F<*W$W[RT
M]3R8!E!BQ3IA[]7^(Q[TW#B\0@GC?V'?^TY& 12=L:HY!!.#ALO^GST=ZG 2
M,(U_$) > E+/NT_D6;YGEBUF6NU!.V]"<PLOU4<3.2[=I3Q83:><XNQBU1G:
M,0;6JLFY9*Y4!JX>62[07,\B2SF<9U0<\%8]7OH#O#%\4M+6!GZ5)9;_C8^(
MVT P/1)<I1<!EZT.(4[>0!JGV06\;!"<>;SLIP1_6>;&:GHB7\])[A%'YQ%=
MV]R:EA4X#Z@O#.H=!HO7KY)Q_.X"W]' =W0)??% ;5AV D%5<(^%VDK^#Y9P
M5Z*TO.*T7!J#UL"R^-YQ33:3)?S.6<X%MQR-.^^:_]]%+^QBZO/"'FL$JRP3
MT':ZJ*DAH-6\0-@S TP(53!+)*R"E1(EZM>OIFDR>6? ,KGE]*H\/WZ@[YX9
M</ERUFMQ+N)$@NN[$JB)+65'8WGCDU2,:]@QT9$+9:<*_:%VV.2H(7WK7PR]
M&SH@3*#Y96O(W10*8<U,#;] $KZELA6JDY138X%\YPDE809W<D<4E7Z&C*P_
M*;$^LLO"^"6L9<_LJ(H5A>Z(%S[1S#1$ZBH+T^OAKLZ+O87WN"-:K:L:%K54
M0FV?89*%8UC[ 4"9-8K^I=:\A30))_"H68D@64-IDG!$(!5J=_U<%A1"Y7Y"
M\P8D2;]**. :/BA5[KD0,)Z&4]@<;V_C;X^*,8[#!,Z]V.ADO!"9K1^B!GP!
M^DDS[ YS>MF/IQ?W?LA_8GK+J=\$5A0:AY.; '0_.'O#JM8/JUQ94NZ7-7UK
M4#L'.J^4LD?#)1B^7HM_ 5!+ P04    " "!/J)6KB1 ]6L"  !4!0  &0
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M-AB0?F.HY+T0 @P/:?D/4$L#!!0    ( ($^HE:T_KT_'P0  +8*   9
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M[;_"M+XBW\+K'PV:[Q4G.@*7E$J;C$RKZ\N[;EA5^0MSH2Q=O[Y:T/\.:A=
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M-9E2#U-OZ/YUZ 6K6C^15\I2X?QV2P\J:J= YVNE[$%P#H8G>OX?4$L#!!0
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M\2T5I@M\O"I+%_!\9HS?+$C!]CD\^A=02P,$%     @ @3ZB5O-"F^CW P
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M1CI.\XIIS3<\=P%HB/J$]/)%%D?Q*^@-+)/,'T%$'J+G]9%U&T4C/[/Y_C(
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MYME]7FT#VM\_E&7S]F+;P4M9?=T-Y_I_4$L#!!0    ( ($^HE9AN1:G'00
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MGR C>?6)OM6.:!'@-8)3$YP^P;M"<&N"^Z,[>#7!^]$=_)I0FFY5MI>.BY!
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M*S;*HV#R*9$\L7C 1YP=,/@%G$>K)_#'4X[!^P@+1!+^03[[\AB!]^\^@'>
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MHQB/K:S+OKJCQ=;6-4]"8Y5DFQNLE$$: YQ?":&?.\9!6WLG_P)02P,$%
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M/"3,1\("$*SB7.O@7 M? UA(+R-A-A+F(&$N$N8A83X2%H!@%2\/#UX>ZFN
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MYD-I 8I6M>\Q[3/T<=_-0EV1*?$9C>2FUJ[(K&@.I=E0F@.EN5":!Z7Y4%J
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M^'ZM^GY'IMMB(?-]*F4:%YL;1I7I\P[J]56:RJ>=?(##?PR8_@=02P,$%
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MI-CRTP'9Z4:RNCDR6C.IUM[F,@>UU'!=03W?,B9?;O0I5'=,.?\'4$L#!!0
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M:>[NZ3F/PV1'=(-1$K::5?<JU;U_RCT]_N-9[^UG_3+L["C=-^KL*XUJ!;-
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MM:+@UU'PM06FO=G6E M9 Y8;.2F/")T5P#<9%)-@@4FPT!!8*RB7=5 N>U0
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M2'Y(<2;!%Z4AH402+/2*<*=7A*>+*T*9,>I4'IZO"%:? 6S12A'=UMMF_=_
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MO\$ #T(-#TS#^;[L\?_.WA!C6,V;H>8;?G/>H&LJ)-^!>4CQ!KT#;T(G[YF
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M'U%3B>/VSN_=EECTY;!S2M!=+Y=!YWU2='E.)UU7[B,JI'!K!ZLYX6M]HBW
M86&\Q5E9U5J=FE_JL^)6^Y5_L? -[9$Z9=<'N4?ZXHC^!G/P9H$RLH)4WF "
M)>/%J7=Q(]E6'^O>,RE9KB\W!">$JP!XOF),/MRH!-5_#_/_ %!+ P04
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M@+J^8$P^'^B/IO5'\MG_4$L#!!0    ( ($^HE:0T[XA.P,  *<,   9
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MQI/Q9+SEXD6N !1Y+?)23IR54M6=Z\K%"@HJ>[R"$E<R+@JJ<"B6KJP$T-2
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M"ML_\[C"3P 0V@#7,\[5?J W:#\JHO\ 4$L#!!0    ( ($^HE8]8$F^G@(
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M=,O-0NZ_09//P/)EDFOW)?O:=WCED6RKC2P;,"HHF:C_]*6IPP&@U_\ $#6
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M',7)-]'PX7X-OG[^!CZ#. ,W<9((/%N,N(BRU!J%=417543VD8C&X(9D?,>
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M@3ZB5E"4T-?N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ @3ZB5IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "!/J)6N](C
MVL<%  "^'@  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ @3ZB5II\O%RV!P  ^R4  !@
M ("!"@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( ($^
MHE;@*ZCBC0,  .X+   8              " @?85  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " "!/J)6:I-X#YT"  #3!P  &
M        @(&Y&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ @3ZB5LXDJ2F$!@  /!L  !@              ("!C!P  'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ($^HE9GT%XTZ@(  (8)   8
M              " @48C  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " "!/J)6$>_DYXT2   9Y@  &               @(%F)@  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ @3ZB5G!/3 TM"
M_2(  !@              ("!*3D  'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( ($^HE:/4N[@?P4  "P-   8              " @8Q!
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "!/J)6O]T)
M1]0#  "L#   &0              @(%!1P  >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( ($^HE;TS:*RX@8  '@3   9
M  " @4Q+  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
M@3ZB5C%KC1D)"@  I1H  !D              ("!95(  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " "!/J)61+RH!%H%  #6#   &0
M            @(&E7   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( ($^HE9\,+3[6@4  +T,   9              " @39B  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ @3ZB5CNGULG<"
M[Q<  !D              ("!QV<  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " "!/J)6%?+F?JL)  !$'@  &0              @(':
M<   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ($^HE:Z
MS8;2=PP  "\E   9              " @;QZ  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ @3ZB5DC!CMD0 P  !P<  !D
M     ("!:H<  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ($^HE;FO,9-S0,  &L(   9              "
M@3"E  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ @3ZB
M5HLJC%Q? @  :@4  !D              ("!-*D  'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " "!/J)6$]_M!FD#  !/"0  &0
M        @('*JP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( ($^HE9FL[V8' ,  !P'   9              " @6JO  !X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ @3ZB5C!,JL!O$0  S#$
M !D              ("!O;(  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " "!/J)6_RXBE\@%   +#@  &0              @(%CQ
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( ($^HE9()< %
M#P0  #4*   9              " @6+*  !X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ @3ZB5@3$)\Q  P  R08  !D
M ("!J,X  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " "!
M/J)6KB1 ]6L"  !4!0  &0              @($?T@  >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ($^HE:T_KT_'P0  +8*   9
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M970S-BYX;6Q02P$"% ,4    " "!/J)6]-M!9:4$   :"P  &0
M    @($0Z0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M ($^HE;S0IOH]P,  !4)   9              " @>SM  !X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ @3ZB5GO/P91I @  9P4  !D
M             ("!&O(  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " "!/J)6,7\XO'<#  ! "0  &0              @(&Z]   >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ($^HE8[Q^SV* P
M +F    9              " @6CX  !X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ @3ZB5F&Y%J<=!   "A@  !D              ("!
MQP0! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "!/J)6
M6JDH(6D$   =&0  &0              @($;"0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( ($^HE9X4MP(Z0(  $H)   9
M      " @;L- 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ @3ZB5J]>&+]& P  FA(  !D              ("!VQ ! 'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "!/J)6I%^OJ"H"  "U!
M&0              @(%8% $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( ($^HE:ZC5O9J 8   @U   9              " @;D6 0!X
M;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ @3ZB5E[=Q8Q3
M P  APL  !D              ("!F!T! 'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6Q02P$"% ,4    " "!/J)6H$9F=@<$  "C%0  &0
M@($B(0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( ($^
MHE:6>O8#<08  #U    9              " @6 E 0!X;"]W;W)K<VAE971S
M+W-H965T-3 N>&UL4$L! A0#%     @ @3ZB5E6>>N@"!   LA0  !D
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M=#4U+GAM;%!+ 0(4 Q0    ( ($^HE8FRBL2&P,   4*   9
M  " @0=# 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @
M@3ZB5OH.1\[5 P  .A0  !D              ("!648! 'AL+W=O<FMS:&5E
M=',O<VAE970U-RYX;6Q02P$"% ,4    " "!/J)6:?;G1!H$    &0  &0
M            @(%E2@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4
M Q0    ( ($^HE:D/67O>@0  (<8   9              " @;9. 0!X;"]W
M;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ @3ZB5LB0 SS,!
M,!\  !D              ("!9U,! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6Q02P$"% ,4    " "!/J)6D-.^(3L#  "G#   &0              @(%J
M6 $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( ($^HE;#
MM60BU0(  !,)   9              " @=Q; 0!X;"]W;W)K<VAE971S+W-H
M965T-C(N>&UL4$L! A0#%     @ @3ZB5H84M1C= P  T X  !D
M     ("!Z%X! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ($^HE8AK0[^6@4  +\=   9              "
M@<5T 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ @3ZB
M5E$(B/U: P  O0\  !D              ("!5GH! 'AL+W=O<FMS:&5E=',O
M<VAE970V.2YX;6Q02P$"% ,4    " "!/J)6[SJ>WR<(  "[/0  &0
M        @('G?0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0
M   ( ($^HE;75S_$_P,  $T8   9              " @46& 0!X;"]W;W)K
M<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ @3ZB5I#(0WJ" @  L0<
M !D              ("!>XH! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q0
M2P$"% ,4    " "!/J)6GUG&E1$%   U'0  &0              @($TC0$
M>&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( ($^HE;$]AA$
M@P(  $@&   9              " @7R2 0!X;"]W;W)K<VAE971S+W-H965T
M-S0N>&UL4$L! A0#%     @ @3ZB5BR\28'P @  _@<  !D
M ("!-I4! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " "!
M/J)6RNVFW'P%  "V(@  &0              @(%=F $ >&PO=V]R:W-H965T
M<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( ($^HE8&7F^J. ,  /$,   9
M          " @1"> 0!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#
M%     @ @3ZB5KWC%"9$ P  K!0   T              ( !?Z$! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "!/J)6EXJ[',     3 @  "P
M    @ 'NI $ 7W)E;',O+G)E;'-02P$"% ,4    " "!/J)6,EXPI=0%  #=
M,@  #P              @ '7I0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ @3ZB5GKM3FU6 @  CBT  !H              ( !V*L! 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ @3ZB5E6HN6<2 @  <RP
M !,              ( !9JX! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ %4 50!*%P  J; !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>443</ContextCount>
  <ElementCount>295</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>93</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Share Repurchase</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchase</Role>
      <ShortName>Share Repurchase</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Revenue from Contract with Customer (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies</Role>
      <ShortName>Revenue from Contract with Customer (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Derivatives</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails</Role>
      <ShortName>Fair Value Measurements - Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringDetails</Role>
      <ShortName>Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Restructuring</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails</Role>
      <ShortName>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails</Role>
      <ShortName>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Commitments and Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesDetail</Role>
      <ShortName>Commitments and Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Share Repurchase Share repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails</Role>
      <ShortName>Share Repurchase Share repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. holx-20230401.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 29 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. holx-20230401.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  holx-20230401.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="holx-20230401.htm">holx-20230401.htm</File>
    <File>holx-20230401.xsd</File>
    <File>holx-20230401_cal.xml</File>
    <File>holx-20230401_def.xml</File>
    <File>holx-20230401_lab.xml</File>
    <File>holx-20230401_pre.xml</File>
    <File>holx_q2-2023ex311.htm</File>
    <File>holx_q2-2023ex312.htm</File>
    <File>holx_q2-2023ex321.htm</File>
    <File>holx_q2-2023ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1116">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20230401.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1116,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 443,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20230401_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20230401_def.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20230401.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20230401_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20230401_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20230401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 510,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 34,
   "keyStandard": 261,
   "memberCustom": 44,
   "memberStandard": 43,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20230401",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.hologic.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Business Combinations",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses",
     "shortName": "Trade Receivables and Allowance for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Restructuring",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.hologic.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Borrowings and Credit Arrangements",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Derivatives",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.hologic.com/role/Derivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Net Income (Loss) Per Share",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.hologic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Other Balance Sheet Information",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformation",
     "shortName": "Other Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Business Segments and Geographic Information",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.hologic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Intangible Assets and Goodwill",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Product Warranties",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.hologic.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Accumulated Other Comprehensive Loss",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Share Repurchase",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.hologic.com/role/ShareRepurchase",
     "shortName": "Share Repurchase",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Revenue from Contract with Customer (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies",
     "shortName": "Revenue from Contract with Customer (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Business Combinations (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Derivatives (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.hologic.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.hologic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Other Balance Sheet Information (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationTables",
     "shortName": "Other Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Business Segments and Geographic Information (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Product Warranties (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.hologic.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "1",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "1",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue - Business Revenue (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ie287b34c173446e4b3ae5678053afeb1_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Revenue - Geographical Revenue (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ibf88f343c6864289a9a9f06679e1a3c8_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Revenue - Revenue by Type (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i24dcaeab411b4af8a6f85a2871d1bbc9_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i04aefe98ed524fa9b9e204dc0508b87f_I20230401",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Revenue - Remaining Performance Obligation (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
     "shortName": "Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i04aefe98ed524fa9b9e204dc0508b87f_I20230401",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Leases - Additional Lease Information (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails",
     "shortName": "Fair Value Measurements - Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i2eb35d6e301b41d0b02c28ea9d23ac79_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i1c8339ad8e024acf93252e724b2036bd_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i1c8339ad8e024acf93252e724b2036bd_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Business Combination - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "id50c2cc367d14c69bf24fbf9db98aefb_D20211129-20211129",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i9c89a75c14ea452587934b85e1cfe79f_I20211129",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Restructuring (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.hologic.com/role/RestructuringDetails",
     "shortName": "Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i24a5378b5efe4b46aadd68616949b0e6_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i2b2a1019aa334a0fbbb95328240c2789_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i4d7c9aaa6a5f49db88edb7f5d795dfac_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i4b4c567216914b23a257e8ed2e840c5c_I20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "if26561fc220c41d4965d21fca20289a2_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Derivatives - Additional Information (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
     "shortName": "Derivatives - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "id7733cefdaf04d268e9460397af1c814_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:NotationalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
     "shortName": "Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ie9e9cf22ce03491e8e69aa97d1533ec0_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i388bb22d67bc405a988ad5c4cc5a8547_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
     "shortName": "Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i419d4edca16d4132b372c619b71876ba_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Commitments and Contingencies (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
     "shortName": "Commitments and Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i419d4edca16d4132b372c619b71876ba_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "iecf3f6abc67d4877941f93e271d67d0d_D20220925-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Other Balance Sheet Information - Inventories (Detail)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail",
     "shortName": "Other Balance Sheet Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail",
     "shortName": "Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i0c50822a02cc41e8ae2d8167253aad8b_D20220925-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ia5e31f17a8d64c899b2a4d460af241d4_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ia5e31f17a8d64c899b2a4d460af241d4_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.hologic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i8aa6a9b0f7204e52bbb68b547acb3605_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Product Warranties - Product Warranty Activity (Detail)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail",
     "shortName": "Product Warranties - Product Warranty Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i5e15af082687422bbd21dc55ec8a2595_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Accumulated Other Comprehensive Income (Detail)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
     "shortName": "Accumulated Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Share Repurchase Share repurchase (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails",
     "shortName": "Share Repurchase Share repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "i05712ecb21ed4aa891aed64db77823bb_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.hologic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20230401.htm",
      "contextRef": "ic065f866815c4aabaab37b2623211e1e_D20220925-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 93,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2021CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Credit Agreement",
        "label": "2021 Credit Agreement [Member]",
        "terseLabel": "2021 Credit Agreement"
       }
      }
     },
     "localname": "A2021CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Revolver",
        "label": "2021 Revolver [Member]",
        "terseLabel": "2021 Revolver"
       }
      }
     },
     "localname": "A2021RevolverMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan",
        "label": "2021 Term Loan [Member]",
        "terseLabel": "2021 Term Loan"
       }
      }
     },
     "localname": "A2021TermLoanMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028And2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 and 2029 Senior Notes",
        "label": "2028 and 2029 Senior Notes [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "A2028And2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccumulatedOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Abstract]",
        "label": "Accumulated Other Comprehensive Income [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.hologic.com/20230401",
     "xbrltype": "stringItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Total acquired intangible assets"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Cost of Goods Sold",
        "label": "Amortization, Cost of Goods Sold",
        "terseLabel": "Amortization, Cost of Goods Sold"
       }
      }
     },
     "localname": "AmortizationCostofGoodsSold",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountAssessedInDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount assessed in damages.",
        "label": "Amount Assessed In Damages",
        "terseLabel": "Assessed damages"
       }
      }
     },
     "localname": "AmountAssessedInDamages",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AnnualIncrementalRevenueGrowthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Incremental Revenue Growth Period",
        "label": "Annual Incremental Revenue Growth Period",
        "terseLabel": "Annual incremental revenue growth period"
       }
      }
     },
     "localname": "AnnualIncrementalRevenueGrowthPeriod",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_AssetSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Securitization",
        "label": "Asset Securitization [Member]",
        "terseLabel": "Asset Securitization"
       }
      }
     },
     "localname": "AssetSecuritizationMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BasisofPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation [Abstract]",
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationAbstract",
     "nsuri": "http://www.hologic.com/20230401",
     "xbrltype": "stringItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "terseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BolderSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bolder Surgical",
        "label": "Bolder Surgical [Member]",
        "terseLabel": "Bolder Surgical"
       }
      }
     },
     "localname": "BolderSurgicalMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessCombinationContingentConsiderationPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Payments",
        "label": "Business Combination, Contingent Consideration, Payments",
        "terseLabel": "Contingent consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationPayments",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationship"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Intangible assets, fair value (percentage)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software embedded in products"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Disposables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Costofservice": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of service",
        "label": "Cost of service",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "Costofservice",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DanburyClosureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Danbury closure",
        "label": "Danbury closure [Member]",
        "terseLabel": "Danbury closure"
       }
      }
     },
     "localname": "DanburyClosureMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_December112020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2020",
        "label": "December 11, 2020 [Member]",
        "terseLabel": "December 11, 2020"
       }
      }
     },
     "localname": "December112020Member",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DetailsOfCertainBalanceSheetAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of certain balance sheet accounts.",
        "label": "Details Of Certain Balance Sheet Accounts [Text Block]",
        "terseLabel": "Other Balance Sheet Information"
       }
      }
     },
     "localname": "DetailsOfCertainBalanceSheetAccountsTextBlock",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment under customer usage agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GermanyPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Germany Plan",
        "label": "Germany Plan [Member]",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "GermanyPlanMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_GrantsReceivedFromDepartmentOfDefense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received from Department of defense",
        "label": "Grants received from Department of defense",
        "terseLabel": "Grants received from Department of defense"
       }
      }
     },
     "localname": "GrantsReceivedFromDepartmentOfDefense",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "GYN Surgical"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterestRateSwap2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2023",
        "label": "Interest Rate Swap, 2023 [Member]",
        "terseLabel": "Interest Rate Swap, 2023"
       }
      }
     },
     "localname": "InterestRateSwap2023Member",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterestRateSwap2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2024",
        "label": "Interest Rate Swap, 2024 [Member]",
        "terseLabel": "Interest Rate Swap, 2024"
       }
      }
     },
     "localname": "InterestRateSwap2024Member",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total (percentage)"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Awards [Member]",
        "label": "Market Based Awards [Member]",
        "terseLabel": "Market Based Awards"
       }
      }
     },
     "localname": "MarketBasedAwardsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MinervaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minerva [Member]",
        "label": "Minerva [Member]",
        "terseLabel": "Minerva"
       }
      }
     },
     "localname": "MinervaMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Netincome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income attributable to Hologic",
        "label": "Net income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "Netincome",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotationalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notational Amount",
        "label": "Notational Amount",
        "terseLabel": "Notational Amount"
       }
      }
     },
     "localname": "NotationalAmount",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentOfDeferredAcquisitionConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of deferred acquisition consideration",
        "label": "Payment of deferred acquisition consideration",
        "terseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentOfDeferredAcquisitionConsideration",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsUnderFinanceLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments under finance lease obligations",
        "label": "Payments under finance lease obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "PaymentsUnderFinanceLeaseObligations",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrepaidIncomeTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Income Taxes-Current",
        "label": "Prepaid Income Taxes-Current",
        "terseLabel": "Prepaid Income Taxes-Current"
       }
      }
     },
     "localname": "PrepaidIncomeTaxesCurrent",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "verboseLabel": "Borrowed principal"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from government grants for capacity expansion",
        "label": "Proceeds received from government grants for capacity expansion",
        "terseLabel": "Proceeds received from government grants for capacity expansion"
       }
      }
     },
     "localname": "ProceedsReceivedFromGovernmentGrantsForCapacityExpansion",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Revenue",
        "label": "Product Revenue",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RSUPSUMSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSU, PSU, MSU [Member]",
        "label": "RSU, PSU, MSU [Member]",
        "terseLabel": "RSU, PSU, MSU"
       }
      }
     },
     "localname": "RSUPSUMSUMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Repaymentsofacquiredlongtermdebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of acquired long term debt",
        "label": "Repayments of acquired long term debt",
        "negatedTerseLabel": "Repayments of acquired long term debt"
       }
      }
     },
     "localname": "Repaymentsofacquiredlongtermdebt",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Schedule Of Interest Expense Under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SecuredTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Term Loan",
        "label": "Secured Term Loan [Member]",
        "terseLabel": "Secured Term Loan"
       }
      }
     },
     "localname": "SecuredTermLoanMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_September222022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 22, 2022",
        "label": "September 22, 2022 [Member]",
        "terseLabel": "September 22, 2022"
       }
      }
     },
     "localname": "September222022Member",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ServiceRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "ServiceRevenue",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that must lapse in order for the restricted stock units to vest.",
        "label": "Shared Based Compensation Arrangement Restricted Stock Vesting Period",
        "verboseLabel": "Performance stock units vesting period"
       }
      }
     },
     "localname": "SharedBasedCompensationArrangementRestrictedStockVestingPeriod",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharerepurchaseplanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for share repurchase plan [Table]",
        "label": "share repurchase plan [Line Items]",
        "terseLabel": "share repurchase plan [Line Items]"
       }
      }
     },
     "localname": "SharerepurchaseplanLineItems",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharerepurchaseplanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "share repurchase plan [Table]",
        "label": "share repurchase plan [Table]",
        "terseLabel": "share repurchase plan [Table]"
       }
      }
     },
     "localname": "SharerepurchaseplanTable",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20230401",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r233",
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r233",
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r294",
      "r585",
      "r660",
      "r676",
      "r716",
      "r717",
      "r723",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r294",
      "r585",
      "r660",
      "r676",
      "r716",
      "r717",
      "r723",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r295",
      "r296",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r661",
      "r677",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r629",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r661",
      "r677",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r15",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r28",
      "r32",
      "r126",
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r78",
      "r195"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less \u2013 accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r210",
      "r217",
      "r218",
      "r496",
      "r646",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r201",
      "r597",
      "r609",
      "r613"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r216",
      "r217",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r29",
      "r32",
      "r126",
      "r554",
      "r604",
      "r605",
      "r687",
      "r688",
      "r689",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r27",
      "r32",
      "r126",
      "r217",
      "r218",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r7",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r699",
      "r700",
      "r701",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r54",
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r303",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r462",
      "r463",
      "r464",
      "r474",
      "r475",
      "r476",
      "r477",
      "r489",
      "r490",
      "r491",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r538",
      "r539",
      "r542",
      "r543",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r587",
      "r588",
      "r589",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r104",
      "r105",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r202",
      "r302",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs, Payments and Foreign Exchange"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r54",
      "r68",
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r164",
      "r176",
      "r199",
      "r230",
      "r278",
      "r284",
      "r290",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r494",
      "r497",
      "r521",
      "r675",
      "r719",
      "r720",
      "r737"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r192",
      "r205",
      "r230",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r494",
      "r497",
      "r521",
      "r675",
      "r719",
      "r720",
      "r737"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r134",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r487",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r487",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r116",
      "r117",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r493",
      "r694"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration - fair value adjustments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r493",
      "r694"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r115",
      "r118",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r110",
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r50",
      "r56",
      "r57"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r157"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Interest rate swap at fair value",
        "verboseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all liability derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Liabilities at Fair Value",
        "terseLabel": "Cash Flow Hedge Derivative Instrument Liabilities at Fair Value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r80",
      "r356",
      "r357",
      "r630",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r699",
      "r700",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r6",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013 750,000 shares authorized; 299,676 and 298,533 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r33",
      "r213",
      "r215",
      "r222",
      "r593",
      "r599"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r44",
      "r221",
      "r592",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r40",
      "r585"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r228",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r390",
      "r397",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r165",
      "r166",
      "r175",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r541",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r159",
      "r161",
      "r374",
      "r541",
      "r656",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r388",
      "r520",
      "r656",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r20",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r541",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r94",
      "r95",
      "r96",
      "r97",
      "r158",
      "r159",
      "r161",
      "r174",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r541",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r160",
      "r721"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r54",
      "r107",
      "r473",
      "r480",
      "r481",
      "r698"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r466",
      "r467"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r54",
      "r76"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r26",
      "r136",
      "r162",
      "r206",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Foreign currency option contracts"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of realized gain (loss) recognized in income"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r135",
      "r137",
      "r142",
      "r143",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r132",
      "r135",
      "r142",
      "r143",
      "r146",
      "r147",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r141",
      "r731"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r139",
      "r142",
      "r144",
      "r145",
      "r147",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r148",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Derivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivative instruments designated as a cash flow hedge"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r419",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r431",
      "r458",
      "r459",
      "r461",
      "r465",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r223",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r250",
      "r252",
      "r257",
      "r258",
      "r259",
      "r263",
      "r514",
      "r515",
      "r594",
      "r600",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r223",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r252",
      "r257",
      "r258",
      "r259",
      "r263",
      "r514",
      "r515",
      "r594",
      "r600",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r93",
      "r187",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r265",
      "r311",
      "r416",
      "r462",
      "r463",
      "r464",
      "r476",
      "r477",
      "r513",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537",
      "r554",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.",
        "label": "Equity Method Investments [Member]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r149",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r388",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r518",
      "r558",
      "r559",
      "r560",
      "r656",
      "r657",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r388",
      "r421",
      "r426",
      "r518",
      "r558",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r388",
      "r421",
      "r426",
      "r518",
      "r559",
      "r656",
      "r657",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r388",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r518",
      "r560",
      "r656",
      "r657",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r388",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r558",
      "r559",
      "r560",
      "r656",
      "r657",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r134",
      "r139",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r315",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r399",
      "r414",
      "r503",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r653",
      "r707",
      "r708",
      "r709",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r197",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r586",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r73",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r69",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r645",
      "r667",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency option contracts",
        "verboseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r54",
      "r90",
      "r91"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "terseLabel": "Debt extinguishment loss"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r196",
      "r327",
      "r591",
      "r654",
      "r675",
      "r711",
      "r712"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r39",
      "r230",
      "r278",
      "r283",
      "r289",
      "r292",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r521",
      "r652",
      "r719"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r132",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r35",
      "r163",
      "r170",
      "r183",
      "r278",
      "r283",
      "r289",
      "r292",
      "r595",
      "r652"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r342",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r231",
      "r470",
      "r471",
      "r472",
      "r478",
      "r482",
      "r484",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r232",
      "r247",
      "r248",
      "r276",
      "r468",
      "r479",
      "r483",
      "r601"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r648"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r259",
      "r430"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r67",
      "r71"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r160",
      "r173",
      "r219",
      "r272",
      "r540"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r65",
      "r642"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r203",
      "r640",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r65",
      "r644"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r65",
      "r643"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r42",
      "r271"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r167",
      "r179",
      "r675",
      "r697",
      "r710",
      "r734"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r193",
      "r230",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r495",
      "r497",
      "r498",
      "r521",
      "r675",
      "r719",
      "r737",
      "r738"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r16",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Trade Receivables and Allowance for Credit Losses"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r4",
      "r166",
      "r177",
      "r387",
      "r401",
      "r656",
      "r657"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r81",
      "r82",
      "r358",
      "r359",
      "r360",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Petitions filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r690",
      "r691",
      "r695",
      "r740",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on Sale of Investments",
        "terseLabel": "Loss on Sale of Investments"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r52",
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r36",
      "r55",
      "r171",
      "r182",
      "r191",
      "r211",
      "r214",
      "r218",
      "r230",
      "r237",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r256",
      "r278",
      "r283",
      "r289",
      "r292",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r515",
      "r521",
      "r652",
      "r719"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r278",
      "r283",
      "r289",
      "r292",
      "r652"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r207",
      "r208"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Gain (loss) recognized in other comprehensive income (loss), net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r207",
      "r208",
      "r499",
      "r500",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of (loss) gain recognized in other comprehensive income, net of taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r93",
      "r212",
      "r215",
      "r221",
      "r531",
      "r536",
      "r537",
      "r592",
      "r598",
      "r687",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income activity"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r212",
      "r215"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r134",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r692",
      "r693"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Payments for (Proceeds from) Other Investing Activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromProductiveAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.",
        "label": "Payments for (Proceeds from) Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsForProceedsFromProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of business, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to Acquire Equity Method Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r225",
      "r725",
      "r726",
      "r727"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r5",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r5",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r204",
      "r325",
      "r326",
      "r641"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid Expense, Current"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r226",
      "r647"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Financing Activities",
        "terseLabel": "Proceeds from Derivative Instrument, Financing Activities"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r46",
      "r103"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Proceeds from Legal Settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from other long-term debt.",
        "label": "Proceeds from (Repayments of) Other Long-Term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r85",
      "r86",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at End\u00a0of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r77",
      "r194"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r79",
      "r180",
      "r596",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r224",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other.",
        "label": "Repayments of Other Debt",
        "terseLabel": "Repayments of Other Debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r106",
      "r184",
      "r739"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r344",
      "r346",
      "r349",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r345",
      "r348",
      "r351",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r54",
      "r350",
      "r351",
      "r713"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Costs [Abstract]"
       }
      }
     },
     "localname": "RestructuringCostsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r98",
      "r178",
      "r608",
      "r613",
      "r675"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r187",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r311",
      "r462",
      "r463",
      "r464",
      "r476",
      "r477",
      "r513",
      "r604",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenuefromContractwithCustomerPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r220",
      "r230",
      "r269",
      "r270",
      "r282",
      "r287",
      "r288",
      "r294",
      "r295",
      "r298",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r521",
      "r595",
      "r719"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r32",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Changes in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Assets at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r135",
      "r142",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r69",
      "r72",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r69",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r12",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r38",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r427",
      "r429",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Utilized to Value Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r348",
      "r353",
      "r654",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r278",
      "r281",
      "r286",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r169",
      "r181"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based compensation, stock options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of options outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise prices (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r190",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r343",
      "r348",
      "r353",
      "r654",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r93",
      "r187",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r265",
      "r311",
      "r416",
      "r462",
      "r463",
      "r464",
      "r476",
      "r477",
      "r513",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537",
      "r554",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r265",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r93",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock Repurchased During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r63",
      "r675",
      "r697",
      "r710",
      "r734"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r122",
      "r127",
      "r187",
      "r188",
      "r217",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r311",
      "r416",
      "r462",
      "r463",
      "r464",
      "r476",
      "r477",
      "r513",
      "r531",
      "r532",
      "r537",
      "r554",
      "r605",
      "r606",
      "r697",
      "r710",
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r229",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Share Repurchase"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchase"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r399",
      "r414",
      "r503",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r707",
      "r708",
      "r709",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r23",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r23",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r23",
      "r99",
      "r100"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 53,566 and 51,401 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r93",
      "r98",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r303",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r462",
      "r463",
      "r464",
      "r474",
      "r475",
      "r476",
      "r477",
      "r489",
      "r490",
      "r491",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r538",
      "r539",
      "r542",
      "r543",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r587",
      "r588",
      "r589",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Amount of unrealized gain (loss) recognized in income"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r251",
      "r259"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r250",
      "r259"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r681": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r682": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r683": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0000859737-23-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-23-000011-xbrl.zip
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M4"%5*E!&&1;-Y'R"G<%G"U( &X*L*'OLU5'G"!6!M";@DK5V/Z+/G8'L6E,
MF[)WJ=3:G'(>T_/%Q"%$D4[DI?D:Y?K F>H.1*P%?1/HA)#B2"3R6/!DD6-S
M-<<+<9PO9\*N8=?RG,73NR(X?_P\V)M[K_^$"*9$A5-U1N9@/KQPU.0).V U
M7Y[<[@$Z60K@^L$=-3EKQ%&?QT&)GKS/E+R/#NRM-@6X\[AO0S=Y'"NDQYAH
M+.P%JLFG'%C([^"@V(84P/4#K5XA,R67P<++0&CQ_PAADFI/Z6)_T4X!?9T+
M.R:!-**WL"?9* 6"8-K9!4$6SUE*C$+75TYESL+D2NJ\U+%7N95 +0:09/A$
M$.[!25&?8]X9:";*ZFP(INA<R"$$]#Y!S;Z&S Y=X&:A3L&V,S!==U9G0_@D
M31U]YZ8Y00F>(3@"$25R/2?<&7RV(*NS(<BX599:72*/T&LRI+AF*BDUD-!V
M![)KS>IL")S@(L8@/?H\2MI&;MP]>!?L1=+:WB[[&GR(5UZ+;L[2X5T)^+'U
M:$>[MH.XB7JT9V6)S7T94!DB$_H"&D-+CFSH:=P]0"?+:5P_N$Z2PQ#(9/UH
M.8&D9C]]+B%%HH8\ ;BSN&_2JB>JSC<'$+URU5);:AP=<>@[:.6V(J=Q_4!W
MRIC8I:2M 189-5-"%=:0I.28=@_H:\YI7#^D34+-M8;J($'V-F"YLU**+?+H
MR7 N'W< R>O+:;P%S9_94.Y;M7%5-;D./4C-N=J80R())6;=&6BFR6EL"B89
MZ[*E@L HP*4%64";9W+1)<#=&4'7G-/8%#[%HB[O'/1( BX .W;8M++OI<<8
M=@:?Z7,:FX*LF:6+%!VW+%!<)8\QH_H@:'^JVQG(KC.GL2EP@G),+6MTGL$D
M_Y@%":A46[ 15J[1WDUU!P C%XO[64L'Z:TV#IG!=2^]</83M%"9LWAZ2P1?
M5V^7MUUXC^K)5R>U@>-<*84H,4GH$:%-T1-G5R37]. &4V8><B*Q,9I#)1$(
M66LNZ+.ONH/@3IZ=F 1H5 N*),<$OH!'8I=8'$CMYJ8Z[B#0UYF=F ;2(2/Z
M,,=% <&SQ50Y9 NVQE:J\&83X'DC>5W9B<WU%G(>I18QCYG<J)]<D<N(K<1K
M:5AV!YHILA.;@ZGG3#%1C-DC0!9.(6#-,;1:4[PH?+<+,%UK=F)S^#2VP9(P
M6A3A@$$I9<RAF[6SX)<!=P:?J;,3FX.,I!6+%YI%NQ;TA4;>L;HBJ4ORJ>_.
MD+J^[,3FP$&GR90".8O,(1I&P"EB9FS-2>MS$($GJ_67/ZR6[536]U8/=/5B
M(7H.S.A-_.7-E^OEX?+)RQ_LIAS3ASW11UWO%2.^U>63%3U_NA Z/+^H+$^/
MUZN77_[XX-^_Q&^(]_7IB1GKDY,'YW?EY(W?=VM!3XZ7)^N%7($-GU[2MM#$
MU"LK10\)D<$'JCT4<BVXFF="T-\AS!F*W]E/7AW3N7#:!$.O<T3LZ?JZ<'(V
M*^IB3J,)MQ8@9@P^D197*TN:"5WW[)DF]U8ZUXR +A< "Q$Q]Y!=3Y)2D19F
M4-UT[XVOB:"3U&H5S*(M2!I-:"T28V.J= W%.:V0YE!G>>^-/QVZ!I<2!G01
M:P/.:*XX!J;*T5Z3RTY^6T_7/7NF,7:I<G 6!DLS55<K2<#:6Z'N:U:J\]=R
M=Y:'*J>'M/IX)/<.>:L48_+FC8/X@C6!<JL4:PHEIM)*E@(SX>@V.>2K&!1[
MQK[16 =:9\J462";.XZ8LO,0Q!RSXAQ6 ^T)-"6!H'?M,0 (%M!1[=AAIU%@
M/:31_&7^HF[OEN<N'8//R. B.550R-2+U!QS3V;\+!29"4?W;OF38:R$YJKY
M9@UM=/PKHR!ORQX%1O&6R[[H6\_8/8$F,WGB4&KJT4N$*( A9F4418D^Y3)_
M7??UX7+9'LA*=:R8V3OD.8E& O9:>*2JS2&7S!JYY]I#2U%=D)FP<YL<\F:'
MPYZKKZL^]5CRZ#C>DX=$";O+#:$71LU>YK"]8D^=B<P<58RC%CSD##@ZH<?B
M$VJAX8(;S5_%[9WP?"6B=';LI6M1!FZ>QE;56"&SM&#_SX2=>R?\"7"58T7.
M7="U ID"(VGJXG(5&CT;9L+5/76NGSHI&U',$6OK"DZ0BE&H2_<0?%.<2R3\
M2?K%:51;3EI+\$Y3@5"0(8%H0I HU+#-GS";]XM[^KR>$',Q0E/N8^LVC0V\
M)1IW1M^\5KN;0[RX1_/U1M%:M9C,Z%5@M/Y@!D>%NL;LH>0=6&*YN]YC&KFA
M7-A!PLA@8;_G-/;+%.WJ0X4PEYF;O?>8:-Z&2Q@M'5O.!#74RDS-NZXR>G D
MG0%]]FB^KMZ&GDI/(8R2HP*M)J^EU%I2\>)3WS$M\/78<KO^N]+A^ND,<H$?
MBLC/?LUW1_3DPP'Y++5- %+)$#OXT>2GLQ.BLQ8_D>*HGKIGY]:XR$^=J^1C
M+EF$QUK#/*IB-BKF_%KIT!WN6E2U::Y^RM3QO<7@<LXI-P!/F(/SDH8>MU=T
M#B'<EIJY'7/"DTC$[&M+)00&(<"6*?71#<>4OR\1^JX)_KT3GC%71]5I2B0I
M,X(6(B;RU6QJJ1SJ+&;A]DYXHL4&K&;7$BD;7P"E9K 77 NBQJFRCX2WV0F?
M&=$7X\X-*WK^VQXL#T_'\YW,^HN%%.B3< OFE!G&XM2 H4OO%'V:PQ3@EK+U
MVIWR)\?=7K*>=7@STD)*2-1*:+UZS=$SSZ&&W)8ZZ4^.2H0])Y9*&2(4KPRY
MUIJP)3()Z/:QR=YI;Y'$S$FEMAQ:X0!&6HK-!:>U-XB]Z3XZV3OMK>6N;W'L
MFX]4@CEM]56T9HV]1OL_Z!Q*(^V=]G90"3BTQIV=%X&HF9KI/D'Q.4J'6=2\
MW%(S^!%.>Y8RKZN*:@7@FF$L3X@%P>="W:F [N>!K\]QSI(_Y"6BCQ4E!NB^
M4@@H(0=)T+2Z\.GR9Y9P:C8U8NXB90$ #68&(%%&!$[27-]KD2UV()-(CHBE
M@4M9C2) XM&U0%0T1M.OH>X9,Q\',HUD]4RC?!AH3$ M,&1PZJ$ZQ<IE#OND
MM]2!3 /G@#"ZBJEE@.XH.4)I4HMKN>_<[,FW+X\?G*Z>C$$[?_\QS0JMT$=7
M2]>B+] :54Z8.QLU.F&O<RE"N;5[)CZ>H;.D#S8DY R"W>ACW.%:O6HQ.=(M
M%IE#U=T]FJ^S$8@JP:<03!#DTA =^)990<P>]#D4%/UDO<<T.^[0^RH]J$<%
M&]S42G,)4D_)A1;+# BS]QX3[KB+WA1'P)(H L1"*6#@7))FTR1M#ALV]VB^
MEI*8QV9[T% \J"!!Q)RU@/T;M,RALN ?0?/!3WJH:SK<E?35-!4;U'LN+B"X
M4?VJ$&)HF"&C),EI#OIQJQW('R+I+!DT:E.EEF7L[QUSKMR+^)28P;MJ_\V
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MIYH6C$/Q)@J08T%QCF(3CX9-S',82U> SMY)OH<J9F\Q1R5H#@"Q$'3U)44
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M@)RB);R&#J66&KF-I2#56=2.40!S:L[3#,K>;AV0D]2]'<T:A3Q+,4!I)&7
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M7-[6 SR)QP4L8U]JC24E ,DU]*C0G9(%/?E"0.V0QYUV!$\1OQ)0$N%$H0&
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MA<TBX_8>N!TV\Y'0._<^3L?JBYKN?2[V._ZWN[23#462QY5NU89DY"'2+=[
M7%0NURFVP0BYCUSWHQ!'OLEPUV(8/KLHXD.CF)8^H1^9/%FWF^%R?)R&0W3W
M1;/5:^I6\:[3M%WGB]KA@Y$Q%&GG3^YOSZ,NZGNMRZ@M=WN#M2)T>VT]B"^(
M0Q,U]3@"W9;1K59W8+H72[D-O&J:U^]X?6</'UT=G-1/CT]KIWNP_OH=3->F
M/\<[;]%1^^_F\8>#5JUA1_>\C^]BG>-&%];B/?$=N-ZNQ:TAMK/Q-FT9\<_Q
MY_K.^V:\MW7\^MU%'<FO;QI;@]HAO'C3V/U:O_J,ZE\_!H$Y@@H"$1P"E @*
M%'8>4":4P9(S$5BB024H_V-\+_G&%R,4_&*!CRWKE@^3V.^>/;Z06Z[GM^^V
M#AJ[!V^.BH/=?_8/&L4_[PX.WVW5&T5COXA"?"-*Z@4BQ?Y!@=@+]UNQ_ZIH
M_+5;W)#OO\GV6]N-]#52A/XP1#_7KVZ0+'H44>YNV\.K;J\8G/CBO]=H+(:&
MGL)WG'>/(>3]4[YO=VAN^H$%7KKX&]".[SQ)MP&G+\&EUSW@.TM)!P^7"NNG
M6Q^-@]@%Z8'!(6)98P6DAPX@BI0@Q",CHE"X==9KMH9R"5HOTKC_6D1\,FWC
M;DNTV[MN\7R9XT&B[$U8WX;K+$Y5+T[=8;?Y)D%-3M=WJ]JUJ0RD)[RD24C[
M]JO>T.J\@=E4B6V%9;/2;::9O&9673BK7;V[K.,:KE_53XZN+*WOO&.UTU8S
M"FO-_<;[*+19=OQAE]2O:N/"V56]L4>.KF)/\:O3V#]8;WR^W/^P%X6U/58*
M>%>MUE'#DMITX2QR-M,2<\"T@R"=B  M10 A:O<<HZ )-"/AC-XNG V/.E9
M1&L<;-4/]TI![*EDM$79\:Z%LL$W&%Y+9:'7;1?SV0[O8C(9KA[G;:IG'IOU
M\CQ*B;UTU?5&^?@_GVXTUC8?:2JFKY)!]QET?=E6X;((U=O==KO93[X+Q:MF
ME$[COF)\[^4\%;[=TFDAO6WXLJ64&F:R[../PCHM'$1 ,Q] RI8&E. !<"<0
M]MY1#=7:)@(D"@#T09H;>9)%]G3G8H_27TSO!*JY@^? ?VKVDU0P2(7XGA^
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M24*YP!AH:2% F&O"+19,J[5-@O%">:]FR"ZZ,2U#MBK(3GJO1$[E2DN F?*
M&L]!W%PE4(P;[(V+W\*U32;E["?C&;*+"]G*K6 9LE5!=L+T1:"A!K,(5&9M
MA"R#P&@3!6/%@Z7$,J?UVB:GU9F\%\BVM1R*^%:[&QMS56893[8N;?][WNR5
MN6 'NO.IF7*VZG[?I]3A.7CD,8)';LY(XJ;ND)LR(=V3D/:G1))0R26D@8-
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M43H%PJ$ *)$!&,T\L- 9:1S3DK#$0;RJ@,S,09F#'HN#9C0A9PZ:#P=-))&
M!#KB260>*@#%& '-# +$&^P%BBH9A&N;9$,LDBY6D:UX.4Q9.\W6^<"[^_KA
MWLU"N(KT>O\!6#GRG;<A;+0F,_W>BW[?3JGMQ74<?X<!#*G4@&8,:.T\,-)I
M14/ 4+O2%%95 -S=4?'$T3:9WS*_/9F1+?/; _EM7+PT'G%IHU"))9%@5)]<
M02 $1@SYH+3'I9D-9G[+_);Y[9$,>)G?'L9O$R8\P;CCD%@@K(_\YAD$QB$.
MB*/<(Q$<PJ8TX<V<!2GS6^:WE>&W>1L',[\]D-\FY#?'A/9*Q)6#/*"!6J 9
MM !1YI4UQ.B4:9]LB*KR/<R?WYY#(OX/Y3^\*W1LE?[DB\YYV_A>T0U#;]-^
MT3T?] >Z4_;H0:ZGDW[!5;M+WC5K9V[EHK?R6=GKI[J>/M?<,4.VJ3B) 1G?
M_J_I;FO(=O62[/9#*0KT][\SW>C,\"ZI84F6&.X@,1Q-R<$8C-+.!J @#JFP
MO8P:47# 2Z()I<SPY%B%J5@7I"JCSP*I/1GH%0;X9Z O$- G<D C)!2F!ECJ
M'*!46: <Y2!(8S6W@L@4@X896F=BD9)+9:!7#_19@]\ST!<'Z!,VSCB3D;M=
M ,(Y&7=T%("AS@+H"'*&.RL"'N[H#&>@KS;09PT,ST!?(*!/Y/NA)&!K*+!0
M1J!S+8$T<5MW!EK*4?P.I^1E#*\SLD@)F9]59.LM[H!W8JD?+3C#;DPSXLQX
M-K/L)/=8]HG15$YP7::YZFC.3EHHG);6*1@U%6LIH(8R8!3A(*HIB$85QD:B
M2_*,6A>JXN(U54!N^8IE9:)Y8OM()II'(9J)&%,6+&5* 4>P A1R Y2)BE/\
MY'P0$)+DW(L96>>LJO"*3#29:)[./I.)YC&(9C*0E AO;## "LH!3?98PZ4#
M3A-!O-,"!S^4:"I0W#+19*)Y<OM0)II'(9J),Q]N&/<2 JZ\ S0H 21*A46T
MH@S';R5+Y40879>5!:TO -&4!J;?!SH^-_[MFE\V_Q-_7+?\QK.L3_5G'Q^I
M."'UT/M"6]MMQW=?QBX7G>[ ]S>^C?=XNT<W4[PA6'S!6;??3-/TLN=;>M#\
MXO_XVG2#DVL:N''C:"K@]UNTZ7<3(&^]95'&B/PX&C=_IM:6K&"=D @136E
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M0V"<-4 3%[<>9Y#E(6FLHNH$A4\OK%1H='K&,*_NE"K#O#J8CXLGPEN(''$
M!IW.E;$#DDL+-'9.><X08R3"7**J\^(OD'"RA/D(]CH#W?G43$EWAH:4APLD
MS^+(O#IWU^MQ'^I0D8-V+VSK/ W=ZV[7?6VV6EFAJHZQWDX*)L@%):Q!0%EH
M &5! RDC@2%ND" B&"SHVB9:CQ.Z4"?LV0UF006,C.E'Q_1$-G3CF&%. T(D
MC%*(B'H&,QQ8#:U"6@<<>(EI6<$Q]N)YS2RTJ'$-@>P@,V_A(I--]63S;E*
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MJ]OY!"))M>.N:B8<XV8V<"W<$-Q=%IO6Q941MZI2)=_$Y=.(JV<G+IX< _\
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MP VY0'!]#E:&\9B:;%QX:I%AY,2?]90'LL^4Y!Q(2ZB=8"#N#.E0%VF@<#
M6X.4$#C(Y*"'\.SLD\T*BPO4.47;9* ^'*B31;X(-EAA$ S$@"HEHYB *# 0
M<6IM\J_"44Q8J!PZS\&>,"SP]3VK:K8E/':]KYL*22:<AQ'.E/P<C 2N.76
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MIN6_\?1LPL["C>>_GW" 5F8SJ$H*O%%09*OC\M8PSZUA2O5 2"US6 I@B/.
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M?QA'IX EMAN_6(HL(4O($K*TE*-4EE4C<#(:?'A2AJGI*(6N;#%7)N8<)Z#
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M#$I1-'3?4-MF&HS$F*3W3!#E'1"I7"#6V4289L5T,Y.L#UN[QID=G*JBLFV
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M#2E[+AL$]05!*P=(-@4>M0\,K!<,#&CF3096CV5=CH@ZD9:OW!K4_!XQJ(^
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M'# 5A)?!9BVXW]H10K7L  TL^O$KE24":=U)"0LIH0_:F1((%@JZXD4#B][
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MD>2YKBR'C3FN.U6R!UZ2 JY,(9V.>&,2R LD)<%XH9KUJ2?R6C%4%^%$(JV
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MXEQ1H*)Q!J3S2/\6;HSU6:"*KEFI>@&GDPNL5 H=\A29B*DPX-XQ;XQAT9I
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MLA (]EAVP3!0H)@W/++@LK39@PC>;^WXC6)]K5S$ID! RVW9RD7<"^2\(!F
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M&5ZFTWP+.VKIS$P]2X/S*M5\-L2P&&^ Y\U=5.Z%+6TDOL]:.%^$)9_X+[<
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MJMB>N=_ON^.3=W/N]JOL;:? 1]^!PUS&%1<#CG6XY#+?ZV'$',]>7!Q^Z9S
M_3YV_GP!SWS]Y</[-N^<=GH?#O9$Y\]7E^TOKR[:I^_8<LSQ\.#WTS9]"6-_
MC0\/CC]WGJ>Q'],V_4^O_?PC/CQ]]:5]NG?9.?"QW<67RXT3HM"%B5PB;H-#
M7&B)="@<(I&;@C&2#O0\>4:W5W;J87?X:P#PX0%@(9D+WE!12,NCP3J5Y&:$
M:ZU=452G5@FA5#0 >.<!$"\#( E*!I>RYPG# (#4(*,9 "!F&!?$T$+Y)\\D
M:5J<-@#X2 %0!"),Q I407)*K?64>"=$< I049<)YA1KRAL O/, 2)<!T'%G
M3;0$,6("XI$S9 @K4%2"AZ"8T[9A@ T /F8 -"(P$HDTRA?<*:TM-=SS IM(
MP27F)0,$ &P8X-T'0+X,@)X6WF%#D2-<(:X*@U3T'DFA0PQ61Z(B,$"Q2^X%
M '[K*<MM]'6[#ZBWJ5%:RAF9YMT8]]])=]1=UT"MJ4-7PR,6DM#@+"7!<V.4
M!B(!0.FME(HR:X^>Y[Q#@@FZ90+B+7%R TS^,QFZ$S,*#_QLS8^"T,O5**(
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MF39/GA&Z9N?MUZ9"YUU%@0<4+;E*]QNBM U,6$U'*CR5BB@D"@L^$Q,$*6*
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M91#6.V18P(C[U(!'&XU22]#@M.;2\H:T-LC:(&M#6AMDO0)95XLLV<C!_6?
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M _#1EK1OEG0&JMJM!"KKTDI"VDHFW;SK"+,VSH'NQ4!4Z7:NL98IPA[&R2(
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M.>9%*%C -79^,S.^&]B9J?._<RVX9]>W%JFJQ:6Q\$4 ^U$UBK^#PN<[WKR
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M401>LI0&GX0O"\_33)#253 F<V?&T@(E Z3]/UWGI2*$&<XCX2YZXZ-G-$J
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MOC;\L<VN&+Q/YC+OP4!S\[*J[W0KMK]4/<W@6;'\:>2D'\,E+L;VE <_<FO
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MJ9W@RF9V4"P6<[/74<R] L2/O1%!^^$..SC\P#ZG0(R(#",AB(8P1GEDE?&
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M-IZO48>0&F,?ATI])7O?/Q.B%*'6((\Q0UR+@$P4"KGD4X(/X/_UU1A[UH7
MN'EF6T7>*LF]1B@^5JZ*4;KR(W-,78GM[!>F)39'.<U"V5MQ^4XR "\C?M%$
MXQ.E/F+& 4YTE 8\%A6(8"QZ?-W313G]E;-?)?EU(8L7#/<[A2QXIS_.%#^*
M_CGW+Y@G+[^#8%IL"(LAH9PM15QB4OF1GG-%K<72!7])W[+&J'/.95RRSSI!
M,NZ7,PS)V2]R)/WO%2%Z](,JBW5YPJ1WD5E(S6ZO?Y%).;;?1CT&+L^EC/,C
MQ?J-D@/P-5C&BX1+=1&_H /OY9QH6/)9H]LL>M9$QJ)*N,A?Q*>Q-\R-+ANA
MN@3"G2QA4CINJ;.&N\23$-PS;[ <8@ZC["Y-WK-#EL,=<7#X =[GZ.?>S[?D
MX.UG@BG(B<6(>&S!HY1@^8QA2"IBA?5*,1Z6*J6+0H/G0GA@5'$?M!%1"@TW
M@L@W>,_JE;VGE8V&"4:P0XFS@#@7$1EFP9S(I*E0##Y.&]L"SYN/2^W)!>Q4
M"+>ZK,32\>;-Q*R.-V\F3Q3D2>5>2DQRY+2+B">7?V(4Q9@PUS9Q[7P^W,+E
M?.PY9Z\>4')N9GIJR;F9Y#"0'&:QB SDA9I<ILN=1R X C%..=;!!HAS\V$!
MHY?+6BS8HZTS%7>:J:C=MC50*7ZP\UFSX(,T"@7/%>*"1>0@:D>&V&!8E& <
M8^VV/<:53;"B0>B$& X:<:8$LH)3)+@-D03E/?77=-NFN^C>6Y;J(BC,&:I;
MIZ<L53@%D0AEE&NMM"7@;H "))8B3'B=GGI(F?V0&R5A%1E CD+6!8JX!G%U
M3' $009G8"5"X>LD"ZBPID6T*B-IC2W8346&8,( SRSSV'$L%;RBQC@);9D(
M*=*5B<Q_AD-MQEINEI2;'_M?/CM-+<[931651]Q!=&JEHLA0E[PU1!@5,X7:
M9?Q(X[ 4G)JSRM]JG6\^VZSGDD6LKX8]R48-$*ICB?Y\W FA]$JJ4IN3C1+&
MUQV4JJ.+JY[X]%Z[X+5DD'M5 GG4^"T-)\^/)B^.)ME/3?+<=55IU\15):CI
M-[_DF&=43#NNDZU*P$K=ZT17QHMJI@E;?_F(2MO8K<;[W*_RXFY5J=-TJ\>)
M"H/9@*H$*%5MVKB&M^IL6R*T7,=;A3?-\1!RX^9A-U882+GKAZWW6XV0VV-U
M-[/[<@KQ#817^:.7@VZGRMQ_^/\:?^?#FM5O.R 879 1N,/HBV5\MFW#W!^/
M<YUQ;!P-;'N<HOC+PHN4O\:J%*<7YR=K8M7@?:;W##JCQKZY 6:[5T%6KW&:
MFV$.G2QPH^#UN_D^@VY5<3PN>BY6L!NKYK43Q<&YQ,SF+?IA3#PU@B^Q#=/<
M@KG)I69GI5-'@<%..S;.H^WFQJLMN/U,F-D,52/7W(9S5)<Y6[:6)V!:2B_M
M4;BHUB1[@<M8[Z 48SXF\!HP#U3J:+C$S"B;B-?D2H?ON-/Z\3M$'[:./Z[>
M:OPJLO^&N;#1$^2]"H@;A9$.7J.$A321*D%$WFK$>&N^KF3*$@\ELX*1R^*)
M*6EJ]B8+T$,3?NFW<E/=<3'W,-\QF0ZL0&)4BIYK7MN]^-MF[@S^U&W\%86U
M,*P\CUE'!^WNZ-<O8",JQ1TU2!Z"^.12C$I:O\=N50/;:;?.%]6K5D<9)A)4
M&25FH6-SA!WY<$4<MCMO_FB<=DHCG9@;Z2P"D'S=@N:FLRY>&:3M#5NM]GZ_
M6:_3J\]!/?=FIZ9N=KH>8[F;9J<+C_E=>6QOYI@?8X$EK:F)7O-@O,-&9+);
M24&H+$M7'?/;N+_&UXMB^-YK0,?<=.]-^SWX#"6Q?Y!>C4YU_1V[Q7-H^^=\
ML/4G1.LX4*V)T4CH"%Y"Y (9$#DD'1,Q<)UB4+,'5>^Y[RU R1:NX&39QK>,
M;($4K;Z/J-BBBM]%TU-V!TU/Z\'>Y6"O)UVW;2=KUJWWY#7;+!X6/W')1HM/
M=C9^V71R=1V'+VT$^"NB]S6<KE6U]7O"4[0T(?XSG*/G+$;FME)T3RTE3ILA
MM.*JW_YZ#9)WQK7/4[F5QK]R7N6W&2J%*C]UF\X35\O,VC:2K4=X5R-<6LU2
M^;_U4+-K4K>^NFS7;)R#O#9SYX*W?VK4O(M><;VI>9?A"K<F4<-P3,$YKJ0S
MWFC.A=&>)L(=+@D@A@DFES;*RYEJ^.GR6K51"NB@/5&_%M>&H?>F&9\A0^]?
MS?W=KS_W3M^=')U^8 <POH/#=\?[)Q_8T<_0W/OY 9[EQ=''O>]S#+VG;_#!
M(8SG]7[STZ'GY;FO7]+]PW"R3]_\W#^$]_K9.C[Z^6=AZ)VE"6=&4);[7M%
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MK"WR2G5X+BUAF<X=V0G"29ELD3G2RE*4C,%&:6YT4!O;ZE99B5IUU]<8K_P
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M,]$C-*D"OHHI,\,IQ/M#9,DN5^:Q+?M:ME?\4G )RK;LE]@NL7W9X ^GX R
M02\1S;@IYPBGYM O-?/:%A#<JL8X_^]\LYB9[DTS%:_/J^4+J5N^K,=8'J;E
MRV5%=PM;NEQ9T;G^Q7I%Z&>3W&HV5I\JTIMUZ%^<]\_]N&2O\7=5X=+;;/SG
M/R\N$I/YHAL5[NUW2MC4GJK@>P'S"!>TFW:FA&]AP<YHD.._@'MJ8<"QL;/[
MS\[^BY>[URP4FPW>2^'8V:APC&BY2?&H;B__-"X<&TTG6(#19NET15,>X^+4
MVB]G?6IWM224QZ\V'#P8E^_P>?YO;!]#[ $3OL@^3>X"M\"496\[-?,R@F3
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M;37 )>M& *3NLEZ7P,%:1E6*F'!JK;%@S;5E4<LD84R?W]R/LW4PZ/?ZH *
MU>!4N]BM#>ABP?GPXS,U!$<&,D,"A%Y<<(>L%1'A(&DB&L(S&3/AXWQ1W-B
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M0GO#(^$6_@/B9[B#AO-4R.#SDKOM]3]^[@7+!?;)("?S[E,L(K(NYFS0AK/
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MTYYPC+B4P-XIK/.A0 JLCSNDI8LR8IA]&A[-S:Z?=L$3QVRP)G4C1WOD#==
ME67O'+5\NY42RNYT]:N,B_>2ODOB5DM6^)5U_7R^PZ@6N3_A3\#O&=['64K%
M\VC?*Q.^_9]Y18* Y%FAD' 4)-!BB6P0.:-  *=#::5S%:9:(D99Z"<WV(+_
MT#VJQ:8F]R!"-=5?KJ7C\A8$L&/=_4[K9ZSE[WSFJO@C?XY5S^9]O*=5%^A,
M?6,O A_JY8UBL?=7ZSS2<^'19-\CS^[1^,7YIN->U^7MP-.Z4(>%3L!#JFHA
M'1YGGZ@.\9R9]\O"[GNM ;S.KE0;]8/!(P*[;"M_D.6L:G5&2C/Q]MDOS<&D
M\W;!;W^-1/+J#HVZ91=N&0R$#7EW\>S!&K]_/"+G$:^+UIVW#%I]9$-L+(@U
M9Y2V1!X6# 8.-]CVVE[PPKJ@%?(ZYT9-42.888Z,H9%Q[&B*M/$@%HB/)Y*G
M)*WE^5A\=,)S$Q.@$(=VE"#6<Q,E#A8E@#D)@G,DE0J($RN0%=0CDX#.1NW
MU/L;1.G(]K[' 1H!O<T3=+$G9/,^L:A'<^(VRUKIJV/QAY_(UGY9*WV]TT\W
M3Y[56NF804\P8."VL3>PF5EV\U)H_7:0C@"-Z8U63'MQO&8 J&;/EU./(UR1
MC_@=CTAFC8$GF3'70?Z0&W>?N.R<,E[BL@NH*[M\ZV0/9M429@*R.A $4XN1
MDX8B#;962&4ET6QIU:@5,X,CW/L8Q7QDLTC3(DJ3V%K;XUYXEW($([',-X-!
MECN*B#8:1TU%$FEI58D5SF9'^6N@JX;],X*XF<6F>F=[[2Z0Q9%#GDEI-\1V
M=JU3*P_X!5&<Q0S/<?"68;%[85T)BSV$4.V?@!/#!6;,.HE,G8/7484 +AQ*
MD01/,'QFCQ06@YD92666IJD8V=70V$JU-ICASBR/ U@GMG_7;28T>E"N(!2Q
MW%ME+2:",*5RU%#KM+?QU#&>K>YX"]?6F"87SWR64'_'P%&=\M:0*)$E00)'
ME0G9J"(*R@?B6/)6D*55LJ*N]\P!_NS^?B_N9Z$>GNV>RZ=VE^ME@.6+!8':
MA\X?NL-!?P!_ =RL5 TD57BVV1EN5,Y?\IJI(\;!@I%0*6+"J;7&&BZU95'+
M)+F7MU7-]T?'[>YIC%]&2#);4\^UK%;*_DYV$"[__J[;'VQU![L1&C>&LQ(D
MFZV*/]=^;J[M,2^ !$N++!5YS<]C^!0T_.,YV!?K@@/[0O1%,:K9 =>[2(P5
M2H'$.,6-RMM<'*"!)RHP;76TNDC,XDH,.$U)!@(39Q'!V"$.[ 3<)Q&1$D&#
MNMN@) 6:JU9FL-Q+^P*'G7/"$:Y9A\M.?MY&W1W'%LZ25F=YNW)*+]_>:]6+
M<>G7-N ?,X[=N5A=:DK-:&:<JQM'+. %OZ+/T2<&CIWS4@6NE3*<),,B56#H
M5,#A%F4S'TRJ1Q3[0[<W_BI?]])J^\TAW!NGVY_V#(>9,GGEB5*>]U"# #CN
M$1!M&4/(H*675ND*G:+9ET*G,R7C7IDXBF0LA&3\W-K?L\YH3:D%H7 *_C%Y
M2S3(".%@M'1DS+N:LYHIR:C=L@F__"IIS'=D86EUAO4</0P?'5- 3E>4 )IX
MW.W7$_WF+)CZ]J05!@=GF?LNW3A*=?8&7]QB7;_;'@ZNOV4JP]D3,5W*)D;Z
MTK^YN;4D^Z T(<QRG@CW*=B00-,3&#3IH_9F3[&ELYL.>F==. :K@%POVN_(
M)NCA&]L^L:?]I7]>&8BC5@=-#/SDF%T[,BDU,C)JQLB,1 @83;=72]R;(4A3
M+U\%;;(+TY;JH)?!\V^WF**EU9VS;2WO,NZ"B_ZO?]K56=-_/N;7*,Q#B^JL
M05A:_3MA__BE!;E7S89+H;GU.+"M=G\[O1LMK_QFVWDMYLM!C(,U[[M#&+(=
M>-MO;:!63PWRIV.0/WK_$P"9;>]LL&\?-^CFS\_M7?I>P+OQ]L==NDG_./GV
M\1/=/-P]F03YW7PL:MV+S<, AF+WY];'/P]W=[ZS[?5/_!O\_6WGM^_?UG=/
MMPY_2YN'[T]R8$)[13!GB B*$3>>(A.B09P8KR6#0<9\Y,P 5(.)S<:1F*"H
M\I;D+//4<DTEC48*DH(AC)NE*H+#<)Q!L3<$]:H#1]5X\*MZ]*N-SLC6@O1?
M6_.W%LP)0S&:I!M;<",T/W A>'\0P[ =MU,^YM@9='NG[X:]'GRJ5?8UR]S6
MVEZBFGHK*&)1I5'Q=9W7ZSUUT1GO=.1A4H;^56<:O;#//0#,G-6T;8_[\<W9
MA[>AU3]NV],WK4X--_5-;X]L;Q^,TMBH9X,TD=FT%I#1SV-;9<R*PBJ;JW'5
MI/&+QY9LI;9D$^E61[])N0)2<>W/>(5<^]NO'DOX"I"Q>SWVU[\)QAZFL;=[
M[ V5J6ZL5#=]Z8P,V..4LX^2)UK?9/IJ%E0'(RNR7)OCC"+75OI^^6/Q)1X/
MZIUD%>7G T+GJ_R^T/7+9@_#F:5HQ?XMA.':+H^A<= ]?I-3.X/7T@K56>OO
M($)WSE/_L(V\)4Y<SFA-S,+,^.Q<\9_M294WBO=:MCTUYS,Z]KRS^[^0)/X3
MD7UMK;3&X:0HYE%0YYS43G!EO6,2B]M&]L]Y(@C%YIE,;,7!=OH<\TIS7A]>
ME"C\_5CC*,_^T0;9_;G+-W]^Q[N'GP_S/=]V=L7F.K1CYSO=/6P?;.] 6W>^
M?9_,L[][^.?AUN'^3_B]M?5Q,S/-]M;A]Y--^B?<\ZVU_17>_?%#>^OH<]J<
M40'.1)I++0@$GG3.%H$3<M(Z\'R,=8Z1J SXU-2P&7'\7^;9?[AB(3?4!"G@
ML-C@(&(^68?!.]6*4\"&0$GP0D2O+15F! [9D^0%'!X7'*8*J!EIJ$^6HJ"$
M0[GL!G*))"2),<9K$;6H2PS1BW#WXX%#0_3W>;"BK]W>=P3N^G&OZV/_>B[\
MJQKEMRV-]*S1I7'JD4=^H_.?T;@7>+DWO)Q.<P\6$L][") CAB-NDD9&"/@D
M7'(>X,,DN[0JQ8Q-)\^^@%G1V ?C T5CF]+8*4) &/>,*(9,/E#$ Z;(U#E"
M%"<T))@C(4!CK\\(]F1%N5Y8E.1#J]/J'\10[7>[X39TX&5C2.-6_VQ\/^;A
M+1AR7PS9>C?#ZCN)9306!>Q-WEN%P?X'0)/H#0\NJI3 J6!4KTSG5%NPB,.K
MT[/&;771LZ;T;,I64V5EL#8@A8- W$4.MEIZ)*AAE%LJ/66@9P3/.%^Q\,[[
M7>L!C]=6QJO=#%H=NL.\=GZF7K=:?'G^(<7'&* 7@W:-LPH N )K=X&U+]/T
M@2NA60)8HRF&7++$()>P0!$K)6D2(E@)+HA6,ZH^WL\':4XU%KQH>@') I)/
M3PD+2-X9)*>X7_1@I(0QB"D/W"_:B$QP#@G%A.)12:QS9)6RNW*_!0;)J[77
M)W?/7FSJ?MA-KO_I=8^AE:?_:=O.8*U3'Q@_SB?%7_'VUA^;^WLQ$4*CTLB)
M*/*Y&8&<90E%RR/SF@;@5T^_O54+=M_MK=P\R(Y1<;_'WK2]]6'VXLKK?[['
M]M;%HA"S]R>>J?MR=9P5OC[^%\]4_F&VK][WTE>U7O[^NCF8>ZUMX;IZ9Q;[
M,GGHO,[Z..]@9YC@775VSG,9 C/^I9L&)W42KY? 3 _]R>;/;P>;ZVMX^^L?
M>'O]<^O;SAK?VMG@6U]_/]K]N0_/^YZ/SYY.,M.M?/K_Z/W)YOHG\6WG$]_Z
M^'M[<WV?;![ND]VC;X?;0 NV=_+QV=_3Y@SWG7!G55() :W*M<9I+E[O*$HN
M$/#@?03FM;3*<7/N^S-RP OX+%+?'M$)+N#S$. SY1:'9*PBV1DVW.3884 .
M&XV2M]0ZK$*]GY$9OE [CNY,W%+]?\^<N%7U\>_*#_O0F%S[J)_3K]C]7JP3
MM-UO"^2,D7EYB[2-,*'S>?@C3\.[\2S\D2=A[7P."B#=!9!FG+Z(F+D8I45)
M1HRX$!@92A)*BCMM,%,V9VD66,X/2+\ A8=B0Q.OO-<6R%>AL8W0AZ*Q#Z"Q
M4Q1"Z>0)X"JR1 .%H+DN%B$1)9R(]%($Y0+X+UK>=??2@VKLJXK]_#9LM4.=
M0;X3JM91KL,]!V5X%7NPF]KI<#;T??!:-BZ-_,=>MU^PYT[8,^.\A+ J&,PY
M2D(H8 O4(XT]0=P(0I7TG%F6:SK(B[QT"^"^E ,3"\86BK(^@+).$07GN$Y:
M4Q23 17EP!8,-A&I2%*.<NKH[-(J,7)EN@1+B34\BL[].]I^75%F?I;P*MR4
MIEC"^;@7U)D'=68=KA ZI""(1RG0F.LF$F0Q=2@PJSU,$=@-!^Z)FO^ 5HDG
M+*ZB-L40BJ(VI:C3)RDEL'4K&,)2",0#, -+M$(J29*L8RR0O [:P$I$"2/<
MDQW83B@1@P?G C#*!4SN B8S-E6()(S6FB$I' =?(Y<<T\8CESCVW%C%!?@:
MG"S4L>P2%UA4JU]4\LXJ.9TZ"5Q_E31&,N93SI)(I).+0,2)]$12293)^YSN
MFCFI>/^-I5 8]D"7AKU8KQ.DUH_\N7C_#V[QS\=]K1,^C$>]^!1WQIP9NPED
MX$+XP)&A.B%.%48V.HJP)=$J[0*F*H<<YU\>*,[_XNII4S2@Z&E#>CK%#311
M23%BD"(:Z'JNLV>B\,AKG%A0,C&&04_E_(?SBN]_[_1*=5F.=@Z 5?7HU,7J
MX _;[\?K3_:\>B>D,98PFH$Z ODY-V4[_=&/:WGP"_[<!7]F["/PAG")O4#4
M<N )0@MD>.2(.9)GST9"[=*J7N$+Y)J4:,&BTH2BJ$TIZO0B05T%VW@D)9>(
M:P.$'AN+E 2^H P56H*BJOFW&BY0#.'69Z;&][W:G"1W[O^+@:ZF.,:UN1K&
M;LZSJ/[\#*!M>\9&A7SH,W F$&98(^XC<! F'))Y&[4@(L!_P =:IDS.ST/N
MJBI/',LHD%<@[X'86H&\1X.\*3:7(@%S%8##$:80E\$@+9Q%DH([1I1BV,0,
M>42KQB*TCY-UZ;6$A?X=^_WJ__Y-4T+>5M;[X=&P;0<Q@,H=]T!+1L58\W*2
M/>I"LW^.2[F^JF#1WY^ R:U=S,7ZI:F S^V8/P#2K5V:D6M1L&#<73!NQDX4
M;S71+@5$1$J( \=#-IF ,%7!*&5<E!P\5C8KN?<_2ESI)>AT4U2EZ/33Z/04
M;['.:FT]N&HT,<0C#LAIAY$,WA#JL(TQZS06,U+V/(E./U$(JN3-?80!6FR<
M7*0@UHO)H_M8A_AVU@;G&<MV<AO_8'M)*R6<\DAK$A"W7J%<F0S9:)E,CG!P
MXY96N5'S[^-K7%>>1Q2KH&9!S06*@Q74O =JGDZ@)J:<^B0!*RTQB'.J,F!Z
M9+D12;(07+WY69/YDSPN#&K>-OWXJ%^N]\_5\SZ>_7C6RTLO/ASV!ZUT.FI+
MJQ- 0M]05>/L(VLJS9JZT:F^Q.-!/'*Q5X&FX3K8M>T'W;,OEJO!0:S>=8^@
M=:?5B>U7]L3"T(=JOP>JUL_;J/[/'12>6Y8,*#IQ(?& A3-<>T*#M%PG&UF=
MDAUC236J/Q@J?Y$CZ6/=AL_1Q]9?,7SH=8_ G;2]0=;\[;0>4^STXXN.@M\_
MC_O.>[X7K?52"(H\4PIQS"+2&#-$94PY 8D+$><-"=>I-8AD^RQ$>A<IB X#
M?E!-,$^<L60YUEXY8Z@!X$]N+ 4&@"9_(+1(P4-)P0;98UBSP(-"@6""N/0)
M.:88"EI1YB7U5K&E54+,"ONU'"Q7O=@_CO#+7[%]NEPEF(H:/R[F(^/%>$:J
MW[LM^&+-@ZWNMVJ1V;'][]6';L_'ZN\Y+D_QV_7M]?H3>?N/:M"MXH_C+&S'
MO6X8CL3,VV/K6X/3/+^7P:J.ZZNW_6IPTJV^K'W^@MYU_T0T;_BTI_V5:N<@
M0AO&*'82>['*36^E;!':I_E=">Q2?GQK8-L76>!K86];,$!5J_-7[-?=ZN?K
M6QW?JS>8'EW._'K1P-S\3ET"X3*FPK?Y,'8KQ,I6'DR2;77R>L-P-%COMO_<
M6$?$5 -X5;\"EE,=@2H=G'?WCY4O*_#&WO<XJ#MU_N"##-;>YP<!7)]=GCO5
MAWD:*<LX*^?@\ECDV^""UI$;]OKQ;-+RO<?#GH>GQAFC<O75N:SYL ?7U7-E
M6Q>OGSV<G9AK^]K>:1:@+KPEU@/J<D:;JCL<5"UH%XQHJYW',=\!<-(?]$ $
MZJ=>'?!LY^K[CV(<_=[+K^N-SKN?33.T#@8Z_UKW^R(5Z4KU9>CZ<$=N'3SE
M\F0=V]/\AFM[,S*7(+,7 QBN/&!X#"+;&M1-JX5C/.&76[A2_6_W) ([N?RT
M?%5^5FN0Y6?4JGKO<O_2M)S/YD5OENOA&MV6S?< .MM/L9=G9Z)S==LF&P:J
M#8+7S2,ZEH*K@QT3#$:6&GA+U^5;ZE1MQUFF860N( !Z,3BP9_-Q!A,7SP=Y
M#96+,3<!YF#M_'TQ/SE5J94Q.I,2>I64Y/L\?&['+.>@O)?;/&-$ZJ;FH3BQ
MK<'9;)XWV)V>-7>E6A]U,?_=CR!QH?KO$' ,'GBE/>QJ>\YUJU:W5@<NRIT_
M>\-HJ"Y^ Y&J6W5EI.[(JK!0A$;O*(F!6ZL-L3%(#KQ<:<K<R)XRG.']%KEB
MZU+;,5RQJ!^[((^=T<Z"C!( TN_&N/8^0W(?6EA,["P3N[7S"9[Y!]E>?P]M
MW#_="]HZ2HU BN<UM< \,D%&I)3045CII$XY[=NUVT#/K>W)0<L?U*(,,M>M
M6?D8O,^,XUB%?+<_J)SMM_K34'X)PD<ZMW;<:[5';R++8_GN=*LNW-8;&Z:Q
MP;1G&G2N/?5:.6A@B*F&JTN:6-]QKJ<K5[VEW-$LT:W.L%[]N85S50N1#TH3
MPBSGB7"?@@TI,)J4"-)'[<V>DDNW\L@>O]Y,[8#]G?!_5 ]<PNI+W,_3^SD>
MY]6USOXZ %>[VP?[O"@UK+9:YRIYNK6>K]LXW=SY!.J3@Q7?6EL??_^^N?/A
M8'MGDV]_W#C9_OIIADINX"UHT^[AQH^M]0VZM;Z/OQUMX-VC3S\VO[X7FS_W
M^>[AFOBVGEFO)YN?]AA)C@JOD6;6Y7,3,B]N4R0BC4*%1#W&(Z %L8QA+0.;
M]#HY;"PU-'*C@N9!>]!C3[" 68F3-:]^&_8S&^E7XUD8H?_'V 72<0SJ6VUT
M1J!9;RR9##/<.J"P],P#$?^:T/^1/-X\V%<G)V'/HL9)8*EXX-S8X%R4E$@'
M*!O#TNHD/[[6QO9'TS5I9[W X(M83+WG)&H;:=!$*BJ8M4&[J]I("657[.S&
MUH=)Y82Y=K&7RV1G[<S.P9F@7+&F,*X^6]030/E^[)P;4_S*-'?KY\9> IA3
MP6J4I#&(LUR$CNA\W%(KB8EW,M"EU01NQ)3]!,MX-LS5>(;[;ZKUEMWO@(5L
M^?YR]5MVX0;5_T;;'APL5Q]WM\ =Z.UGK[!6W2_?(Q@P^&-TQ56_YPCNS>=J
M1W7#P"""-,-?V7N9\>9LD<%&@MB-OX&+_HH@S6,V#;Z>K<TK.);=(S"W(6OM
MB+?''[X]#"-/$B@XD.ELNJ&OR-O^006VO;<?H3O](3 $$'3PM&UGOY5?7WL-
M5W:T9:\Z>^3+U7ZW&TZ 7HQR+4_>TX)>MGIU2\]?4/L38^T9WQ3W>U<>VQ\Q
M[ L_OU\'"FKWK6;8R[4[ET.X%SON +;@DE%"A_.7@?O7VA]=<_Y=/50U-^GF
M:H& 2A6\;=@9]H<P2ZU!/ *':@;!F!\D;T#;,<!QNJ)RO<+C[JCS;WJQ;;/K
M,RY3.%XSN73C..J-+VZQ#D9G.+C^EDN-]M#*V'LB'*=\@M==^O>@=U'/;C\B
M!XKV'0PN-/:-;9_8T_[2/Z_TZ:C501-C.-G]:SN9TH.1MI$TA$RX:TEZ4[N8
M^2IHDUV8ME0'O6RR_G8+B@QFL<:E'&W*UJY.FFI79\WD3#-]H]F=Y%!6.P'_
M2V#?>?#>&)RB2C0E9Y/B[%K17C#2LI$;T$HM>XZ0_?/(T"RXSR#7ZM= W1I7
M1VYE!)O$V?X%#H_@[?A752FO6J TS,%+<,&ZOC8]5W8RC_&XCE7.-DG3$42X
MO1\[9Y&5$="V9G3<YO[UCK,@GGU7/PS@N_;\[K(H3*F4V DL+.54)$=L5$(9
MZ9+-E.J&:,8,EO5Y;%>O1BA2ZT<,Z&?L=1<F./'8?&I[??]T3P$H:*TMDAQ[
MQ!U0*PNJB%1R3#)CM;+X3JOZQD0OG2%)!\^C9L9A0(-D,8N6*I;J"21Y5:>F
MR9A=7=XI$WC'"=2>RH250"9H#1.(,;(<O%D9L2-"*\]<NM,$6I@1JP0WTB>N
MN7"!),&3L9Z$H&4836!>G"T3V,0$&FF$3@;TSDEP:0SSR KN$'.<LHA5TIK<
M:0)=2$)(L/K1!6Z]-&!6DPW26"ZDQ7AFV*A,X+TG,!!0.J$-<@$KQ#V3R)*0
MBWH80Y57,N0\W9WNE$=ZCR]J%ZN'IGS&<+%:,0#R-\J#UV_]&*T7]O,Z"ECQ
MZ>AN?=VF[?F#T==4UM_3E>K+0T<F_4$,PW;<3I,QRDM1L=].QS^^XF@EWCK9
M(\"N*586!2(2B!BQR#$FD&8J,,F9$,Q/,FT1% 8F%6@RD<OHM&:68444M<"F
ML)R,5HY%JG4Q^E6KIG:I"XSRI/]FCA#E7;SHF6[&C9VYT2,><]TS+[O>00;.
M0ML>]^.;LP]O0ZL/-/OT3:M34_[ZIK='MK</_NC8-<^^Z,3NL?I]HY_';JHQ
M*YR([*F.SRZ,7SQV8E=J)W9B0]SH-T97A)+7_HQ7R+6__>JQA*\8:N[UV%__
M)I@HC7U6C67T5H^]X>3-Q#[+I]FNK6^U)WGV-M3S/IG;]&F$(T_3JZGH3]VK
MG=K.;X[L^_MLWZ_MX?2L77OF\9D.QA>@.M<.14.ID)^QB-^BLW?95+W8LE"S
MW(HLU]PBT\\''Y9KM>E5C7OM1E3@09P-/)UGX,O8%IE^^G&_0:8;RIBRT&?=
M=KIYQ?LLTO#F7H(W[O;#"=YM4SJ41BYT(Y\U4[NE/EW:<3)/[N\7>E#V91YU
MY9@Q'J)+E'MNN3=),<T]E=P$D_#M]VA/1^2?=^1]?+ZU?9"?L[7^Q\_MG5T.
M]Y!O7S?%]OHNV:6_P_>_'6[O_'FTM;[[8_)\Z_;7#[G->&MG4VP=[M.M]3^A
M[=_A&7\>[AYMXDWHS];77;QU^&%F'6[)DB'8.214L(BSR)%-EJ)$E Y&*$N(
M7EKEDB]4 O]'.M9?\&:1^G8'O*%.40E@$Z2TW%!CG+.!X!2]U3&*>,,B?,&;
MIO!FNI0X%5(RJY&PDB!.&$'&)(&8)D$KJ[ )?FG5Z!=9U;?@S0O%FZB3D5A9
M#,R%4TNTU)8'9I37-&_<OV'+P:_PYCD<*WLF8$2FR$\25'O#$*:.(6Z41,X:
MAX(S@%,<@Q.7<A9;3/D*+G!4X.B9P!%SDE EG,/,<F>%P3FW%Y%>*B&8IC=L
M82MP]"APQ*:2:DLLG.(!)2$QX@&\8>>Q1EHIXH$UR<1XAB/#&BB3TB <O88H
M\)6C4:\L"_9=-L\2#TR>&>T9Y8D82VG>H$N]X"$:3$N@YS' 96M&D1+O/19<
MY_K-7".@J0 ND6K$O).662:M-DNK3(M2*NTE*R@GT'&M.(],<!NH W' D7"#
MHS9.V1(9>20%G8Z,)*%]8!HYHR4X(]@A2XA"2EK)0SYX[0@H*,%%05^R@@I+
MHPH^8942=RP9!9;4)8TM3UI2/D<HH2CH711T*EJ@*2,\&HEPX QQ&'JPH#H@
MDPCE,L44F%I:5<0L5 W#HJ -*ZCC.2V'3IQ0#1^YY89H\*HCJ"I8TSB'<UT4
M]"X*.N4_"P\$ADJ)+!/@/T=#04$)AFD0GAEN9/)V:55*,W^"\P6J\/ <O.?+
MF43NY3S?-B+YK)%%!VVUD]SKI'AP0CMC2(PJ:I[ D>;%>7X49)E1"DKB$(3U
M$D7E*>*$)V15P$A+2Z3%BBN<%PHX7]$+%)=K>L?QJU=0((#!&JJ5L(QSIJR@
MFCJI1)2<RF"*\_Q("CKE/$O&A-9*(XQ-0IP&@FRNZT0C,=Y8IP27.8VSNC:-
M<U'0%Z"@BJ3HI;?4BL09I28R4+_HJ&51)YF*\_Q("CJ]U$YCG9<!:<RR\TQY
M7M8RR 2:@@@!UQ:4&MU8\:&BH NHH& O/256$T? (>-$>QP# ]JK-'-)J>(\
M/Y*"3CG/5%JJC&1(FKSXS/+ZD#,8"6DL81[H3G"@H**Y.C=EZ?EVZC61=;,L
M/E_K/SN9<F8_(TCD+$H %$^$<(X#HL#_*_[SHX!+:]I_5@DHE_8"*6T<XL$(
MY+RB2.0MOS%QP;G*:UOS8TN)G"^N?E*>DQ1;G$!/N0O".&R3EEYY(:T(K+C/
MCZ2?4^XS2Y)'+CU8>QX0-P&/2H-ZPAB.AD5K:5V689$"YT4_&]9/0&09<KI*
MGQSWD3EG,>5,85PGXC/%>WXD_9SRGHU*P67O65 F$+><HGJC:-#1)&MX(%$O
MK0H]?W2KZ.?BZF?,5;6YU=I%R7E@3D9)F P TBP(*HKS_$CZ.>4\2T.(59G5
M&E!2'AU#!@/=33 %U&*IK+9+J[R!RMJ/M_!\E@H0&AM_K=+ERJM7SKNB?\_J
MX]-Y)E[#"9Y;=O[%&('&RMV5LST/92&V9VR_%R02PRTPYR UXBE19!FF2-J<
MU34D+YD='364C9WMN9UJ+/@AQ )NKPC<6+(>)TYQX)'KI(RD/$1EA<981"[F
MB! 5<&L,W*;"1Q$[S)+#2%F?BV@0AS15!'DMF'7&FHAU!C?.1&-I9 JX%7!;
M@%[?);QVGZ(!!=P>&=RF8F^<I!P#I4#:G$$<RXA<Y %)GY1C,5<4 7"CRR /
M!=P*N+U2<*-)A*2-R0M[W#CX@+G36%O+/36:EY03BP!N4X%+#T3;*<:0,BJ@
MG+H(:68B,DY*[)D"EY5G<#-8-K8Q[V'![37L"-H8U<1-O>[16:7<;J>QU,0,
M1CYTA[E<S )GU"VM?/Q6OH:C:B4]\:V[^&+(2^/IB;?/RI>/D/K?W7Y98[U3
M=JR=M9JFU'1E9XUM[_S!]A*6(3)C$8[Y_'W4%AD:*7*"$)@W";XU6UHE6+S$
M,SX%>UXH]C2>JKA@3P/8<SJ!/5PKR[G7B+$(V .N$;*4)Q0#IEH%HHFU2ZN"
MXX4Z'5&PIV#/HZ8M+M@S/_9L3?(>BH.*E@G$K(V(>^%0O9/ &PJ42!+OI,@G
ML^3\B<$*]A3L>:XYBF=B3XD=-PA,DZ0(P[P8PQ6R5N<]3<SD7:\641IQ,(HI
M;D?ITQ5=*&AZ#2'BDJ_X:?(5%P8T+]"\GX[\4$FT,<8C3*Q!G J,M(H):9&D
M\\)*Z3+0X,5*[%;.ORQZ[N*BK THZR0KH$R[Y*A'3F*.N& )&<89(IGNR2"9
MDGYIE9MR5NTEZVKC:8R+KLZOJU.A!1A^HZ@1"#L'#-XFBRS!KM9:KV7@SALP
MK*KD''_1RMIX2N.BK THZZ1AM31H:R3XUUB"88TT.][.@?0DQZF.W-!\A(B1
M^6N5E?3&);WQXJ<W+B@S+\IL3/O:3CBCL#1(,)4SJ7*%P#Q0Q#4F*2JE1JDF
MZ$O<9%%T]<$R'1==;4!7IQB!='GGFD)<FIRSD5GD(@8.+[SVU'!L&05=?8FE
MVXNJ/EC.XZ*J\ZOJE*>MG'=.18P8N%6(*V*0S1EB8$J,"T%ZHC)YQPV0]Z*L
MBZNLC><_+LK:@+).A;!U,,Q0AK3S*1_Y]&!2DT#,V,2-)-$*N;3*%HL#OX95
M[9(*^:E2(1><F1=G-J=];<*-BH9B1+W+))X%9(V1R&$GK/$,>X^75GG)BOSL
M5/7OCYL6N0\=AD]%:1] ::><[JB]($HB[K+2:D>1]J"YDC.I:< X>@%,?D86
MKW\4?5U4?7W*+,E%2^?7TNF5;9.8%&!:F1,$<4LI,CI:9!TWSD<##K=?6I7S
MA\:*JBZP:6T@8W(QK0^GM).FU6@F:*ZPK>I\2UIKI,%;03'E)4*B%5=@6O$,
MM_M)3&M)H%P2*"]<B*1DJGKL!,K%%,QK"OZ8#HUP8W0RX%9QX8&_8<.1CCZB
M1)10D5K&*< %572%/(NT5$^-9*\=S%XNGC6>,[G@60-X-DEM@Y)44,) 7/)9
M2:$3,H:"/ZHMCY%I1@U>6A6&/SR>O11(>]5X]D+!K/$<R07,Y@>SJ> :UM89
MQSWR,@!#D]@@2VA TA$N#8N,!@Y@QG@I95'(V:LF9XVG12Y9+AX:[*:8F_,I
M<H:13-XASJQ"+@2+J%!6,H%3&%7NH4PTEN7BP;G;:]@LM!Z/>Z $=7+DRG9"
M98^ZT+J?]1<E67)I94F67)(EE\1=3YXL^3).KUV"Z+5.6/.^%_/GK3@H3.9.
M3,9/Q]2#=9R(I) /RN6C?199#O\8%0,&SSLQDMTVV5@(ZAGY9@6.%JEO3YD_
MN<#1 \'1I&.E0_ L8(J$IPIQ*W0^:8P1CI(Z(R*7(6_1TBNTP%&!HV<"1XVG
M5"YP]#!P-'U"DWE#*<P+ISCO.- .:0U6P]. '=>"Z.265@F1+_&$9L&C%XI'
MC:=9+GCT0'@TM1D68^VY]B@Z%G-VY8!TH $I&YAP.#D<<$[WI!:JY,1K""R7
MW,I/DUNY0,]#0,_^=*#(>\*M5PIA+BCB)'!D#%:(.:T5]D:D'"@BM*1;?LGZ
MVWBZY:*_#Z2_4_DKA,8I6($,2>#/1&Z0$RXB)[7'RCLM5<C48?Y ;]'?Q=7?
MQE,P%_U]&/V="D7DO8]<,8-TU*"_.%K0Y,B1B(X':H2RR2^M4CG_]KJBOXNK
MOXUG92[Z^T#Z.VE_A4E!4HP1TXD@KH1")O_C$WCM! <.LPCZJQ<JL<MKV*]2
M$C4_2:+F CP/ 3S?IQUW+!B--E$4O/*(AQB \W.'A-):<QJQICDW#5FHD&%)
M,KGHR9N+_CZ0_DX2!\:LP]XZ9*+,I5ZQ1Q8T&@DCM0I.8JDX$(<&,L(5_5U<
M_6T\HW/1WX?1WRG'G5AC7- $!6L9XD1$<.$E1MBKD!D4"XF!_K+Y ^=%?Q=7
M?QM/\EST]X'T=^JL%Q/8D 2..P$CS ,QR'AK$=?61:-DBA3L+U>-G6LM2^XE
M\?-B)WXNV/, V'.X-NV[VY24!IZ/E"42\>0L,A*X/S@ .BH*WWJ:D]_-O1NZ
MQ/P75WT;R 5=U/=1U'>2.H#/IID4! F?JS.*G' 61X,4AN]I B>.BZ*^+UQ]
M&\\-7=3W8=1WRG.GCB9A T-2QI1WVV)D&#8(]-88+H6--LY./5O4]\6H;P/I
MHHOZ/HKZ3CGNUGEAI0+'W6@$OHY&EMA<;4T8B@6+EI&LOHM4QKRDCR[IHQ<N
MT%(R%#YV^NAB(Q["1LRH;,TLYE0P@C3%,N^J%,@1,.4FSZ''FE@3EE8U7M$E
M:6$!MU<);HWGDB[@]D#@-DF ';94!>&12HX@3K5")@2!0F2&!>)UE'5]X>:2
M^Q1T*^BV +U^RN32!=T>!MVFHG.11<T"<\@0;H"Z>8JR34+".R6-54G*O*]5
M-E#/K:!;0;?%Z?53IIHNZ/9 Z#;)W9)W7(?DD+.$(RXY04XDBH3A2H*!,M'A
MI55*'J$V2-F0=$O%?&>/6WD_4OQQ'#NA-1CV8K_DE"ZM+#FE2T[IDJ7LR7-*
M_\>>'L7.H+_37?/_';9Z\3^];AA"._Z*:_U^')0B0'=C+9]F9)/VQC.M!)*:
M!Y3/B2+CL4.8: U?,QP(!=;2P(ZGQ3OK4(#HA0)1X]FD"Q U#D33I145\]9X
M)'RPB'-AD/82_E1>NJ #T2PVDRVE %$!HN>:1[H 4=- -!6E9C%8F!R*3!0$
M<4<L @,":,1@^F,R8%P B%BIKU& Z/D 4>,)I L0-0Y$4_FGI"-!6)T3V.-\
M##TA[:)#"6,1HJ3)VK"T*LHQUI(Y>B$QI_',T05SFL6</V;LKF3."<892L2I
MG'/6(<<\1@FF4E!J?(ID:566E-$O67$;3QE=%+=QQ9TJPZ6%43)0Y*.5B#/C
MD8LVZW' .76P\C@GJYQ_5W11W,55W,9S11?%;5IQI[-$\T@YX18IZ@3B009@
M^<8A$ITCPG"O)5M:;6+72-'<Q=7<QK-$%\UM7',G32X&707W!;P7:2SB3N5<
M$=JBZ+CABG*5#)A<-7^AN9(>NJ2'7OSTT 5QFD6<W5EG'\$$.,.0!M\,<9(4
M<@I[)(PU2C&!0VR&Y"_>RD11W ?+"UT4MW'%G:0*,7 5L-*(*8)SD6R/=" )
M&28$EU9%Y616W!=8D[8H[H,EA"Z*V[3B3GGG6B8K=2Z?2+5&@+8,.1X%DH9X
MEKC&'M!UM;D#:T5Q%U!Q&\\$712W<<6=.HV5URM\M"@(DC/!@0K#W'GX)XKD
M!1<1XZ75YLYBE;7SD@)ZL5- %]!I%G3\M'^NI,%888PHRQ7C+%9(2YD0]IH9
M;J-,^0@H+J'\EZRXC2=_+HK;N.).L043K0-_#!A^IOF:Y5*M*G^B00B6C&:L
M*.X+5]S&TSX7Q6U:<:=+-3FL"$X2*>HYT'R5P.):@L!G]R[2I*/&)5_["U?<
MQA,^%\5M7'&G"BTP8,1*>12("HCC$!$8X(0$P*T+R<'DR453W)+J>4%3/3^'
MP,>[;N^XV[.#6+8D7'M@P!KEHO/,8<P58\YXQ@TXSE['?&:IA#R>&,=GU*J6
M.((Y-1I1E3TGP1TR.8,_T2:HQ*4.^9 27:@X:UD@:7K?,<$:#+>U.E"> C.)
M*<%,--:P2*0L(8^G5]SI? M4."<ITH1&Q /-I7*B1"9QDVCB(?G:<RHU;E^R
MXGJ>D^E3'@WE8&V=T@[T,PC.+;7R[KETB^(VK;A3(0\7N90P;\@#QB(>742&
M!HI2,(Z );8^EZA;K)7-HKA-*Z[T1/F<<50H4%YB+&,^8AU%B$I15T(>3Z^X
M4YL 352)4(VPJ,O*FX"<"P8)2P47GE(MY-(J62C%G7=+PJT3C%S-ICEJQ&1"
MS5>:";O)H7DQ -AX :<"@(T"X,\9M;$5=TPR3I 5)B_6: ;.A_/(N,!EWL\.
M_UE:90T$"QI4F2=>Y2F 60!S,8M"%<!L'# G&2.7UL0D"'+,$G#U8D*.> G0
M"6X>34P Q:\!LZEZQ@4P"V 6P'R@.E,%,)L&S.G8F"7@2AN#,(T6<2,2,@1<
M;"^UC$XS);186I6DL6T%!3 +8!; ?*#2504P&P?,J6U8FANK8$9\<AAQ02.R
MVF@4-*>4 \^LTX9)TUC"OZ<$S#J8^<^!A=?!?T/KK]5_P3]G3;[T+ ]2%WN-
M:QR]2>-HUKBKXUJW]GQ41\,#+6G;XWY\<_;A[=FFJE:G?EY]T]LCV]MO=<Z&
M6AQ/C4[=X]'/;T]:87#PQI@5\ "SVH]CON,7CWXE*S4B3$SUZ#<I5S VU_Z,
M5\BUO_WJL82O&"7O]=A?_R:8>IC&ZEL]]H:X^AT*4_UB#]Q(C!_'G.@)V58S
MK<G:<:_5KLCROUSOGZN9-=^BUMI+'8LO\7@0CUSL592?#PB],B"OX4#H1H"9
M::56C7.V-NM-5>"[:D(N6Y$%*AIWRT:^ABVRCUTS[J@50CLNO+-QK\($3]JW
M.T59@B4AD12)Y3QPYQU5@2F?DM9&V;V-VP57SAR"U.T=V0$\^,?@36=XA$)W
M@,;WO1!OX>#HV]%[^NWKI]/=K[]_A_:UOJWOBJWUS/KWV=;.;^VMK^!!?-PX
MG?(6/GX[VMWYUOZV_CM\_PGG]VP=?L?;._MT>]V3S8]_0#O__+Y[^'O:;(T]
MA2_XQ^:Z%UL[?H^X$(W1#AEN%>*,8@2399 W-' OE236+:W29</Q"G_230SG
MTK_PQ5$*!CT]!@7-G#;..4L5!SBRT8=  ]4L$!\)JS$H1WIYP:!'QJ"?DQ@4
M@G)&4HTB5PYQP21R*49D#$_!8!J#RO4JE[4F3YR4Z2H&O08J7^JBW/*8$Z:!
M >%)A'*;K%7&)$F]M;FX A.%\CP1W)Q.4QYN!&;*4,2-3(A[@9'VP2,M(I$6
M!\]RXD:R3$4#)R7*&?/%55H:HS,AN)2SKKJ\'X,;2H#I6AL8L;APA"=3VBF.
M 'ZCHA&\DY1SK'+""#+$,J0E)=1::1U+M=)RL5#U4%Y#C*<D9[^51R(QB3PI
M9JCG0 Y,<IPG;[&G^:@'+13A:=!FZ]TT1="86V.!'5 M ^(J,624E$@2ZO)<
MI<1$1ALN^?S;3LJ9K,556DD(ET 6DR>, SF$#\K8R*A.GMNH"D5X,J6=$4;@
M3I @\B%*CW(1#.0DXT#SB:?.\HB3'"DM>4[E55] :I=G&/<H.6UOB9!&*\]]
M,C;_US%F1=#6I\B%= *X^5UI30'!VX/@C/6<E*QD!$?$>?['"($T-@(Y0EF2
MCH% @I]$Z?R!U!+96%REI%$$H*Z<RTBY9M0:ATT(5$;!F13^KK2E*.5=E'**
MF7"1* U6('  @8]0;I'CX%@8H[50%#--&2AE U7?2^2B)'!K%DJ2-!P'1W3$
MG%LP\3:7?;<4YV)S8.]+V.*)<&;&RD;@'-B72(@Q0A&76B.M9$2!8!4P2=+G
ME-=L62F\4!Y0"5LTK+1$8(&QB=8+SBGAEGL@!%9@S<!)UB5L\71*.T4.G."6
M$D>1%RX 8P\&.1\Y,O WYSQ&16E66B[X0I6D6J@T,K\\:%).KMUU@%X,$.J\
M- C.3P*6S:.@SN6\XH(KZQV3N.S+>"(@W)ZQZ&*Y$<%+AW"*!O'@  .)-R@7
MWO9!RR2265HURYSKQJ(7S>G,<S[Q6]"SH.?,C(21")NPIE(K3@$\ R7!"Q&]
MME0846CDDZ'G%(VTCE,IC$36:IN+'%&D'17(*4ZD4M3 Y&7TQ.J1,B4\"GK.
M./Z;NY:EN-49VKIOEP\$C\_/Y@:)F8<)ZV]:G7R [0U5-<2.QB0?YCL?GU^<
M,SX<]@>M='K=@QY1V^N3QSL'L7K7/8(WGU8'-E2=;N6AA=VCV.M7@P,[J'KQ
MN!?[N?>AVN]%"Z.0?^A4!/]/U4T9$>IYL_F"7OPK=H;0O##LP=S!A1'^?R_&
MRG9 7EH_JB-HTD&_BM#S4-5G0T>R19:K3+7JZS9MSQ^,OJ:R_IZN-#"V+V*2
MNL<Q!R3[5:M3C^Z1/>SVJOW8W>_9XX.6KVS>D0WSF*=C?(V+[>Y)Y0]L;[!2
M?1Y-40439JM6OW*V#U<.CP'JSV:^:G=]K1LKU3;</Y[O_*0_P!C U5\&N0G+
M65KZ,,V@T1[4?] [K:RO/\$U .8PV;UXL["L5)<Z^'__IBE1;_M5'^"^[N7[
M80\ZG?M5@22&[E&K8SN#]BF8E%[KK_RF7O?H<NO^'S0)+ENN/D:P)YW3Y0IP
MK./C<O7EV+8ZR]7&P,+M6=+R75LQ][$-?][4DK5^RZ+_6-]*HW'^57O>'<#7
MR]4:#&D/A,K6K_O=PH-'+\E/I_CMY]@?Y('YVNVU0_T=>0L/ZH,4UC, K_7M
M(7Q1O;,=&^")_X;OH2DP38!ZYYW8K$\>5.]M?S"A*K_$N\:49RROG*ZH#)S'
MW7XKO^Q-+[9M3MXQ3C8PIAB7;AP;!WQQBW4@(L/!];<\?-:&VZDE%1,C?>G?
M@][% ?7]B!PHY7=D$S3VC6V?V-/^TC^O&AZP.A-C.-G]:SN94B.=G#JR#IT<
M20-PL+P*DB<'C#SH2JO>[&$7IBT5F!@@I']K^: T(<QRG@CW*=B0 J-)Y:JZ
M47NSIP!-ZV/GH'/O,I?M#/K_^J==G363$XHSXIW2:B?@?TEZS8/WQH [JA)-
MR=FD.#LGT%O#6D4;2#!VE2Q_\0<Q#-MQ.XV1_ / S?L?(%D=VWYW9KO7!H->
MRX$6A9WN!T!A4)9W-42W8O^WTX_GYF(-!','FO<;0/[WYTFMV_%_/Y]^^QJ.
M'>5R=V<#;T&;=@\W?FRM;]"M]7W\[6@# V7^L?GUO=C\N<]W#]?$M_7?TN:.
M)UO[>T08F$UJ4$@V5\5($5D>- HA.*,,S#"G2U4$_^,X@T]O&*^%HP7C#9_/
MV)@[/6<(8/?ZE:V 163L!&S*FC#HYJU,Y^3M)/9R7@8PX6T@#I=R,YRA_B)D
MR;E5,I]'3Z7#B;A/*AU&5\0]<][<E)V&WB]#STVI=$1I[+-J+*--)BEZTA#?
M9*Z=V7&LV2&+\SZ9YYE!:*=VIC='3O3[[$0WD4[IF0[&E]:/ZX?BU4CRI56!
M.X33%GMF[Y,TK+$L4"]F%.LX6D7E-:G&YLZ]]G)&JLC;(\C;:S@7<B5 .L^I
MD/G66Y_1LF)GF!,B3JXLXLB$28D:[[D#Y]PGHD*2F&OF? HWE/IA9T&3@V[[
MQYO_G/NZYS&3BSWKB#[/J,?%@N+Z>_SMZP;=7/_M<&O]$_MV^.'@V^$??//G
M!MV&9VWOA/S,GS,6%.&YG]N[A[LGFSF?\'HXVOSZX6AK9__GYN&NV#W<$%LT
M1U*V9F8&$U)&*AE!F.?29MKS?)S.(.4=YIYQ+Y)=6E6\Z33"#[)8^!0:\3_S
MI+QLXHS+ZX881J.C'M/(*><Z1*>(9C(&0;5FB<8;BN,4B&D<8J;V+!@ %.<2
MR15P3#ZGJY$37"*! XM.>A(-K3.5-UP\K$!,@9@F((8D+9Q,7!L6>63U\==H
M(QA-^!);>T,YF0(QC4,,F808:I)/U$;$ O>(8X:1$58BK4GTQ%$NL $6TUS2
MH (Q!6(:A!ALC;<D*6%"/EY/='"$$>Y-U,X8HV\HP%(@IG&(89,0@UDD5DB%
M3#( ,5H;!,0S(&JL-=HIK.L"568%%XBY!<0\A[C^+3LVVMEVBRC1BX<QE[1.
MC+-<M(U3;2S\+V$IE0'=85Z7>,_CPMB,P\-2^N 3>%]:)0=,25ADF=(HR:C!
M!%'#*%E:)?RN3.G9 ](]EU%>D7:GH(2PVE#M&5>2Z>"%4BH* I3$6%Y"+8^M
MW5.A%@_SC)4*R& -VJUB@D^<H\2\PM3DN>)+JQ3?M>QPT>Z7K]T4<^&5H\1%
M3CSHN0M.<!:(U3(I4Z(<CZW=TU$.C[EQ,2#-<HU<;0ER.J<^C)@S9RWGU-:V
M^XXGOXIVOWSM3@)S[;W!CO(HL5/>VR"X431R8TD),#RV=D\%&(S2EH94&^N8
M<Y]+Y,!W0@J4W05#X$=1V^X[+I,\>^U^#1M.+I])*UE(?P%D6@)L2:69LHH'
MH0RS40"L:0S>B*.IA!@>%<AFI57W6GHO%4% 4##BABMDG;+(.V9]I!SLC%M:
ME?,7FFLF#>+3 UQ)C/H *RJ2:\XCB=XE#ES'A.1"2)(%K##WJ00K'ALGIH(5
M3$A",$TH,@-.#+<1&0E@X:)--'A.@?DLK:H567"BX,1#X035@3JF Z.4<R&(
M#LD$*8@1VH"M*IL['ATGIL(>G(F 7<YR*G+A2);SG//(4$@11X5%BDEG/M'4
M]K&"$P4GIG#""$4L8]'5)6&2-))XR\#OX))'KG@)H#PV3DP%4!0#9D<]0[FB
M->+1<V2I S^0&L.4#(F.^,2"5'M\>IQX07LPKB3@*5LQP/_QC%FMC/#,<I*$
M"P(G@V,0SK@D:(F3/"Y>?9E1Q"42)G*R$J P$O%$,=(\:12$$4EQ[IDD2ZOL
MKGCU[&&IK.;<I-Q6,:=!NY64AL,'HQ2SB8L0M;7$TA+<>&SEGL[WCKFRG'%$
M3**($Y*/ORB#L#7$!4ZC\2(K]QUWBQ;E?O'*[82)BE.6P()S':AU%KN <2(\
M*#-6[A*1>$3EGHI(R&"42$ZA*#5&G'.-7,PV7%M0<L6XU;Q8[J+<T\HM3:[3
M8JB*TG+*0=5!K9,S%*R%3,J7,,)C*_?T/@PB:%24(\L"*#?S KF4#(K8"2<Q
MD5K:UVBYFZX$<X_380]5UV#QAOZ.SKY0A$;O*(F!6_ 'B(U!\N"4TI0Y=X.S
MO['UH>!*L[@R(],&(#U3B43D#0:/(!EP]QEG2/$0E<()O(5<;1[CID^0/4WB
M_J<'K()3BX93+%F/$Z<X\,AU4D;2+/Q6:(Q%Y.*&N$7!J0? J:G(10!W4PCP
M+L';!/X3HT<NP">'J4]"1\9R&=N"4P6G7BQ.W2N_>\&I!\6IJ2",C@+X;BZF
MZ?,V4QO 3_,XHI@$\TEC0U0H.%5PZ@7C%$TB)&U,XBYPX^ #YDYC;2WWU.B;
M-J44G'H G)J*)R7MP9@PC)C/V]=""DC#I"$=-6&!*\%$X5.-!ZJFJ\5=%'.Y
M?36E*X6)KJN=5&O%S25KS-*MJI4]^!#.*LJSM/IW(OY1/7#-FXV.[Q[%'?MC
MO=7W[6Y_V(N+4K1F^\L9N/P.[_F$MW?@NIU/?'OG$]LZ_-#:_/CIY-MA.-K]
MFNL\_GD P#-=M.8(KEW_) ",VEOK^W"=IYM?-TZ^K?]VM$6_ =A\QUM?W__8
MRD5K#C_]W/RTQQ16#+Q?A*/C@ W9S:))(J^=Q3# Q#H^PGR0U!C6<E5-P'PN
M';C13'MNA# Z>,V<5%1PS)R=+'(S&O4*ACVG,IY4A$EAOE8NKU;#X75QJU\H
MQLRJ2S<V_9E4Y-GHU!7R>B'7HZM.6H.#:NW+NTIQO%R=#<,#M:M^XIO6 ,;%
MWZJEER?_05OVRW8L5]'Z@ZJ5X;1UE.L6M;HAURW,I01;8(SJ,H>#N-^S[6K0
MK8OAV0X(3WM\[?*H1I[]4<4?Q['3C_GFHV@SB(1JF.L7PA4@^@,@-SEW]_AN
ML(?1Y])U];VYYN)*M0;7@6@.3O,S>O&_PU9^!KRUEZN2Y8;4@W;Y977K_SNT
MO5PW<U1K,0OUH'_]>RZU)1=1S#U*PW:[2JW,J*K3:'MUGX;]."[1F6^"5ASW
MNG_!D-1W730%Y@+>:"L_[/6@]?7]8,%1+L*86]3JPQ"%K"CC%P9X3R\.ZIOK
M^DF9T0W&Y4"['IYSN;SGU9FYOD[GF!V@O /T#9-7^?0KJ-QY7DYR>L+[Y_-\
MMUJI=9VN1UWP89.6^?U99\Y-]&?HT+L1@,-T;]?E2J%="^0//+;)WCI<.]V3
MX&N)& 3RG"C$P0%#5@J,A)/,)DVE(F#%*)F1/NM_:H%XU$!4F>?[S;/8<]HY
M[35%D=.(N&<)::(]PDZ#AF$<M'3U/*OI>5X&.](_'HUS^W099A208VQA'G6]
MI$S_?9CYSIK8WOD#^K/[<W-]DVU_VB.,@LXE@I1C!I2>1:2E,<APH8(*3!$Q
MRLPQ0QCNH?1S1G7*K,\_ZWQK?P][31)SH/V.@V\&3@K246:\)XQ$2S%7N)[U
MZ6Q+4Q!P1@R 7N8?NIW,H<9<Z[P&.# #N"SSNI6J 9+TK-E6P^SJ !Y_I0#Z
MRI<5Z)8=# ?=WND%98?;CRP\XA2H<<W%+[D",'&Q]U>NEYZ?L-_N.F#Q0)MM
M9[^5Z76[>X(R3S_W'^J:WWV0AY'ODE\7KQ#ZY0KLPJ!EV_"^;DK].,@E7FLV
M#A;#UP>:SEL+W1N.T"./0QH5 SXO5GZI':,WC%MY45#^",8*GC=^/PA9!VX;
MOVZ2V];.P*AR.?2Q/W3@HK5L+CJ\7)W PP[JLNFCSHX=EW[N_RV&>#06*4+#
MX=$7XY)_!W<E@$MUO?,Q=U1BT>6?T/GDOR[=-9)_*FL%H",%N-WD3,M_,\)X
M7M]^$>5QE@Y.Z^I=A/*^ OAP\G;'J-%6MX,N(D<@50,8__Z]58FNO!"M',ME
M#AN!$!Z"AM8Z4L>)X)TC"1TIZE^V/8S(!M"4Y:H/I*J/ZK!1EK?37K?='@%A
M=Y#M$G '=,G2M ;QJ+]2K54C>CC6O!R%NOR6+/+=SGXW,PE@$'^!/G2'_>IP
MV&OU0ZO63GC(Y68/['<8#Q][ PLW3+STN-MOC1X\IB-7'I2_'&E:"Y"@)HR@
M$]7&Z-).MP?<$]C-L->O*Y&[')"+_;&MG%3GBU?E(0#N.[:3.1C7K@-FV?(.
M^M<W$=[4!K0 0G4 FAL[^WE@P4 /VX/Q<-A^']Y_5$>\<MWT[E^ (/G/;'6&
M@X-N#QZ5N_ ?://0=NJ9S$%<+O"55E<'MC\.#$+#VMU^?QR/WX\=W\IEUG/X
M=TSW\D/ZN;GG4W;>YI7JRS #U5%WF-M4HW*G.ZARA+ '^'-/>I.OFX'Z*]77
M@U8[7NF(B^U6! )3#^U%<#)W*5[J8I:K7K1]P%I \.5S>;'#4,<[>[D2>ZO=
M/A>^W(0<%1S#,TQ);S]>FJ/S)X\%*PT'PUZ< -3;KL@]%NF=\T%W@+PQRG!:
MDY>W9P+SIM8%L*?CJO3C_0&7;ARO[^*+6ZSK=]O#P?6W7+>T^=@4G\J)V;_T
M[^V75#4]7U(]Z%T$J/<C<B# WY%-T,,WMGUB3_M+_[PR$ "C:&+@)\?LVI%)
MZ<'684="%++"U%KP9@CRU,M709OLPK2E HA*_]_2WVZQZ@V&LUY\ $#,$8>,
MQ__ZIUV=-?V+N2PN'V%9_(PNKP$2#_H+MSK.-\^VWAQ^.-C]Z>GFQS];6T>[
M?'O]<QNN%9L[G]BW];4?F^N_'VT>;;4VZ>\'D]&8S:\?#K=^[I[D+3C?#O?Y
MUL<_H5W??VRMA^^;Z^]/-H]V3W?IQL_=HP]I\W#WYUY(6"L2,))<!\2)3L@I
M'!!,%(<1=9$J/+DVCA5WB5O)L "99,P$*[6V-@6A%8M\>FW\W%,9C?T<"^1W
M70R_L:VK#RQW7_P!N''MN)T^M'*]XW]GYVU2&&OM?;UR^ GO,1RQ"M8@Z8U"
M@'0!&688LMK)* RVUL9)N5IXEV:\.>!<^FT]V:/5^'H%>>SM)_!4NB=Y.]A3
M^K'T5MV9V"QWUL[5?]5;P2Y84[WW#1K5ML?]^.;LP]O0ZA^W[>F;5J=^='W3
MVR/@LD 5QE0KTX2)?6]U[T<_7S"(%3QB$>/3DN,WCW]>J7^:V,LW^HWI%5T[
MF[-_QBODVM]^]5C"5IAB]WKLKW\3[/J7EL8N9&/-K1X[/NL[X:(07D/5Q#[P
M7O?D5\?XGRQSF+Z)X.%?\^UU@/1>ZSA_?>TV>'.;+H\\K<7I=,XVG_&]CB94
MXT!"$WD<GO5H?(G'@UB'VR@?Q5!FG7Z?T B&9VG$54MSJUW6BSU"'WO=?K_F
MM>]LKW<*[:[_^#/'.&]S1.0V W&M5+W$ 5WS?G@TK&.=]4BN'76A;3_M+\'F
M#IKX$L>L".%3">&K*,#BQ]N 6Y-.T9O;"-=<17QO(W7W/F57&KG0C;RS;J7Z
M_V:>TB)TA8H%U[/U^%=L=X]C&'GK@^@/.O#J_=-;'W*;,0 S#W<N7-?_SUQ=
M7.P3>-?N<!SVP\3V1AZ,HLHXHR+CACD;18I816R)"-:EO8U96YF1F Q?_B)H
M65.%I;RB>F1S6/C'X$UG>(1"M_;U\A//=SK*YQG2')]J_0;M^7:X^?43_;;3
M/MPZ_'PX.HGZB6[2]R>;.VM\\^OO+7CFX>2I5GC'CZVCS1_0EO;VUTVZ]7&3
M??OXH;6UO@OMSN_;_[%[M''R[>LU=:0I=3I*CKQ0 G$N)3+.692<=R9JZK7
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M<!DS$VN9Q$9L+LKA)'8=B5T(9(0)RU(#6M@H#8X!R6(\]B[V!25,QYF.4JI
M%:]]>HX35R>N3A7?GV O>/PTC%(L]O-#QH3/1<Q\*87P4U#$L50L2,E.JN+'
MEE_S?%3!RW59E])CX7DWOZCNY.3?-OCZH*$J(-A?2QB24<45)=*(6#%)%>$Q
MEY0Y)W\; +3DM&Q"3,A"8\"HD!GX F!>2*V(;V*BA>(1C4S\Y!#33=8\=?,A
M;) X>;U'>5UI6C@)7D>"%[SY*"8!RS+J$T,82##Z!B(*?#P%@<J$F@ ;.H0\
MWL<$#"?!K02')N8)> A!JB/.B!14!IQ+)1+@")DJY\MO1UX7#U@*I. ZHGY
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MMK%VK@YJ'=0ZJ%V9S*=)*/#4@BB).06D592H+ QUE@@:IJ$K[MM%8%V(-HI
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M,<HC1?TD"IBO AIG22(TD11]M7T^%.QAA*D<9CX(S%PGL'5/H.D"6W<#RX7
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M?&$RZ8=<IEPIHQ.1/.)8YP9&Z\*DNX*N#PM@79CT84/M0LV$!I;.TC3V(Z;
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M^"*EQJ=I0AC'-OJ1<5%3AY(.)5V$\]&@Y$**KHE2PB.>^+$.(I_K*/73,.(
ME0P_%YG)-MPU[X%CI MQ.MQU(4Z'MK=!V\4N?)(E--3&3])484:D\67&4E]E
M*E1*JAATY2..<7YSM,YP=0#J@J"/$$H7D\MCGD0Q"V-?"R-\S@+F)RP+_3 -
M@E F,N TV)<@J,UY_=56)QS:R2"[YH.1K6)8^HG*+P__#?^T,ULX(+F1PL-_
MR_+7PS$YQK=9GLQ4G!#"!.>&\,PHH8QBU,1XC(-.LO2?E#RY^5V?1M4P-]>;
M%GD2?.O@96IEGJ2_>(W<GXSZ\)!L[DS%( I-$D4)"3,.4@[_9[&D$664$$VT
MK3FAV-$3:TY8P /R;=$^*8;Z15YEO:(:E?H,7O9;#Z[9KIR'QZ>-G/=!OC[!
M=9]./H&\?CI^\6?PYF_[GN['L^,O'^B?%&2<?3@[Z8/,]O0?[ZX__JTN).71
MQT\?KD_Z[_)C"B/Y_?CJY,6?X<??7WT&^>T=?WWU"=]W\DEUC^E'<W)V'/Y#
M%!@V@0Y\H1/I<Z(S7](D\$DFLS 6"<8$:NP%UM7J"$MP$RV"0*4RIG'&%=<B
M@_LPK)JP0#$)"Z !.B^0S\H1&$NG75%J[YV^&)595U2Z%?9FP9?P]K?8=)5,
MK+ROEN9\H$"RGM+86B8_EM\7=!QMG81I'*@Y[IL$/7PS\$[UQ5#WI2X]2@\\
MY/H#;]C5WF^%*)57&.]%7NIL6)25)T;#;E'"L)0G8(; VEXYIKYW41;GI>@?
M>%?YL L7F/Q2^]=:E!Z #GP\+*:O'EW@!S^M$WHWG!$9J4 )S4F<"!ZF)DYD
M2$*:<E(?@]I(ZC>]FPG7O*V'?32>VU$?U,"0S-:&#T9]7Q5#OWGP6(FGCTRX
MC\\^7/T# "D,BT.?@)7D\X2#5Q.KS$]-H$,2TPC<38P<+19WU:Z,S'L]7&Q@
M+N2TYT4?1.;:%H/'SRJO& VKH:@K(;*BWR\&-;,=>*"0@16Q4:RHVKL1;;7]
MHQ3VEBF&9C5#=[RS;EXMX57\J"<RX&=\TD6I+_-B5*W%E30#!6)PXB'E-%-I
M"H9#++3MBD9BZ;CR/KCRZ\NO_X ;K3.BJ4\I'L%+E?(%S;B?AIP0$Z1QI,+;
M<&6+<A9(.]Z+48E<A0PR[)8:6&\ 5F/^Q0.^''8K3P/X*^_HHLQ[]7.(93IV
M,,W;4[RGO)7<5:%"J^9=DI2)+ F$(4G$E4C24(LX#CE7!HS@IM\>"TA _#MQ
MFJHG^!843Z%.FQ'<ALFV[+_<OUWSXBCXQR@N,A4&?B(H0!^AT@>'0_E)DC L
MU> QBY\<!BNC./V6R0;K\D$8@?J+HC@,$LY#PL'E24@D%:="@S5+EEJLC@]^
MA'W[9XA^[YL7+X,W9R_Y/S***5$I\:-4:%"'C/BI-)E/3 B>1!P%8*P\.:0=
M^@V>J)<=55D^K&8T'ZX#F$M#T4.>J')P.6HS#ZY=1UD%84RHSB0E&O@8L(0(
MK0!59!PGE$FY42QY+WI@I3L66@HE'[[\(R*F0Z:,'\M8 91$*8"*"/U8\3C+
M8BFS*'AR& 8K%=8TEJS#!7?R?1T7_$@@(<>?/I!_PH1'@G'F:[!7?"YBAFHF
M]"77FL9)&(?8-8%\FR4.P-ZH+FI3N7?=\8XLJBRS47;' 7NG^R(? -],;-[)
M-6M9OX^.CUY\OL+])1;&08KF"!@F8!F"32(#/ B/"PH**N:@A));P$EI%P)]
M_$N1]S#R"$P!&@?LV;R:LXZ7!2#G@B>WBJPTP0Q..W%X,7QV450Y/NUIJ7L"
MF?C95:Z&W79'=.K&)BX;3&X1LBIZH^'J6U8%1.\[9D.367),_[M&(#8>!V*[
M93N%"W&N?5EJ\=D7!F;X5/2NQ'7UY-<90O3S@3]'^'F:K:2,,3\L>EO'U$"H
MB]K(>6JY#Z^",8F=&8L'SB"@XG]]>XE@A<ZL& $&/T= '0RK?_\J#I<M_RX&
MTU\/==^CG7:XVY 5KX:HQ7_O9U#+Z7(L!B!G?5C.<>@*H_^CJFJMLJ.!Z%U7
MN=6^K_*!&&0YF/#  \IBE;WFG:Y&O:&]Y,U%8]=7]Q"ZWA(S/3_ZZ^SUFY.C
M=Q^\T[.CLY?'+T_.'E&@_A2/MVHBE]50#"W[5-;.JI5N/JCU;*DOBG)H.405
MV:B^#(_'*B\0B^!*B5$EHTL]R+37A9]P*VZ(@(ET)4KE]XKB,T:NIEZ#D7G[
M NWUM4!C"\=RJJT94 L4C8_:\<'G8,@/<YC]43;$3TG*P&848 7T;=CKP(YO
M]G[R<LG]+[^ &3<XUU,/XM,/\G[&&U",:/!L^F+[$7GV"X9P=35#LWQP6?0N
MM?=Y4%S5HC0:U+^7>?6Y.H _,UTB6>T0\(+"'CEF1+V=<=7-LZ[7%]=>)D88
M0QZ5'OC9^ ,8!?BFG,2DX981B&Y9"^N!!Y)J35&D/=PCLFZN+YN!#0M/ H%A
MH"6(>^_:4[FQZS3T3%GT/8P'FM%P9(\VN\7S])<+N XCA_!-WK_HY?7J(\E6
M+W;'>[6:$7#2P$R]D=('GAP-+>,,BJ'7R_LY,M>P.)B^OM3G\"3<S-Z S'U#
M>/NB/ ?+!#?4&=J"]2ZZC\DV3TDRFX&S[$T^(1T:;DW"+<=&]Z28E@UAEF*Q
M->R>'"*S%(/S AD!10'LY2I'HZ3AQ'IKQ:JA\UXA,=+4!>;5((? GC6OX+U]
MD94%V$.#HI]GLR)61[R!Y1#$_OI<(J =-#(WOD/E53FZL$K.CN.OSFG'_M*\
MM=29KA4HW $/'\!C,= %0@F:%6Q]7=8W5J,+E(3FK^82.:K@I17<8\;J-FO5
M[4$K;CC)8JQK[?V9J+J>Z157S>/@64+FO7QXC>*L2G$%,'Q5OZ34%GC*9XZ%
M[YV%:S9M-<Q54?84^"P:V!G6"K-H:MXH[,I/N/.Z5J3Y98ZL-</0^!P 58%/
M'=A-1(3E\U%/C$VTH8 Y&,O?8FBQ4RA8_TH#MC>WVIW(HJH5=B5J8Q^9Y:(L
MU"BSZLIK1@,7C@;#TDH,(OH@ T^MTN-G@&;2+4*/,.[KC?<M6Z6"&D.4PYI9
M]7]&^45_K%[PK6/A<#RZLS!KU^@:8=:RQ #L#635!>9LPC U&,%]6=EP.H+2
MF"%J%"OZ%\5 SSVDT@"\ ((C-'O@??E%96VO*]WKX4_+M_G -!P/HYEAL^RS
M.&^G T,<5&B8VDL=<]T_<]4,-6:&' -88X4*RZMT3UP#-PPM#L P1FCNUGO8
M\!O>V */M1^!MY O 60J-->!W7KPQ(&-NDWIV-Q8L[4!M:H CJ[@MPQ1*P<;
M$]'H>NIU> \^VSZX9O21 Z,M\(L"-Z)7U.H!5F\ ;T.4T,/<KO!09]T!#/&\
M=9%:?>76ZG[7:L[B!(]/Y6!7B R$$M"X5[M[2O=QD4SCIK:+=3"S=$VX?GKE
M+787[4<>JIJAMFL.G\)PT+\$Z2T_:[B]&F5H@YL1^*Z.#>Z7#<89L?-+_?S-
M^]<O?)*"PJX X)]Y;F'N'4N'>1\^/_"J#+S'VO0>NR-F5%I'=^S/6LT\L'82
MV&KG!3@, Y1%T3MH_8NBO$9'%;<M#S"=3(.C47LJ%R/9 V>YJT$;=^UF+JCW
M6EIM5EG+#$ <A=:=O6DJKC1[/UB,<+-CF7MFF8L"MWIL".):HKMHPZ'7-HU0
M-+X;K/BYQH ;*N41< PN5E\[V+U_Z9[2OOH+K-50C^7X'-4EZ&)PM.M=YF;Q
M)J&#6O[ +\LOZN"\'FB3UXX>+FW/+O+"$V8^:+S^]G*OB=37(NTX8JL<@?XY
M5G8A'[1AG,89FO6Q)ML,4Q%&C".A]D S3@K<$,3+FMT8.5(  7791#$:CB.D
MN#DS%=)L;;AF:V"&VZP'7UT/=&EM.ILU88/X:,MUO3K-PRF +?/0M%V-7"/.
M)[&BHCP7@R:KI@UB-D9ZYM7;83,QG3EW00R'F,R#5@2X=:*!KE);/OVLKST-
MF%)<Z\;)PP0?^Y4>G#=;V*TY SRE!QG&'C$1"#08!ED_PX67>5E8 ^8F/EK!
M.%OG$D*WSB4PA%MY?H6T*S,Q$3UQ 9[=Y3C&U].BQ'W":HD;N!#6[MG%'2<+
MXZ<O1R5 $\S]KP%^>HR.)K#<"WV99S7?O!YX[_-A67@O<G$^ &P!'GPW"8F7
M&' NZYW!@UE^LKHKM[N8M@JLUF5?:N;"71,<VB2Z[B!I&Y"4H2^"X%-C1-Z7
M(S!.+0A@*F55JRPS$]F[$-=%Z99K&\LUO8O5B'"[7V5JS=]DC]@5! @OVHTA
MH[%0H->X@9FP"0>89N#U0*]4C3C/;9TV7+%DH]29H/>_^.>C7&F\O,*H =:$
MZ(&JE^.@L1( [V$<UN.ONG5FR*4H;2'CM%71F(56-]11A%&UL$OIEGB;6]H3
M)Z/9A\.OIX2WS4IRJ[35V'Q?ZV$K,6V*  HI:-5KK\I !D>])=:94Y[;WE(!
M;R8;-OE]0]WKZ3JI[P+M831R;#\6MT[;WM:V63;CS:PZ)%:[%[BQA6L(6DZ7
M)>9PVAWO)J6BK ,O5WE5YS(V.94VS702+''@N84@R%2L:FY#NMUTO-)>A?DH
M<SE3&-MH(JU-^&198M70Y@8WCW+RN^45GLYEQL6;CH4[A;C%A1J[>)/]?[<&
M][P&TX(R+,&9F_7+4#Z6I"ZC<EOJDZ_*9&TRPW0U],HV'(PGWL-B>=FH+&V,
M5[>%%J8W0E/(>?E;8 A8HKQOV4%4E:[C\+V\M5LOL7S>2>DV5-I$E)JDBJ'X
M,ATX6RTHC[*:.5U=S>P*D_>J,-E!S@_*_+,!)5#D8SMM)H?,)6-N40O4U155
M6W'SY4+;?+RB3HO'I/KS.FK;)/%(]%?E)XPW@54W**[J2I_IA!ZGT^\_'+BX
M/WVIP=B>K\#&2Y66L.SGI=9-T@,LO%NQ>U^Q7OZ?40Y.T/6!EXF+?%@78=O2
MDTD2GE#Z/R.1V1SY4A>F<]N%VK\& Z_AC=AC(!,5[AE>%R/X%?L!8RJJN;ZI
M.P"6E.NR7S5)8U5;CP]X=M#4X;<?7>6]WOQG5;<8]=3\I]FR#Z^6?8B@BDDL
M<Q]?]( :\Q^B8@37>?[CB7.]\)74/4R;6_B\=;\6WUL6GY:.IZ[,6/B\EW_6
MO05"U5B_0*HZ_K)P]3AC>.$&K3\OO/&\$+WVH[HI*?"3*-M^ 7;/MR94G0MX
M"QY8TF8!-QZ+0>^Z+4D9YZZNUW_A8$D#AG$Y[:3_PGR?A1Y&BVL]B]W,+ Y,
MQ1</-M)\8>V7K.K(8 7G)NK^#MY?&ZZ>(P]*:BU"]>8%]B7&#8\1#K31645[
M[TWO..I5Q<$WK\,&(S '&X4'NH_%H$Y+KJI1OZTIQ+6?M%NV&;!U<E#;I*2#
M[3WTQ=!>-=Z!:;+$+%UZXNH +:.&;G95JJPG\GH]"MEKS2>@I_5DAN)S$Q&#
MR=OJZ+JD <<"=XPNE!VL#8LU1=TV#W)P W>O[K)B7V-P/] ^H8F*-89 C4MB
M7&$Y>P7PA$V#&X?J[#597F:C/G:Q1C6%9J'M-3)50GG#RJ#$2>RCV/%>34N*
MA=)65DH[FS*7F*>.I5T-F^/[FH$W;#X))[81Q*;S1UUP+D;6O<"MZ\D0,!"%
M>43=<6.9P=@P:F0X!]US7K>4F>_V@A>/F[@\+_K]W*+1?*RR@;%W@!;M1%LX
MF[R_+I!?T?4&1O16P/J]?GW@V2Y5Y&C,FW^.X!MPB:_QA !<9%B%5[@=2 +_
MSYGZYV$7.X@K765 SHD!>#08(!0MWOT_=3M6M.1M[8YGF]S7,#MN/MYTP^%U
M!_*6;YK,\*:*=B0K$!(@. P2Z*E5PX\@Q']K#RR:'J*UP%VQ;S)-W0^F6K&@
MJPVB[V_;<KL^=20(=OK$D#?O7[Y[__KEWX^H%Q7P&$*-:+=D=7DP4\$]TV8%
M61# NY^/^H U;5IP-95[W&\2B4&/V'X!U74%W->FJ8W [L[J9(MZV]84V<AJ
M4 !',%@'XU9+3=&:K9  "?6EK@&C+$;G70]$#=6'30,8]^? >BKD<RLW=AO9
MOE.7-J5Y9K>X?8Y 7U#F@W%JM++'7-C>'=7,[4"7JA@,=/U0X0WTT*;$VST6
MI2^T74C4:#4<%VV#&ONDL9JUD=]:LNOM&PM?Q@*!/K=2^G0JX1KH]ANV!1EZ
M?UAZ''B_?SCQ3ELRVKY;8'!J=(CJ*SJK PH;Z\VTD\QLD_O/FG5%>DY1L:6M
M-3\*5)&P@K9C3&FUDUWX<9+[A)D;?5W:+$DLK0:N+O->76R1JS:4 RI#ZT%;
M]],\J>[WUQW!G) KT'J!=7]CN1 ?<STSP*D\AEHKVYJB HR1$1KS4Z.K*W_;
ML96C<>JN4)=H:."H@ ='DXS_1@2]G]^"9]1%^6Y^\5Z-QDT*S_)S,-A_.;"/
M.NOF@[? LUYV/<2V -?-,P[&OO8[\,*5]\HRWJM<EL4 )7'@G8$)6<_RZ )M
M2:]>9IOCL7HV'A#+4MA6IZ-0PYOZ!5:XV'%BA=1YTUDJ']C3/S"QM9]G95%G
MMU;]UCRRAE';-EU_&5GSWW8LZ>=#FWK2+(8UZ$_/7L OK:N;=7NB?PW#JWM1
M%8.B+ &([)7/SWY__FQ<]=4%IO/1P_'JABU3BWT!I.GU@)<O\W)4O^6/M^\G
M@;X?)!?VB4\Q-))GMY&4$MBG "+!M"\1JN&^ZF![53%/#NO35T0IJAR-V?%B
MPL*V8\VQ:NZ9=WR=%> 95<!>YR!W..51O_9^_]#E!=QQFM<5)W8)X&]BOZ06
M=P5X1@T(P-? O[U" .?I:EB-33JPNL AFU3,_*$O!/;*J+S?O&99)Q\];S^J
MUS_O]T>#0NEQ$=44'[Q^7XM0?25*5U^?BUXQ=<WS8[@&QV$-_%JT6WF=2'8C
MD!VLTL&@6=W9;(QN$I2W=7WKM2W:8L,,#]11HO[4#KX1P';B,^ UONJ@5I3]
M!BO&]3QYKRX:JP_DP;YP=?=H>[?5YW CVL4U)-AW>6C;F@(NJU>B ;QJ&A4F
MBR$F""UL,2Y6P<.JV9*H%@IF$R!.C]Z=^L^+]SX]&*? 3PDIMC@":_MK+>/(
M;^-/#MJJA_$;JFM80%N\;1>HYDI;05'C+I)L#DS'2 G&O 9/;71QCMW$[ [;
MU/JUB]:FX:.K-W[4U.*V5?\KB_[MJK>VFZH3!\1H@ G(]H8&AR=4:9:A1?*%
M[W]]U1LUU_RL!0 CKF6K;*J6)>W93'@VV.R8?QD_=XXL"^__>?&92RGYBR7#
M,=Q1GTH&LWW^TK=9?O"BJ\(VLYGHEE8]SCWKY6_OT1=$PMNW(V_-"_G+"WA?
M/O!_$V79"N2*V?SV/]]^G#T^[7_J![41M7:\C=0A)]4>9 DFWN0!E\CGHN=C
ML;#W]OF[]OJ;.*Y]14L 0!40AK%CWBPSH,OTP \PKM&V.IQ[++#IJ#E1:X"G
MEL,]",$@%];2L:^Q+YV8"Z=V)*C-)Z:2U>OY8&)*"'0ELC9Q::QZK9V-V4YH
MQ)03F^IV-@>.)T?0N.A>5P"\PD8];3(-?-&$&JR^KCT8'V/<GLQ+M)A;I0#*
MI#;)6Z._Q+C."+/XVY9ZS__W]9&/1D!N,-K7$[)HH,(B* ;0;&WCN/1:UN9[
M,ROK.X!CTH=)H%^.9;WVFQ_JF^^RV5Z[W4#9&3^G-=AK=0:" G1$+3W1'=@Z
M#W-BK+9!VL\2VE;*3)BP,=0%7H.WXB%QEAL/VOO0-=78B06T>K=AU%FGLHF)
MCU_:6NKL!:BN<[LGU1>@(P'N@0DGCB]ZPIAZ)WK7M2]2F.&5]2F&>2__:H7)
M\I.-SM4U"?FYMB%G>+O5:>AJ5L-69D8]D,D*CZEMW6SPNT%3]ZVMFP\NP4P"
M"&EF)O/BHKJV-60V?#P>V.SWUNJRL%IB,+P 66QJQD!(+_!P#=#F4W3+T!MN
M N535+&IOLU2H-XJ;;%O0]VQFU/; WW;*K-U6YJ[VL !(,X08^\PF%/P<,'V
M X<)QE"-7\,F?Q\TQ$0U"4^]1B!#(Z8N^(!7VF6R*]$H\:I;@-H 2N9@RM1'
MD)Z/K*G00\EO+FU@O!Y:ZW-=Z3KX:+W RE[P.XP/[H5W'$^Q@/XB^H_6'Q\+
M]DS$8JF?>U)<BE,,4K\<*# :A]9P/9)-9>II8U 5DPMK+_7XNK!W_8$7E 7V
M8P(\/<NK:H0'PO:Q6G[Z[N;Z^N97:/(-\0?HE$D/_['Y5K27U)<?8=&!\-Z6
MQ?O1ZA5]C"E_+-A"RM\R@=B%J/)R$O4$N!DM?UH(-:4-^8-S*%HVGV*\&68;
M^Q.3K0IKB!1%[U2C8X);D#U0F*)G87/B735FW7_#W-_A:";A5U E@'IE;;V-
MI6]R:VX/GKO AF&JQ<#Q9<__]^CT]/5S^_SQAT<OWA^=/'_Y CV1O$W*L/B.
MK;QQ;^-@]BGOP^;2L>LY5K76V9,#W'?M>=@-"PCJ@?ND41768VY%OQKE]49D
M^]K&7K !U:+9NZR5P"6&^P!U[#:AW\/$NK+!"$SN17LR5]CJMNA=7\QL5$\L
M@JF3$W!<C5W?8DDUMGX%YM+GJFGO,H4KXZHV'$W5I+78H#%NR@,7J+I_T'2$
M#,=19_J#3N_.8!T\"#0G$*(9R!+&:88SJBV#IHF5FAF.C9#,\.C$P#B8V U]
M,-S;&*=E8F\)%Z.7BNL(7HX-T:.Q.[R^J%5I2^1ZL&,.GN*[-A: %#XK,?@
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M>(C<-:5M>RRT=4O8Z0*G"W:,0<D!C9*[UOLX;>"T0:T-DK6;V&R=A9PV<-K
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M0ZZ?BLV;5CZU*/'S8H"J=?R<YLL+^*OTKK4H.][S-6;9? >/R4HM*AC/&G.
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M@\[1TTG"G"FA4@J@3PDB68(8+@!(!TG$%-9Y E)%ORC$6F/D40<:GJZL,9]
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MC4G$<#2A$8X2!C2\?WMEL/D\"F^A06!*F$;&S=67FXOK\/<+&RN(LOO8-#X
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ME2180.(TSNL[SK!ZK6A<I$Y6&Z]C25X5#E<M46&Z\HQ7,VE^BJ7A2") Y;P
M)A]Y+Z8?J[\MY9$HLK?09J'>+K6:U5U4M<15>>IBS<ADRA)1V)S!^@LLUYF:
M:S(UWR)OWWW'%%S@XI2$]I<PCA<&I],R]YV6V3.MWF[)42>4CJ5IU;1J6C6M
M.BWS/!(-=5JF3LO4Z1@ZUTOG>C6(C3HM4ZNJ5M6C8*-.RSRM^=2)/IH[.@U*
MIV4VA3%:XS1WM#W2:9E[&/#2F\AZYV_M3>1#0['..L3RF.(K_^<O ]NR7^\Y
M$J])099:AK4,GZT,G[L8:TFN]]!TU+N>X(,SHUE)FF=M)[61;)*%U#)\ZC+\
MHFWV]Y?6=A*R>^[B>V02?#XUC,_037T!_S0L[_;P#NKJ,H%R>!=HH2CMI#BT
M<KVM)J>TK,ESHP2?L1?%B?%'RJ($<ZG&\$$,,T;5Y%K&'3?HR)_2AS#/R_A2
M2%*ZFO' I?-F^&IY+M>=ETR--RSXALW#.Q&(1,OXU;PRC:^48A2"Q+DQ=!9Q
M(XU%[M*<4>H7T0@$S P_9$$I$:Z80F8-%KJE5"PG# +N4(H349%,O=A((F ;
MDY]BPI2#HN["X"AABI>/TITIBR:4WO@<S*0!,^'#BZ:ATZ&*TO0IP;*!'T0]
MP1<2'_)ERPAXLC ^G1&U+".J:_5VRHCJFI>=Q\@N&+:7?_N03(B!IO7,:>UI
M>=6T/A*M.B/J+')\=$:4SHC2D= ZS4*G632(C3HC2JNJ5M6C8*/.B#JM^=0Q
M]IH[.@-!9T0UA3%:XS1WM#W2&5&[#WCG0G6;W$;J$*>S"G&RS>%IASAI03X7
M0;:T(&M!/GY!;IN#TQ;D<PXZ[0R::*8.'W>J;:2VD5O%;H/?VJC0;2W%6HJW
M'?C@U--+M""?AR"_L*USJ+:\01N[GI<V;TY__'&+Q* U*1F=RX.E\_SXXV<>
MX6DTFW C"!-CQED DS!._:4Y#S)) 2>1:LR==M:3A7'![\.HICI6L2I62R0)
M,4=4Y\I+7<DZ8!SK(QG,F#"/"GH]M\V!R@HRQE$X$^U3< 564:(B83%UA_E*
MM\Q/*9O(]\;X/7PCZWT%2<0<*F^5%7#"Y*:L-!@6Z^)!+"J)S7W@G1MYMSS
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MB,ZFB$Z=>BRJT;J*OYF,K#6-GONW9^N72JL]?+:-A_AX\EB?GGS#)Y2 _D6
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M#^Z]GD$\L:X.\#B+_^6ZLAH:^E;C,A_J&$H7!VB$;)X!++.N#'"P%:CSP!
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MD(4[I*A5Z!PY(13A*;!5T?!AMD8>,":1<V';R?+^T8%#T"_<:\=<KL_83'Y
M%926]'R@&&,FS\*@%40WBB444P; H%#,5%2I@UNM/$8,#YNZO7;3#IMJ=>\P
MATP^HBD[17I$[+X\3/?&+74V$,Z]0/J5N> 2$!US04E$P@E!4'ET;S BF:#Y
MPLCD/.I//>; JW1YP.(P@(?O,SES83(3:@:H(ZA""B;,SH]0Q!1@V;U BL',
M@2@_CLB@S.1I2>;*82ZPR)RE[8/0G IB(8OC5%PIQ89$_\@V&W1&*-WP7/@D
M-!?N!<(Z-?H0X!E002NDRRT>]P2L/4P%#D^2.L9R#$@17HN TZ8.D_",'@L
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M\M7X\(%2="WKM?'IZS_>?3$^_/K^TY>/5U\_?/IUY[0VN]_XM#;IRRP];Q!
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MSS3TO__G#_L"I95_[UB6.4U@[W&-7!X#GQ.9&"BM8I84>/WNDS%/HSAEL%6
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M502IC@YA>0\9ITG($XKPU'HJKO(8\7BO3\@5_@ZU]6="*7D6=9;VG1K<D%*
MITXSB4F*$8_?M/&LD*@Z1M85JD([!-(YI&*4X.C)>O"J<A@;_\-ZXU>X.]3*
M8N:<(ZYL2UHQP5R8'\0ALF[U-@E&%([74:A(2_M 55Z'<+F!/-UU4E%T2$<S
M0&T]M'I>(Q::7RSD9%M?P:]2U%\"(2Q0TCJ$A(JC?18>5B2W'"!F+@&*!F83
M%@>:[ZP$]96DH"JJ0T#<\AFDU?CW)18+QKD+'*TBC*!HCK<2MQHY#RH2.X1-
M[HF-X#2?";Y",J5@,4.A.T[6XHR8:7Y[X3/FLM4T4TKO*(#I./\ 7JSG_2J'
M$0;-=<_F%<7>J6;F8BV/A.\[%/YM:MB$1,\HMMT,;)-@A$'SR$MI02HN[0V9
MP X!<T=))#SA;T Z6]Q^]:OS&4'0W/!,1E *Z5###\,PF<M2"'8YG6Z:8F26
M8P1&\\<K,K.YOM,I16KE?P\7"0UG*G/3;@F\QF6$0?/,E82@%-&A)L^VS.0A
M*ND)4Q!R>;;J+&%<3)_TCL3(P56WE6:$2'/;,\GI::]<=GH,+)<>_)K+[U(V
M2=8P#RK<[093QF,$0_/;<S!^325TJ;EK=_><&K]-@@F*0\UM;]@E["(T=7M^
M3LBT"# "H[GNM5N'783%8<?/"2UWN480-5_>>3^QBP ;MJG<NJ"5+".0^D:^
M<>.KB\A5=J2<4-+YC(AH@8&*C"XV?>T6BA,(;1*,<&@A@I:MF"["4[^MXH1/
MJP@C0%JHH&E_IHOHM.VR.&%D(<B(E!9-,&S:=!$PV^V6C9;KED*-0&HQ!Y>=
MG"ZBVK)3X 2D68X1.RU$T;[OT$6TM(T$)XR:N$W('&D1"WTSHHMH&'<3G-"Q
ME69$2PMCV.Q0=!&_+ 2:3Q'9SW/( 8H=P[ -,HQ8:=&*/"Q;F;F*2&TFM8,0
ME?,UB+>!J46.$2HM'E%"517[!E<"LW_&2_EB(Z!J)1@AT@(4)43Y7^-EH$K;
M871NY*0M@S8;(:-Q&U&I.5&0HU((ZS(>]W .A% \O8-4^2+"Y;P=QVBJBK=A
M][$1:41."V!4^U.F(:BH"$H=;X :6O^/P2M ^L?@#=1=@YH>G!U&D1((8O6[
M$C5PZZ"VTHPP:B&K5+)<[A?"TV>K(8X.(EB[6U\\+.(55PB,48RD-YL11@3?
MPS"A\N2;.O^?-MXV20+;J#7:A!;]:LHL6'E3B:U4RI(S1(&PFJ(XV34(F15U
MWHCN21Q?$/H,:.0V#-A*,T*N!<V:(9?B@TS^VSB0-TPY6FJC\#98MHDU@?K>
M.D-H9;"O&>:[A&Y-YL^&GHZ-)".&5LE$G7>!ZM*UZI[=95F]=Q2%4.;NA!NL
MO7:DS A]\W&BE3RR^J?](%<?*/U!68!.6HA#BIB;-6P@V(B\%B/<(/FL@QBO
M7#'A&O"H837B5!,HK(CI) :&K#VY8P3PDI5D3FND3:4;D=2"BQ99@NH" :GO
MSZQ*WL4U4SLLVZ^-MU!@A'Z#FU'>%LSVX%]B#D7]^)<7F:<&,X(IA>JUX\IK
M%ZJ,!J&%Q*P,(E<>9-H+LES_VW1@1&P$,2+TAG#71=C6:HQ&H6>$;604J>I
MZ>ZD051RO5M&[0VRSUNE&>'5XE_5G'33:-]5 .7'ZZ(DAK>3LYFT>H2+&-;M
MI*3+CV@Z]ND=*#+!_IL6(5N%/=<;W$Z"5'. <#6*)IZ7',59U,[W[ (=4D'G
M F'AJR+9/Z63I(;(C2W"68/1%+1 VZHI5$ G*Z 72H.*UJX;P%> L Q$D+*C
M_AU&4\CN84BF&/U'3)9X>'MVN;$!.&LP&H 6;ELU *DP/P]#5@:!5&]0*I:#
MA%3=22MHN:+/R>4SRS$BJH716B_\ZZ+O5GMP3!JR:)$8J<*1B=RK#45SG:,X
MD1\FD#3#N?S>HANB.U)FA%V+RK4=:.L'JR60H[LJ@S*0K!09;5:.+AI*_0FV
M^J>9KX-PT^<L;A>0IML43O;SNF4PFI46(FP\AM?R*O<#Q0S1\F6.LG!OMI8W
MW?9!1'>Y1INP/YKY%C$T ?P-RJ^TPVCX)(Q_*A.;DOE"=8)'+D9GL:[B1"VX
M%/OM8E<#R#9ZC0:BWR_5;"!Y0?I928)*48*\+ $GV;)320JR\G31C-I.[%[B
M)U$Q0EU7G6XRC?!K44/3@6 9,BRTO(&Z"L!=^D7?Y9UXR\7R3'YG;%&&]G<
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M-!"%K&<[O%Y(-0C:!9Z\JGU\6A\][ 5X3&[UPWET99_ZT6S8W/=^BPD)"?F
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M[>I^'J8,F)SJ4::1R;6^U_GRW<^(, \2YZ9:_2.M79?PMQ+X=YP/F+2)^ZQ
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ME_V,]L#5D:N["]/C.+O'ZNQ."API\,X3M&[@$\P3!JX!0]!D6G@/(7@':,F
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M:0&1FUSOS1$05/0@"FJ>O+.!M3[L/8&DZA;:N;=$_!#1=N S; D+!D?C<-R
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M"2QX5B70VL.Z!]-SHDA3^7>0*/8;CG$:1H3O1?Y(<JX9)#4.?1ND9(8<02=
M6B&@-NR$$)(#AD(JSIA-J;4GLQ>PY\24]IKHI9GJ]H#NBYP7#PZCU^,RF7Y<
M"JEQ&/ZNEW056M][8&OA\E!H4M=:>&V$BBB\9+*>ZF$ND2M3=H3+[WK=HX?
MM32Y>&M(5V0(*:<$>,T=:"_JX&32?%VSSS4$O@>"Y4T_L]_HB_/9Z_$[G XG
M>:!X(1(4 UP63LL_)SO2DAV9B#K)"D3;?&5M.X(G&7(_A+G[A=Q[(4 7H?H'
MQ^2V#F<M7_67+SA-PQF^FPX3#IAR@==+SEB,M:PU1AJJ(=%CX(HG+RQOW7"Y
MQ^%]GP@G0ITNO*@CY_R-3.U5QYSH0N+D_]5&H63')0PUN8.\ )&9RCFFG%K?
M0-!\$-\9WRL-.O#^&@[HSNF;,HO%D\,2:L!5H4:(#BT$J>EG;T5@)V,I'C:T
M[W/@!"C30:'3@X?YRW]?#.=?;[2<7K3J_^,\C+?;?[Q$$=!%2%@;[ FR!)W*
M&D+D.LL8#/?-,QQZ&MOWN7$*I-F<'.JI3(ZU!6+QX<]ACE>WR S0^<!T0,"L
MJO<4(D1I-9#?5"^A"8*LQB<Z>^X=_/?I]21HMSG_].G.O]\GX\\XFU\U]LS6
M>):4!69X/;T*U>]" ]85IADS3)C6E;J]#>[[_#D)VFS.#W-L[['AQXN/?X3I
M&<YO%TR_GLTN,+]=)J'37%]$U,<)%Q,_T< &EGL1Z[$^SR*#,K* 8]:#DTY;
M9:..83U$M;-5V8-1?#/$[%=?FT2SQQ$M?+D;^$):=Z%GQ=(FH@I$6^OTD=7R
M5YHF*2&+PKE@R_KJNH-MQT+YQBC7J^8V>>>.XMT":+Y+=.]I+28G>E%#0R/X
M+_J5W.V5[Q"50_2.09&*T=JL-7@5'#";2X[,<\_WZX=_'(YOBW$]ZFR3;OY8
M>_.7CY]&DZ^('W#Z>5AOCMTFR"L;8"&SV1^390^NJ\]K#MWOD_G_A_/K6S\'
MF+BR(EN0G/%:\AK!1U.@>*8RIA1L\][]G0WFFV'T:=%BRW'/T:>BG8UL.9]_
MG4Q7?ZK?XP.3C(PT8/!!U&32VBPL.]*)MZ$D#.BL>"JS8.L(OT^-TR'0EOER
M_/EHLQH?C4F5'!@857LB(_F0H9[[^EB*B(RY]IGKWV+!WU%AA$=1]JD4_"WA
MTY<7-26<*Z:TK8VWC :5ZD85R"-(3&8F6"K&M+Y1Y!: IU_4=Q 'UIN>/%@7
MCY$CLE,0U\,8Y]J=XT;GCWW&U%'U7Q?C>:3F4 ^G2;.4I\8Z?BK\=2%ER[0
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M]P4[$7:>&C.<;%I;B_=W\\7T2YY]S.-E+#F_&=W.WY/?/@-<K#.ZT21=>*B
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M,C R,S T,#%?;&%B+GAM;-2]:8_<.)HN^GU^!6\/,%T-)+NT4 M[EH/T5FW
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M;YH7\5(O/QZ-\FW96T!*=F$0NBM^9(6:(SW6\& \])S2RM2ZL'I 6H(5A#^
MHN2B5'/@$^8</;1O<Z;FOY5X)=K_?9M_J@OV^WVQ5FU4KU57]=/'8KU^4Y1?
M2<E7<>IY1*M;$*811$F"(18BA91%B9=X/O>BV$8D+/M?FGCT\,$/O0%_ ED.
M]FWX(VBM +]I.T!GB*6VV Z3F>9,2/[$6C0![]92-9(]1Q)FV_NLTC:2FN>2
M-[:9<5+XH2R^9'K[0#7WJMC06F[6MXP5F[S6DR.1<B1"&)# 4[H7"4BYY# )
M/)P@S'$0I3:Z-]39TD3N92EX5H-W1579J=8@HV82Y8JGB?6HAP0^"B:R+X2N
MQ0W8XPV\_O8H<JU7'X7>I"+K/[D3(A..'*G.8%>S2HR)T<_UQ.@>._'@(EN]
MSFLE1+><JR>J^E!4:I7W_V6/+PLN5FI!Y:4!"R'AV(<(AS[$)(Q@S$B D."A
M1-A$-H:[69I@M$A!!_4&M&"!0@LT7#,1N<#LL'RXXVMBX1A+E;%(F#%Q0AXJ
MP?Y\5WSY4370*H/Z82<(%YJ=10K,3.M%P/!JN]=?346^K?1$Y%&?)?R:JSM>
M;JJZ>!#EKQ6Y$[=WI1#Z3]5*JBE$D(H8DH@BB$+F08Q]#E,2I#0(4<HP-Y$"
M\RX7)PL]:+#1J 'K8(.-Q@W(%KB90%AP/RP6TS ZM7!LR6P @QXQ:""#V^G(
MY-W)67/L,S.I!WU/1^Y/I9ZSD0<],P"D!O6] )2L]=D7J.Z%J $GM0"%!.LB
MOX/K[(O@-X"+QU*P3$_^ *DJH>]3-Y-2 +$=K<>UZI+K1K>/_[H[0JN +$KP
M]3YC]T#IE&HEJT!>J&9*DE=2E&H^">JB0?.R>'@D^=,?JVTSU9^O_UC8#UKW
MX5#WZ6]#Z"&O.;3[5XN69OE6V%O6?S=&W#EN_?DFR_4#]DZO=#_JD^;W\M=*
MW.H':44(EVG@!U#$@JIYI/YNB$"HSPCWPE0DW$=&'P^#OI;VU>B@@@;K#6C0
MPD)"A1<T@&\ D0H(4#/YS<-FW1SFWSX499W]3_-:V:U9AT;!;,GJB-N)OQ_3
MT6J]?C4@S-'R=:BG65>O!B8_7[R:W#+V#."+J.I&PMZ0K/P;66_$JZQBZZ+:
ME&(E AD$!*<P%$D(D60,$B^2D/*$\C A) XBNRW_H>Z6)C_-H:WM9OT@GZ9[
M\ZY8FGPK?@OT!FBHH,$*=F!=;KF;D.)LAWVPLYDWU$T,/]X_-[IKG&J\$K1^
MFU=UV4S(FY-N$41">DD,H]B3$ 5Q#&E "0Q(ZL419D&,K#;)C[M8FCIHA& '
M<93?P DBS23B.GHFE@5+9JREX+SQCE[_$QW,^LJ?-_#Y:SYPY>B3L$=1UD\?
MU(C6MSG?KGZ:=?&*$T0XBC@D*4D@TK,"RE(?I@1%+)$)HBQ>U5MG)Y,SGH'N
MK%[Y,XY<+A_L'NV-7LKK[8&<[Y;W-^"N''-,-D2W\4&9(Q(G%H8=?Q^V_+W>
M\??3(']CSL8,:'%W.C;4V=SG8P:&GS@A,[EKG*R\RW+Q7K:GHF\(R]99_?0S
M^98];!Y>%&59?,WRNY=$/3;J]ZN H3#!)(0L1@%$C'LP34D*?21H&.$ ^;Z5
M-Z)-YTN;97P47XKU%P40L/9(678& -I#MY0<JZ$P$Z"I")Y8CC1LO9';'=;W
MR&] AQULP8,>O3MU&L.9(ZVRZGI6Y1I#RG,=&]7&: _*XD%\)M]V*ZM;JB9C
MA-4K+GU/38\XC&/A0802#*FD$>04>TK%A/1I8NDM>:ZOI6E6"Q4HK'L[ 6H5
MT,&U]W\\2[+I?HH3ZB;?3!G)VACOQ4M\N/-4/-O3W%Z)ETP^X8%X\187VR?;
M[9E50E@BD%(+SX]2B(B:_& J).0BC%D2\$!P*P?K,_TL32Z:C<,OS<:A^AAS
MO7F0;5%?LY^R8W;,ILHHON;=69E\T_4"(Y-LM^QZ^8Y[+D>F#F^\'%\^PI?H
MA79TKO\JR+J^_UD\4%&N2(BBP*<,2A9*B$0<0!HB#C'&'/D,^WY@-(DXT_[2
ME*!%"%J(%LXK)Y@;?N,=\#'QFWY !?BMQ6<X<SK'B87WSG7<S.2JTW%TWZ!T
MY0)SWO)!?Y<3M\WGW'(>\X$GR\!EHS>+F1"\>J/@O!)E]D4-^!>Q)XO-N;5:
M;]TR]8>LSD2U2J*0"X%2*!*N)SF<0!+ZOA(W%@I&4QS&5NNB$1B6)GN]"6WR
MB9T1AU_ZW@ZP,\1ZK]EZM(PWH*<<@^EWI1W3/V:K>BR![O:OK1',O:D]EJ(3
M.]VCFQKIWU>4(KO+7W]C]^K)$R^+O%E'=M_E-.*2QU1)(D811#0D$(N(PA11
MA!DB@?J5E8??4&]+$[\N@$_[OVK0@&W*4N3L"; .MJ7*#5-MIF?.")Q8N3J<
MH <*>J27)XSVGGHFG+CRU1OL:UYO/1.SC_SUC&X:LT1LPE\_;<J[C)%U]TQC
M(CPIJ=2+Q%0["&LG/>S!2# 4!I1++S22C[,]+$TR6HR@!VFS*#K%G\E2\4I6
MIEXL'A(R:KEXBAF;!>.5#,VU9#1\="S7C /&#Z\:3]TXX[IQ /?ARG'HPG%3
MHEO.FT0F9/V!9/QM_I(\9C59KSS!$R)1",.8Z;#9A$,L*8(!8B1..94$(YO)
MT)E^EJ9I.YC@4>&$60Y9B]1N^G..5K.)CP.R)I:Z/9XT1)WYX^4%GJRG.A=8
M<#3).=?+K-.;"Z8^G]A<NGR<%'SN8MRJVYQ_$N673*^]WLMN&4;6NY59]5GU
M4)W^TZOB@63Y*L$T2$(?099&.DM1BB#VA1*1)/*BP(N9YQ$;_7 );FFBLT6Z
MM]51@=]:L);']$X'T4RMOM?03+VJ&S<JUC(W!7V.M-$IM%D%=0I2GZOP)'V,
M/ $@3VV,25'N[ZJ]K^]%V8:@'.XGQ]+C)&$8"J(S(20L@32()61QA!.J)5KR
MU5$JU<L;T'8PC%YVL_2Q3C>B.RN:6/ ?#K:E_P0:6\#6F/&G )8C9G@",,$
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M4"Q-O1OH^QOXS:[_[7I=?&V"J721N6ZB]*ZH*MN,C>-&RE2()N9_<IU2^&]
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ML?G/EY+F-XX\\<ORK!;OLB_'=5Y^)O]=E"_7I*I^48]2=\K$A(\BGS#HQ6D
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M_%EYP#GD<2:%_*DLJ@J0AV*CTP56_1R7=FD:JR9-H\Z:HO^R+O([N-:A<C>
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M,$TXE$DS+20QI)$(H!0A"0*/8$\U;IZZ:20,HX=W_C1-#3Y8*( WH,O$T8:
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M684A@2&/@E1PB1'E5CG"1\%8FCR^45\LL@;JR4TL$X6/&P4SU9N>VXFUKS4
M-A: Y].ZFZ:\%=.ZN&_-#="& &V)PQSB5S'I*H7X.!#S9A"_BJBC!.+7M39.
M&'7(IKKI_C;GK\07L2X>FQH-;1\K&B,6QF$$<1S':HV:$)A2B=225?I^S#T6
M$*L#J,'>EB9S/=AF4<IW<.TT;YA@,VES1MO$"G; V![2OC2?.XDR8L21$@WW
M-:O@&)G]7%?,;KJBS*XN&_563=^*+^U1TD^EFKFM(NJE-(UB&.!$:0?E%!)$
M!?1E$@4BC 7CR+KD[LFNEB8<6Z0@VX,ZH@;O:6+--,,-71,+QHZI?90WH,'I
MN$[O(!<N:_:>[FC^^KV#!I^LY3M\QW41<A^5].0;\7)3ZAK?*RK"* PQA93Y
M%*(P2F'JQPQBF4KABQ#'GM7N]^ENEJ8,/4I0MC#'Q<4]H]),#ZXG:&(MV'+3
M(;P!'4;W87&G.7 <%?>LD^\2%'?:T',Q<6>N'ADEHK--O= IF?76CIIJM''^
M9:G&O%&7%T^[2SZ0)_VKVZ^DY'WUR3XA?M7L#WV^)_G[QZ9BTD^JB;IJ,O]F
M!5\Q/TZ59G"8""PA2F4,28 DC%-)$N0G0<B-SKSG!KXT;>JRH=]ID.HMU*GS
MVFS;EOGR9AMX,]U;XG!.K*2-/; Q".P;#?:L;@):]J[K+ >-Z3== >&]JB15
MMQU?*_M!1X">IVD*=*Z(E@2',3$S#YNK0)JY8,\;?3/S8!R%[,S=_^B]M+K,
M]!YMDX+QUSRKJX^??NVJIV$_H@3S5'VBXDC]AS0%JD*8I#A$02BBE%FEA!CL
M;6D?EQW8KCK#1L.UWDD;H-=X)\T-:=/OI/5\M45)&J3@!X55GWLZ+V9LQ(N[
M_;2!ON;>3[ML]HG]-(.;QDG(:RD%J[='H)_)MX^D%FT\]R;+[]X_BK*KGAO*
MB#'&/5W_7*V@"=<I9CB"G 8>84P2EAKY6-MWO31Q>;DMI"1Z&T!-O@$%UW*%
M;4&_F=Y,0^K$XK,%W;M;*-A X]9) =6+E:VS[O#Q4FTD:QVRY\N1*%ET/*M"
MV1/R7*Y&M'!M7HAW6:[^^[(4/*O?$-:5L]OY84:"\U@*"B-.,41<ZFW )(:8
M1Q%.))4>]L=E@[C0\]*4:S\!@8:N_[<%#W;HQ^9ZN#0*ANOG*;B=>@%L0FN7
MQP%,XB)KS9KS1 Z7^OU.Z1L,Z3B?M,&T@7$:]F)3J?:K2DTI:)8WLGC*D5R@
M@%$O3J 0:0!12"1,?1Q PF2<>$$:!79Y1,VZ79IZ]:C!'FQ+M3+DVTRJW+,X
ML4Z=(G!Z]WT[FAP)DV&GLZJ2'1'/)<GR[A&I8T[TL,WL5:N?JHQW4[=NSZM:
M19Y/HX FD(98S:QPY,-4D@BF.@:7>Y$4H=$FT\C^EZ90.[B [>,%CRU@B]PF
M(P9C6+5FH/@[R-<-V./\P(";_HS!\!,QEG6+M#+3LC]3;AGGHV"7:68\AX/I
M9D8T.U_.F?$V'R2>N:*9L6&IK-1^/J]$^[]O\SZ_C>J@R?HG8A][/ A@DG(!
MD1H2F%(FH?0QQWY"$8FM4M->['%I7XQM"JS'%I]M$.HE@LUFLDYIF_@KT&,%
M/_1H_Z0/A+=$?KA Y(CP4T-RG 6?7NIOYM!30_./ T]-;QPQ5WU7Y'>?1?F@
M<YN_I^OLKET-_CVK[XN-%K,OHJQU0,,O12VJ58K53!6'",8X5@MHGX:08!+
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M/.[RT/=A'VT >6_VS;_(1Z,^L+S?R\)_+)?R=BL?-O,THT4FDP)0&.< 850
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M:^:4<D#R3 ",>"9CPG!*A5L'W,N#6CT$H[:MW1MJG@=>;Q]MW#?3+ "W8Y!
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M&"/%1[:@N(5!I]WN#7A>7#)>:'/:UH,@YLQ'?"OIV/9VN=FNJ^G]I.>FE=[
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MHS$S:NULNS0,H.-@@T@@[N@=:E3VL''Z)7]877.U0G>WV'DN54HS! G(L4
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M^(/^=C5;9%"F:<QR!6A"4H!23 "E,@$(LXQ"1FDFB']WXOU 4XLLFC932],
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MN"Q 08A1P,\R0%*. ,V8D F/DYQ;K=W.W']J-%&;&%4V[@Y&[*CA'(+];!
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M&KL8 PVW5"8Z+(R/<;/8N[@*C8$9X0 ('TF&8T0<5OE7(3/2 MT1(;=%]5D
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M*%!1K$ZS>TM?G=XU7H&K3HT/REAU7^6WVJF#,WZ5FZ>5:(6$;5T_B=1T)&*
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MG[_$TS$[7\XW\L/\N]1KF(T>C?FNA>2'^5+>;^2W<D89XIPG"6 2(;UC25)
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MC!!<R#QS6Q192)T:A31*MPMSM_2.]HK?>)5+MQL)VZ5,8'P'7\N$@M9C1>,
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M3&K0!F:VK:U1R]B;:&]NU+9W&^"RM;A:IK1LCAJC;YK.Z7N[FSO#.3A&&Z-
MWI'A]1W5M3(:_,=^F?$$7QEHWZH3<,O*RILZ4PDE@JH42,KU]T68H)TBHT#E
MDHB<9!F)_4+ESPB;VL*Q%1'7+J'P^U9?W\CU<SC;T7PH] 9F:'_@_$/!>Q )
M'<Q]3M3KA&/W&-T94-UWC^_9E9*:CD239KBGIQDD5*2*Q("+/-'LP1E@24$
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M-\N26U72U4:&\BP\$Q"%\8AJ$\$8[L!3*4UPFNHSLR">I^$PE#0<NJS,YB9
M\_YCFDQN51_Q06I)/'A5#L0D%#BN+% K4F)H52M3PPW9G/,P4#0<RCR3C4V
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MUPQ^F::I)(<X*S6SED#( >W4R"0XY"R4I\FB\-8ROZ^EP.DH?D3*0#UT+X'
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MD\0J,)PJD,1X/*YY3*)Z(\1=A+1@[5:!Q_EL;@ KZW[;.@43=$2SBTJ!WGW
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MTCY=HJ(<CXY: I26OC^ESZ;-E$*TF27ILXJ^]HW")7HM/@R5(:_?S+MI8V=
MWK['./+!<"DH :\] :%]*1UG A05%+=@1A^W]@7P890-';^LC)S]D<PJXFG
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M!4'Y=EKQ;I?DT=!-7,N?(J-9-88-+>Z7\^06R_](;K+\N"9?)\Y1;A9-=<I
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M9[5BR7E)F/,6A! HF!12JR$:TK7O^K KNKM.:PF#BO!OP&A33<90P'L7(=G
M9,[&)+'=?'6(0'N_'2 .P< ^0?7#V=[![;KC 8$KUC'D 5AM":>DL."L5A"9
M\$9*$=R]6NF1GN(,]Y:[C7B??I!S"*^[0\N=0D*7N!6AU!&=9#C4+EWDJ28'
M@G,7K996#=S@L^,'.0?)>-\'.8<P?.R2V]W5XR@YEPDS1),T*/)4(3I2OUR3
M$LXJ*.7VJ\4_O@S__(]R#A+;K"D/.U ?N]3JK=^14K).,?([C*=S8K.&4,@M
M< :U]#;Y:)MW?'V,H)$;2PQR!;630 =PVO(J;GV0"Q\,6EDRB%A?IK ZH5%$
M!IE\S3IS4?OFXWT>)*8_2^9(@3]0,'D:]SN T2X6W0V^OUH/ <7Y9)8O2N"D
M=).!DFIPI&@+(1HZBUDJZ]$(P5L7Q!U"7W\ZJPW8!I/1,\#?B^5Z7S]/\X7A
M,DOI%*!-M5,W&G"U04QQR.H#O"CN-= :&GYWR!NY-\]HZ#M60C]$-/-./NIL
MD<P=:YX_BOG4QH>-8 J;(HL*H=:HK[,XL<;K99%T]3IG7=AN:__<(I@V.RFS
M4B!3,+49>*[/2A.8*(NU9/TR<PYEUV\$\Q ,[!_!/(3M/5R?N[IO8K2DA[4#
M<K=)VSNNP$LN06DN23L[M'F(SOU]=;)M).)]^MD>PN\.,;.)SBAIM(S*0BR<
M=L&MAI@*TGE27,A<O.+-4R;/I9_M01+>KY_M(>SN #3WG[OG2.:+T@(B-[G.
MZA,05/0@"FJ>O+.!M78&C^LL<.ZFMP=)]LENAX>PN0.<[$@!!$?[=IQ<4*;(
M(Y7D&7B) IBR=:"CR"'_Z-WMAKF,3N1U=VBYDRHH6:-")L#4 ;+*9#+SHF;@
MM&?H-6-H_VU3:@?)>-^4VB$,'SNE]D CGI"D3CEXT$03*.L-N!PX^-J)WA=O
M2MY_Y.:1[8S.GU0[2'![M#,ZA(L] &%'(YY87ZT'&X%GIT!%^IU/K@ J6Y*L
MG2#O34]LWL[H_"WO3@+"B5SL 0CNQ33OWHDDLRLJI8'(]W3'HH'(8@0RZ(MW
M2CFK]\?#@\OT](RUF7YHPM,.#(W'P^.ZFN22F*)6Q7!8'^%&5Q_AQJ*9UE*8
MUNUE'B6HOU1"@\A),PET *<#'G@KS8+))8!8-5AQ(H%C0M/V@F=1)]2Q=5BE
M\=/[D=+S!T'B^ ?XA\BG ^0]7'B +',9O 9K.&EDX4R=Z6: %+4-VJ+-OG4%
MT6EE'R-EXD_!51ON=YKYO'VR\MAXRJ,2G/M^ND4>\ZAM-$M7WG_ULR ;ZK\P
M?_SNW<^.?!;=H9Q43@#G20<I4U\"F4QN?9UYE52(Q;6?Q7DTN>T>7:]-BUCJ
M5!##(*G:KJ*054$:F(' ()5(3K'<6GMMD3"V?W\>Y#S\]/IP.71P'3[:5+,D
MPXNV"1C3Y,&RP"%(AY 3*65F>12\NR:V9P#8$8(^I('M(5SO"D$[>FJJH!UG
MDBP$S6MW1)3@E360>' JHLY:MN\ ^"P;V!XD]4,:V!XB@@[@]% G55&$)]L2
MLI$:E*W/8)*N%2LY99.2+;;UL[)GU\#V($GOV<#V +8?#9ZO.(^S1O!Y/9OC
MY./TY[_2IUIY]^;+G3EG3F5NZYP)S4J=;11<G7.F@"=A$;63=/0:8^@1<L:.
M@@\$I%8"Z 5-?X9YOF;13>S6,L8%.;\FZMH#0ZY.A:\M"%GP)16#K:LG=U,R
M=LA\. R=RO:Q$RK;^K1Z\YMMF$*,(0,1)+$(%.<:/"<>I2A-X2Q++-OHV9U-
M>7B-L?LU-L9%2XYV" RUV8;VB0M)'BC36 C?6(.H@H$)6J"5WHNXWWSSA]<8
MNP/CF8!Q#$<[L'UO^7,;;74LNFR+!.ERKEL(X#BW@,XZXZ--ZE[NM9T'=5A"
M[0S&2DO7^S@>=P63K;Z1BB6FDY%05"HU/%^?KEDRWE-$KWQ-8P\W+N:(;IUG
M<)..%/*^G3H/X7A7R-G9)Y(IE[(C_2B46HTK<1"P-O#2F4LAC6&V=2^]!ITZ
MSZ!V6J/H9.YW@*678?'I]>7LSQI@QUVAK=7 \<6+Y>LPF?\]7%[AA4PA,HFI
MCM2QH )MSGMCR%A3L7:V,+EY$.=P*GOQJ=I@;F IC6U-DSH.WREDRP*/*@3(
M%@4HX0T$1R>)N1(9*TS:LCW;>[<-O?WE7ERJTV!Q.M.>@^;YC91K+5J8X'?
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MG>'RIO]KD3%HZ5+M+13KFP,+KF0)RA<M&5?*-P?1/2*Z!,XQ MYN]G@2MSN
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M47;?-"RM+0\\CZFP+#X37:E*?>IXJ"94E*8 IJVO1F)LT1-O@*]/1R)'D:$
M;;2(@M8,B:#V#O#%VI(%V'MG !P_(P '(AY,N"H]6U%T19JB0)03Q,5N*/06
MM<06[!MN-]=^'J_H".:TH<*,=.F>MF";_, 7TH+*Y_2/=SPLFA?F?@F*X G8
MX^%& ^P"Y))G!+F*,T,TUU%!^^ZJ</,M&Z'W!4Q)^5S'<6DH]BO)<X/63%N'
MYW2("5TVAJ+J!(?M/=$E!8C!88^D*\.Q71+^R(!.$_)R8=>K8-68VT6E0>SG
M02\2GQ:\/RK*GC$E[X6JS@\>R=?_M(MV">@'.[(/\V>)R7R)U)<D19RY"M,E
M7Q'0OJ#T6"MB%Z9Q%+).&[O(]OX!5&:9=$Z(W\D(D48]0>V)A'U>R1[ # *V
M1/#X2^7T? 6*7TL)\_UJ*_/8'S.\^O]VZR_+\A<*!1H*1@FDT0Z7]LJQ%(!&
ME:D7VYZIX/>4>D/!YI.O+S7]8>?\2.B+ %?M4,+YP@9>XPDZ6K&@M2?!616H
MZ&+H50_6AL__%LG?EAGP 2?YR53I9./AV2Y1WC/<#UT@A:<&M%%'V(5G.@#'
MGTU7"*N'#"CSB58306DPYZ/JB-U4Y"BR0NF90.MTK ,C\L_P"[Q]E1JA^<S?
MZUW!:9X6V0<^>_FB<]@^[=;#.^\UR[^VA=VM+ Q&;>-&GQ//G-^(5JT15K$P
M#=BJ>&%%?_[C%/FO4'S6E[D?T7<ZK71%VCF=D;K3"2515%_5*VB_+D-S]3[^
MY*1YU#ZB5_+.X'\R'[AZ6]_T;^M;+EEOVS]NGK2?;FXW.T^V?26U+6]R,!N.
ML07/7]=ZM7F':OGUN\4#ZVQZ%?_8.\$QWQ[([0"3?2Q,?PV(6;^NO\!>H*IR
MU>]XH<U\GMO*<Q7J_-(NX DZKV-S%SQ7MZY]]^#=^LU\]L]RR^58BI2]7?#]
M;:BP_Y1O6IZ$-E#<HP^!"AV^A.J'0^.)6/LT:(E#3V3M91<> 8RE>[K+4]_;
M//F=474-7SWY[Z_._P=02P,$%     @ @3ZB5HR0:H!;!0  GA,  !4   !H
M;VQX7W$R+3(P,C-E>#,R,2YH=&W=6.MSVC@0_WY_Q9;,I70&/R$0'LT,,4[P
M# &*G4O[Z4;8(FAJ;%<6(?2OOY4,:1)"KYUK+KGC@P=[']K'3[LK==[T1D[P
M:>S"7"QB&%^>#CP'2IIA7%4=P^@%/>@'%P.HZ:8% 2=)S@1+$Q(;ACLL06DN
M1-8RC-5JI:^J>LJOC6!B2%4U(T[3G.J1B$HG'?D%GY1$)[]UWF@:]-)PN:")
M@)!3(F@$RYPEUW 5T?PS:-J&RTFS-6?7<P&V:5?A*N6?V0TIZ(*)F)YL]72,
MXKUCJ$4ZTS1:GW0B=@,L>E]BLRBJ'D?AD56?F36K;DUK-5*E==*,PC"L-<P_
M+3320/9")A?KF+XO+5BBS:E<OU6S]<91)MHK%HEYRS+-WTN*]:0S2Q.!ZW&4
M+_X6:G:4"7HK-!*SZZ2E7"H5HEMRF,8I;QV8ZM>6%&U&%BQ>M]X&;$%S&-(5
M3-(%2=Y6<DR#EE/.9@5CSKY2M G-4Z^KPN0&ZHE90K<N6+8TVKV=LRD34+5U
MZZ'%]QTG_!I]%VF&4JCVGNTA!IOR%S+>H5RP&0N)Q.!>ZU^+M>,ESY<$UQ4I
M^#24-A\>6'6SW33KD,Y S"GXA$])0G-M=!O3-71#(2FV:=JOWKVROYSFA5LY
ME,F[PC>21%">;E[0E0>.6]4CLP+.G&1H-M2KTM= [ENPCBMPF3!9"7R!!2''
MO1_1=S^'4)9$&)"675-[]=G#4GLR+%X%/:#9G"8PUN&"A!<LCDDBW69T!NXM
M#9>"W5 8S1#)& :,01]MNV9A!;PDU"M H$=CLB*<0ICR+.4*[U"6@#D\.+9M
ML^VDBXPD:_5FM=]5($IA3CF=KB%4FV1=@>P?X0_*^?/GMX)&$'%X<'3<_N%4
M9R2*L%=H,9W)'.A'C]*O6<<OEORR=0?9?W_YAY&IZ]6:C$. 6?ZP)!PS$J]A
M0A%.F.,$SE*^ ,O4/L LY0H+7PHNH!C'"+H99_$FK96B_]X'X)WX%H);1&V0
M";-EC.N%^!8S]'#%Q%S1.?VR9)S*IIW#+H 0:(#V6$?EZ$XELBPYSAVHQKT-
MYR2YIEND6LUJ#>'3; ,"\_\!(?M50H@E")-%48A"U$)0,L*O*D'WL$28A%G&
M:2X37)$<)(X!)=$>$F/Z\PPSGE>4X(PE) GE=]09J=%2)E)R+>,"'VE&B_J7
M/T*8OI/N7QTQ^X<25B#W1[!7-"5!IE@0-]1IRB/*-;0U)EE.6]L_[8CE64S6
M+9:H%950>Z-KF@J1+J2Z]HTL]B&)-P.! G%!WHRJS:;>,!MR6A4XHHIHN_!F
MD-75(&N(:)=6.]:;YGZRJ5M[:;](K:%,+LS&P.28]?>E:FDKL,%JR\YNP7HX
MI4KX[L0FS4K/ I._W5C*W9X\YJA.AT/!N@"-71361R>'35A^SN-B%'S:YY=P
M]_"@UFCGZEGXNOM\:DS:Q[OO>1>ZG\"+*6-7^FZ@-]M2-8P,8Y?&+()MT%YE
M%G9F=)6%IT+\3"'[#T4%!U2&O0QG\C$V&B9;ONHZ>R;TW8 9JAQ_O]@W7FR"
MZ(+OG0_='HPFWKDW[ Y@= 9!W_/A:N(%@3L$/^@&[H4[#&#B?KCT)LA[^@E\
MUPF\T1#D\4!)N.!W)Z?=H>MKHX\#]Q-TG4!2U/&@W_7AU$5EX\GH#Z^'*H(1
M]$>#T;GGX$%FZ.C0'?;@RAL,D \7"KK>L%AHE^OL<C+T_'ZA1"WL.I=HK.?Z
MBNY^=/K=X;D+SNCBPO-]:>9H E[@2U_.SN!RC%^D,ZX?[ X&VPP\NLS)TN(V
MJ\7QN"4SOG.]\ZT>J(YK?A,A4RP*2[%?9-\Q?>]=T>99W%RI.[23OP!02P,$
M%     @ @3ZB5A9(F>M"!0  7!,  !4   !H;VQX7W$R+3(P,C-E>#,R,BYH
M=&W=6&USVC@0_GZ_8DOF4CJ#7S$AO#0SQ#C!<P12[%S:3S?"%D%38[NR".%^
M_:UD2)-P]-JYMLD='SS(JUWM/OMHM5;W57_LAA\N/9B+10*75Z=#WX6*9AC7
M==<P^F$?!N'%$!S=M"#D)"V88%E*$L/P1A6HS(7(VX:Q6JWT55W/^(T13@QI
MRC&2+"NH'HNX<M*5;_!)27SR2_>5ID$_BY8+F@J(."6"QK L6'H#US$M/H*F
M;6:Y6;[F[&8NP#;M.EQG_".[):5<,)'0DZV=KE&.NX9:I#O-XO5)-V:WP.*W
M%=:RK6GD-&VS$9E.1"BI-^AQDSI.:]9P8K/QAX5.&CB]U"G$.J%O*PN6:G,J
MUV\[MMYLY**S8K&8MRW3_+6BIIYT9UDJ<#V.^N7?TLR.,4'OA$82=I.V54B5
M4G4KCK(DX^T#4_TZ4J+-R((EZ_;KD"UH 2.Z@DFV(.GK6H%IT K*V:R<6+ _
M*?J$[JGAJG2YB782EM)M")8MG?;NYFS*!-1MW7[L\</ ";_!V$66HQ::?>![
MA&!3_DS.NY0+-F,1D1S<Z_U+\?9RR8LEP75%!@&-I,^'!]:1V6F91Y#-0,PI
M!(1/24H+;7R7T#7T(B$EMFGN3\Y+":\:+*=%&58!5?*FC(VD,52GFP&&\BAP
MJ]XP:^#.28YNPU%=QAK*?0O6<0VN4B8K02"P(!2X]V/ZYML8RM(8 6G;CMJK
M/QP6YV]A\6OP&^$)I2E<Z#">(F6S5 ;-Z S.6$K2B)$$QC/D,8* " S0LQL6
MU<!/([T&!/HT(2O"*409SS.NV Y529?#@V/;-CMNMLA)NE8CJ_.F!G$&<\KI
M= V1VB+K&N3_BGU0+7Y\=FOH!!&'!XWCSE<G.B=QC">%EM"9S(#>>))\S3I^
MMM17K7O"_OSE'R-SI-<=B4.(67ZW)!PSDJQA0I%.F.,4SC*^ ,O4WL$LXXH+
MG\I90!''&'HY9\DFK;7R]'U(P'OU+06WC-HP$V;+!->+<)0PC'#%Q%S).?VT
M9)S*([N 70(AT0#]L1K5^-XD3EER[#K0C'<7S4EZ0[=,M5IU!^G3Z@ 2\_]!
M(?M%4HBE2)-%68@BM$)0,\:W*D$/N$28I%G.:2$37),S2)( :J(_6/50D&/&
MBYI2G-U70[09J\92)E+.6B8E/[*<EO6O>,(P?2?=WQLQ^ZL25C+W:[A7'DF"
M3+$@;J33C,>4:^AK0O*"MK=_.C$K\H2LVRQ5*RJESL;6-!,B6TASG5M9[".2
M;-H!1>)2O&E46RV]:39EKRJP017Q=N%-&ZNK-M80\:[,.=9;YGZQJ5M[9=_)
MK*%<+MU&8 K,^MM*O;)5V'"U;>=W8#WN425]GV)3PE+Y(4SYQ[VE(N[+[QQU
MV,$%69>\L<O:^N3388/,MP5=]H)[PWZ.B \/G&:G4,\RW-WG;JMTC\4W<,"4
M8%2^B-QFJZE#($<DLH3%L(7@I<*ZTW@K6'\:9O\M6/9TV+O8&*J<?KE8-Y^M
M ^A!X)^/O#Z,)_ZY/^H-87P&X< /X'KBAZ$W@B#LA=Z%-PIAXKV[\B<X]_0#
M!)X;^N,1R/9>:7@0]":GO9$7:./W0^\#]-Q02E1[/^@%<.JAL<O)^'>_CR;"
M,0S&P_&Y[^*'R,C5H3?JP[4_'.(\7"CL^:-RH=U99U>3D1\,2B-J8<^]0F=]
M+U!R[[T[Z(W./7#'%Q=^$$@WQQ/PPT#&<G8&5Y?X1@;C!>'NP;[-P).KF#PK
M[Z+:'#^7!+NE.Y<SG_>^.C'-SRIDB@5@*?:K[/O(WGO3LWF6]T[J!NSD+U!+
M 0(4 Q0    ( ($^HE9/RG&YN,D" /> )P 1              "  0    !H
M;VQX+3(P,C,P-# Q+FAT;5!+ 0(4 Q0    ( ($^HE97ZF+>7!,  %'C   1
M              "  >?) @!H;VQX+3(P,C,P-# Q+GAS9%!+ 0(4 Q0    (
M ($^HE:5)$X?J1X  *4F 0 5              "  7+= @!H;VQX+3(P,C,P
M-# Q7V-A;"YX;6Q02P$"% ,4    " "!/J)64G0WKE]7  !3L0, %0
M        @ %._ ( :&]L>"TR,#(S,#0P,5]D968N>&UL4$L! A0#%     @
M@3ZB5F^\8)6][    [,) !4              ( !X%,# &AO;'@M,C R,S T
M,#%?;&%B+GAM;%!+ 0(4 Q0    ( ($^HE;B330!$I4  %V"!@ 5
M      "  =! ! !H;VQX+3(P,C,P-# Q7W!R92YX;6Q02P$"% ,4    " "!
M/J)6]2:'7@@(   ?)@  %0              @ $5U@0 :&]L>%]Q,BTR,#(S
M97@S,3$N:'1M4$L! A0#%     @ @3ZB5L*P1O/K!P  VB4  !4
M     ( !4-X$ &AO;'A?<3(M,C R,V5X,S$R+FAT;5!+ 0(4 Q0    ( ($^
MHE:,D&J 6P4  )X3   5              "  6[F! !H;VQX7W$R+3(P,C-E
M>#,R,2YH=&U02P$"% ,4    " "!/J)6%DB9ZT(%  !<$P  %0
M    @ '\ZP0 :&]L>%]Q,BTR,#(S97@S,C(N:'1M4$L%!@     *  H E@(
' ''Q!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
